data_2lbu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lbu _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.977 0.418 . . . . 10.0 110.367 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -113.7 111.01 21.11 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.605 -0.887 . . . . 10.0 108.605 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.06 144.85 50.28 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.052 0.76 . . . . 10.0 113.052 -178.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.41 151.73 47.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.106 -0.952 . . . . 10.0 108.683 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -102.75 -61.24 1.42 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.031 0.752 . . . . 10.0 113.031 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -131.79 117.24 18.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.06 0.457 . . . . 10.0 111.882 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 56.0 mt -124.05 136.96 58.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.561 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.3 ptp85 -126.29 105.21 8.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.099 0.476 . . . . 10.0 111.662 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.21 120.33 39.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.011 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -132.46 140.45 48.4 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.405 0.52 . . . . 10.0 112.405 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 65.61 86.01 0.13 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.162 -0.926 . . . . 10.0 113.231 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 96.7 mtm-85 50.66 35.17 11.12 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.361 -0.836 . . . . 10.0 112.738 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.59 146.95 25.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.69 -0.232 . . . . 10.0 110.45 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -124.83 159.29 31.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.562 -0.29 . . . . 10.0 110.413 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.4 p -142.73 126.32 14.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.857 0.36 . . . . 10.0 111.218 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -118.96 139.57 51.45 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.817 -0.438 . . . . 10.0 109.817 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.13 119.43 26.48 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.095 -0.335 . . . . 10.0 110.095 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 152.31 -108.05 0.36 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.751 -0.737 . . . . 10.0 111.967 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -153.85 158.98 41.63 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.864 -0.421 . . . . 10.0 109.864 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 18.1 t -110.88 113.19 43.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.126 0.489 . . . . 10.0 112.233 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 57.9 t -101.5 114.22 40.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 5.0 m -106.28 141.79 37.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.241 -0.436 . . . . 10.0 109.933 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.54 -18.15 27.2 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.539 0.57 . . . . 10.0 112.539 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -73.26 -23.49 60.34 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.287 -0.415 . . . . 10.0 111.353 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -110.26 46.19 1.06 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.199 0.523 . . . . 10.0 110.597 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 2.2 mm? 66.36 -155.33 0.24 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.254 -0.884 . . . . 10.0 112.112 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -89.46 -175.64 4.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.147 -0.478 . . . . 10.0 110.849 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -76.06 77.91 1.29 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.079 -0.582 . . . . 10.0 112.463 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -67.78 -43.63 83.35 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.26 -0.495 . . . . 10.0 112.086 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 1.3 mp 69.4 136.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 112.779 0.659 . . . . 10.0 112.779 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? 65.83 89.57 0.1 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.499 -0.773 . . . . 10.0 111.977 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 3.5 mp -129.91 -55.38 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.127 -0.488 . . . . 10.0 111.462 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 5.6 p -105.87 -87.91 0.45 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.631 0.604 . . . . 10.0 112.631 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.25 42.95 17.62 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.76 -0.655 . . . . 10.0 111.634 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -84.45 -21.84 30.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.821 -0.627 . . . . 10.0 111.748 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 6.6 t -131.97 143.29 49.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.903 0.382 . . . . 10.0 111.119 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.06 144.12 27.02 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.757 -0.656 . . . . 10.0 109.85 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -122.06 122.96 40.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.818 0.342 . . . . 10.0 110.449 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.92 134.49 31.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.156 -0.474 . . . . 10.0 110.894 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.8 p -131.43 137.78 54.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.072 0.463 . . . . 10.0 111.342 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -77.85 -79.25 0.12 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.862 -0.608 . . . . 10.0 112.344 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.4 p -120.82 128.58 52.99 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.978 0.733 . . . . 10.0 112.978 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 4.2 t -119.31 127.18 75.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.852 -0.613 . . . . 10.0 109.817 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 24.8 t -114.73 120.04 63.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.459 -0.337 . . . . 10.0 110.415 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.23 107.66 0.83 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.892 -0.671 . . . . 10.0 111.714 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -126.36 148.23 49.62 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.428 -0.212 . . . . 10.0 110.428 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 76.84 58.96 3.32 Favored Glycine 0 C--O 1.226 -0.356 0 C-N-CA 120.797 -0.716 . . . . 10.0 113.47 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 62.15 21.29 12.32 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.923 0.712 . . . . 10.0 112.923 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 70.0 m -73.17 139.13 46.12 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.997 0.427 . . . . 10.0 111.202 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 12.5 mtt180 -104.57 123.45 47.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 10.0 111.393 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 46.0 t -102.15 117.32 47.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.087 -0.506 . . . . 10.0 109.912 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.41 114.12 21.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.867 0.365 . . . . 10.0 111.511 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 25.9 mm -107.8 103.02 14.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.842 -0.617 . . . . 10.0 109.693 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.34 142.04 3.91 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.792 -0.718 . . . . 10.0 111.908 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -61.85 149.71 39.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.933 0.397 . . . . 10.0 111.683 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.53 158.17 18.27 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.132 -0.485 . . . . 10.0 111.543 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -140.09 101.36 4.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.326 -0.852 . . . . 10.0 109.1 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -150.87 -115.37 0.7 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.517 -0.849 . . . . 10.0 113.055 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 146.6 -60.79 0.47 Allowed Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.225 -0.75 . . . . 10.0 111.225 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -79.9 85.37 5.55 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.009 -0.738 . . . . 10.0 109.009 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.45 105.43 2.07 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.67 -0.972 . . . . 10.0 110.67 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -75.71 76.24 2.69 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.402 -0.221 . . . . 10.0 110.402 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 18.2 t90 69.38 -58.4 0.51 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.9 -0.591 . . . . 10.0 112.098 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -135.21 90.53 2.63 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.064 -0.717 . . . . 10.0 109.064 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -150.34 119.79 6.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.781 0.324 . . . . 10.0 111.631 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -157.93 55.25 0.47 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.398 0.618 . . . . 10.0 109.972 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -105.5 121.56 44.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.644 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -123.24 2.36 9.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.16 0.505 . . . . 10.0 110.797 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -84.01 116.19 22.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.521 -0.763 . . . . 10.0 109.974 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -89.41 127.26 35.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.133 0.492 . . . . 10.0 111.081 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 1.1 p80 . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.355 -0.831 . . . . 10.0 110.711 179.489 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.201 -0.296 . . . . 10.0 110.201 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -119.13 114.04 21.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.538 -0.542 . . . . 10.0 109.538 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 3.4 m -129.3 134.1 47.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.011 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.71 143.38 50.7 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.695 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -89.99 -79.57 0.34 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.344 -0.389 . . . . 10.0 111.723 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . 0.435 ' CG ' HH21 ' B' ' 232' ' ' ARG . 18.8 t70 -122.56 126.08 47.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.311 0.577 . . . . 10.0 112.498 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 65.6 mt -122.76 114.66 43.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.563 -0.744 . . . . 10.0 109.053 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . 0.435 HH21 ' CG ' ' B' ' 230' ' ' ASP . 1.7 ttm180 -109.87 106.78 16.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.926 0.393 . . . . 10.0 110.66 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.08 128.69 55.0 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.13 -0.486 . . . . 10.0 111.106 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -141.26 168.23 20.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.535 -0.302 . . . . 10.0 111.373 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 65.34 62.65 0.68 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.89 -0.595 . . . . 10.0 111.777 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 81.8 mtm-85 57.05 44.91 21.88 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.924 -0.58 . . . . 10.0 112.227 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.08 163.43 14.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.865 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.09 122.31 22.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.097 0.475 . . . . 10.0 110.362 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 p -115.86 125.61 73.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.312 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -119.79 128.24 53.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.849 -0.614 . . . . 10.0 111.089 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.35 97.51 6.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.027 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 156.18 169.15 20.03 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.909 -0.663 . . . . 10.0 112.186 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -87.95 137.86 31.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.831 0.348 . . . . 10.0 110.84 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 94.0 t -91.16 123.28 43.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.969 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 17.7 t -121.96 102.29 11.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.41 0.624 . . . . 10.0 110.493 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 68.4 p -81.57 162.8 23.0 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.661 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.95 -14.15 32.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.104 0.478 . . . . 10.0 111.254 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -75.95 -14.83 60.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.692 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -95.44 -2.16 49.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 10.0 111.111 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 87.9 mt -76.17 140.35 41.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.334 -0.394 . . . . 10.0 110.385 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 65.97 28.51 10.51 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 123.597 0.56 . . . . 10.0 110.862 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -131.11 174.22 20.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.055 -0.593 . . . . 10.0 111.714 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -83.08 115.83 4.1 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.131 -0.557 . . . . 10.0 112.478 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 29.5 pt -109.71 17.97 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.026 0.441 . . . . 10.0 111.672 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 255' ' ' ARG . . . . . 0.445 HH12 ' CG ' ' B' ' 258' ' ' ASP . 0.0 OUTLIER -129.03 103.82 7.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.27 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 20.1 pt -132.18 35.73 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 111.866 0.321 . . . . 10.0 111.866 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 62.3 m 64.29 33.53 11.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.326 0.584 . . . . 10.0 111.466 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . 0.445 ' CG ' HH12 ' B' ' 255' ' ' ARG . 0.7 OUTLIER -77.79 71.43 4.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.465 -0.789 . . . . 10.0 111.902 -179.582 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -96.15 113.8 25.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.024 -0.535 . . . . 10.0 109.777 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 14.7 t -158.82 141.76 14.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.551 0.691 . . . . 10.0 111.961 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.14 95.96 5.92 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.298 -0.864 . . . . 10.0 108.813 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -91.37 132.21 36.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.386 -0.37 . . . . 10.0 110.66 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.9 p -145.52 136.05 24.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.656 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 8.0 p -124.56 131.53 72.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.884 -0.598 . . . . 10.0 110.103 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -73.14 -62.74 1.36 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.333 0.494 . . . . 10.0 112.333 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 24.8 m -135.46 124.44 24.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.147 0.499 . . . . 10.0 112.087 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 20.7 t -111.33 118.95 58.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.736 -0.665 . . . . 10.0 109.356 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 39.9 t -103.88 116.73 48.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.904 0.383 . . . . 10.0 110.829 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.75 113.34 2.35 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.395 -0.682 . . . . 10.0 111.395 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 2.4 ttpp -128.76 131.05 47.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.665 0.269 . . . . 10.0 111.456 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.47 71.94 1.2 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.571 -0.823 . . . . 10.0 113.479 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 53.05 43.8 31.22 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.386 0.884 . . . . 10.0 113.386 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.61 149.73 34.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.236 0.541 . . . . 10.0 111.552 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -120.0 118.7 31.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.652 -0.704 . . . . 10.0 110.024 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 47.4 t -110.11 127.17 67.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.138 -0.483 . . . . 10.0 111.062 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.83 109.61 13.84 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.857 -0.423 . . . . 10.0 109.857 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 36.4 mm -102.25 100.37 10.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.993 -0.373 . . . . 10.0 109.993 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.41 176.54 19.45 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.685 -0.566 . . . . 10.0 111.685 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -97.99 156.63 16.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.9 0.35 . . . . 10.0 110.576 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -128.83 161.47 29.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.912 0.386 . . . . 10.0 111.422 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -134.33 127.04 30.92 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.546 -0.752 . . . . 10.0 109.852 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 167.74 152.34 7.47 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.774 -0.727 . . . . 10.0 112.04 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -123.97 8.38 8.64 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.509 -0.853 . . . . 10.0 111.982 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -97.67 15.17 24.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.055 0.455 . . . . 10.0 110.863 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 156.93 -176.44 34.19 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.218 -0.753 . . . . 10.0 111.218 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -127.29 64.09 1.33 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.389 -0.597 . . . . 10.0 109.389 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 17.3 t90 70.46 -54.21 0.64 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.948 0.78 . . . . 10.0 111.42 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 288' ' ' ASP . . . . . 0.446 ' CG ' HH11 ' C' ' 238' ' ' ARG . 3.0 t70 -109.13 -168.52 1.35 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.688 -0.687 . . . . 10.0 109.617 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -111.42 132.71 54.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.058 0.456 . . . . 10.0 111.689 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.41 125.08 6.44 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.91 143.4 12.62 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.121 -0.326 . . . . 10.0 110.121 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -173.69 -161.99 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.398 -0.364 . . . . 10.0 110.462 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -122.41 149.0 44.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.613 -0.267 . . . . 10.0 111.105 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -83.85 -179.16 7.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.709 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 . . . . . 0 C--O 1.252 1.186 0 CA-C-O 117.909 -1.044 . . . . 10.0 108.852 -179.699 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 1.7 ptt-85 . . . . . 0 N--CA 1.483 1.175 0 N-CA-C 110.21 -0.293 . . . . 10.0 110.21 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -131.26 129.06 41.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.349 . . . . 10.0 110.661 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.07 135.46 45.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.166 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.12 138.33 45.16 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.964 -0.384 . . . . 10.0 109.964 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 18.6 tttm -94.2 -78.65 0.43 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.07 0.396 . . . . 10.0 112.07 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -109.81 116.25 31.32 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.301 0.482 . . . . 10.0 112.301 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 63.4 mt -123.93 117.45 51.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.087 -0.506 . . . . 10.0 110.101 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -109.26 120.69 43.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.888 0.375 . . . . 10.0 111.074 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.96 112.85 16.41 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.907 -0.775 . . . . 10.0 108.907 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -138.08 161.07 37.72 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.347 0.499 . . . . 10.0 112.347 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 64.73 69.89 0.49 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.883 -1.053 . . . . 10.0 110.943 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 55.58 63.14 2.16 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.845 -1.071 . . . . 10.0 110.449 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -118.47 167.67 11.38 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.766 -0.652 . . . . 10.0 110.442 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . 0.446 HH11 ' CG ' ' B' ' 288' ' ' ASP . 0.0 OUTLIER -153.24 141.6 20.64 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.602 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 5.7 p -125.13 132.81 70.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.499 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -106.72 122.62 46.72 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.592 -0.731 . . . . 10.0 109.122 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.62 69.72 0.7 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.519 -0.309 . . . . 10.0 111.442 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 175.51 -169.5 42.29 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.409 -0.901 . . . . 10.0 112.228 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -95.66 144.93 25.67 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.265 -0.272 . . . . 10.0 110.265 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.96 105.99 19.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.295 -0.411 . . . . 10.0 110.363 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.66 118.71 53.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.254 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 246' ' ' THR . . . . . 0.413 ' C ' ' H ' ' C' ' 248' ' ' ALA . 32.2 p -76.98 163.86 26.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.069 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -72.89 16.05 0.17 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.685 0.624 . . . . 10.0 112.685 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . 0.413 ' H ' ' C ' ' C' ' 246' ' ' THR . . . -121.39 0.67 10.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.067 0.461 . . . . 10.0 109.921 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -109.71 67.14 0.64 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.143 0.497 . . . . 10.0 110.576 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.31 25.84 9.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.059 -0.519 . . . . 10.0 111.295 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -113.99 67.76 0.68 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.36 0.6 . . . . 10.0 111.559 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -140.08 143.04 13.15 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.942 -0.863 . . . . 10.0 110.942 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -95.57 -145.8 19.6 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.113 -1.041 . . . . 10.0 111.833 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 6.9 tp -132.52 110.55 16.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.255 0.55 . . . . 10.0 110.475 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 42.6 ttt85 -158.26 140.5 14.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.782 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 9.6 tt -102.93 134.95 42.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 121.448 0.642 . . . . 10.0 111.587 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 57.9 m -159.73 -170.74 3.01 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.526 -0.761 . . . . 10.0 109.16 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.1 155.42 36.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.789 0.328 . . . . 10.0 111.419 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.02 132.84 12.32 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.247 -0.649 . . . . 10.0 109.247 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 3.7 t -68.39 154.14 42.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.328 0.585 . . . . 10.0 112.043 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 52.8 m -123.44 120.61 33.46 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.451 -0.795 . . . . 10.0 110.23 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -107.64 125.98 52.01 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.113 -0.699 . . . . 10.0 109.113 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 13.4 m -136.37 131.72 34.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.016 0.436 . . . . 10.0 110.87 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 6.9 p -118.77 139.19 46.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.335 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -74.75 -58.59 3.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.199 -0.455 . . . . 10.0 112.046 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 2.7 m -136.51 133.98 37.08 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.386 0.513 . . . . 10.0 112.386 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 24.9 t -123.73 116.72 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.469 -0.937 . . . . 10.0 108.469 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 6.5 t -113.9 108.74 26.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 120.94 0.4 . . . . 10.0 110.906 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.55 125.02 6.17 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.907 -0.877 . . . . 10.0 110.907 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -133.22 117.77 17.8 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.933 0.345 . . . . 10.0 111.933 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 90.33 91.39 1.27 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.885 -0.674 . . . . 10.0 113.122 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 59.25 36.24 23.63 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.94 0.4 . . . . 10.0 111.688 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.85 145.67 42.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.837 -0.62 . . . . 10.0 112.447 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -139.14 109.58 6.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.714 -0.675 . . . . 10.0 110.483 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.68 132.74 48.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.052 -0.522 . . . . 10.0 110.651 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.75 106.31 11.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.685 0.278 . . . . 10.0 110.812 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 23.2 mm -101.69 85.98 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.312 0.577 . . . . 10.0 110.063 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 160.83 -170.33 36.69 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.541 -0.754 . . . . 10.0 111.219 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -102.67 154.94 18.66 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.202 -0.587 . . . . 10.0 110.967 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -108.4 142.67 38.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.321 -0.399 . . . . 10.0 110.407 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.34 97.09 3.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.157 -0.474 . . . . 10.0 109.728 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . -145.96 158.87 27.82 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.861 -0.685 . . . . 10.0 112.781 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -106.5 -15.07 18.25 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.706 -0.759 . . . . 10.0 112.51 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -74.17 -38.59 63.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.275 0.56 . . . . 10.0 110.285 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 170.65 -112.39 0.45 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.147 -1.181 . . . . 10.0 110.147 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -126.08 -169.9 2.09 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.72 -0.474 . . . . 10.0 109.72 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -57.97 -24.3 57.48 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.272 0.558 . . . . 10.0 111.545 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -110.72 157.08 20.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.943 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -133.85 19.84 3.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.151 0.5 . . . . 10.0 111.307 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -81.15 -10.13 59.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.706 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.52 168.37 22.1 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.305 0.483 . . . . 10.0 112.305 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 66.51 174.04 0.24 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.5 -0.773 . . . . 10.0 112.646 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 N-CA-C 112.351 0.5 . . . . 10.0 112.351 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 7.5 m120 . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 120.634 0.254 . . . . 10.0 110.995 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 1.8 m -146.42 153.46 40.5 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.277 -0.42 . . . . 10.0 110.764 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.29 148.74 46.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.624 0.249 . . . . 10.0 110.922 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -89.67 -77.78 0.38 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.393 -0.367 . . . . 10.0 111.045 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -125.13 120.18 30.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.923 0.392 . . . . 10.0 110.913 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 62.1 mt -118.69 124.28 72.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.908 -0.587 . . . . 10.0 110.541 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 6.1 mtm105 -108.5 127.87 54.3 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.882 -0.599 . . . . 10.0 109.786 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.77 111.56 11.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.356 -0.384 . . . . 10.0 110.079 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -124.57 154.56 40.46 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.68 0.622 . . . . 10.0 112.68 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 58.15 78.42 0.25 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 114.996 -1.002 . . . . 10.0 113.365 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 52.82 50.62 17.65 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.237 -0.892 . . . . 10.0 111.783 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.97 154.86 19.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.187 -0.461 . . . . 10.0 110.423 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.05 144.68 43.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.885 0.374 . . . . 10.0 110.912 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.96 131.26 71.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.556 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -113.28 121.7 45.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.353 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -116.06 93.49 4.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.941 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 174.64 -120.2 0.77 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.229 -0.986 . . . . 10.0 112.791 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -152.56 152.95 32.47 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.734 -0.469 . . . . 10.0 109.734 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 22.6 t -97.12 106.37 18.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.163 -0.471 . . . . 10.0 111.873 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.16 93.48 2.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.278 -0.638 . . . . 10.0 109.278 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 246' ' ' THR . . . . . 0.405 ' C ' ' H ' ' D' ' 248' ' ' ALA . 41.6 p -74.16 153.54 39.47 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.821 -0.351 . . . . 10.0 110.387 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.29 11.63 0.72 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.826 0.346 . . . . 10.0 111.731 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . 0.405 ' H ' ' C ' ' D' ' 246' ' ' THR . . . -95.7 -3.99 45.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.25 0.548 . . . . 10.0 109.653 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -99.61 137.13 38.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.692 -0.686 . . . . 10.0 110.168 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 6.9 tp -118.24 -157.38 0.68 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.626 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -91.15 63.88 5.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.038 0.447 . . . . 10.0 111.338 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -132.28 36.67 2.15 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 111.063 -0.815 . . . . 10.0 111.063 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 107.52 52.35 0.72 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.418 -0.673 . . . . 10.0 111.418 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 20.1 tt -87.48 -20.89 7.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.953 0.406 . . . . 10.0 110.87 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -83.97 70.18 10.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.02 0.438 . . . . 10.0 110.794 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 18.1 tt -64.25 -30.2 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.751 -0.659 . . . . 10.0 111.851 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 7.3 m 66.18 -172.8 0.19 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.924 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.92 93.94 6.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.911 0.386 . . . . 10.0 110.557 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -94.59 -44.05 8.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.12 -0.491 . . . . 10.0 111.431 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 10.3 t -123.25 150.36 43.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.921 0.391 . . . . 10.0 111.003 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 5.5 m -104.46 103.69 13.43 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.415 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -102.64 110.23 22.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.206 -0.452 . . . . 10.0 109.869 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 25.8 m -124.81 131.9 53.4 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.942 0.401 . . . . 10.0 111.047 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 11.3 p -126.95 138.13 55.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.141 -0.481 . . . . 10.0 110.375 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -86.55 -73.02 0.48 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.784 0.661 . . . . 10.0 112.784 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.55 125.8 52.23 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.716 0.635 . . . . 10.0 112.716 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 4.2 t -127.82 113.88 32.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.247 -0.649 . . . . 10.0 109.247 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 42.0 t -116.2 113.1 42.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 120.685 0.279 . . . . 10.0 110.976 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.55 137.09 9.44 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.001 -0.619 . . . . 10.0 112.11 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.23 135.8 19.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.638 -0.331 . . . . 10.0 111.122 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.63 89.75 0.23 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.15 -0.547 . . . . 10.0 112.861 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 59.48 38.31 22.61 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.033 0.444 . . . . 10.0 111.444 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 1.5 t -87.56 143.99 26.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.086 -0.506 . . . . 10.0 111.358 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 72.0 mtt85 -131.5 110.53 11.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.408 -0.815 . . . . 10.0 109.712 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 36.2 t -101.33 105.35 17.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.994 -0.373 . . . . 10.0 109.994 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -107.42 103.59 12.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.929 0.395 . . . . 10.0 110.628 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 42.9 mm -105.03 96.81 4.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.216 -0.447 . . . . 10.0 109.819 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 158.28 178.84 32.69 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.508 -0.637 . . . . 10.0 111.508 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -96.0 156.95 16.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.61 0.243 . . . . 10.0 110.395 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -118.44 131.23 56.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.843 0.354 . . . . 10.0 110.926 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -122.01 123.23 41.14 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.045 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 155.53 178.68 30.0 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.378 -0.915 . . . . 10.0 112.796 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -108.59 32.77 6.68 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.945 -0.645 . . . . 10.0 112.156 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.19 -9.15 59.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.897 0.379 . . . . 10.0 110.748 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.25 -51.51 1.41 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.076 -0.583 . . . . 10.0 111.709 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -171.42 145.95 2.19 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.831 -0.803 . . . . 10.0 108.831 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -56.07 -64.06 0.98 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.041 0.448 . . . . 10.0 110.383 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -136.29 132.33 35.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.3 0.572 . . . . 10.0 110.473 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -171.85 146.64 2.08 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -69.57 -58.96 3.3 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.849 0.685 . . . . 10.0 112.849 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -161.08 -163.04 0.97 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.826 0.306 . . . . 10.0 111.826 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -86.06 -170.49 3.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.891 -0.595 . . . . 10.0 109.819 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -72.76 117.78 14.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.012 0.434 . . . . 10.0 110.987 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -99.07 148.11 24.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.86 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 117.764 -1.112 . . . . 10.0 108.392 178.888 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 110.283 -0.265 . . . . 10.0 110.283 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -128.5 121.33 28.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.369 . . . . 10.0 110.998 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.0 144.46 49.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.718 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -139.62 125.83 20.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.29 -0.413 . . . . 10.0 109.938 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -84.0 -62.59 1.53 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.05 0.759 . . . . 10.0 113.05 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -130.85 125.4 33.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.779 0.323 . . . . 10.0 111.142 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 86.5 mt -133.59 123.97 47.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.042 -0.526 . . . . 10.0 110.306 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -122.23 120.35 33.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.143 -0.481 . . . . 10.0 110.538 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 1.2 p -130.45 93.78 3.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.518 -0.764 . . . . 10.0 110.295 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -119.29 152.11 37.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.334 -0.393 . . . . 10.0 111.0 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 70.72 77.22 0.19 Allowed 'General case' 0 C--O 1.236 0.362 0 O-C-N 123.912 0.757 . . . . 10.0 112.335 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 33.1 mtp180 60.67 24.43 14.23 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.078 -0.965 . . . . 10.0 112.246 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -103.47 150.93 23.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.197 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.55 164.57 30.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.201 -0.454 . . . . 10.0 111.777 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 7.7 p -134.63 142.58 40.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.767 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 25.5 tm0? -129.89 131.44 46.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.796 -0.638 . . . . 10.0 109.313 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.98 95.35 4.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.075 0.464 . . . . 10.0 111.786 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 166.32 170.76 31.64 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.435 -0.666 . . . . 10.0 111.435 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -88.14 147.59 24.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.827 0.346 . . . . 10.0 110.924 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.15 125.15 49.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.561 -0.533 . . . . 10.0 109.561 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.9 98.51 7.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.002 0.43 . . . . 10.0 109.86 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.7 t -60.93 161.92 7.62 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.729 -0.669 . . . . 10.0 111.578 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.09 -19.38 64.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.29 -0.414 . . . . 10.0 111.805 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -74.49 -23.47 58.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.536 -0.302 . . . . 10.0 110.242 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 58.07 -170.28 0.11 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.384 -0.826 . . . . 10.0 112.199 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 6.8 mp -83.99 115.66 22.44 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.234 -0.654 . . . . 10.0 109.234 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 . . . . . 0 C--N 1.325 -0.459 0 N-CA-C 112.019 0.378 . . . . 10.0 112.019 -179.354 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 15.3 pt . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.802 0.334 . . . . 10.0 111.42 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.24 159.24 8.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.919 -0.582 . . . . 10.0 109.833 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.83 140.75 32.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.835 0.35 . . . . 10.0 110.225 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -114.11 -65.91 1.14 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.056 0.455 . . . . 10.0 111.113 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 15.3 t -71.46 146.31 48.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.278 0.561 . . . . 10.0 111.868 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 91.8 m -123.8 110.05 14.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.566 -0.743 . . . . 10.0 109.624 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -111.08 130.76 55.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.84 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 25.1 m -132.66 120.97 22.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.169 -0.469 . . . . 10.0 109.871 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 7.9 p -98.39 143.59 12.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.418 -0.355 . . . . 10.0 110.393 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -76.79 -75.89 0.18 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.358 -0.383 . . . . 10.0 111.895 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 7.7 m -139.81 120.22 14.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.968 0.414 . . . . 10.0 111.14 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 15.1 t -106.4 115.6 48.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.587 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 42.2 t -116.41 97.73 5.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.514 -0.55 . . . . 10.0 109.514 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.89 119.6 4.2 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.864 -0.684 . . . . 10.0 112.08 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 15.5 mtpt -132.04 133.32 44.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.525 0.202 . . . . 10.0 110.644 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.75 73.91 1.17 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.747 -0.739 . . . . 10.0 112.696 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 62.92 25.05 14.88 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.023 0.749 . . . . 10.0 113.023 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 4.6 m -79.06 157.77 27.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.206 0.527 . . . . 10.0 111.352 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -142.18 126.15 17.24 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.556 -0.747 . . . . 10.0 109.752 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 18.8 t -102.63 117.64 48.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.448 -0.342 . . . . 10.0 110.142 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.9 103.27 12.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.267 -0.424 . . . . 10.0 110.315 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 37.7 mm -116.52 91.82 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.102 0.477 . . . . 10.0 110.538 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 173.91 -164.59 36.04 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.932 -0.867 . . . . 10.0 110.932 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -95.45 126.76 40.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.722 0.261 . . . . 10.0 110.49 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -88.41 127.77 35.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.258 0.552 . . . . 10.0 111.77 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -161.99 77.12 0.5 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.847 -0.615 . . . . 10.0 109.961 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . -112.92 -82.11 1.14 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.862 -0.685 . . . . 10.0 112.499 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . 135.15 39.85 0.17 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.638 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.21 -63.98 1.21 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.949 0.351 . . . . 10.0 111.949 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 135.84 28.28 0.4 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.318 -0.944 . . . . 10.0 113.293 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -150.68 105.43 3.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.188 -0.671 . . . . 10.0 109.188 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER 68.26 18.03 9.25 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.892 0.853 . . . . 10.0 108.92 -177.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.2 170.48 21.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.938 -1.483 . . . . 10.0 108.098 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -155.37 165.44 36.61 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 121.237 -0.185 . . . . 10.0 110.654 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 31.5 p-80 -160.24 164.35 32.8 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -81.5 -68.27 0.71 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.304 -0.158 . . . . 10.0 110.699 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 3.8 t60 69.71 171.5 0.3 Allowed 'General case' 0 CA--C 1.533 0.29 0 O-C-N 123.737 0.648 . . . . 10.0 111.862 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -101.32 116.88 33.8 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.971 -0.558 . . . . 10.0 110.138 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -103.02 127.16 50.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.934 -0.575 . . . . 10.0 110.219 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.834 0 CA-C-O 118.34 -0.838 . . . . 10.0 109.334 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.569 0.223 . . . . 10.0 110.585 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -121.82 120.15 33.74 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.352 -0.61 . . . . 10.0 109.352 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 60.6 m -137.29 135.89 37.53 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.589 0.588 . . . . 10.0 112.589 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.48 129.55 43.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.517 -0.765 . . . . 10.0 109.101 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -89.86 -72.47 0.56 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.526 0.565 . . . . 10.0 112.526 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -113.32 120.48 41.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.08 0.467 . . . . 10.0 111.369 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 8.2 pt -129.18 127.68 65.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.753 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 3.6 ptp85 -129.54 125.56 36.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.918 0.389 . . . . 10.0 111.341 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.35 108.49 10.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.231 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -114.57 141.62 47.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 10.0 112.164 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 64.82 93.74 0.06 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 114.189 1.181 . . . . 10.0 114.189 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 50.33 35.12 10.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.564 -0.743 . . . . 10.0 112.94 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -108.8 159.39 16.82 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.201 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -150.4 156.12 40.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.143 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.1 p -136.53 133.45 49.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.164 -0.471 . . . . 10.0 111.107 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -121.29 148.21 44.62 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.772 -0.455 . . . . 10.0 109.772 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 tt -124.99 129.34 50.13 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.068 -0.345 . . . . 10.0 110.068 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 135.85 -146.68 18.67 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.938 -0.648 . . . . 10.0 112.207 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -121.98 151.46 40.76 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 48.2 t -120.57 101.11 10.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.22 0.533 . . . . 10.0 111.331 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 65.3 t -92.89 115.83 32.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.176 -0.676 . . . . 10.0 109.176 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 43.9 p -82.63 171.05 14.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.741 0.305 . . . . 10.0 111.0 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -71.38 -6.65 41.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.123 0.487 . . . . 10.0 110.958 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -95.51 7.48 46.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.192 0.52 . . . . 10.0 110.14 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -115.2 32.18 6.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.416 -0.811 . . . . 10.0 109.977 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 69.62 -85.13 0.03 OUTLIER 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.161 -0.927 . . . . 10.0 112.893 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -148.46 166.58 27.73 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.843 0.354 . . . . 10.0 111.495 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -78.69 69.77 2.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.115 -0.564 . . . . 10.0 112.056 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -76.28 -43.79 19.52 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 121.155 -0.545 . . . . 10.0 112.043 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 64.3 mt 71.41 146.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 123.005 0.522 . . . . 10.0 111.331 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? 70.48 80.33 0.17 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.501 0.667 . . . . 10.0 111.746 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 3.9 mp -114.09 -46.61 4.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.508 -0.769 . . . . 10.0 110.005 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.44 -65.06 0.78 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.901 -0.59 . . . . 10.0 110.234 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 55.95 31.93 18.85 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.992 -0.549 . . . . 10.0 112.157 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -91.07 12.51 19.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.641 -0.709 . . . . 10.0 112.328 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 15.1 t -117.4 143.38 46.05 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.564 0.697 . . . . 10.0 112.674 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.0 101.23 9.05 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.226 -1.027 . . . . 10.0 108.226 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 -98.52 127.19 44.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.053 -0.521 . . . . 10.0 110.428 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.02 123.08 19.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.848 -0.615 . . . . 10.0 110.983 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.8 p -123.65 133.82 68.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.287 0.565 . . . . 10.0 111.57 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -79.6 -70.88 0.48 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.569 -0.742 . . . . 10.0 112.175 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.2 m -129.81 126.92 39.21 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.101 0.477 . . . . 10.0 112.105 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 3.6 t -117.09 126.64 74.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.979 -0.555 . . . . 10.0 109.64 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 41.9 t -117.73 122.59 70.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.85 0.357 . . . . 10.0 111.474 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.52 119.62 3.89 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.218 -1.153 . . . . 10.0 110.218 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -126.43 110.58 13.47 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.439 0.533 . . . . 10.0 112.439 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.53 91.7 0.77 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.945 -0.645 . . . . 10.0 114.198 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 51.92 44.06 29.74 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.721 0.637 . . . . 10.0 112.721 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.9 m -96.45 132.58 41.85 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.121 0.486 . . . . 10.0 110.689 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -107.2 114.25 28.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.065 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 30.0 t -105.36 123.12 59.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.508 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.94 108.51 15.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.15 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 25.1 mm -93.13 90.4 2.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.768 -0.456 . . . . 10.0 109.768 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 152.34 -172.52 31.54 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.972 -0.558 . . . . 10.0 112.041 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -101.47 161.24 13.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.077 0.465 . . . . 10.0 111.089 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.99 175.09 7.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.985 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -139.31 67.14 1.39 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.495 -0.775 . . . . 10.0 109.272 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -81.98 115.19 3.97 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.67 -0.695 . . . . 10.0 113.611 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -101.97 -28.78 6.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.824 -0.703 . . . . 10.0 111.854 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -89.8 -45.67 9.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.327 0.584 . . . . 10.0 109.764 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -163.33 156.53 28.35 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.472 -1.051 . . . . 10.0 110.472 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -67.5 112.38 4.64 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 109.549 -0.538 . . . . 10.0 109.549 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 2.3 t90 65.92 -80.38 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 O-C-N 123.797 0.686 . . . . 10.0 110.693 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -162.61 28.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.743 0.782 . . . . 10.0 109.353 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -74.84 117.34 16.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.572 -0.74 . . . . 10.0 111.458 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 -129.06 105.08 7.95 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.919 0.39 . . . . 10.0 110.4 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -115.12 141.68 47.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.673 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -121.4 -53.75 2.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.045 0.45 . . . . 10.0 110.998 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -71.74 142.34 49.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.749 -0.659 . . . . 10.0 110.511 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -143.69 147.35 34.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.347 -0.388 . . . . 10.0 110.427 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 2.7 p80 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.089 -0.958 . . . . 10.0 110.465 179.717 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 109.845 -0.428 . . . . 10.0 109.845 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -117.59 116.25 26.72 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.522 -0.548 . . . . 10.0 109.522 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 18.5 m -130.15 136.91 49.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.894 0.378 . . . . 10.0 111.018 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.76 148.34 52.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.599 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -102.84 -80.52 0.51 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 112.855 0.687 . . . . 10.0 112.855 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -112.66 115.0 27.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.778 0.323 . . . . 10.0 111.665 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 62.2 mt -120.14 111.07 30.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.349 -0.612 . . . . 10.0 109.349 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 12.0 mtt180 -109.93 107.68 17.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.064 0.459 . . . . 10.0 111.387 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.51 122.31 45.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.629 -0.714 . . . . 10.0 110.727 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -130.83 155.52 46.57 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 112.403 0.52 . . . . 10.0 112.403 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 65.31 77.04 0.32 Allowed 'General case' 0 C--O 1.232 0.136 0 N-CA-C 113.914 1.079 . . . . 10.0 113.914 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 44.2 mtm-85 56.13 26.72 10.53 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.55 -0.75 . . . . 10.0 112.824 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -79.49 151.88 30.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.991 0.424 . . . . 10.0 110.806 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.81 133.02 49.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.968 -0.56 . . . . 10.0 110.789 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 4.2 p -130.71 137.43 56.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.09 -0.504 . . . . 10.0 110.976 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -125.22 130.06 51.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.978 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -103.24 73.01 1.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.731 -0.668 . . . . 10.0 110.42 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . -179.41 -178.59 48.45 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.315 -0.945 . . . . 10.0 112.824 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.58 157.58 15.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.662 0.268 . . . . 10.0 110.355 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 56.6 t -104.36 123.95 58.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.084 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 16.9 t -122.02 100.25 8.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.297 -0.631 . . . . 10.0 109.297 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 29.8 p -80.59 170.09 16.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.399 -0.364 . . . . 10.0 110.885 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.29 -10.05 52.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.066 -0.516 . . . . 10.0 111.599 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -79.24 -17.36 54.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.83 0.347 . . . . 10.0 110.681 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -88.48 -0.61 57.39 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.776 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 44.6 tp -72.65 117.0 13.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.707 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 50.2 m80 67.98 76.69 0.26 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.298 -0.864 . . . . 10.0 111.24 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -171.24 -166.08 29.52 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.663 -0.699 . . . . 10.0 111.705 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -87.6 109.55 3.49 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.817 -0.706 . . . . 10.0 111.87 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 26.2 pt -101.98 13.72 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.992 0.425 . . . . 10.0 111.207 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 12.0 tpt85 -141.37 104.68 4.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.036 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 10.4 pt -107.0 29.04 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.711 0.291 . . . . 10.0 111.172 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.7 t 64.39 28.54 13.64 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.7 0.762 . . . . 10.0 110.198 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -74.88 139.8 43.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.928 -1.033 . . . . 10.0 111.054 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 19.9 tm0? -152.2 106.52 3.17 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.742 -0.663 . . . . 10.0 109.917 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 6.3 t -162.07 163.02 28.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.373 -0.376 . . . . 10.0 111.017 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.24 122.45 37.79 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.836 -0.62 . . . . 10.0 109.456 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -103.85 111.31 23.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.975 0.417 . . . . 10.0 109.918 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 9.8 m -131.51 119.17 21.17 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.163 0.506 . . . . 10.0 111.118 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 12.3 p -115.15 135.25 55.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.865 -0.607 . . . . 10.0 109.978 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -82.65 -73.15 0.41 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.575 0.583 . . . . 10.0 112.575 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.6 125.83 53.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.889 0.376 . . . . 10.0 111.948 -178.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 2.3 t -124.18 121.68 62.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.864 -0.607 . . . . 10.0 109.584 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 47.6 t -112.63 118.61 58.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.765 0.317 . . . . 10.0 111.079 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.79 113.82 2.28 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 111.288 -0.725 . . . . 10.0 111.288 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -127.92 132.1 49.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.646 0.26 . . . . 10.0 111.074 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.81 66.9 1.44 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.922 -0.656 . . . . 10.0 112.358 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 53.43 46.89 25.31 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.819 0.674 . . . . 10.0 112.819 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 6.4 t -77.53 167.16 22.08 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.247 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -135.49 117.46 15.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.099 -0.5 . . . . 10.0 110.017 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 34.5 t -112.11 119.51 60.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.087 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.95 113.59 22.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.961 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 23.1 mm -104.25 86.93 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.101 0.476 . . . . 10.0 109.847 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 158.46 168.62 20.92 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.871 -0.891 . . . . 10.0 110.871 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -88.33 167.39 13.57 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.31 0.555 . . . . 10.0 111.235 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.49 167.2 19.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.151 0.5 . . . . 10.0 111.672 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -147.7 78.77 1.47 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.42 -0.809 . . . . 10.0 108.954 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -94.43 -111.4 2.33 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.832 -0.699 . . . . 10.0 112.865 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 132.27 -36.3 2.21 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.713 -0.756 . . . . 10.0 111.379 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -101.82 23.8 10.83 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 165.06 -175.97 40.86 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.516 -1.434 . . . . 10.0 109.516 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -131.11 65.79 1.55 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 117.068 0.434 . . . . 10.0 109.859 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 26.6 t90 71.26 -47.28 0.66 Allowed 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.836 0.71 . . . . 10.0 111.872 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -116.0 -169.92 1.69 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.791 -0.641 . . . . 10.0 109.31 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -118.3 126.06 51.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.333 0.587 . . . . 10.0 111.849 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -156.47 123.6 5.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.461 -0.791 . . . . 10.0 109.359 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -155.55 138.05 15.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.509 -0.314 . . . . 10.0 110.691 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -168.58 -176.61 2.84 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.512 -0.551 . . . . 10.0 109.512 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -105.76 159.38 16.04 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.678 0.275 . . . . 10.0 110.608 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -91.49 -164.45 1.18 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.013 0.435 . . . . 10.0 111.317 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.067 -0.968 . . . . 10.0 109.63 179.91 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.681 0.277 . . . . 10.0 110.962 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -132.19 113.99 13.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 16.5 m -124.67 141.58 52.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.102 0.477 . . . . 10.0 111.905 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.9 139.54 52.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.636 -0.711 . . . . 10.0 110.512 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -84.96 -69.11 0.67 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.121 -0.491 . . . . 10.0 111.912 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -129.4 117.0 19.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.915 0.388 . . . . 10.0 111.658 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 70.2 mt -120.14 120.6 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.138 -0.483 . . . . 10.0 109.749 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 15.1 ttm-85 -116.21 115.54 26.17 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.215 -0.448 . . . . 10.0 111.269 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.53 99.0 6.09 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.248 0.546 . . . . 10.0 110.88 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -121.22 170.99 9.04 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.004 -0.543 . . . . 10.0 110.557 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 67.87 59.18 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.841 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 10.4 mtp180 63.29 16.79 9.74 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.026 0.75 . . . . 10.0 113.026 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -77.38 176.69 8.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.869 0.366 . . . . 10.0 111.171 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.09 152.05 20.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.203 -0.453 . . . . 10.0 110.747 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 8.2 p -131.92 140.35 48.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.052 0.453 . . . . 10.0 111.428 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -117.14 121.81 42.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.855 -0.611 . . . . 10.0 110.175 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -106.44 86.23 2.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.62 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.28 -173.09 43.65 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.341 -0.933 . . . . 10.0 112.816 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -97.99 145.82 26.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.72 0.295 . . . . 10.0 110.656 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 36.8 t -106.87 103.64 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.087 0.47 . . . . 10.0 110.868 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 19.9 t -111.58 112.37 40.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.014 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 34.2 p -82.34 160.94 22.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.426 -0.352 . . . . 10.0 111.145 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.0 5.39 1.17 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.249 0.463 . . . . 10.0 112.249 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -96.48 3.4 52.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.196 -0.457 . . . . 10.0 109.826 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -116.03 84.66 2.15 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.906 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 84.8 mt -95.85 -9.73 30.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.596 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -84.0 110.78 18.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.701 -0.681 . . . . 10.0 109.69 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -144.2 -90.14 0.11 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.51 -0.852 . . . . 10.0 112.786 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 100.66 -156.23 19.35 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.686 -0.769 . . . . 10.0 111.608 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 8.0 tt -147.99 104.23 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.281 0.562 . . . . 10.0 111.304 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -157.43 137.49 12.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.965 -0.561 . . . . 10.0 109.931 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 15.3 tt -103.57 133.87 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.034 0.445 . . . . 10.0 110.813 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 41.1 m -155.96 179.66 9.0 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.404 -0.591 . . . . 10.0 109.404 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -72.84 167.13 21.57 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.714 -0.221 . . . . 10.0 110.868 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -158.93 152.98 23.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.606 -0.27 . . . . 10.0 110.521 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 6.8 t -64.98 132.27 48.81 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.238 0.542 . . . . 10.0 111.152 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 32.5 m -92.36 126.29 37.38 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.001 -0.545 . . . . 10.0 109.759 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -118.9 123.76 45.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.688 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 14.2 m -141.75 142.3 33.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.079 -0.509 . . . . 10.0 110.244 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 8.8 p -133.51 144.13 36.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.066 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -83.19 -75.92 0.3 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.291 0.478 . . . . 10.0 112.291 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 24.3 m -113.52 127.61 56.15 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.125 0.787 . . . . 10.0 113.125 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.92 109.31 20.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.357 -0.838 . . . . 10.0 108.958 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 37.1 t -107.41 125.99 63.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.025 0.44 . . . . 10.0 110.864 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -134.04 120.93 2.6 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.885 -0.598 . . . . 10.0 112.022 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -138.53 124.65 20.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.141 0.496 . . . . 10.0 111.2 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 97.25 74.96 1.21 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.83 -0.7 . . . . 10.0 113.101 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 59.06 22.36 10.41 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.665 0.617 . . . . 10.0 112.665 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 16.0 m -69.55 149.61 48.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.085 0.469 . . . . 10.0 111.916 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -132.37 122.29 24.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.171 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.91 129.61 63.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.742 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -121.31 110.51 16.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.289 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 30.5 mm -107.93 94.14 2.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.135 0.493 . . . . 10.0 110.316 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 160.28 -160.08 31.38 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.565 -0.614 . . . . 10.0 111.565 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -115.53 150.49 36.49 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.315 -0.254 . . . . 10.0 110.315 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -119.29 145.23 46.3 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.075 0.464 . . . . 10.0 112.166 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -127.63 98.59 5.26 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.373 -0.831 . . . . 10.0 108.943 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . -145.55 159.93 28.0 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.546 -0.835 . . . . 10.0 112.757 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -106.95 -30.86 4.07 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.748 -0.739 . . . . 10.0 112.894 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -59.72 -45.09 93.22 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.922 0.391 . . . . 10.0 111.036 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 173.47 -128.2 1.46 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.642 -0.983 . . . . 10.0 110.642 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -110.12 -166.18 1.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.209 -0.293 . . . . 10.0 110.209 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -54.4 -30.11 51.16 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.156 0.798 . . . . 10.0 113.156 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.83 157.28 31.44 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 122.336 -0.227 . . . . 10.0 110.718 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -123.83 30.4 6.18 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.36 0.504 . . . . 10.0 112.36 -178.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -85.7 -17.67 35.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.454 -0.339 . . . . 10.0 110.942 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.67 153.68 51.5 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.995 -0.441 . . . . 10.0 111.619 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.86 179.23 0.16 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 123.654 0.596 . . . . 10.0 110.875 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.333 -0.124 0 N-CA-C 113.992 1.108 . . . . 10.0 113.992 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 20.0 m120 . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 109.859 -0.423 . . . . 10.0 109.859 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.02 140.72 51.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.985 0.422 . . . . 10.0 111.668 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.01 147.48 51.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.135 -0.484 . . . . 10.0 110.509 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -92.79 -72.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.259 -0.428 . . . . 10.0 111.743 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -126.26 117.19 22.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.668 0.271 . . . . 10.0 111.321 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 63.5 mt -121.93 123.62 69.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.096 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -120.22 113.94 21.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.15 0.5 . . . . 10.0 110.662 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 1.7 p -117.31 111.75 19.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.749 -0.659 . . . . 10.0 110.278 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -124.89 151.54 45.22 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.143 0.423 . . . . 10.0 112.143 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 65.01 79.19 0.26 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.975 1.102 . . . . 10.0 113.975 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 58.57 19.44 6.65 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.259 -0.882 . . . . 10.0 113.344 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -81.74 162.23 23.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.857 0.361 . . . . 10.0 111.24 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.39 147.76 38.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.061 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 1.9 p -128.81 127.44 66.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.138 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -113.47 126.79 55.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.623 -0.717 . . . . 10.0 109.211 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.97 97.98 5.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.406 -0.361 . . . . 10.0 110.593 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 164.15 -108.48 0.33 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.517 -0.849 . . . . 10.0 112.778 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -163.8 153.14 14.32 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.678 0.275 . . . . 10.0 110.388 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 t -112.24 106.26 20.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.801 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 52.6 t -104.55 112.89 39.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 81.6 p -80.33 150.77 29.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.09 0.471 . . . . 10.0 111.694 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.58 8.06 2.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.928 -0.578 . . . . 10.0 111.39 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -101.33 -8.48 22.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.934 -0.575 . . . . 10.0 109.796 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -91.3 110.11 21.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.058 -0.519 . . . . 10.0 109.731 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.79 163.06 24.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.387 0.613 . . . . 10.0 111.707 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -84.25 63.24 7.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.725 -0.671 . . . . 10.0 112.192 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -131.66 59.08 0.69 Allowed Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 110.405 -1.078 . . . . 10.0 110.405 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 109.71 20.54 7.63 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.27 -1.132 . . . . 10.0 110.27 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 16.6 tt -67.1 -30.8 50.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.851 -0.674 . . . . 10.0 111.425 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -80.05 71.37 6.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.059 0.456 . . . . 10.0 110.874 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 20.0 tt -65.04 -19.26 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.669 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 4.4 m 66.35 -96.02 0.04 OUTLIER 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.664 -0.698 . . . . 10.0 111.783 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -149.19 172.27 15.1 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.411 -0.589 . . . . 10.0 109.411 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -169.27 -74.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.91 0.386 . . . . 10.0 110.581 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 13.5 t -96.17 162.46 13.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.352 0.596 . . . . 10.0 110.838 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 12.8 m -116.9 111.98 20.4 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.055 -0.52 . . . . 10.0 109.872 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -97.25 105.49 17.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.024 -0.535 . . . . 10.0 109.961 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 24.1 m -115.59 118.54 33.42 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.591 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 11.4 p -121.83 137.27 55.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.947 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -84.68 -83.61 0.16 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.919 0.711 . . . . 10.0 112.919 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.69 122.75 46.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.298 0.851 . . . . 10.0 113.298 -177.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 43.7 t -121.16 114.5 43.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.233 -0.654 . . . . 10.0 109.233 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 16.9 t -111.54 119.87 60.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.816 0.341 . . . . 10.0 111.403 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.8 125.93 6.02 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.336 -0.705 . . . . 10.0 111.336 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 19.3 tptt -134.4 108.71 8.32 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.825 0.306 . . . . 10.0 111.825 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.92 102.38 0.64 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 114.698 0.639 . . . . 10.0 114.698 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 51.69 36.17 16.87 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.561 0.578 . . . . 10.0 112.561 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 4.0 m -85.25 139.2 31.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.162 0.506 . . . . 10.0 111.853 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -118.94 113.24 20.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.558 -0.746 . . . . 10.0 110.273 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 46.0 t -102.49 113.45 39.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.357 -0.608 . . . . 10.0 109.357 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -117.39 97.57 5.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.171 0.51 . . . . 10.0 110.867 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 44.1 mm -102.0 91.91 2.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.645 -0.872 . . . . 10.0 108.645 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 166.17 -163.01 36.53 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.639 -0.709 . . . . 10.0 111.564 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -120.41 156.02 32.26 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.73 -0.277 . . . . 10.0 110.922 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -114.62 136.02 53.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.218 -0.447 . . . . 10.0 110.621 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -124.59 113.35 17.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.347 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 156.21 171.58 22.69 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.232 -0.985 . . . . 10.0 112.819 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -110.05 53.86 0.57 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.613 -0.803 . . . . 10.0 112.825 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -89.29 -18.11 27.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.204 0.526 . . . . 10.0 109.983 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 118.95 -47.9 0.99 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.775 -0.93 . . . . 10.0 110.775 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 4.7 t80 176.15 145.62 0.08 Allowed 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.871 -1.159 . . . . 10.0 107.871 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 17.1 t90 -50.38 -74.47 0.03 OUTLIER 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.435 0.46 . . . . 10.0 111.761 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -134.81 133.24 39.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.185 0.517 . . . . 10.0 111.301 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -172.51 147.55 1.88 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -73.68 -57.52 3.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.816 0.341 . . . . 10.0 110.984 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -154.74 175.02 14.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.072 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -97.25 -154.72 0.46 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.599 -0.273 . . . . 10.0 111.455 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -58.91 125.78 24.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.124 0.488 . . . . 10.0 111.486 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -123.51 147.6 47.07 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.691 -0.686 . . . . 10.0 109.939 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.186 -0.911 . . . . 10.0 109.623 179.688 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 110.662 -0.125 . . . . 10.0 110.662 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -137.55 111.82 8.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.65 0.262 . . . . 10.0 110.466 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 21.3 m -122.4 138.35 54.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.157 0.503 . . . . 10.0 111.084 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.4 129.27 42.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.851 -0.613 . . . . 10.0 109.547 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -84.77 -64.63 1.12 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.57 0.581 . . . . 10.0 112.57 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -130.79 127.39 38.59 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.779 -0.368 . . . . 10.0 111.278 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 90.9 mt -128.03 123.27 60.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.761 -0.459 . . . . 10.0 109.761 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -116.75 118.29 32.11 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.385 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.66 111.19 12.92 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.013 -0.539 . . . . 10.0 110.862 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -129.87 145.56 51.6 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.154 0.427 . . . . 10.0 112.154 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 66.39 81.9 0.19 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.2 0.815 . . . . 10.0 113.2 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 58.35 26.09 13.61 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.902 -0.59 . . . . 10.0 112.246 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.2 153.32 18.13 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.9 160.52 41.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.829 0.347 . . . . 10.0 111.544 -178.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.34 134.28 49.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.889 -0.596 . . . . 10.0 110.779 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 21.0 tm0? -127.84 127.52 43.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.932 -0.576 . . . . 10.0 109.845 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.16 105.48 8.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.442 -0.345 . . . . 10.0 110.587 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 164.36 -158.02 30.54 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.757 -0.735 . . . . 10.0 112.445 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -117.34 144.32 45.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.917 0.389 . . . . 10.0 110.649 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 61.6 t -101.24 120.33 50.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.111 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 3.6 t -116.92 101.37 12.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.98 0.419 . . . . 10.0 110.867 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 15.0 t -67.53 173.7 3.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.169 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.76 -19.66 64.19 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.794 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -75.52 -22.34 57.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.277 -0.42 . . . . 10.0 110.727 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 55.84 -161.68 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.871 -0.604 . . . . 10.0 111.861 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 5.1 mp -103.27 89.13 3.3 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.034 0.445 . . . . 10.0 110.362 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 . . . . . 0 C--N 1.327 -0.399 0 CA-C-O 121.418 0.628 . . . . 10.0 110.159 179.375 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 256' ' ' ILE . . . . . 0.422 ' C ' ' HG ' ' E' ' 257' ' ' SER . 6.5 pt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.134 0.492 . . . . 10.0 110.928 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 257' ' ' SER . . . . . 0.422 ' HG ' ' C ' ' E' ' 256' ' ' ILE . 1.4 m -145.04 151.12 38.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.1 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -85.86 84.3 7.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.769 0.795 . . . . 10.0 111.105 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -70.25 -25.73 63.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.227 -0.897 . . . . 10.0 112.251 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 14.6 t -107.24 148.51 28.85 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.09 0.472 . . . . 10.0 111.334 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 79.7 m -129.21 114.3 16.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.583 -0.735 . . . . 10.0 111.206 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -107.85 100.1 9.5 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.311 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 12.9 m -109.04 117.64 34.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.157 -0.474 . . . . 10.0 109.767 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 4.8 p -107.26 152.27 8.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.842 0.353 . . . . 10.0 111.074 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -86.47 -88.11 0.13 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.152 -0.477 . . . . 10.0 111.457 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 9.0 m -125.12 120.95 32.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.966 0.413 . . . . 10.0 111.605 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.16 116.28 51.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.46 110.61 32.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.856 0.36 . . . . 10.0 111.24 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.6 136.14 10.21 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.642 -0.583 . . . . 10.0 111.642 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -140.03 126.6 20.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.017 0.437 . . . . 10.0 111.024 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.89 82.07 1.17 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.748 -0.739 . . . . 10.0 113.647 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 61.43 22.58 12.97 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.295 0.85 . . . . 10.0 113.295 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 45.2 m -73.1 152.32 41.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.886 0.374 . . . . 10.0 111.291 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -131.45 120.48 23.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.815 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 40.3 t -102.44 118.99 50.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.921 -0.581 . . . . 10.0 109.464 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.57 110.28 16.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.744 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 46.4 mm -117.74 95.96 4.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.144 0.497 . . . . 10.0 110.178 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 170.89 -126.57 1.34 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.515 -0.634 . . . . 10.0 111.515 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -141.01 151.85 44.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 10.0 111.156 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -105.29 138.61 41.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.095 -0.502 . . . . 10.0 111.913 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -162.55 71.28 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.956 -0.566 . . . . 10.0 110.193 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . -112.9 -105.83 2.75 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.853 -0.689 . . . . 10.0 112.626 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . 179.37 25.2 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.564 -0.827 . . . . 10.0 113.364 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.1 -119.79 0.3 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.987 0.394 . . . . 10.0 111.819 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -168.69 46.64 0.22 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.478 -0.868 . . . . 10.0 113.258 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -174.38 103.43 0.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.543 -0.54 . . . . 10.0 109.543 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 72.55 5.47 5.25 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.762 0.664 . . . . 10.0 109.616 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.49 131.94 1.5 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.133 -1.394 . . . . 10.0 107.388 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -136.2 172.76 12.53 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.649 -0.251 . . . . 10.0 111.147 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -157.82 -163.36 1.32 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.333 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -110.67 -73.06 0.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.513 -0.18 . . . . 10.0 110.513 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 37.8 t60 70.89 150.31 0.09 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.722 0.639 . . . . 10.0 112.38 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -88.58 112.92 23.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.417 -0.586 . . . . 10.0 109.417 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -96.23 143.28 27.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.268 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.376 -0.821 . . . . 10.0 110.368 -179.713 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 110.62 -0.141 . . . . 10.0 110.62 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -116.24 134.72 54.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.769 0.318 . . . . 10.0 110.201 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 57.0 m -147.89 157.79 43.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.181 0.515 . . . . 10.0 111.771 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.17 154.66 45.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.533 -0.758 . . . . 10.0 109.168 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -107.34 -70.97 0.77 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.571 0.582 . . . . 10.0 112.571 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -124.02 110.35 14.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.366 -177.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 66.8 mt -119.4 126.37 75.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.385 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.9 ptp85 -124.31 116.26 22.34 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.102 0.477 . . . . 10.0 110.658 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.52 127.6 48.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.827 -0.624 . . . . 10.0 110.768 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -141.91 169.41 17.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.602 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.2 60.11 1.0 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.843 -0.617 . . . . 10.0 111.674 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 62.72 29.49 16.78 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.723 -0.671 . . . . 10.0 112.479 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.63 157.29 19.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.43 -0.35 . . . . 10.0 110.612 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -135.22 151.2 50.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.247 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.24 139.52 36.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.832 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -137.78 130.12 29.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.266 -0.425 . . . . 10.0 110.205 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 5.8 mp -116.82 118.55 32.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.491 -0.322 . . . . 10.0 110.526 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 152.74 -169.55 31.8 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.824 -0.703 . . . . 10.0 112.694 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.63 126.58 41.0 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.057 -0.349 . . . . 10.0 110.057 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 90.9 t -98.29 116.39 40.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.207 0.527 . . . . 10.0 112.075 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 77.8 t -111.49 116.9 53.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.783 -0.644 . . . . 10.0 109.756 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.77 158.97 15.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.714 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.57 -19.99 65.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.019 0.437 . . . . 10.0 110.766 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -85.98 11.46 11.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.772 -0.649 . . . . 10.0 110.632 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -121.36 36.03 4.72 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.5 -0.556 . . . . 10.0 109.5 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 75.99 -82.22 0.03 OUTLIER 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.44 -0.8 . . . . 10.0 112.645 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 26.0 p-80 -158.22 171.89 19.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.445 -0.343 . . . . 10.0 110.514 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -80.62 64.39 4.07 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.002 -0.618 . . . . 10.0 112.749 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -69.63 -46.41 54.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.311 -0.471 . . . . 10.0 112.187 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 84.1 mt 74.15 141.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 122.981 0.513 . . . . 10.0 111.67 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 30.1 ttt-85 68.54 82.98 0.16 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.341 0.591 . . . . 10.0 111.245 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 55.6 mt -112.17 -45.92 5.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.765 -0.652 . . . . 10.0 111.532 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 7.0 p -135.28 -82.98 0.41 Allowed 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.293 0.479 . . . . 10.0 112.293 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 11.3 t70 59.4 76.57 0.35 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.478 -0.783 . . . . 10.0 110.981 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -118.05 24.41 11.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.726 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 5.2 t -155.32 143.04 19.79 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.208 0.528 . . . . 10.0 111.43 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 4.1 m -91.31 120.53 32.27 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.507 -0.923 . . . . 10.0 108.507 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -111.08 111.71 23.0 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.954 -0.387 . . . . 10.0 109.954 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.7 m -141.07 132.96 27.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.043 0.449 . . . . 10.0 111.708 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 9.9 p -121.6 139.22 49.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.795 -0.639 . . . . 10.0 110.004 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -79.35 -77.29 0.18 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.29 0.478 . . . . 10.0 112.29 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 1.7 m -115.28 133.36 56.11 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.735 0.643 . . . . 10.0 112.735 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 17.4 t -128.47 124.72 62.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.459 -0.791 . . . . 10.0 109.035 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 39.7 t -116.65 121.88 68.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.85 0.357 . . . . 10.0 111.116 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -126.63 118.59 3.1 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.979 -0.629 . . . . 10.0 112.056 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -132.81 110.56 10.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.724 0.297 . . . . 10.0 110.966 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 107.45 67.71 0.65 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.636 -0.792 . . . . 10.0 112.563 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 56.48 32.0 19.93 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 13.2 m -69.19 141.67 54.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.253 0.549 . . . . 10.0 110.611 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 19.6 mtt180 -114.87 107.08 14.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.386 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 40.8 t -98.97 113.88 35.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.06 -0.518 . . . . 10.0 111.226 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.71 114.79 26.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.246 -0.434 . . . . 10.0 109.863 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 29.2 mm -108.91 114.22 46.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.776 -0.453 . . . . 10.0 109.776 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 132.48 163.61 10.7 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.631 -0.795 . . . . 10.0 112.281 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -76.9 147.07 37.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.127 0.489 . . . . 10.0 111.503 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -126.39 152.65 46.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.12 -0.491 . . . . 10.0 111.069 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -129.63 116.63 19.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.726 -0.67 . . . . 10.0 110.581 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -166.8 153.3 22.9 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.137 -0.554 . . . . 10.0 111.751 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -128.3 -7.7 4.33 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.431 -0.89 . . . . 10.0 113.327 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -80.07 -43.43 21.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.124 0.487 . . . . 10.0 110.805 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -155.48 157.18 27.53 Favored Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 110.3 -1.12 . . . . 10.0 110.3 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -80.97 74.53 7.96 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.917 0.358 . . . . 10.0 110.894 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 25.0 t90 67.36 -63.93 0.28 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.219 0.949 . . . . 10.0 112.874 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -144.08 96.64 2.92 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.118 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -160.34 144.34 14.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.936 -0.575 . . . . 10.0 110.354 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -157.06 60.7 0.51 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.116 -0.698 . . . . 10.0 109.116 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -83.86 103.73 13.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.852 -0.613 . . . . 10.0 111.769 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -101.56 -31.8 10.68 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.647 -0.706 . . . . 10.0 110.084 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -84.61 124.6 31.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.577 -0.738 . . . . 10.0 109.905 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.42 139.72 47.75 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.785 0.326 . . . . 10.0 110.72 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.509 -0.758 . . . . 10.0 110.378 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 4.7 ttm-85 . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 110.286 -0.265 . . . . 10.0 110.286 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -126.54 124.23 39.54 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.326 -0.62 . . . . 10.0 109.326 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 5.1 m -139.32 152.95 47.61 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.624 0.25 . . . . 10.0 111.184 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -144.24 148.5 35.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.154 -0.476 . . . . 10.0 111.448 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -90.56 -62.35 1.48 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.217 -0.447 . . . . 10.0 111.957 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -145.6 132.25 19.92 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.006 0.431 . . . . 10.0 111.412 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 64.9 mt -125.24 122.92 64.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.086 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -102.74 112.52 25.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.165 -0.471 . . . . 10.0 109.95 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.23 115.0 22.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.882 0.372 . . . . 10.0 111.327 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.34 164.32 28.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.339 -0.391 . . . . 10.0 111.477 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 65.64 62.59 0.64 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.595 -0.729 . . . . 10.0 111.872 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 63.6 mtm-85 57.83 32.29 21.71 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.894 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.12 159.59 22.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.887 0.375 . . . . 10.0 111.065 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.62 141.82 41.23 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.951 0.405 . . . . 10.0 111.238 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 4.3 p -127.1 135.81 62.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.723 -0.671 . . . . 10.0 110.989 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -118.74 123.23 44.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.61 -0.723 . . . . 10.0 109.227 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.78 84.78 1.98 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.877 0.37 . . . . 10.0 110.504 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 165.41 179.06 38.98 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.482 -0.866 . . . . 10.0 112.233 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -92.26 131.64 37.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.798 0.332 . . . . 10.0 110.664 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 46.7 t -95.77 109.13 22.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.014 0.435 . . . . 10.0 110.707 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 20.3 t -109.24 114.11 46.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 32.8 p -81.91 169.01 17.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.087 -0.506 . . . . 10.0 111.324 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -72.12 -4.92 31.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.691 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -78.43 -18.17 55.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.601 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -91.01 3.1 55.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.647 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 20.6 tp -64.58 131.19 46.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.426 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 1.9 t60 60.07 47.89 9.13 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.261 0.553 . . . . 10.0 110.89 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -137.48 -156.52 7.27 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.884 -0.674 . . . . 10.0 111.866 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.51 120.4 4.29 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.987 -0.625 . . . . 10.0 111.736 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 52.5 mt -103.5 -33.48 3.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.22 0.533 . . . . 10.0 110.733 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -79.82 81.06 6.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.975 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 21.4 pt -102.34 37.51 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.798 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.7 t 65.87 36.22 6.18 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.925 -0.58 . . . . 10.0 110.616 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -65.94 122.43 17.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.397 -0.82 . . . . 10.0 110.154 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -139.28 109.25 6.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.333 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 8.5 t -175.38 177.1 1.89 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.998 0.428 . . . . 10.0 110.56 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 71.2 m -150.48 117.47 5.92 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.901 -0.777 . . . . 10.0 108.901 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -99.69 116.06 30.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.991 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 50.8 m -135.78 113.9 11.37 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.881 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 13.2 p -113.14 146.2 18.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.556 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -85.01 -75.5 0.35 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.173 0.435 . . . . 10.0 112.173 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 4.3 m -123.24 130.14 52.34 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.748 0.647 . . . . 10.0 112.748 -178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 37.3 t -119.77 122.87 69.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.376 -0.829 . . . . 10.0 109.041 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 35.3 t -104.3 114.02 42.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.815 0.34 . . . . 10.0 110.348 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.41 97.6 0.72 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.556 -0.618 . . . . 10.0 111.556 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -119.89 118.98 32.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.728 0.299 . . . . 10.0 111.189 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 100.65 62.57 0.79 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.325 -0.941 . . . . 10.0 112.595 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 54.58 37.68 28.45 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.124 0.786 . . . . 10.0 113.124 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 7.3 m -77.81 151.16 34.1 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.899 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 13.2 mtt85 -116.25 121.08 40.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.344 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 40.8 t -108.84 119.42 58.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.486 -0.561 . . . . 10.0 109.486 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.97 113.37 21.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.666 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 43.3 mm -103.54 88.33 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.896 0.379 . . . . 10.0 110.074 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 158.66 175.07 29.18 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.899 -0.667 . . . . 10.0 111.974 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -93.05 159.35 15.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.152 -0.314 . . . . 10.0 110.152 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.46 160.83 27.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.192 0.52 . . . . 10.0 111.684 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.02 71.27 1.33 Allowed 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -97.3 -65.03 0.9 Allowed Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.213 -0.903 . . . . 10.0 111.885 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 82.35 -46.99 3.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.247 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -67.35 -26.69 66.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.411 0.624 . . . . 10.0 110.126 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -152.73 164.22 30.66 Favored Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 110.216 -1.154 . . . . 10.0 110.216 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -97.87 64.18 1.71 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.93 -0.396 . . . . 10.0 109.93 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 16.1 t90 71.19 -43.11 0.55 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.387 -0.824 . . . . 10.0 112.341 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -139.02 -170.54 2.89 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.863 -0.421 . . . . 10.0 109.863 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.38 142.19 58.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.419 -0.355 . . . . 10.0 110.777 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -166.48 89.73 0.39 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 110.397 -0.223 . . . . 10.0 110.397 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -155.52 119.35 4.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.82 0.343 . . . . 10.0 111.796 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.97 -176.49 5.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.125 -0.488 . . . . 10.0 110.457 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.6 154.17 17.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.817 0.341 . . . . 10.0 111.477 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -116.16 -174.07 2.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.41 -0.814 . . . . 10.0 109.211 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.218 -0.896 . . . . 10.0 109.73 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.485 0.183 . . . . 10.0 110.549 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -127.72 111.51 13.77 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.28 152.59 47.94 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.051 0.453 . . . . 10.0 111.572 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -149.06 143.82 26.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.774 -0.648 . . . . 10.0 109.995 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -91.91 -72.27 0.6 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.633 0.605 . . . . 10.0 112.633 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -122.06 126.29 48.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.865 0.365 . . . . 10.0 111.558 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 49.7 mt -129.52 115.05 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.382 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 14.7 ttm-85 -101.45 115.12 29.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.396 -0.365 . . . . 10.0 110.561 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -125.29 100.7 6.64 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.447 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -125.32 161.58 26.66 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.014 0.376 . . . . 10.0 112.014 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 66.45 75.15 0.33 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.358 -0.837 . . . . 10.0 112.108 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 53.33 55.17 9.1 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.297 -0.865 . . . . 10.0 111.133 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -107.97 165.89 11.12 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.712 -0.676 . . . . 10.0 111.164 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -153.1 138.01 17.14 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.854 -0.612 . . . . 10.0 110.16 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.06 136.46 51.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.191 -0.459 . . . . 10.0 110.614 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -126.07 128.61 47.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.993 0.425 . . . . 10.0 111.043 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -105.24 91.41 3.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.769 -0.651 . . . . 10.0 109.831 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 168.19 -174.39 43.03 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.669 -0.777 . . . . 10.0 111.992 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -95.54 155.69 16.64 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.827 0.346 . . . . 10.0 110.95 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 57.3 t -112.68 108.78 26.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.06 -0.518 . . . . 10.0 110.249 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.83 110.64 32.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.218 -0.446 . . . . 10.0 110.342 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 246' ' ' THR . . . . . 0.434 ' C ' ' H ' ' C' ' 248' ' ' ALA . 38.3 p -79.84 159.92 26.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.019 -0.537 . . . . 10.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.68 42.54 0.13 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.273 0.559 . . . . 10.0 111.838 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . 0.434 ' H ' ' C ' ' C' ' 246' ' ' THR . . . -138.19 -13.06 1.4 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.61 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -87.45 67.03 9.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.109 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 55.8 mt -87.12 -4.6 59.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.978 -0.555 . . . . 10.0 111.379 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -94.04 129.24 40.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.305 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 178.77 -158.57 23.01 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.661 -0.78 . . . . 10.0 112.182 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 176.17 -134.66 2.68 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.676 -0.969 . . . . 10.0 110.676 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 13.5 tt -158.42 89.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.498 0.666 . . . . 10.0 111.421 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -140.93 115.31 9.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.367 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 8.5 tt -74.83 129.28 36.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.819 -0.628 . . . . 10.0 109.898 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.44 174.16 15.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.125 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.81 145.6 55.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.92 -0.582 . . . . 10.0 112.155 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -147.76 149.07 31.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.761 -0.654 . . . . 10.0 109.703 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 12.8 t -71.51 140.29 49.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.005 0.431 . . . . 10.0 110.847 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 7.7 m -105.54 134.34 48.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.099 -0.501 . . . . 10.0 110.384 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -122.65 128.36 50.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.875 -0.602 . . . . 10.0 109.5 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 50.0 m -144.63 138.78 27.62 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.737 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.9 p -123.52 145.34 30.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.852 -0.613 . . . . 10.0 110.996 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -82.32 -66.27 0.91 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.491 -0.322 . . . . 10.0 111.735 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.79 129.74 51.04 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.295 0.85 . . . . 10.0 113.295 -178.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 48.3 t -127.19 119.97 54.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.661 -0.7 . . . . 10.0 109.648 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 58.8 t -117.01 120.08 63.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.794 0.33 . . . . 10.0 110.895 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.77 130.95 7.85 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.976 -0.631 . . . . 10.0 112.121 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -133.04 126.68 32.42 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.913 0.338 . . . . 10.0 111.913 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.17 93.23 0.16 Allowed Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.951 -0.568 . . . . 10.0 113.449 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 64.02 32.47 12.91 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.303 0.573 . . . . 10.0 111.403 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.46 121.83 16.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.328 -0.851 . . . . 10.0 111.193 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 41.3 mtt180 -124.74 100.89 6.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.147 0.499 . . . . 10.0 109.763 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 22.3 t -101.78 131.86 48.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.041 -0.527 . . . . 10.0 111.411 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -128.01 113.2 15.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.858 -0.61 . . . . 10.0 109.815 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 56.1 mt -111.0 94.13 2.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.324 0.583 . . . . 10.0 110.756 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 168.19 -165.06 38.5 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.825 -1.31 . . . . 10.0 109.825 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -108.49 148.28 30.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 117.477 0.638 . . . . 10.0 110.946 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -104.94 137.61 42.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.344 -0.389 . . . . 10.0 110.644 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.0 102.16 5.92 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.538 -0.542 . . . . 10.0 109.538 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . -164.98 172.07 40.55 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.689 -0.767 . . . . 10.0 112.434 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -124.34 16.33 7.59 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.782 -0.723 . . . . 10.0 112.522 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -101.68 1.28 37.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.964 0.411 . . . . 10.0 111.179 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 129.86 -116.17 2.04 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.835 -0.906 . . . . 10.0 110.835 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -125.75 -155.78 0.7 Allowed 'General case' 0 C--N 1.323 -0.549 0 O-C-N 123.513 0.184 . . . . 10.0 110.562 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -63.75 -24.0 67.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.635 0.255 . . . . 10.0 111.284 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -133.47 -171.39 2.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.489 -0.323 . . . . 10.0 110.262 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -143.02 35.44 1.37 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.075 0.464 . . . . 10.0 110.966 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -79.99 0.58 31.01 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.276 0.473 . . . . 10.0 112.276 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -164.46 155.82 15.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.455 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 66.34 157.19 0.11 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.399 0.618 . . . . 10.0 112.464 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 N-CA-C 112.117 0.414 . . . . 10.0 112.117 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 19.1 m120 . . . . . 0 CA--C 1.52 -0.178 0 N-CA-C 110.301 -0.259 . . . . 10.0 110.301 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 42.6 m -151.17 142.83 23.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.89 0.376 . . . . 10.0 111.579 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.85 139.59 53.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.51 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 22.5 ttmt -84.54 -66.12 0.93 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.877 0.37 . . . . 10.0 111.601 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -138.51 119.43 14.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.649 0.261 . . . . 10.0 111.113 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 32.7 mt -117.07 130.89 71.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.385 -0.37 . . . . 10.0 110.502 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 22.2 mmm-85 -118.55 106.38 12.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.176 -0.466 . . . . 10.0 110.66 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 1.4 p -112.99 113.3 25.28 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.625 -0.509 . . . . 10.0 109.625 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -131.18 147.34 52.59 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.368 0.506 . . . . 10.0 112.368 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 68.38 79.22 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.162 -0.927 . . . . 10.0 113.278 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 55.68 45.64 24.2 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.287 0.565 . . . . 10.0 111.94 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -111.06 157.23 20.21 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.901 -0.591 . . . . 10.0 110.61 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.33 151.77 39.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.244 -0.434 . . . . 10.0 110.822 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 3.8 p -138.25 133.43 43.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.22 -0.445 . . . . 10.0 110.273 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.21 125.38 53.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.522 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -109.66 92.59 4.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.865 -0.607 . . . . 10.0 110.819 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 175.72 -106.02 0.21 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.716 -0.755 . . . . 10.0 112.466 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -167.91 162.93 13.77 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.637 0.375 . . . . 10.0 110.282 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 35.8 t -110.52 111.92 38.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.842 0.353 . . . . 10.0 111.802 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 17.7 t -113.21 109.98 30.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.383 -0.599 . . . . 10.0 109.383 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 82.3 p -89.75 162.77 15.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.945 0.403 . . . . 10.0 111.611 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -72.87 -0.89 14.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.048 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -88.57 -12.08 43.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.407 0.622 . . . . 10.0 109.782 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -97.06 87.76 4.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.387 -0.824 . . . . 10.0 109.983 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 4.5 mp -84.17 -160.16 0.44 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.809 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -79.69 100.52 7.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.088 0.47 . . . . 10.0 111.087 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -174.15 38.73 0.13 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.819 -0.912 . . . . 10.0 110.819 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 101.96 35.11 4.08 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.818 -0.706 . . . . 10.0 111.451 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 10.0 tt -68.0 -38.02 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 121.161 0.505 . . . . 10.0 111.987 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 42.1 mtt-85 -84.04 83.96 7.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.103 0.478 . . . . 10.0 111.551 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 15.5 tt -67.68 -16.97 21.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.215 -0.902 . . . . 10.0 111.739 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 7.7 m 71.1 -83.23 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.369 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -161.14 167.84 25.42 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -160.09 -41.58 0.05 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.137 0.273 . . . . 10.0 111.56 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 13.9 t -144.07 162.05 37.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.867 0.365 . . . . 10.0 111.231 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 21.8 m -105.44 114.46 28.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.062 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -102.59 104.51 14.9 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.047 -0.524 . . . . 10.0 109.778 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 14.8 m -117.48 126.3 52.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.021 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 9.2 p -123.62 133.37 69.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.151 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -83.71 -82.49 0.16 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.207 -0.451 . . . . 10.0 112.137 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 2.4 p -106.0 119.61 39.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.015 0.436 . . . . 10.0 112.029 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.67 113.7 32.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.02 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 42.0 t -113.0 128.6 69.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.312 -0.404 . . . . 10.0 111.023 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.8 115.02 1.8 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.677 -0.969 . . . . 10.0 110.677 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -124.07 125.63 44.85 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.518 0.562 . . . . 10.0 112.518 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.53 89.58 0.4 Allowed Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.592 -0.731 . . . . 10.0 113.876 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 55.58 52.55 10.91 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.161 0.505 . . . . 10.0 111.555 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 6.3 t -103.38 142.39 34.31 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.968 -0.56 . . . . 10.0 110.858 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -122.56 110.6 15.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.218 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 26.0 t -99.95 114.96 39.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.991 -0.374 . . . . 10.0 109.991 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -116.43 108.85 16.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.313 0.578 . . . . 10.0 111.27 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 44.3 mm -106.2 99.84 9.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.223 -0.658 . . . . 10.0 109.223 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.1 -171.46 32.72 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.792 -0.718 . . . . 10.0 111.313 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -110.28 161.75 15.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.918 0.389 . . . . 10.0 111.205 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -117.06 134.77 54.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.074 -0.512 . . . . 10.0 111.045 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -125.96 113.61 17.38 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.089 -0.505 . . . . 10.0 110.282 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 161.31 -178.15 37.35 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.271 -0.966 . . . . 10.0 112.64 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -108.37 41.6 2.17 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.839 -0.696 . . . . 10.0 112.965 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt -86.82 -22.23 25.97 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.699 -0.482 . . . . 10.0 109.699 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 98.93 -32.76 6.72 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.049 -0.596 . . . . 10.0 112.149 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 2.6 t80 176.71 137.72 0.06 Allowed 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.591 -0.522 . . . . 10.0 109.591 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -55.89 -74.49 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.581 0.55 . . . . 10.0 110.584 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 288' ' ' ASP . . . . . 0.481 ' CG ' ' HE ' ' E' ' 238' ' ' ARG . 48.5 t0 -125.8 117.82 24.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.456 0.646 . . . . 10.0 111.8 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -156.34 160.86 40.08 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.76 -1.2 . . . . 10.0 107.76 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -80.35 -64.62 1.15 Allowed 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.365 0.506 . . . . 10.0 112.365 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -148.57 -160.65 1.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.647 -0.251 . . . . 10.0 110.955 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -91.29 -161.02 0.77 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.814 -0.439 . . . . 10.0 109.814 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -71.18 133.35 46.1 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.475 -0.195 . . . . 10.0 110.475 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -122.33 147.09 46.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.595 -0.275 . . . . 10.0 110.941 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.355 -0.831 . . . . 10.0 109.6 178.949 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 110.21 -0.293 . . . . 10.0 110.21 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -132.13 114.48 14.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.701 0.286 . . . . 10.0 110.716 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 2.4 m -122.77 141.27 52.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.226 0.536 . . . . 10.0 111.719 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -135.69 121.09 19.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.813 -0.63 . . . . 10.0 109.41 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -79.9 -69.91 0.55 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.066 0.765 . . . . 10.0 113.066 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -124.58 126.0 45.08 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.753 -0.379 . . . . 10.0 111.852 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 54.8 mt -134.35 122.16 39.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.095 0.474 . . . . 10.0 110.78 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 37.5 mtm180 -122.41 123.34 41.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.087 -0.506 . . . . 10.0 110.336 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.69 114.06 16.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.877 -0.601 . . . . 10.0 111.568 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -124.83 162.23 24.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.157 -0.474 . . . . 10.0 111.687 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 61.57 74.72 0.43 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.653 0.983 . . . . 10.0 113.653 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 50.4 64.04 1.96 Allowed 'General case' 0 C--O 1.234 0.261 0 O-C-N 123.559 0.537 . . . . 10.0 111.69 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -123.15 174.77 7.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.774 -0.648 . . . . 10.0 110.986 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . 0.481 ' HE ' ' CG ' ' D' ' 288' ' ' ASP . 0.7 OUTLIER -149.63 149.47 30.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.911 0.386 . . . . 10.0 110.721 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 3.1 p -133.48 118.77 32.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.342 -0.844 . . . . 10.0 109.236 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -123.82 128.0 48.89 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.921 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.58 109.72 14.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.387 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 166.82 -173.63 42.15 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.94 -0.648 . . . . 10.0 112.221 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -101.99 137.72 39.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.743 0.306 . . . . 10.0 110.739 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 38.4 t -93.13 123.99 45.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.481 -0.327 . . . . 10.0 110.424 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 24.5 t -121.67 106.61 18.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.979 0.419 . . . . 10.0 110.917 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 8.9 t -68.43 164.73 20.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.845 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.16 -20.54 64.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.092 -0.503 . . . . 10.0 111.967 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -71.52 -19.96 62.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.443 -0.344 . . . . 10.0 110.429 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 59.26 -165.81 0.19 Allowed 'General case' 0 C--O 1.232 0.16 0 O-C-N 123.914 0.759 . . . . 10.0 111.649 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 7.3 tp -95.47 122.45 38.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.421 -0.354 . . . . 10.0 110.082 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 120.919 0.39 . . . . 10.0 111.354 -179.527 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 4.2 pt . . . . . 0 CA--C 1.519 -0.226 0 CA-C-O 121.081 0.467 . . . . 10.0 112.227 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.64 163.7 39.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.448 -0.796 . . . . 10.0 109.339 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -82.98 86.65 6.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.714 0.769 . . . . 10.0 110.709 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -66.21 -59.31 3.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.252 -0.885 . . . . 10.0 111.332 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 14.8 t -83.02 154.86 24.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.727 -0.67 . . . . 10.0 111.418 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 49.3 m -130.81 124.01 30.37 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.335 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -118.16 121.58 40.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.883 -0.599 . . . . 10.0 110.023 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 6.3 m -127.48 104.64 8.01 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.777 -0.453 . . . . 10.0 109.777 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 3.8 p -88.77 152.19 3.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 116.013 -0.54 . . . . 10.0 111.086 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -87.55 -82.9 0.21 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.966 -0.561 . . . . 10.0 111.44 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 18.2 m -132.52 119.96 21.25 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.854 0.359 . . . . 10.0 111.558 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 23.8 t -112.07 111.53 36.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.535 -0.543 . . . . 10.0 109.535 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 18.4 t -113.28 120.51 63.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.307 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -139.46 137.92 8.89 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.67 -0.776 . . . . 10.0 112.158 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -142.71 112.93 7.15 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.354 -0.239 . . . . 10.0 110.354 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 111.65 84.14 1.4 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.861 -0.685 . . . . 10.0 112.355 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 56.31 32.39 20.35 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.361 0.504 . . . . 10.0 112.361 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.3 152.17 38.58 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.002 -0.544 . . . . 10.0 111.449 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -135.88 102.06 4.94 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.894 -0.594 . . . . 10.0 109.987 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 26.7 t -107.58 115.43 48.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.685 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.35 113.58 17.76 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.416 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 46.5 mm -109.48 100.23 10.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.937 0.398 . . . . 10.0 110.653 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 164.28 -148.91 15.33 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.739 -0.664 . . . . 10.0 111.537 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 37.8 p30 -105.38 167.53 9.68 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.747 -0.266 . . . . 10.0 110.693 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -120.48 124.0 44.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.948 0.404 . . . . 10.0 111.397 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -156.84 94.76 1.47 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.822 -0.626 . . . . 10.0 110.261 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . -133.99 -81.08 0.16 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.288 -0.958 . . . . 10.0 112.695 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . 144.12 30.1 0.1 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.477 -0.868 . . . . 10.0 113.583 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -125.88 -51.66 1.57 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.257 0.465 . . . . 10.0 112.257 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.17 30.03 2.01 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.086 -1.054 . . . . 10.0 113.408 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -147.11 97.98 2.96 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.997 -1.112 . . . . 10.0 107.997 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 73.09 24.66 2.45 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 107.919 -1.141 . . . . 10.0 107.919 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -170.37 161.42 8.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.035 -1.438 . . . . 10.0 109.375 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -139.31 161.94 36.21 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.914 -0.402 . . . . 10.0 109.914 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 -152.82 167.72 28.11 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.155 -0.475 . . . . 10.0 111.133 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -74.51 -74.43 0.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.377 -0.374 . . . . 10.0 110.638 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 26.8 t60 67.68 155.18 0.11 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.674 -0.694 . . . . 10.0 111.96 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -122.48 135.97 54.78 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.294 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -93.88 179.36 5.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.564 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 41.3 t60 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.064 -0.97 . . . . 10.0 109.787 -179.664 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.621 0.248 . . . . 10.0 110.334 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -106.55 127.9 53.69 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.668 -0.494 . . . . 10.0 109.668 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 3.3 m -144.98 161.63 38.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.157 0.503 . . . . 10.0 111.572 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.5 158.61 44.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.049 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.4 tttm -108.81 -59.6 1.86 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.933 0.397 . . . . 10.0 111.34 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -143.23 127.61 17.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.939 0.399 . . . . 10.0 111.345 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 26.7 mt -131.1 131.13 63.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.851 0.357 . . . . 10.0 111.106 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -126.83 114.43 17.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.3 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.94 122.82 44.27 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.881 -0.6 . . . . 10.0 111.214 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -135.71 153.39 51.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.619 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 65.34 80.71 0.22 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.145 -0.934 . . . . 10.0 112.974 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 55.02 34.14 21.81 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.801 -0.636 . . . . 10.0 112.141 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -100.94 164.04 12.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.447 -0.342 . . . . 10.0 110.559 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -147.66 153.09 38.9 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.82 0.343 . . . . 10.0 111.161 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.76 128.6 67.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.219 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -129.26 131.81 47.08 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.065 -0.346 . . . . 10.0 110.065 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.97 142.46 51.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.549 -0.296 . . . . 10.0 110.783 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.38 -109.82 0.73 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.114 -0.565 . . . . 10.0 112.023 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -160.34 147.39 15.95 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.334 -0.617 . . . . 10.0 109.334 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 79.2 t -115.59 116.83 53.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.842 0.353 . . . . 10.0 111.204 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 16.8 t -110.5 112.98 42.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.965 -0.562 . . . . 10.0 109.586 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 6.0 m -89.89 151.06 21.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.274 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.01 -15.88 57.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.0 0.428 . . . . 10.0 111.661 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -73.2 -14.36 61.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.906 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -118.99 56.61 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.192 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 64.72 -135.33 0.26 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.317 -0.856 . . . . 10.0 111.951 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 -119.03 -175.45 2.91 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.309 -0.405 . . . . 10.0 110.434 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -75.02 70.92 1.75 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.199 -0.524 . . . . 10.0 112.667 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -65.96 -41.11 95.5 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.114 -0.565 . . . . 10.0 112.815 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 73.6 mt 73.97 141.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 122.946 0.498 . . . . 10.0 111.823 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 61.82 84.18 0.14 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.195 0.522 . . . . 10.0 111.768 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 45.3 mt -124.16 -42.84 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.309 -0.405 . . . . 10.0 110.773 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 6.2 p -125.19 -94.34 0.48 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.203 0.445 . . . . 10.0 112.203 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.1 t0 55.69 67.9 0.94 Allowed 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.653 0.596 . . . . 10.0 110.999 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -120.32 6.62 10.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.732 -0.667 . . . . 10.0 111.005 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 5.2 t -142.93 142.31 31.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.027 0.441 . . . . 10.0 111.282 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.16 119.75 28.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.757 -0.831 . . . . 10.0 108.757 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -113.73 117.22 30.9 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.606 -0.516 . . . . 10.0 109.606 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.0 m -145.72 137.15 24.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.897 0.379 . . . . 10.0 111.424 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.6 p -123.75 144.81 32.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.642 -0.503 . . . . 10.0 109.642 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -84.96 -76.33 0.32 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 112.695 0.628 . . . . 10.0 112.695 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.95 125.63 54.6 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.452 0.538 . . . . 10.0 112.452 -177.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 35.9 t -122.37 122.13 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.079 -0.51 . . . . 10.0 110.004 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 21.5 t -114.49 118.05 57.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.395 -0.366 . . . . 10.0 110.797 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.14 119.7 4.63 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.019 -0.832 . . . . 10.0 111.019 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -128.9 103.16 6.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.331 0.493 . . . . 10.0 112.331 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 92.37 91.3 1.47 Allowed Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.766 -0.73 . . . . 10.0 114.628 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 58.3 24.85 12.02 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.949 0.722 . . . . 10.0 112.949 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 9.9 m -74.99 135.04 41.34 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.231 0.539 . . . . 10.0 111.666 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 8.2 mtt180 -117.41 106.48 13.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.662 -0.699 . . . . 10.0 109.431 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 41.7 t -92.23 118.32 37.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.382 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -117.57 105.77 12.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.501 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 22.7 mm -100.71 89.23 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.632 -0.507 . . . . 10.0 109.632 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 161.66 161.49 11.91 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.505 -0.77 . . . . 10.0 111.897 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -76.76 156.65 32.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.677 0.275 . . . . 10.0 110.759 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.08 152.71 35.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.213 -0.449 . . . . 10.0 110.908 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -137.96 93.11 2.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.521 -0.763 . . . . 10.0 109.718 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -137.02 -93.75 0.34 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.447 -0.882 . . . . 10.0 112.842 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 125.32 -66.85 0.53 Allowed Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.223 -0.751 . . . . 10.0 111.223 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -86.49 93.1 9.07 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.253 -0.647 . . . . 10.0 109.253 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.56 86.82 1.74 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.789 -0.924 . . . . 10.0 110.789 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -58.1 98.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.048 0.388 . . . . 10.0 112.048 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 4.0 t90 59.92 -79.37 0.02 OUTLIER 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.192 0.812 . . . . 10.0 113.192 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -141.39 74.78 1.47 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.317 -0.623 . . . . 10.0 109.317 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -151.78 132.69 14.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.952 -0.567 . . . . 10.0 111.493 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -151.62 97.56 2.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.987 -0.551 . . . . 10.0 109.739 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -113.54 128.86 56.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.912 -0.585 . . . . 10.0 111.187 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -115.38 -23.99 8.61 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.977 -0.556 . . . . 10.0 109.973 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -72.77 138.53 46.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.766 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -142.73 136.1 28.61 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.357 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.296 -0.859 . . . . 10.0 110.059 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 110.016 -0.364 . . . . 10.0 110.016 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -123.4 116.53 23.41 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 123.413 0.445 . . . . 10.0 110.179 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.32 141.72 51.69 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.047 -0.524 . . . . 10.0 110.72 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.58 146.3 50.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.787 0.327 . . . . 10.0 111.823 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -90.02 -79.98 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.837 0.68 . . . . 10.0 112.837 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.47 123.06 32.67 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.442 0.639 . . . . 10.0 112.094 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 48.6 mt -121.02 125.72 74.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.507 -0.77 . . . . 10.0 110.656 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 19.6 mtt180 -117.82 117.64 29.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.641 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 1.2 p -118.93 120.07 36.2 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.819 -0.628 . . . . 10.0 110.834 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -131.0 153.46 49.21 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.084 0.401 . . . . 10.0 112.084 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 64.31 72.71 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.387 0.884 . . . . 10.0 113.387 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 48.6 mtm-85 60.27 24.29 13.71 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.845 0.683 . . . . 10.0 112.845 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.58 147.14 26.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.837 0.351 . . . . 10.0 110.871 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.73 153.18 48.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.477 -0.329 . . . . 10.0 110.832 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.65 137.25 47.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.658 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -126.29 136.4 52.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.021 0.439 . . . . 10.0 110.741 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.2 93.82 4.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.741 -0.663 . . . . 10.0 110.183 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 164.87 174.58 34.74 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.434 -0.889 . . . . 10.0 112.596 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -87.02 144.36 26.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.703 0.287 . . . . 10.0 110.973 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 48.3 t -102.96 111.26 32.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.523 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 48.3 t -117.76 109.39 27.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.078 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 43.1 p -84.27 171.89 12.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.011 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.23 -11.18 38.25 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.099 -0.5 . . . . 10.0 111.517 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -77.88 -21.48 51.23 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.198 0.523 . . . . 10.0 110.731 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -82.83 -7.83 59.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.786 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 40.1 tp -66.93 133.85 50.82 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.292 -0.633 . . . . 10.0 109.292 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 64.2 m80 66.11 26.56 10.65 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.457 0.473 . . . . 10.0 110.801 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -114.66 169.69 12.97 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.04 -0.6 . . . . 10.0 111.643 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -94.46 79.68 0.93 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.766 -0.73 . . . . 10.0 112.376 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 9.9 mt -79.42 63.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.007 0.432 . . . . 10.0 111.328 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -168.05 78.22 0.15 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.179 0.514 . . . . 10.0 110.398 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 22.6 pt -106.84 38.05 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.547 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 65.78 43.03 3.28 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.634 -0.712 . . . . 10.0 110.362 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -63.74 99.15 0.22 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.152 -0.931 . . . . 10.0 110.616 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -130.49 93.07 3.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.501 -0.772 . . . . 10.0 111.508 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 5.4 t -160.24 146.54 15.59 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.886 -0.597 . . . . 10.0 109.932 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.15 121.03 44.01 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.867 -0.606 . . . . 10.0 109.634 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -107.53 122.71 47.21 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.66 -0.496 . . . . 10.0 109.66 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 65.8 m -146.53 129.99 16.8 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.946 0.403 . . . . 10.0 110.955 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.53 142.46 43.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.699 -0.682 . . . . 10.0 109.889 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -87.27 -75.04 0.42 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.488 0.551 . . . . 10.0 112.488 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.6 m -108.46 124.65 50.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.41 0.522 . . . . 10.0 112.41 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 3.1 t -122.36 107.51 19.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.763 -0.653 . . . . 10.0 109.94 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.81 118.54 44.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.418 -0.355 . . . . 10.0 111.07 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.48 113.25 2.26 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.312 -0.715 . . . . 10.0 111.312 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -130.39 120.35 24.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.231 0.456 . . . . 10.0 112.231 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 95.5 69.17 1.03 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.618 -0.801 . . . . 10.0 113.412 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 56.86 27.16 12.55 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 112.797 0.665 . . . . 10.0 112.797 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 17.7 m -67.33 156.51 36.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.464 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -128.38 116.06 19.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.686 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 46.0 t -100.64 115.13 41.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.914 -0.584 . . . . 10.0 109.683 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.17 112.66 24.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.399 -0.364 . . . . 10.0 110.515 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 28.1 mm -105.42 89.05 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.217 0.532 . . . . 10.0 109.659 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 159.93 175.06 30.49 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.594 -0.73 . . . . 10.0 111.603 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -93.74 164.87 12.97 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.364 -0.235 . . . . 10.0 110.364 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.1 157.93 36.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.8 0.334 . . . . 10.0 111.317 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.7 71.69 1.36 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.395 -0.82 . . . . 10.0 108.888 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -97.19 -87.99 1.85 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.015 -0.612 . . . . 10.0 112.975 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 113.84 -49.1 0.87 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.765 -0.731 . . . . 10.0 111.861 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -87.71 20.52 2.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.268 0.556 . . . . 10.0 110.45 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 171.57 174.38 39.16 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.493 -1.043 . . . . 10.0 110.493 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -122.57 76.36 1.33 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.028 -0.73 . . . . 10.0 109.028 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 15.6 t90 69.82 -59.52 0.5 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.311 -0.859 . . . . 10.0 111.641 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -118.51 -172.48 2.28 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.769 -0.826 . . . . 10.0 108.769 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -101.52 126.69 48.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.224 0.535 . . . . 10.0 112.02 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -155.21 124.95 6.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.894 -0.594 . . . . 10.0 109.923 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -159.74 137.09 9.68 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.519 -0.549 . . . . 10.0 109.519 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -148.42 -167.8 2.91 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 123.148 0.28 . . . . 10.0 110.421 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -104.46 143.15 33.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.784 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -95.19 -173.1 2.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.744 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 4.2 t60 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.905 -1.045 . . . . 10.0 109.178 179.285 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 110.253 -0.277 . . . . 10.0 110.253 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -127.8 102.9 7.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.015 -0.538 . . . . 10.0 109.812 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.04 133.55 48.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.843 -0.617 . . . . 10.0 111.808 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.96 129.9 46.03 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.22 -0.659 . . . . 10.0 109.22 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -87.55 -81.75 0.23 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.087 0.403 . . . . 10.0 112.087 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -119.06 119.12 33.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.091 0.472 . . . . 10.0 111.872 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 59.3 mt -122.4 133.19 69.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.171 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 21.9 ttm-85 -122.97 118.83 28.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.087 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.73 101.54 7.52 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.352 -0.386 . . . . 10.0 110.634 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -120.44 156.56 31.19 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.99 0.367 . . . . 10.0 111.99 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 68.86 68.75 0.28 Allowed 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.966 0.791 . . . . 10.0 111.946 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 57.58 33.18 22.92 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.453 -0.794 . . . . 10.0 112.603 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.29 149.15 22.47 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.864 0.364 . . . . 10.0 110.091 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.19 140.75 47.73 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.327 -0.397 . . . . 10.0 110.831 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 4.5 p -127.53 138.86 53.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.252 -0.431 . . . . 10.0 111.011 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -123.7 123.94 41.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.974 0.416 . . . . 10.0 110.55 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -103.23 86.72 2.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.353 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.37 -177.78 42.82 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.553 -0.832 . . . . 10.0 112.707 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -93.63 151.14 19.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.667 0.27 . . . . 10.0 110.577 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 45.9 t -109.0 111.11 34.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.774 0.321 . . . . 10.0 110.617 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 23.7 t -113.94 110.76 33.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.178 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 21.3 p -75.75 161.74 28.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.854 0.359 . . . . 10.0 110.974 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.44 12.78 0.55 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.159 -0.473 . . . . 10.0 112.211 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -109.42 -6.7 15.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.159 0.504 . . . . 10.0 110.135 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -99.72 89.57 4.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.749 -0.659 . . . . 10.0 110.85 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 3.2 mp -118.41 7.08 11.85 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.869 -0.605 . . . . 10.0 111.337 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -93.84 80.66 4.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.217 0.532 . . . . 10.0 109.778 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -123.65 148.54 16.78 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.438 -0.887 . . . . 10.0 113.188 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -140.77 127.15 3.34 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.118 -1.193 . . . . 10.0 110.118 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 11.9 tt -65.15 109.13 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.395 0.617 . . . . 10.0 112.155 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 -164.5 122.33 1.71 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.482 -0.781 . . . . 10.0 110.574 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 19.1 tt -96.35 137.53 23.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.213 0.53 . . . . 10.0 111.281 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 14.2 m -156.21 -169.6 3.1 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.621 -0.881 . . . . 10.0 108.621 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.96 163.49 27.77 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.384 -0.228 . . . . 10.0 110.384 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -153.4 159.45 42.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.744 0.307 . . . . 10.0 111.113 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.17 113.72 15.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.681 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.78 143.69 30.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.308 -0.405 . . . . 10.0 110.749 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -141.84 132.52 25.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.892 0.377 . . . . 10.0 110.683 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 16.7 m -140.97 136.85 32.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.224 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 10.3 p -122.81 137.21 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 120.877 0.37 . . . . 10.0 111.145 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -79.22 -73.19 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.533 0.568 . . . . 10.0 112.533 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 1.3 m -120.67 123.79 43.63 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.899 0.703 . . . . 10.0 112.899 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 2.8 t -121.06 116.63 50.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.248 -0.649 . . . . 10.0 109.248 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 59.9 t -114.08 117.15 54.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.898 0.38 . . . . 10.0 111.357 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.09 126.02 6.89 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.762 -0.935 . . . . 10.0 110.762 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -133.43 125.43 29.02 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.912 0.338 . . . . 10.0 111.912 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.67 86.87 0.62 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 121.281 -0.485 . . . . 10.0 113.822 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 51.1 37.53 18.33 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.283 0.563 . . . . 10.0 111.699 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 8.0 t -78.29 163.28 25.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.698 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -143.53 121.64 12.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.791 -0.641 . . . . 10.0 110.457 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 33.8 t -111.35 116.56 52.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.152 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.03 109.89 21.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.095 0.474 . . . . 10.0 110.472 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 27.1 mm -105.89 91.21 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.409 -0.36 . . . . 10.0 110.448 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 157.66 -174.09 35.05 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.664 -0.779 . . . . 10.0 111.476 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -97.67 149.11 22.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.873 0.336 . . . . 10.0 110.59 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -116.08 142.66 46.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.864 0.364 . . . . 10.0 111.64 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -124.04 96.39 4.92 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.633 -0.876 . . . . 10.0 108.633 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . -111.18 166.34 12.26 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.848 -0.692 . . . . 10.0 112.935 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -116.51 -51.51 0.38 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.776 -0.726 . . . . 10.0 112.386 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -75.58 -40.82 56.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.434 0.635 . . . . 10.0 109.725 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -165.2 -159.24 11.22 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.715 -0.954 . . . . 10.0 110.715 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -84.11 -173.02 4.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.65 0.225 . . . . 10.0 111.07 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 13.7 t90 -55.0 -33.29 62.44 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.185 0.517 . . . . 10.0 111.386 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -102.28 150.54 23.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.244 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -131.56 54.1 1.95 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.556 0.693 . . . . 10.0 110.38 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -109.37 -18.84 13.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.434 -0.803 . . . . 10.0 111.348 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -138.05 160.17 40.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.588 -0.278 . . . . 10.0 111.113 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 5.0 m170 68.73 175.05 0.28 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.857 0.688 . . . . 10.0 112.857 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 4.3 t60 . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.168 179.452 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 7.7 m120 . . . . . 0 N--CA 1.445 -0.714 0 N-CA-C 109.535 -0.542 . . . . 10.0 109.535 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 29.0 m -137.9 124.5 20.9 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.745 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -116.83 127.72 54.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.159 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -86.25 -73.85 0.44 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.347 0.499 . . . . 10.0 112.347 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -120.36 114.78 22.35 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.643 0.238 . . . . 10.0 111.643 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 54.1 mt -122.94 112.7 34.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.808 -0.441 . . . . 10.0 109.808 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 36.5 mtm180 -113.44 114.79 27.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.385 -0.371 . . . . 10.0 110.446 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.71 113.07 18.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.272 -0.422 . . . . 10.0 111.781 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . 0.423 ' CD ' ' HZ2' ' D' ' 270' ' ' LYS . 9.2 pt-20 -128.65 169.97 13.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.985 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 67.72 63.4 0.41 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.065 -0.516 . . . . 10.0 111.658 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 60.2 19.69 9.07 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.451 -0.795 . . . . 10.0 112.659 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -71.3 165.45 23.68 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.006 0.373 . . . . 10.0 112.006 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.85 143.56 27.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.148 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 4.9 p -137.64 141.72 38.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.47 -0.332 . . . . 10.0 111.459 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.93 134.79 52.51 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.313 -0.403 . . . . 10.0 110.783 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -118.11 96.11 5.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.949 -0.569 . . . . 10.0 110.394 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 170.81 -105.63 0.22 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.504 -0.855 . . . . 10.0 112.822 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -166.64 158.17 12.97 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.095 -0.335 . . . . 10.0 110.095 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 26.2 t -110.85 108.12 24.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.928 0.394 . . . . 10.0 111.594 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 28.6 t -107.47 123.44 62.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.558 -0.904 . . . . 10.0 108.558 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 246' ' ' THR . . . . . 0.408 ' C ' ' H ' ' D' ' 248' ' ' ALA . 34.7 p -104.58 157.83 16.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.89 0.376 . . . . 10.0 111.802 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.44 9.28 1.4 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.806 -0.634 . . . . 10.0 111.298 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' D' ' 246' ' ' THR . . . -95.9 -6.13 39.91 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.067 -0.716 . . . . 10.0 109.067 178.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -105.64 113.51 27.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.509 -0.769 . . . . 10.0 109.923 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 87.8 mt -90.39 -175.16 4.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.137 -0.483 . . . . 10.0 111.026 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -78.06 72.2 4.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.207 0.527 . . . . 10.0 111.192 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -145.04 59.63 0.5 Allowed Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.305 -0.718 . . . . 10.0 111.305 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 88.46 41.67 6.04 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 110.957 -0.857 . . . . 10.0 110.957 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 20.3 tt -84.05 -27.25 7.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.122 0.487 . . . . 10.0 110.707 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 57.8 mtt-85 -78.73 77.71 5.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.767 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 19.7 tt -64.89 -19.63 25.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.485 . . . . 10.0 111.274 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 7.5 m 64.94 -134.54 0.24 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.495 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -118.82 112.28 19.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.143 -0.317 . . . . 10.0 110.143 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -110.85 -79.43 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.862 0.319 . . . . 10.0 111.862 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 15.3 t -90.34 157.35 17.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.143 0.496 . . . . 10.0 111.894 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 55.9 m -108.64 111.97 24.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.421 -0.809 . . . . 10.0 109.512 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -103.08 109.38 20.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.854 0.359 . . . . 10.0 110.255 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 16.4 m -119.29 123.27 43.82 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.273 -0.422 . . . . 10.0 110.506 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 8.8 p -125.42 129.93 72.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.605 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -87.5 -73.96 0.46 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.371 0.878 . . . . 10.0 113.371 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 7.4 m -102.48 122.1 43.66 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.652 0.612 . . . . 10.0 112.652 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.35 117.72 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.199 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 33.0 t -114.25 128.02 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.024 0.44 . . . . 10.0 111.352 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -132.84 109.5 0.84 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.834 -0.621 . . . . 10.0 111.971 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . 0.423 ' HZ2' ' CD ' ' D' ' 234' ' ' GLU . 6.3 tttp -125.92 106.73 9.85 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.814 0.301 . . . . 10.0 111.814 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 97.84 88.92 1.9 Allowed Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.834 -0.698 . . . . 10.0 114.353 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 54.24 25.43 5.8 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.338 0.866 . . . . 10.0 113.338 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 18.9 m -74.75 142.98 44.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.104 0.478 . . . . 10.0 110.998 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 26.5 mtm180 -128.32 116.47 19.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.756 -0.656 . . . . 10.0 110.83 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 23.9 t -101.81 122.76 54.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.705 -0.679 . . . . 10.0 110.173 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.81 101.83 7.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.145 0.498 . . . . 10.0 110.658 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 41.7 mm -100.97 104.24 15.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.239 -0.652 . . . . 10.0 109.239 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.34 -161.32 30.04 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.892 -0.883 . . . . 10.0 110.892 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -120.86 156.94 30.89 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.232 0.516 . . . . 10.0 111.355 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -114.57 131.58 56.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.661 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -129.18 116.37 19.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.18 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 160.27 177.5 33.42 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.182 -1.008 . . . . 10.0 113.46 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -100.74 44.12 1.63 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.974 -0.632 . . . . 10.0 112.709 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -91.18 -18.81 23.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.128 0.489 . . . . 10.0 110.217 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.91 -32.83 6.81 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.643 -0.708 . . . . 10.0 112.419 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 3.9 t80 170.13 147.59 0.03 OUTLIER 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.022 -0.733 . . . . 10.0 109.022 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 35.4 t90 -52.5 -67.28 0.26 Allowed 'General case' 0 C--O 1.233 0.23 0 O-C-N 123.558 0.536 . . . . 10.0 109.821 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -150.35 144.77 25.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.088 0.471 . . . . 10.0 111.785 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -163.56 141.89 7.79 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.139 -1.06 . . . . 10.0 108.139 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -63.64 -33.83 76.49 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.073 0.768 . . . . 10.0 113.073 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -166.82 -172.22 2.04 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.984 0.364 . . . . 10.0 111.984 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -99.43 -154.13 0.46 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.654 -0.869 . . . . 10.0 108.654 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -71.34 121.88 19.3 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.047 -0.353 . . . . 10.0 110.047 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -98.38 127.52 44.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.405 -0.361 . . . . 10.0 110.28 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.326 -0.845 . . . . 10.0 110.069 179.758 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.355 0.121 . . . . 10.0 110.93 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -135.35 121.67 20.38 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.99 0.424 . . . . 10.0 110.805 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.69 128.62 52.04 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.777 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.3 118.21 22.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -82.09 -68.49 0.69 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.273 0.472 . . . . 10.0 112.273 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -124.87 125.25 43.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.653 0.263 . . . . 10.0 111.33 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 79.2 mt -128.02 118.35 48.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.023 -0.535 . . . . 10.0 110.82 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -115.39 105.36 12.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.423 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.06 104.81 11.22 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.78 -0.645 . . . . 10.0 110.111 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -123.26 149.02 45.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.246 0.461 . . . . 10.0 112.246 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 64.08 86.94 0.12 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 114.036 1.124 . . . . 10.0 114.036 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 56.45 29.36 15.17 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.603 -0.726 . . . . 10.0 112.712 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.9 155.94 17.82 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.912 -0.585 . . . . 10.0 111.336 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.82 147.19 46.44 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.081 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 1.6 p -133.01 125.48 51.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.409 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 8.4 tm0? -118.66 128.49 54.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.156 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.4 92.94 3.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.538 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 170.51 -161.9 34.93 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.681 -0.771 . . . . 10.0 112.274 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -107.26 147.96 29.55 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.809 0.338 . . . . 10.0 110.6 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 63.3 t -108.32 118.52 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.04 -0.527 . . . . 10.0 109.768 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 39.9 t -118.41 112.46 38.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.001 0.429 . . . . 10.0 111.701 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 7.9 t -69.69 167.23 17.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.504 -0.771 . . . . 10.0 110.749 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.46 -17.33 62.6 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.336 -0.393 . . . . 10.0 111.554 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -67.66 -24.76 65.47 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.406 -0.361 . . . . 10.0 110.766 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 57.01 -163.04 0.18 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.572 -0.74 . . . . 10.0 112.46 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 29.7 mt -89.94 125.13 35.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.856 -0.611 . . . . 10.0 109.847 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 10.0 112.045 -179.13 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 3.1 pt . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 112.943 0.72 . . . . 10.0 112.943 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 69.5 m -118.06 139.05 51.79 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -69.03 136.69 52.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.889 0.376 . . . . 10.0 111.194 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -117.93 -48.48 2.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.132 -0.486 . . . . 10.0 110.526 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 4.8 t -78.03 149.8 33.94 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.011 -0.541 . . . . 10.0 110.256 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 55.8 m -127.58 113.18 15.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.306 0.574 . . . . 10.0 111.564 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -94.86 102.09 13.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.615 -0.72 . . . . 10.0 109.683 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 10.9 m -114.51 120.11 39.12 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.777 0.322 . . . . 10.0 110.455 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.1 p -114.74 144.5 22.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.229 -0.442 . . . . 10.0 111.169 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -86.27 -79.28 0.26 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 10.0 111.892 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 3.6 m -122.16 119.73 32.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.984 0.421 . . . . 10.0 111.797 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 2.7 t -113.53 105.94 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.042 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.18 125.88 68.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 110.01 -0.367 . . . . 10.0 110.01 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -149.83 136.83 5.89 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.702 -0.761 . . . . 10.0 112.123 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -133.64 151.41 51.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.6 0.238 . . . . 10.0 110.837 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 76.3 76.33 0.82 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.086 -0.578 . . . . 10.0 112.513 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 61.32 42.03 12.34 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.998 0.428 . . . . 10.0 111.707 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 9.6 t -64.95 155.04 35.75 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.604 -0.726 . . . . 10.0 111.715 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -136.65 101.68 4.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.351 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 65.7 t -101.45 119.61 49.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.787 0.327 . . . . 10.0 110.182 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.92 114.92 19.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.351 -0.386 . . . . 10.0 110.762 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 17.2 mm -117.9 84.38 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.799 -0.445 . . . . 10.0 109.799 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 178.9 -147.31 7.71 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.494 -0.86 . . . . 10.0 112.485 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.89 146.34 42.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.766 0.317 . . . . 10.0 110.694 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -107.82 115.27 29.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.108 0.48 . . . . 10.0 111.156 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -142.8 91.8 2.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.002 -0.544 . . . . 10.0 110.037 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . -147.86 -95.83 0.16 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.469 -0.872 . . . . 10.0 112.932 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -168.48 -104.71 0.18 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.877 -0.889 . . . . 10.0 110.877 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? 26.24 -85.28 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.396 1.628 . . . . 10.0 115.396 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.96 32.32 0.36 Allowed Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.549 -1.02 . . . . 10.0 110.549 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -161.33 105.51 1.3 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.822 -0.807 . . . . 10.0 108.822 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 75.15 10.7 3.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.896 0.855 . . . . 10.0 109.257 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -159.83 154.54 24.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.196 -1.366 . . . . 10.0 109.325 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.85 161.86 28.04 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.065 0.394 . . . . 10.0 112.065 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -164.48 167.76 19.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.607 -0.724 . . . . 10.0 109.895 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -106.26 -54.77 2.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.686 0.279 . . . . 10.0 110.679 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 292' ' ' HIS . . . . . 0.417 ' CG ' ' H ' ' E' ' 293' ' ' HIS . 4.9 t-80 63.28 -164.31 0.25 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.705 -0.679 . . . . 10.0 111.153 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 293' ' ' HIS . . . . . 0.417 ' H ' ' CG ' ' E' ' 292' ' ' HIS . 88.2 m-70 -128.0 125.26 39.07 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.693 -0.484 . . . . 10.0 109.693 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -90.45 133.18 35.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.785 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.09 -0.957 . . . . 10.0 109.714 -179.948 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.977 0.418 . . . . 10.0 110.367 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -113.7 111.01 21.11 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.605 -0.887 . . . . 10.0 108.605 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.06 144.85 50.28 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.052 0.76 . . . . 10.0 113.052 -178.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.41 151.73 47.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.106 -0.952 . . . . 10.0 108.683 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -102.75 -61.24 1.42 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.031 0.752 . . . . 10.0 113.031 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -131.79 117.24 18.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.06 0.457 . . . . 10.0 111.882 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 56.0 mt -124.05 136.96 58.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.561 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.3 ptp85 -126.29 105.21 8.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.099 0.476 . . . . 10.0 111.662 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.21 120.33 39.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.011 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -132.46 140.45 48.4 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.405 0.52 . . . . 10.0 112.405 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 65.61 86.01 0.13 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.162 -0.926 . . . . 10.0 113.231 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 96.7 mtm-85 50.66 35.17 11.12 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.361 -0.836 . . . . 10.0 112.738 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.59 146.95 25.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.69 -0.232 . . . . 10.0 110.45 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -124.83 159.29 31.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.562 -0.29 . . . . 10.0 110.413 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.4 p -142.73 126.32 14.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.857 0.36 . . . . 10.0 111.218 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -118.96 139.57 51.45 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.817 -0.438 . . . . 10.0 109.817 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.13 119.43 26.48 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.095 -0.335 . . . . 10.0 110.095 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 152.31 -108.05 0.36 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.751 -0.737 . . . . 10.0 111.967 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -153.85 158.98 41.63 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.864 -0.421 . . . . 10.0 109.864 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 18.1 t -110.88 113.19 43.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.126 0.489 . . . . 10.0 112.233 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 57.9 t -101.5 114.22 40.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 5.0 m -106.28 141.79 37.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.241 -0.436 . . . . 10.0 109.933 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.54 -18.15 27.2 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.539 0.57 . . . . 10.0 112.539 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -73.26 -23.49 60.34 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.287 -0.415 . . . . 10.0 111.353 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -110.26 46.19 1.06 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.199 0.523 . . . . 10.0 110.597 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 2.2 mm? 66.36 -155.33 0.24 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.254 -0.884 . . . . 10.0 112.112 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -89.46 -175.64 4.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.147 -0.478 . . . . 10.0 110.849 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -76.06 77.91 1.29 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.079 -0.582 . . . . 10.0 112.463 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -67.78 -43.63 83.35 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.26 -0.495 . . . . 10.0 112.086 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 1.3 mp 69.4 136.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 112.779 0.659 . . . . 10.0 112.779 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? 65.83 89.57 0.1 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.499 -0.773 . . . . 10.0 111.977 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 3.5 mp -129.91 -55.38 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.127 -0.488 . . . . 10.0 111.462 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 5.6 p -105.87 -87.91 0.45 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.631 0.604 . . . . 10.0 112.631 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.25 42.95 17.62 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.76 -0.655 . . . . 10.0 111.634 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -84.45 -21.84 30.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.821 -0.627 . . . . 10.0 111.748 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 6.6 t -131.97 143.29 49.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.903 0.382 . . . . 10.0 111.119 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.06 144.12 27.02 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.757 -0.656 . . . . 10.0 109.85 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -122.06 122.96 40.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.818 0.342 . . . . 10.0 110.449 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.92 134.49 31.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.156 -0.474 . . . . 10.0 110.894 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.8 p -131.43 137.78 54.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.072 0.463 . . . . 10.0 111.342 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -77.85 -79.25 0.12 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.862 -0.608 . . . . 10.0 112.344 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.4 p -120.82 128.58 52.99 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.978 0.733 . . . . 10.0 112.978 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 4.2 t -119.31 127.18 75.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.852 -0.613 . . . . 10.0 109.817 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 24.8 t -114.73 120.04 63.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.459 -0.337 . . . . 10.0 110.415 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.23 107.66 0.83 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.892 -0.671 . . . . 10.0 111.714 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -126.36 148.23 49.62 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.428 -0.212 . . . . 10.0 110.428 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 76.84 58.96 3.32 Favored Glycine 0 C--O 1.226 -0.356 0 C-N-CA 120.797 -0.716 . . . . 10.0 113.47 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 62.15 21.29 12.32 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.923 0.712 . . . . 10.0 112.923 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 70.0 m -73.17 139.13 46.12 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.997 0.427 . . . . 10.0 111.202 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 12.5 mtt180 -104.57 123.45 47.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 10.0 111.393 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 46.0 t -102.15 117.32 47.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.087 -0.506 . . . . 10.0 109.912 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.41 114.12 21.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.867 0.365 . . . . 10.0 111.511 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 25.9 mm -107.8 103.02 14.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.842 -0.617 . . . . 10.0 109.693 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.34 142.04 3.91 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.792 -0.718 . . . . 10.0 111.908 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -61.85 149.71 39.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.933 0.397 . . . . 10.0 111.683 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.53 158.17 18.27 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.132 -0.485 . . . . 10.0 111.543 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -140.09 101.36 4.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.326 -0.852 . . . . 10.0 109.1 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -150.87 -115.37 0.7 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.517 -0.849 . . . . 10.0 113.055 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 146.6 -60.79 0.47 Allowed Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.225 -0.75 . . . . 10.0 111.225 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -79.9 85.37 5.55 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.009 -0.738 . . . . 10.0 109.009 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.45 105.43 2.07 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.67 -0.972 . . . . 10.0 110.67 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -75.71 76.24 2.69 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.402 -0.221 . . . . 10.0 110.402 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 18.2 t90 69.38 -58.4 0.51 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.9 -0.591 . . . . 10.0 112.098 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -135.21 90.53 2.63 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.064 -0.717 . . . . 10.0 109.064 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -150.34 119.79 6.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.781 0.324 . . . . 10.0 111.631 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -157.93 55.25 0.47 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.398 0.618 . . . . 10.0 109.972 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -105.5 121.56 44.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.644 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -123.24 2.36 9.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.16 0.505 . . . . 10.0 110.797 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -84.01 116.19 22.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.521 -0.763 . . . . 10.0 109.974 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -89.41 127.26 35.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.133 0.492 . . . . 10.0 111.081 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 1.1 p80 . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.355 -0.831 . . . . 10.0 110.711 179.489 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.201 -0.296 . . . . 10.0 110.201 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -119.13 114.04 21.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.538 -0.542 . . . . 10.0 109.538 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' SER . . . . . 0.433 ' C ' ' HAK' ' B' ' 1' ' ' CGO . 3.4 m -129.3 134.1 47.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.011 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.71 143.38 50.7 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.695 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -89.99 -79.57 0.34 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.344 -0.389 . . . . 10.0 111.723 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . 0.435 ' CG ' HH21 ' B' ' 232' ' ' ARG . 18.8 t70 -122.56 126.08 47.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.311 0.577 . . . . 10.0 112.498 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 65.6 mt -122.76 114.66 43.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.563 -0.744 . . . . 10.0 109.053 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . 0.435 HH21 ' CG ' ' B' ' 230' ' ' ASP . 1.7 ttm180 -109.87 106.78 16.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.926 0.393 . . . . 10.0 110.66 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.08 128.69 55.0 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.13 -0.486 . . . . 10.0 111.106 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -141.26 168.23 20.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.535 -0.302 . . . . 10.0 111.373 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 65.34 62.65 0.68 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.89 -0.595 . . . . 10.0 111.777 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 81.8 mtm-85 57.05 44.91 21.88 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.924 -0.58 . . . . 10.0 112.227 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.08 163.43 14.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.865 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.09 122.31 22.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.097 0.475 . . . . 10.0 110.362 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 p -115.86 125.61 73.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.312 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -119.79 128.24 53.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.849 -0.614 . . . . 10.0 111.089 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.35 97.51 6.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.027 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 156.18 169.15 20.03 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.909 -0.663 . . . . 10.0 112.186 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -87.95 137.86 31.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.831 0.348 . . . . 10.0 110.84 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 94.0 t -91.16 123.28 43.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.969 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 17.7 t -121.96 102.29 11.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.41 0.624 . . . . 10.0 110.493 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 68.4 p -81.57 162.8 23.0 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.661 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.95 -14.15 32.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.104 0.478 . . . . 10.0 111.254 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -75.95 -14.83 60.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.692 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -95.44 -2.16 49.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 10.0 111.111 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 87.9 mt -76.17 140.35 41.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.334 -0.394 . . . . 10.0 110.385 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 65.97 28.51 10.51 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 123.597 0.56 . . . . 10.0 110.862 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -131.11 174.22 20.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.055 -0.593 . . . . 10.0 111.714 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -83.08 115.83 4.1 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.131 -0.557 . . . . 10.0 112.478 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 29.5 pt -109.71 17.97 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.026 0.441 . . . . 10.0 111.672 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . 0.445 HH12 ' CG ' ' B' ' 258' ' ' ASP . 0.0 OUTLIER -129.03 103.82 7.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.27 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 20.1 pt -132.18 35.73 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 111.866 0.321 . . . . 10.0 111.866 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 62.3 m 64.29 33.53 11.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.326 0.584 . . . . 10.0 111.466 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.445 ' CG ' HH12 ' B' ' 255' ' ' ARG . 0.7 OUTLIER -77.79 71.43 4.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.465 -0.789 . . . . 10.0 111.902 -179.582 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -96.15 113.8 25.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.024 -0.535 . . . . 10.0 109.777 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 14.7 t -158.82 141.76 14.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.551 0.691 . . . . 10.0 111.961 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.14 95.96 5.92 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.298 -0.864 . . . . 10.0 108.813 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -91.37 132.21 36.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.386 -0.37 . . . . 10.0 110.66 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.9 p -145.52 136.05 24.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.656 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . 0.436 ' N ' ' HAL' ' B' ' 1' ' ' CGO . 8.0 p -124.56 131.53 72.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.884 -0.598 . . . . 10.0 110.103 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -73.14 -62.74 1.36 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.333 0.494 . . . . 10.0 112.333 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 24.8 m -135.46 124.44 24.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.147 0.499 . . . . 10.0 112.087 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 20.7 t -111.33 118.95 58.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.736 -0.665 . . . . 10.0 109.356 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 39.9 t -103.88 116.73 48.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.904 0.383 . . . . 10.0 110.829 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.75 113.34 2.35 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.395 -0.682 . . . . 10.0 111.395 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 2.4 ttpp -128.76 131.05 47.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.665 0.269 . . . . 10.0 111.456 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.47 71.94 1.2 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.571 -0.823 . . . . 10.0 113.479 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 53.05 43.8 31.22 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.386 0.884 . . . . 10.0 113.386 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.61 149.73 34.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.236 0.541 . . . . 10.0 111.552 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -120.0 118.7 31.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.652 -0.704 . . . . 10.0 110.024 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 47.4 t -110.11 127.17 67.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.138 -0.483 . . . . 10.0 111.062 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.83 109.61 13.84 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.857 -0.423 . . . . 10.0 109.857 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 36.4 mm -102.25 100.37 10.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.993 -0.373 . . . . 10.0 109.993 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.41 176.54 19.45 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.685 -0.566 . . . . 10.0 111.685 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -97.99 156.63 16.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.9 0.35 . . . . 10.0 110.576 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -128.83 161.47 29.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.912 0.386 . . . . 10.0 111.422 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -134.33 127.04 30.92 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.546 -0.752 . . . . 10.0 109.852 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 167.74 152.34 7.47 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.774 -0.727 . . . . 10.0 112.04 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -123.97 8.38 8.64 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.509 -0.853 . . . . 10.0 111.982 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -97.67 15.17 24.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.055 0.455 . . . . 10.0 110.863 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 156.93 -176.44 34.19 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.218 -0.753 . . . . 10.0 111.218 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -127.29 64.09 1.33 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.389 -0.597 . . . . 10.0 109.389 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 17.3 t90 70.46 -54.21 0.64 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.948 0.78 . . . . 10.0 111.42 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . 0.446 ' CG ' HH11 ' C' ' 238' ' ' ARG . 3.0 t70 -109.13 -168.52 1.35 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.688 -0.687 . . . . 10.0 109.617 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -111.42 132.71 54.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.058 0.456 . . . . 10.0 111.689 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.41 125.08 6.44 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.91 143.4 12.62 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.121 -0.326 . . . . 10.0 110.121 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -173.69 -161.99 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.398 -0.364 . . . . 10.0 110.462 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -122.41 149.0 44.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.613 -0.267 . . . . 10.0 111.105 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -83.85 -179.16 7.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.709 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 . . . . . 0 C--O 1.252 1.186 0 CA-C-O 117.909 -1.044 . . . . 10.0 108.852 -179.699 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 1.7 ptt-85 . . . . . 0 N--CA 1.483 1.175 0 N-CA-C 110.21 -0.293 . . . . 10.0 110.21 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -131.26 129.06 41.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.349 . . . . 10.0 110.661 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.07 135.46 45.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.166 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.12 138.33 45.16 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.964 -0.384 . . . . 10.0 109.964 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 18.6 tttm -94.2 -78.65 0.43 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.07 0.396 . . . . 10.0 112.07 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -109.81 116.25 31.32 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.301 0.482 . . . . 10.0 112.301 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 63.4 mt -123.93 117.45 51.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.087 -0.506 . . . . 10.0 110.101 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -109.26 120.69 43.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.888 0.375 . . . . 10.0 111.074 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.96 112.85 16.41 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.907 -0.775 . . . . 10.0 108.907 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -138.08 161.07 37.72 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.347 0.499 . . . . 10.0 112.347 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 64.73 69.89 0.49 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.883 -1.053 . . . . 10.0 110.943 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 55.58 63.14 2.16 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.845 -1.071 . . . . 10.0 110.449 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -118.47 167.67 11.38 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.766 -0.652 . . . . 10.0 110.442 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . 0.446 HH11 ' CG ' ' B' ' 288' ' ' ASP . 0.0 OUTLIER -153.24 141.6 20.64 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.602 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 5.7 p -125.13 132.81 70.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.499 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -106.72 122.62 46.72 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.592 -0.731 . . . . 10.0 109.122 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.62 69.72 0.7 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.519 -0.309 . . . . 10.0 111.442 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 175.51 -169.5 42.29 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.409 -0.901 . . . . 10.0 112.228 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -95.66 144.93 25.67 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.265 -0.272 . . . . 10.0 110.265 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.96 105.99 19.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.295 -0.411 . . . . 10.0 110.363 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.66 118.71 53.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.254 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 246' ' ' THR . . . . . 0.413 ' C ' ' H ' ' C' ' 248' ' ' ALA . 32.2 p -76.98 163.86 26.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.069 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -72.89 16.05 0.17 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.685 0.624 . . . . 10.0 112.685 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . 0.413 ' H ' ' C ' ' C' ' 246' ' ' THR . . . -121.39 0.67 10.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.067 0.461 . . . . 10.0 109.921 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -109.71 67.14 0.64 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.143 0.497 . . . . 10.0 110.576 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.31 25.84 9.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.059 -0.519 . . . . 10.0 111.295 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -113.99 67.76 0.68 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.36 0.6 . . . . 10.0 111.559 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -140.08 143.04 13.15 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.942 -0.863 . . . . 10.0 110.942 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -95.57 -145.8 19.6 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.113 -1.041 . . . . 10.0 111.833 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 6.9 tp -132.52 110.55 16.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.255 0.55 . . . . 10.0 110.475 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 42.6 ttt85 -158.26 140.5 14.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.782 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 9.6 tt -102.93 134.95 42.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 121.448 0.642 . . . . 10.0 111.587 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 57.9 m -159.73 -170.74 3.01 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.526 -0.761 . . . . 10.0 109.16 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.1 155.42 36.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.789 0.328 . . . . 10.0 111.419 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.02 132.84 12.32 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.247 -0.649 . . . . 10.0 109.247 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 3.7 t -68.39 154.14 42.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.328 0.585 . . . . 10.0 112.043 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 52.8 m -123.44 120.61 33.46 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.451 -0.795 . . . . 10.0 110.23 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -107.64 125.98 52.01 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.113 -0.699 . . . . 10.0 109.113 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 13.4 m -136.37 131.72 34.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.016 0.436 . . . . 10.0 110.87 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 6.9 p -118.77 139.19 46.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.335 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -74.75 -58.59 3.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.199 -0.455 . . . . 10.0 112.046 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 2.7 m -136.51 133.98 37.08 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.386 0.513 . . . . 10.0 112.386 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 24.9 t -123.73 116.72 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.469 -0.937 . . . . 10.0 108.469 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 6.5 t -113.9 108.74 26.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 120.94 0.4 . . . . 10.0 110.906 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.55 125.02 6.17 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.907 -0.877 . . . . 10.0 110.907 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -133.22 117.77 17.8 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.933 0.345 . . . . 10.0 111.933 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 90.33 91.39 1.27 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.885 -0.674 . . . . 10.0 113.122 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 59.25 36.24 23.63 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.94 0.4 . . . . 10.0 111.688 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.85 145.67 42.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.837 -0.62 . . . . 10.0 112.447 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -139.14 109.58 6.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.714 -0.675 . . . . 10.0 110.483 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.68 132.74 48.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.052 -0.522 . . . . 10.0 110.651 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.75 106.31 11.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.685 0.278 . . . . 10.0 110.812 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 23.2 mm -101.69 85.98 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.312 0.577 . . . . 10.0 110.063 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 160.83 -170.33 36.69 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.541 -0.754 . . . . 10.0 111.219 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -102.67 154.94 18.66 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.202 -0.587 . . . . 10.0 110.967 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -108.4 142.67 38.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.321 -0.399 . . . . 10.0 110.407 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.34 97.09 3.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.157 -0.474 . . . . 10.0 109.728 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . -145.96 158.87 27.82 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.861 -0.685 . . . . 10.0 112.781 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -106.5 -15.07 18.25 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.706 -0.759 . . . . 10.0 112.51 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -74.17 -38.59 63.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.275 0.56 . . . . 10.0 110.285 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 170.65 -112.39 0.45 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.147 -1.181 . . . . 10.0 110.147 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -126.08 -169.9 2.09 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.72 -0.474 . . . . 10.0 109.72 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -57.97 -24.3 57.48 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.272 0.558 . . . . 10.0 111.545 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -110.72 157.08 20.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.943 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -133.85 19.84 3.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.151 0.5 . . . . 10.0 111.307 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -81.15 -10.13 59.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.706 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.52 168.37 22.1 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.305 0.483 . . . . 10.0 112.305 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 66.51 174.04 0.24 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.5 -0.773 . . . . 10.0 112.646 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.85 -145.46 0.16 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.351 0.5 . . . . 10.0 112.351 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -68.6 -83.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.923 0.712 . . . . 10.0 112.923 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.08 0 N-CA-C 109.106 -0.702 . . . . 10.0 109.106 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.84 0.352 . . . . 10.0 111.367 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -63.77 123.01 17.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.995 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 1.8 m -146.42 153.46 40.5 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.277 -0.42 . . . . 10.0 110.764 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.29 148.74 46.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.624 0.249 . . . . 10.0 110.922 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -89.67 -77.78 0.38 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.393 -0.367 . . . . 10.0 111.045 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -125.13 120.18 30.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.923 0.392 . . . . 10.0 110.913 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 62.1 mt -118.69 124.28 72.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.908 -0.587 . . . . 10.0 110.541 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 6.1 mtm105 -108.5 127.87 54.3 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.882 -0.599 . . . . 10.0 109.786 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.77 111.56 11.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.356 -0.384 . . . . 10.0 110.079 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -124.57 154.56 40.46 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.68 0.622 . . . . 10.0 112.68 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 58.15 78.42 0.25 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 114.996 -1.002 . . . . 10.0 113.365 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 52.82 50.62 17.65 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.237 -0.892 . . . . 10.0 111.783 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.97 154.86 19.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.187 -0.461 . . . . 10.0 110.423 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.05 144.68 43.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.885 0.374 . . . . 10.0 110.912 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.96 131.26 71.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.556 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -113.28 121.7 45.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.353 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -116.06 93.49 4.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.941 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 174.64 -120.2 0.77 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.229 -0.986 . . . . 10.0 112.791 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -152.56 152.95 32.47 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.734 -0.469 . . . . 10.0 109.734 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 22.6 t -97.12 106.37 18.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.163 -0.471 . . . . 10.0 111.873 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.16 93.48 2.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.278 -0.638 . . . . 10.0 109.278 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 246' ' ' THR . . . . . 0.405 ' C ' ' H ' ' D' ' 248' ' ' ALA . 41.6 p -74.16 153.54 39.47 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.821 -0.351 . . . . 10.0 110.387 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.29 11.63 0.72 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.826 0.346 . . . . 10.0 111.731 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . 0.405 ' H ' ' C ' ' D' ' 246' ' ' THR . . . -95.7 -3.99 45.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.25 0.548 . . . . 10.0 109.653 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -99.61 137.13 38.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.692 -0.686 . . . . 10.0 110.168 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 6.9 tp -118.24 -157.38 0.68 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.626 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -91.15 63.88 5.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.038 0.447 . . . . 10.0 111.338 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -132.28 36.67 2.15 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 111.063 -0.815 . . . . 10.0 111.063 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 107.52 52.35 0.72 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.418 -0.673 . . . . 10.0 111.418 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 20.1 tt -87.48 -20.89 7.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.953 0.406 . . . . 10.0 110.87 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -83.97 70.18 10.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.02 0.438 . . . . 10.0 110.794 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 18.1 tt -64.25 -30.2 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.751 -0.659 . . . . 10.0 111.851 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 7.3 m 66.18 -172.8 0.19 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.924 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.92 93.94 6.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.911 0.386 . . . . 10.0 110.557 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -94.59 -44.05 8.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.12 -0.491 . . . . 10.0 111.431 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 10.3 t -123.25 150.36 43.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.921 0.391 . . . . 10.0 111.003 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 5.5 m -104.46 103.69 13.43 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.415 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -102.64 110.23 22.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.206 -0.452 . . . . 10.0 109.869 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 25.8 m -124.81 131.9 53.4 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.942 0.401 . . . . 10.0 111.047 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 11.3 p -126.95 138.13 55.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.141 -0.481 . . . . 10.0 110.375 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -86.55 -73.02 0.48 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.784 0.661 . . . . 10.0 112.784 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.55 125.8 52.23 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.716 0.635 . . . . 10.0 112.716 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 4.2 t -127.82 113.88 32.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.247 -0.649 . . . . 10.0 109.247 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 42.0 t -116.2 113.1 42.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 120.685 0.279 . . . . 10.0 110.976 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.55 137.09 9.44 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.001 -0.619 . . . . 10.0 112.11 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.23 135.8 19.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.638 -0.331 . . . . 10.0 111.122 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.63 89.75 0.23 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.15 -0.547 . . . . 10.0 112.861 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 59.48 38.31 22.61 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.033 0.444 . . . . 10.0 111.444 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 1.5 t -87.56 143.99 26.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.086 -0.506 . . . . 10.0 111.358 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 72.0 mtt85 -131.5 110.53 11.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.408 -0.815 . . . . 10.0 109.712 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 36.2 t -101.33 105.35 17.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.994 -0.373 . . . . 10.0 109.994 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -107.42 103.59 12.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.929 0.395 . . . . 10.0 110.628 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 42.9 mm -105.03 96.81 4.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.216 -0.447 . . . . 10.0 109.819 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 158.28 178.84 32.69 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.508 -0.637 . . . . 10.0 111.508 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -96.0 156.95 16.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.61 0.243 . . . . 10.0 110.395 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -118.44 131.23 56.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.843 0.354 . . . . 10.0 110.926 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -122.01 123.23 41.14 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.045 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 155.53 178.68 30.0 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.378 -0.915 . . . . 10.0 112.796 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -108.59 32.77 6.68 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.945 -0.645 . . . . 10.0 112.156 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.19 -9.15 59.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.897 0.379 . . . . 10.0 110.748 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.25 -51.51 1.41 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.076 -0.583 . . . . 10.0 111.709 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -171.42 145.95 2.19 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.831 -0.803 . . . . 10.0 108.831 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -56.07 -64.06 0.98 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.041 0.448 . . . . 10.0 110.383 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -136.29 132.33 35.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.3 0.572 . . . . 10.0 110.473 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -171.85 146.64 2.08 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -69.57 -58.96 3.3 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.849 0.685 . . . . 10.0 112.849 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -161.08 -163.04 0.97 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.826 0.306 . . . . 10.0 111.826 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -86.06 -170.49 3.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.891 -0.595 . . . . 10.0 109.819 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -72.76 117.78 14.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.012 0.434 . . . . 10.0 110.987 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -99.07 148.11 24.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.86 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 117.764 -1.112 . . . . 10.0 108.392 178.888 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 110.283 -0.265 . . . . 10.0 110.283 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -128.5 121.33 28.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.369 . . . . 10.0 110.998 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.0 144.46 49.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.718 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -139.62 125.83 20.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.29 -0.413 . . . . 10.0 109.938 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -84.0 -62.59 1.53 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.05 0.759 . . . . 10.0 113.05 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -130.85 125.4 33.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.779 0.323 . . . . 10.0 111.142 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 86.5 mt -133.59 123.97 47.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.042 -0.526 . . . . 10.0 110.306 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -122.23 120.35 33.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.143 -0.481 . . . . 10.0 110.538 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 1.2 p -130.45 93.78 3.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.518 -0.764 . . . . 10.0 110.295 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -119.29 152.11 37.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.334 -0.393 . . . . 10.0 111.0 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 70.72 77.22 0.19 Allowed 'General case' 0 C--O 1.236 0.362 0 O-C-N 123.912 0.757 . . . . 10.0 112.335 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 33.1 mtp180 60.67 24.43 14.23 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.078 -0.965 . . . . 10.0 112.246 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -103.47 150.93 23.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.197 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.55 164.57 30.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.201 -0.454 . . . . 10.0 111.777 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 7.7 p -134.63 142.58 40.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.767 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 25.5 tm0? -129.89 131.44 46.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.796 -0.638 . . . . 10.0 109.313 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.98 95.35 4.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.075 0.464 . . . . 10.0 111.786 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 166.32 170.76 31.64 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.435 -0.666 . . . . 10.0 111.435 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -88.14 147.59 24.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.827 0.346 . . . . 10.0 110.924 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.15 125.15 49.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.561 -0.533 . . . . 10.0 109.561 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.9 98.51 7.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.002 0.43 . . . . 10.0 109.86 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.7 t -60.93 161.92 7.62 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.729 -0.669 . . . . 10.0 111.578 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.09 -19.38 64.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.29 -0.414 . . . . 10.0 111.805 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -74.49 -23.47 58.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.536 -0.302 . . . . 10.0 110.242 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 58.07 -170.28 0.11 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.384 -0.826 . . . . 10.0 112.199 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 6.8 mp -83.99 115.66 22.44 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.234 -0.654 . . . . 10.0 109.234 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -80.42 1.32 29.63 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.019 0.378 . . . . 10.0 112.019 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -177.75 152.95 12.36 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.697 -0.561 . . . . 10.0 111.697 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 111.93 107.81 2.95 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.652 -0.785 . . . . 10.0 112.673 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 36.3 mt -96.3 -22.15 5.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.252 0.549 . . . . 10.0 109.951 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -82.56 58.89 4.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.813 -0.63 . . . . 10.0 110.71 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 15.3 pt -67.8 119.05 12.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.056 -0.52 . . . . 10.0 111.42 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.24 159.24 8.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.919 -0.582 . . . . 10.0 109.833 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.83 140.75 32.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.835 0.35 . . . . 10.0 110.225 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -114.11 -65.91 1.14 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.056 0.455 . . . . 10.0 111.113 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 15.3 t -71.46 146.31 48.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.278 0.561 . . . . 10.0 111.868 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 91.8 m -123.8 110.05 14.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.566 -0.743 . . . . 10.0 109.624 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -111.08 130.76 55.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.84 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 25.1 m -132.66 120.97 22.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.169 -0.469 . . . . 10.0 109.871 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 7.9 p -98.39 143.59 12.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.418 -0.355 . . . . 10.0 110.393 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -76.79 -75.89 0.18 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.358 -0.383 . . . . 10.0 111.895 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 7.7 m -139.81 120.22 14.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.968 0.414 . . . . 10.0 111.14 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 15.1 t -106.4 115.6 48.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.587 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 42.2 t -116.41 97.73 5.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.514 -0.55 . . . . 10.0 109.514 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.89 119.6 4.2 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.864 -0.684 . . . . 10.0 112.08 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 15.5 mtpt -132.04 133.32 44.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.525 0.202 . . . . 10.0 110.644 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.75 73.91 1.17 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.747 -0.739 . . . . 10.0 112.696 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 62.92 25.05 14.88 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.023 0.749 . . . . 10.0 113.023 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 4.6 m -79.06 157.77 27.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.206 0.527 . . . . 10.0 111.352 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -142.18 126.15 17.24 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.556 -0.747 . . . . 10.0 109.752 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 18.8 t -102.63 117.64 48.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.448 -0.342 . . . . 10.0 110.142 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.9 103.27 12.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.267 -0.424 . . . . 10.0 110.315 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 37.7 mm -116.52 91.82 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.102 0.477 . . . . 10.0 110.538 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 173.91 -164.59 36.04 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.932 -0.867 . . . . 10.0 110.932 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -95.45 126.76 40.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.722 0.261 . . . . 10.0 110.49 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -88.41 127.77 35.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.258 0.552 . . . . 10.0 111.77 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -161.99 77.12 0.5 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.847 -0.615 . . . . 10.0 109.961 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . -112.92 -82.11 1.14 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.862 -0.685 . . . . 10.0 112.499 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . 135.15 39.85 0.17 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.638 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.21 -63.98 1.21 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.949 0.351 . . . . 10.0 111.949 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 135.84 28.28 0.4 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.318 -0.944 . . . . 10.0 113.293 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -150.68 105.43 3.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.188 -0.671 . . . . 10.0 109.188 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER 68.26 18.03 9.25 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.892 0.853 . . . . 10.0 108.92 -177.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.2 170.48 21.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.938 -1.483 . . . . 10.0 108.098 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -155.37 165.44 36.61 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 121.237 -0.185 . . . . 10.0 110.654 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 31.5 p-80 -160.24 164.35 32.8 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -81.5 -68.27 0.71 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.304 -0.158 . . . . 10.0 110.699 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 3.8 t60 69.71 171.5 0.3 Allowed 'General case' 0 CA--C 1.533 0.29 0 O-C-N 123.737 0.648 . . . . 10.0 111.862 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -101.32 116.88 33.8 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.971 -0.558 . . . . 10.0 110.138 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -103.02 127.16 50.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.934 -0.575 . . . . 10.0 110.219 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.834 0 CA-C-O 118.34 -0.838 . . . . 10.0 109.334 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' CGO . . . . . 0.694 ' OAU' ' HBT' ' B' ' 1' ' ' CGO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.569 0.223 . . . . 10.0 110.585 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -121.82 120.15 33.74 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.352 -0.61 . . . . 10.0 109.352 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 60.6 m -137.29 135.89 37.53 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.589 0.588 . . . . 10.0 112.589 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.48 129.55 43.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.517 -0.765 . . . . 10.0 109.101 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -89.86 -72.47 0.56 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.526 0.565 . . . . 10.0 112.526 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -113.32 120.48 41.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.08 0.467 . . . . 10.0 111.369 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 8.2 pt -129.18 127.68 65.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.753 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 3.6 ptp85 -129.54 125.56 36.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.918 0.389 . . . . 10.0 111.341 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.35 108.49 10.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.231 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -114.57 141.62 47.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 10.0 112.164 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 64.82 93.74 0.06 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 114.189 1.181 . . . . 10.0 114.189 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 50.33 35.12 10.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.564 -0.743 . . . . 10.0 112.94 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -108.8 159.39 16.82 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.201 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -150.4 156.12 40.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.143 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.1 p -136.53 133.45 49.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.164 -0.471 . . . . 10.0 111.107 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -121.29 148.21 44.62 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.772 -0.455 . . . . 10.0 109.772 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 tt -124.99 129.34 50.13 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.068 -0.345 . . . . 10.0 110.068 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 135.85 -146.68 18.67 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.938 -0.648 . . . . 10.0 112.207 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -121.98 151.46 40.76 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 48.2 t -120.57 101.11 10.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.22 0.533 . . . . 10.0 111.331 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 65.3 t -92.89 115.83 32.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.176 -0.676 . . . . 10.0 109.176 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 43.9 p -82.63 171.05 14.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.741 0.305 . . . . 10.0 111.0 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -71.38 -6.65 41.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.123 0.487 . . . . 10.0 110.958 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -95.51 7.48 46.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.192 0.52 . . . . 10.0 110.14 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -115.2 32.18 6.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.416 -0.811 . . . . 10.0 109.977 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 69.62 -85.13 0.03 OUTLIER 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.161 -0.927 . . . . 10.0 112.893 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -148.46 166.58 27.73 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.843 0.354 . . . . 10.0 111.495 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -78.69 69.77 2.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.115 -0.564 . . . . 10.0 112.056 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -76.28 -43.79 19.52 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 121.155 -0.545 . . . . 10.0 112.043 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 64.3 mt 71.41 146.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 123.005 0.522 . . . . 10.0 111.331 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? 70.48 80.33 0.17 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.501 0.667 . . . . 10.0 111.746 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 3.9 mp -114.09 -46.61 4.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.508 -0.769 . . . . 10.0 110.005 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.44 -65.06 0.78 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.901 -0.59 . . . . 10.0 110.234 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 55.95 31.93 18.85 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.992 -0.549 . . . . 10.0 112.157 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -91.07 12.51 19.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.641 -0.709 . . . . 10.0 112.328 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 15.1 t -117.4 143.38 46.05 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.564 0.697 . . . . 10.0 112.674 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.0 101.23 9.05 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.226 -1.027 . . . . 10.0 108.226 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 -98.52 127.19 44.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.053 -0.521 . . . . 10.0 110.428 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.02 123.08 19.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.848 -0.615 . . . . 10.0 110.983 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.8 p -123.65 133.82 68.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.287 0.565 . . . . 10.0 111.57 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -79.6 -70.88 0.48 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.569 -0.742 . . . . 10.0 112.175 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.2 m -129.81 126.92 39.21 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.101 0.477 . . . . 10.0 112.105 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 3.6 t -117.09 126.64 74.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.979 -0.555 . . . . 10.0 109.64 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 41.9 t -117.73 122.59 70.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.85 0.357 . . . . 10.0 111.474 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.52 119.62 3.89 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.218 -1.153 . . . . 10.0 110.218 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -126.43 110.58 13.47 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.439 0.533 . . . . 10.0 112.439 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.53 91.7 0.77 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.945 -0.645 . . . . 10.0 114.198 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 51.92 44.06 29.74 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.721 0.637 . . . . 10.0 112.721 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.9 m -96.45 132.58 41.85 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.121 0.486 . . . . 10.0 110.689 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -107.2 114.25 28.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.065 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 30.0 t -105.36 123.12 59.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.508 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.94 108.51 15.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.15 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 25.1 mm -93.13 90.4 2.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.768 -0.456 . . . . 10.0 109.768 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 152.34 -172.52 31.54 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.972 -0.558 . . . . 10.0 112.041 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -101.47 161.24 13.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.077 0.465 . . . . 10.0 111.089 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.99 175.09 7.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.985 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -139.31 67.14 1.39 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.495 -0.775 . . . . 10.0 109.272 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -81.98 115.19 3.97 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.67 -0.695 . . . . 10.0 113.611 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -101.97 -28.78 6.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.824 -0.703 . . . . 10.0 111.854 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -89.8 -45.67 9.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.327 0.584 . . . . 10.0 109.764 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -163.33 156.53 28.35 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.472 -1.051 . . . . 10.0 110.472 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -67.5 112.38 4.64 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 109.549 -0.538 . . . . 10.0 109.549 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 2.3 t90 65.92 -80.38 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 O-C-N 123.797 0.686 . . . . 10.0 110.693 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -162.61 28.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.743 0.782 . . . . 10.0 109.353 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -74.84 117.34 16.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.572 -0.74 . . . . 10.0 111.458 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 -129.06 105.08 7.95 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.919 0.39 . . . . 10.0 110.4 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -115.12 141.68 47.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.673 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -121.4 -53.75 2.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.045 0.45 . . . . 10.0 110.998 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -71.74 142.34 49.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.749 -0.659 . . . . 10.0 110.511 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -143.69 147.35 34.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.347 -0.388 . . . . 10.0 110.427 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 2.7 p80 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.089 -0.958 . . . . 10.0 110.465 179.717 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 109.845 -0.428 . . . . 10.0 109.845 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -117.59 116.25 26.72 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.522 -0.548 . . . . 10.0 109.522 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' SER . . . . . 0.472 ' C ' ' HAK' ' B' ' 1' ' ' CGO . 18.5 m -130.15 136.91 49.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.894 0.378 . . . . 10.0 111.018 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.76 148.34 52.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.599 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -102.84 -80.52 0.51 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 112.855 0.687 . . . . 10.0 112.855 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -112.66 115.0 27.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.778 0.323 . . . . 10.0 111.665 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 62.2 mt -120.14 111.07 30.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.349 -0.612 . . . . 10.0 109.349 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 12.0 mtt180 -109.93 107.68 17.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.064 0.459 . . . . 10.0 111.387 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.51 122.31 45.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.629 -0.714 . . . . 10.0 110.727 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -130.83 155.52 46.57 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 112.403 0.52 . . . . 10.0 112.403 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 65.31 77.04 0.32 Allowed 'General case' 0 C--O 1.232 0.136 0 N-CA-C 113.914 1.079 . . . . 10.0 113.914 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 44.2 mtm-85 56.13 26.72 10.53 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.55 -0.75 . . . . 10.0 112.824 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -79.49 151.88 30.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.991 0.424 . . . . 10.0 110.806 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.81 133.02 49.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.968 -0.56 . . . . 10.0 110.789 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 4.2 p -130.71 137.43 56.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.09 -0.504 . . . . 10.0 110.976 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -125.22 130.06 51.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.978 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -103.24 73.01 1.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.731 -0.668 . . . . 10.0 110.42 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . -179.41 -178.59 48.45 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.315 -0.945 . . . . 10.0 112.824 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.58 157.58 15.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.662 0.268 . . . . 10.0 110.355 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 56.6 t -104.36 123.95 58.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.084 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 16.9 t -122.02 100.25 8.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.297 -0.631 . . . . 10.0 109.297 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 29.8 p -80.59 170.09 16.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.399 -0.364 . . . . 10.0 110.885 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.29 -10.05 52.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.066 -0.516 . . . . 10.0 111.599 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -79.24 -17.36 54.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.83 0.347 . . . . 10.0 110.681 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -88.48 -0.61 57.39 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.776 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 44.6 tp -72.65 117.0 13.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.707 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 50.2 m80 67.98 76.69 0.26 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.298 -0.864 . . . . 10.0 111.24 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -171.24 -166.08 29.52 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.663 -0.699 . . . . 10.0 111.705 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -87.6 109.55 3.49 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.817 -0.706 . . . . 10.0 111.87 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 26.2 pt -101.98 13.72 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.992 0.425 . . . . 10.0 111.207 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 12.0 tpt85 -141.37 104.68 4.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.036 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 10.4 pt -107.0 29.04 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.711 0.291 . . . . 10.0 111.172 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.7 t 64.39 28.54 13.64 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.7 0.762 . . . . 10.0 110.198 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -74.88 139.8 43.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.928 -1.033 . . . . 10.0 111.054 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 19.9 tm0? -152.2 106.52 3.17 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.742 -0.663 . . . . 10.0 109.917 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 6.3 t -162.07 163.02 28.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.373 -0.376 . . . . 10.0 111.017 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.24 122.45 37.79 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.836 -0.62 . . . . 10.0 109.456 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -103.85 111.31 23.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.975 0.417 . . . . 10.0 109.918 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 9.8 m -131.51 119.17 21.17 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.163 0.506 . . . . 10.0 111.118 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 12.3 p -115.15 135.25 55.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.865 -0.607 . . . . 10.0 109.978 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -82.65 -73.15 0.41 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.575 0.583 . . . . 10.0 112.575 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.6 125.83 53.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.889 0.376 . . . . 10.0 111.948 -178.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 2.3 t -124.18 121.68 62.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.864 -0.607 . . . . 10.0 109.584 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 47.6 t -112.63 118.61 58.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.765 0.317 . . . . 10.0 111.079 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.79 113.82 2.28 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 111.288 -0.725 . . . . 10.0 111.288 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -127.92 132.1 49.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.646 0.26 . . . . 10.0 111.074 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.81 66.9 1.44 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.922 -0.656 . . . . 10.0 112.358 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 53.43 46.89 25.31 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.819 0.674 . . . . 10.0 112.819 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 6.4 t -77.53 167.16 22.08 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.247 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -135.49 117.46 15.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.099 -0.5 . . . . 10.0 110.017 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 34.5 t -112.11 119.51 60.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.087 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.95 113.59 22.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.961 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 23.1 mm -104.25 86.93 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.101 0.476 . . . . 10.0 109.847 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 158.46 168.62 20.92 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.871 -0.891 . . . . 10.0 110.871 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -88.33 167.39 13.57 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.31 0.555 . . . . 10.0 111.235 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.49 167.2 19.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.151 0.5 . . . . 10.0 111.672 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -147.7 78.77 1.47 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.42 -0.809 . . . . 10.0 108.954 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -94.43 -111.4 2.33 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.832 -0.699 . . . . 10.0 112.865 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 132.27 -36.3 2.21 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.713 -0.756 . . . . 10.0 111.379 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -101.82 23.8 10.83 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 165.06 -175.97 40.86 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.516 -1.434 . . . . 10.0 109.516 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -131.11 65.79 1.55 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 117.068 0.434 . . . . 10.0 109.859 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 26.6 t90 71.26 -47.28 0.66 Allowed 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.836 0.71 . . . . 10.0 111.872 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -116.0 -169.92 1.69 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.791 -0.641 . . . . 10.0 109.31 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -118.3 126.06 51.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.333 0.587 . . . . 10.0 111.849 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -156.47 123.6 5.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.461 -0.791 . . . . 10.0 109.359 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -155.55 138.05 15.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.509 -0.314 . . . . 10.0 110.691 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -168.58 -176.61 2.84 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.512 -0.551 . . . . 10.0 109.512 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -105.76 159.38 16.04 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.678 0.275 . . . . 10.0 110.608 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -91.49 -164.45 1.18 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.013 0.435 . . . . 10.0 111.317 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.067 -0.968 . . . . 10.0 109.63 179.91 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.681 0.277 . . . . 10.0 110.962 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -132.19 113.99 13.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 16.5 m -124.67 141.58 52.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.102 0.477 . . . . 10.0 111.905 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.9 139.54 52.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.636 -0.711 . . . . 10.0 110.512 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -84.96 -69.11 0.67 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.121 -0.491 . . . . 10.0 111.912 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -129.4 117.0 19.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.915 0.388 . . . . 10.0 111.658 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 70.2 mt -120.14 120.6 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.138 -0.483 . . . . 10.0 109.749 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 15.1 ttm-85 -116.21 115.54 26.17 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.215 -0.448 . . . . 10.0 111.269 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.53 99.0 6.09 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.248 0.546 . . . . 10.0 110.88 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -121.22 170.99 9.04 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.004 -0.543 . . . . 10.0 110.557 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 67.87 59.18 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.841 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 10.4 mtp180 63.29 16.79 9.74 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.026 0.75 . . . . 10.0 113.026 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -77.38 176.69 8.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.869 0.366 . . . . 10.0 111.171 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.09 152.05 20.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.203 -0.453 . . . . 10.0 110.747 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 8.2 p -131.92 140.35 48.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.052 0.453 . . . . 10.0 111.428 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -117.14 121.81 42.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.855 -0.611 . . . . 10.0 110.175 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -106.44 86.23 2.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.62 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.28 -173.09 43.65 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.341 -0.933 . . . . 10.0 112.816 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -97.99 145.82 26.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.72 0.295 . . . . 10.0 110.656 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 36.8 t -106.87 103.64 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.087 0.47 . . . . 10.0 110.868 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 19.9 t -111.58 112.37 40.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.014 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 34.2 p -82.34 160.94 22.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.426 -0.352 . . . . 10.0 111.145 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.0 5.39 1.17 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.249 0.463 . . . . 10.0 112.249 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -96.48 3.4 52.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.196 -0.457 . . . . 10.0 109.826 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -116.03 84.66 2.15 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.906 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 84.8 mt -95.85 -9.73 30.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.596 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -84.0 110.78 18.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.701 -0.681 . . . . 10.0 109.69 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -144.2 -90.14 0.11 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.51 -0.852 . . . . 10.0 112.786 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 100.66 -156.23 19.35 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.686 -0.769 . . . . 10.0 111.608 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 8.0 tt -147.99 104.23 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.281 0.562 . . . . 10.0 111.304 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -157.43 137.49 12.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.965 -0.561 . . . . 10.0 109.931 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 15.3 tt -103.57 133.87 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.034 0.445 . . . . 10.0 110.813 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 41.1 m -155.96 179.66 9.0 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.404 -0.591 . . . . 10.0 109.404 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -72.84 167.13 21.57 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.714 -0.221 . . . . 10.0 110.868 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -158.93 152.98 23.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.606 -0.27 . . . . 10.0 110.521 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 6.8 t -64.98 132.27 48.81 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.238 0.542 . . . . 10.0 111.152 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 32.5 m -92.36 126.29 37.38 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.001 -0.545 . . . . 10.0 109.759 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -118.9 123.76 45.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.688 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 14.2 m -141.75 142.3 33.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.079 -0.509 . . . . 10.0 110.244 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 8.8 p -133.51 144.13 36.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.066 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -83.19 -75.92 0.3 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.291 0.478 . . . . 10.0 112.291 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 24.3 m -113.52 127.61 56.15 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.125 0.787 . . . . 10.0 113.125 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.92 109.31 20.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.357 -0.838 . . . . 10.0 108.958 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 37.1 t -107.41 125.99 63.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.025 0.44 . . . . 10.0 110.864 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -134.04 120.93 2.6 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.885 -0.598 . . . . 10.0 112.022 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -138.53 124.65 20.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.141 0.496 . . . . 10.0 111.2 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 97.25 74.96 1.21 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.83 -0.7 . . . . 10.0 113.101 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 59.06 22.36 10.41 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.665 0.617 . . . . 10.0 112.665 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 16.0 m -69.55 149.61 48.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.085 0.469 . . . . 10.0 111.916 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -132.37 122.29 24.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.171 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.91 129.61 63.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.742 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -121.31 110.51 16.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.289 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 30.5 mm -107.93 94.14 2.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.135 0.493 . . . . 10.0 110.316 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 160.28 -160.08 31.38 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.565 -0.614 . . . . 10.0 111.565 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -115.53 150.49 36.49 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.315 -0.254 . . . . 10.0 110.315 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -119.29 145.23 46.3 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.075 0.464 . . . . 10.0 112.166 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -127.63 98.59 5.26 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.373 -0.831 . . . . 10.0 108.943 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . -145.55 159.93 28.0 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.546 -0.835 . . . . 10.0 112.757 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -106.95 -30.86 4.07 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.748 -0.739 . . . . 10.0 112.894 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -59.72 -45.09 93.22 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.922 0.391 . . . . 10.0 111.036 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 173.47 -128.2 1.46 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.642 -0.983 . . . . 10.0 110.642 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -110.12 -166.18 1.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.209 -0.293 . . . . 10.0 110.209 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -54.4 -30.11 51.16 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.156 0.798 . . . . 10.0 113.156 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.83 157.28 31.44 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 122.336 -0.227 . . . . 10.0 110.718 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -123.83 30.4 6.18 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.36 0.504 . . . . 10.0 112.36 -178.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -85.7 -17.67 35.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.454 -0.339 . . . . 10.0 110.942 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.67 153.68 51.5 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.995 -0.441 . . . . 10.0 111.619 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.86 179.23 0.16 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 123.654 0.596 . . . . 10.0 110.875 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -165.27 -99.72 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 113.992 1.108 . . . . 10.0 113.992 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -100.73 -88.64 0.36 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.612 0.597 . . . . 10.0 112.612 -177.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 3.7 t60 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.428 -0.796 . . . . 10.0 111.269 -177.969 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . 0.502 ' H ' ' CG ' ' D' ' 258' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 110.15 -0.315 . . . . 10.0 110.15 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -127.84 111.44 13.62 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.859 -0.423 . . . . 10.0 109.859 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.02 140.72 51.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.985 0.422 . . . . 10.0 111.668 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.01 147.48 51.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.135 -0.484 . . . . 10.0 110.509 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -92.79 -72.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.259 -0.428 . . . . 10.0 111.743 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -126.26 117.19 22.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.668 0.271 . . . . 10.0 111.321 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 63.5 mt -121.93 123.62 69.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.096 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -120.22 113.94 21.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.15 0.5 . . . . 10.0 110.662 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 1.7 p -117.31 111.75 19.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.749 -0.659 . . . . 10.0 110.278 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -124.89 151.54 45.22 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.143 0.423 . . . . 10.0 112.143 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 65.01 79.19 0.26 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.975 1.102 . . . . 10.0 113.975 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 58.57 19.44 6.65 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.259 -0.882 . . . . 10.0 113.344 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -81.74 162.23 23.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.857 0.361 . . . . 10.0 111.24 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.39 147.76 38.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.061 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 1.9 p -128.81 127.44 66.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.138 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -113.47 126.79 55.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.623 -0.717 . . . . 10.0 109.211 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.97 97.98 5.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.406 -0.361 . . . . 10.0 110.593 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 164.15 -108.48 0.33 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.517 -0.849 . . . . 10.0 112.778 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -163.8 153.14 14.32 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.678 0.275 . . . . 10.0 110.388 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 t -112.24 106.26 20.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.801 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 52.6 t -104.55 112.89 39.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 81.6 p -80.33 150.77 29.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.09 0.471 . . . . 10.0 111.694 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -74.58 8.06 2.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.928 -0.578 . . . . 10.0 111.39 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -101.33 -8.48 22.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.934 -0.575 . . . . 10.0 109.796 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -91.3 110.11 21.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.058 -0.519 . . . . 10.0 109.731 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.79 163.06 24.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.387 0.613 . . . . 10.0 111.707 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -84.25 63.24 7.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.725 -0.671 . . . . 10.0 112.192 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -131.66 59.08 0.69 Allowed Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 110.405 -1.078 . . . . 10.0 110.405 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 109.71 20.54 7.63 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.27 -1.132 . . . . 10.0 110.27 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 16.6 tt -67.1 -30.8 50.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.851 -0.674 . . . . 10.0 111.425 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -80.05 71.37 6.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.059 0.456 . . . . 10.0 110.874 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 20.0 tt -65.04 -19.26 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.669 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 4.4 m 66.35 -96.02 0.04 OUTLIER 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.664 -0.698 . . . . 10.0 111.783 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' D' ' 225' ' ' ARG . 2.5 t0 -149.19 172.27 15.1 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.411 -0.589 . . . . 10.0 109.411 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -169.27 -74.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.91 0.386 . . . . 10.0 110.581 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 13.5 t -96.17 162.46 13.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.352 0.596 . . . . 10.0 110.838 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 12.8 m -116.9 111.98 20.4 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.055 -0.52 . . . . 10.0 109.872 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -97.25 105.49 17.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.024 -0.535 . . . . 10.0 109.961 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 24.1 m -115.59 118.54 33.42 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.591 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 11.4 p -121.83 137.27 55.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.947 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -84.68 -83.61 0.16 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.919 0.711 . . . . 10.0 112.919 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.69 122.75 46.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.298 0.851 . . . . 10.0 113.298 -177.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 43.7 t -121.16 114.5 43.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.233 -0.654 . . . . 10.0 109.233 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 16.9 t -111.54 119.87 60.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.816 0.341 . . . . 10.0 111.403 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.8 125.93 6.02 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.336 -0.705 . . . . 10.0 111.336 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 19.3 tptt -134.4 108.71 8.32 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.825 0.306 . . . . 10.0 111.825 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.92 102.38 0.64 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 114.698 0.639 . . . . 10.0 114.698 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 51.69 36.17 16.87 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.561 0.578 . . . . 10.0 112.561 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 4.0 m -85.25 139.2 31.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.162 0.506 . . . . 10.0 111.853 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -118.94 113.24 20.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.558 -0.746 . . . . 10.0 110.273 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 46.0 t -102.49 113.45 39.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.357 -0.608 . . . . 10.0 109.357 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -117.39 97.57 5.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.171 0.51 . . . . 10.0 110.867 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 44.1 mm -102.0 91.91 2.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.645 -0.872 . . . . 10.0 108.645 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 166.17 -163.01 36.53 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.639 -0.709 . . . . 10.0 111.564 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -120.41 156.02 32.26 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.73 -0.277 . . . . 10.0 110.922 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -114.62 136.02 53.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.218 -0.447 . . . . 10.0 110.621 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -124.59 113.35 17.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.347 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 156.21 171.58 22.69 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.232 -0.985 . . . . 10.0 112.819 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -110.05 53.86 0.57 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.613 -0.803 . . . . 10.0 112.825 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -89.29 -18.11 27.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.204 0.526 . . . . 10.0 109.983 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 118.95 -47.9 0.99 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.775 -0.93 . . . . 10.0 110.775 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 4.7 t80 176.15 145.62 0.08 Allowed 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.871 -1.159 . . . . 10.0 107.871 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 17.1 t90 -50.38 -74.47 0.03 OUTLIER 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.435 0.46 . . . . 10.0 111.761 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -134.81 133.24 39.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.185 0.517 . . . . 10.0 111.301 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -172.51 147.55 1.88 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -73.68 -57.52 3.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.816 0.341 . . . . 10.0 110.984 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -154.74 175.02 14.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.072 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -97.25 -154.72 0.46 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.599 -0.273 . . . . 10.0 111.455 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -58.91 125.78 24.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.124 0.488 . . . . 10.0 111.486 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -123.51 147.6 47.07 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.691 -0.686 . . . . 10.0 109.939 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.186 -0.911 . . . . 10.0 109.623 179.688 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 110.662 -0.125 . . . . 10.0 110.662 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -137.55 111.82 8.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.65 0.262 . . . . 10.0 110.466 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 21.3 m -122.4 138.35 54.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.157 0.503 . . . . 10.0 111.084 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.4 129.27 42.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.851 -0.613 . . . . 10.0 109.547 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -84.77 -64.63 1.12 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.57 0.581 . . . . 10.0 112.57 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -130.79 127.39 38.59 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.779 -0.368 . . . . 10.0 111.278 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 90.9 mt -128.03 123.27 60.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.761 -0.459 . . . . 10.0 109.761 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -116.75 118.29 32.11 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.385 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.66 111.19 12.92 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.013 -0.539 . . . . 10.0 110.862 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -129.87 145.56 51.6 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.154 0.427 . . . . 10.0 112.154 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 66.39 81.9 0.19 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.2 0.815 . . . . 10.0 113.2 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 58.35 26.09 13.61 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.902 -0.59 . . . . 10.0 112.246 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.2 153.32 18.13 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.9 160.52 41.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.829 0.347 . . . . 10.0 111.544 -178.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.34 134.28 49.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.889 -0.596 . . . . 10.0 110.779 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 21.0 tm0? -127.84 127.52 43.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.932 -0.576 . . . . 10.0 109.845 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.16 105.48 8.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.442 -0.345 . . . . 10.0 110.587 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 164.36 -158.02 30.54 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.757 -0.735 . . . . 10.0 112.445 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -117.34 144.32 45.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.917 0.389 . . . . 10.0 110.649 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 61.6 t -101.24 120.33 50.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.111 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 3.6 t -116.92 101.37 12.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.98 0.419 . . . . 10.0 110.867 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 15.0 t -67.53 173.7 3.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.169 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.76 -19.66 64.19 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.794 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -75.52 -22.34 57.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.277 -0.42 . . . . 10.0 110.727 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 55.84 -161.68 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.871 -0.604 . . . . 10.0 111.861 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 5.1 mp -103.27 89.13 3.3 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.034 0.445 . . . . 10.0 110.362 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -79.92 90.24 5.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.418 0.628 . . . . 10.0 110.159 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 112.2 68.88 0.54 Allowed Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.651 -0.98 . . . . 10.0 110.651 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -165.49 75.03 0.16 Allowed Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.263 -0.735 . . . . 10.0 111.263 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 28.9 mt -70.28 -35.56 63.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.031 0.443 . . . . 10.0 110.351 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -103.19 101.94 11.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.469 -0.332 . . . . 10.0 110.587 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . 0.422 ' C ' ' HG ' ' E' ' 257' ' ' SER . 6.5 pt -99.87 113.0 33.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.134 0.492 . . . . 10.0 110.928 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 257' ' ' SER . . . . . 0.422 ' HG ' ' C ' ' E' ' 256' ' ' ILE . 1.4 m -145.04 151.12 38.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.1 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -85.86 84.3 7.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.769 0.795 . . . . 10.0 111.105 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -70.25 -25.73 63.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.227 -0.897 . . . . 10.0 112.251 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 14.6 t -107.24 148.51 28.85 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.09 0.472 . . . . 10.0 111.334 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 79.7 m -129.21 114.3 16.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.583 -0.735 . . . . 10.0 111.206 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -107.85 100.1 9.5 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.311 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 12.9 m -109.04 117.64 34.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.157 -0.474 . . . . 10.0 109.767 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 4.8 p -107.26 152.27 8.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.842 0.353 . . . . 10.0 111.074 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -86.47 -88.11 0.13 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.152 -0.477 . . . . 10.0 111.457 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 9.0 m -125.12 120.95 32.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.966 0.413 . . . . 10.0 111.605 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.16 116.28 51.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.46 110.61 32.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.856 0.36 . . . . 10.0 111.24 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.6 136.14 10.21 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.642 -0.583 . . . . 10.0 111.642 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -140.03 126.6 20.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.017 0.437 . . . . 10.0 111.024 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.89 82.07 1.17 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.748 -0.739 . . . . 10.0 113.647 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 61.43 22.58 12.97 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.295 0.85 . . . . 10.0 113.295 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 45.2 m -73.1 152.32 41.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.886 0.374 . . . . 10.0 111.291 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -131.45 120.48 23.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.815 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 40.3 t -102.44 118.99 50.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.921 -0.581 . . . . 10.0 109.464 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.57 110.28 16.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.744 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 46.4 mm -117.74 95.96 4.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.144 0.497 . . . . 10.0 110.178 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 170.89 -126.57 1.34 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.515 -0.634 . . . . 10.0 111.515 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -141.01 151.85 44.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 10.0 111.156 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -105.29 138.61 41.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.095 -0.502 . . . . 10.0 111.913 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -162.55 71.28 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.956 -0.566 . . . . 10.0 110.193 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . -112.9 -105.83 2.75 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.853 -0.689 . . . . 10.0 112.626 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . 179.37 25.2 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.564 -0.827 . . . . 10.0 113.364 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.1 -119.79 0.3 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.987 0.394 . . . . 10.0 111.819 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -168.69 46.64 0.22 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.478 -0.868 . . . . 10.0 113.258 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -174.38 103.43 0.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.543 -0.54 . . . . 10.0 109.543 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 72.55 5.47 5.25 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.762 0.664 . . . . 10.0 109.616 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.49 131.94 1.5 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.133 -1.394 . . . . 10.0 107.388 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -136.2 172.76 12.53 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.649 -0.251 . . . . 10.0 111.147 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -157.82 -163.36 1.32 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.333 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -110.67 -73.06 0.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.513 -0.18 . . . . 10.0 110.513 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 37.8 t60 70.89 150.31 0.09 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.722 0.639 . . . . 10.0 112.38 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -88.58 112.92 23.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.417 -0.586 . . . . 10.0 109.417 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -96.23 143.28 27.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.268 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.376 -0.821 . . . . 10.0 110.368 -179.713 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' CGO . . . . . 0.831 ' OBE' ' HBT' ' B' ' 1' ' ' CGO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 110.62 -0.141 . . . . 10.0 110.62 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -116.24 134.72 54.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.769 0.318 . . . . 10.0 110.201 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 57.0 m -147.89 157.79 43.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.181 0.515 . . . . 10.0 111.771 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.17 154.66 45.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.533 -0.758 . . . . 10.0 109.168 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -107.34 -70.97 0.77 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.571 0.582 . . . . 10.0 112.571 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -124.02 110.35 14.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.366 -177.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 66.8 mt -119.4 126.37 75.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.385 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.9 ptp85 -124.31 116.26 22.34 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.102 0.477 . . . . 10.0 110.658 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.52 127.6 48.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.827 -0.624 . . . . 10.0 110.768 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -141.91 169.41 17.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.602 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.2 60.11 1.0 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.843 -0.617 . . . . 10.0 111.674 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 62.72 29.49 16.78 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.723 -0.671 . . . . 10.0 112.479 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.63 157.29 19.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.43 -0.35 . . . . 10.0 110.612 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -135.22 151.2 50.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.247 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.24 139.52 36.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.832 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -137.78 130.12 29.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.266 -0.425 . . . . 10.0 110.205 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 5.8 mp -116.82 118.55 32.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.491 -0.322 . . . . 10.0 110.526 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 152.74 -169.55 31.8 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.824 -0.703 . . . . 10.0 112.694 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.63 126.58 41.0 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.057 -0.349 . . . . 10.0 110.057 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 90.9 t -98.29 116.39 40.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.207 0.527 . . . . 10.0 112.075 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 77.8 t -111.49 116.9 53.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.783 -0.644 . . . . 10.0 109.756 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.77 158.97 15.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.714 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.57 -19.99 65.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.019 0.437 . . . . 10.0 110.766 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -85.98 11.46 11.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.772 -0.649 . . . . 10.0 110.632 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -121.36 36.03 4.72 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.5 -0.556 . . . . 10.0 109.5 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 75.99 -82.22 0.03 OUTLIER 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.44 -0.8 . . . . 10.0 112.645 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 26.0 p-80 -158.22 171.89 19.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.445 -0.343 . . . . 10.0 110.514 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -80.62 64.39 4.07 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.002 -0.618 . . . . 10.0 112.749 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -69.63 -46.41 54.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.311 -0.471 . . . . 10.0 112.187 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 84.1 mt 74.15 141.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 122.981 0.513 . . . . 10.0 111.67 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 30.1 ttt-85 68.54 82.98 0.16 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.341 0.591 . . . . 10.0 111.245 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 55.6 mt -112.17 -45.92 5.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.765 -0.652 . . . . 10.0 111.532 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 7.0 p -135.28 -82.98 0.41 Allowed 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.293 0.479 . . . . 10.0 112.293 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 11.3 t70 59.4 76.57 0.35 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.478 -0.783 . . . . 10.0 110.981 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -118.05 24.41 11.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.726 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 5.2 t -155.32 143.04 19.79 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.208 0.528 . . . . 10.0 111.43 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 4.1 m -91.31 120.53 32.27 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.507 -0.923 . . . . 10.0 108.507 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -111.08 111.71 23.0 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.954 -0.387 . . . . 10.0 109.954 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.7 m -141.07 132.96 27.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.043 0.449 . . . . 10.0 111.708 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 9.9 p -121.6 139.22 49.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.795 -0.639 . . . . 10.0 110.004 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -79.35 -77.29 0.18 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.29 0.478 . . . . 10.0 112.29 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 1.7 m -115.28 133.36 56.11 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.735 0.643 . . . . 10.0 112.735 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 17.4 t -128.47 124.72 62.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.459 -0.791 . . . . 10.0 109.035 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 39.7 t -116.65 121.88 68.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.85 0.357 . . . . 10.0 111.116 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -126.63 118.59 3.1 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.979 -0.629 . . . . 10.0 112.056 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -132.81 110.56 10.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.724 0.297 . . . . 10.0 110.966 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 107.45 67.71 0.65 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.636 -0.792 . . . . 10.0 112.563 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 56.48 32.0 19.93 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 13.2 m -69.19 141.67 54.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.253 0.549 . . . . 10.0 110.611 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 19.6 mtt180 -114.87 107.08 14.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.386 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 40.8 t -98.97 113.88 35.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.06 -0.518 . . . . 10.0 111.226 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.71 114.79 26.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.246 -0.434 . . . . 10.0 109.863 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 29.2 mm -108.91 114.22 46.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.776 -0.453 . . . . 10.0 109.776 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 132.48 163.61 10.7 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.631 -0.795 . . . . 10.0 112.281 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -76.9 147.07 37.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.127 0.489 . . . . 10.0 111.503 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -126.39 152.65 46.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.12 -0.491 . . . . 10.0 111.069 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -129.63 116.63 19.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.726 -0.67 . . . . 10.0 110.581 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -166.8 153.3 22.9 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.137 -0.554 . . . . 10.0 111.751 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -128.3 -7.7 4.33 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.431 -0.89 . . . . 10.0 113.327 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -80.07 -43.43 21.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.124 0.487 . . . . 10.0 110.805 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -155.48 157.18 27.53 Favored Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 110.3 -1.12 . . . . 10.0 110.3 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -80.97 74.53 7.96 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.917 0.358 . . . . 10.0 110.894 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 25.0 t90 67.36 -63.93 0.28 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.219 0.949 . . . . 10.0 112.874 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -144.08 96.64 2.92 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.118 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -160.34 144.34 14.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.936 -0.575 . . . . 10.0 110.354 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -157.06 60.7 0.51 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.116 -0.698 . . . . 10.0 109.116 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -83.86 103.73 13.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.852 -0.613 . . . . 10.0 111.769 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -101.56 -31.8 10.68 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.647 -0.706 . . . . 10.0 110.084 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -84.61 124.6 31.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.577 -0.738 . . . . 10.0 109.905 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.42 139.72 47.75 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.785 0.326 . . . . 10.0 110.72 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.509 -0.758 . . . . 10.0 110.378 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 4.7 ttm-85 . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 110.286 -0.265 . . . . 10.0 110.286 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -126.54 124.23 39.54 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.326 -0.62 . . . . 10.0 109.326 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 5.1 m -139.32 152.95 47.61 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.624 0.25 . . . . 10.0 111.184 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . 0.449 ' N ' ' HAK' ' B' ' 1' ' ' CGO . . . -144.24 148.5 35.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.154 -0.476 . . . . 10.0 111.448 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -90.56 -62.35 1.48 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.217 -0.447 . . . . 10.0 111.957 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -145.6 132.25 19.92 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.006 0.431 . . . . 10.0 111.412 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 64.9 mt -125.24 122.92 64.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.086 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -102.74 112.52 25.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.165 -0.471 . . . . 10.0 109.95 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.23 115.0 22.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.882 0.372 . . . . 10.0 111.327 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.34 164.32 28.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.339 -0.391 . . . . 10.0 111.477 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 65.64 62.59 0.64 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.595 -0.729 . . . . 10.0 111.872 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 63.6 mtm-85 57.83 32.29 21.71 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.894 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.12 159.59 22.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.887 0.375 . . . . 10.0 111.065 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.62 141.82 41.23 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.951 0.405 . . . . 10.0 111.238 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 4.3 p -127.1 135.81 62.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.723 -0.671 . . . . 10.0 110.989 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -118.74 123.23 44.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.61 -0.723 . . . . 10.0 109.227 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.78 84.78 1.98 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.877 0.37 . . . . 10.0 110.504 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 165.41 179.06 38.98 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.482 -0.866 . . . . 10.0 112.233 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -92.26 131.64 37.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.798 0.332 . . . . 10.0 110.664 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 46.7 t -95.77 109.13 22.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.014 0.435 . . . . 10.0 110.707 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 20.3 t -109.24 114.11 46.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 32.8 p -81.91 169.01 17.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.087 -0.506 . . . . 10.0 111.324 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -72.12 -4.92 31.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.691 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -78.43 -18.17 55.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.601 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -91.01 3.1 55.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.647 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 20.6 tp -64.58 131.19 46.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.426 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 1.9 t60 60.07 47.89 9.13 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.261 0.553 . . . . 10.0 110.89 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -137.48 -156.52 7.27 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.884 -0.674 . . . . 10.0 111.866 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.51 120.4 4.29 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.987 -0.625 . . . . 10.0 111.736 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 52.5 mt -103.5 -33.48 3.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.22 0.533 . . . . 10.0 110.733 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -79.82 81.06 6.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.975 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 21.4 pt -102.34 37.51 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.798 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.7 t 65.87 36.22 6.18 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.925 -0.58 . . . . 10.0 110.616 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -65.94 122.43 17.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.397 -0.82 . . . . 10.0 110.154 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -139.28 109.25 6.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.333 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 8.5 t -175.38 177.1 1.89 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.998 0.428 . . . . 10.0 110.56 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 71.2 m -150.48 117.47 5.92 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.901 -0.777 . . . . 10.0 108.901 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -99.69 116.06 30.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.991 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 50.8 m -135.78 113.9 11.37 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.881 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 13.2 p -113.14 146.2 18.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.556 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -85.01 -75.5 0.35 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.173 0.435 . . . . 10.0 112.173 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 4.3 m -123.24 130.14 52.34 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.748 0.647 . . . . 10.0 112.748 -178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 37.3 t -119.77 122.87 69.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.376 -0.829 . . . . 10.0 109.041 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 35.3 t -104.3 114.02 42.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.815 0.34 . . . . 10.0 110.348 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.41 97.6 0.72 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.556 -0.618 . . . . 10.0 111.556 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -119.89 118.98 32.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.728 0.299 . . . . 10.0 111.189 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 100.65 62.57 0.79 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.325 -0.941 . . . . 10.0 112.595 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 54.58 37.68 28.45 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.124 0.786 . . . . 10.0 113.124 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 7.3 m -77.81 151.16 34.1 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.899 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 13.2 mtt85 -116.25 121.08 40.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.344 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 40.8 t -108.84 119.42 58.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.486 -0.561 . . . . 10.0 109.486 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.97 113.37 21.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.666 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 43.3 mm -103.54 88.33 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.896 0.379 . . . . 10.0 110.074 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 158.66 175.07 29.18 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.899 -0.667 . . . . 10.0 111.974 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -93.05 159.35 15.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.152 -0.314 . . . . 10.0 110.152 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.46 160.83 27.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.192 0.52 . . . . 10.0 111.684 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.02 71.27 1.33 Allowed 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -97.3 -65.03 0.9 Allowed Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.213 -0.903 . . . . 10.0 111.885 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 82.35 -46.99 3.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.247 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -67.35 -26.69 66.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.411 0.624 . . . . 10.0 110.126 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -152.73 164.22 30.66 Favored Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 110.216 -1.154 . . . . 10.0 110.216 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -97.87 64.18 1.71 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.93 -0.396 . . . . 10.0 109.93 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 16.1 t90 71.19 -43.11 0.55 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.387 -0.824 . . . . 10.0 112.341 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -139.02 -170.54 2.89 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.863 -0.421 . . . . 10.0 109.863 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.38 142.19 58.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.419 -0.355 . . . . 10.0 110.777 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -166.48 89.73 0.39 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 110.397 -0.223 . . . . 10.0 110.397 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -155.52 119.35 4.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.82 0.343 . . . . 10.0 111.796 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.97 -176.49 5.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.125 -0.488 . . . . 10.0 110.457 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.6 154.17 17.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.817 0.341 . . . . 10.0 111.477 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -116.16 -174.07 2.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.41 -0.814 . . . . 10.0 109.211 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.218 -0.896 . . . . 10.0 109.73 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.485 0.183 . . . . 10.0 110.549 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -127.72 111.51 13.77 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.28 152.59 47.94 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.051 0.453 . . . . 10.0 111.572 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -149.06 143.82 26.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.774 -0.648 . . . . 10.0 109.995 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -91.91 -72.27 0.6 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.633 0.605 . . . . 10.0 112.633 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -122.06 126.29 48.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.865 0.365 . . . . 10.0 111.558 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 49.7 mt -129.52 115.05 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.382 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 14.7 ttm-85 -101.45 115.12 29.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.396 -0.365 . . . . 10.0 110.561 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -125.29 100.7 6.64 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.447 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -125.32 161.58 26.66 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.014 0.376 . . . . 10.0 112.014 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 66.45 75.15 0.33 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.358 -0.837 . . . . 10.0 112.108 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 53.33 55.17 9.1 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.297 -0.865 . . . . 10.0 111.133 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -107.97 165.89 11.12 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.712 -0.676 . . . . 10.0 111.164 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -153.1 138.01 17.14 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.854 -0.612 . . . . 10.0 110.16 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.06 136.46 51.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.191 -0.459 . . . . 10.0 110.614 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -126.07 128.61 47.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.993 0.425 . . . . 10.0 111.043 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -105.24 91.41 3.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.769 -0.651 . . . . 10.0 109.831 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 168.19 -174.39 43.03 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.669 -0.777 . . . . 10.0 111.992 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -95.54 155.69 16.64 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.827 0.346 . . . . 10.0 110.95 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 57.3 t -112.68 108.78 26.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.06 -0.518 . . . . 10.0 110.249 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.83 110.64 32.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.218 -0.446 . . . . 10.0 110.342 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 246' ' ' THR . . . . . 0.434 ' C ' ' H ' ' C' ' 248' ' ' ALA . 38.3 p -79.84 159.92 26.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.019 -0.537 . . . . 10.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.68 42.54 0.13 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.273 0.559 . . . . 10.0 111.838 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . 0.434 ' H ' ' C ' ' C' ' 246' ' ' THR . . . -138.19 -13.06 1.4 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.61 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -87.45 67.03 9.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.109 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 55.8 mt -87.12 -4.6 59.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.978 -0.555 . . . . 10.0 111.379 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -94.04 129.24 40.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.305 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 178.77 -158.57 23.01 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.661 -0.78 . . . . 10.0 112.182 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 176.17 -134.66 2.68 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.676 -0.969 . . . . 10.0 110.676 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 13.5 tt -158.42 89.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.498 0.666 . . . . 10.0 111.421 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -140.93 115.31 9.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.367 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 8.5 tt -74.83 129.28 36.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.819 -0.628 . . . . 10.0 109.898 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.44 174.16 15.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.125 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.81 145.6 55.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.92 -0.582 . . . . 10.0 112.155 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -147.76 149.07 31.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.761 -0.654 . . . . 10.0 109.703 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 12.8 t -71.51 140.29 49.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.005 0.431 . . . . 10.0 110.847 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 7.7 m -105.54 134.34 48.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.099 -0.501 . . . . 10.0 110.384 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -122.65 128.36 50.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.875 -0.602 . . . . 10.0 109.5 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 50.0 m -144.63 138.78 27.62 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.737 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.9 p -123.52 145.34 30.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.852 -0.613 . . . . 10.0 110.996 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -82.32 -66.27 0.91 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.491 -0.322 . . . . 10.0 111.735 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.79 129.74 51.04 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.295 0.85 . . . . 10.0 113.295 -178.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 48.3 t -127.19 119.97 54.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.661 -0.7 . . . . 10.0 109.648 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 58.8 t -117.01 120.08 63.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.794 0.33 . . . . 10.0 110.895 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.77 130.95 7.85 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.976 -0.631 . . . . 10.0 112.121 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -133.04 126.68 32.42 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.913 0.338 . . . . 10.0 111.913 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.17 93.23 0.16 Allowed Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.951 -0.568 . . . . 10.0 113.449 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 64.02 32.47 12.91 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.303 0.573 . . . . 10.0 111.403 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.46 121.83 16.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.328 -0.851 . . . . 10.0 111.193 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 41.3 mtt180 -124.74 100.89 6.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.147 0.499 . . . . 10.0 109.763 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 22.3 t -101.78 131.86 48.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.041 -0.527 . . . . 10.0 111.411 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -128.01 113.2 15.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.858 -0.61 . . . . 10.0 109.815 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 56.1 mt -111.0 94.13 2.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.324 0.583 . . . . 10.0 110.756 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 168.19 -165.06 38.5 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.825 -1.31 . . . . 10.0 109.825 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -108.49 148.28 30.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 117.477 0.638 . . . . 10.0 110.946 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -104.94 137.61 42.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.344 -0.389 . . . . 10.0 110.644 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.0 102.16 5.92 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.538 -0.542 . . . . 10.0 109.538 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . -164.98 172.07 40.55 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.689 -0.767 . . . . 10.0 112.434 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -124.34 16.33 7.59 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.782 -0.723 . . . . 10.0 112.522 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -101.68 1.28 37.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.964 0.411 . . . . 10.0 111.179 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 129.86 -116.17 2.04 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.835 -0.906 . . . . 10.0 110.835 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -125.75 -155.78 0.7 Allowed 'General case' 0 C--N 1.323 -0.549 0 O-C-N 123.513 0.184 . . . . 10.0 110.562 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -63.75 -24.0 67.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.635 0.255 . . . . 10.0 111.284 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -133.47 -171.39 2.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.489 -0.323 . . . . 10.0 110.262 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -143.02 35.44 1.37 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.075 0.464 . . . . 10.0 110.966 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -79.99 0.58 31.01 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.276 0.473 . . . . 10.0 112.276 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -164.46 155.82 15.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.455 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 66.34 157.19 0.11 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.399 0.618 . . . . 10.0 112.464 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.26 -93.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.117 0.414 . . . . 10.0 112.117 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -79.69 -81.03 0.12 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.208 0.448 . . . . 10.0 112.208 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 . . . . . 0 C--O 1.249 1.026 0 N-CA-C 109.813 -0.439 . . . . 10.0 109.813 -179.122 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 6.4 mtt85 . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.094 -0.336 . . . . 10.0 110.094 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -132.36 129.2 39.11 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 121.015 -0.274 . . . . 10.0 110.301 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 42.6 m -151.17 142.83 23.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.89 0.376 . . . . 10.0 111.579 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.85 139.59 53.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.51 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 22.5 ttmt -84.54 -66.12 0.93 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.877 0.37 . . . . 10.0 111.601 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -138.51 119.43 14.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.649 0.261 . . . . 10.0 111.113 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 32.7 mt -117.07 130.89 71.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.385 -0.37 . . . . 10.0 110.502 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 22.2 mmm-85 -118.55 106.38 12.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.176 -0.466 . . . . 10.0 110.66 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 1.4 p -112.99 113.3 25.28 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.625 -0.509 . . . . 10.0 109.625 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -131.18 147.34 52.59 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.368 0.506 . . . . 10.0 112.368 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 68.38 79.22 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.162 -0.927 . . . . 10.0 113.278 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 55.68 45.64 24.2 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.287 0.565 . . . . 10.0 111.94 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -111.06 157.23 20.21 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.901 -0.591 . . . . 10.0 110.61 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.33 151.77 39.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.244 -0.434 . . . . 10.0 110.822 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 3.8 p -138.25 133.43 43.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.22 -0.445 . . . . 10.0 110.273 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.21 125.38 53.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.522 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -109.66 92.59 4.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.865 -0.607 . . . . 10.0 110.819 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 175.72 -106.02 0.21 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.716 -0.755 . . . . 10.0 112.466 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -167.91 162.93 13.77 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.637 0.375 . . . . 10.0 110.282 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 35.8 t -110.52 111.92 38.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.842 0.353 . . . . 10.0 111.802 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 17.7 t -113.21 109.98 30.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.383 -0.599 . . . . 10.0 109.383 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 82.3 p -89.75 162.77 15.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.945 0.403 . . . . 10.0 111.611 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -72.87 -0.89 14.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.048 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -88.57 -12.08 43.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.407 0.622 . . . . 10.0 109.782 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -97.06 87.76 4.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.387 -0.824 . . . . 10.0 109.983 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 4.5 mp -84.17 -160.16 0.44 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.809 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -79.69 100.52 7.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.088 0.47 . . . . 10.0 111.087 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -174.15 38.73 0.13 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.819 -0.912 . . . . 10.0 110.819 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 101.96 35.11 4.08 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.818 -0.706 . . . . 10.0 111.451 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 10.0 tt -68.0 -38.02 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 121.161 0.505 . . . . 10.0 111.987 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 42.1 mtt-85 -84.04 83.96 7.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.103 0.478 . . . . 10.0 111.551 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 15.5 tt -67.68 -16.97 21.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.215 -0.902 . . . . 10.0 111.739 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 7.7 m 71.1 -83.23 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.369 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -161.14 167.84 25.42 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -160.09 -41.58 0.05 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.137 0.273 . . . . 10.0 111.56 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 13.9 t -144.07 162.05 37.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.867 0.365 . . . . 10.0 111.231 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 21.8 m -105.44 114.46 28.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.062 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -102.59 104.51 14.9 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.047 -0.524 . . . . 10.0 109.778 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 14.8 m -117.48 126.3 52.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.021 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 9.2 p -123.62 133.37 69.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.151 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -83.71 -82.49 0.16 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.207 -0.451 . . . . 10.0 112.137 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 2.4 p -106.0 119.61 39.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.015 0.436 . . . . 10.0 112.029 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.67 113.7 32.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.02 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 42.0 t -113.0 128.6 69.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.312 -0.404 . . . . 10.0 111.023 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.8 115.02 1.8 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.677 -0.969 . . . . 10.0 110.677 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -124.07 125.63 44.85 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.518 0.562 . . . . 10.0 112.518 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.53 89.58 0.4 Allowed Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.592 -0.731 . . . . 10.0 113.876 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 55.58 52.55 10.91 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.161 0.505 . . . . 10.0 111.555 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 6.3 t -103.38 142.39 34.31 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.968 -0.56 . . . . 10.0 110.858 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -122.56 110.6 15.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.218 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 26.0 t -99.95 114.96 39.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.991 -0.374 . . . . 10.0 109.991 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -116.43 108.85 16.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.313 0.578 . . . . 10.0 111.27 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 44.3 mm -106.2 99.84 9.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.223 -0.658 . . . . 10.0 109.223 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.1 -171.46 32.72 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.792 -0.718 . . . . 10.0 111.313 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -110.28 161.75 15.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.918 0.389 . . . . 10.0 111.205 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -117.06 134.77 54.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.074 -0.512 . . . . 10.0 111.045 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -125.96 113.61 17.38 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.089 -0.505 . . . . 10.0 110.282 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 161.31 -178.15 37.35 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.271 -0.966 . . . . 10.0 112.64 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -108.37 41.6 2.17 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.839 -0.696 . . . . 10.0 112.965 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt -86.82 -22.23 25.97 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.699 -0.482 . . . . 10.0 109.699 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 98.93 -32.76 6.72 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.049 -0.596 . . . . 10.0 112.149 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 2.6 t80 176.71 137.72 0.06 Allowed 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.591 -0.522 . . . . 10.0 109.591 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -55.89 -74.49 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.581 0.55 . . . . 10.0 110.584 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . 0.481 ' CG ' ' HE ' ' E' ' 238' ' ' ARG . 48.5 t0 -125.8 117.82 24.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.456 0.646 . . . . 10.0 111.8 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -156.34 160.86 40.08 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.76 -1.2 . . . . 10.0 107.76 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -80.35 -64.62 1.15 Allowed 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.365 0.506 . . . . 10.0 112.365 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -148.57 -160.65 1.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.647 -0.251 . . . . 10.0 110.955 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -91.29 -161.02 0.77 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.814 -0.439 . . . . 10.0 109.814 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -71.18 133.35 46.1 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.475 -0.195 . . . . 10.0 110.475 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -122.33 147.09 46.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.595 -0.275 . . . . 10.0 110.941 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.355 -0.831 . . . . 10.0 109.6 178.949 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 110.21 -0.293 . . . . 10.0 110.21 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -132.13 114.48 14.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.701 0.286 . . . . 10.0 110.716 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 2.4 m -122.77 141.27 52.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.226 0.536 . . . . 10.0 111.719 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -135.69 121.09 19.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.813 -0.63 . . . . 10.0 109.41 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -79.9 -69.91 0.55 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.066 0.765 . . . . 10.0 113.066 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -124.58 126.0 45.08 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.753 -0.379 . . . . 10.0 111.852 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 54.8 mt -134.35 122.16 39.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.095 0.474 . . . . 10.0 110.78 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 37.5 mtm180 -122.41 123.34 41.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.087 -0.506 . . . . 10.0 110.336 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.69 114.06 16.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.877 -0.601 . . . . 10.0 111.568 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -124.83 162.23 24.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.157 -0.474 . . . . 10.0 111.687 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 61.57 74.72 0.43 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.653 0.983 . . . . 10.0 113.653 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 50.4 64.04 1.96 Allowed 'General case' 0 C--O 1.234 0.261 0 O-C-N 123.559 0.537 . . . . 10.0 111.69 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -123.15 174.77 7.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.774 -0.648 . . . . 10.0 110.986 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . 0.481 ' HE ' ' CG ' ' D' ' 288' ' ' ASP . 0.7 OUTLIER -149.63 149.47 30.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.911 0.386 . . . . 10.0 110.721 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 3.1 p -133.48 118.77 32.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.342 -0.844 . . . . 10.0 109.236 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -123.82 128.0 48.89 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.921 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.58 109.72 14.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.387 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 166.82 -173.63 42.15 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.94 -0.648 . . . . 10.0 112.221 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -101.99 137.72 39.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.743 0.306 . . . . 10.0 110.739 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 38.4 t -93.13 123.99 45.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.481 -0.327 . . . . 10.0 110.424 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 24.5 t -121.67 106.61 18.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.979 0.419 . . . . 10.0 110.917 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 8.9 t -68.43 164.73 20.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.845 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.16 -20.54 64.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.092 -0.503 . . . . 10.0 111.967 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -71.52 -19.96 62.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.443 -0.344 . . . . 10.0 110.429 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 59.26 -165.81 0.19 Allowed 'General case' 0 C--O 1.232 0.16 0 O-C-N 123.914 0.759 . . . . 10.0 111.649 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 7.3 tp -95.47 122.45 38.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.421 -0.354 . . . . 10.0 110.082 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -95.61 80.6 3.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.919 0.39 . . . . 10.0 111.354 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 112.57 161.57 15.44 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.687 -0.688 . . . . 10.0 112.094 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 73.43 73.32 0.9 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.912 -0.661 . . . . 10.0 112.015 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 4.3 mt -82.23 51.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.369 0.605 . . . . 10.0 111.045 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -169.04 84.75 0.15 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.158 -0.928 . . . . 10.0 109.022 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 4.2 pt -98.23 153.67 4.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.953 -0.567 . . . . 10.0 112.227 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.64 163.7 39.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.448 -0.796 . . . . 10.0 109.339 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -82.98 86.65 6.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.714 0.769 . . . . 10.0 110.709 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -66.21 -59.31 3.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.252 -0.885 . . . . 10.0 111.332 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 14.8 t -83.02 154.86 24.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.727 -0.67 . . . . 10.0 111.418 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 49.3 m -130.81 124.01 30.37 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.335 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -118.16 121.58 40.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.883 -0.599 . . . . 10.0 110.023 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 6.3 m -127.48 104.64 8.01 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.777 -0.453 . . . . 10.0 109.777 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 3.8 p -88.77 152.19 3.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 116.013 -0.54 . . . . 10.0 111.086 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -87.55 -82.9 0.21 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.966 -0.561 . . . . 10.0 111.44 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 18.2 m -132.52 119.96 21.25 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.854 0.359 . . . . 10.0 111.558 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 23.8 t -112.07 111.53 36.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.535 -0.543 . . . . 10.0 109.535 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 18.4 t -113.28 120.51 63.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.307 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -139.46 137.92 8.89 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.67 -0.776 . . . . 10.0 112.158 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -142.71 112.93 7.15 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.354 -0.239 . . . . 10.0 110.354 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 111.65 84.14 1.4 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.861 -0.685 . . . . 10.0 112.355 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 56.31 32.39 20.35 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.361 0.504 . . . . 10.0 112.361 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.3 152.17 38.58 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.002 -0.544 . . . . 10.0 111.449 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -135.88 102.06 4.94 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.894 -0.594 . . . . 10.0 109.987 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 26.7 t -107.58 115.43 48.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.685 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.35 113.58 17.76 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.416 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 46.5 mm -109.48 100.23 10.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.937 0.398 . . . . 10.0 110.653 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 164.28 -148.91 15.33 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.739 -0.664 . . . . 10.0 111.537 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 37.8 p30 -105.38 167.53 9.68 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.747 -0.266 . . . . 10.0 110.693 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -120.48 124.0 44.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.948 0.404 . . . . 10.0 111.397 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -156.84 94.76 1.47 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.822 -0.626 . . . . 10.0 110.261 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . -133.99 -81.08 0.16 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.288 -0.958 . . . . 10.0 112.695 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . 144.12 30.1 0.1 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.477 -0.868 . . . . 10.0 113.583 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -125.88 -51.66 1.57 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.257 0.465 . . . . 10.0 112.257 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.17 30.03 2.01 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.086 -1.054 . . . . 10.0 113.408 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -147.11 97.98 2.96 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.997 -1.112 . . . . 10.0 107.997 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 73.09 24.66 2.45 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 107.919 -1.141 . . . . 10.0 107.919 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -170.37 161.42 8.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.035 -1.438 . . . . 10.0 109.375 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -139.31 161.94 36.21 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.914 -0.402 . . . . 10.0 109.914 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 -152.82 167.72 28.11 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.155 -0.475 . . . . 10.0 111.133 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -74.51 -74.43 0.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.377 -0.374 . . . . 10.0 110.638 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 26.8 t60 67.68 155.18 0.11 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.674 -0.694 . . . . 10.0 111.96 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -122.48 135.97 54.78 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.294 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -93.88 179.36 5.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.564 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 41.3 t60 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.064 -0.97 . . . . 10.0 109.787 -179.664 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' CGO . . . . . 0.791 ' OAU' ' HBT' ' B' ' 1' ' ' CGO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.621 0.248 . . . . 10.0 110.334 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -106.55 127.9 53.69 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.668 -0.494 . . . . 10.0 109.668 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 3.3 m -144.98 161.63 38.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.157 0.503 . . . . 10.0 111.572 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.5 158.61 44.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.049 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.4 tttm -108.81 -59.6 1.86 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.933 0.397 . . . . 10.0 111.34 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -143.23 127.61 17.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.939 0.399 . . . . 10.0 111.345 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 26.7 mt -131.1 131.13 63.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.851 0.357 . . . . 10.0 111.106 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -126.83 114.43 17.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.3 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.94 122.82 44.27 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.881 -0.6 . . . . 10.0 111.214 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -135.71 153.39 51.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.619 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 65.34 80.71 0.22 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.145 -0.934 . . . . 10.0 112.974 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 55.02 34.14 21.81 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.801 -0.636 . . . . 10.0 112.141 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -100.94 164.04 12.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.447 -0.342 . . . . 10.0 110.559 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -147.66 153.09 38.9 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.82 0.343 . . . . 10.0 111.161 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.76 128.6 67.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.219 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -129.26 131.81 47.08 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.065 -0.346 . . . . 10.0 110.065 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.97 142.46 51.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.549 -0.296 . . . . 10.0 110.783 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.38 -109.82 0.73 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.114 -0.565 . . . . 10.0 112.023 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -160.34 147.39 15.95 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.334 -0.617 . . . . 10.0 109.334 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 79.2 t -115.59 116.83 53.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.842 0.353 . . . . 10.0 111.204 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 16.8 t -110.5 112.98 42.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.965 -0.562 . . . . 10.0 109.586 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 6.0 m -89.89 151.06 21.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.274 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.01 -15.88 57.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.0 0.428 . . . . 10.0 111.661 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -73.2 -14.36 61.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.906 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -118.99 56.61 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.192 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 64.72 -135.33 0.26 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.317 -0.856 . . . . 10.0 111.951 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 -119.03 -175.45 2.91 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.309 -0.405 . . . . 10.0 110.434 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -75.02 70.92 1.75 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.199 -0.524 . . . . 10.0 112.667 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -65.96 -41.11 95.5 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.114 -0.565 . . . . 10.0 112.815 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 73.6 mt 73.97 141.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 122.946 0.498 . . . . 10.0 111.823 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 61.82 84.18 0.14 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.195 0.522 . . . . 10.0 111.768 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 45.3 mt -124.16 -42.84 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.309 -0.405 . . . . 10.0 110.773 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 6.2 p -125.19 -94.34 0.48 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.203 0.445 . . . . 10.0 112.203 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.1 t0 55.69 67.9 0.94 Allowed 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.653 0.596 . . . . 10.0 110.999 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -120.32 6.62 10.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.732 -0.667 . . . . 10.0 111.005 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 5.2 t -142.93 142.31 31.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.027 0.441 . . . . 10.0 111.282 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.16 119.75 28.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.757 -0.831 . . . . 10.0 108.757 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -113.73 117.22 30.9 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.606 -0.516 . . . . 10.0 109.606 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.0 m -145.72 137.15 24.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.897 0.379 . . . . 10.0 111.424 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.6 p -123.75 144.81 32.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.642 -0.503 . . . . 10.0 109.642 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -84.96 -76.33 0.32 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 112.695 0.628 . . . . 10.0 112.695 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.95 125.63 54.6 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.452 0.538 . . . . 10.0 112.452 -177.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 35.9 t -122.37 122.13 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.079 -0.51 . . . . 10.0 110.004 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 21.5 t -114.49 118.05 57.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.395 -0.366 . . . . 10.0 110.797 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.14 119.7 4.63 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.019 -0.832 . . . . 10.0 111.019 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -128.9 103.16 6.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.331 0.493 . . . . 10.0 112.331 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 92.37 91.3 1.47 Allowed Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.766 -0.73 . . . . 10.0 114.628 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 58.3 24.85 12.02 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.949 0.722 . . . . 10.0 112.949 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 9.9 m -74.99 135.04 41.34 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.231 0.539 . . . . 10.0 111.666 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 8.2 mtt180 -117.41 106.48 13.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.662 -0.699 . . . . 10.0 109.431 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 41.7 t -92.23 118.32 37.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.382 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -117.57 105.77 12.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.501 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 22.7 mm -100.71 89.23 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.632 -0.507 . . . . 10.0 109.632 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 161.66 161.49 11.91 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.505 -0.77 . . . . 10.0 111.897 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -76.76 156.65 32.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.677 0.275 . . . . 10.0 110.759 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.08 152.71 35.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.213 -0.449 . . . . 10.0 110.908 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -137.96 93.11 2.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.521 -0.763 . . . . 10.0 109.718 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -137.02 -93.75 0.34 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.447 -0.882 . . . . 10.0 112.842 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 125.32 -66.85 0.53 Allowed Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.223 -0.751 . . . . 10.0 111.223 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -86.49 93.1 9.07 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.253 -0.647 . . . . 10.0 109.253 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.56 86.82 1.74 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.789 -0.924 . . . . 10.0 110.789 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -58.1 98.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.048 0.388 . . . . 10.0 112.048 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 4.0 t90 59.92 -79.37 0.02 OUTLIER 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.192 0.812 . . . . 10.0 113.192 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -141.39 74.78 1.47 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.317 -0.623 . . . . 10.0 109.317 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -151.78 132.69 14.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.952 -0.567 . . . . 10.0 111.493 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -151.62 97.56 2.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.987 -0.551 . . . . 10.0 109.739 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -113.54 128.86 56.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.912 -0.585 . . . . 10.0 111.187 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -115.38 -23.99 8.61 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.977 -0.556 . . . . 10.0 109.973 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -72.77 138.53 46.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.766 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -142.73 136.1 28.61 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.357 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.296 -0.859 . . . . 10.0 110.059 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 110.016 -0.364 . . . . 10.0 110.016 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -123.4 116.53 23.41 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 123.413 0.445 . . . . 10.0 110.179 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.32 141.72 51.69 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.047 -0.524 . . . . 10.0 110.72 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . 0.431 ' N ' ' HBP' ' B' ' 1' ' ' CGO . . . -133.58 146.3 50.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.787 0.327 . . . . 10.0 111.823 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -90.02 -79.98 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.837 0.68 . . . . 10.0 112.837 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.47 123.06 32.67 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.442 0.639 . . . . 10.0 112.094 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 48.6 mt -121.02 125.72 74.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.507 -0.77 . . . . 10.0 110.656 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 19.6 mtt180 -117.82 117.64 29.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.641 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 1.2 p -118.93 120.07 36.2 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.819 -0.628 . . . . 10.0 110.834 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -131.0 153.46 49.21 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.084 0.401 . . . . 10.0 112.084 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 64.31 72.71 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.387 0.884 . . . . 10.0 113.387 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 48.6 mtm-85 60.27 24.29 13.71 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.845 0.683 . . . . 10.0 112.845 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.58 147.14 26.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.837 0.351 . . . . 10.0 110.871 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.73 153.18 48.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.477 -0.329 . . . . 10.0 110.832 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.65 137.25 47.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.658 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -126.29 136.4 52.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.021 0.439 . . . . 10.0 110.741 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.2 93.82 4.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.741 -0.663 . . . . 10.0 110.183 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 164.87 174.58 34.74 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.434 -0.889 . . . . 10.0 112.596 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -87.02 144.36 26.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.703 0.287 . . . . 10.0 110.973 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 48.3 t -102.96 111.26 32.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.523 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 48.3 t -117.76 109.39 27.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.078 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 43.1 p -84.27 171.89 12.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.011 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.23 -11.18 38.25 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.099 -0.5 . . . . 10.0 111.517 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -77.88 -21.48 51.23 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.198 0.523 . . . . 10.0 110.731 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -82.83 -7.83 59.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.786 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 40.1 tp -66.93 133.85 50.82 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.292 -0.633 . . . . 10.0 109.292 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 64.2 m80 66.11 26.56 10.65 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.457 0.473 . . . . 10.0 110.801 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -114.66 169.69 12.97 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.04 -0.6 . . . . 10.0 111.643 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -94.46 79.68 0.93 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.766 -0.73 . . . . 10.0 112.376 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 9.9 mt -79.42 63.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.007 0.432 . . . . 10.0 111.328 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -168.05 78.22 0.15 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.179 0.514 . . . . 10.0 110.398 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 22.6 pt -106.84 38.05 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.547 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 65.78 43.03 3.28 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.634 -0.712 . . . . 10.0 110.362 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -63.74 99.15 0.22 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.152 -0.931 . . . . 10.0 110.616 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -130.49 93.07 3.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.501 -0.772 . . . . 10.0 111.508 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 5.4 t -160.24 146.54 15.59 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.886 -0.597 . . . . 10.0 109.932 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.15 121.03 44.01 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.867 -0.606 . . . . 10.0 109.634 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -107.53 122.71 47.21 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.66 -0.496 . . . . 10.0 109.66 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 65.8 m -146.53 129.99 16.8 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.946 0.403 . . . . 10.0 110.955 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.53 142.46 43.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.699 -0.682 . . . . 10.0 109.889 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -87.27 -75.04 0.42 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.488 0.551 . . . . 10.0 112.488 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.6 m -108.46 124.65 50.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.41 0.522 . . . . 10.0 112.41 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 3.1 t -122.36 107.51 19.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.763 -0.653 . . . . 10.0 109.94 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.81 118.54 44.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.418 -0.355 . . . . 10.0 111.07 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.48 113.25 2.26 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.312 -0.715 . . . . 10.0 111.312 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -130.39 120.35 24.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.231 0.456 . . . . 10.0 112.231 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 95.5 69.17 1.03 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.618 -0.801 . . . . 10.0 113.412 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 56.86 27.16 12.55 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 112.797 0.665 . . . . 10.0 112.797 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 17.7 m -67.33 156.51 36.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.464 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -128.38 116.06 19.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.686 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 46.0 t -100.64 115.13 41.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.914 -0.584 . . . . 10.0 109.683 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.17 112.66 24.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.399 -0.364 . . . . 10.0 110.515 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 28.1 mm -105.42 89.05 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.217 0.532 . . . . 10.0 109.659 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 159.93 175.06 30.49 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.594 -0.73 . . . . 10.0 111.603 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -93.74 164.87 12.97 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.364 -0.235 . . . . 10.0 110.364 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.1 157.93 36.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.8 0.334 . . . . 10.0 111.317 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.7 71.69 1.36 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.395 -0.82 . . . . 10.0 108.888 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -97.19 -87.99 1.85 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.015 -0.612 . . . . 10.0 112.975 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 113.84 -49.1 0.87 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.765 -0.731 . . . . 10.0 111.861 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -87.71 20.52 2.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.268 0.556 . . . . 10.0 110.45 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 171.57 174.38 39.16 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.493 -1.043 . . . . 10.0 110.493 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -122.57 76.36 1.33 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.028 -0.73 . . . . 10.0 109.028 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 15.6 t90 69.82 -59.52 0.5 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.311 -0.859 . . . . 10.0 111.641 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -118.51 -172.48 2.28 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.769 -0.826 . . . . 10.0 108.769 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -101.52 126.69 48.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.224 0.535 . . . . 10.0 112.02 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -155.21 124.95 6.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.894 -0.594 . . . . 10.0 109.923 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -159.74 137.09 9.68 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.519 -0.549 . . . . 10.0 109.519 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -148.42 -167.8 2.91 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 123.148 0.28 . . . . 10.0 110.421 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -104.46 143.15 33.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.784 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -95.19 -173.1 2.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.744 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 4.2 t60 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.905 -1.045 . . . . 10.0 109.178 179.285 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 110.253 -0.277 . . . . 10.0 110.253 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -127.8 102.9 7.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.015 -0.538 . . . . 10.0 109.812 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.04 133.55 48.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.843 -0.617 . . . . 10.0 111.808 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.96 129.9 46.03 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.22 -0.659 . . . . 10.0 109.22 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -87.55 -81.75 0.23 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.087 0.403 . . . . 10.0 112.087 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -119.06 119.12 33.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.091 0.472 . . . . 10.0 111.872 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 59.3 mt -122.4 133.19 69.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.171 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 21.9 ttm-85 -122.97 118.83 28.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.087 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.73 101.54 7.52 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.352 -0.386 . . . . 10.0 110.634 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -120.44 156.56 31.19 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.99 0.367 . . . . 10.0 111.99 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 68.86 68.75 0.28 Allowed 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.966 0.791 . . . . 10.0 111.946 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 57.58 33.18 22.92 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.453 -0.794 . . . . 10.0 112.603 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.29 149.15 22.47 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.864 0.364 . . . . 10.0 110.091 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.19 140.75 47.73 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.327 -0.397 . . . . 10.0 110.831 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 4.5 p -127.53 138.86 53.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.252 -0.431 . . . . 10.0 111.011 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -123.7 123.94 41.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.974 0.416 . . . . 10.0 110.55 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -103.23 86.72 2.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.353 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.37 -177.78 42.82 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.553 -0.832 . . . . 10.0 112.707 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -93.63 151.14 19.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.667 0.27 . . . . 10.0 110.577 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 45.9 t -109.0 111.11 34.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.774 0.321 . . . . 10.0 110.617 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 23.7 t -113.94 110.76 33.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.178 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 21.3 p -75.75 161.74 28.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.854 0.359 . . . . 10.0 110.974 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.44 12.78 0.55 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.159 -0.473 . . . . 10.0 112.211 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -109.42 -6.7 15.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.159 0.504 . . . . 10.0 110.135 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -99.72 89.57 4.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.749 -0.659 . . . . 10.0 110.85 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 3.2 mp -118.41 7.08 11.85 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.869 -0.605 . . . . 10.0 111.337 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -93.84 80.66 4.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.217 0.532 . . . . 10.0 109.778 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -123.65 148.54 16.78 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.438 -0.887 . . . . 10.0 113.188 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -140.77 127.15 3.34 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.118 -1.193 . . . . 10.0 110.118 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 11.9 tt -65.15 109.13 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.395 0.617 . . . . 10.0 112.155 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 -164.5 122.33 1.71 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.482 -0.781 . . . . 10.0 110.574 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 19.1 tt -96.35 137.53 23.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.213 0.53 . . . . 10.0 111.281 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 14.2 m -156.21 -169.6 3.1 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.621 -0.881 . . . . 10.0 108.621 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.96 163.49 27.77 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.384 -0.228 . . . . 10.0 110.384 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -153.4 159.45 42.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.744 0.307 . . . . 10.0 111.113 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.17 113.72 15.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.681 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.78 143.69 30.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.308 -0.405 . . . . 10.0 110.749 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -141.84 132.52 25.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.892 0.377 . . . . 10.0 110.683 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 16.7 m -140.97 136.85 32.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.224 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 10.3 p -122.81 137.21 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 120.877 0.37 . . . . 10.0 111.145 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -79.22 -73.19 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.533 0.568 . . . . 10.0 112.533 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 1.3 m -120.67 123.79 43.63 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.899 0.703 . . . . 10.0 112.899 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 2.8 t -121.06 116.63 50.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.248 -0.649 . . . . 10.0 109.248 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 59.9 t -114.08 117.15 54.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.898 0.38 . . . . 10.0 111.357 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.09 126.02 6.89 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.762 -0.935 . . . . 10.0 110.762 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -133.43 125.43 29.02 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.912 0.338 . . . . 10.0 111.912 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.67 86.87 0.62 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 121.281 -0.485 . . . . 10.0 113.822 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 51.1 37.53 18.33 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.283 0.563 . . . . 10.0 111.699 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 8.0 t -78.29 163.28 25.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.698 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -143.53 121.64 12.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.791 -0.641 . . . . 10.0 110.457 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 33.8 t -111.35 116.56 52.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.152 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.03 109.89 21.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.095 0.474 . . . . 10.0 110.472 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 27.1 mm -105.89 91.21 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.409 -0.36 . . . . 10.0 110.448 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 157.66 -174.09 35.05 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.664 -0.779 . . . . 10.0 111.476 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -97.67 149.11 22.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.873 0.336 . . . . 10.0 110.59 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -116.08 142.66 46.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.864 0.364 . . . . 10.0 111.64 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -124.04 96.39 4.92 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.633 -0.876 . . . . 10.0 108.633 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . -111.18 166.34 12.26 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.848 -0.692 . . . . 10.0 112.935 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -116.51 -51.51 0.38 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.776 -0.726 . . . . 10.0 112.386 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -75.58 -40.82 56.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.434 0.635 . . . . 10.0 109.725 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -165.2 -159.24 11.22 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.715 -0.954 . . . . 10.0 110.715 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -84.11 -173.02 4.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.65 0.225 . . . . 10.0 111.07 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 13.7 t90 -55.0 -33.29 62.44 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.185 0.517 . . . . 10.0 111.386 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -102.28 150.54 23.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.244 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -131.56 54.1 1.95 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.556 0.693 . . . . 10.0 110.38 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -109.37 -18.84 13.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.434 -0.803 . . . . 10.0 111.348 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -138.05 160.17 40.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.588 -0.278 . . . . 10.0 111.113 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 5.0 m170 68.73 175.05 0.28 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.857 0.688 . . . . 10.0 112.857 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -158.74 -85.46 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.168 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -114.8 -71.67 0.73 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.48 -0.327 . . . . 10.0 110.668 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.361 -0.828 . . . . 10.0 110.045 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 121.589 0.709 . . . . 10.0 109.466 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -101.84 135.6 43.1 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.461 -0.79 . . . . 10.0 109.535 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 29.0 m -137.9 124.5 20.9 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.745 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -116.83 127.72 54.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.159 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -86.25 -73.85 0.44 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.347 0.499 . . . . 10.0 112.347 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -120.36 114.78 22.35 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.643 0.238 . . . . 10.0 111.643 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 54.1 mt -122.94 112.7 34.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.808 -0.441 . . . . 10.0 109.808 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 36.5 mtm180 -113.44 114.79 27.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.385 -0.371 . . . . 10.0 110.446 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.71 113.07 18.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.272 -0.422 . . . . 10.0 111.781 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . 0.423 ' CD ' ' HZ2' ' D' ' 270' ' ' LYS . 9.2 pt-20 -128.65 169.97 13.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.985 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 67.72 63.4 0.41 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.065 -0.516 . . . . 10.0 111.658 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 60.2 19.69 9.07 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.451 -0.795 . . . . 10.0 112.659 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -71.3 165.45 23.68 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.006 0.373 . . . . 10.0 112.006 -179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.85 143.56 27.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.148 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 4.9 p -137.64 141.72 38.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.47 -0.332 . . . . 10.0 111.459 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.93 134.79 52.51 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.313 -0.403 . . . . 10.0 110.783 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -118.11 96.11 5.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.949 -0.569 . . . . 10.0 110.394 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 170.81 -105.63 0.22 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.504 -0.855 . . . . 10.0 112.822 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -166.64 158.17 12.97 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.095 -0.335 . . . . 10.0 110.095 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 26.2 t -110.85 108.12 24.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.928 0.394 . . . . 10.0 111.594 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 28.6 t -107.47 123.44 62.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.558 -0.904 . . . . 10.0 108.558 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 246' ' ' THR . . . . . 0.408 ' C ' ' H ' ' D' ' 248' ' ' ALA . 34.7 p -104.58 157.83 16.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.89 0.376 . . . . 10.0 111.802 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.44 9.28 1.4 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.806 -0.634 . . . . 10.0 111.298 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' D' ' 246' ' ' THR . . . -95.9 -6.13 39.91 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.067 -0.716 . . . . 10.0 109.067 178.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -105.64 113.51 27.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.509 -0.769 . . . . 10.0 109.923 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 87.8 mt -90.39 -175.16 4.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.137 -0.483 . . . . 10.0 111.026 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -78.06 72.2 4.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.207 0.527 . . . . 10.0 111.192 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -145.04 59.63 0.5 Allowed Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.305 -0.718 . . . . 10.0 111.305 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 88.46 41.67 6.04 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 110.957 -0.857 . . . . 10.0 110.957 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 20.3 tt -84.05 -27.25 7.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.122 0.487 . . . . 10.0 110.707 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 57.8 mtt-85 -78.73 77.71 5.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.767 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 19.7 tt -64.89 -19.63 25.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.485 . . . . 10.0 111.274 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 7.5 m 64.94 -134.54 0.24 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.495 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -118.82 112.28 19.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.143 -0.317 . . . . 10.0 110.143 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -110.85 -79.43 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.862 0.319 . . . . 10.0 111.862 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 15.3 t -90.34 157.35 17.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.143 0.496 . . . . 10.0 111.894 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 55.9 m -108.64 111.97 24.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.421 -0.809 . . . . 10.0 109.512 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -103.08 109.38 20.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.854 0.359 . . . . 10.0 110.255 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 16.4 m -119.29 123.27 43.82 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.273 -0.422 . . . . 10.0 110.506 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . 0.481 ' C ' ' HAK' ' B' ' 1' ' ' CGO . 8.8 p -125.42 129.93 72.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.605 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -87.5 -73.96 0.46 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.371 0.878 . . . . 10.0 113.371 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 7.4 m -102.48 122.1 43.66 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.652 0.612 . . . . 10.0 112.652 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.35 117.72 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.199 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 33.0 t -114.25 128.02 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.024 0.44 . . . . 10.0 111.352 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -132.84 109.5 0.84 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.834 -0.621 . . . . 10.0 111.971 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . 0.423 ' HZ2' ' CD ' ' D' ' 234' ' ' GLU . 6.3 tttp -125.92 106.73 9.85 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.814 0.301 . . . . 10.0 111.814 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 97.84 88.92 1.9 Allowed Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.834 -0.698 . . . . 10.0 114.353 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 54.24 25.43 5.8 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.338 0.866 . . . . 10.0 113.338 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 18.9 m -74.75 142.98 44.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.104 0.478 . . . . 10.0 110.998 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 26.5 mtm180 -128.32 116.47 19.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.756 -0.656 . . . . 10.0 110.83 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 23.9 t -101.81 122.76 54.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.705 -0.679 . . . . 10.0 110.173 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.81 101.83 7.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.145 0.498 . . . . 10.0 110.658 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 41.7 mm -100.97 104.24 15.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.239 -0.652 . . . . 10.0 109.239 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.34 -161.32 30.04 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.892 -0.883 . . . . 10.0 110.892 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -120.86 156.94 30.89 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.232 0.516 . . . . 10.0 111.355 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -114.57 131.58 56.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.661 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -129.18 116.37 19.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.18 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 160.27 177.5 33.42 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.182 -1.008 . . . . 10.0 113.46 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -100.74 44.12 1.63 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.974 -0.632 . . . . 10.0 112.709 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -91.18 -18.81 23.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.128 0.489 . . . . 10.0 110.217 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.91 -32.83 6.81 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.643 -0.708 . . . . 10.0 112.419 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 3.9 t80 170.13 147.59 0.03 OUTLIER 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.022 -0.733 . . . . 10.0 109.022 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 35.4 t90 -52.5 -67.28 0.26 Allowed 'General case' 0 C--O 1.233 0.23 0 O-C-N 123.558 0.536 . . . . 10.0 109.821 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -150.35 144.77 25.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.088 0.471 . . . . 10.0 111.785 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -163.56 141.89 7.79 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.139 -1.06 . . . . 10.0 108.139 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -63.64 -33.83 76.49 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.073 0.768 . . . . 10.0 113.073 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -166.82 -172.22 2.04 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.984 0.364 . . . . 10.0 111.984 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -99.43 -154.13 0.46 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.654 -0.869 . . . . 10.0 108.654 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -71.34 121.88 19.3 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.047 -0.353 . . . . 10.0 110.047 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -98.38 127.52 44.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.405 -0.361 . . . . 10.0 110.28 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.326 -0.845 . . . . 10.0 110.069 179.758 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.355 0.121 . . . . 10.0 110.93 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -135.35 121.67 20.38 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.99 0.424 . . . . 10.0 110.805 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.69 128.62 52.04 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.777 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.3 118.21 22.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -82.09 -68.49 0.69 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.273 0.472 . . . . 10.0 112.273 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -124.87 125.25 43.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.653 0.263 . . . . 10.0 111.33 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 79.2 mt -128.02 118.35 48.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.023 -0.535 . . . . 10.0 110.82 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -115.39 105.36 12.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.423 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.06 104.81 11.22 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.78 -0.645 . . . . 10.0 110.111 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -123.26 149.02 45.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.246 0.461 . . . . 10.0 112.246 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 64.08 86.94 0.12 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 114.036 1.124 . . . . 10.0 114.036 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 56.45 29.36 15.17 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.603 -0.726 . . . . 10.0 112.712 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.9 155.94 17.82 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.912 -0.585 . . . . 10.0 111.336 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.82 147.19 46.44 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.081 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 1.6 p -133.01 125.48 51.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.409 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 8.4 tm0? -118.66 128.49 54.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.156 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.4 92.94 3.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.538 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 170.51 -161.9 34.93 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.681 -0.771 . . . . 10.0 112.274 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -107.26 147.96 29.55 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.809 0.338 . . . . 10.0 110.6 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 63.3 t -108.32 118.52 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.04 -0.527 . . . . 10.0 109.768 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 39.9 t -118.41 112.46 38.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.001 0.429 . . . . 10.0 111.701 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 7.9 t -69.69 167.23 17.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.504 -0.771 . . . . 10.0 110.749 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.46 -17.33 62.6 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.336 -0.393 . . . . 10.0 111.554 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -67.66 -24.76 65.47 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.406 -0.361 . . . . 10.0 110.766 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 57.01 -163.04 0.18 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.572 -0.74 . . . . 10.0 112.46 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 29.7 mt -89.94 125.13 35.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.856 -0.611 . . . . 10.0 109.847 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -83.65 32.44 0.47 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 10.0 112.045 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 134.22 161.4 9.57 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.833 -0.699 . . . . 10.0 112.381 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 83.89 95.72 0.63 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.143 -0.551 . . . . 10.0 112.507 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 20.2 pt -81.34 -12.72 12.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.981 0.42 . . . . 10.0 111.537 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.01 90.61 8.41 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.697 -0.483 . . . . 10.0 109.697 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 3.1 pt -113.54 92.92 2.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.943 0.72 . . . . 10.0 112.943 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 69.5 m -118.06 139.05 51.79 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -69.03 136.69 52.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.889 0.376 . . . . 10.0 111.194 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -117.93 -48.48 2.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.132 -0.486 . . . . 10.0 110.526 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 4.8 t -78.03 149.8 33.94 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.011 -0.541 . . . . 10.0 110.256 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 55.8 m -127.58 113.18 15.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.306 0.574 . . . . 10.0 111.564 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -94.86 102.09 13.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.615 -0.72 . . . . 10.0 109.683 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 10.9 m -114.51 120.11 39.12 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.777 0.322 . . . . 10.0 110.455 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.1 p -114.74 144.5 22.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.229 -0.442 . . . . 10.0 111.169 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -86.27 -79.28 0.26 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 10.0 111.892 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 3.6 m -122.16 119.73 32.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.984 0.421 . . . . 10.0 111.797 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 2.7 t -113.53 105.94 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.042 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.18 125.88 68.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 110.01 -0.367 . . . . 10.0 110.01 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -149.83 136.83 5.89 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.702 -0.761 . . . . 10.0 112.123 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -133.64 151.41 51.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.6 0.238 . . . . 10.0 110.837 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 76.3 76.33 0.82 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.086 -0.578 . . . . 10.0 112.513 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 61.32 42.03 12.34 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.998 0.428 . . . . 10.0 111.707 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 9.6 t -64.95 155.04 35.75 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.604 -0.726 . . . . 10.0 111.715 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -136.65 101.68 4.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.351 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 65.7 t -101.45 119.61 49.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.787 0.327 . . . . 10.0 110.182 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.92 114.92 19.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.351 -0.386 . . . . 10.0 110.762 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 17.2 mm -117.9 84.38 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.799 -0.445 . . . . 10.0 109.799 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 178.9 -147.31 7.71 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.494 -0.86 . . . . 10.0 112.485 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.89 146.34 42.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.766 0.317 . . . . 10.0 110.694 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -107.82 115.27 29.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.108 0.48 . . . . 10.0 111.156 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -142.8 91.8 2.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.002 -0.544 . . . . 10.0 110.037 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . -147.86 -95.83 0.16 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.469 -0.872 . . . . 10.0 112.932 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -168.48 -104.71 0.18 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.877 -0.889 . . . . 10.0 110.877 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? 26.24 -85.28 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.396 1.628 . . . . 10.0 115.396 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.96 32.32 0.36 Allowed Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.549 -1.02 . . . . 10.0 110.549 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -161.33 105.51 1.3 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.822 -0.807 . . . . 10.0 108.822 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 75.15 10.7 3.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.896 0.855 . . . . 10.0 109.257 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -159.83 154.54 24.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.196 -1.366 . . . . 10.0 109.325 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.85 161.86 28.04 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.065 0.394 . . . . 10.0 112.065 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -164.48 167.76 19.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.607 -0.724 . . . . 10.0 109.895 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -106.26 -54.77 2.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.686 0.279 . . . . 10.0 110.679 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . 0.417 ' CG ' ' H ' ' E' ' 293' ' ' HIS . 4.9 t-80 63.28 -164.31 0.25 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.705 -0.679 . . . . 10.0 111.153 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . 0.417 ' H ' ' CG ' ' E' ' 292' ' ' HIS . 88.2 m-70 -128.0 125.26 39.07 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.693 -0.484 . . . . 10.0 109.693 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -90.45 133.18 35.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.785 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.09 -0.957 . . . . 10.0 109.714 -179.948 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' CGO . . . . . 0.881 ' OBE' ' HBT' ' B' ' 1' ' ' CGO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.759 ' HB3' HG22 ' A' ' 261' ' ' THR . 2.9 tmm_? . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.977 0.418 . . . . 10.0 110.367 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -113.7 111.01 21.11 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.605 -0.887 . . . . 10.0 108.605 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 263' ' ' SER . 0.7 OUTLIER -133.06 144.85 50.28 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.052 0.76 . . . . 10.0 113.052 -178.489 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.41 151.73 47.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.106 -0.952 . . . . 10.0 108.683 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.44 ' HE3' ' HB2' ' A' ' 229' ' ' LYS . 24.1 ttmt -102.75 -61.24 1.42 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.031 0.752 . . . . 10.0 113.031 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.592 ' O ' ' HA ' ' A' ' 266' ' ' THR . 19.9 t0 -131.79 117.24 18.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.06 0.457 . . . . 10.0 111.882 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.553 HG23 ' HB ' ' A' ' 267' ' ' VAL . 56.0 mt -124.05 136.96 58.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.561 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.3 ptp85 -126.29 105.21 8.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.099 0.476 . . . . 10.0 111.662 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.21 120.33 39.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.011 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.517 ' HB2' ' HG2' ' A' ' 270' ' ' LYS . 17.6 mt-10 -132.46 140.45 48.4 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.405 0.52 . . . . 10.0 112.405 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.421 ' OE1' ' HA2' ' A' ' 271' ' ' GLY . 37.9 tt0 65.61 86.01 0.13 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.162 -0.926 . . . . 10.0 113.231 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 96.7 mtm-85 50.66 35.17 11.12 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.361 -0.836 . . . . 10.0 112.738 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.59 146.95 25.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.69 -0.232 . . . . 10.0 110.45 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -124.83 159.29 31.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.562 -0.29 . . . . 10.0 110.413 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.4 p -142.73 126.32 14.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.857 0.36 . . . . 10.0 111.218 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -118.96 139.57 51.45 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.817 -0.438 . . . . 10.0 109.817 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.13 119.43 26.48 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.095 -0.335 . . . . 10.0 110.095 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 152.31 -108.05 0.36 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.751 -0.737 . . . . 10.0 111.967 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -153.85 158.98 41.63 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.864 -0.421 . . . . 10.0 109.864 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 280' ' ' GLU . 18.1 t -110.88 113.19 43.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.126 0.489 . . . . 10.0 112.233 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 57.9 t -101.5 114.22 40.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 5.0 m -106.28 141.79 37.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.241 -0.436 . . . . 10.0 109.933 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.54 -18.15 27.2 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.539 0.57 . . . . 10.0 112.539 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -73.26 -23.49 60.34 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.287 -0.415 . . . . 10.0 111.353 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -110.26 46.19 1.06 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.199 0.523 . . . . 10.0 110.597 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 250' ' ' LEU . 2.2 mm? 66.36 -155.33 0.24 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.254 -0.884 . . . . 10.0 112.112 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -89.46 -175.64 4.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.147 -0.478 . . . . 10.0 110.849 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -76.06 77.91 1.29 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.079 -0.582 . . . . 10.0 112.463 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -67.78 -43.63 83.35 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.26 -0.495 . . . . 10.0 112.086 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 1.3 mp 69.4 136.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 112.779 0.659 . . . . 10.0 112.779 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? 65.83 89.57 0.1 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.499 -0.773 . . . . 10.0 111.977 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 3.5 mp -129.91 -55.38 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.127 -0.488 . . . . 10.0 111.462 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 5.6 p -105.87 -87.91 0.45 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.631 0.604 . . . . 10.0 112.631 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.25 42.95 17.62 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.76 -0.655 . . . . 10.0 111.634 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.414 ' H ' ' HG2' ' A' ' 259' ' ' GLN . 6.8 pt20 -84.45 -21.84 30.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.821 -0.627 . . . . 10.0 111.748 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' THR . . . . . 0.419 ' HG1' ' N ' ' B' ' 225' ' ' ARG . 6.6 t -131.97 143.29 49.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.903 0.382 . . . . 10.0 111.119 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 225' ' ' ARG . 0.2 OUTLIER -87.06 144.12 27.02 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.757 -0.656 . . . . 10.0 109.85 179.306 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -122.06 122.96 40.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.818 0.342 . . . . 10.0 110.449 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' B' ' 227' ' ' SER . 0.9 OUTLIER -139.92 134.49 31.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.156 -0.474 . . . . 10.0 110.894 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.8 p -131.43 137.78 54.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.072 0.463 . . . . 10.0 111.342 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.583 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 40.6 tp10 -77.85 -79.25 0.12 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.862 -0.608 . . . . 10.0 112.344 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 230' ' ' ASP . 3.4 p -120.82 128.58 52.99 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.978 0.733 . . . . 10.0 112.978 -178.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.553 ' HB ' HG23 ' A' ' 231' ' ' ILE . 4.2 t -119.31 127.18 75.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.852 -0.613 . . . . 10.0 109.817 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.477 ' HB ' ' HA ' ' B' ' 232' ' ' ARG . 24.8 t -114.73 120.04 63.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.459 -0.337 . . . . 10.0 110.415 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.23 107.66 0.83 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.892 -0.671 . . . . 10.0 111.714 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.517 ' HG2' ' HB2' ' A' ' 234' ' ' GLU . 89.0 mttt -126.36 148.23 49.62 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.428 -0.212 . . . . 10.0 110.428 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' GLY . . . . . 0.421 ' HA2' ' OE1' ' A' ' 235' ' ' GLU . . . 76.84 58.96 3.32 Favored Glycine 0 C--O 1.226 -0.356 0 C-N-CA 120.797 -0.716 . . . . 10.0 113.47 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 62.15 21.29 12.32 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.923 0.712 . . . . 10.0 112.923 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 70.0 m -73.17 139.13 46.12 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.997 0.427 . . . . 10.0 111.202 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 12.5 mtt180 -104.57 123.45 47.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 10.0 111.393 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 46.0 t -102.15 117.32 47.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.087 -0.506 . . . . 10.0 109.912 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.41 114.12 21.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.867 0.365 . . . . 10.0 111.511 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 25.9 mm -107.8 103.02 14.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.842 -0.617 . . . . 10.0 109.693 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.34 142.04 3.91 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.792 -0.718 . . . . 10.0 111.908 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -61.85 149.71 39.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.933 0.397 . . . . 10.0 111.683 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.415 ' HA ' ' HB ' ' A' ' 244' ' ' VAL . 0.0 OUTLIER -109.53 158.17 18.27 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.132 -0.485 . . . . 10.0 111.543 -179.42 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -140.09 101.36 4.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.326 -0.852 . . . . 10.0 109.1 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -150.87 -115.37 0.7 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.517 -0.849 . . . . 10.0 113.055 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 146.6 -60.79 0.47 Allowed Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.225 -0.75 . . . . 10.0 111.225 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.492 ' HE2' ' HB3' ' A' ' 284' ' ' LYS . 20.9 ttpt -79.9 85.37 5.55 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.009 -0.738 . . . . 10.0 109.009 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 289' ' ' ASN . . . 95.45 105.43 2.07 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.67 -0.972 . . . . 10.0 110.67 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -75.71 76.24 2.69 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.402 -0.221 . . . . 10.0 110.402 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 18.2 t90 69.38 -58.4 0.51 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.9 -0.591 . . . . 10.0 112.098 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -135.21 90.53 2.63 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.064 -0.717 . . . . 10.0 109.064 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' ASN . . . . . 0.428 ' HB3' ' HA2' ' A' ' 285' ' ' GLY . 25.1 t-20 -150.34 119.79 6.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.781 0.324 . . . . 10.0 111.631 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -157.93 55.25 0.47 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.398 0.618 . . . . 10.0 109.972 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -105.5 121.56 44.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.644 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -123.24 2.36 9.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.16 0.505 . . . . 10.0 110.797 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -84.01 116.19 22.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.521 -0.763 . . . . 10.0 109.974 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -89.41 127.26 35.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.133 0.492 . . . . 10.0 111.081 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' HIS . . . . . 0.686 ' HE1' ' H ' ' B' ' 291' ' ' HIS . 1.1 p80 . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.355 -0.831 . . . . 10.0 110.711 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.447 ' HB3' HG22 ' B' ' 261' ' ' THR . 14.7 ttm180 . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.201 -0.296 . . . . 10.0 110.201 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -119.13 114.04 21.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.538 -0.542 . . . . 10.0 109.538 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 227' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' B' ' 263' ' ' SER . 3.4 m -129.3 134.1 47.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.011 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.71 143.38 50.7 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.695 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.586 ' HB3' ' O ' ' B' ' 265' ' ' GLU . 12.8 tptm -89.99 -79.57 0.34 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.344 -0.389 . . . . 10.0 111.723 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 230' ' ' ASP . . . . . 0.44 ' CG ' HH21 ' B' ' 232' ' ' ARG . 18.8 t70 -122.56 126.08 47.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.311 0.577 . . . . 10.0 112.498 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.403 HG23 ' HB ' ' B' ' 267' ' ' VAL . 65.6 mt -122.76 114.66 43.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.563 -0.744 . . . . 10.0 109.053 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 232' ' ' ARG . . . . . 0.477 ' HA ' ' HB ' ' A' ' 268' ' ' VAL . 1.7 ttm180 -109.87 106.78 16.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.926 0.393 . . . . 10.0 110.66 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.624 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 0.8 OUTLIER -118.08 128.69 55.0 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.13 -0.486 . . . . 10.0 111.106 -179.266 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -141.26 168.23 20.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.535 -0.302 . . . . 10.0 111.373 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 235' ' ' GLU . . . . . 0.487 ' OE1' ' HG2' ' B' ' 270' ' ' LYS . 34.8 mt-10 65.34 62.65 0.68 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.89 -0.595 . . . . 10.0 111.777 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 81.8 mtm-85 57.05 44.91 21.88 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.924 -0.58 . . . . 10.0 112.227 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.624 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -90.08 163.43 14.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.865 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -134.09 122.31 22.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.097 0.475 . . . . 10.0 110.362 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 p -115.86 125.61 73.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.312 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -119.79 128.24 53.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.849 -0.614 . . . . 10.0 111.089 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.35 97.51 6.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.027 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 156.18 169.15 20.03 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.909 -0.663 . . . . 10.0 112.186 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -87.95 137.86 31.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.831 0.348 . . . . 10.0 110.84 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 94.0 t -91.16 123.28 43.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.969 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 17.7 t -121.96 102.29 11.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.41 0.624 . . . . 10.0 110.493 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 68.4 p -81.57 162.8 23.0 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.661 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.412 ' HA ' ' HG ' ' B' ' 250' ' ' LEU . . . -61.95 -14.15 32.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.104 0.478 . . . . 10.0 111.254 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -75.95 -14.83 60.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.692 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -95.44 -2.16 49.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 10.0 111.111 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.412 ' HG ' ' HA ' ' B' ' 247' ' ' ALA . 87.9 mt -76.17 140.35 41.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.334 -0.394 . . . . 10.0 110.385 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 65.97 28.51 10.51 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 123.597 0.56 . . . . 10.0 110.862 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -131.11 174.22 20.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.055 -0.593 . . . . 10.0 111.714 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -83.08 115.83 4.1 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.131 -0.557 . . . . 10.0 112.478 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 29.5 pt -109.71 17.97 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.026 0.441 . . . . 10.0 111.672 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 255' ' ' ARG . . . . . 0.49 ' HA ' HH11 ' B' ' 255' ' ' ARG . 0.0 OUTLIER -129.03 103.82 7.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.27 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 20.1 pt -132.18 35.73 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 111.866 0.321 . . . . 10.0 111.866 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 62.3 m 64.29 33.53 11.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.326 0.584 . . . . 10.0 111.466 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 258' ' ' ASP . . . . . 0.428 ' CG ' HH12 ' B' ' 255' ' ' ARG . 0.7 OUTLIER -77.79 71.43 4.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.465 -0.789 . . . . 10.0 111.902 -179.582 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -96.15 113.8 25.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.024 -0.535 . . . . 10.0 109.777 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 14.7 t -158.82 141.76 14.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.551 0.691 . . . . 10.0 111.961 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 261' ' ' THR . . . . . 0.521 ' O ' ' HD2' ' C' ' 225' ' ' ARG . 0.0 OUTLIER -110.14 95.96 5.92 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.298 -0.864 . . . . 10.0 108.813 178.601 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -91.37 132.21 36.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.386 -0.37 . . . . 10.0 110.66 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 263' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' B' ' 227' ' ' SER . 1.9 p -145.52 136.05 24.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.656 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.442 HG21 HG22 ' B' ' 267' ' ' VAL . 8.0 p -124.56 131.53 72.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.884 -0.598 . . . . 10.0 110.103 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 265' ' ' GLU . . . . . 0.586 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 17.3 tp10 -73.14 -62.74 1.36 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.333 0.494 . . . . 10.0 112.333 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' B' ' 230' ' ' ASP . 24.8 m -135.46 124.44 24.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.147 0.499 . . . . 10.0 112.087 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.442 HG22 HG21 ' B' ' 264' ' ' VAL . 20.7 t -111.33 118.95 58.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.736 -0.665 . . . . 10.0 109.356 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 268' ' ' VAL . . . . . 0.464 ' HB ' ' HA ' ' C' ' 232' ' ' ARG . 39.9 t -103.88 116.73 48.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.904 0.383 . . . . 10.0 110.829 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.75 113.34 2.35 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.395 -0.682 . . . . 10.0 111.395 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 270' ' ' LYS . . . . . 0.487 ' HG2' ' OE1' ' B' ' 235' ' ' GLU . 2.4 ttpp -128.76 131.05 47.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.665 0.269 . . . . 10.0 111.456 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 271' ' ' GLY . . . . . 0.464 ' H ' ' HB2' ' B' ' 235' ' ' GLU . . . 78.47 71.94 1.2 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.571 -0.823 . . . . 10.0 113.479 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 53.05 43.8 31.22 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.386 0.884 . . . . 10.0 113.386 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.61 149.73 34.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.236 0.541 . . . . 10.0 111.552 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 274' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 38.3 mtt180 -120.0 118.7 31.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.652 -0.704 . . . . 10.0 110.024 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 47.4 t -110.11 127.17 67.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.138 -0.483 . . . . 10.0 111.062 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.51 ' HB2' ' CZ2' ' B' ' 287' ' ' TRP . 0.7 OUTLIER -123.83 109.61 13.84 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.857 -0.423 . . . . 10.0 109.857 179.269 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 36.4 mm -102.25 100.37 10.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.993 -0.373 . . . . 10.0 109.993 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.41 176.54 19.45 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.685 -0.566 . . . . 10.0 111.685 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -97.99 156.63 16.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.9 0.35 . . . . 10.0 110.576 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 280' ' ' GLU . . . . . 0.417 ' OE2' ' HB2' ' B' ' 287' ' ' TRP . 8.1 pt-20 -128.83 161.47 29.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.912 0.386 . . . . 10.0 111.422 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 281' ' ' TYR . . . . . 0.431 ' HE1' ' HA ' ' C' ' 247' ' ' ALA . 2.7 t80 -134.33 127.04 30.92 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.546 -0.752 . . . . 10.0 109.852 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 282' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' C' ' 246' ' ' THR . . . 167.74 152.34 7.47 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.774 -0.727 . . . . 10.0 112.04 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -123.97 8.38 8.64 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.509 -0.853 . . . . 10.0 111.982 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -97.67 15.17 24.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.055 0.455 . . . . 10.0 110.863 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 156.93 -176.44 34.19 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.218 -0.753 . . . . 10.0 111.218 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -127.29 64.09 1.33 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.389 -0.597 . . . . 10.0 109.389 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.638 ' CZ3' ' HB2' ' C' ' 238' ' ' ARG . 17.3 t90 70.46 -54.21 0.64 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.948 0.78 . . . . 10.0 111.42 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 288' ' ' ASP . . . . . 0.447 ' CG ' HH11 ' C' ' 238' ' ' ARG . 3.0 t70 -109.13 -168.52 1.35 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.688 -0.687 . . . . 10.0 109.617 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -111.42 132.71 54.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.058 0.456 . . . . 10.0 111.689 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.41 125.08 6.44 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 291' ' ' HIS . . . . . 0.686 ' H ' ' HE1' ' A' ' 295' ' ' HIS . 0.5 OUTLIER -160.91 143.4 12.62 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.121 -0.326 . . . . 10.0 110.121 -179.077 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -173.69 -161.99 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.398 -0.364 . . . . 10.0 110.462 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -122.41 149.0 44.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.613 -0.267 . . . . 10.0 111.105 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -83.85 -179.16 7.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.709 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 . . . . . 0 C--O 1.252 1.186 0 CA-C-O 117.909 -1.044 . . . . 10.0 108.852 -179.699 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 225' ' ' ARG . . . . . 0.706 ' N ' ' HG1' ' C' ' 261' ' ' THR . 1.7 ptt-85 . . . . . 0 N--CA 1.483 1.175 0 N-CA-C 110.21 -0.293 . . . . 10.0 110.21 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 226' ' ' ASN . . . . . 0.539 ' HB3' HG22 ' C' ' 277' ' ' ILE . 4.2 m120 -131.26 129.06 41.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.349 . . . . 10.0 110.661 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 227' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' C' ' 263' ' ' SER . 0.3 OUTLIER -133.07 135.46 45.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.166 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.12 138.33 45.16 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.964 -0.384 . . . . 10.0 109.964 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 229' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 18.6 tttm -94.2 -78.65 0.43 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.07 0.396 . . . . 10.0 112.07 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -109.81 116.25 31.32 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.301 0.482 . . . . 10.0 112.301 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 63.4 mt -123.93 117.45 51.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.087 -0.506 . . . . 10.0 110.101 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.533 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 9.3 ttm180 -109.26 120.69 43.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.888 0.375 . . . . 10.0 111.074 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.96 112.85 16.41 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.907 -0.775 . . . . 10.0 108.907 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 234' ' ' GLU . . . . . 0.533 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 11.5 pt-20 -138.08 161.07 37.72 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.347 0.499 . . . . 10.0 112.347 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 64.73 69.89 0.49 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.883 -1.053 . . . . 10.0 110.943 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 55.58 63.14 2.16 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.845 -1.071 . . . . 10.0 110.449 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -118.47 167.67 11.38 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.766 -0.652 . . . . 10.0 110.442 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 238' ' ' ARG . . . . . 0.638 ' HB2' ' CZ3' ' B' ' 287' ' ' TRP . 0.0 OUTLIER -153.24 141.6 20.64 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.602 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.666 HG23 ' HB ' ' C' ' 275' ' ' VAL . 5.7 p -125.13 132.81 70.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.499 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.434 ' HB3' HD22 ' C' ' 276' ' ' LEU . 4.0 tm0? -106.72 122.62 46.72 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.592 -0.731 . . . . 10.0 109.122 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.62 69.72 0.7 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.519 -0.309 . . . . 10.0 111.442 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 175.51 -169.5 42.29 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.409 -0.901 . . . . 10.0 112.228 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -95.66 144.93 25.67 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.265 -0.272 . . . . 10.0 110.265 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.96 105.99 19.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.295 -0.411 . . . . 10.0 110.363 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.66 118.71 53.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.254 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 246' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' B' ' 282' ' ' GLY . 32.2 p -76.98 163.86 26.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.069 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 247' ' ' ALA . . . . . 0.431 ' HA ' ' HE1' ' B' ' 281' ' ' TYR . . . -72.89 16.05 0.17 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.685 0.624 . . . . 10.0 112.685 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -121.39 0.67 10.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.067 0.461 . . . . 10.0 109.921 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -109.71 67.14 0.64 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.143 0.497 . . . . 10.0 110.576 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.31 25.84 9.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.059 -0.519 . . . . 10.0 111.295 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -113.99 67.76 0.68 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.36 0.6 . . . . 10.0 111.559 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -140.08 143.04 13.15 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.942 -0.863 . . . . 10.0 110.942 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -95.57 -145.8 19.6 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.113 -1.041 . . . . 10.0 111.833 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 6.9 tp -132.52 110.55 16.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.255 0.55 . . . . 10.0 110.475 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 42.6 ttt85 -158.26 140.5 14.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.782 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 9.6 tt -102.93 134.95 42.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 121.448 0.642 . . . . 10.0 111.587 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 57.9 m -159.73 -170.74 3.01 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.526 -0.761 . . . . 10.0 109.16 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.1 155.42 36.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.789 0.328 . . . . 10.0 111.419 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.02 132.84 12.32 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.247 -0.649 . . . . 10.0 109.247 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 260' ' ' THR . . . . . 0.5 ' HA ' ' OD1' ' D' ' 258' ' ' ASP . 3.7 t -68.39 154.14 42.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.328 0.585 . . . . 10.0 112.043 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 261' ' ' THR . . . . . 0.706 ' HG1' ' N ' ' C' ' 225' ' ' ARG . 52.8 m -123.44 120.61 33.46 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.451 -0.795 . . . . 10.0 110.23 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 262' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' D' ' 226' ' ' ASN . 29.5 t-20 -107.64 125.98 52.01 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.113 -0.699 . . . . 10.0 109.113 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 263' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' C' ' 227' ' ' SER . 13.4 m -136.37 131.72 34.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.016 0.436 . . . . 10.0 110.87 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 6.9 p -118.77 139.19 46.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.335 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 265' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' D' ' 229' ' ' LYS . 43.2 mt-10 -74.75 -58.59 3.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.199 -0.455 . . . . 10.0 112.046 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 2.7 m -136.51 133.98 37.08 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.386 0.513 . . . . 10.0 112.386 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 24.9 t -123.73 116.72 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.469 -0.937 . . . . 10.0 108.469 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 6.5 t -113.9 108.74 26.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 120.94 0.4 . . . . 10.0 110.906 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 269' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -119.55 125.02 6.17 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.907 -0.877 . . . . 10.0 110.907 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 270' ' ' LYS . . . . . 0.505 ' HG3' ' HG3' ' C' ' 234' ' ' GLU . 45.4 tttm -133.22 117.77 17.8 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.933 0.345 . . . . 10.0 111.933 -178.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 90.33 91.39 1.27 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.885 -0.674 . . . . 10.0 113.122 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 59.25 36.24 23.63 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.94 0.4 . . . . 10.0 111.688 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.85 145.67 42.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.837 -0.62 . . . . 10.0 112.447 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -139.14 109.58 6.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.714 -0.675 . . . . 10.0 110.483 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.666 ' HB ' HG23 ' C' ' 239' ' ' VAL . 22.0 t -102.68 132.74 48.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.052 -0.522 . . . . 10.0 110.651 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.434 HD22 ' HB3' ' C' ' 240' ' ' GLN . 0.2 OUTLIER -121.75 106.31 11.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.685 0.278 . . . . 10.0 110.812 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.539 HG22 ' HB3' ' C' ' 226' ' ' ASN . 23.2 mm -101.69 85.98 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.312 0.577 . . . . 10.0 110.063 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 160.83 -170.33 36.69 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.541 -0.754 . . . . 10.0 111.219 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -102.67 154.94 18.66 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.202 -0.587 . . . . 10.0 110.967 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -108.4 142.67 38.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.321 -0.399 . . . . 10.0 110.407 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 281' ' ' TYR . . . . . 0.559 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.3 OUTLIER -136.34 97.09 3.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.157 -0.474 . . . . 10.0 109.728 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . -145.96 158.87 27.82 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.861 -0.685 . . . . 10.0 112.781 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -106.5 -15.07 18.25 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.706 -0.759 . . . . 10.0 112.51 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -74.17 -38.59 63.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.275 0.56 . . . . 10.0 110.285 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 170.65 -112.39 0.45 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.147 -1.181 . . . . 10.0 110.147 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -126.08 -169.9 2.09 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.72 -0.474 . . . . 10.0 109.72 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -57.97 -24.3 57.48 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.272 0.558 . . . . 10.0 111.545 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -110.72 157.08 20.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.943 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 289' ' ' ASN . . . . . 0.413 ' OD1' ' HA ' ' B' ' 291' ' ' HIS . 7.5 p30 -133.85 19.84 3.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.151 0.5 . . . . 10.0 111.307 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 290' ' ' HIS . . . . . 0.666 ' HB3' ' NH2' ' D' ' 274' ' ' ARG . 5.2 t-80 -81.15 -10.13 59.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.706 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.52 168.37 22.1 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.305 0.483 . . . . 10.0 112.305 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 66.51 174.04 0.24 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.5 -0.773 . . . . 10.0 112.646 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 N-CA-C 112.351 0.5 . . . . 10.0 112.351 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 226' ' ' ASN . . . . . 0.493 ' O ' ' HA ' ' C' ' 262' ' ' ASN . 18.8 m-80 . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 120.634 0.254 . . . . 10.0 110.995 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 1.8 m -146.42 153.46 40.5 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.277 -0.42 . . . . 10.0 110.764 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.29 148.74 46.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.624 0.249 . . . . 10.0 110.922 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 229' ' ' LYS . . . . . 0.653 ' HB2' ' HA ' ' D' ' 265' ' ' GLU . 17.5 mttt -89.67 -77.78 0.38 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.393 -0.367 . . . . 10.0 111.045 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -125.13 120.18 30.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.923 0.392 . . . . 10.0 110.913 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 62.1 mt -118.69 124.28 72.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.908 -0.587 . . . . 10.0 110.541 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 232' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' D' ' 232' ' ' ARG . 6.1 mtm105 -108.5 127.87 54.3 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.882 -0.599 . . . . 10.0 109.786 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 233' ' ' THR . . . . . 0.502 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 0.7 OUTLIER -131.77 111.56 11.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.356 -0.384 . . . . 10.0 110.079 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -124.57 154.56 40.46 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.68 0.622 . . . . 10.0 112.68 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 58.15 78.42 0.25 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 114.996 -1.002 . . . . 10.0 113.365 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 52.82 50.62 17.65 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.237 -0.892 . . . . 10.0 111.783 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 237' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' D' ' 233' ' ' THR . . . -104.97 154.86 19.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.187 -0.461 . . . . 10.0 110.423 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.05 144.68 43.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.885 0.374 . . . . 10.0 110.912 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 239' ' ' VAL . . . . . 0.664 HG23 ' HB ' ' D' ' 275' ' ' VAL . 7.6 p -126.96 131.26 71.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.556 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -113.28 121.7 45.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.353 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 241' ' ' LEU . . . . . 0.416 HD23 HD13 ' C' ' 277' ' ' ILE . 2.6 mm? -116.06 93.49 4.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.941 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 174.64 -120.2 0.77 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.229 -0.986 . . . . 10.0 112.791 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -152.56 152.95 32.47 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.734 -0.469 . . . . 10.0 109.734 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 244' ' ' VAL . . . . . 0.517 HG11 ' HD1' ' D' ' 287' ' ' TRP . 22.6 t -97.12 106.37 18.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.163 -0.471 . . . . 10.0 111.873 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 245' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 21.2 t -110.16 93.48 2.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.278 -0.638 . . . . 10.0 109.278 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 246' ' ' THR . . . . . 0.428 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 41.6 p -74.16 153.54 39.47 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.821 -0.351 . . . . 10.0 110.387 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 247' ' ' ALA . . . . . 0.442 ' HA ' ' HE1' ' C' ' 281' ' ' TYR . . . -73.29 11.63 0.72 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.826 0.346 . . . . 10.0 111.731 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -95.7 -3.99 45.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.25 0.548 . . . . 10.0 109.653 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -99.61 137.13 38.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.692 -0.686 . . . . 10.0 110.168 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 250' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' D' ' 250' ' ' LEU . 6.9 tp -118.24 -157.38 0.68 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.626 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -91.15 63.88 5.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.038 0.447 . . . . 10.0 111.338 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -132.28 36.67 2.15 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 111.063 -0.815 . . . . 10.0 111.063 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 107.52 52.35 0.72 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.418 -0.673 . . . . 10.0 111.418 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 20.1 tt -87.48 -20.89 7.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.953 0.406 . . . . 10.0 110.87 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -83.97 70.18 10.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.02 0.438 . . . . 10.0 110.794 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 18.1 tt -64.25 -30.2 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.751 -0.659 . . . . 10.0 111.851 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 7.3 m 66.18 -172.8 0.19 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.924 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 258' ' ' ASP . . . . . 0.5 ' OD1' ' HA ' ' C' ' 260' ' ' THR . 4.0 m-20 -80.92 93.94 6.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.911 0.386 . . . . 10.0 110.557 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -94.59 -44.05 8.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.12 -0.491 . . . . 10.0 111.431 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 10.3 t -123.25 150.36 43.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.921 0.391 . . . . 10.0 111.003 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 5.5 m -104.46 103.69 13.43 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.415 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 262' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' D' ' 226' ' ' ASN . 2.6 m120 -102.64 110.23 22.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.206 -0.452 . . . . 10.0 109.869 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 25.8 m -124.81 131.9 53.4 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.942 0.401 . . . . 10.0 111.047 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 264' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' E' ' 228' ' ' ALA . 11.3 p -126.95 138.13 55.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.141 -0.481 . . . . 10.0 110.375 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 265' ' ' GLU . . . . . 0.653 ' HA ' ' HB2' ' D' ' 229' ' ' LYS . 19.8 mt-10 -86.55 -73.02 0.48 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.784 0.661 . . . . 10.0 112.784 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.55 125.8 52.23 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.716 0.635 . . . . 10.0 112.716 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 4.2 t -127.82 113.88 32.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.247 -0.649 . . . . 10.0 109.247 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 268' ' ' VAL . . . . . 0.68 ' HB ' ' HG2' ' E' ' 232' ' ' ARG . 42.0 t -116.2 113.1 42.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 120.685 0.279 . . . . 10.0 110.976 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.55 137.09 9.44 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.001 -0.619 . . . . 10.0 112.11 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.23 135.8 19.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.638 -0.331 . . . . 10.0 111.122 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.63 89.75 0.23 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.15 -0.547 . . . . 10.0 112.861 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 59.48 38.31 22.61 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.033 0.444 . . . . 10.0 111.444 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 1.5 t -87.56 143.99 26.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.086 -0.506 . . . . 10.0 111.358 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 274' ' ' ARG . . . . . 0.666 ' NH2' ' HB3' ' C' ' 290' ' ' HIS . 72.0 mtt85 -131.5 110.53 11.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.408 -0.815 . . . . 10.0 109.712 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 275' ' ' VAL . . . . . 0.664 ' HB ' HG23 ' D' ' 239' ' ' VAL . 36.2 t -101.33 105.35 17.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.994 -0.373 . . . . 10.0 109.994 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 276' ' ' LEU . . . . . 0.548 HD12 ' HG2' ' E' ' 240' ' ' GLN . 2.1 tm? -107.42 103.59 12.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.929 0.395 . . . . 10.0 110.628 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 42.9 mm -105.03 96.81 4.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.216 -0.447 . . . . 10.0 109.819 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 158.28 178.84 32.69 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.508 -0.637 . . . . 10.0 111.508 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -96.0 156.95 16.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.61 0.243 . . . . 10.0 110.395 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 280' ' ' GLU . . . . . 0.516 ' HA ' ' HB ' ' D' ' 244' ' ' VAL . 6.0 pt-20 -118.44 131.23 56.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.843 0.354 . . . . 10.0 110.926 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -122.01 123.23 41.14 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.045 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 282' ' ' GLY . . . . . 0.428 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 155.53 178.68 30.0 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.378 -0.915 . . . . 10.0 112.796 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -108.59 32.77 6.68 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.945 -0.645 . . . . 10.0 112.156 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.19 -9.15 59.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.897 0.379 . . . . 10.0 110.748 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.25 -51.51 1.41 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.076 -0.583 . . . . 10.0 111.709 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -171.42 145.95 2.19 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.831 -0.803 . . . . 10.0 108.831 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 287' ' ' TRP . . . . . 0.517 ' HD1' HG11 ' D' ' 244' ' ' VAL . 11.5 t90 -56.07 -64.06 0.98 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.041 0.448 . . . . 10.0 110.383 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 288' ' ' ASP . . . . . 0.418 ' CG ' ' HE ' ' E' ' 238' ' ' ARG . 29.6 t0 -136.29 132.33 35.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.3 0.572 . . . . 10.0 110.473 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -171.85 146.64 2.08 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -69.57 -58.96 3.3 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.849 0.685 . . . . 10.0 112.849 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -161.08 -163.04 0.97 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.826 0.306 . . . . 10.0 111.826 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -86.06 -170.49 3.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.891 -0.595 . . . . 10.0 109.819 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -72.76 117.78 14.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.012 0.434 . . . . 10.0 110.987 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -99.07 148.11 24.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.86 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 117.764 -1.112 . . . . 10.0 108.392 178.888 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 225' ' ' ARG . . . . . 0.517 ' N ' ' HG1' ' E' ' 261' ' ' THR . 57.9 mtt180 . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 110.283 -0.265 . . . . 10.0 110.283 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -128.5 121.33 28.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.369 . . . . 10.0 110.998 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 227' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' E' ' 263' ' ' SER . 0.6 OUTLIER -123.0 144.46 49.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.718 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 228' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' D' ' 264' ' ' VAL . . . -139.62 125.83 20.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.29 -0.413 . . . . 10.0 109.938 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 229' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' D' ' 265' ' ' GLU . 33.5 mttm -84.0 -62.59 1.53 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.05 0.759 . . . . 10.0 113.05 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 230' ' ' ASP . . . . . 0.733 ' HB3' HG23 ' E' ' 266' ' ' THR . 8.9 t0 -130.85 125.4 33.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.779 0.323 . . . . 10.0 111.142 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 86.5 mt -133.59 123.97 47.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.042 -0.526 . . . . 10.0 110.306 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 232' ' ' ARG . . . . . 0.68 ' HG2' ' HB ' ' D' ' 268' ' ' VAL . 7.5 mtt180 -122.23 120.35 33.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.143 -0.481 . . . . 10.0 110.538 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 1.2 p -130.45 93.78 3.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.518 -0.764 . . . . 10.0 110.295 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 234' ' ' GLU . . . . . 0.631 ' HB2' ' HE3' ' E' ' 270' ' ' LYS . 36.1 mt-10 -119.29 152.11 37.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.334 -0.393 . . . . 10.0 111.0 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 70.72 77.22 0.19 Allowed 'General case' 0 C--O 1.236 0.362 0 O-C-N 123.912 0.757 . . . . 10.0 112.335 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 33.1 mtp180 60.67 24.43 14.23 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.078 -0.965 . . . . 10.0 112.246 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -103.47 150.93 23.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.197 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 238' ' ' ARG . . . . . 0.419 ' HB3' ' HB2' ' D' ' 274' ' ' ARG . 0.0 OUTLIER -144.55 164.57 30.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.201 -0.454 . . . . 10.0 111.777 -179.203 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 239' ' ' VAL . . . . . 0.743 HG23 ' HB ' ' E' ' 275' ' ' VAL . 7.7 p -134.63 142.58 40.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.767 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 240' ' ' GLN . . . . . 0.548 ' HG2' HD12 ' D' ' 276' ' ' LEU . 25.5 tm0? -129.89 131.44 46.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.796 -0.638 . . . . 10.0 109.313 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 241' ' ' LEU . . . . . 0.469 ' HG ' ' HB ' ' E' ' 277' ' ' ILE . 0.4 OUTLIER -128.98 95.35 4.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.075 0.464 . . . . 10.0 111.786 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 166.32 170.76 31.64 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.435 -0.666 . . . . 10.0 111.435 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -88.14 147.59 24.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.827 0.346 . . . . 10.0 110.924 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.15 125.15 49.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.561 -0.533 . . . . 10.0 109.561 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.9 98.51 7.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.002 0.43 . . . . 10.0 109.86 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 246' ' ' THR . . . . . 0.449 ' HB ' ' HA2' ' E' ' 282' ' ' GLY . 14.7 t -60.93 161.92 7.62 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.729 -0.669 . . . . 10.0 111.578 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.09 -19.38 64.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.29 -0.414 . . . . 10.0 111.805 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -74.49 -23.47 58.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.536 -0.302 . . . . 10.0 110.242 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 58.07 -170.28 0.11 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.384 -0.826 . . . . 10.0 112.199 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 6.8 mp -83.99 115.66 22.44 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.234 -0.654 . . . . 10.0 109.234 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 . . . . . 0 C--N 1.325 -0.459 0 N-CA-C 112.019 0.378 . . . . 10.0 112.019 -179.354 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 15.3 pt . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.802 0.334 . . . . 10.0 111.42 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.24 159.24 8.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.919 -0.582 . . . . 10.0 109.833 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.83 140.75 32.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.835 0.35 . . . . 10.0 110.225 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -114.11 -65.91 1.14 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.056 0.455 . . . . 10.0 111.113 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 15.3 t -71.46 146.31 48.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.278 0.561 . . . . 10.0 111.868 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 261' ' ' THR . . . . . 0.517 ' HG1' ' N ' ' E' ' 225' ' ' ARG . 91.8 m -123.8 110.05 14.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.566 -0.743 . . . . 10.0 109.624 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -111.08 130.76 55.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.84 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 263' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' E' ' 227' ' ' SER . 25.1 m -132.66 120.97 22.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.169 -0.469 . . . . 10.0 109.871 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 7.9 p -98.39 143.59 12.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.418 -0.355 . . . . 10.0 110.393 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -76.79 -75.89 0.18 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.358 -0.383 . . . . 10.0 111.895 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 266' ' ' THR . . . . . 0.733 HG23 ' HB3' ' E' ' 230' ' ' ASP . 7.7 m -139.81 120.22 14.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.968 0.414 . . . . 10.0 111.14 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 15.1 t -106.4 115.6 48.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.587 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 42.2 t -116.41 97.73 5.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.514 -0.55 . . . . 10.0 109.514 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.89 119.6 4.2 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.864 -0.684 . . . . 10.0 112.08 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 270' ' ' LYS . . . . . 0.631 ' HE3' ' HB2' ' E' ' 234' ' ' GLU . 15.5 mtpt -132.04 133.32 44.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.525 0.202 . . . . 10.0 110.644 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.75 73.91 1.17 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.747 -0.739 . . . . 10.0 112.696 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 62.92 25.05 14.88 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.023 0.749 . . . . 10.0 113.023 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 4.6 m -79.06 157.77 27.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.206 0.527 . . . . 10.0 111.352 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -142.18 126.15 17.24 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.556 -0.747 . . . . 10.0 109.752 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 275' ' ' VAL . . . . . 0.743 ' HB ' HG23 ' E' ' 239' ' ' VAL . 18.8 t -102.63 117.64 48.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.448 -0.342 . . . . 10.0 110.142 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 276' ' ' LEU . . . . . 0.445 HD22 ' HB3' ' E' ' 240' ' ' GLN . 0.2 OUTLIER -109.9 103.27 12.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.267 -0.424 . . . . 10.0 110.315 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 277' ' ' ILE . . . . . 0.469 ' HB ' ' HG ' ' E' ' 241' ' ' LEU . 37.7 mm -116.52 91.82 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.102 0.477 . . . . 10.0 110.538 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 173.91 -164.59 36.04 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.932 -0.867 . . . . 10.0 110.932 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -95.45 126.76 40.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.722 0.261 . . . . 10.0 110.49 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 280' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' E' ' 280' ' ' GLU . 3.4 pm0 -88.41 127.77 35.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.258 0.552 . . . . 10.0 111.77 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -161.99 77.12 0.5 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.847 -0.615 . . . . 10.0 109.961 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 282' ' ' GLY . . . . . 0.449 ' HA2' ' HB ' ' E' ' 246' ' ' THR . . . -112.92 -82.11 1.14 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.862 -0.685 . . . . 10.0 112.499 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 283' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' E' ' 290' ' ' HIS . . . 135.15 39.85 0.17 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.638 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.21 -63.98 1.21 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.949 0.351 . . . . 10.0 111.949 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 135.84 28.28 0.4 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.318 -0.944 . . . . 10.0 113.293 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -150.68 105.43 3.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.188 -0.671 . . . . 10.0 109.188 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER 68.26 18.03 9.25 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.892 0.853 . . . . 10.0 108.92 -177.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.2 170.48 21.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.938 -1.483 . . . . 10.0 108.098 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -155.37 165.44 36.61 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 121.237 -0.185 . . . . 10.0 110.654 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 290' ' ' HIS . . . . . 0.592 ' HB3' ' HA2' ' E' ' 283' ' ' GLY . 7.0 p80 -160.24 164.35 32.8 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -81.5 -68.27 0.71 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.304 -0.158 . . . . 10.0 110.699 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 3.8 t60 69.71 171.5 0.3 Allowed 'General case' 0 CA--C 1.533 0.29 0 O-C-N 123.737 0.648 . . . . 10.0 111.862 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -101.32 116.88 33.8 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.971 -0.558 . . . . 10.0 110.138 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -103.02 127.16 50.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.934 -0.575 . . . . 10.0 110.219 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.834 0 CA-C-O 118.34 -0.838 . . . . 10.0 109.334 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 225' ' ' ARG . 35.5 ttt180 . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.569 0.223 . . . . 10.0 110.585 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -121.82 120.15 33.74 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.352 -0.61 . . . . 10.0 109.352 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 60.6 m -137.29 135.89 37.53 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.589 0.588 . . . . 10.0 112.589 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.48 129.55 43.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.517 -0.765 . . . . 10.0 109.101 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -89.86 -72.47 0.56 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.526 0.565 . . . . 10.0 112.526 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 266' ' ' THR . 41.3 t0 -113.32 120.48 41.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.08 0.467 . . . . 10.0 111.369 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.425 HD12 HG11 ' A' ' 239' ' ' VAL . 8.2 pt -129.18 127.68 65.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.753 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.423 ' HG3' ' HA ' ' A' ' 268' ' ' VAL . 3.6 ptp85 -129.54 125.56 36.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.918 0.389 . . . . 10.0 111.341 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.35 108.49 10.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.231 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.4 ' HB2' ' HD3' ' A' ' 270' ' ' LYS . 5.2 mt-10 -114.57 141.62 47.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 10.0 112.164 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 64.82 93.74 0.06 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 114.189 1.181 . . . . 10.0 114.189 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 50.33 35.12 10.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.564 -0.743 . . . . 10.0 112.94 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -108.8 159.39 16.82 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.201 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -150.4 156.12 40.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.143 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.425 HG11 HD12 ' A' ' 231' ' ' ILE . 4.1 p -136.53 133.45 49.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.164 -0.471 . . . . 10.0 111.107 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -121.29 148.21 44.62 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.772 -0.455 . . . . 10.0 109.772 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 tt -124.99 129.34 50.13 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.068 -0.345 . . . . 10.0 110.068 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.675 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 135.85 -146.68 18.67 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.938 -0.648 . . . . 10.0 112.207 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -121.98 151.46 40.76 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 48.2 t -120.57 101.11 10.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.22 0.533 . . . . 10.0 111.331 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 65.3 t -92.89 115.83 32.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.176 -0.676 . . . . 10.0 109.176 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 43.9 p -82.63 171.05 14.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.741 0.305 . . . . 10.0 111.0 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -71.38 -6.65 41.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.123 0.487 . . . . 10.0 110.958 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -95.51 7.48 46.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.192 0.52 . . . . 10.0 110.14 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -115.2 32.18 6.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.416 -0.811 . . . . 10.0 109.977 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 250' ' ' LEU . 2.9 mm? 69.62 -85.13 0.03 OUTLIER 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.161 -0.927 . . . . 10.0 112.893 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -148.46 166.58 27.73 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.843 0.354 . . . . 10.0 111.495 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -78.69 69.77 2.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.115 -0.564 . . . . 10.0 112.056 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -76.28 -43.79 19.52 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 121.155 -0.545 . . . . 10.0 112.043 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 64.3 mt 71.41 146.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 123.005 0.522 . . . . 10.0 111.331 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? 70.48 80.33 0.17 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.501 0.667 . . . . 10.0 111.746 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 3.9 mp -114.09 -46.61 4.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.508 -0.769 . . . . 10.0 110.005 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.44 -65.06 0.78 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.901 -0.59 . . . . 10.0 110.234 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 55.95 31.93 18.85 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.992 -0.549 . . . . 10.0 112.157 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -91.07 12.51 19.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.641 -0.709 . . . . 10.0 112.328 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 15.1 t -117.4 143.38 46.05 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.564 0.697 . . . . 10.0 112.674 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.564 ' HB ' ' HG3' ' B' ' 225' ' ' ARG . 0.6 OUTLIER -114.0 101.23 9.05 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.226 -1.027 . . . . 10.0 108.226 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.446 ' ND2' ' HA2' ' B' ' 242' ' ' GLY . 52.2 m-20 -98.52 127.19 44.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.053 -0.521 . . . . 10.0 110.428 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' B' ' 227' ' ' SER . 0.3 OUTLIER -138.02 123.08 19.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.848 -0.615 . . . . 10.0 110.983 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.451 HG21 HG22 ' A' ' 267' ' ' VAL . 14.8 p -123.65 133.82 68.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.287 0.565 . . . . 10.0 111.57 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.583 ' HB3' ' HA ' ' B' ' 229' ' ' LYS . 37.3 tp10 -79.6 -70.88 0.48 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.569 -0.742 . . . . 10.0 112.175 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 230' ' ' ASP . 3.2 m -129.81 126.92 39.21 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.101 0.477 . . . . 10.0 112.105 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.451 HG22 HG21 ' A' ' 264' ' ' VAL . 3.6 t -117.09 126.64 74.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.979 -0.555 . . . . 10.0 109.64 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.451 ' HB ' ' HA ' ' B' ' 232' ' ' ARG . 41.9 t -117.73 122.59 70.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.85 0.357 . . . . 10.0 111.474 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.52 119.62 3.89 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.218 -1.153 . . . . 10.0 110.218 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.4 ' HD3' ' HB2' ' A' ' 234' ' ' GLU . 2.0 tppt? -126.43 110.58 13.47 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.439 0.533 . . . . 10.0 112.439 -178.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.53 91.7 0.77 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.945 -0.645 . . . . 10.0 114.198 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' B' ' 236' ' ' ARG . 38.6 mt-10 51.92 44.06 29.74 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.721 0.637 . . . . 10.0 112.721 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.9 m -96.45 132.58 41.85 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.121 0.486 . . . . 10.0 110.689 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -107.2 114.25 28.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.065 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 30.0 t -105.36 123.12 59.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.508 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.94 108.51 15.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.15 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.496 ' HA ' ' HB2' ' B' ' 241' ' ' LEU . 25.1 mm -93.13 90.4 2.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.768 -0.456 . . . . 10.0 109.768 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.675 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 152.34 -172.52 31.54 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.972 -0.558 . . . . 10.0 112.041 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -101.47 161.24 13.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.077 0.465 . . . . 10.0 111.089 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.99 175.09 7.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.985 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -139.31 67.14 1.39 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.495 -0.775 . . . . 10.0 109.272 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -81.98 115.19 3.97 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.67 -0.695 . . . . 10.0 113.611 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -101.97 -28.78 6.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.824 -0.703 . . . . 10.0 111.854 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -89.8 -45.67 9.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.327 0.584 . . . . 10.0 109.764 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -163.33 156.53 28.35 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.472 -1.051 . . . . 10.0 110.472 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -67.5 112.38 4.64 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 109.549 -0.538 . . . . 10.0 109.549 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 2.3 t90 65.92 -80.38 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 O-C-N 123.797 0.686 . . . . 10.0 110.693 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -162.61 28.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.743 0.782 . . . . 10.0 109.353 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -74.84 117.34 16.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.572 -0.74 . . . . 10.0 111.458 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 -129.06 105.08 7.95 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.919 0.39 . . . . 10.0 110.4 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -115.12 141.68 47.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.673 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -121.4 -53.75 2.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.045 0.45 . . . . 10.0 110.998 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -71.74 142.34 49.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.749 -0.659 . . . . 10.0 110.511 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -143.69 147.35 34.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.347 -0.388 . . . . 10.0 110.427 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 2.7 p80 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.089 -0.958 . . . . 10.0 110.465 179.717 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.564 ' HG3' ' HB ' ' A' ' 261' ' ' THR . 22.9 ttm180 . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 109.845 -0.428 . . . . 10.0 109.845 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -117.59 116.25 26.72 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.522 -0.548 . . . . 10.0 109.522 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 227' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' B' ' 263' ' ' SER . 18.5 m -130.15 136.91 49.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.894 0.378 . . . . 10.0 111.018 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.76 148.34 52.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.599 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.583 ' HA ' ' HB3' ' A' ' 265' ' ' GLU . 56.8 tttp -102.84 -80.52 0.51 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 112.855 0.687 . . . . 10.0 112.855 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -112.66 115.0 27.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.778 0.323 . . . . 10.0 111.665 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.42 HG21 HG21 ' B' ' 239' ' ' VAL . 62.2 mt -120.14 111.07 30.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.349 -0.612 . . . . 10.0 109.349 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 232' ' ' ARG . . . . . 0.451 ' HA ' ' HB ' ' A' ' 268' ' ' VAL . 12.0 mtt180 -109.93 107.68 17.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.064 0.459 . . . . 10.0 111.387 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 0.6 OUTLIER -115.51 122.31 45.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.629 -0.714 . . . . 10.0 110.727 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -130.83 155.52 46.57 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 112.403 0.52 . . . . 10.0 112.403 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 65.31 77.04 0.32 Allowed 'General case' 0 C--O 1.232 0.136 0 N-CA-C 113.914 1.079 . . . . 10.0 113.914 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 236' ' ' ARG . . . . . 0.611 ' HB2' ' HG2' ' B' ' 272' ' ' GLU . 44.2 mtm-85 56.13 26.72 10.53 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.55 -0.75 . . . . 10.0 112.824 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.466 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -79.49 151.88 30.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.991 0.424 . . . . 10.0 110.806 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.81 133.02 49.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.968 -0.56 . . . . 10.0 110.789 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.603 HG23 ' HB ' ' B' ' 275' ' ' VAL . 4.2 p -130.71 137.43 56.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.09 -0.504 . . . . 10.0 110.976 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -125.22 130.06 51.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.978 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 277' ' ' ILE . 4.0 mm? -103.24 73.01 1.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.731 -0.668 . . . . 10.0 110.42 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 242' ' ' GLY . . . . . 0.446 ' HA2' ' ND2' ' A' ' 262' ' ' ASN . . . -179.41 -178.59 48.45 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.315 -0.945 . . . . 10.0 112.824 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.58 157.58 15.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.662 0.268 . . . . 10.0 110.355 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 56.6 t -104.36 123.95 58.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.084 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 16.9 t -122.02 100.25 8.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.297 -0.631 . . . . 10.0 109.297 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 29.8 p -80.59 170.09 16.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.399 -0.364 . . . . 10.0 110.885 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.29 -10.05 52.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.066 -0.516 . . . . 10.0 111.599 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -79.24 -17.36 54.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.83 0.347 . . . . 10.0 110.681 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -88.48 -0.61 57.39 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.776 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 44.6 tp -72.65 117.0 13.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.707 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 50.2 m80 67.98 76.69 0.26 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.298 -0.864 . . . . 10.0 111.24 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -171.24 -166.08 29.52 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.663 -0.699 . . . . 10.0 111.705 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -87.6 109.55 3.49 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.817 -0.706 . . . . 10.0 111.87 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 26.2 pt -101.98 13.72 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.992 0.425 . . . . 10.0 111.207 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 12.0 tpt85 -141.37 104.68 4.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.036 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 256' ' ' ILE . . . . . 0.862 ' HA ' ' HA3' ' C' ' 252' ' ' GLY . 10.4 pt -107.0 29.04 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.711 0.291 . . . . 10.0 111.172 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.7 t 64.39 28.54 13.64 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.7 0.762 . . . . 10.0 110.198 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -74.88 139.8 43.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.928 -1.033 . . . . 10.0 111.054 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 19.9 tm0? -152.2 106.52 3.17 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.742 -0.663 . . . . 10.0 109.917 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 6.3 t -162.07 163.02 28.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.373 -0.376 . . . . 10.0 111.017 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.24 122.45 37.79 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.836 -0.62 . . . . 10.0 109.456 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -103.85 111.31 23.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.975 0.417 . . . . 10.0 109.918 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 263' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' B' ' 227' ' ' SER . 9.8 m -131.51 119.17 21.17 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.163 0.506 . . . . 10.0 111.118 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 12.3 p -115.15 135.25 55.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.865 -0.607 . . . . 10.0 109.978 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 265' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 44.8 tt0 -82.65 -73.15 0.41 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.575 0.583 . . . . 10.0 112.575 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.6 125.83 53.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.889 0.376 . . . . 10.0 111.948 -178.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 2.3 t -124.18 121.68 62.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.864 -0.607 . . . . 10.0 109.584 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 47.6 t -112.63 118.61 58.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.765 0.317 . . . . 10.0 111.079 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.79 113.82 2.28 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 111.288 -0.725 . . . . 10.0 111.288 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -127.92 132.1 49.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.646 0.26 . . . . 10.0 111.074 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.81 66.9 1.44 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.922 -0.656 . . . . 10.0 112.358 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 272' ' ' GLU . . . . . 0.611 ' HG2' ' HB2' ' B' ' 236' ' ' ARG . 28.9 mt-10 53.43 46.89 25.31 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.819 0.674 . . . . 10.0 112.819 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 6.4 t -77.53 167.16 22.08 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.247 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -135.49 117.46 15.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.099 -0.5 . . . . 10.0 110.017 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.603 ' HB ' HG23 ' B' ' 239' ' ' VAL . 34.5 t -112.11 119.51 60.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.087 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.95 113.59 22.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.961 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 23.1 mm -104.25 86.93 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.101 0.476 . . . . 10.0 109.847 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 158.46 168.62 20.92 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.871 -0.891 . . . . 10.0 110.871 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -88.33 167.39 13.57 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.31 0.555 . . . . 10.0 111.235 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.49 167.2 19.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.151 0.5 . . . . 10.0 111.672 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -147.7 78.77 1.47 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.42 -0.809 . . . . 10.0 108.954 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -94.43 -111.4 2.33 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.832 -0.699 . . . . 10.0 112.865 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 132.27 -36.3 2.21 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.713 -0.756 . . . . 10.0 111.379 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -101.82 23.8 10.83 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 165.06 -175.97 40.86 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.516 -1.434 . . . . 10.0 109.516 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -131.11 65.79 1.55 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 117.068 0.434 . . . . 10.0 109.859 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 26.6 t90 71.26 -47.28 0.66 Allowed 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.836 0.71 . . . . 10.0 111.872 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -116.0 -169.92 1.69 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.791 -0.641 . . . . 10.0 109.31 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -118.3 126.06 51.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.333 0.587 . . . . 10.0 111.849 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -156.47 123.6 5.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.461 -0.791 . . . . 10.0 109.359 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -155.55 138.05 15.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.509 -0.314 . . . . 10.0 110.691 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -168.58 -176.61 2.84 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.512 -0.551 . . . . 10.0 109.512 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -105.76 159.38 16.04 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.678 0.275 . . . . 10.0 110.608 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -91.49 -164.45 1.18 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.013 0.435 . . . . 10.0 111.317 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.067 -0.968 . . . . 10.0 109.63 179.91 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.681 0.277 . . . . 10.0 110.962 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 226' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' C' ' 262' ' ' ASN . 2.2 m120 -132.19 113.99 13.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 16.5 m -124.67 141.58 52.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.102 0.477 . . . . 10.0 111.905 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.9 139.54 52.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.636 -0.711 . . . . 10.0 110.512 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 229' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' B' ' 265' ' ' GLU . 2.4 tmtm? -84.96 -69.11 0.67 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.121 -0.491 . . . . 10.0 111.912 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -129.4 117.0 19.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.915 0.388 . . . . 10.0 111.658 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.404 HG21 HG21 ' C' ' 239' ' ' VAL . 70.2 mt -120.14 120.6 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.138 -0.483 . . . . 10.0 109.749 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.584 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 15.1 ttm-85 -116.21 115.54 26.17 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.215 -0.448 . . . . 10.0 111.269 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.53 99.0 6.09 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.248 0.546 . . . . 10.0 110.88 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 234' ' ' GLU . . . . . 0.584 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 8.8 pt-20 -121.22 170.99 9.04 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.004 -0.543 . . . . 10.0 110.557 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 235' ' ' GLU . . . . . 0.451 ' HB3' ' H ' ' C' ' 271' ' ' GLY . 0.8 OUTLIER 67.87 59.18 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.841 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 10.4 mtp180 63.29 16.79 9.74 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.026 0.75 . . . . 10.0 113.026 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -77.38 176.69 8.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.869 0.366 . . . . 10.0 111.171 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.09 152.05 20.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.203 -0.453 . . . . 10.0 110.747 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.738 HG23 ' HB ' ' C' ' 275' ' ' VAL . 8.2 p -131.92 140.35 48.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.052 0.453 . . . . 10.0 111.428 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -117.14 121.81 42.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.855 -0.611 . . . . 10.0 110.175 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.533 HD13 ' HB ' ' C' ' 277' ' ' ILE . 3.7 mm? -106.44 86.23 2.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.62 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.28 -173.09 43.65 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.341 -0.933 . . . . 10.0 112.816 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -97.99 145.82 26.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.72 0.295 . . . . 10.0 110.656 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 36.8 t -106.87 103.64 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.087 0.47 . . . . 10.0 110.868 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 19.9 t -111.58 112.37 40.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.014 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 34.2 p -82.34 160.94 22.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.426 -0.352 . . . . 10.0 111.145 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.0 5.39 1.17 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.249 0.463 . . . . 10.0 112.249 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -96.48 3.4 52.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.196 -0.457 . . . . 10.0 109.826 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -116.03 84.66 2.15 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.906 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 84.8 mt -95.85 -9.73 30.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.596 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -84.0 110.78 18.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.701 -0.681 . . . . 10.0 109.69 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 252' ' ' GLY . . . . . 0.862 ' HA3' ' HA ' ' B' ' 256' ' ' ILE . . . -144.2 -90.14 0.11 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.51 -0.852 . . . . 10.0 112.786 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 100.66 -156.23 19.35 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.686 -0.769 . . . . 10.0 111.608 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 8.0 tt -147.99 104.23 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.281 0.562 . . . . 10.0 111.304 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -157.43 137.49 12.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.965 -0.561 . . . . 10.0 109.931 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 15.3 tt -103.57 133.87 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.034 0.445 . . . . 10.0 110.813 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 41.1 m -155.96 179.66 9.0 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.404 -0.591 . . . . 10.0 109.404 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 258' ' ' ASP . . . . . 0.553 ' HB3' ' HB3' ' D' ' 257' ' ' SER . 25.8 t0 -72.84 167.13 21.57 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.714 -0.221 . . . . 10.0 110.868 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -158.93 152.98 23.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.606 -0.27 . . . . 10.0 110.521 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 260' ' ' THR . . . . . 0.443 ' HA ' ' OD2' ' D' ' 258' ' ' ASP . 6.8 t -64.98 132.27 48.81 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.238 0.542 . . . . 10.0 111.152 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 32.5 m -92.36 126.29 37.38 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.001 -0.545 . . . . 10.0 109.759 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 262' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' D' ' 226' ' ' ASN . 1.8 m-80 -118.9 123.76 45.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.688 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 263' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' D' ' 227' ' ' SER . 14.2 m -141.75 142.3 33.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.079 -0.509 . . . . 10.0 110.244 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 264' ' ' VAL . . . . . 0.522 HG23 ' HB3' ' D' ' 228' ' ' ALA . 8.8 p -133.51 144.13 36.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.066 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 265' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' D' ' 229' ' ' LYS . 43.1 mt-10 -83.19 -75.92 0.3 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.291 0.478 . . . . 10.0 112.291 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 24.3 m -113.52 127.61 56.15 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.125 0.787 . . . . 10.0 113.125 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.92 109.31 20.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.357 -0.838 . . . . 10.0 108.958 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 268' ' ' VAL . . . . . 0.561 ' HB ' ' HG2' ' D' ' 232' ' ' ARG . 37.1 t -107.41 125.99 63.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.025 0.44 . . . . 10.0 110.864 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 269' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -134.04 120.93 2.6 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.885 -0.598 . . . . 10.0 112.022 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -138.53 124.65 20.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.141 0.496 . . . . 10.0 111.2 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 271' ' ' GLY . . . . . 0.451 ' H ' ' HB3' ' C' ' 235' ' ' GLU . . . 97.25 74.96 1.21 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.83 -0.7 . . . . 10.0 113.101 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 59.06 22.36 10.41 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.665 0.617 . . . . 10.0 112.665 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 16.0 m -69.55 149.61 48.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.085 0.469 . . . . 10.0 111.916 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 274' ' ' ARG . . . . . 0.46 ' HB3' ' CZ3' ' C' ' 287' ' ' TRP . 2.3 mtm180 -132.37 122.29 24.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.171 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.738 ' HB ' HG23 ' C' ' 239' ' ' VAL . 41.3 t -108.91 129.61 63.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.742 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.409 HD12 HE21 ' D' ' 240' ' ' GLN . 1.8 tm? -121.31 110.51 16.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.289 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.533 ' HB ' HD13 ' C' ' 241' ' ' LEU . 30.5 mm -107.93 94.14 2.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.135 0.493 . . . . 10.0 110.316 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 160.28 -160.08 31.38 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.565 -0.614 . . . . 10.0 111.565 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -115.53 150.49 36.49 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.315 -0.254 . . . . 10.0 110.315 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -119.29 145.23 46.3 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.075 0.464 . . . . 10.0 112.166 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 281' ' ' TYR . . . . . 0.523 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.3 OUTLIER -127.63 98.59 5.26 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.373 -0.831 . . . . 10.0 108.943 179.363 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 282' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' D' ' 246' ' ' THR . . . -145.55 159.93 28.0 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.546 -0.835 . . . . 10.0 112.757 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -106.95 -30.86 4.07 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.748 -0.739 . . . . 10.0 112.894 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -59.72 -45.09 93.22 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.922 0.391 . . . . 10.0 111.036 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 173.47 -128.2 1.46 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.642 -0.983 . . . . 10.0 110.642 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -110.12 -166.18 1.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.209 -0.293 . . . . 10.0 110.209 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.46 ' CZ3' ' HB3' ' C' ' 274' ' ' ARG . 0.8 OUTLIER -54.4 -30.11 51.16 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.156 0.798 . . . . 10.0 113.156 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.83 157.28 31.44 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 122.336 -0.227 . . . . 10.0 110.718 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -123.83 30.4 6.18 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.36 0.504 . . . . 10.0 112.36 -178.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 290' ' ' HIS . . . . . 0.719 ' HB3' ' NH2' ' D' ' 274' ' ' ARG . 1.5 t-80 -85.7 -17.67 35.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.454 -0.339 . . . . 10.0 110.942 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.67 153.68 51.5 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.995 -0.441 . . . . 10.0 111.619 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.86 179.23 0.16 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 123.654 0.596 . . . . 10.0 110.875 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.333 -0.124 0 N-CA-C 113.992 1.108 . . . . 10.0 113.992 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 226' ' ' ASN . . . . . 0.632 ' HB3' HG22 ' D' ' 277' ' ' ILE . 20.0 m120 . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 109.859 -0.423 . . . . 10.0 109.859 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 227' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' C' ' 263' ' ' SER . 0.0 OUTLIER -129.02 140.72 51.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.985 0.422 . . . . 10.0 111.668 -178.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 228' ' ' ALA . . . . . 0.522 ' HB3' HG23 ' C' ' 264' ' ' VAL . . . -130.01 147.48 51.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.135 -0.484 . . . . 10.0 110.509 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 229' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' C' ' 265' ' ' GLU . 39.2 ttmt -92.79 -72.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.259 -0.428 . . . . 10.0 111.743 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -126.26 117.19 22.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.668 0.271 . . . . 10.0 111.321 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 63.5 mt -121.93 123.62 69.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.096 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 232' ' ' ARG . . . . . 0.561 ' HG2' ' HB ' ' C' ' 268' ' ' VAL . 26.0 mtm180 -120.22 113.94 21.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.15 0.5 . . . . 10.0 110.662 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 233' ' ' THR . . . . . 0.42 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 1.7 p -117.31 111.75 19.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.749 -0.659 . . . . 10.0 110.278 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -124.89 151.54 45.22 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.143 0.423 . . . . 10.0 112.143 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 235' ' ' GLU . . . . . 0.406 ' OE2' ' HE3' ' D' ' 270' ' ' LYS . 46.2 mt-10 65.01 79.19 0.26 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.975 1.102 . . . . 10.0 113.975 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 58.57 19.44 6.65 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.259 -0.882 . . . . 10.0 113.344 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -81.74 162.23 23.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.857 0.361 . . . . 10.0 111.24 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 238' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' D' ' 238' ' ' ARG . 0.1 OUTLIER -141.39 147.76 38.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.061 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 239' ' ' VAL . . . . . 0.464 HG13 HG13 ' C' ' 275' ' ' VAL . 1.9 p -128.81 127.44 66.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.138 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 240' ' ' GLN . . . . . 0.409 HE21 HD12 ' C' ' 276' ' ' LEU . 8.6 tm0? -113.47 126.79 55.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.623 -0.717 . . . . 10.0 109.211 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.97 97.98 5.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.406 -0.361 . . . . 10.0 110.593 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 164.15 -108.48 0.33 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.517 -0.849 . . . . 10.0 112.778 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -163.8 153.14 14.32 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.678 0.275 . . . . 10.0 110.388 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 t -112.24 106.26 20.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.801 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 245' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 52.6 t -104.55 112.89 39.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 246' ' ' THR . . . . . 0.508 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 81.6 p -80.33 150.77 29.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.09 0.471 . . . . 10.0 111.694 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 247' ' ' ALA . . . . . 0.426 ' HA ' ' HE1' ' C' ' 281' ' ' TYR . . . -74.58 8.06 2.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.928 -0.578 . . . . 10.0 111.39 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -101.33 -8.48 22.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.934 -0.575 . . . . 10.0 109.796 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -91.3 110.11 21.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.058 -0.519 . . . . 10.0 109.731 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.79 163.06 24.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.387 0.613 . . . . 10.0 111.707 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -84.25 63.24 7.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.725 -0.671 . . . . 10.0 112.192 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -131.66 59.08 0.69 Allowed Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 110.405 -1.078 . . . . 10.0 110.405 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 109.71 20.54 7.63 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.27 -1.132 . . . . 10.0 110.27 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 254' ' ' ILE . . . . . 0.43 HD11 HG11 ' D' ' 245' ' ' VAL . 16.6 tt -67.1 -30.8 50.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.851 -0.674 . . . . 10.0 111.425 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -80.05 71.37 6.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.059 0.456 . . . . 10.0 110.874 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 256' ' ' ILE . . . . . 0.411 ' HB ' ' HE2' ' D' ' 281' ' ' TYR . 20.0 tt -65.04 -19.26 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.669 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 257' ' ' SER . . . . . 0.553 ' HB3' ' HB3' ' C' ' 258' ' ' ASP . 4.4 m 66.35 -96.02 0.04 OUTLIER 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.664 -0.698 . . . . 10.0 111.783 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 258' ' ' ASP . . . . . 0.443 ' OD2' ' HA ' ' C' ' 260' ' ' THR . 2.5 t0 -149.19 172.27 15.1 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.411 -0.589 . . . . 10.0 109.411 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -169.27 -74.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.91 0.386 . . . . 10.0 110.581 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 13.5 t -96.17 162.46 13.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.352 0.596 . . . . 10.0 110.838 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 12.8 m -116.9 111.98 20.4 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.055 -0.52 . . . . 10.0 109.872 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -97.25 105.49 17.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.024 -0.535 . . . . 10.0 109.961 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 24.1 m -115.59 118.54 33.42 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.591 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 264' ' ' VAL . . . . . 0.519 HG23 ' HB3' ' E' ' 228' ' ' ALA . 11.4 p -121.83 137.27 55.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.947 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 265' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' E' ' 229' ' ' LYS . 22.5 mt-10 -84.68 -83.61 0.16 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.919 0.711 . . . . 10.0 112.919 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.69 122.75 46.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.298 0.851 . . . . 10.0 113.298 -177.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 43.7 t -121.16 114.5 43.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.233 -0.654 . . . . 10.0 109.233 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 16.9 t -111.54 119.87 60.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.816 0.341 . . . . 10.0 111.403 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 269' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' E' ' 233' ' ' THR . . . -123.8 125.93 6.02 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.336 -0.705 . . . . 10.0 111.336 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 270' ' ' LYS . . . . . 0.406 ' HE3' ' OE2' ' D' ' 235' ' ' GLU . 19.3 tptt -134.4 108.71 8.32 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.825 0.306 . . . . 10.0 111.825 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.92 102.38 0.64 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 114.698 0.639 . . . . 10.0 114.698 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 51.69 36.17 16.87 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.561 0.578 . . . . 10.0 112.561 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 273' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' E' ' 237' ' ' ALA . 4.0 m -85.25 139.2 31.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.162 0.506 . . . . 10.0 111.853 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 274' ' ' ARG . . . . . 0.719 ' NH2' ' HB3' ' C' ' 290' ' ' HIS . 81.2 mtt85 -118.94 113.24 20.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.558 -0.746 . . . . 10.0 110.273 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 46.0 t -102.49 113.45 39.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.357 -0.608 . . . . 10.0 109.357 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 276' ' ' LEU . . . . . 0.408 HD12 ' HG2' ' E' ' 240' ' ' GLN . 1.7 tm? -117.39 97.57 5.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.171 0.51 . . . . 10.0 110.867 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 277' ' ' ILE . . . . . 0.632 HG22 ' HB3' ' D' ' 226' ' ' ASN . 44.1 mm -102.0 91.91 2.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.645 -0.872 . . . . 10.0 108.645 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 278' ' ' GLY . . . . . 0.426 ' O ' ' HA3' ' E' ' 242' ' ' GLY . . . 166.17 -163.01 36.53 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.639 -0.709 . . . . 10.0 111.564 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -120.41 156.02 32.26 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.73 -0.277 . . . . 10.0 110.922 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -114.62 136.02 53.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.218 -0.447 . . . . 10.0 110.621 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 281' ' ' TYR . . . . . 0.411 ' HE2' ' HB ' ' D' ' 256' ' ' ILE . 0.5 OUTLIER -124.59 113.35 17.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.347 -179.837 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 282' ' ' GLY . . . . . 0.508 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 156.21 171.58 22.69 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.232 -0.985 . . . . 10.0 112.819 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -110.05 53.86 0.57 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.613 -0.803 . . . . 10.0 112.825 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -89.29 -18.11 27.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.204 0.526 . . . . 10.0 109.983 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 118.95 -47.9 0.99 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.775 -0.93 . . . . 10.0 110.775 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 286' ' ' PHE . . . . . 0.453 ' CE1' HG21 ' E' ' 244' ' ' VAL . 4.7 t80 176.15 145.62 0.08 Allowed 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.871 -1.159 . . . . 10.0 107.871 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 17.1 t90 -50.38 -74.47 0.03 OUTLIER 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.435 0.46 . . . . 10.0 111.761 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -134.81 133.24 39.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.185 0.517 . . . . 10.0 111.301 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -172.51 147.55 1.88 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -73.68 -57.52 3.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.816 0.341 . . . . 10.0 110.984 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -154.74 175.02 14.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.072 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 292' ' ' HIS . . . . . 0.751 ' HD2' ' HB3' ' E' ' 286' ' ' PHE . 5.9 m80 -97.25 -154.72 0.46 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.599 -0.273 . . . . 10.0 111.455 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -58.91 125.78 24.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.124 0.488 . . . . 10.0 111.486 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -123.51 147.6 47.07 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.691 -0.686 . . . . 10.0 109.939 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.186 -0.911 . . . . 10.0 109.623 179.688 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 225' ' ' ARG . . . . . 0.551 ' N ' ' HG1' ' E' ' 261' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 110.662 -0.125 . . . . 10.0 110.662 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 226' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' E' ' 262' ' ' ASN . 21.4 m120 -137.55 111.82 8.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.65 0.262 . . . . 10.0 110.466 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 227' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' E' ' 263' ' ' SER . 21.3 m -122.4 138.35 54.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.157 0.503 . . . . 10.0 111.084 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 228' ' ' ALA . . . . . 0.519 ' HB3' HG23 ' D' ' 264' ' ' VAL . . . -130.4 129.27 42.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.851 -0.613 . . . . 10.0 109.547 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 229' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' D' ' 265' ' ' GLU . 8.0 mttm -84.77 -64.63 1.12 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.57 0.581 . . . . 10.0 112.57 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 230' ' ' ASP . . . . . 0.805 ' HB3' HG23 ' E' ' 266' ' ' THR . 4.6 t70 -130.79 127.39 38.59 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.779 -0.368 . . . . 10.0 111.278 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 90.9 mt -128.03 123.27 60.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.761 -0.459 . . . . 10.0 109.761 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 232' ' ' ARG . . . . . 0.404 ' HE ' ' HB2' ' E' ' 232' ' ' ARG . 1.2 ttm180 -116.75 118.29 32.11 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.385 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 233' ' ' THR . . . . . 0.426 ' O ' ' HA2' ' D' ' 269' ' ' GLY . 0.8 OUTLIER -128.66 111.19 12.92 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.013 -0.539 . . . . 10.0 110.862 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -129.87 145.56 51.6 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.154 0.427 . . . . 10.0 112.154 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 66.39 81.9 0.19 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.2 0.815 . . . . 10.0 113.2 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 58.35 26.09 13.61 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.902 -0.59 . . . . 10.0 112.246 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 237' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' D' ' 273' ' ' SER . . . -94.2 153.32 18.13 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.9 160.52 41.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.829 0.347 . . . . 10.0 111.544 -178.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.34 134.28 49.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.889 -0.596 . . . . 10.0 110.779 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 240' ' ' GLN . . . . . 0.562 ' HB3' HD22 ' E' ' 276' ' ' LEU . 0.6 OUTLIER -127.84 127.52 43.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.932 -0.576 . . . . 10.0 109.845 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 241' ' ' LEU . . . . . 0.77 ' HG ' ' HB ' ' E' ' 277' ' ' ILE . 0.7 OUTLIER -126.16 105.48 8.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.442 -0.345 . . . . 10.0 110.587 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 242' ' ' GLY . . . . . 0.493 ' O ' ' HA3' ' E' ' 278' ' ' GLY . . . 164.36 -158.02 30.54 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.757 -0.735 . . . . 10.0 112.445 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -117.34 144.32 45.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.917 0.389 . . . . 10.0 110.649 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 244' ' ' VAL . . . . . 0.453 HG21 ' CE1' ' D' ' 286' ' ' PHE . 61.6 t -101.24 120.33 50.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.111 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 3.6 t -116.92 101.37 12.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.98 0.419 . . . . 10.0 110.867 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 246' ' ' THR . . . . . 0.557 HG23 ' H ' ' E' ' 248' ' ' ALA . 15.0 t -67.53 173.7 3.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.169 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.76 -19.66 64.19 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.794 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 248' ' ' ALA . . . . . 0.557 ' H ' HG23 ' E' ' 246' ' ' THR . . . -75.52 -22.34 57.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.277 -0.42 . . . . 10.0 110.727 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 55.84 -161.68 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.871 -0.604 . . . . 10.0 111.861 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 5.1 mp -103.27 89.13 3.3 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.034 0.445 . . . . 10.0 110.362 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 . . . . . 0 C--N 1.327 -0.399 0 CA-C-O 121.418 0.628 . . . . 10.0 110.159 179.375 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 6.5 pt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.134 0.492 . . . . 10.0 110.928 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 1.4 m -145.04 151.12 38.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.1 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -85.86 84.3 7.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.769 0.795 . . . . 10.0 111.105 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -70.25 -25.73 63.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.227 -0.897 . . . . 10.0 112.251 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 14.6 t -107.24 148.51 28.85 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.09 0.472 . . . . 10.0 111.334 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 261' ' ' THR . . . . . 0.551 ' HG1' ' N ' ' E' ' 225' ' ' ARG . 79.7 m -129.21 114.3 16.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.583 -0.735 . . . . 10.0 111.206 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 262' ' ' ASN . . . . . 0.407 ' HB2' ' ND2' ' E' ' 226' ' ' ASN . 14.1 m120 -107.85 100.1 9.5 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.311 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 263' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' E' ' 227' ' ' SER . 12.9 m -109.04 117.64 34.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.157 -0.474 . . . . 10.0 109.767 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 4.8 p -107.26 152.27 8.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.842 0.353 . . . . 10.0 111.074 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -86.47 -88.11 0.13 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.152 -0.477 . . . . 10.0 111.457 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 266' ' ' THR . . . . . 0.805 HG23 ' HB3' ' E' ' 230' ' ' ASP . 9.0 m -125.12 120.95 32.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.966 0.413 . . . . 10.0 111.605 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.16 116.28 51.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.46 110.61 32.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.856 0.36 . . . . 10.0 111.24 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.6 136.14 10.21 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.642 -0.583 . . . . 10.0 111.642 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -140.03 126.6 20.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.017 0.437 . . . . 10.0 111.024 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.89 82.07 1.17 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.748 -0.739 . . . . 10.0 113.647 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 61.43 22.58 12.97 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.295 0.85 . . . . 10.0 113.295 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 45.2 m -73.1 152.32 41.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.886 0.374 . . . . 10.0 111.291 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -131.45 120.48 23.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.815 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 40.3 t -102.44 118.99 50.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.921 -0.581 . . . . 10.0 109.464 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 276' ' ' LEU . . . . . 0.562 HD22 ' HB3' ' E' ' 240' ' ' GLN . 0.2 OUTLIER -120.57 110.28 16.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.744 -179.345 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 277' ' ' ILE . . . . . 0.77 ' HB ' ' HG ' ' E' ' 241' ' ' LEU . 46.4 mm -117.74 95.96 4.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.144 0.497 . . . . 10.0 110.178 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 278' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' E' ' 242' ' ' GLY . . . 170.89 -126.57 1.34 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.515 -0.634 . . . . 10.0 111.515 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -141.01 151.85 44.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 10.0 111.156 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 280' ' ' GLU . . . . . 0.695 ' HB2' ' HA ' ' E' ' 288' ' ' ASP . 2.6 pt-20 -105.29 138.61 41.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.095 -0.502 . . . . 10.0 111.913 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -162.55 71.28 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.956 -0.566 . . . . 10.0 110.193 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 282' ' ' GLY . . . . . 0.505 ' HA2' ' HB ' ' E' ' 246' ' ' THR . . . -112.9 -105.83 2.75 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.853 -0.689 . . . . 10.0 112.626 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 283' ' ' GLY . . . . . 0.601 ' HA2' ' HB3' ' E' ' 290' ' ' HIS . . . 179.37 25.2 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.564 -0.827 . . . . 10.0 113.364 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.1 -119.79 0.3 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.987 0.394 . . . . 10.0 111.819 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -168.69 46.64 0.22 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.478 -0.868 . . . . 10.0 113.258 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 286' ' ' PHE . . . . . 0.751 ' HB3' ' HD2' ' D' ' 292' ' ' HIS . 46.2 t80 -174.38 103.43 0.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.543 -0.54 . . . . 10.0 109.543 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 72.55 5.47 5.25 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.762 0.664 . . . . 10.0 109.616 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 288' ' ' ASP . . . . . 0.695 ' HA ' ' HB2' ' E' ' 280' ' ' GLU . 0.4 OUTLIER -168.49 131.94 1.5 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.133 -1.394 . . . . 10.0 107.388 179.29 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -136.2 172.76 12.53 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.649 -0.251 . . . . 10.0 111.147 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 290' ' ' HIS . . . . . 0.601 ' HB3' ' HA2' ' E' ' 283' ' ' GLY . 2.9 p-80 -157.82 -163.36 1.32 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.333 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -110.67 -73.06 0.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.513 -0.18 . . . . 10.0 110.513 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 292' ' ' HIS . . . . . 0.43 ' HB2' ' CD2' ' E' ' 290' ' ' HIS . 37.8 t60 70.89 150.31 0.09 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.722 0.639 . . . . 10.0 112.38 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -88.58 112.92 23.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.417 -0.586 . . . . 10.0 109.417 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -96.23 143.28 27.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.268 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.376 -0.821 . . . . 10.0 110.368 -179.713 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 110.62 -0.141 . . . . 10.0 110.62 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' A' ' 262' ' ' ASN . 14.7 m-80 -116.24 134.72 54.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.769 0.318 . . . . 10.0 110.201 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 263' ' ' SER . 57.0 m -147.89 157.79 43.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.181 0.515 . . . . 10.0 111.771 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.17 154.66 45.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.533 -0.758 . . . . 10.0 109.168 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.561 ' HB2' ' HA ' ' A' ' 265' ' ' GLU . 44.7 mttt -107.34 -70.97 0.77 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.571 0.582 . . . . 10.0 112.571 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.561 ' O ' ' HA ' ' A' ' 266' ' ' THR . 43.0 t0 -124.02 110.35 14.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.366 -177.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 66.8 mt -119.4 126.37 75.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.385 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.9 ptp85 -124.31 116.26 22.34 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.102 0.477 . . . . 10.0 110.658 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 0.7 OUTLIER -123.52 127.6 48.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.827 -0.624 . . . . 10.0 110.768 -179.305 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -141.91 169.41 17.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.602 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.2 60.11 1.0 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.843 -0.617 . . . . 10.0 111.674 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 62.72 29.49 16.78 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.723 -0.671 . . . . 10.0 112.479 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.409 ' HB3' ' HB ' ' A' ' 233' ' ' THR . . . -86.63 157.29 19.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.43 -0.35 . . . . 10.0 110.612 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -135.22 151.2 50.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.247 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.24 139.52 36.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.832 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -137.78 130.12 29.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.266 -0.425 . . . . 10.0 110.205 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.534 ' HG ' ' HB ' ' A' ' 277' ' ' ILE . 5.8 mp -116.82 118.55 32.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.491 -0.322 . . . . 10.0 110.526 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.48 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 152.74 -169.55 31.8 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.824 -0.703 . . . . 10.0 112.694 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.63 126.58 41.0 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.057 -0.349 . . . . 10.0 110.057 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 90.9 t -98.29 116.39 40.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.207 0.527 . . . . 10.0 112.075 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.806 HG11 ' HA2' ' A' ' 252' ' ' GLY . 77.8 t -111.49 116.9 53.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.783 -0.644 . . . . 10.0 109.756 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.77 158.97 15.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.714 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.57 -19.99 65.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.019 0.437 . . . . 10.0 110.766 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -85.98 11.46 11.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.772 -0.649 . . . . 10.0 110.632 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 250' ' ' LEU . . . -121.36 36.03 4.72 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.5 -0.556 . . . . 10.0 109.5 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 3.6 mm? 75.99 -82.22 0.03 OUTLIER 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.44 -0.8 . . . . 10.0 112.645 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 26.0 p-80 -158.22 171.89 19.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.445 -0.343 . . . . 10.0 110.514 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.806 ' HA2' HG11 ' A' ' 245' ' ' VAL . . . -80.62 64.39 4.07 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.002 -0.618 . . . . 10.0 112.749 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -69.63 -46.41 54.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.311 -0.471 . . . . 10.0 112.187 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 84.1 mt 74.15 141.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 122.981 0.513 . . . . 10.0 111.67 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 255' ' ' ARG . 30.1 ttt-85 68.54 82.98 0.16 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.341 0.591 . . . . 10.0 111.245 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 55.6 mt -112.17 -45.92 5.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.765 -0.652 . . . . 10.0 111.532 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 7.0 p -135.28 -82.98 0.41 Allowed 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.293 0.479 . . . . 10.0 112.293 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 11.3 t70 59.4 76.57 0.35 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.478 -0.783 . . . . 10.0 110.981 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -118.05 24.41 11.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.726 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' THR . . . . . 0.683 ' HG1' ' N ' ' B' ' 225' ' ' ARG . 5.2 t -155.32 143.04 19.79 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.208 0.528 . . . . 10.0 111.43 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 4.1 m -91.31 120.53 32.27 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.507 -0.923 . . . . 10.0 108.507 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.441 ' O ' ' HA ' ' A' ' 226' ' ' ASN . 67.2 m-20 -111.08 111.71 23.0 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.954 -0.387 . . . . 10.0 109.954 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 227' ' ' SER . 49.7 m -141.07 132.96 27.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.043 0.449 . . . . 10.0 111.708 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.6 HG23 ' HB3' ' B' ' 228' ' ' ALA . 9.9 p -121.6 139.22 49.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.795 -0.639 . . . . 10.0 110.004 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.561 ' HA ' ' HB2' ' A' ' 229' ' ' LYS . 6.0 tt0 -79.35 -77.29 0.18 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.29 0.478 . . . . 10.0 112.29 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 230' ' ' ASP . 1.7 m -115.28 133.36 56.11 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.735 0.643 . . . . 10.0 112.735 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 17.4 t -128.47 124.72 62.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.459 -0.791 . . . . 10.0 109.035 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.459 ' HB ' ' HD3' ' B' ' 232' ' ' ARG . 39.7 t -116.65 121.88 68.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.85 0.357 . . . . 10.0 111.116 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -126.63 118.59 3.1 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.979 -0.629 . . . . 10.0 112.056 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -132.81 110.56 10.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.724 0.297 . . . . 10.0 110.966 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 107.45 67.71 0.65 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.636 -0.792 . . . . 10.0 112.563 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 56.48 32.0 19.93 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 13.2 m -69.19 141.67 54.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.253 0.549 . . . . 10.0 110.611 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' ARG . . . . . 0.401 ' HB2' ' HB3' ' B' ' 238' ' ' ARG . 19.6 mtt180 -114.87 107.08 14.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.386 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 40.8 t -98.97 113.88 35.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.06 -0.518 . . . . 10.0 111.226 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.71 114.79 26.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.246 -0.434 . . . . 10.0 109.863 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.534 ' HB ' ' HG ' ' A' ' 241' ' ' LEU . 29.2 mm -108.91 114.22 46.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.776 -0.453 . . . . 10.0 109.776 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 132.48 163.61 10.7 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.631 -0.795 . . . . 10.0 112.281 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -76.9 147.07 37.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.127 0.489 . . . . 10.0 111.503 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -126.39 152.65 46.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.12 -0.491 . . . . 10.0 111.069 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -129.63 116.63 19.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.726 -0.67 . . . . 10.0 110.581 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' B' ' 246' ' ' THR . . . -166.8 153.3 22.9 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.137 -0.554 . . . . 10.0 111.751 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -128.3 -7.7 4.33 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.431 -0.89 . . . . 10.0 113.327 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -80.07 -43.43 21.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.124 0.487 . . . . 10.0 110.805 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -155.48 157.18 27.53 Favored Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 110.3 -1.12 . . . . 10.0 110.3 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -80.97 74.53 7.96 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.917 0.358 . . . . 10.0 110.894 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 25.0 t90 67.36 -63.93 0.28 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.219 0.949 . . . . 10.0 112.874 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -144.08 96.64 2.92 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.118 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -160.34 144.34 14.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.936 -0.575 . . . . 10.0 110.354 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -157.06 60.7 0.51 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.116 -0.698 . . . . 10.0 109.116 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -83.86 103.73 13.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.852 -0.613 . . . . 10.0 111.769 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -101.56 -31.8 10.68 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.647 -0.706 . . . . 10.0 110.084 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -84.61 124.6 31.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.577 -0.738 . . . . 10.0 109.905 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.42 139.72 47.75 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.785 0.326 . . . . 10.0 110.72 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.509 -0.758 . . . . 10.0 110.378 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.683 ' N ' ' HG1' ' A' ' 260' ' ' THR . 4.7 ttm-85 . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 110.286 -0.265 . . . . 10.0 110.286 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.442 ' HB3' HG22 ' B' ' 277' ' ' ILE . 69.9 m-20 -126.54 124.23 39.54 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.326 -0.62 . . . . 10.0 109.326 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 227' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 263' ' ' SER . 5.1 m -139.32 152.95 47.61 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.624 0.25 . . . . 10.0 111.184 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.6 ' HB3' HG23 ' A' ' 264' ' ' VAL . . . -144.24 148.5 35.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.154 -0.476 . . . . 10.0 111.448 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.49 ' HB2' ' HA ' ' B' ' 265' ' ' GLU . 1.1 tmtm? -90.56 -62.35 1.48 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.217 -0.447 . . . . 10.0 111.957 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 230' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 266' ' ' THR . 7.3 t0 -145.6 132.25 19.92 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.006 0.431 . . . . 10.0 111.412 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 64.9 mt -125.24 122.92 64.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.086 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 232' ' ' ARG . . . . . 0.459 ' HD3' ' HB ' ' A' ' 268' ' ' VAL . 3.8 mmt180 -102.74 112.52 25.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.165 -0.471 . . . . 10.0 109.95 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.407 ' O ' ' HA2' ' A' ' 269' ' ' GLY . 1.0 OUTLIER -121.23 115.0 22.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.882 0.372 . . . . 10.0 111.327 -179.226 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.34 164.32 28.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.339 -0.391 . . . . 10.0 111.477 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 235' ' ' GLU . . . . . 0.43 ' HB2' ' H ' ' B' ' 271' ' ' GLY . 25.8 mt-10 65.64 62.59 0.64 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.595 -0.729 . . . . 10.0 111.872 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 236' ' ' ARG . . . . . 0.461 ' HB2' ' HG2' ' B' ' 272' ' ' GLU . 63.6 mtm-85 57.83 32.29 21.71 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.894 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.12 159.59 22.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.887 0.375 . . . . 10.0 111.065 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.401 ' HB3' ' HB2' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -137.62 141.82 41.23 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.951 0.405 . . . . 10.0 111.238 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 4.3 p -127.1 135.81 62.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.723 -0.671 . . . . 10.0 110.989 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -118.74 123.23 44.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.61 -0.723 . . . . 10.0 109.227 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.78 84.78 1.98 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.877 0.37 . . . . 10.0 110.504 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 165.41 179.06 38.98 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.482 -0.866 . . . . 10.0 112.233 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -92.26 131.64 37.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.798 0.332 . . . . 10.0 110.664 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 46.7 t -95.77 109.13 22.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.014 0.435 . . . . 10.0 110.707 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 20.3 t -109.24 114.11 46.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 246' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 282' ' ' GLY . 32.8 p -81.91 169.01 17.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.087 -0.506 . . . . 10.0 111.324 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -72.12 -4.92 31.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.691 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -78.43 -18.17 55.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.601 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -91.01 3.1 55.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.647 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 20.6 tp -64.58 131.19 46.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.426 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 1.9 t60 60.07 47.89 9.13 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.261 0.553 . . . . 10.0 110.89 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -137.48 -156.52 7.27 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.884 -0.674 . . . . 10.0 111.866 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.51 120.4 4.29 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.987 -0.625 . . . . 10.0 111.736 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 52.5 mt -103.5 -33.48 3.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.22 0.533 . . . . 10.0 110.733 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 255' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' B' ' 255' ' ' ARG . 4.0 tpt180 -79.82 81.06 6.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.975 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 21.4 pt -102.34 37.51 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.798 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.7 t 65.87 36.22 6.18 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.925 -0.58 . . . . 10.0 110.616 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -65.94 122.43 17.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.397 -0.82 . . . . 10.0 110.154 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 259' ' ' GLN . . . . . 0.4 ' OE1' HG13 ' C' ' 256' ' ' ILE . 12.8 tt0 -139.28 109.25 6.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.333 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 8.5 t -175.38 177.1 1.89 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.998 0.428 . . . . 10.0 110.56 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 71.2 m -150.48 117.47 5.92 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.901 -0.777 . . . . 10.0 108.901 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -99.69 116.06 30.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.991 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 50.8 m -135.78 113.9 11.37 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.881 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' C' ' 228' ' ' ALA . 13.2 p -113.14 146.2 18.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.556 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 265' ' ' GLU . . . . . 0.49 ' HA ' ' HB2' ' B' ' 229' ' ' LYS . 28.4 mt-10 -85.01 -75.5 0.35 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.173 0.435 . . . . 10.0 112.173 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' B' ' 230' ' ' ASP . 4.3 m -123.24 130.14 52.34 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.748 0.647 . . . . 10.0 112.748 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 37.3 t -119.77 122.87 69.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.376 -0.829 . . . . 10.0 109.041 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 268' ' ' VAL . . . . . 0.418 ' HB ' ' HA ' ' C' ' 232' ' ' ARG . 35.3 t -104.3 114.02 42.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.815 0.34 . . . . 10.0 110.348 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.41 97.6 0.72 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.556 -0.618 . . . . 10.0 111.556 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -119.89 118.98 32.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.728 0.299 . . . . 10.0 111.189 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 271' ' ' GLY . . . . . 0.43 ' H ' ' HB2' ' B' ' 235' ' ' GLU . . . 100.65 62.57 0.79 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.325 -0.941 . . . . 10.0 112.595 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 272' ' ' GLU . . . . . 0.461 ' HG2' ' HB2' ' B' ' 236' ' ' ARG . 12.1 mt-10 54.58 37.68 28.45 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.124 0.786 . . . . 10.0 113.124 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 273' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' C' ' 237' ' ' ALA . 7.3 m -77.81 151.16 34.1 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.899 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 13.2 mtt85 -116.25 121.08 40.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.344 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 40.8 t -108.84 119.42 58.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.486 -0.561 . . . . 10.0 109.486 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.597 ' HB3' ' HG3' ' C' ' 240' ' ' GLN . 0.1 OUTLIER -117.97 113.37 21.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.666 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.442 HG22 ' HB3' ' B' ' 226' ' ' ASN . 43.3 mm -103.54 88.33 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.896 0.379 . . . . 10.0 110.074 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 158.66 175.07 29.18 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.899 -0.667 . . . . 10.0 111.974 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -93.05 159.35 15.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.152 -0.314 . . . . 10.0 110.152 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.46 160.83 27.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.192 0.52 . . . . 10.0 111.684 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.02 71.27 1.33 Allowed 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -97.3 -65.03 0.9 Allowed Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.213 -0.903 . . . . 10.0 111.885 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 283' ' ' GLY . . . . . 0.533 ' HA3' ' H ' ' C' ' 247' ' ' ALA . . . 82.35 -46.99 3.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.247 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 284' ' ' LYS . . . . . 0.407 ' HE3' ' HB3' ' B' ' 284' ' ' LYS . 27.9 mtpp -67.35 -26.69 66.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.411 0.624 . . . . 10.0 110.126 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -152.73 164.22 30.66 Favored Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 110.216 -1.154 . . . . 10.0 110.216 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -97.87 64.18 1.71 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.93 -0.396 . . . . 10.0 109.93 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.447 ' CH2' ' HB2' ' C' ' 238' ' ' ARG . 16.1 t90 71.19 -43.11 0.55 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.387 -0.824 . . . . 10.0 112.341 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -139.02 -170.54 2.89 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.863 -0.421 . . . . 10.0 109.863 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.38 142.19 58.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.419 -0.355 . . . . 10.0 110.777 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -166.48 89.73 0.39 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 110.397 -0.223 . . . . 10.0 110.397 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -155.52 119.35 4.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.82 0.343 . . . . 10.0 111.796 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.97 -176.49 5.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.125 -0.488 . . . . 10.0 110.457 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.6 154.17 17.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.817 0.341 . . . . 10.0 111.477 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 294' ' ' HIS . . . . . 0.565 ' HB2' ' HA ' ' C' ' 291' ' ' HIS . 29.1 p80 -116.16 -174.07 2.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.41 -0.814 . . . . 10.0 109.211 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.218 -0.896 . . . . 10.0 109.73 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 225' ' ' ARG . . . . . 0.675 ' N ' ' HG1' ' C' ' 261' ' ' THR . 31.2 ptt180 . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.485 0.183 . . . . 10.0 110.549 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 226' ' ' ASN . . . . . 0.442 ' HB3' HG22 ' C' ' 277' ' ' ILE . 52.4 m-80 -127.72 111.51 13.77 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.28 152.59 47.94 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.051 0.453 . . . . 10.0 111.572 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.413 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -149.06 143.82 26.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.774 -0.648 . . . . 10.0 109.995 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 229' ' ' LYS . . . . . 0.456 ' HG2' ' OE2' ' B' ' 265' ' ' GLU . 38.3 mttm -91.91 -72.27 0.6 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.633 0.605 . . . . 10.0 112.633 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -122.06 126.29 48.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.865 0.365 . . . . 10.0 111.558 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 49.7 mt -129.52 115.05 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.382 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.428 ' HD2' HG13 ' C' ' 268' ' ' VAL . 14.7 ttm-85 -101.45 115.12 29.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.396 -0.365 . . . . 10.0 110.561 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -125.29 100.7 6.64 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.447 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -125.32 161.58 26.66 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.014 0.376 . . . . 10.0 112.014 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 66.45 75.15 0.33 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.358 -0.837 . . . . 10.0 112.108 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 53.33 55.17 9.1 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.297 -0.865 . . . . 10.0 111.133 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 237' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' B' ' 273' ' ' SER . . . -107.97 165.89 11.12 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.712 -0.676 . . . . 10.0 111.164 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 238' ' ' ARG . . . . . 0.447 ' HB2' ' CH2' ' B' ' 287' ' ' TRP . 1.5 ptp180 -153.1 138.01 17.14 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.854 -0.612 . . . . 10.0 110.16 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.484 HG23 ' HB ' ' C' ' 275' ' ' VAL . 4.4 p -135.06 136.46 51.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.191 -0.459 . . . . 10.0 110.614 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.597 ' HG3' ' HB3' ' B' ' 276' ' ' LEU . 27.6 tt0 -126.07 128.61 47.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.993 0.425 . . . . 10.0 111.043 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -105.24 91.41 3.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.769 -0.651 . . . . 10.0 109.831 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 168.19 -174.39 43.03 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.669 -0.777 . . . . 10.0 111.992 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -95.54 155.69 16.64 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.827 0.346 . . . . 10.0 110.95 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 57.3 t -112.68 108.78 26.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.06 -0.518 . . . . 10.0 110.249 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.83 110.64 32.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.218 -0.446 . . . . 10.0 110.342 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 38.3 p -79.84 159.92 26.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.019 -0.537 . . . . 10.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 247' ' ' ALA . . . . . 0.533 ' H ' ' HA3' ' B' ' 283' ' ' GLY . . . -73.68 42.54 0.13 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.273 0.559 . . . . 10.0 111.838 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -138.19 -13.06 1.4 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.61 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -87.45 67.03 9.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.109 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 55.8 mt -87.12 -4.6 59.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.978 -0.555 . . . . 10.0 111.379 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -94.04 129.24 40.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.305 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 178.77 -158.57 23.01 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.661 -0.78 . . . . 10.0 112.182 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 176.17 -134.66 2.68 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.676 -0.969 . . . . 10.0 110.676 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 13.5 tt -158.42 89.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.498 0.666 . . . . 10.0 111.421 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -140.93 115.31 9.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.367 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 256' ' ' ILE . . . . . 0.4 HG13 ' OE1' ' B' ' 259' ' ' GLN . 8.5 tt -74.83 129.28 36.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.819 -0.628 . . . . 10.0 109.898 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.44 174.16 15.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.125 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.81 145.6 55.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.92 -0.582 . . . . 10.0 112.155 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -147.76 149.07 31.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.761 -0.654 . . . . 10.0 109.703 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 12.8 t -71.51 140.29 49.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.005 0.431 . . . . 10.0 110.847 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 261' ' ' THR . . . . . 0.675 ' HG1' ' N ' ' C' ' 225' ' ' ARG . 7.7 m -105.54 134.34 48.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.099 -0.501 . . . . 10.0 110.384 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 262' ' ' ASN . . . . . 0.55 ' HA ' ' O ' ' D' ' 226' ' ' ASN . 18.6 t-20 -122.65 128.36 50.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.875 -0.602 . . . . 10.0 109.5 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 50.0 m -144.63 138.78 27.62 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.737 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.9 p -123.52 145.34 30.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.852 -0.613 . . . . 10.0 110.996 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 265' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' D' ' 229' ' ' LYS . 54.8 mt-10 -82.32 -66.27 0.91 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.491 -0.322 . . . . 10.0 111.735 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.79 129.74 51.04 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.295 0.85 . . . . 10.0 113.295 -178.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 48.3 t -127.19 119.97 54.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.661 -0.7 . . . . 10.0 109.648 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 268' ' ' VAL . . . . . 0.609 ' HB ' ' HD2' ' D' ' 232' ' ' ARG . 58.8 t -117.01 120.08 63.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.794 0.33 . . . . 10.0 110.895 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 269' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -123.77 130.95 7.85 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.976 -0.631 . . . . 10.0 112.121 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -133.04 126.68 32.42 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.913 0.338 . . . . 10.0 111.913 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.17 93.23 0.16 Allowed Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.951 -0.568 . . . . 10.0 113.449 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 64.02 32.47 12.91 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.303 0.573 . . . . 10.0 111.403 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 273' ' ' SER . . . . . 0.459 ' HB3' ' HA3' ' C' ' 269' ' ' GLY . 0.2 OUTLIER -66.46 121.83 16.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.328 -0.851 . . . . 10.0 111.193 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 41.3 mtt180 -124.74 100.89 6.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.147 0.499 . . . . 10.0 109.763 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.484 ' HB ' HG23 ' C' ' 239' ' ' VAL . 22.3 t -101.78 131.86 48.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.041 -0.527 . . . . 10.0 111.411 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' D' ' 240' ' ' GLN . 2.2 tm? -128.01 113.2 15.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.858 -0.61 . . . . 10.0 109.815 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.48 HG12 HD23 ' D' ' 241' ' ' LEU . 56.1 mt -111.0 94.13 2.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.324 0.583 . . . . 10.0 110.756 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 168.19 -165.06 38.5 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.825 -1.31 . . . . 10.0 109.825 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -108.49 148.28 30.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 117.477 0.638 . . . . 10.0 110.946 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -104.94 137.61 42.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.344 -0.389 . . . . 10.0 110.644 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 281' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.2 OUTLIER -131.0 102.16 5.92 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.538 -0.542 . . . . 10.0 109.538 179.411 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 282' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' D' ' 246' ' ' THR . . . -164.98 172.07 40.55 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.689 -0.767 . . . . 10.0 112.434 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -124.34 16.33 7.59 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.782 -0.723 . . . . 10.0 112.522 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -101.68 1.28 37.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.964 0.411 . . . . 10.0 111.179 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 129.86 -116.17 2.04 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.835 -0.906 . . . . 10.0 110.835 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 286' ' ' PHE . . . . . 0.511 ' HB3' ' NE1' ' D' ' 287' ' ' TRP . 0.8 OUTLIER -125.75 -155.78 0.7 Allowed 'General case' 0 C--N 1.323 -0.549 0 O-C-N 123.513 0.184 . . . . 10.0 110.562 179.131 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.417 ' H ' ' HB2' ' C' ' 286' ' ' PHE . 1.7 t90 -63.75 -24.0 67.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.635 0.255 . . . . 10.0 111.284 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 288' ' ' ASP . . . . . 0.405 ' OD2' ' HD2' ' D' ' 238' ' ' ARG . 1.9 p30 -133.47 -171.39 2.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.489 -0.323 . . . . 10.0 110.262 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -143.02 35.44 1.37 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.075 0.464 . . . . 10.0 110.966 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -79.99 0.58 31.01 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.276 0.473 . . . . 10.0 112.276 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 291' ' ' HIS . . . . . 0.661 ' HB2' HH12 ' D' ' 274' ' ' ARG . 0.2 OUTLIER -164.46 155.82 15.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.455 179.125 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 66.34 157.19 0.11 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.399 0.618 . . . . 10.0 112.464 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 N-CA-C 112.117 0.414 . . . . 10.0 112.117 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 226' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' C' ' 262' ' ' ASN . 19.1 m120 . . . . . 0 CA--C 1.52 -0.178 0 N-CA-C 110.301 -0.259 . . . . 10.0 110.301 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 42.6 m -151.17 142.83 23.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.89 0.376 . . . . 10.0 111.579 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.85 139.59 53.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.51 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 229' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' C' ' 265' ' ' GLU . 22.5 ttmt -84.54 -66.12 0.93 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.877 0.37 . . . . 10.0 111.601 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -138.51 119.43 14.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.649 0.261 . . . . 10.0 111.113 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 231' ' ' ILE . . . . . 0.422 HG12 HG23 ' D' ' 267' ' ' VAL . 32.7 mt -117.07 130.89 71.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.385 -0.37 . . . . 10.0 110.502 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 232' ' ' ARG . . . . . 0.609 ' HD2' ' HB ' ' C' ' 268' ' ' VAL . 22.2 mmm-85 -118.55 106.38 12.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.176 -0.466 . . . . 10.0 110.66 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 233' ' ' THR . . . . . 0.554 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 1.4 p -112.99 113.3 25.28 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.625 -0.509 . . . . 10.0 109.625 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 234' ' ' GLU . . . . . 0.406 ' HG3' ' HG3' ' D' ' 270' ' ' LYS . 4.2 pt-20 -131.18 147.34 52.59 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.368 0.506 . . . . 10.0 112.368 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 68.38 79.22 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.162 -0.927 . . . . 10.0 113.278 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 55.68 45.64 24.2 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.287 0.565 . . . . 10.0 111.94 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -111.06 157.23 20.21 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.901 -0.591 . . . . 10.0 110.61 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 238' ' ' ARG . . . . . 0.405 ' HD2' ' OD2' ' C' ' 288' ' ' ASP . 0.0 OUTLIER -144.33 151.77 39.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.244 -0.434 . . . . 10.0 110.822 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 239' ' ' VAL . . . . . 0.451 HG23 ' HB ' ' D' ' 275' ' ' VAL . 3.8 p -138.25 133.43 43.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.22 -0.445 . . . . 10.0 110.273 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 240' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' C' ' 276' ' ' LEU . 0.0 OUTLIER -115.21 125.38 53.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.522 179.657 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 241' ' ' LEU . . . . . 0.48 HD23 HG12 ' C' ' 277' ' ' ILE . 3.0 mm? -109.66 92.59 4.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.865 -0.607 . . . . 10.0 110.819 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 175.72 -106.02 0.21 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.716 -0.755 . . . . 10.0 112.466 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -167.91 162.93 13.77 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.637 0.375 . . . . 10.0 110.282 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 244' ' ' VAL . . . . . 0.402 HG21 ' CD1' ' D' ' 287' ' ' TRP . 35.8 t -110.52 111.92 38.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.842 0.353 . . . . 10.0 111.802 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 245' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 17.7 t -113.21 109.98 30.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.383 -0.599 . . . . 10.0 109.383 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 246' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' C' ' 282' ' ' GLY . 82.3 p -89.75 162.77 15.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.945 0.403 . . . . 10.0 111.611 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -72.87 -0.89 14.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.048 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -88.57 -12.08 43.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.407 0.622 . . . . 10.0 109.782 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -97.06 87.76 4.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.387 -0.824 . . . . 10.0 109.983 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 4.5 mp -84.17 -160.16 0.44 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.809 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -79.69 100.52 7.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.088 0.47 . . . . 10.0 111.087 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -174.15 38.73 0.13 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.819 -0.912 . . . . 10.0 110.819 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 101.96 35.11 4.08 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.818 -0.706 . . . . 10.0 111.451 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 10.0 tt -68.0 -38.02 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 121.161 0.505 . . . . 10.0 111.987 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 42.1 mtt-85 -84.04 83.96 7.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.103 0.478 . . . . 10.0 111.551 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 15.5 tt -67.68 -16.97 21.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.215 -0.902 . . . . 10.0 111.739 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 7.7 m 71.1 -83.23 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.369 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -161.14 167.84 25.42 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -160.09 -41.58 0.05 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.137 0.273 . . . . 10.0 111.56 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 13.9 t -144.07 162.05 37.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.867 0.365 . . . . 10.0 111.231 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 21.8 m -105.44 114.46 28.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.062 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -102.59 104.51 14.9 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.047 -0.524 . . . . 10.0 109.778 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 14.8 m -117.48 126.3 52.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.021 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 9.2 p -123.62 133.37 69.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.151 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 265' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' E' ' 229' ' ' LYS . 67.7 mt-10 -83.71 -82.49 0.16 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.207 -0.451 . . . . 10.0 112.137 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 2.4 p -106.0 119.61 39.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.015 0.436 . . . . 10.0 112.029 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 267' ' ' VAL . . . . . 0.422 HG23 HG12 ' D' ' 231' ' ' ILE . 0.1 OUTLIER -127.67 113.7 32.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.02 179.5 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 268' ' ' VAL . . . . . 0.536 ' HB ' ' HG2' ' E' ' 232' ' ' ARG . 42.0 t -113.0 128.6 69.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.312 -0.404 . . . . 10.0 111.023 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 269' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' E' ' 233' ' ' THR . . . -129.8 115.02 1.8 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.677 -0.969 . . . . 10.0 110.677 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 270' ' ' LYS . . . . . 0.638 ' HB3' ' HG2' ' E' ' 234' ' ' GLU . 5.6 tttp -124.07 125.63 44.85 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.518 0.562 . . . . 10.0 112.518 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.53 89.58 0.4 Allowed Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.592 -0.731 . . . . 10.0 113.876 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 55.58 52.55 10.91 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.161 0.505 . . . . 10.0 111.555 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 6.3 t -103.38 142.39 34.31 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.968 -0.56 . . . . 10.0 110.858 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 274' ' ' ARG . . . . . 0.661 HH12 ' HB2' ' C' ' 291' ' ' HIS . 2.1 mpt_? -122.56 110.6 15.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.218 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 275' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' D' ' 239' ' ' VAL . 26.0 t -99.95 114.96 39.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.991 -0.374 . . . . 10.0 109.991 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 276' ' ' LEU . . . . . 0.456 ' HB3' ' HG3' ' E' ' 240' ' ' GLN . 1.2 tm? -116.43 108.85 16.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.313 0.578 . . . . 10.0 111.27 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 44.3 mm -106.2 99.84 9.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.223 -0.658 . . . . 10.0 109.223 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.1 -171.46 32.72 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.792 -0.718 . . . . 10.0 111.313 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -110.28 161.75 15.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.918 0.389 . . . . 10.0 111.205 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -117.06 134.77 54.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.074 -0.512 . . . . 10.0 111.045 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -125.96 113.61 17.38 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.089 -0.505 . . . . 10.0 110.282 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 282' ' ' GLY . . . . . 0.536 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 161.31 -178.15 37.35 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.271 -0.966 . . . . 10.0 112.64 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -108.37 41.6 2.17 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.839 -0.696 . . . . 10.0 112.965 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt -86.82 -22.23 25.97 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.699 -0.482 . . . . 10.0 109.699 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 98.93 -32.76 6.72 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.049 -0.596 . . . . 10.0 112.149 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 286' ' ' PHE . . . . . 0.79 ' HZ ' ' HG ' ' E' ' 276' ' ' LEU . 2.6 t80 176.71 137.72 0.06 Allowed 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.591 -0.522 . . . . 10.0 109.591 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 287' ' ' TRP . . . . . 0.511 ' NE1' ' HB3' ' C' ' 286' ' ' PHE . 9.6 t90 -55.89 -74.49 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.581 0.55 . . . . 10.0 110.584 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 288' ' ' ASP . . . . . 0.505 ' CG ' ' HE ' ' E' ' 238' ' ' ARG . 48.5 t0 -125.8 117.82 24.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.456 0.646 . . . . 10.0 111.8 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 289' ' ' ASN . . . . . 0.582 ' HA ' ' HD3' ' E' ' 274' ' ' ARG . 10.1 t-20 -156.34 160.86 40.08 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.76 -1.2 . . . . 10.0 107.76 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -80.35 -64.62 1.15 Allowed 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.365 0.506 . . . . 10.0 112.365 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -148.57 -160.65 1.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.647 -0.251 . . . . 10.0 110.955 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -91.29 -161.02 0.77 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.814 -0.439 . . . . 10.0 109.814 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -71.18 133.35 46.1 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.475 -0.195 . . . . 10.0 110.475 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -122.33 147.09 46.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.595 -0.275 . . . . 10.0 110.941 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.355 -0.831 . . . . 10.0 109.6 178.949 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 225' ' ' ARG . . . . . 0.633 ' N ' ' HG1' ' E' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 110.21 -0.293 . . . . 10.0 110.21 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -132.13 114.48 14.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.701 0.286 . . . . 10.0 110.716 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 2.4 m -122.77 141.27 52.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.226 0.536 . . . . 10.0 111.719 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 228' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' E' ' 264' ' ' VAL . . . -135.69 121.09 19.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.813 -0.63 . . . . 10.0 109.41 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 229' ' ' LYS . . . . . 0.545 ' O ' ' HB2' ' D' ' 265' ' ' GLU . 9.7 mttm -79.9 -69.91 0.55 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.066 0.765 . . . . 10.0 113.066 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 230' ' ' ASP . . . . . 0.516 ' HB3' HG23 ' E' ' 266' ' ' THR . 19.9 t70 -124.58 126.0 45.08 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.753 -0.379 . . . . 10.0 111.852 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 54.8 mt -134.35 122.16 39.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.095 0.474 . . . . 10.0 110.78 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 232' ' ' ARG . . . . . 0.536 ' HG2' ' HB ' ' D' ' 268' ' ' VAL . 37.5 mtm180 -122.41 123.34 41.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.087 -0.506 . . . . 10.0 110.336 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 233' ' ' THR . . . . . 0.484 ' O ' ' HA2' ' D' ' 269' ' ' GLY . 0.6 OUTLIER -127.69 114.06 16.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.877 -0.601 . . . . 10.0 111.568 -179.37 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 234' ' ' GLU . . . . . 0.638 ' HG2' ' HB3' ' D' ' 270' ' ' LYS . 48.0 mt-10 -124.83 162.23 24.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.157 -0.474 . . . . 10.0 111.687 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 61.57 74.72 0.43 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.653 0.983 . . . . 10.0 113.653 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 236' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' E' ' 272' ' ' GLU . 18.1 ttp180 50.4 64.04 1.96 Allowed 'General case' 0 C--O 1.234 0.261 0 O-C-N 123.559 0.537 . . . . 10.0 111.69 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -123.15 174.77 7.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.774 -0.648 . . . . 10.0 110.986 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 238' ' ' ARG . . . . . 0.972 ' HD3' ' HG3' ' E' ' 274' ' ' ARG . 0.7 OUTLIER -149.63 149.47 30.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.911 0.386 . . . . 10.0 110.721 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 3.1 p -133.48 118.77 32.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.342 -0.844 . . . . 10.0 109.236 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 240' ' ' GLN . . . . . 0.456 ' HG3' ' HB3' ' D' ' 276' ' ' LEU . 47.5 tt0 -123.82 128.0 48.89 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.921 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 241' ' ' LEU . . . . . 0.568 ' HG ' ' HB ' ' E' ' 277' ' ' ILE . 4.8 mp -123.58 109.72 14.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.387 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 166.82 -173.63 42.15 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.94 -0.648 . . . . 10.0 112.221 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -101.99 137.72 39.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.743 0.306 . . . . 10.0 110.739 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 244' ' ' VAL . . . . . 0.414 ' O ' ' HB3' ' E' ' 281' ' ' TYR . 38.4 t -93.13 123.99 45.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.481 -0.327 . . . . 10.0 110.424 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 24.5 t -121.67 106.61 18.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.979 0.419 . . . . 10.0 110.917 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 246' ' ' THR . . . . . 0.631 ' HB ' ' HA2' ' E' ' 282' ' ' GLY . 8.9 t -68.43 164.73 20.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.845 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.16 -20.54 64.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.092 -0.503 . . . . 10.0 111.967 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -71.52 -19.96 62.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.443 -0.344 . . . . 10.0 110.429 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 59.26 -165.81 0.19 Allowed 'General case' 0 C--O 1.232 0.16 0 O-C-N 123.914 0.759 . . . . 10.0 111.649 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 7.3 tp -95.47 122.45 38.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.421 -0.354 . . . . 10.0 110.082 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 120.919 0.39 . . . . 10.0 111.354 -179.527 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 4.2 pt . . . . . 0 CA--C 1.519 -0.226 0 CA-C-O 121.081 0.467 . . . . 10.0 112.227 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.64 163.7 39.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.448 -0.796 . . . . 10.0 109.339 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -82.98 86.65 6.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.714 0.769 . . . . 10.0 110.709 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -66.21 -59.31 3.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.252 -0.885 . . . . 10.0 111.332 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 14.8 t -83.02 154.86 24.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.727 -0.67 . . . . 10.0 111.418 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 261' ' ' THR . . . . . 0.633 ' HG1' ' N ' ' E' ' 225' ' ' ARG . 49.3 m -130.81 124.01 30.37 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.335 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -118.16 121.58 40.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.883 -0.599 . . . . 10.0 110.023 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 6.3 m -127.48 104.64 8.01 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.777 -0.453 . . . . 10.0 109.777 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 264' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' E' ' 228' ' ' ALA . 3.8 p -88.77 152.19 3.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 116.013 -0.54 . . . . 10.0 111.086 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 265' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' E' ' 229' ' ' LYS . 76.0 mm-40 -87.55 -82.9 0.21 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.966 -0.561 . . . . 10.0 111.44 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 266' ' ' THR . . . . . 0.516 HG23 ' HB3' ' E' ' 230' ' ' ASP . 18.2 m -132.52 119.96 21.25 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.854 0.359 . . . . 10.0 111.558 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 23.8 t -112.07 111.53 36.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.535 -0.543 . . . . 10.0 109.535 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 18.4 t -113.28 120.51 63.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.307 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -139.46 137.92 8.89 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.67 -0.776 . . . . 10.0 112.158 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 270' ' ' LYS . . . . . 0.518 ' HG3' ' HB2' ' E' ' 234' ' ' GLU . 24.7 ttpp -142.71 112.93 7.15 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.354 -0.239 . . . . 10.0 110.354 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 111.65 84.14 1.4 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.861 -0.685 . . . . 10.0 112.355 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 272' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' E' ' 236' ' ' ARG . 3.5 mm-40 56.31 32.39 20.35 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.361 0.504 . . . . 10.0 112.361 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.3 152.17 38.58 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.002 -0.544 . . . . 10.0 111.449 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 274' ' ' ARG . . . . . 0.972 ' HG3' ' HD3' ' E' ' 238' ' ' ARG . 2.7 ttm180 -135.88 102.06 4.94 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.894 -0.594 . . . . 10.0 109.987 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 26.7 t -107.58 115.43 48.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.685 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 276' ' ' LEU . . . . . 0.79 ' HG ' ' HZ ' ' D' ' 286' ' ' PHE . 0.7 OUTLIER -125.35 113.58 17.76 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.416 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 277' ' ' ILE . . . . . 0.568 ' HB ' ' HG ' ' E' ' 241' ' ' LEU . 46.5 mm -109.48 100.23 10.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.937 0.398 . . . . 10.0 110.653 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 164.28 -148.91 15.33 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.739 -0.664 . . . . 10.0 111.537 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 37.8 p30 -105.38 167.53 9.68 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.747 -0.266 . . . . 10.0 110.693 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 280' ' ' GLU . . . . . 1.032 ' HB2' ' HA ' ' E' ' 288' ' ' ASP . 0.5 OUTLIER -120.48 124.0 44.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.948 0.404 . . . . 10.0 111.397 -179.05 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 281' ' ' TYR . . . . . 0.414 ' HB3' ' O ' ' E' ' 244' ' ' VAL . 9.5 t80 -156.84 94.76 1.47 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.822 -0.626 . . . . 10.0 110.261 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 282' ' ' GLY . . . . . 0.631 ' HA2' ' HB ' ' E' ' 246' ' ' THR . . . -133.99 -81.08 0.16 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.288 -0.958 . . . . 10.0 112.695 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 283' ' ' GLY . . . . . 0.708 ' HA2' ' HB3' ' E' ' 290' ' ' HIS . . . 144.12 30.1 0.1 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.477 -0.868 . . . . 10.0 113.583 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 284' ' ' LYS . . . . . 0.591 ' HG3' ' OD1' ' E' ' 288' ' ' ASP . 6.0 pttp -125.88 -51.66 1.57 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.257 0.465 . . . . 10.0 112.257 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.17 30.03 2.01 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.086 -1.054 . . . . 10.0 113.408 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -147.11 97.98 2.96 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.997 -1.112 . . . . 10.0 107.997 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 73.09 24.66 2.45 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 107.919 -1.141 . . . . 10.0 107.919 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 288' ' ' ASP . . . . . 1.032 ' HA ' ' HB2' ' E' ' 280' ' ' GLU . 2.4 p-10 -170.37 161.42 8.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.035 -1.438 . . . . 10.0 109.375 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -139.31 161.94 36.21 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.914 -0.402 . . . . 10.0 109.914 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 290' ' ' HIS . . . . . 0.708 ' HB3' ' HA2' ' E' ' 283' ' ' GLY . 5.9 p80 -152.82 167.72 28.11 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.155 -0.475 . . . . 10.0 111.133 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -74.51 -74.43 0.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.377 -0.374 . . . . 10.0 110.638 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 26.8 t60 67.68 155.18 0.11 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.674 -0.694 . . . . 10.0 111.96 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -122.48 135.97 54.78 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.294 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -93.88 179.36 5.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.564 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 41.3 t60 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.064 -0.97 . . . . 10.0 109.787 -179.664 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.621 0.248 . . . . 10.0 110.334 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -106.55 127.9 53.69 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.668 -0.494 . . . . 10.0 109.668 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 263' ' ' SER . 3.3 m -144.98 161.63 38.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.157 0.503 . . . . 10.0 111.572 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.5 158.61 44.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.049 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.553 ' HD3' ' HG3' ' A' ' 265' ' ' GLU . 7.4 tttm -108.81 -59.6 1.86 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.933 0.397 . . . . 10.0 111.34 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -143.23 127.61 17.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.939 0.399 . . . . 10.0 111.345 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 26.7 mt -131.1 131.13 63.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.851 0.357 . . . . 10.0 111.106 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.467 ' HG3' ' HA ' ' A' ' 268' ' ' VAL . 2.0 ptp85 -126.83 114.43 17.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.3 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.94 122.82 44.27 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.881 -0.6 . . . . 10.0 111.214 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -135.71 153.39 51.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.619 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 65.34 80.71 0.22 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.145 -0.934 . . . . 10.0 112.974 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 55.02 34.14 21.81 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.801 -0.636 . . . . 10.0 112.141 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -100.94 164.04 12.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.447 -0.342 . . . . 10.0 110.559 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -147.66 153.09 38.9 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.82 0.343 . . . . 10.0 111.161 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.76 128.6 67.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.219 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.452 ' HB3' HD22 ' A' ' 276' ' ' LEU . 37.0 tt0 -129.26 131.81 47.08 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.065 -0.346 . . . . 10.0 110.065 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.957 ' HG ' ' HB ' ' A' ' 277' ' ' ILE . 0.8 OUTLIER -124.97 142.46 51.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.549 -0.296 . . . . 10.0 110.783 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.38 -109.82 0.73 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.114 -0.565 . . . . 10.0 112.023 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -160.34 147.39 15.95 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.334 -0.617 . . . . 10.0 109.334 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 79.2 t -115.59 116.83 53.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.842 0.353 . . . . 10.0 111.204 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 16.8 t -110.5 112.98 42.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.965 -0.562 . . . . 10.0 109.586 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.416 ' HB ' ' HA2' ' A' ' 282' ' ' GLY . 6.0 m -89.89 151.06 21.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.274 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.01 -15.88 57.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.0 0.428 . . . . 10.0 111.661 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -73.2 -14.36 61.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.906 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -118.99 56.61 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.192 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.488 ' HB3' ' H ' ' A' ' 251' ' ' HIS . 3.3 mm? 64.72 -135.33 0.26 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.317 -0.856 . . . . 10.0 111.951 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.488 ' H ' ' HB3' ' A' ' 250' ' ' LEU . 52.8 p-80 -119.03 -175.45 2.91 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.309 -0.405 . . . . 10.0 110.434 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -75.02 70.92 1.75 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.199 -0.524 . . . . 10.0 112.667 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -65.96 -41.11 95.5 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.114 -0.565 . . . . 10.0 112.815 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 73.6 mt 73.97 141.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 122.946 0.498 . . . . 10.0 111.823 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 61.82 84.18 0.14 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.195 0.522 . . . . 10.0 111.768 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 45.3 mt -124.16 -42.84 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.309 -0.405 . . . . 10.0 110.773 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 6.2 p -125.19 -94.34 0.48 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.203 0.445 . . . . 10.0 112.203 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.1 t0 55.69 67.9 0.94 Allowed 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.653 0.596 . . . . 10.0 110.999 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -120.32 6.62 10.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.732 -0.667 . . . . 10.0 111.005 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' THR . . . . . 0.495 ' HG1' ' N ' ' B' ' 225' ' ' ARG . 5.2 t -142.93 142.31 31.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.027 0.441 . . . . 10.0 111.282 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.16 119.75 28.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.757 -0.831 . . . . 10.0 108.757 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.476 ' HB3' HD12 ' B' ' 241' ' ' LEU . 69.6 m-20 -113.73 117.22 30.9 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.606 -0.516 . . . . 10.0 109.606 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 227' ' ' SER . 19.0 m -145.72 137.15 24.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.897 0.379 . . . . 10.0 111.424 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.538 HG23 ' HB3' ' B' ' 228' ' ' ALA . 7.6 p -123.75 144.81 32.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.642 -0.503 . . . . 10.0 109.642 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.553 ' HG3' ' HD3' ' A' ' 229' ' ' LYS . 32.3 tt0 -84.96 -76.33 0.32 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 112.695 0.628 . . . . 10.0 112.695 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.95 125.63 54.6 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.452 0.538 . . . . 10.0 112.452 -177.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 35.9 t -122.37 122.13 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.079 -0.51 . . . . 10.0 110.004 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.467 ' HA ' ' HG3' ' A' ' 232' ' ' ARG . 21.5 t -114.49 118.05 57.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.395 -0.366 . . . . 10.0 110.797 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.14 119.7 4.63 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.019 -0.832 . . . . 10.0 111.019 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -128.9 103.16 6.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.331 0.493 . . . . 10.0 112.331 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 92.37 91.3 1.47 Allowed Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.766 -0.73 . . . . 10.0 114.628 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 58.3 24.85 12.02 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.949 0.722 . . . . 10.0 112.949 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 9.9 m -74.99 135.04 41.34 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.231 0.539 . . . . 10.0 111.666 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 8.2 mtt180 -117.41 106.48 13.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.662 -0.699 . . . . 10.0 109.431 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 41.7 t -92.23 118.32 37.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.382 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' A' ' 240' ' ' GLN . 0.9 OUTLIER -117.57 105.77 12.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.501 -179.688 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.957 ' HB ' ' HG ' ' A' ' 241' ' ' LEU . 22.7 mm -100.71 89.23 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.632 -0.507 . . . . 10.0 109.632 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 161.66 161.49 11.91 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.505 -0.77 . . . . 10.0 111.897 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -76.76 156.65 32.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.677 0.275 . . . . 10.0 110.759 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.08 152.71 35.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.213 -0.449 . . . . 10.0 110.908 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -137.96 93.11 2.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.521 -0.763 . . . . 10.0 109.718 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.416 ' HA2' ' HB ' ' A' ' 246' ' ' THR . . . -137.02 -93.75 0.34 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.447 -0.882 . . . . 10.0 112.842 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.444 ' HA2' ' HB ' ' B' ' 246' ' ' THR . . . 125.32 -66.85 0.53 Allowed Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.223 -0.751 . . . . 10.0 111.223 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -86.49 93.1 9.07 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.253 -0.647 . . . . 10.0 109.253 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.56 86.82 1.74 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.789 -0.924 . . . . 10.0 110.789 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -58.1 98.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.048 0.388 . . . . 10.0 112.048 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 4.0 t90 59.92 -79.37 0.02 OUTLIER 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.192 0.812 . . . . 10.0 113.192 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -141.39 74.78 1.47 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.317 -0.623 . . . . 10.0 109.317 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -151.78 132.69 14.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.952 -0.567 . . . . 10.0 111.493 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -151.62 97.56 2.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.987 -0.551 . . . . 10.0 109.739 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -113.54 128.86 56.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.912 -0.585 . . . . 10.0 111.187 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -115.38 -23.99 8.61 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.977 -0.556 . . . . 10.0 109.973 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -72.77 138.53 46.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.766 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -142.73 136.1 28.61 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.357 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.296 -0.859 . . . . 10.0 110.059 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.495 ' N ' ' HG1' ' A' ' 260' ' ' THR . 5.1 tmm_? . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 110.016 -0.364 . . . . 10.0 110.016 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.511 ' ND2' ' HA2' ' B' ' 278' ' ' GLY . 74.5 m-20 -123.4 116.53 23.41 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 123.413 0.445 . . . . 10.0 110.179 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 227' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' B' ' 263' ' ' SER . 0.0 OUTLIER -123.32 141.72 51.69 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.047 -0.524 . . . . 10.0 110.72 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.538 ' HB3' HG23 ' A' ' 264' ' ' VAL . . . -133.58 146.3 50.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.787 0.327 . . . . 10.0 111.823 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.746 ' HB2' ' HA ' ' B' ' 265' ' ' GLU . 6.0 mmtt -90.02 -79.98 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.837 0.68 . . . . 10.0 112.837 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.47 123.06 32.67 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.442 0.639 . . . . 10.0 112.094 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.478 HG23 ' HB ' ' B' ' 267' ' ' VAL . 48.6 mt -121.02 125.72 74.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.507 -0.77 . . . . 10.0 110.656 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 232' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' B' ' 232' ' ' ARG . 19.6 mtt180 -117.82 117.64 29.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.641 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 1.2 p -118.93 120.07 36.2 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.819 -0.628 . . . . 10.0 110.834 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -131.0 153.46 49.21 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.084 0.401 . . . . 10.0 112.084 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 64.31 72.71 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.387 0.884 . . . . 10.0 113.387 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 48.6 mtm-85 60.27 24.29 13.71 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.845 0.683 . . . . 10.0 112.845 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -86.58 147.14 26.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.837 0.351 . . . . 10.0 110.871 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -129.73 153.18 48.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.477 -0.329 . . . . 10.0 110.832 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.461 HG23 ' HB ' ' B' ' 275' ' ' VAL . 2.7 p -136.65 137.25 47.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.658 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -126.29 136.4 52.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.021 0.439 . . . . 10.0 110.741 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.476 HD12 ' HB3' ' A' ' 262' ' ' ASN . 0.2 OUTLIER -115.2 93.82 4.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.741 -0.663 . . . . 10.0 110.183 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 164.87 174.58 34.74 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.434 -0.889 . . . . 10.0 112.596 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -87.02 144.36 26.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.703 0.287 . . . . 10.0 110.973 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 48.3 t -102.96 111.26 32.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.523 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 48.3 t -117.76 109.39 27.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.078 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 246' ' ' THR . . . . . 0.444 ' HB ' ' HA2' ' A' ' 283' ' ' GLY . 43.1 p -84.27 171.89 12.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.011 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.23 -11.18 38.25 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.099 -0.5 . . . . 10.0 111.517 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -77.88 -21.48 51.23 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.198 0.523 . . . . 10.0 110.731 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -82.83 -7.83 59.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.786 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 40.1 tp -66.93 133.85 50.82 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.292 -0.633 . . . . 10.0 109.292 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 64.2 m80 66.11 26.56 10.65 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.457 0.473 . . . . 10.0 110.801 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -114.66 169.69 12.97 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.04 -0.6 . . . . 10.0 111.643 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -94.46 79.68 0.93 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.766 -0.73 . . . . 10.0 112.376 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 9.9 mt -79.42 63.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.007 0.432 . . . . 10.0 111.328 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 255' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' B' ' 255' ' ' ARG . 0.3 OUTLIER -168.05 78.22 0.15 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.179 0.514 . . . . 10.0 110.398 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 256' ' ' ILE . . . . . 0.411 HG22 ' HA3' ' C' ' 252' ' ' GLY . 22.6 pt -106.84 38.05 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.547 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 65.78 43.03 3.28 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.634 -0.712 . . . . 10.0 110.362 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -63.74 99.15 0.22 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.152 -0.931 . . . . 10.0 110.616 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -130.49 93.07 3.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.501 -0.772 . . . . 10.0 111.508 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 260' ' ' THR . . . . . 0.637 ' HG1' ' N ' ' C' ' 225' ' ' ARG . 5.4 t -160.24 146.54 15.59 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.886 -0.597 . . . . 10.0 109.932 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.15 121.03 44.01 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.867 -0.606 . . . . 10.0 109.634 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -107.53 122.71 47.21 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.66 -0.496 . . . . 10.0 109.66 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 263' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' B' ' 227' ' ' SER . 65.8 m -146.53 129.99 16.8 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.946 0.403 . . . . 10.0 110.955 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 7.3 p -126.53 142.46 43.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.699 -0.682 . . . . 10.0 109.889 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 265' ' ' GLU . . . . . 0.746 ' HA ' ' HB2' ' B' ' 229' ' ' LYS . 18.3 mt-10 -87.27 -75.04 0.42 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.488 0.551 . . . . 10.0 112.488 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.6 m -108.46 124.65 50.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.41 0.522 . . . . 10.0 112.41 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.478 ' HB ' HG23 ' B' ' 231' ' ' ILE . 3.1 t -122.36 107.51 19.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.763 -0.653 . . . . 10.0 109.94 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.81 118.54 44.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.418 -0.355 . . . . 10.0 111.07 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.48 113.25 2.26 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.312 -0.715 . . . . 10.0 111.312 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -130.39 120.35 24.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.231 0.456 . . . . 10.0 112.231 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 95.5 69.17 1.03 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.618 -0.801 . . . . 10.0 113.412 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 56.86 27.16 12.55 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 112.797 0.665 . . . . 10.0 112.797 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 17.7 m -67.33 156.51 36.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.464 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -128.38 116.06 19.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.686 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.461 ' HB ' HG23 ' B' ' 239' ' ' VAL . 46.0 t -100.64 115.13 41.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.914 -0.584 . . . . 10.0 109.683 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.546 ' HB2' ' CZ2' ' B' ' 287' ' ' TRP . 0.2 OUTLIER -113.17 112.66 24.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.399 -0.364 . . . . 10.0 110.515 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.429 HG22 ' HB3' ' B' ' 226' ' ' ASN . 28.1 mm -105.42 89.05 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.217 0.532 . . . . 10.0 109.659 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 278' ' ' GLY . . . . . 0.511 ' HA2' ' ND2' ' B' ' 226' ' ' ASN . . . 159.93 175.06 30.49 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.594 -0.73 . . . . 10.0 111.603 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 279' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' C' ' 243' ' ' ASN . 16.3 p-10 -93.74 164.87 12.97 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.364 -0.235 . . . . 10.0 110.364 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.1 157.93 36.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.8 0.334 . . . . 10.0 111.317 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.7 71.69 1.36 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.395 -0.82 . . . . 10.0 108.888 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -97.19 -87.99 1.85 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.015 -0.612 . . . . 10.0 112.975 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 113.84 -49.1 0.87 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.765 -0.731 . . . . 10.0 111.861 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -87.71 20.52 2.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.268 0.556 . . . . 10.0 110.45 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 171.57 174.38 39.16 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.493 -1.043 . . . . 10.0 110.493 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -122.57 76.36 1.33 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.028 -0.73 . . . . 10.0 109.028 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.555 ' CH2' ' HB2' ' C' ' 238' ' ' ARG . 15.6 t90 69.82 -59.52 0.5 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.311 -0.859 . . . . 10.0 111.641 -178.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -118.51 -172.48 2.28 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.769 -0.826 . . . . 10.0 108.769 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -101.52 126.69 48.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.224 0.535 . . . . 10.0 112.02 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -155.21 124.95 6.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.894 -0.594 . . . . 10.0 109.923 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 291' ' ' HIS . . . . . 0.609 ' HA ' ' OD1' ' C' ' 289' ' ' ASN . 30.7 t60 -159.74 137.09 9.68 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.519 -0.549 . . . . 10.0 109.519 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -148.42 -167.8 2.91 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 123.148 0.28 . . . . 10.0 110.421 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -104.46 143.15 33.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.784 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -95.19 -173.1 2.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.744 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 4.2 t60 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.905 -1.045 . . . . 10.0 109.178 179.285 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 225' ' ' ARG . . . . . 0.637 ' N ' ' HG1' ' B' ' 260' ' ' THR . 25.4 ttt180 . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 110.253 -0.277 . . . . 10.0 110.253 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 226' ' ' ASN . . . . . 0.407 ' HB3' HG22 ' C' ' 277' ' ' ILE . 29.3 m-80 -127.8 102.9 7.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.015 -0.538 . . . . 10.0 109.812 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.04 133.55 48.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.843 -0.617 . . . . 10.0 111.808 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.438 ' HB1' HD11 ' C' ' 231' ' ' ILE . . . -128.96 129.9 46.03 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.22 -0.659 . . . . 10.0 109.22 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 229' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 5.3 tmtm? -87.55 -81.75 0.23 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.087 0.403 . . . . 10.0 112.087 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -119.06 119.12 33.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.091 0.472 . . . . 10.0 111.872 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.438 HD11 ' HB1' ' C' ' 228' ' ' ALA . 59.3 mt -122.4 133.19 69.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.171 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.522 ' HD3' ' OE1' ' C' ' 234' ' ' GLU . 21.9 ttm-85 -122.97 118.83 28.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.087 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.73 101.54 7.52 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.352 -0.386 . . . . 10.0 110.634 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 234' ' ' GLU . . . . . 0.522 ' OE1' ' HD3' ' C' ' 232' ' ' ARG . 8.0 pt-20 -120.44 156.56 31.19 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.99 0.367 . . . . 10.0 111.99 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 235' ' ' GLU . . . . . 0.473 ' OE2' ' HG3' ' C' ' 270' ' ' LYS . 42.5 mt-10 68.86 68.75 0.28 Allowed 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.966 0.791 . . . . 10.0 111.946 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 57.58 33.18 22.92 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.453 -0.794 . . . . 10.0 112.603 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.29 149.15 22.47 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.864 0.364 . . . . 10.0 110.091 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 238' ' ' ARG . . . . . 0.555 ' HB2' ' CH2' ' B' ' 287' ' ' TRP . 0.3 OUTLIER -133.19 140.75 47.73 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.327 -0.397 . . . . 10.0 110.831 -179.515 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.618 HG23 ' HB ' ' C' ' 275' ' ' VAL . 4.5 p -127.53 138.86 53.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.252 -0.431 . . . . 10.0 111.011 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -123.7 123.94 41.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.974 0.416 . . . . 10.0 110.55 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -103.23 86.72 2.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.353 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.37 -177.78 42.82 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.553 -0.832 . . . . 10.0 112.707 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 243' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' B' ' 279' ' ' ASN . 2.4 p30 -93.63 151.14 19.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.667 0.27 . . . . 10.0 110.577 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 45.9 t -109.0 111.11 34.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.774 0.321 . . . . 10.0 110.617 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 23.7 t -113.94 110.76 33.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.178 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 21.3 p -75.75 161.74 28.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.854 0.359 . . . . 10.0 110.974 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.44 12.78 0.55 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.159 -0.473 . . . . 10.0 112.211 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -109.42 -6.7 15.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.159 0.504 . . . . 10.0 110.135 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -99.72 89.57 4.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.749 -0.659 . . . . 10.0 110.85 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 3.2 mp -118.41 7.08 11.85 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.869 -0.605 . . . . 10.0 111.337 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -93.84 80.66 4.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.217 0.532 . . . . 10.0 109.778 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 252' ' ' GLY . . . . . 0.411 ' HA3' HG22 ' B' ' 256' ' ' ILE . . . -123.65 148.54 16.78 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.438 -0.887 . . . . 10.0 113.188 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -140.77 127.15 3.34 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.118 -1.193 . . . . 10.0 110.118 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 11.9 tt -65.15 109.13 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.395 0.617 . . . . 10.0 112.155 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 -164.5 122.33 1.71 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.482 -0.781 . . . . 10.0 110.574 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 19.1 tt -96.35 137.53 23.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.213 0.53 . . . . 10.0 111.281 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 257' ' ' SER . . . . . 0.551 ' HB2' ' HD3' ' D' ' 255' ' ' ARG . 14.2 m -156.21 -169.6 3.1 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.621 -0.881 . . . . 10.0 108.621 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 258' ' ' ASP . . . . . 0.725 ' HB3' ' HB3' ' D' ' 257' ' ' SER . 0.8 OUTLIER -71.96 163.49 27.77 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.384 -0.228 . . . . 10.0 110.384 179.685 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -153.4 159.45 42.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.744 0.307 . . . . 10.0 111.113 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.17 113.72 15.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.681 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 261' ' ' THR . . . . . 0.602 HG22 ' HB3' ' C' ' 225' ' ' ARG . 0.3 OUTLIER -82.78 143.69 30.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.308 -0.405 . . . . 10.0 110.749 179.726 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -141.84 132.52 25.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.892 0.377 . . . . 10.0 110.683 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 16.7 m -140.97 136.85 32.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.224 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 264' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' D' ' 228' ' ' ALA . 10.3 p -122.81 137.21 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 120.877 0.37 . . . . 10.0 111.145 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 265' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 47.7 mt-10 -79.22 -73.19 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.533 0.568 . . . . 10.0 112.533 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 1.3 m -120.67 123.79 43.63 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.899 0.703 . . . . 10.0 112.899 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.436 ' HB ' HG23 ' C' ' 231' ' ' ILE . 2.8 t -121.06 116.63 50.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.248 -0.649 . . . . 10.0 109.248 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 268' ' ' VAL . . . . . 0.431 ' HB ' ' HG2' ' D' ' 232' ' ' ARG . 59.9 t -114.08 117.15 54.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.898 0.38 . . . . 10.0 111.357 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 269' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -116.09 126.02 6.89 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.762 -0.935 . . . . 10.0 110.762 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 270' ' ' LYS . . . . . 0.473 ' HG3' ' OE2' ' C' ' 235' ' ' GLU . 20.5 ttmm -133.43 125.43 29.02 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.912 0.338 . . . . 10.0 111.912 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 271' ' ' GLY . . . . . 0.46 ' H ' ' HB2' ' C' ' 235' ' ' GLU . . . 80.67 86.87 0.62 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 121.281 -0.485 . . . . 10.0 113.822 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 51.1 37.53 18.33 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.283 0.563 . . . . 10.0 111.699 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 8.0 t -78.29 163.28 25.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.698 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -143.53 121.64 12.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.791 -0.641 . . . . 10.0 110.457 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.618 ' HB ' HG23 ' C' ' 239' ' ' VAL . 33.8 t -111.35 116.56 52.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.152 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' C' ' 276' ' ' LEU . 0.4 OUTLIER -108.03 109.89 21.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.095 0.474 . . . . 10.0 110.472 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.407 HG22 ' HB3' ' C' ' 226' ' ' ASN . 27.1 mm -105.89 91.21 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.409 -0.36 . . . . 10.0 110.448 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 157.66 -174.09 35.05 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.664 -0.779 . . . . 10.0 111.476 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -97.67 149.11 22.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.873 0.336 . . . . 10.0 110.59 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -116.08 142.66 46.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.864 0.364 . . . . 10.0 111.64 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 281' ' ' TYR . . . . . 0.552 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.4 OUTLIER -124.04 96.39 4.92 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.633 -0.876 . . . . 10.0 108.633 178.583 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . -111.18 166.34 12.26 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.848 -0.692 . . . . 10.0 112.935 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -116.51 -51.51 0.38 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.776 -0.726 . . . . 10.0 112.386 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -75.58 -40.82 56.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.434 0.635 . . . . 10.0 109.725 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -165.2 -159.24 11.22 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.715 -0.954 . . . . 10.0 110.715 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -84.11 -173.02 4.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.65 0.225 . . . . 10.0 111.07 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 13.7 t90 -55.0 -33.29 62.44 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.185 0.517 . . . . 10.0 111.386 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -102.28 150.54 23.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.244 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 289' ' ' ASN . . . . . 0.609 ' OD1' ' HA ' ' B' ' 291' ' ' HIS . 4.8 p30 -131.56 54.1 1.95 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.556 0.693 . . . . 10.0 110.38 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -109.37 -18.84 13.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.434 -0.803 . . . . 10.0 111.348 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 291' ' ' HIS . . . . . 0.444 ' HB3' ' OD1' ' D' ' 288' ' ' ASP . 25.3 m80 -138.05 160.17 40.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.588 -0.278 . . . . 10.0 111.113 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 5.0 m170 68.73 175.05 0.28 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.857 0.688 . . . . 10.0 112.857 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 4.3 t60 . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.168 179.452 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 . . . . . 0 N--CA 1.445 -0.714 0 N-CA-C 109.535 -0.542 . . . . 10.0 109.535 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 29.0 m -137.9 124.5 20.9 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.745 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 228' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' C' ' 264' ' ' VAL . . . -116.83 127.72 54.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.159 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 229' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' D' ' 265' ' ' GLU . 30.7 ttmt -86.25 -73.85 0.44 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.347 0.499 . . . . 10.0 112.347 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -120.36 114.78 22.35 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.643 0.238 . . . . 10.0 111.643 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 54.1 mt -122.94 112.7 34.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.808 -0.441 . . . . 10.0 109.808 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 232' ' ' ARG . . . . . 0.431 ' HG2' ' HB ' ' C' ' 268' ' ' VAL . 36.5 mtm180 -113.44 114.79 27.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.385 -0.371 . . . . 10.0 110.446 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 233' ' ' THR . . . . . 0.432 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 0.9 OUTLIER -123.71 113.07 18.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.272 -0.422 . . . . 10.0 111.781 -179.116 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -128.65 169.97 13.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.985 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 67.72 63.4 0.41 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.065 -0.516 . . . . 10.0 111.658 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 60.2 19.69 9.07 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.451 -0.795 . . . . 10.0 112.659 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 237' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' D' ' 233' ' ' THR . . . -71.3 165.45 23.68 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.006 0.373 . . . . 10.0 112.006 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 238' ' ' ARG . . . . . 0.411 ' HG2' ' HG2' ' D' ' 274' ' ' ARG . 0.1 OUTLIER -147.85 143.56 27.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.148 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 239' ' ' VAL . . . . . 0.684 HG23 ' HB ' ' D' ' 275' ' ' VAL . 4.9 p -137.64 141.72 38.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.47 -0.332 . . . . 10.0 111.459 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 240' ' ' GLN . . . . . 0.531 ' HB3' HD22 ' D' ' 276' ' ' LEU . 0.1 OUTLIER -124.93 134.79 52.51 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.313 -0.403 . . . . 10.0 110.783 179.173 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 241' ' ' LEU . . . . . 0.618 HD13 ' HB ' ' D' ' 277' ' ' ILE . 4.0 mm? -118.11 96.11 5.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.949 -0.569 . . . . 10.0 110.394 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 170.81 -105.63 0.22 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.504 -0.855 . . . . 10.0 112.822 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -166.64 158.17 12.97 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.095 -0.335 . . . . 10.0 110.095 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 26.2 t -110.85 108.12 24.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.928 0.394 . . . . 10.0 111.594 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 245' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 28.6 t -107.47 123.44 62.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.558 -0.904 . . . . 10.0 108.558 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 246' ' ' THR . . . . . 0.533 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 34.7 p -104.58 157.83 16.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.89 0.376 . . . . 10.0 111.802 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.44 9.28 1.4 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.806 -0.634 . . . . 10.0 111.298 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -95.9 -6.13 39.91 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.067 -0.716 . . . . 10.0 109.067 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -105.64 113.51 27.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.509 -0.769 . . . . 10.0 109.923 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 87.8 mt -90.39 -175.16 4.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.137 -0.483 . . . . 10.0 111.026 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -78.06 72.2 4.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.207 0.527 . . . . 10.0 111.192 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -145.04 59.63 0.5 Allowed Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.305 -0.718 . . . . 10.0 111.305 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 88.46 41.67 6.04 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 110.957 -0.857 . . . . 10.0 110.957 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 20.3 tt -84.05 -27.25 7.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.122 0.487 . . . . 10.0 110.707 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 255' ' ' ARG . . . . . 0.551 ' HD3' ' HB2' ' C' ' 257' ' ' SER . 57.8 mtt-85 -78.73 77.71 5.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.767 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 19.7 tt -64.89 -19.63 25.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.485 . . . . 10.0 111.274 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 257' ' ' SER . . . . . 0.725 ' HB3' ' HB3' ' C' ' 258' ' ' ASP . 7.5 m 64.94 -134.54 0.24 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.495 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -118.82 112.28 19.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.143 -0.317 . . . . 10.0 110.143 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -110.85 -79.43 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.862 0.319 . . . . 10.0 111.862 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 15.3 t -90.34 157.35 17.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.143 0.496 . . . . 10.0 111.894 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 55.9 m -108.64 111.97 24.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.421 -0.809 . . . . 10.0 109.512 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 262' ' ' ASN . . . . . 0.501 ' HB3' HD23 ' E' ' 241' ' ' LEU . 18.3 m120 -103.08 109.38 20.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.854 0.359 . . . . 10.0 110.255 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 16.4 m -119.29 123.27 43.82 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.273 -0.422 . . . . 10.0 110.506 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 8.8 p -125.42 129.93 72.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.605 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 265' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' D' ' 229' ' ' LYS . 3.3 mt-10 -87.5 -73.96 0.46 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.371 0.878 . . . . 10.0 113.371 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 7.4 m -102.48 122.1 43.66 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.652 0.612 . . . . 10.0 112.652 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.35 117.72 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.199 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 33.0 t -114.25 128.02 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.024 0.44 . . . . 10.0 111.352 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 269' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' E' ' 233' ' ' THR . . . -132.84 109.5 0.84 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.834 -0.621 . . . . 10.0 111.971 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -125.92 106.73 9.85 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.814 0.301 . . . . 10.0 111.814 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 97.84 88.92 1.9 Allowed Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.834 -0.698 . . . . 10.0 114.353 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 54.24 25.43 5.8 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.338 0.866 . . . . 10.0 113.338 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 273' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' E' ' 237' ' ' ALA . 18.9 m -74.75 142.98 44.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.104 0.478 . . . . 10.0 110.998 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 274' ' ' ARG . . . . . 0.411 ' HG2' ' HG2' ' D' ' 238' ' ' ARG . 26.5 mtm180 -128.32 116.47 19.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.756 -0.656 . . . . 10.0 110.83 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 275' ' ' VAL . . . . . 0.684 ' HB ' HG23 ' D' ' 239' ' ' VAL . 23.9 t -101.81 122.76 54.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.705 -0.679 . . . . 10.0 110.173 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 276' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' D' ' 240' ' ' GLN . 0.3 OUTLIER -120.81 101.83 7.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.145 0.498 . . . . 10.0 110.658 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 277' ' ' ILE . . . . . 0.618 ' HB ' HD13 ' D' ' 241' ' ' LEU . 41.7 mm -100.97 104.24 15.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.239 -0.652 . . . . 10.0 109.239 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 278' ' ' GLY . . . . . 0.554 ' O ' ' HA3' ' E' ' 242' ' ' GLY . . . 154.34 -161.32 30.04 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.892 -0.883 . . . . 10.0 110.892 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -120.86 156.94 30.89 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.232 0.516 . . . . 10.0 111.355 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -114.57 131.58 56.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.661 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -129.18 116.37 19.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.18 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 282' ' ' GLY . . . . . 0.533 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 160.27 177.5 33.42 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.182 -1.008 . . . . 10.0 113.46 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -100.74 44.12 1.63 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.974 -0.632 . . . . 10.0 112.709 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -91.18 -18.81 23.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.128 0.489 . . . . 10.0 110.217 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 285' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' D' ' 286' ' ' PHE . . . 99.91 -32.83 6.81 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.643 -0.708 . . . . 10.0 112.419 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 286' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' D' ' 285' ' ' GLY . 3.9 t80 170.13 147.59 0.03 OUTLIER 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.022 -0.733 . . . . 10.0 109.022 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 35.4 t90 -52.5 -67.28 0.26 Allowed 'General case' 0 C--O 1.233 0.23 0 O-C-N 123.558 0.536 . . . . 10.0 109.821 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 288' ' ' ASP . . . . . 0.473 ' OD2' ' HD3' ' E' ' 238' ' ' ARG . 26.8 t0 -150.35 144.77 25.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.088 0.471 . . . . 10.0 111.785 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -163.56 141.89 7.79 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.139 -1.06 . . . . 10.0 108.139 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 290' ' ' HIS . . . . . 0.5 ' HD2' ' HD2' ' D' ' 291' ' ' HIS . 14.5 t60 -63.64 -33.83 76.49 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.073 0.768 . . . . 10.0 113.073 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 291' ' ' HIS . . . . . 0.5 ' HD2' ' HD2' ' D' ' 290' ' ' HIS . 24.9 p80 -166.82 -172.22 2.04 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.984 0.364 . . . . 10.0 111.984 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -99.43 -154.13 0.46 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.654 -0.869 . . . . 10.0 108.654 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -71.34 121.88 19.3 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.047 -0.353 . . . . 10.0 110.047 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -98.38 127.52 44.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.405 -0.361 . . . . 10.0 110.28 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.326 -0.845 . . . . 10.0 110.069 179.758 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' E' E ' 225' ' ' ARG . . . . . 0.603 ' N ' ' HG1' ' E' ' 261' ' ' THR . 79.1 mtt180 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.355 0.121 . . . . 10.0 110.93 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -135.35 121.67 20.38 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.99 0.424 . . . . 10.0 110.805 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.69 128.62 52.04 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.777 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.3 118.21 22.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 229' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' E' ' 265' ' ' GLU . 30.2 mmmt -82.09 -68.49 0.69 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.273 0.472 . . . . 10.0 112.273 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 230' ' ' ASP . . . . . 0.463 ' HB3' HG23 ' E' ' 266' ' ' THR . 8.3 t70 -124.87 125.25 43.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.653 0.263 . . . . 10.0 111.33 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 79.2 mt -128.02 118.35 48.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.023 -0.535 . . . . 10.0 110.82 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -115.39 105.36 12.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.423 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 233' ' ' THR . . . . . 0.426 HG22 ' HB1' ' E' ' 237' ' ' ALA . 0.3 OUTLIER -118.06 104.81 11.22 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.78 -0.645 . . . . 10.0 110.111 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 234' ' ' GLU . . . . . 0.584 ' HB2' ' HG2' ' E' ' 270' ' ' LYS . 36.0 mt-10 -123.26 149.02 45.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.246 0.461 . . . . 10.0 112.246 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 64.08 86.94 0.12 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 114.036 1.124 . . . . 10.0 114.036 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 56.45 29.36 15.17 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.603 -0.726 . . . . 10.0 112.712 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 237' ' ' ALA . . . . . 0.454 ' HB1' ' HB3' ' E' ' 273' ' ' SER . . . -91.9 155.94 17.82 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.912 -0.585 . . . . 10.0 111.336 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 238' ' ' ARG . . . . . 0.473 ' HD3' ' OD2' ' D' ' 288' ' ' ASP . 0.4 OUTLIER -136.82 147.19 46.44 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.081 179.798 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 239' ' ' VAL . . . . . 0.403 HG13 ' HA ' ' D' ' 275' ' ' VAL . 1.6 p -133.01 125.48 51.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.409 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 240' ' ' GLN . . . . . 0.433 HE21 HD12 ' D' ' 276' ' ' LEU . 8.4 tm0? -118.66 128.49 54.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.156 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 241' ' ' LEU . . . . . 0.61 ' HG ' ' HB ' ' E' ' 277' ' ' ILE . 0.1 OUTLIER -123.4 92.94 3.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.538 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 242' ' ' GLY . . . . . 0.573 ' O ' ' HA3' ' E' ' 278' ' ' GLY . . . 170.51 -161.9 34.93 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.681 -0.771 . . . . 10.0 112.274 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -107.26 147.96 29.55 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.809 0.338 . . . . 10.0 110.6 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 63.3 t -108.32 118.52 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.04 -0.527 . . . . 10.0 109.768 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 39.9 t -118.41 112.46 38.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.001 0.429 . . . . 10.0 111.701 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 246' ' ' THR . . . . . 0.864 ' HB ' ' HA2' ' E' ' 282' ' ' GLY . 7.9 t -69.69 167.23 17.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.504 -0.771 . . . . 10.0 110.749 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.46 -17.33 62.6 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.336 -0.393 . . . . 10.0 111.554 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -67.66 -24.76 65.47 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.406 -0.361 . . . . 10.0 110.766 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 57.01 -163.04 0.18 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.572 -0.74 . . . . 10.0 112.46 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 29.7 mt -89.94 125.13 35.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.856 -0.611 . . . . 10.0 109.847 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 10.0 112.045 -179.13 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 3.1 pt . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 112.943 0.72 . . . . 10.0 112.943 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 69.5 m -118.06 139.05 51.79 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -69.03 136.69 52.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.889 0.376 . . . . 10.0 111.194 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -117.93 -48.48 2.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.132 -0.486 . . . . 10.0 110.526 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 4.8 t -78.03 149.8 33.94 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.011 -0.541 . . . . 10.0 110.256 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 261' ' ' THR . . . . . 0.603 ' HG1' ' N ' ' E' ' 225' ' ' ARG . 55.8 m -127.58 113.18 15.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.306 0.574 . . . . 10.0 111.564 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -94.86 102.09 13.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.615 -0.72 . . . . 10.0 109.683 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 10.9 m -114.51 120.11 39.12 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.777 0.322 . . . . 10.0 110.455 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.1 p -114.74 144.5 22.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.229 -0.442 . . . . 10.0 111.169 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 265' ' ' GLU . . . . . 0.535 ' O ' ' HB2' ' E' ' 229' ' ' LYS . 8.1 mm-40 -86.27 -79.28 0.26 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 10.0 111.892 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 266' ' ' THR . . . . . 0.463 HG23 ' HB3' ' E' ' 230' ' ' ASP . 3.6 m -122.16 119.73 32.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.984 0.421 . . . . 10.0 111.797 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 2.7 t -113.53 105.94 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.042 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.18 125.88 68.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 110.01 -0.367 . . . . 10.0 110.01 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -149.83 136.83 5.89 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.702 -0.761 . . . . 10.0 112.123 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 270' ' ' LYS . . . . . 0.584 ' HG2' ' HB2' ' E' ' 234' ' ' GLU . 6.3 mttt -133.64 151.41 51.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.6 0.238 . . . . 10.0 110.837 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 76.3 76.33 0.82 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.086 -0.578 . . . . 10.0 112.513 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 61.32 42.03 12.34 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.998 0.428 . . . . 10.0 111.707 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 273' ' ' SER . . . . . 0.454 ' HB3' ' HB1' ' E' ' 237' ' ' ALA . 9.6 t -64.95 155.04 35.75 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.604 -0.726 . . . . 10.0 111.715 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -136.65 101.68 4.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.351 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 65.7 t -101.45 119.61 49.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.787 0.327 . . . . 10.0 110.182 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.92 114.92 19.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.351 -0.386 . . . . 10.0 110.762 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 277' ' ' ILE . . . . . 0.61 ' HB ' ' HG ' ' E' ' 241' ' ' LEU . 17.2 mm -117.9 84.38 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.799 -0.445 . . . . 10.0 109.799 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 278' ' ' GLY . . . . . 0.573 ' HA3' ' O ' ' E' ' 242' ' ' GLY . . . 178.9 -147.31 7.71 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.494 -0.86 . . . . 10.0 112.485 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.89 146.34 42.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.766 0.317 . . . . 10.0 110.694 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 280' ' ' GLU . . . . . 0.844 ' HB2' ' HA ' ' E' ' 288' ' ' ASP . 3.0 pt-20 -107.82 115.27 29.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.108 0.48 . . . . 10.0 111.156 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -142.8 91.8 2.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.002 -0.544 . . . . 10.0 110.037 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 282' ' ' GLY . . . . . 0.864 ' HA2' ' HB ' ' E' ' 246' ' ' THR . . . -147.86 -95.83 0.16 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.469 -0.872 . . . . 10.0 112.932 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 283' ' ' GLY . . . . . 0.951 ' HA2' ' HB3' ' E' ' 290' ' ' HIS . . . -168.48 -104.71 0.18 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.877 -0.889 . . . . 10.0 110.877 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? 26.24 -85.28 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.396 1.628 . . . . 10.0 115.396 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.96 32.32 0.36 Allowed Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.549 -1.02 . . . . 10.0 110.549 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -161.33 105.51 1.3 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.822 -0.807 . . . . 10.0 108.822 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 75.15 10.7 3.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.896 0.855 . . . . 10.0 109.257 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 288' ' ' ASP . . . . . 0.844 ' HA ' ' HB2' ' E' ' 280' ' ' GLU . 16.8 p-10 -159.83 154.54 24.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.196 -1.366 . . . . 10.0 109.325 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.85 161.86 28.04 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.065 0.394 . . . . 10.0 112.065 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 290' ' ' HIS . . . . . 0.951 ' HB3' ' HA2' ' E' ' 283' ' ' GLY . 4.6 p80 -164.48 167.76 19.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.607 -0.724 . . . . 10.0 109.895 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -106.26 -54.77 2.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.686 0.279 . . . . 10.0 110.679 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 63.28 -164.31 0.25 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.705 -0.679 . . . . 10.0 111.153 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -128.0 125.26 39.07 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.693 -0.484 . . . . 10.0 109.693 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -90.45 133.18 35.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.785 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.09 -0.957 . . . . 10.0 109.714 -179.948 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.759 ' HB3' HG22 ' A' ' 261' ' ' THR . 2.9 tmm_? . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.977 0.418 . . . . 10.0 110.367 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -113.7 111.01 21.11 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.605 -0.887 . . . . 10.0 108.605 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 263' ' ' SER . 0.7 OUTLIER -133.06 144.85 50.28 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.052 0.76 . . . . 10.0 113.052 -178.489 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.41 151.73 47.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.106 -0.952 . . . . 10.0 108.683 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.44 ' HE3' ' HB2' ' A' ' 229' ' ' LYS . 24.1 ttmt -102.75 -61.24 1.42 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.031 0.752 . . . . 10.0 113.031 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.592 ' O ' ' HA ' ' A' ' 266' ' ' THR . 19.9 t0 -131.79 117.24 18.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.06 0.457 . . . . 10.0 111.882 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.553 HG23 ' HB ' ' A' ' 267' ' ' VAL . 56.0 mt -124.05 136.96 58.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.561 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.3 ptp85 -126.29 105.21 8.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.099 0.476 . . . . 10.0 111.662 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.21 120.33 39.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.011 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.517 ' HB2' ' HG2' ' A' ' 270' ' ' LYS . 17.6 mt-10 -132.46 140.45 48.4 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.405 0.52 . . . . 10.0 112.405 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.421 ' OE1' ' HA2' ' A' ' 271' ' ' GLY . 37.9 tt0 65.61 86.01 0.13 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.162 -0.926 . . . . 10.0 113.231 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 96.7 mtm-85 50.66 35.17 11.12 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.361 -0.836 . . . . 10.0 112.738 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.59 146.95 25.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.69 -0.232 . . . . 10.0 110.45 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -124.83 159.29 31.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.562 -0.29 . . . . 10.0 110.413 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.4 p -142.73 126.32 14.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.857 0.36 . . . . 10.0 111.218 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -118.96 139.57 51.45 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.817 -0.438 . . . . 10.0 109.817 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.13 119.43 26.48 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.095 -0.335 . . . . 10.0 110.095 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 152.31 -108.05 0.36 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.751 -0.737 . . . . 10.0 111.967 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -153.85 158.98 41.63 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.864 -0.421 . . . . 10.0 109.864 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 280' ' ' GLU . 18.1 t -110.88 113.19 43.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.126 0.489 . . . . 10.0 112.233 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 57.9 t -101.5 114.22 40.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 5.0 m -106.28 141.79 37.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.241 -0.436 . . . . 10.0 109.933 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.54 -18.15 27.2 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.539 0.57 . . . . 10.0 112.539 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -73.26 -23.49 60.34 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.287 -0.415 . . . . 10.0 111.353 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -110.26 46.19 1.06 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.199 0.523 . . . . 10.0 110.597 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 250' ' ' LEU . 2.2 mm? 66.36 -155.33 0.24 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.254 -0.884 . . . . 10.0 112.112 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -89.46 -175.64 4.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.147 -0.478 . . . . 10.0 110.849 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -76.06 77.91 1.29 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.079 -0.582 . . . . 10.0 112.463 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -67.78 -43.63 83.35 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.26 -0.495 . . . . 10.0 112.086 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 1.3 mp 69.4 136.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 112.779 0.659 . . . . 10.0 112.779 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? 65.83 89.57 0.1 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.499 -0.773 . . . . 10.0 111.977 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 3.5 mp -129.91 -55.38 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.127 -0.488 . . . . 10.0 111.462 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 5.6 p -105.87 -87.91 0.45 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.631 0.604 . . . . 10.0 112.631 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.25 42.95 17.62 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.76 -0.655 . . . . 10.0 111.634 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.414 ' H ' ' HG2' ' A' ' 259' ' ' GLN . 6.8 pt20 -84.45 -21.84 30.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.821 -0.627 . . . . 10.0 111.748 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.419 ' HG1' ' N ' ' B' ' 225' ' ' ARG . 6.6 t -131.97 143.29 49.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.903 0.382 . . . . 10.0 111.119 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 225' ' ' ARG . 0.2 OUTLIER -87.06 144.12 27.02 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.757 -0.656 . . . . 10.0 109.85 179.306 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -122.06 122.96 40.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.818 0.342 . . . . 10.0 110.449 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' B' ' 227' ' ' SER . 0.9 OUTLIER -139.92 134.49 31.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.156 -0.474 . . . . 10.0 110.894 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.8 p -131.43 137.78 54.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.072 0.463 . . . . 10.0 111.342 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.583 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 40.6 tp10 -77.85 -79.25 0.12 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.862 -0.608 . . . . 10.0 112.344 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 230' ' ' ASP . 3.4 p -120.82 128.58 52.99 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.978 0.733 . . . . 10.0 112.978 -178.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.553 ' HB ' HG23 ' A' ' 231' ' ' ILE . 4.2 t -119.31 127.18 75.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.852 -0.613 . . . . 10.0 109.817 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.477 ' HB ' ' HA ' ' B' ' 232' ' ' ARG . 24.8 t -114.73 120.04 63.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.459 -0.337 . . . . 10.0 110.415 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.23 107.66 0.83 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.892 -0.671 . . . . 10.0 111.714 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.517 ' HG2' ' HB2' ' A' ' 234' ' ' GLU . 89.0 mttt -126.36 148.23 49.62 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.428 -0.212 . . . . 10.0 110.428 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' GLY . . . . . 0.421 ' HA2' ' OE1' ' A' ' 235' ' ' GLU . . . 76.84 58.96 3.32 Favored Glycine 0 C--O 1.226 -0.356 0 C-N-CA 120.797 -0.716 . . . . 10.0 113.47 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 62.15 21.29 12.32 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.923 0.712 . . . . 10.0 112.923 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 70.0 m -73.17 139.13 46.12 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.997 0.427 . . . . 10.0 111.202 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 12.5 mtt180 -104.57 123.45 47.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 10.0 111.393 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 46.0 t -102.15 117.32 47.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.087 -0.506 . . . . 10.0 109.912 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.41 114.12 21.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.867 0.365 . . . . 10.0 111.511 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 25.9 mm -107.8 103.02 14.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.842 -0.617 . . . . 10.0 109.693 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.34 142.04 3.91 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.792 -0.718 . . . . 10.0 111.908 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -61.85 149.71 39.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.933 0.397 . . . . 10.0 111.683 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.415 ' HA ' ' HB ' ' A' ' 244' ' ' VAL . 0.0 OUTLIER -109.53 158.17 18.27 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.132 -0.485 . . . . 10.0 111.543 -179.42 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -140.09 101.36 4.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.326 -0.852 . . . . 10.0 109.1 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -150.87 -115.37 0.7 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.517 -0.849 . . . . 10.0 113.055 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 146.6 -60.79 0.47 Allowed Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.225 -0.75 . . . . 10.0 111.225 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.492 ' HE2' ' HB3' ' A' ' 284' ' ' LYS . 20.9 ttpt -79.9 85.37 5.55 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.009 -0.738 . . . . 10.0 109.009 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 289' ' ' ASN . . . 95.45 105.43 2.07 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.67 -0.972 . . . . 10.0 110.67 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -75.71 76.24 2.69 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.402 -0.221 . . . . 10.0 110.402 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 18.2 t90 69.38 -58.4 0.51 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.9 -0.591 . . . . 10.0 112.098 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -135.21 90.53 2.63 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.064 -0.717 . . . . 10.0 109.064 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ASN . . . . . 0.428 ' HB3' ' HA2' ' A' ' 285' ' ' GLY . 25.1 t-20 -150.34 119.79 6.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.781 0.324 . . . . 10.0 111.631 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -157.93 55.25 0.47 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.398 0.618 . . . . 10.0 109.972 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -105.5 121.56 44.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.644 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -123.24 2.36 9.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.16 0.505 . . . . 10.0 110.797 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -84.01 116.19 22.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.521 -0.763 . . . . 10.0 109.974 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -89.41 127.26 35.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.133 0.492 . . . . 10.0 111.081 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' HIS . . . . . 0.686 ' HE1' ' H ' ' B' ' 291' ' ' HIS . 1.1 p80 . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.355 -0.831 . . . . 10.0 110.711 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.447 ' HB3' HG22 ' B' ' 261' ' ' THR . 14.7 ttm180 . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.201 -0.296 . . . . 10.0 110.201 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -119.13 114.04 21.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.538 -0.542 . . . . 10.0 109.538 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 227' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' B' ' 263' ' ' SER . 3.4 m -129.3 134.1 47.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.011 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.459 ' CA ' ' HAK' ' B' ' 1' ' ' CGO . . . -130.71 143.38 50.7 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.695 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.586 ' HB3' ' O ' ' B' ' 265' ' ' GLU . 12.8 tptm -89.99 -79.57 0.34 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.344 -0.389 . . . . 10.0 111.723 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 230' ' ' ASP . . . . . 0.44 ' CG ' HH21 ' B' ' 232' ' ' ARG . 18.8 t70 -122.56 126.08 47.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.311 0.577 . . . . 10.0 112.498 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.403 HG23 ' HB ' ' B' ' 267' ' ' VAL . 65.6 mt -122.76 114.66 43.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.563 -0.744 . . . . 10.0 109.053 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 232' ' ' ARG . . . . . 0.477 ' HA ' ' HB ' ' A' ' 268' ' ' VAL . 1.7 ttm180 -109.87 106.78 16.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.926 0.393 . . . . 10.0 110.66 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.624 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 0.8 OUTLIER -118.08 128.69 55.0 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.13 -0.486 . . . . 10.0 111.106 -179.266 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -141.26 168.23 20.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.535 -0.302 . . . . 10.0 111.373 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.487 ' OE1' ' HG2' ' B' ' 270' ' ' LYS . 34.8 mt-10 65.34 62.65 0.68 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.89 -0.595 . . . . 10.0 111.777 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 81.8 mtm-85 57.05 44.91 21.88 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.924 -0.58 . . . . 10.0 112.227 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.624 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -90.08 163.43 14.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.865 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -134.09 122.31 22.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.097 0.475 . . . . 10.0 110.362 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 p -115.86 125.61 73.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.312 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -119.79 128.24 53.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.849 -0.614 . . . . 10.0 111.089 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.35 97.51 6.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.027 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 156.18 169.15 20.03 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.909 -0.663 . . . . 10.0 112.186 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -87.95 137.86 31.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.831 0.348 . . . . 10.0 110.84 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 94.0 t -91.16 123.28 43.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.969 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 17.7 t -121.96 102.29 11.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.41 0.624 . . . . 10.0 110.493 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 68.4 p -81.57 162.8 23.0 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.661 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.412 ' HA ' ' HG ' ' B' ' 250' ' ' LEU . . . -61.95 -14.15 32.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.104 0.478 . . . . 10.0 111.254 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -75.95 -14.83 60.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.692 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -95.44 -2.16 49.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 10.0 111.111 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.412 ' HG ' ' HA ' ' B' ' 247' ' ' ALA . 87.9 mt -76.17 140.35 41.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.334 -0.394 . . . . 10.0 110.385 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 65.97 28.51 10.51 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 123.597 0.56 . . . . 10.0 110.862 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -131.11 174.22 20.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.055 -0.593 . . . . 10.0 111.714 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -83.08 115.83 4.1 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.131 -0.557 . . . . 10.0 112.478 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 29.5 pt -109.71 17.97 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.026 0.441 . . . . 10.0 111.672 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 255' ' ' ARG . . . . . 0.49 ' HA ' HH11 ' B' ' 255' ' ' ARG . 0.0 OUTLIER -129.03 103.82 7.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.27 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 20.1 pt -132.18 35.73 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 111.866 0.321 . . . . 10.0 111.866 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 62.3 m 64.29 33.53 11.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.326 0.584 . . . . 10.0 111.466 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.428 ' CG ' HH12 ' B' ' 255' ' ' ARG . 0.7 OUTLIER -77.79 71.43 4.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.465 -0.789 . . . . 10.0 111.902 -179.582 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -96.15 113.8 25.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.024 -0.535 . . . . 10.0 109.777 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 14.7 t -158.82 141.76 14.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.551 0.691 . . . . 10.0 111.961 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 261' ' ' THR . . . . . 0.521 ' O ' ' HD2' ' C' ' 225' ' ' ARG . 0.0 OUTLIER -110.14 95.96 5.92 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.298 -0.864 . . . . 10.0 108.813 178.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -91.37 132.21 36.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.386 -0.37 . . . . 10.0 110.66 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 263' ' ' SER . . . . . 0.621 ' HB2' ' CAL' ' B' ' 1' ' ' CGO . 1.9 p -145.52 136.05 24.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.656 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.52 ' N ' ' HAL' ' B' ' 1' ' ' CGO . 8.0 p -124.56 131.53 72.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.884 -0.598 . . . . 10.0 110.103 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 265' ' ' GLU . . . . . 0.586 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 17.3 tp10 -73.14 -62.74 1.36 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.333 0.494 . . . . 10.0 112.333 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' B' ' 230' ' ' ASP . 24.8 m -135.46 124.44 24.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.147 0.499 . . . . 10.0 112.087 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.442 HG22 HG21 ' B' ' 264' ' ' VAL . 20.7 t -111.33 118.95 58.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.736 -0.665 . . . . 10.0 109.356 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 268' ' ' VAL . . . . . 0.464 ' HB ' ' HA ' ' C' ' 232' ' ' ARG . 39.9 t -103.88 116.73 48.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.904 0.383 . . . . 10.0 110.829 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.75 113.34 2.35 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.395 -0.682 . . . . 10.0 111.395 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.487 ' HG2' ' OE1' ' B' ' 235' ' ' GLU . 2.4 ttpp -128.76 131.05 47.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.665 0.269 . . . . 10.0 111.456 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 271' ' ' GLY . . . . . 0.464 ' H ' ' HB2' ' B' ' 235' ' ' GLU . . . 78.47 71.94 1.2 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.571 -0.823 . . . . 10.0 113.479 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 53.05 43.8 31.22 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.386 0.884 . . . . 10.0 113.386 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.61 149.73 34.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.236 0.541 . . . . 10.0 111.552 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 274' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 38.3 mtt180 -120.0 118.7 31.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.652 -0.704 . . . . 10.0 110.024 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 47.4 t -110.11 127.17 67.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.138 -0.483 . . . . 10.0 111.062 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.51 ' HB2' ' CZ2' ' B' ' 287' ' ' TRP . 0.7 OUTLIER -123.83 109.61 13.84 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.857 -0.423 . . . . 10.0 109.857 179.269 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 36.4 mm -102.25 100.37 10.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.993 -0.373 . . . . 10.0 109.993 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.41 176.54 19.45 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.685 -0.566 . . . . 10.0 111.685 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -97.99 156.63 16.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.9 0.35 . . . . 10.0 110.576 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 280' ' ' GLU . . . . . 0.417 ' OE2' ' HB2' ' B' ' 287' ' ' TRP . 8.1 pt-20 -128.83 161.47 29.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.912 0.386 . . . . 10.0 111.422 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.431 ' HE1' ' HA ' ' C' ' 247' ' ' ALA . 2.7 t80 -134.33 127.04 30.92 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.546 -0.752 . . . . 10.0 109.852 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 282' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' C' ' 246' ' ' THR . . . 167.74 152.34 7.47 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.774 -0.727 . . . . 10.0 112.04 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -123.97 8.38 8.64 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.509 -0.853 . . . . 10.0 111.982 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -97.67 15.17 24.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.055 0.455 . . . . 10.0 110.863 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 156.93 -176.44 34.19 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.218 -0.753 . . . . 10.0 111.218 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -127.29 64.09 1.33 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.389 -0.597 . . . . 10.0 109.389 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.638 ' CZ3' ' HB2' ' C' ' 238' ' ' ARG . 17.3 t90 70.46 -54.21 0.64 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.948 0.78 . . . . 10.0 111.42 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 288' ' ' ASP . . . . . 0.447 ' CG ' HH11 ' C' ' 238' ' ' ARG . 3.0 t70 -109.13 -168.52 1.35 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.688 -0.687 . . . . 10.0 109.617 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -111.42 132.71 54.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.058 0.456 . . . . 10.0 111.689 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.41 125.08 6.44 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 291' ' ' HIS . . . . . 0.686 ' H ' ' HE1' ' A' ' 295' ' ' HIS . 0.5 OUTLIER -160.91 143.4 12.62 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.121 -0.326 . . . . 10.0 110.121 -179.077 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -173.69 -161.99 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.398 -0.364 . . . . 10.0 110.462 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -122.41 149.0 44.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.613 -0.267 . . . . 10.0 111.105 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -83.85 -179.16 7.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.709 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 . . . . . 0 C--O 1.252 1.186 0 CA-C-O 117.909 -1.044 . . . . 10.0 108.852 -179.699 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 225' ' ' ARG . . . . . 0.706 ' N ' ' HG1' ' C' ' 261' ' ' THR . 1.7 ptt-85 . . . . . 0 N--CA 1.483 1.175 0 N-CA-C 110.21 -0.293 . . . . 10.0 110.21 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 226' ' ' ASN . . . . . 0.539 ' HB3' HG22 ' C' ' 277' ' ' ILE . 4.2 m120 -131.26 129.06 41.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.349 . . . . 10.0 110.661 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 227' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' C' ' 263' ' ' SER . 0.3 OUTLIER -133.07 135.46 45.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.166 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.12 138.33 45.16 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.964 -0.384 . . . . 10.0 109.964 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 229' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 18.6 tttm -94.2 -78.65 0.43 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.07 0.396 . . . . 10.0 112.07 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -109.81 116.25 31.32 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.301 0.482 . . . . 10.0 112.301 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 63.4 mt -123.93 117.45 51.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.087 -0.506 . . . . 10.0 110.101 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.533 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 9.3 ttm180 -109.26 120.69 43.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.888 0.375 . . . . 10.0 111.074 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.96 112.85 16.41 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.907 -0.775 . . . . 10.0 108.907 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 234' ' ' GLU . . . . . 0.533 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 11.5 pt-20 -138.08 161.07 37.72 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.347 0.499 . . . . 10.0 112.347 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 64.73 69.89 0.49 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.883 -1.053 . . . . 10.0 110.943 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 55.58 63.14 2.16 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.845 -1.071 . . . . 10.0 110.449 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -118.47 167.67 11.38 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.766 -0.652 . . . . 10.0 110.442 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 238' ' ' ARG . . . . . 0.638 ' HB2' ' CZ3' ' B' ' 287' ' ' TRP . 0.0 OUTLIER -153.24 141.6 20.64 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.602 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.666 HG23 ' HB ' ' C' ' 275' ' ' VAL . 5.7 p -125.13 132.81 70.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.499 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.434 ' HB3' HD22 ' C' ' 276' ' ' LEU . 4.0 tm0? -106.72 122.62 46.72 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.592 -0.731 . . . . 10.0 109.122 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.62 69.72 0.7 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.519 -0.309 . . . . 10.0 111.442 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 175.51 -169.5 42.29 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.409 -0.901 . . . . 10.0 112.228 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -95.66 144.93 25.67 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.265 -0.272 . . . . 10.0 110.265 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.96 105.99 19.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.295 -0.411 . . . . 10.0 110.363 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.66 118.71 53.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.254 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 246' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' B' ' 282' ' ' GLY . 32.2 p -76.98 163.86 26.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.069 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 247' ' ' ALA . . . . . 0.431 ' HA ' ' HE1' ' B' ' 281' ' ' TYR . . . -72.89 16.05 0.17 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.685 0.624 . . . . 10.0 112.685 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -121.39 0.67 10.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.067 0.461 . . . . 10.0 109.921 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -109.71 67.14 0.64 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.143 0.497 . . . . 10.0 110.576 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.31 25.84 9.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.059 -0.519 . . . . 10.0 111.295 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -113.99 67.76 0.68 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.36 0.6 . . . . 10.0 111.559 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -140.08 143.04 13.15 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.942 -0.863 . . . . 10.0 110.942 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -95.57 -145.8 19.6 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.113 -1.041 . . . . 10.0 111.833 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 6.9 tp -132.52 110.55 16.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.255 0.55 . . . . 10.0 110.475 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 42.6 ttt85 -158.26 140.5 14.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.782 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 9.6 tt -102.93 134.95 42.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 121.448 0.642 . . . . 10.0 111.587 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 57.9 m -159.73 -170.74 3.01 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.526 -0.761 . . . . 10.0 109.16 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.1 155.42 36.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.789 0.328 . . . . 10.0 111.419 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.02 132.84 12.32 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.247 -0.649 . . . . 10.0 109.247 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 260' ' ' THR . . . . . 0.5 ' HA ' ' OD1' ' D' ' 258' ' ' ASP . 3.7 t -68.39 154.14 42.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.328 0.585 . . . . 10.0 112.043 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 261' ' ' THR . . . . . 0.706 ' HG1' ' N ' ' C' ' 225' ' ' ARG . 52.8 m -123.44 120.61 33.46 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.451 -0.795 . . . . 10.0 110.23 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 262' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' D' ' 226' ' ' ASN . 29.5 t-20 -107.64 125.98 52.01 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.113 -0.699 . . . . 10.0 109.113 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 263' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' C' ' 227' ' ' SER . 13.4 m -136.37 131.72 34.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.016 0.436 . . . . 10.0 110.87 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 6.9 p -118.77 139.19 46.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.335 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 265' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' D' ' 229' ' ' LYS . 43.2 mt-10 -74.75 -58.59 3.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.199 -0.455 . . . . 10.0 112.046 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 2.7 m -136.51 133.98 37.08 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.386 0.513 . . . . 10.0 112.386 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 24.9 t -123.73 116.72 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.469 -0.937 . . . . 10.0 108.469 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 6.5 t -113.9 108.74 26.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 120.94 0.4 . . . . 10.0 110.906 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 269' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -119.55 125.02 6.17 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.907 -0.877 . . . . 10.0 110.907 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 270' ' ' LYS . . . . . 0.505 ' HG3' ' HG3' ' C' ' 234' ' ' GLU . 45.4 tttm -133.22 117.77 17.8 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.933 0.345 . . . . 10.0 111.933 -178.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 90.33 91.39 1.27 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.885 -0.674 . . . . 10.0 113.122 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 59.25 36.24 23.63 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.94 0.4 . . . . 10.0 111.688 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.85 145.67 42.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.837 -0.62 . . . . 10.0 112.447 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -139.14 109.58 6.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.714 -0.675 . . . . 10.0 110.483 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.666 ' HB ' HG23 ' C' ' 239' ' ' VAL . 22.0 t -102.68 132.74 48.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.052 -0.522 . . . . 10.0 110.651 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.434 HD22 ' HB3' ' C' ' 240' ' ' GLN . 0.2 OUTLIER -121.75 106.31 11.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.685 0.278 . . . . 10.0 110.812 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.539 HG22 ' HB3' ' C' ' 226' ' ' ASN . 23.2 mm -101.69 85.98 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.312 0.577 . . . . 10.0 110.063 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 160.83 -170.33 36.69 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.541 -0.754 . . . . 10.0 111.219 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -102.67 154.94 18.66 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.202 -0.587 . . . . 10.0 110.967 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -108.4 142.67 38.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.321 -0.399 . . . . 10.0 110.407 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 281' ' ' TYR . . . . . 0.559 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.3 OUTLIER -136.34 97.09 3.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.157 -0.474 . . . . 10.0 109.728 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . -145.96 158.87 27.82 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.861 -0.685 . . . . 10.0 112.781 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -106.5 -15.07 18.25 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.706 -0.759 . . . . 10.0 112.51 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -74.17 -38.59 63.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.275 0.56 . . . . 10.0 110.285 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 170.65 -112.39 0.45 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.147 -1.181 . . . . 10.0 110.147 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -126.08 -169.9 2.09 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.72 -0.474 . . . . 10.0 109.72 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -57.97 -24.3 57.48 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.272 0.558 . . . . 10.0 111.545 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -110.72 157.08 20.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.943 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 289' ' ' ASN . . . . . 0.413 ' OD1' ' HA ' ' B' ' 291' ' ' HIS . 7.5 p30 -133.85 19.84 3.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.151 0.5 . . . . 10.0 111.307 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 290' ' ' HIS . . . . . 0.666 ' HB3' ' NH2' ' D' ' 274' ' ' ARG . 5.2 t-80 -81.15 -10.13 59.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.706 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.52 168.37 22.1 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.305 0.483 . . . . 10.0 112.305 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 66.51 174.04 0.24 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.5 -0.773 . . . . 10.0 112.646 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 293' ' ' HIS . . . . . 0.454 ' HB3' ' H ' ' C' ' 294' ' ' HIS . 0.1 OUTLIER -155.85 -145.46 0.16 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.351 0.5 . . . . 10.0 112.351 -179.47 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 294' ' ' HIS . . . . . 0.454 ' H ' ' HB3' ' C' ' 293' ' ' HIS . 20.1 t-80 -68.6 -83.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.923 0.712 . . . . 10.0 112.923 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.08 0 N-CA-C 109.106 -0.702 . . . . 10.0 109.106 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 225' ' ' ARG . . . . . 0.487 ' HG3' HG23 ' D' ' 261' ' ' THR . 3.1 mpt_? . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.84 0.352 . . . . 10.0 111.367 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 226' ' ' ASN . . . . . 0.493 ' O ' ' HA ' ' C' ' 262' ' ' ASN . 18.8 m-80 -63.77 123.01 17.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.995 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 1.8 m -146.42 153.46 40.5 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.277 -0.42 . . . . 10.0 110.764 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.29 148.74 46.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.624 0.249 . . . . 10.0 110.922 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 229' ' ' LYS . . . . . 0.653 ' HB2' ' HA ' ' D' ' 265' ' ' GLU . 17.5 mttt -89.67 -77.78 0.38 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.393 -0.367 . . . . 10.0 111.045 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -125.13 120.18 30.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.923 0.392 . . . . 10.0 110.913 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 62.1 mt -118.69 124.28 72.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.908 -0.587 . . . . 10.0 110.541 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 232' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' D' ' 232' ' ' ARG . 6.1 mtm105 -108.5 127.87 54.3 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.882 -0.599 . . . . 10.0 109.786 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 233' ' ' THR . . . . . 0.502 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 0.7 OUTLIER -131.77 111.56 11.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.356 -0.384 . . . . 10.0 110.079 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -124.57 154.56 40.46 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.68 0.622 . . . . 10.0 112.68 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 58.15 78.42 0.25 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 114.996 -1.002 . . . . 10.0 113.365 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 52.82 50.62 17.65 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.237 -0.892 . . . . 10.0 111.783 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 237' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' D' ' 233' ' ' THR . . . -104.97 154.86 19.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.187 -0.461 . . . . 10.0 110.423 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.05 144.68 43.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.885 0.374 . . . . 10.0 110.912 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 239' ' ' VAL . . . . . 0.664 HG23 ' HB ' ' D' ' 275' ' ' VAL . 7.6 p -126.96 131.26 71.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.556 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -113.28 121.7 45.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.353 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 241' ' ' LEU . . . . . 0.416 HD23 HD13 ' C' ' 277' ' ' ILE . 2.6 mm? -116.06 93.49 4.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.941 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 174.64 -120.2 0.77 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.229 -0.986 . . . . 10.0 112.791 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -152.56 152.95 32.47 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.734 -0.469 . . . . 10.0 109.734 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 244' ' ' VAL . . . . . 0.517 HG11 ' HD1' ' D' ' 287' ' ' TRP . 22.6 t -97.12 106.37 18.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.163 -0.471 . . . . 10.0 111.873 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 245' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 21.2 t -110.16 93.48 2.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.278 -0.638 . . . . 10.0 109.278 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 246' ' ' THR . . . . . 0.428 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 41.6 p -74.16 153.54 39.47 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.821 -0.351 . . . . 10.0 110.387 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 247' ' ' ALA . . . . . 0.442 ' HA ' ' HE1' ' C' ' 281' ' ' TYR . . . -73.29 11.63 0.72 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.826 0.346 . . . . 10.0 111.731 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -95.7 -3.99 45.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.25 0.548 . . . . 10.0 109.653 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -99.61 137.13 38.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.692 -0.686 . . . . 10.0 110.168 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 250' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' D' ' 250' ' ' LEU . 6.9 tp -118.24 -157.38 0.68 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.626 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -91.15 63.88 5.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.038 0.447 . . . . 10.0 111.338 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -132.28 36.67 2.15 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 111.063 -0.815 . . . . 10.0 111.063 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 107.52 52.35 0.72 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.418 -0.673 . . . . 10.0 111.418 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 20.1 tt -87.48 -20.89 7.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.953 0.406 . . . . 10.0 110.87 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -83.97 70.18 10.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.02 0.438 . . . . 10.0 110.794 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 18.1 tt -64.25 -30.2 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.751 -0.659 . . . . 10.0 111.851 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 7.3 m 66.18 -172.8 0.19 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.924 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 258' ' ' ASP . . . . . 0.5 ' OD1' ' HA ' ' C' ' 260' ' ' THR . 4.0 m-20 -80.92 93.94 6.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.911 0.386 . . . . 10.0 110.557 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -94.59 -44.05 8.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.12 -0.491 . . . . 10.0 111.431 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 10.3 t -123.25 150.36 43.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.921 0.391 . . . . 10.0 111.003 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 261' ' ' THR . . . . . 0.487 HG23 ' HG3' ' D' ' 225' ' ' ARG . 5.5 m -104.46 103.69 13.43 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.415 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 262' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' D' ' 226' ' ' ASN . 2.6 m120 -102.64 110.23 22.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.206 -0.452 . . . . 10.0 109.869 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 25.8 m -124.81 131.9 53.4 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.942 0.401 . . . . 10.0 111.047 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 264' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' E' ' 228' ' ' ALA . 11.3 p -126.95 138.13 55.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.141 -0.481 . . . . 10.0 110.375 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 265' ' ' GLU . . . . . 0.653 ' HA ' ' HB2' ' D' ' 229' ' ' LYS . 19.8 mt-10 -86.55 -73.02 0.48 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.784 0.661 . . . . 10.0 112.784 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.55 125.8 52.23 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.716 0.635 . . . . 10.0 112.716 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 4.2 t -127.82 113.88 32.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.247 -0.649 . . . . 10.0 109.247 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 268' ' ' VAL . . . . . 0.68 ' HB ' ' HG2' ' E' ' 232' ' ' ARG . 42.0 t -116.2 113.1 42.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 120.685 0.279 . . . . 10.0 110.976 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.55 137.09 9.44 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.001 -0.619 . . . . 10.0 112.11 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.23 135.8 19.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.638 -0.331 . . . . 10.0 111.122 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.63 89.75 0.23 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.15 -0.547 . . . . 10.0 112.861 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 59.48 38.31 22.61 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.033 0.444 . . . . 10.0 111.444 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 1.5 t -87.56 143.99 26.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.086 -0.506 . . . . 10.0 111.358 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 274' ' ' ARG . . . . . 0.666 ' NH2' ' HB3' ' C' ' 290' ' ' HIS . 72.0 mtt85 -131.5 110.53 11.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.408 -0.815 . . . . 10.0 109.712 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 275' ' ' VAL . . . . . 0.664 ' HB ' HG23 ' D' ' 239' ' ' VAL . 36.2 t -101.33 105.35 17.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.994 -0.373 . . . . 10.0 109.994 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 276' ' ' LEU . . . . . 0.548 HD12 ' HG2' ' E' ' 240' ' ' GLN . 2.1 tm? -107.42 103.59 12.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.929 0.395 . . . . 10.0 110.628 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 42.9 mm -105.03 96.81 4.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.216 -0.447 . . . . 10.0 109.819 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 158.28 178.84 32.69 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.508 -0.637 . . . . 10.0 111.508 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -96.0 156.95 16.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.61 0.243 . . . . 10.0 110.395 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 280' ' ' GLU . . . . . 0.516 ' HA ' ' HB ' ' D' ' 244' ' ' VAL . 6.0 pt-20 -118.44 131.23 56.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.843 0.354 . . . . 10.0 110.926 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -122.01 123.23 41.14 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.045 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 282' ' ' GLY . . . . . 0.428 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 155.53 178.68 30.0 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.378 -0.915 . . . . 10.0 112.796 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -108.59 32.77 6.68 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.945 -0.645 . . . . 10.0 112.156 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.19 -9.15 59.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.897 0.379 . . . . 10.0 110.748 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.25 -51.51 1.41 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.076 -0.583 . . . . 10.0 111.709 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -171.42 145.95 2.19 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.831 -0.803 . . . . 10.0 108.831 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 287' ' ' TRP . . . . . 0.517 ' HD1' HG11 ' D' ' 244' ' ' VAL . 11.5 t90 -56.07 -64.06 0.98 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.041 0.448 . . . . 10.0 110.383 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 288' ' ' ASP . . . . . 0.418 ' CG ' ' HE ' ' E' ' 238' ' ' ARG . 29.6 t0 -136.29 132.33 35.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.3 0.572 . . . . 10.0 110.473 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -171.85 146.64 2.08 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -69.57 -58.96 3.3 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.849 0.685 . . . . 10.0 112.849 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -161.08 -163.04 0.97 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.826 0.306 . . . . 10.0 111.826 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -86.06 -170.49 3.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.891 -0.595 . . . . 10.0 109.819 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -72.76 117.78 14.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.012 0.434 . . . . 10.0 110.987 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -99.07 148.11 24.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.86 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 117.764 -1.112 . . . . 10.0 108.392 178.888 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 225' ' ' ARG . . . . . 0.517 ' N ' ' HG1' ' E' ' 261' ' ' THR . 57.9 mtt180 . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 110.283 -0.265 . . . . 10.0 110.283 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -128.5 121.33 28.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.369 . . . . 10.0 110.998 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 227' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' E' ' 263' ' ' SER . 0.6 OUTLIER -123.0 144.46 49.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.718 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 228' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' D' ' 264' ' ' VAL . . . -139.62 125.83 20.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.29 -0.413 . . . . 10.0 109.938 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 229' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' D' ' 265' ' ' GLU . 33.5 mttm -84.0 -62.59 1.53 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.05 0.759 . . . . 10.0 113.05 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 230' ' ' ASP . . . . . 0.733 ' HB3' HG23 ' E' ' 266' ' ' THR . 8.9 t0 -130.85 125.4 33.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.779 0.323 . . . . 10.0 111.142 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 86.5 mt -133.59 123.97 47.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.042 -0.526 . . . . 10.0 110.306 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 232' ' ' ARG . . . . . 0.68 ' HG2' ' HB ' ' D' ' 268' ' ' VAL . 7.5 mtt180 -122.23 120.35 33.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.143 -0.481 . . . . 10.0 110.538 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 1.2 p -130.45 93.78 3.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.518 -0.764 . . . . 10.0 110.295 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 234' ' ' GLU . . . . . 0.631 ' HB2' ' HE3' ' E' ' 270' ' ' LYS . 36.1 mt-10 -119.29 152.11 37.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.334 -0.393 . . . . 10.0 111.0 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 70.72 77.22 0.19 Allowed 'General case' 0 C--O 1.236 0.362 0 O-C-N 123.912 0.757 . . . . 10.0 112.335 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 33.1 mtp180 60.67 24.43 14.23 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.078 -0.965 . . . . 10.0 112.246 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -103.47 150.93 23.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.197 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 238' ' ' ARG . . . . . 0.419 ' HB3' ' HB2' ' D' ' 274' ' ' ARG . 0.0 OUTLIER -144.55 164.57 30.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.201 -0.454 . . . . 10.0 111.777 -179.203 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 239' ' ' VAL . . . . . 0.743 HG23 ' HB ' ' E' ' 275' ' ' VAL . 7.7 p -134.63 142.58 40.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.767 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 240' ' ' GLN . . . . . 0.548 ' HG2' HD12 ' D' ' 276' ' ' LEU . 25.5 tm0? -129.89 131.44 46.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.796 -0.638 . . . . 10.0 109.313 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 241' ' ' LEU . . . . . 0.469 ' HG ' ' HB ' ' E' ' 277' ' ' ILE . 0.4 OUTLIER -128.98 95.35 4.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.075 0.464 . . . . 10.0 111.786 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 166.32 170.76 31.64 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.435 -0.666 . . . . 10.0 111.435 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -88.14 147.59 24.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.827 0.346 . . . . 10.0 110.924 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.15 125.15 49.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.561 -0.533 . . . . 10.0 109.561 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.9 98.51 7.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.002 0.43 . . . . 10.0 109.86 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 246' ' ' THR . . . . . 0.449 ' HB ' ' HA2' ' E' ' 282' ' ' GLY . 14.7 t -60.93 161.92 7.62 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.729 -0.669 . . . . 10.0 111.578 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.09 -19.38 64.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.29 -0.414 . . . . 10.0 111.805 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -74.49 -23.47 58.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.536 -0.302 . . . . 10.0 110.242 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 58.07 -170.28 0.11 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.384 -0.826 . . . . 10.0 112.199 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 6.8 mp -83.99 115.66 22.44 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.234 -0.654 . . . . 10.0 109.234 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -80.42 1.32 29.63 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.019 0.378 . . . . 10.0 112.019 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -177.75 152.95 12.36 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.697 -0.561 . . . . 10.0 111.697 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 111.93 107.81 2.95 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.652 -0.785 . . . . 10.0 112.673 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 36.3 mt -96.3 -22.15 5.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.252 0.549 . . . . 10.0 109.951 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -82.56 58.89 4.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.813 -0.63 . . . . 10.0 110.71 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 15.3 pt -67.8 119.05 12.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.056 -0.52 . . . . 10.0 111.42 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.24 159.24 8.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.919 -0.582 . . . . 10.0 109.833 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.83 140.75 32.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.835 0.35 . . . . 10.0 110.225 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -114.11 -65.91 1.14 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.056 0.455 . . . . 10.0 111.113 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 15.3 t -71.46 146.31 48.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.278 0.561 . . . . 10.0 111.868 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 261' ' ' THR . . . . . 0.517 ' HG1' ' N ' ' E' ' 225' ' ' ARG . 91.8 m -123.8 110.05 14.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.566 -0.743 . . . . 10.0 109.624 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -111.08 130.76 55.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.84 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 263' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' E' ' 227' ' ' SER . 25.1 m -132.66 120.97 22.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.169 -0.469 . . . . 10.0 109.871 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 7.9 p -98.39 143.59 12.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.418 -0.355 . . . . 10.0 110.393 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -76.79 -75.89 0.18 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.358 -0.383 . . . . 10.0 111.895 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 266' ' ' THR . . . . . 0.733 HG23 ' HB3' ' E' ' 230' ' ' ASP . 7.7 m -139.81 120.22 14.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.968 0.414 . . . . 10.0 111.14 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 15.1 t -106.4 115.6 48.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.587 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 42.2 t -116.41 97.73 5.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.514 -0.55 . . . . 10.0 109.514 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.89 119.6 4.2 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.864 -0.684 . . . . 10.0 112.08 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 270' ' ' LYS . . . . . 0.631 ' HE3' ' HB2' ' E' ' 234' ' ' GLU . 15.5 mtpt -132.04 133.32 44.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.525 0.202 . . . . 10.0 110.644 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.75 73.91 1.17 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.747 -0.739 . . . . 10.0 112.696 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 62.92 25.05 14.88 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.023 0.749 . . . . 10.0 113.023 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 4.6 m -79.06 157.77 27.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.206 0.527 . . . . 10.0 111.352 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -142.18 126.15 17.24 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.556 -0.747 . . . . 10.0 109.752 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 275' ' ' VAL . . . . . 0.743 ' HB ' HG23 ' E' ' 239' ' ' VAL . 18.8 t -102.63 117.64 48.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.448 -0.342 . . . . 10.0 110.142 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 276' ' ' LEU . . . . . 0.445 HD22 ' HB3' ' E' ' 240' ' ' GLN . 0.2 OUTLIER -109.9 103.27 12.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.267 -0.424 . . . . 10.0 110.315 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 277' ' ' ILE . . . . . 0.469 ' HB ' ' HG ' ' E' ' 241' ' ' LEU . 37.7 mm -116.52 91.82 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.102 0.477 . . . . 10.0 110.538 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 173.91 -164.59 36.04 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.932 -0.867 . . . . 10.0 110.932 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -95.45 126.76 40.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.722 0.261 . . . . 10.0 110.49 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 280' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' E' ' 280' ' ' GLU . 3.4 pm0 -88.41 127.77 35.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.258 0.552 . . . . 10.0 111.77 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -161.99 77.12 0.5 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.847 -0.615 . . . . 10.0 109.961 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 282' ' ' GLY . . . . . 0.449 ' HA2' ' HB ' ' E' ' 246' ' ' THR . . . -112.92 -82.11 1.14 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.862 -0.685 . . . . 10.0 112.499 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 283' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' E' ' 290' ' ' HIS . . . 135.15 39.85 0.17 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.638 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.21 -63.98 1.21 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.949 0.351 . . . . 10.0 111.949 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 135.84 28.28 0.4 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.318 -0.944 . . . . 10.0 113.293 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -150.68 105.43 3.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.188 -0.671 . . . . 10.0 109.188 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER 68.26 18.03 9.25 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.892 0.853 . . . . 10.0 108.92 -177.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.2 170.48 21.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.938 -1.483 . . . . 10.0 108.098 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -155.37 165.44 36.61 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 121.237 -0.185 . . . . 10.0 110.654 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 290' ' ' HIS . . . . . 0.592 ' HB3' ' HA2' ' E' ' 283' ' ' GLY . 7.0 p80 -160.24 164.35 32.8 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -81.5 -68.27 0.71 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.304 -0.158 . . . . 10.0 110.699 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 3.8 t60 69.71 171.5 0.3 Allowed 'General case' 0 CA--C 1.533 0.29 0 O-C-N 123.737 0.648 . . . . 10.0 111.862 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -101.32 116.88 33.8 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.971 -0.558 . . . . 10.0 110.138 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -103.02 127.16 50.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.934 -0.575 . . . . 10.0 110.219 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.834 0 CA-C-O 118.34 -0.838 . . . . 10.0 109.334 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' CGO . . . . . 0.741 ' HBT' ' OAU' ' B' ' 1' ' ' CGO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 225' ' ' ARG . 35.5 ttt180 . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.569 0.223 . . . . 10.0 110.585 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -121.82 120.15 33.74 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.352 -0.61 . . . . 10.0 109.352 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 60.6 m -137.29 135.89 37.53 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.589 0.588 . . . . 10.0 112.589 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.48 129.55 43.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.517 -0.765 . . . . 10.0 109.101 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -89.86 -72.47 0.56 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.526 0.565 . . . . 10.0 112.526 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 266' ' ' THR . 41.3 t0 -113.32 120.48 41.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.08 0.467 . . . . 10.0 111.369 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.425 HD12 HG11 ' A' ' 239' ' ' VAL . 8.2 pt -129.18 127.68 65.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.753 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.423 ' HG3' ' HA ' ' A' ' 268' ' ' VAL . 3.6 ptp85 -129.54 125.56 36.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.918 0.389 . . . . 10.0 111.341 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.35 108.49 10.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.231 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.4 ' HB2' ' HD3' ' A' ' 270' ' ' LYS . 5.2 mt-10 -114.57 141.62 47.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 10.0 112.164 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 64.82 93.74 0.06 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 114.189 1.181 . . . . 10.0 114.189 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 50.33 35.12 10.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.564 -0.743 . . . . 10.0 112.94 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -108.8 159.39 16.82 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.201 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -150.4 156.12 40.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.143 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.425 HG11 HD12 ' A' ' 231' ' ' ILE . 4.1 p -136.53 133.45 49.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.164 -0.471 . . . . 10.0 111.107 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -121.29 148.21 44.62 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.772 -0.455 . . . . 10.0 109.772 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 tt -124.99 129.34 50.13 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.068 -0.345 . . . . 10.0 110.068 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.675 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 135.85 -146.68 18.67 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.938 -0.648 . . . . 10.0 112.207 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -121.98 151.46 40.76 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 48.2 t -120.57 101.11 10.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.22 0.533 . . . . 10.0 111.331 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 65.3 t -92.89 115.83 32.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.176 -0.676 . . . . 10.0 109.176 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 43.9 p -82.63 171.05 14.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.741 0.305 . . . . 10.0 111.0 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -71.38 -6.65 41.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.123 0.487 . . . . 10.0 110.958 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -95.51 7.48 46.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.192 0.52 . . . . 10.0 110.14 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -115.2 32.18 6.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.416 -0.811 . . . . 10.0 109.977 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 250' ' ' LEU . 2.9 mm? 69.62 -85.13 0.03 OUTLIER 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.161 -0.927 . . . . 10.0 112.893 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -148.46 166.58 27.73 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.843 0.354 . . . . 10.0 111.495 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -78.69 69.77 2.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.115 -0.564 . . . . 10.0 112.056 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -76.28 -43.79 19.52 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 121.155 -0.545 . . . . 10.0 112.043 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 64.3 mt 71.41 146.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 123.005 0.522 . . . . 10.0 111.331 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? 70.48 80.33 0.17 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.501 0.667 . . . . 10.0 111.746 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 3.9 mp -114.09 -46.61 4.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.508 -0.769 . . . . 10.0 110.005 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.44 -65.06 0.78 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.901 -0.59 . . . . 10.0 110.234 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 55.95 31.93 18.85 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.992 -0.549 . . . . 10.0 112.157 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -91.07 12.51 19.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.641 -0.709 . . . . 10.0 112.328 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 15.1 t -117.4 143.38 46.05 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.564 0.697 . . . . 10.0 112.674 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.564 ' HB ' ' HG3' ' B' ' 225' ' ' ARG . 0.6 OUTLIER -114.0 101.23 9.05 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.226 -1.027 . . . . 10.0 108.226 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.446 ' ND2' ' HA2' ' B' ' 242' ' ' GLY . 52.2 m-20 -98.52 127.19 44.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.053 -0.521 . . . . 10.0 110.428 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' B' ' 227' ' ' SER . 0.3 OUTLIER -138.02 123.08 19.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.848 -0.615 . . . . 10.0 110.983 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.451 HG21 HG22 ' A' ' 267' ' ' VAL . 14.8 p -123.65 133.82 68.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.287 0.565 . . . . 10.0 111.57 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.583 ' HB3' ' HA ' ' B' ' 229' ' ' LYS . 37.3 tp10 -79.6 -70.88 0.48 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.569 -0.742 . . . . 10.0 112.175 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 230' ' ' ASP . 3.2 m -129.81 126.92 39.21 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.101 0.477 . . . . 10.0 112.105 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.451 HG22 HG21 ' A' ' 264' ' ' VAL . 3.6 t -117.09 126.64 74.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.979 -0.555 . . . . 10.0 109.64 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.451 ' HB ' ' HA ' ' B' ' 232' ' ' ARG . 41.9 t -117.73 122.59 70.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.85 0.357 . . . . 10.0 111.474 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.52 119.62 3.89 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.218 -1.153 . . . . 10.0 110.218 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.4 ' HD3' ' HB2' ' A' ' 234' ' ' GLU . 2.0 tppt? -126.43 110.58 13.47 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.439 0.533 . . . . 10.0 112.439 -178.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.53 91.7 0.77 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.945 -0.645 . . . . 10.0 114.198 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' B' ' 236' ' ' ARG . 38.6 mt-10 51.92 44.06 29.74 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.721 0.637 . . . . 10.0 112.721 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.9 m -96.45 132.58 41.85 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.121 0.486 . . . . 10.0 110.689 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -107.2 114.25 28.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.065 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 30.0 t -105.36 123.12 59.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.508 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.94 108.51 15.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.15 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.496 ' HA ' ' HB2' ' B' ' 241' ' ' LEU . 25.1 mm -93.13 90.4 2.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.768 -0.456 . . . . 10.0 109.768 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.675 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 152.34 -172.52 31.54 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.972 -0.558 . . . . 10.0 112.041 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -101.47 161.24 13.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.077 0.465 . . . . 10.0 111.089 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.99 175.09 7.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.985 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -139.31 67.14 1.39 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.495 -0.775 . . . . 10.0 109.272 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -81.98 115.19 3.97 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.67 -0.695 . . . . 10.0 113.611 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -101.97 -28.78 6.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.824 -0.703 . . . . 10.0 111.854 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -89.8 -45.67 9.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.327 0.584 . . . . 10.0 109.764 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -163.33 156.53 28.35 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.472 -1.051 . . . . 10.0 110.472 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -67.5 112.38 4.64 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 109.549 -0.538 . . . . 10.0 109.549 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 2.3 t90 65.92 -80.38 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 O-C-N 123.797 0.686 . . . . 10.0 110.693 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -162.61 28.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.743 0.782 . . . . 10.0 109.353 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -74.84 117.34 16.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.572 -0.74 . . . . 10.0 111.458 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 -129.06 105.08 7.95 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.919 0.39 . . . . 10.0 110.4 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -115.12 141.68 47.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.673 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -121.4 -53.75 2.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.045 0.45 . . . . 10.0 110.998 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -71.74 142.34 49.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.749 -0.659 . . . . 10.0 110.511 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -143.69 147.35 34.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.347 -0.388 . . . . 10.0 110.427 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 2.7 p80 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.089 -0.958 . . . . 10.0 110.465 179.717 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.564 ' HG3' ' HB ' ' A' ' 261' ' ' THR . 22.9 ttm180 . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 109.845 -0.428 . . . . 10.0 109.845 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -117.59 116.25 26.72 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.522 -0.548 . . . . 10.0 109.522 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 227' ' ' SER . . . . . 0.561 ' C ' ' HAK' ' B' ' 1' ' ' CGO . 18.5 m -130.15 136.91 49.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.894 0.378 . . . . 10.0 111.018 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.76 148.34 52.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.599 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.583 ' HA ' ' HB3' ' A' ' 265' ' ' GLU . 56.8 tttp -102.84 -80.52 0.51 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 112.855 0.687 . . . . 10.0 112.855 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -112.66 115.0 27.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.778 0.323 . . . . 10.0 111.665 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.42 HG21 HG21 ' B' ' 239' ' ' VAL . 62.2 mt -120.14 111.07 30.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.349 -0.612 . . . . 10.0 109.349 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 232' ' ' ARG . . . . . 0.451 ' HA ' ' HB ' ' A' ' 268' ' ' VAL . 12.0 mtt180 -109.93 107.68 17.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.064 0.459 . . . . 10.0 111.387 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 0.6 OUTLIER -115.51 122.31 45.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.629 -0.714 . . . . 10.0 110.727 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -130.83 155.52 46.57 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 112.403 0.52 . . . . 10.0 112.403 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 65.31 77.04 0.32 Allowed 'General case' 0 C--O 1.232 0.136 0 N-CA-C 113.914 1.079 . . . . 10.0 113.914 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 236' ' ' ARG . . . . . 0.611 ' HB2' ' HG2' ' B' ' 272' ' ' GLU . 44.2 mtm-85 56.13 26.72 10.53 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.55 -0.75 . . . . 10.0 112.824 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.466 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -79.49 151.88 30.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.991 0.424 . . . . 10.0 110.806 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.81 133.02 49.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.968 -0.56 . . . . 10.0 110.789 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.603 HG23 ' HB ' ' B' ' 275' ' ' VAL . 4.2 p -130.71 137.43 56.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.09 -0.504 . . . . 10.0 110.976 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -125.22 130.06 51.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.978 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 277' ' ' ILE . 4.0 mm? -103.24 73.01 1.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.731 -0.668 . . . . 10.0 110.42 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 242' ' ' GLY . . . . . 0.446 ' HA2' ' ND2' ' A' ' 262' ' ' ASN . . . -179.41 -178.59 48.45 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.315 -0.945 . . . . 10.0 112.824 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.58 157.58 15.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.662 0.268 . . . . 10.0 110.355 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 56.6 t -104.36 123.95 58.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.084 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 16.9 t -122.02 100.25 8.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.297 -0.631 . . . . 10.0 109.297 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 29.8 p -80.59 170.09 16.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.399 -0.364 . . . . 10.0 110.885 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.29 -10.05 52.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.066 -0.516 . . . . 10.0 111.599 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -79.24 -17.36 54.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.83 0.347 . . . . 10.0 110.681 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -88.48 -0.61 57.39 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.776 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 44.6 tp -72.65 117.0 13.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.707 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 50.2 m80 67.98 76.69 0.26 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.298 -0.864 . . . . 10.0 111.24 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -171.24 -166.08 29.52 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.663 -0.699 . . . . 10.0 111.705 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -87.6 109.55 3.49 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.817 -0.706 . . . . 10.0 111.87 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 26.2 pt -101.98 13.72 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.992 0.425 . . . . 10.0 111.207 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 12.0 tpt85 -141.37 104.68 4.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.036 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 256' ' ' ILE . . . . . 0.862 ' HA ' ' HA3' ' C' ' 252' ' ' GLY . 10.4 pt -107.0 29.04 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.711 0.291 . . . . 10.0 111.172 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.7 t 64.39 28.54 13.64 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.7 0.762 . . . . 10.0 110.198 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -74.88 139.8 43.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.928 -1.033 . . . . 10.0 111.054 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 19.9 tm0? -152.2 106.52 3.17 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.742 -0.663 . . . . 10.0 109.917 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 6.3 t -162.07 163.02 28.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.373 -0.376 . . . . 10.0 111.017 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.24 122.45 37.79 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.836 -0.62 . . . . 10.0 109.456 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -103.85 111.31 23.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.975 0.417 . . . . 10.0 109.918 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 263' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' B' ' 227' ' ' SER . 9.8 m -131.51 119.17 21.17 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.163 0.506 . . . . 10.0 111.118 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 12.3 p -115.15 135.25 55.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.865 -0.607 . . . . 10.0 109.978 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 265' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 44.8 tt0 -82.65 -73.15 0.41 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.575 0.583 . . . . 10.0 112.575 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.6 125.83 53.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.889 0.376 . . . . 10.0 111.948 -178.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 2.3 t -124.18 121.68 62.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.864 -0.607 . . . . 10.0 109.584 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 47.6 t -112.63 118.61 58.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.765 0.317 . . . . 10.0 111.079 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.79 113.82 2.28 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 111.288 -0.725 . . . . 10.0 111.288 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -127.92 132.1 49.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.646 0.26 . . . . 10.0 111.074 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.81 66.9 1.44 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.922 -0.656 . . . . 10.0 112.358 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 272' ' ' GLU . . . . . 0.611 ' HG2' ' HB2' ' B' ' 236' ' ' ARG . 28.9 mt-10 53.43 46.89 25.31 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.819 0.674 . . . . 10.0 112.819 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 6.4 t -77.53 167.16 22.08 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.247 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -135.49 117.46 15.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.099 -0.5 . . . . 10.0 110.017 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.603 ' HB ' HG23 ' B' ' 239' ' ' VAL . 34.5 t -112.11 119.51 60.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.087 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.95 113.59 22.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.961 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 23.1 mm -104.25 86.93 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.101 0.476 . . . . 10.0 109.847 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 158.46 168.62 20.92 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.871 -0.891 . . . . 10.0 110.871 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -88.33 167.39 13.57 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.31 0.555 . . . . 10.0 111.235 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.49 167.2 19.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.151 0.5 . . . . 10.0 111.672 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -147.7 78.77 1.47 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.42 -0.809 . . . . 10.0 108.954 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -94.43 -111.4 2.33 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.832 -0.699 . . . . 10.0 112.865 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 132.27 -36.3 2.21 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.713 -0.756 . . . . 10.0 111.379 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -101.82 23.8 10.83 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 165.06 -175.97 40.86 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.516 -1.434 . . . . 10.0 109.516 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -131.11 65.79 1.55 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 117.068 0.434 . . . . 10.0 109.859 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 26.6 t90 71.26 -47.28 0.66 Allowed 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.836 0.71 . . . . 10.0 111.872 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -116.0 -169.92 1.69 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.791 -0.641 . . . . 10.0 109.31 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -118.3 126.06 51.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.333 0.587 . . . . 10.0 111.849 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -156.47 123.6 5.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.461 -0.791 . . . . 10.0 109.359 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -155.55 138.05 15.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.509 -0.314 . . . . 10.0 110.691 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -168.58 -176.61 2.84 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.512 -0.551 . . . . 10.0 109.512 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -105.76 159.38 16.04 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.678 0.275 . . . . 10.0 110.608 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -91.49 -164.45 1.18 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.013 0.435 . . . . 10.0 111.317 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.067 -0.968 . . . . 10.0 109.63 179.91 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.681 0.277 . . . . 10.0 110.962 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 226' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' C' ' 262' ' ' ASN . 2.2 m120 -132.19 113.99 13.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 16.5 m -124.67 141.58 52.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.102 0.477 . . . . 10.0 111.905 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.9 139.54 52.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.636 -0.711 . . . . 10.0 110.512 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 229' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' B' ' 265' ' ' GLU . 2.4 tmtm? -84.96 -69.11 0.67 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.121 -0.491 . . . . 10.0 111.912 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -129.4 117.0 19.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.915 0.388 . . . . 10.0 111.658 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.404 HG21 HG21 ' C' ' 239' ' ' VAL . 70.2 mt -120.14 120.6 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.138 -0.483 . . . . 10.0 109.749 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.584 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 15.1 ttm-85 -116.21 115.54 26.17 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.215 -0.448 . . . . 10.0 111.269 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.53 99.0 6.09 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.248 0.546 . . . . 10.0 110.88 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 234' ' ' GLU . . . . . 0.584 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 8.8 pt-20 -121.22 170.99 9.04 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.004 -0.543 . . . . 10.0 110.557 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 235' ' ' GLU . . . . . 0.451 ' HB3' ' H ' ' C' ' 271' ' ' GLY . 0.8 OUTLIER 67.87 59.18 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.841 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 10.4 mtp180 63.29 16.79 9.74 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.026 0.75 . . . . 10.0 113.026 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -77.38 176.69 8.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.869 0.366 . . . . 10.0 111.171 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.09 152.05 20.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.203 -0.453 . . . . 10.0 110.747 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.738 HG23 ' HB ' ' C' ' 275' ' ' VAL . 8.2 p -131.92 140.35 48.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.052 0.453 . . . . 10.0 111.428 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -117.14 121.81 42.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.855 -0.611 . . . . 10.0 110.175 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.533 HD13 ' HB ' ' C' ' 277' ' ' ILE . 3.7 mm? -106.44 86.23 2.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.62 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.28 -173.09 43.65 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.341 -0.933 . . . . 10.0 112.816 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -97.99 145.82 26.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.72 0.295 . . . . 10.0 110.656 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 36.8 t -106.87 103.64 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.087 0.47 . . . . 10.0 110.868 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 19.9 t -111.58 112.37 40.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.014 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 34.2 p -82.34 160.94 22.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.426 -0.352 . . . . 10.0 111.145 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.0 5.39 1.17 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.249 0.463 . . . . 10.0 112.249 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -96.48 3.4 52.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.196 -0.457 . . . . 10.0 109.826 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -116.03 84.66 2.15 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.906 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 84.8 mt -95.85 -9.73 30.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.596 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -84.0 110.78 18.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.701 -0.681 . . . . 10.0 109.69 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 252' ' ' GLY . . . . . 0.862 ' HA3' ' HA ' ' B' ' 256' ' ' ILE . . . -144.2 -90.14 0.11 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.51 -0.852 . . . . 10.0 112.786 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 100.66 -156.23 19.35 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.686 -0.769 . . . . 10.0 111.608 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 8.0 tt -147.99 104.23 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.281 0.562 . . . . 10.0 111.304 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -157.43 137.49 12.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.965 -0.561 . . . . 10.0 109.931 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 15.3 tt -103.57 133.87 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.034 0.445 . . . . 10.0 110.813 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 41.1 m -155.96 179.66 9.0 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.404 -0.591 . . . . 10.0 109.404 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 258' ' ' ASP . . . . . 0.553 ' HB3' ' HB3' ' D' ' 257' ' ' SER . 25.8 t0 -72.84 167.13 21.57 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.714 -0.221 . . . . 10.0 110.868 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -158.93 152.98 23.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.606 -0.27 . . . . 10.0 110.521 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 260' ' ' THR . . . . . 0.703 ' HG1' ' N ' ' D' ' 225' ' ' ARG . 6.8 t -64.98 132.27 48.81 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.238 0.542 . . . . 10.0 111.152 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 32.5 m -92.36 126.29 37.38 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.001 -0.545 . . . . 10.0 109.759 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 262' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' D' ' 226' ' ' ASN . 1.8 m-80 -118.9 123.76 45.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.688 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 263' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' D' ' 227' ' ' SER . 14.2 m -141.75 142.3 33.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.079 -0.509 . . . . 10.0 110.244 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 264' ' ' VAL . . . . . 0.522 HG23 ' HB3' ' D' ' 228' ' ' ALA . 8.8 p -133.51 144.13 36.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.066 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 265' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' D' ' 229' ' ' LYS . 43.1 mt-10 -83.19 -75.92 0.3 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.291 0.478 . . . . 10.0 112.291 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 24.3 m -113.52 127.61 56.15 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.125 0.787 . . . . 10.0 113.125 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.92 109.31 20.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.357 -0.838 . . . . 10.0 108.958 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 268' ' ' VAL . . . . . 0.561 ' HB ' ' HG2' ' D' ' 232' ' ' ARG . 37.1 t -107.41 125.99 63.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.025 0.44 . . . . 10.0 110.864 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 269' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -134.04 120.93 2.6 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.885 -0.598 . . . . 10.0 112.022 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -138.53 124.65 20.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.141 0.496 . . . . 10.0 111.2 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 271' ' ' GLY . . . . . 0.451 ' H ' ' HB3' ' C' ' 235' ' ' GLU . . . 97.25 74.96 1.21 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.83 -0.7 . . . . 10.0 113.101 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 59.06 22.36 10.41 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.665 0.617 . . . . 10.0 112.665 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 16.0 m -69.55 149.61 48.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.085 0.469 . . . . 10.0 111.916 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 274' ' ' ARG . . . . . 0.46 ' HB3' ' CZ3' ' C' ' 287' ' ' TRP . 2.3 mtm180 -132.37 122.29 24.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.171 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.738 ' HB ' HG23 ' C' ' 239' ' ' VAL . 41.3 t -108.91 129.61 63.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.742 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.409 HD12 HE21 ' D' ' 240' ' ' GLN . 1.8 tm? -121.31 110.51 16.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.289 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.533 ' HB ' HD13 ' C' ' 241' ' ' LEU . 30.5 mm -107.93 94.14 2.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.135 0.493 . . . . 10.0 110.316 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 160.28 -160.08 31.38 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.565 -0.614 . . . . 10.0 111.565 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -115.53 150.49 36.49 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.315 -0.254 . . . . 10.0 110.315 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -119.29 145.23 46.3 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.075 0.464 . . . . 10.0 112.166 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 281' ' ' TYR . . . . . 0.523 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.3 OUTLIER -127.63 98.59 5.26 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.373 -0.831 . . . . 10.0 108.943 179.363 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 282' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' D' ' 246' ' ' THR . . . -145.55 159.93 28.0 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.546 -0.835 . . . . 10.0 112.757 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -106.95 -30.86 4.07 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.748 -0.739 . . . . 10.0 112.894 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -59.72 -45.09 93.22 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.922 0.391 . . . . 10.0 111.036 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 173.47 -128.2 1.46 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.642 -0.983 . . . . 10.0 110.642 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -110.12 -166.18 1.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.209 -0.293 . . . . 10.0 110.209 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.46 ' CZ3' ' HB3' ' C' ' 274' ' ' ARG . 0.8 OUTLIER -54.4 -30.11 51.16 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.156 0.798 . . . . 10.0 113.156 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.83 157.28 31.44 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 122.336 -0.227 . . . . 10.0 110.718 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -123.83 30.4 6.18 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.36 0.504 . . . . 10.0 112.36 -178.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 290' ' ' HIS . . . . . 0.719 ' HB3' ' NH2' ' D' ' 274' ' ' ARG . 1.5 t-80 -85.7 -17.67 35.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.454 -0.339 . . . . 10.0 110.942 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.67 153.68 51.5 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.995 -0.441 . . . . 10.0 111.619 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.86 179.23 0.16 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 123.654 0.596 . . . . 10.0 110.875 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 293' ' ' HIS . . . . . 0.43 ' HB3' ' H ' ' C' ' 294' ' ' HIS . 0.2 OUTLIER -165.27 -99.72 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 113.992 1.108 . . . . 10.0 113.992 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 294' ' ' HIS . . . . . 0.43 ' H ' ' HB3' ' C' ' 293' ' ' HIS . 8.0 t-160 -100.73 -88.64 0.36 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.612 0.597 . . . . 10.0 112.612 -177.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 3.7 t60 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.428 -0.796 . . . . 10.0 111.269 -177.969 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 225' ' ' ARG . . . . . 0.703 ' N ' ' HG1' ' C' ' 260' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 110.15 -0.315 . . . . 10.0 110.15 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 226' ' ' ASN . . . . . 0.632 ' HB3' HG22 ' D' ' 277' ' ' ILE . 52.1 m-80 -127.84 111.44 13.62 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.859 -0.423 . . . . 10.0 109.859 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 227' ' ' SER . . . . . 0.621 ' HB2' ' NBD' ' B' ' 1' ' ' CGO . 0.0 OUTLIER -129.02 140.72 51.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.985 0.422 . . . . 10.0 111.668 -178.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 228' ' ' ALA . . . . . 0.522 ' HB3' HG23 ' C' ' 264' ' ' VAL . . . -130.01 147.48 51.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.135 -0.484 . . . . 10.0 110.509 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 229' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' C' ' 265' ' ' GLU . 39.2 ttmt -92.79 -72.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.259 -0.428 . . . . 10.0 111.743 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -126.26 117.19 22.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.668 0.271 . . . . 10.0 111.321 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 63.5 mt -121.93 123.62 69.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.096 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 232' ' ' ARG . . . . . 0.561 ' HG2' ' HB ' ' C' ' 268' ' ' VAL . 26.0 mtm180 -120.22 113.94 21.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.15 0.5 . . . . 10.0 110.662 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 233' ' ' THR . . . . . 0.42 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 1.7 p -117.31 111.75 19.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.749 -0.659 . . . . 10.0 110.278 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -124.89 151.54 45.22 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.143 0.423 . . . . 10.0 112.143 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 235' ' ' GLU . . . . . 0.406 ' OE2' ' HE3' ' D' ' 270' ' ' LYS . 46.2 mt-10 65.01 79.19 0.26 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.975 1.102 . . . . 10.0 113.975 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 58.57 19.44 6.65 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.259 -0.882 . . . . 10.0 113.344 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -81.74 162.23 23.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.857 0.361 . . . . 10.0 111.24 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 238' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' D' ' 238' ' ' ARG . 0.1 OUTLIER -141.39 147.76 38.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.061 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 239' ' ' VAL . . . . . 0.464 HG13 HG13 ' C' ' 275' ' ' VAL . 1.9 p -128.81 127.44 66.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.138 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 240' ' ' GLN . . . . . 0.409 HE21 HD12 ' C' ' 276' ' ' LEU . 8.6 tm0? -113.47 126.79 55.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.623 -0.717 . . . . 10.0 109.211 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.97 97.98 5.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.406 -0.361 . . . . 10.0 110.593 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 164.15 -108.48 0.33 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.517 -0.849 . . . . 10.0 112.778 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -163.8 153.14 14.32 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.678 0.275 . . . . 10.0 110.388 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 t -112.24 106.26 20.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.801 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 245' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 52.6 t -104.55 112.89 39.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 246' ' ' THR . . . . . 0.508 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 81.6 p -80.33 150.77 29.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.09 0.471 . . . . 10.0 111.694 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 247' ' ' ALA . . . . . 0.426 ' HA ' ' HE1' ' C' ' 281' ' ' TYR . . . -74.58 8.06 2.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.928 -0.578 . . . . 10.0 111.39 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -101.33 -8.48 22.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.934 -0.575 . . . . 10.0 109.796 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -91.3 110.11 21.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.058 -0.519 . . . . 10.0 109.731 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.79 163.06 24.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.387 0.613 . . . . 10.0 111.707 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -84.25 63.24 7.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.725 -0.671 . . . . 10.0 112.192 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -131.66 59.08 0.69 Allowed Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 110.405 -1.078 . . . . 10.0 110.405 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 109.71 20.54 7.63 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.27 -1.132 . . . . 10.0 110.27 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 254' ' ' ILE . . . . . 0.43 HD11 HG11 ' D' ' 245' ' ' VAL . 16.6 tt -67.1 -30.8 50.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.851 -0.674 . . . . 10.0 111.425 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -80.05 71.37 6.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.059 0.456 . . . . 10.0 110.874 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 256' ' ' ILE . . . . . 0.411 ' HB ' ' HE2' ' D' ' 281' ' ' TYR . 20.0 tt -65.04 -19.26 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.669 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 257' ' ' SER . . . . . 0.553 ' HB3' ' HB3' ' C' ' 258' ' ' ASP . 4.4 m 66.35 -96.02 0.04 OUTLIER 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.664 -0.698 . . . . 10.0 111.783 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 258' ' ' ASP . . . . . 0.454 ' OD2' ' HD3' ' D' ' 225' ' ' ARG . 2.5 t0 -149.19 172.27 15.1 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.411 -0.589 . . . . 10.0 109.411 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -169.27 -74.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.91 0.386 . . . . 10.0 110.581 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 13.5 t -96.17 162.46 13.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.352 0.596 . . . . 10.0 110.838 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 261' ' ' THR . . . . . 0.513 HG23 ' HB3' ' D' ' 225' ' ' ARG . 12.8 m -116.9 111.98 20.4 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.055 -0.52 . . . . 10.0 109.872 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -97.25 105.49 17.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.024 -0.535 . . . . 10.0 109.961 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 24.1 m -115.59 118.54 33.42 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.591 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 264' ' ' VAL . . . . . 0.519 HG23 ' HB3' ' E' ' 228' ' ' ALA . 11.4 p -121.83 137.27 55.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.947 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 265' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' E' ' 229' ' ' LYS . 22.5 mt-10 -84.68 -83.61 0.16 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.919 0.711 . . . . 10.0 112.919 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.69 122.75 46.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.298 0.851 . . . . 10.0 113.298 -177.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 43.7 t -121.16 114.5 43.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.233 -0.654 . . . . 10.0 109.233 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 16.9 t -111.54 119.87 60.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.816 0.341 . . . . 10.0 111.403 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 269' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' E' ' 233' ' ' THR . . . -123.8 125.93 6.02 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.336 -0.705 . . . . 10.0 111.336 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 270' ' ' LYS . . . . . 0.406 ' HE3' ' OE2' ' D' ' 235' ' ' GLU . 19.3 tptt -134.4 108.71 8.32 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.825 0.306 . . . . 10.0 111.825 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.92 102.38 0.64 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 114.698 0.639 . . . . 10.0 114.698 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 51.69 36.17 16.87 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.561 0.578 . . . . 10.0 112.561 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 273' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' E' ' 237' ' ' ALA . 4.0 m -85.25 139.2 31.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.162 0.506 . . . . 10.0 111.853 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 274' ' ' ARG . . . . . 0.719 ' NH2' ' HB3' ' C' ' 290' ' ' HIS . 81.2 mtt85 -118.94 113.24 20.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.558 -0.746 . . . . 10.0 110.273 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 46.0 t -102.49 113.45 39.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.357 -0.608 . . . . 10.0 109.357 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 276' ' ' LEU . . . . . 0.408 HD12 ' HG2' ' E' ' 240' ' ' GLN . 1.7 tm? -117.39 97.57 5.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.171 0.51 . . . . 10.0 110.867 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 277' ' ' ILE . . . . . 0.632 HG22 ' HB3' ' D' ' 226' ' ' ASN . 44.1 mm -102.0 91.91 2.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.645 -0.872 . . . . 10.0 108.645 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 278' ' ' GLY . . . . . 0.426 ' O ' ' HA3' ' E' ' 242' ' ' GLY . . . 166.17 -163.01 36.53 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.639 -0.709 . . . . 10.0 111.564 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -120.41 156.02 32.26 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.73 -0.277 . . . . 10.0 110.922 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -114.62 136.02 53.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.218 -0.447 . . . . 10.0 110.621 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 281' ' ' TYR . . . . . 0.411 ' HE2' ' HB ' ' D' ' 256' ' ' ILE . 0.5 OUTLIER -124.59 113.35 17.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.347 -179.837 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 282' ' ' GLY . . . . . 0.508 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 156.21 171.58 22.69 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.232 -0.985 . . . . 10.0 112.819 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -110.05 53.86 0.57 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.613 -0.803 . . . . 10.0 112.825 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -89.29 -18.11 27.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.204 0.526 . . . . 10.0 109.983 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 118.95 -47.9 0.99 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.775 -0.93 . . . . 10.0 110.775 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 286' ' ' PHE . . . . . 0.453 ' CE1' HG21 ' E' ' 244' ' ' VAL . 4.7 t80 176.15 145.62 0.08 Allowed 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.871 -1.159 . . . . 10.0 107.871 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 17.1 t90 -50.38 -74.47 0.03 OUTLIER 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.435 0.46 . . . . 10.0 111.761 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -134.81 133.24 39.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.185 0.517 . . . . 10.0 111.301 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -172.51 147.55 1.88 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -73.68 -57.52 3.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.816 0.341 . . . . 10.0 110.984 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -154.74 175.02 14.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.072 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 292' ' ' HIS . . . . . 0.751 ' HD2' ' HB3' ' E' ' 286' ' ' PHE . 5.9 m80 -97.25 -154.72 0.46 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.599 -0.273 . . . . 10.0 111.455 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -58.91 125.78 24.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.124 0.488 . . . . 10.0 111.486 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -123.51 147.6 47.07 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.691 -0.686 . . . . 10.0 109.939 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.186 -0.911 . . . . 10.0 109.623 179.688 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 225' ' ' ARG . . . . . 0.551 ' N ' ' HG1' ' E' ' 261' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 110.662 -0.125 . . . . 10.0 110.662 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 226' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' E' ' 262' ' ' ASN . 21.4 m120 -137.55 111.82 8.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.65 0.262 . . . . 10.0 110.466 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 227' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' E' ' 263' ' ' SER . 21.3 m -122.4 138.35 54.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.157 0.503 . . . . 10.0 111.084 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 228' ' ' ALA . . . . . 0.519 ' HB3' HG23 ' D' ' 264' ' ' VAL . . . -130.4 129.27 42.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.851 -0.613 . . . . 10.0 109.547 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 229' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' D' ' 265' ' ' GLU . 8.0 mttm -84.77 -64.63 1.12 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.57 0.581 . . . . 10.0 112.57 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 230' ' ' ASP . . . . . 0.805 ' HB3' HG23 ' E' ' 266' ' ' THR . 4.6 t70 -130.79 127.39 38.59 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.779 -0.368 . . . . 10.0 111.278 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 90.9 mt -128.03 123.27 60.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.761 -0.459 . . . . 10.0 109.761 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 232' ' ' ARG . . . . . 0.404 ' HE ' ' HB2' ' E' ' 232' ' ' ARG . 1.2 ttm180 -116.75 118.29 32.11 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.385 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 233' ' ' THR . . . . . 0.426 ' O ' ' HA2' ' D' ' 269' ' ' GLY . 0.8 OUTLIER -128.66 111.19 12.92 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.013 -0.539 . . . . 10.0 110.862 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -129.87 145.56 51.6 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.154 0.427 . . . . 10.0 112.154 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 66.39 81.9 0.19 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.2 0.815 . . . . 10.0 113.2 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 58.35 26.09 13.61 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.902 -0.59 . . . . 10.0 112.246 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 237' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' D' ' 273' ' ' SER . . . -94.2 153.32 18.13 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.9 160.52 41.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.829 0.347 . . . . 10.0 111.544 -178.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.34 134.28 49.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.889 -0.596 . . . . 10.0 110.779 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 240' ' ' GLN . . . . . 0.562 ' HB3' HD22 ' E' ' 276' ' ' LEU . 0.6 OUTLIER -127.84 127.52 43.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.932 -0.576 . . . . 10.0 109.845 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 241' ' ' LEU . . . . . 0.77 ' HG ' ' HB ' ' E' ' 277' ' ' ILE . 0.7 OUTLIER -126.16 105.48 8.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.442 -0.345 . . . . 10.0 110.587 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 242' ' ' GLY . . . . . 0.493 ' O ' ' HA3' ' E' ' 278' ' ' GLY . . . 164.36 -158.02 30.54 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.757 -0.735 . . . . 10.0 112.445 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -117.34 144.32 45.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.917 0.389 . . . . 10.0 110.649 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 244' ' ' VAL . . . . . 0.453 HG21 ' CE1' ' D' ' 286' ' ' PHE . 61.6 t -101.24 120.33 50.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.111 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 3.6 t -116.92 101.37 12.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.98 0.419 . . . . 10.0 110.867 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 246' ' ' THR . . . . . 0.557 HG23 ' H ' ' E' ' 248' ' ' ALA . 15.0 t -67.53 173.7 3.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.169 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.76 -19.66 64.19 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.794 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 248' ' ' ALA . . . . . 0.557 ' H ' HG23 ' E' ' 246' ' ' THR . . . -75.52 -22.34 57.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.277 -0.42 . . . . 10.0 110.727 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 55.84 -161.68 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.871 -0.604 . . . . 10.0 111.861 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 5.1 mp -103.27 89.13 3.3 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.034 0.445 . . . . 10.0 110.362 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -79.92 90.24 5.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.418 0.628 . . . . 10.0 110.159 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 112.2 68.88 0.54 Allowed Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.651 -0.98 . . . . 10.0 110.651 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -165.49 75.03 0.16 Allowed Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.263 -0.735 . . . . 10.0 111.263 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 28.9 mt -70.28 -35.56 63.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.031 0.443 . . . . 10.0 110.351 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -103.19 101.94 11.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.469 -0.332 . . . . 10.0 110.587 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 6.5 pt -99.87 113.0 33.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.134 0.492 . . . . 10.0 110.928 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 1.4 m -145.04 151.12 38.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.1 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -85.86 84.3 7.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.769 0.795 . . . . 10.0 111.105 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -70.25 -25.73 63.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.227 -0.897 . . . . 10.0 112.251 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 14.6 t -107.24 148.51 28.85 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.09 0.472 . . . . 10.0 111.334 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 261' ' ' THR . . . . . 0.551 ' HG1' ' N ' ' E' ' 225' ' ' ARG . 79.7 m -129.21 114.3 16.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.583 -0.735 . . . . 10.0 111.206 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 262' ' ' ASN . . . . . 0.407 ' HB2' ' ND2' ' E' ' 226' ' ' ASN . 14.1 m120 -107.85 100.1 9.5 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.311 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 263' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' E' ' 227' ' ' SER . 12.9 m -109.04 117.64 34.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.157 -0.474 . . . . 10.0 109.767 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 4.8 p -107.26 152.27 8.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.842 0.353 . . . . 10.0 111.074 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -86.47 -88.11 0.13 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.152 -0.477 . . . . 10.0 111.457 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 266' ' ' THR . . . . . 0.805 HG23 ' HB3' ' E' ' 230' ' ' ASP . 9.0 m -125.12 120.95 32.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.966 0.413 . . . . 10.0 111.605 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.16 116.28 51.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.46 110.61 32.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.856 0.36 . . . . 10.0 111.24 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.6 136.14 10.21 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.642 -0.583 . . . . 10.0 111.642 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -140.03 126.6 20.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.017 0.437 . . . . 10.0 111.024 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.89 82.07 1.17 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.748 -0.739 . . . . 10.0 113.647 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 61.43 22.58 12.97 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.295 0.85 . . . . 10.0 113.295 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 45.2 m -73.1 152.32 41.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.886 0.374 . . . . 10.0 111.291 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -131.45 120.48 23.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.815 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 40.3 t -102.44 118.99 50.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.921 -0.581 . . . . 10.0 109.464 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 276' ' ' LEU . . . . . 0.562 HD22 ' HB3' ' E' ' 240' ' ' GLN . 0.2 OUTLIER -120.57 110.28 16.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.744 -179.345 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 277' ' ' ILE . . . . . 0.77 ' HB ' ' HG ' ' E' ' 241' ' ' LEU . 46.4 mm -117.74 95.96 4.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.144 0.497 . . . . 10.0 110.178 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 278' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' E' ' 242' ' ' GLY . . . 170.89 -126.57 1.34 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.515 -0.634 . . . . 10.0 111.515 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -141.01 151.85 44.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 10.0 111.156 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 280' ' ' GLU . . . . . 0.695 ' HB2' ' HA ' ' E' ' 288' ' ' ASP . 2.6 pt-20 -105.29 138.61 41.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.095 -0.502 . . . . 10.0 111.913 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -162.55 71.28 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.956 -0.566 . . . . 10.0 110.193 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 282' ' ' GLY . . . . . 0.505 ' HA2' ' HB ' ' E' ' 246' ' ' THR . . . -112.9 -105.83 2.75 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.853 -0.689 . . . . 10.0 112.626 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 283' ' ' GLY . . . . . 0.601 ' HA2' ' HB3' ' E' ' 290' ' ' HIS . . . 179.37 25.2 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.564 -0.827 . . . . 10.0 113.364 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.1 -119.79 0.3 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.987 0.394 . . . . 10.0 111.819 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -168.69 46.64 0.22 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.478 -0.868 . . . . 10.0 113.258 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 286' ' ' PHE . . . . . 0.751 ' HB3' ' HD2' ' D' ' 292' ' ' HIS . 46.2 t80 -174.38 103.43 0.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.543 -0.54 . . . . 10.0 109.543 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 72.55 5.47 5.25 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.762 0.664 . . . . 10.0 109.616 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 288' ' ' ASP . . . . . 0.695 ' HA ' ' HB2' ' E' ' 280' ' ' GLU . 0.4 OUTLIER -168.49 131.94 1.5 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.133 -1.394 . . . . 10.0 107.388 179.29 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -136.2 172.76 12.53 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.649 -0.251 . . . . 10.0 111.147 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 290' ' ' HIS . . . . . 0.601 ' HB3' ' HA2' ' E' ' 283' ' ' GLY . 2.9 p-80 -157.82 -163.36 1.32 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.333 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -110.67 -73.06 0.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.513 -0.18 . . . . 10.0 110.513 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 292' ' ' HIS . . . . . 0.43 ' HB2' ' CD2' ' E' ' 290' ' ' HIS . 37.8 t60 70.89 150.31 0.09 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.722 0.639 . . . . 10.0 112.38 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -88.58 112.92 23.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.417 -0.586 . . . . 10.0 109.417 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -96.23 143.28 27.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.268 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.376 -0.821 . . . . 10.0 110.368 -179.713 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' CGO . . . . . 0.897 ' HBT' ' OBE' ' B' ' 1' ' ' CGO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 110.62 -0.141 . . . . 10.0 110.62 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' A' ' 262' ' ' ASN . 14.7 m-80 -116.24 134.72 54.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.769 0.318 . . . . 10.0 110.201 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 263' ' ' SER . 57.0 m -147.89 157.79 43.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.181 0.515 . . . . 10.0 111.771 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.17 154.66 45.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.533 -0.758 . . . . 10.0 109.168 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.561 ' HB2' ' HA ' ' A' ' 265' ' ' GLU . 44.7 mttt -107.34 -70.97 0.77 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.571 0.582 . . . . 10.0 112.571 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.561 ' O ' ' HA ' ' A' ' 266' ' ' THR . 43.0 t0 -124.02 110.35 14.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.366 -177.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 66.8 mt -119.4 126.37 75.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.385 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.9 ptp85 -124.31 116.26 22.34 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.102 0.477 . . . . 10.0 110.658 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 0.7 OUTLIER -123.52 127.6 48.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.827 -0.624 . . . . 10.0 110.768 -179.305 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -141.91 169.41 17.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.602 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.2 60.11 1.0 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.843 -0.617 . . . . 10.0 111.674 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 62.72 29.49 16.78 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.723 -0.671 . . . . 10.0 112.479 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.409 ' HB3' ' HB ' ' A' ' 233' ' ' THR . . . -86.63 157.29 19.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.43 -0.35 . . . . 10.0 110.612 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -135.22 151.2 50.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.247 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.24 139.52 36.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.832 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -137.78 130.12 29.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.266 -0.425 . . . . 10.0 110.205 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.534 ' HG ' ' HB ' ' A' ' 277' ' ' ILE . 5.8 mp -116.82 118.55 32.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.491 -0.322 . . . . 10.0 110.526 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.48 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 152.74 -169.55 31.8 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.824 -0.703 . . . . 10.0 112.694 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.63 126.58 41.0 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.057 -0.349 . . . . 10.0 110.057 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 90.9 t -98.29 116.39 40.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.207 0.527 . . . . 10.0 112.075 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.806 HG11 ' HA2' ' A' ' 252' ' ' GLY . 77.8 t -111.49 116.9 53.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.783 -0.644 . . . . 10.0 109.756 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.77 158.97 15.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.714 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.57 -19.99 65.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.019 0.437 . . . . 10.0 110.766 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -85.98 11.46 11.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.772 -0.649 . . . . 10.0 110.632 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 250' ' ' LEU . . . -121.36 36.03 4.72 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.5 -0.556 . . . . 10.0 109.5 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 3.6 mm? 75.99 -82.22 0.03 OUTLIER 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.44 -0.8 . . . . 10.0 112.645 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 26.0 p-80 -158.22 171.89 19.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.445 -0.343 . . . . 10.0 110.514 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.806 ' HA2' HG11 ' A' ' 245' ' ' VAL . . . -80.62 64.39 4.07 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.002 -0.618 . . . . 10.0 112.749 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -69.63 -46.41 54.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.311 -0.471 . . . . 10.0 112.187 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 84.1 mt 74.15 141.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 122.981 0.513 . . . . 10.0 111.67 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 255' ' ' ARG . 30.1 ttt-85 68.54 82.98 0.16 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.341 0.591 . . . . 10.0 111.245 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 55.6 mt -112.17 -45.92 5.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.765 -0.652 . . . . 10.0 111.532 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 7.0 p -135.28 -82.98 0.41 Allowed 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.293 0.479 . . . . 10.0 112.293 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 11.3 t70 59.4 76.57 0.35 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.478 -0.783 . . . . 10.0 110.981 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -118.05 24.41 11.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.726 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.683 ' HG1' ' N ' ' B' ' 225' ' ' ARG . 5.2 t -155.32 143.04 19.79 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.208 0.528 . . . . 10.0 111.43 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 4.1 m -91.31 120.53 32.27 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.507 -0.923 . . . . 10.0 108.507 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.441 ' O ' ' HA ' ' A' ' 226' ' ' ASN . 67.2 m-20 -111.08 111.71 23.0 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.954 -0.387 . . . . 10.0 109.954 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 227' ' ' SER . 49.7 m -141.07 132.96 27.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.043 0.449 . . . . 10.0 111.708 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.6 HG23 ' HB3' ' B' ' 228' ' ' ALA . 9.9 p -121.6 139.22 49.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.795 -0.639 . . . . 10.0 110.004 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.561 ' HA ' ' HB2' ' A' ' 229' ' ' LYS . 6.0 tt0 -79.35 -77.29 0.18 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.29 0.478 . . . . 10.0 112.29 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 230' ' ' ASP . 1.7 m -115.28 133.36 56.11 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.735 0.643 . . . . 10.0 112.735 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 17.4 t -128.47 124.72 62.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.459 -0.791 . . . . 10.0 109.035 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.459 ' HB ' ' HD3' ' B' ' 232' ' ' ARG . 39.7 t -116.65 121.88 68.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.85 0.357 . . . . 10.0 111.116 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -126.63 118.59 3.1 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.979 -0.629 . . . . 10.0 112.056 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -132.81 110.56 10.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.724 0.297 . . . . 10.0 110.966 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 107.45 67.71 0.65 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.636 -0.792 . . . . 10.0 112.563 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 56.48 32.0 19.93 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 13.2 m -69.19 141.67 54.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.253 0.549 . . . . 10.0 110.611 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' ARG . . . . . 0.401 ' HB2' ' HB3' ' B' ' 238' ' ' ARG . 19.6 mtt180 -114.87 107.08 14.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.386 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 40.8 t -98.97 113.88 35.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.06 -0.518 . . . . 10.0 111.226 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.71 114.79 26.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.246 -0.434 . . . . 10.0 109.863 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.534 ' HB ' ' HG ' ' A' ' 241' ' ' LEU . 29.2 mm -108.91 114.22 46.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.776 -0.453 . . . . 10.0 109.776 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 132.48 163.61 10.7 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.631 -0.795 . . . . 10.0 112.281 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -76.9 147.07 37.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.127 0.489 . . . . 10.0 111.503 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -126.39 152.65 46.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.12 -0.491 . . . . 10.0 111.069 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -129.63 116.63 19.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.726 -0.67 . . . . 10.0 110.581 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' B' ' 246' ' ' THR . . . -166.8 153.3 22.9 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.137 -0.554 . . . . 10.0 111.751 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -128.3 -7.7 4.33 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.431 -0.89 . . . . 10.0 113.327 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -80.07 -43.43 21.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.124 0.487 . . . . 10.0 110.805 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -155.48 157.18 27.53 Favored Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 110.3 -1.12 . . . . 10.0 110.3 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -80.97 74.53 7.96 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.917 0.358 . . . . 10.0 110.894 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 25.0 t90 67.36 -63.93 0.28 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.219 0.949 . . . . 10.0 112.874 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -144.08 96.64 2.92 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.118 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -160.34 144.34 14.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.936 -0.575 . . . . 10.0 110.354 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -157.06 60.7 0.51 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.116 -0.698 . . . . 10.0 109.116 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -83.86 103.73 13.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.852 -0.613 . . . . 10.0 111.769 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -101.56 -31.8 10.68 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.647 -0.706 . . . . 10.0 110.084 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -84.61 124.6 31.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.577 -0.738 . . . . 10.0 109.905 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.42 139.72 47.75 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.785 0.326 . . . . 10.0 110.72 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.509 -0.758 . . . . 10.0 110.378 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.683 ' N ' ' HG1' ' A' ' 260' ' ' THR . 4.7 ttm-85 . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 110.286 -0.265 . . . . 10.0 110.286 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.442 ' HB3' HG22 ' B' ' 277' ' ' ILE . 69.9 m-20 -126.54 124.23 39.54 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.326 -0.62 . . . . 10.0 109.326 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 227' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 263' ' ' SER . 5.1 m -139.32 152.95 47.61 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.624 0.25 . . . . 10.0 111.184 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.6 ' HB3' HG23 ' A' ' 264' ' ' VAL . . . -144.24 148.5 35.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.154 -0.476 . . . . 10.0 111.448 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.49 ' HB2' ' HA ' ' B' ' 265' ' ' GLU . 1.1 tmtm? -90.56 -62.35 1.48 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.217 -0.447 . . . . 10.0 111.957 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 230' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 266' ' ' THR . 7.3 t0 -145.6 132.25 19.92 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.006 0.431 . . . . 10.0 111.412 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 64.9 mt -125.24 122.92 64.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.086 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 232' ' ' ARG . . . . . 0.459 ' HD3' ' HB ' ' A' ' 268' ' ' VAL . 3.8 mmt180 -102.74 112.52 25.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.165 -0.471 . . . . 10.0 109.95 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.407 ' O ' ' HA2' ' A' ' 269' ' ' GLY . 1.0 OUTLIER -121.23 115.0 22.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.882 0.372 . . . . 10.0 111.327 -179.226 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.34 164.32 28.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.339 -0.391 . . . . 10.0 111.477 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.43 ' HB2' ' H ' ' B' ' 271' ' ' GLY . 25.8 mt-10 65.64 62.59 0.64 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.595 -0.729 . . . . 10.0 111.872 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 236' ' ' ARG . . . . . 0.461 ' HB2' ' HG2' ' B' ' 272' ' ' GLU . 63.6 mtm-85 57.83 32.29 21.71 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.894 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.12 159.59 22.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.887 0.375 . . . . 10.0 111.065 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.401 ' HB3' ' HB2' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -137.62 141.82 41.23 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.951 0.405 . . . . 10.0 111.238 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 4.3 p -127.1 135.81 62.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.723 -0.671 . . . . 10.0 110.989 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -118.74 123.23 44.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.61 -0.723 . . . . 10.0 109.227 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.78 84.78 1.98 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.877 0.37 . . . . 10.0 110.504 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 165.41 179.06 38.98 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.482 -0.866 . . . . 10.0 112.233 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -92.26 131.64 37.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.798 0.332 . . . . 10.0 110.664 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 46.7 t -95.77 109.13 22.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.014 0.435 . . . . 10.0 110.707 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 20.3 t -109.24 114.11 46.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 282' ' ' GLY . 32.8 p -81.91 169.01 17.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.087 -0.506 . . . . 10.0 111.324 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -72.12 -4.92 31.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.691 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -78.43 -18.17 55.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.601 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -91.01 3.1 55.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.647 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 20.6 tp -64.58 131.19 46.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.426 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 1.9 t60 60.07 47.89 9.13 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.261 0.553 . . . . 10.0 110.89 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -137.48 -156.52 7.27 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.884 -0.674 . . . . 10.0 111.866 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.51 120.4 4.29 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.987 -0.625 . . . . 10.0 111.736 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 52.5 mt -103.5 -33.48 3.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.22 0.533 . . . . 10.0 110.733 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 255' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' B' ' 255' ' ' ARG . 4.0 tpt180 -79.82 81.06 6.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.975 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 21.4 pt -102.34 37.51 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.798 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.7 t 65.87 36.22 6.18 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.925 -0.58 . . . . 10.0 110.616 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -65.94 122.43 17.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.397 -0.82 . . . . 10.0 110.154 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 259' ' ' GLN . . . . . 0.4 ' OE1' HG13 ' C' ' 256' ' ' ILE . 12.8 tt0 -139.28 109.25 6.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.333 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 8.5 t -175.38 177.1 1.89 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.998 0.428 . . . . 10.0 110.56 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 71.2 m -150.48 117.47 5.92 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.901 -0.777 . . . . 10.0 108.901 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -99.69 116.06 30.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.991 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 50.8 m -135.78 113.9 11.37 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.881 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' C' ' 228' ' ' ALA . 13.2 p -113.14 146.2 18.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.556 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 265' ' ' GLU . . . . . 0.49 ' HA ' ' HB2' ' B' ' 229' ' ' LYS . 28.4 mt-10 -85.01 -75.5 0.35 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.173 0.435 . . . . 10.0 112.173 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' B' ' 230' ' ' ASP . 4.3 m -123.24 130.14 52.34 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.748 0.647 . . . . 10.0 112.748 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 37.3 t -119.77 122.87 69.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.376 -0.829 . . . . 10.0 109.041 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 268' ' ' VAL . . . . . 0.418 ' HB ' ' HA ' ' C' ' 232' ' ' ARG . 35.3 t -104.3 114.02 42.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.815 0.34 . . . . 10.0 110.348 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.41 97.6 0.72 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.556 -0.618 . . . . 10.0 111.556 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -119.89 118.98 32.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.728 0.299 . . . . 10.0 111.189 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 271' ' ' GLY . . . . . 0.43 ' H ' ' HB2' ' B' ' 235' ' ' GLU . . . 100.65 62.57 0.79 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.325 -0.941 . . . . 10.0 112.595 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 272' ' ' GLU . . . . . 0.461 ' HG2' ' HB2' ' B' ' 236' ' ' ARG . 12.1 mt-10 54.58 37.68 28.45 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.124 0.786 . . . . 10.0 113.124 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 273' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' C' ' 237' ' ' ALA . 7.3 m -77.81 151.16 34.1 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.899 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 13.2 mtt85 -116.25 121.08 40.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.344 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 40.8 t -108.84 119.42 58.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.486 -0.561 . . . . 10.0 109.486 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.597 ' HB3' ' HG3' ' C' ' 240' ' ' GLN . 0.1 OUTLIER -117.97 113.37 21.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.666 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.442 HG22 ' HB3' ' B' ' 226' ' ' ASN . 43.3 mm -103.54 88.33 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.896 0.379 . . . . 10.0 110.074 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 158.66 175.07 29.18 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.899 -0.667 . . . . 10.0 111.974 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -93.05 159.35 15.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.152 -0.314 . . . . 10.0 110.152 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.46 160.83 27.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.192 0.52 . . . . 10.0 111.684 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.02 71.27 1.33 Allowed 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -97.3 -65.03 0.9 Allowed Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.213 -0.903 . . . . 10.0 111.885 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 283' ' ' GLY . . . . . 0.533 ' HA3' ' H ' ' C' ' 247' ' ' ALA . . . 82.35 -46.99 3.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.247 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 284' ' ' LYS . . . . . 0.407 ' HE3' ' HB3' ' B' ' 284' ' ' LYS . 27.9 mtpp -67.35 -26.69 66.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.411 0.624 . . . . 10.0 110.126 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -152.73 164.22 30.66 Favored Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 110.216 -1.154 . . . . 10.0 110.216 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -97.87 64.18 1.71 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.93 -0.396 . . . . 10.0 109.93 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.447 ' CH2' ' HB2' ' C' ' 238' ' ' ARG . 16.1 t90 71.19 -43.11 0.55 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.387 -0.824 . . . . 10.0 112.341 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -139.02 -170.54 2.89 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.863 -0.421 . . . . 10.0 109.863 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.38 142.19 58.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.419 -0.355 . . . . 10.0 110.777 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -166.48 89.73 0.39 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 110.397 -0.223 . . . . 10.0 110.397 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -155.52 119.35 4.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.82 0.343 . . . . 10.0 111.796 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.97 -176.49 5.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.125 -0.488 . . . . 10.0 110.457 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.6 154.17 17.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.817 0.341 . . . . 10.0 111.477 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 294' ' ' HIS . . . . . 0.565 ' HB2' ' HA ' ' C' ' 291' ' ' HIS . 29.1 p80 -116.16 -174.07 2.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.41 -0.814 . . . . 10.0 109.211 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.218 -0.896 . . . . 10.0 109.73 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 225' ' ' ARG . . . . . 0.675 ' N ' ' HG1' ' C' ' 261' ' ' THR . 31.2 ptt180 . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.485 0.183 . . . . 10.0 110.549 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 226' ' ' ASN . . . . . 0.442 ' HB3' HG22 ' C' ' 277' ' ' ILE . 52.4 m-80 -127.72 111.51 13.77 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 227' ' ' SER . . . . . 0.446 ' HB2' ' CAW' ' B' ' 1' ' ' CGO . 0.0 OUTLIER -128.28 152.59 47.94 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.051 0.453 . . . . 10.0 111.572 -178.607 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.413 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -149.06 143.82 26.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.774 -0.648 . . . . 10.0 109.995 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 229' ' ' LYS . . . . . 0.456 ' HG2' ' OE2' ' B' ' 265' ' ' GLU . 38.3 mttm -91.91 -72.27 0.6 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.633 0.605 . . . . 10.0 112.633 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -122.06 126.29 48.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.865 0.365 . . . . 10.0 111.558 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 49.7 mt -129.52 115.05 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.382 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.428 ' HD2' HG13 ' C' ' 268' ' ' VAL . 14.7 ttm-85 -101.45 115.12 29.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.396 -0.365 . . . . 10.0 110.561 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -125.29 100.7 6.64 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.447 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -125.32 161.58 26.66 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.014 0.376 . . . . 10.0 112.014 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 66.45 75.15 0.33 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.358 -0.837 . . . . 10.0 112.108 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 53.33 55.17 9.1 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.297 -0.865 . . . . 10.0 111.133 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 237' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' B' ' 273' ' ' SER . . . -107.97 165.89 11.12 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.712 -0.676 . . . . 10.0 111.164 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 238' ' ' ARG . . . . . 0.447 ' HB2' ' CH2' ' B' ' 287' ' ' TRP . 1.5 ptp180 -153.1 138.01 17.14 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.854 -0.612 . . . . 10.0 110.16 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.484 HG23 ' HB ' ' C' ' 275' ' ' VAL . 4.4 p -135.06 136.46 51.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.191 -0.459 . . . . 10.0 110.614 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.597 ' HG3' ' HB3' ' B' ' 276' ' ' LEU . 27.6 tt0 -126.07 128.61 47.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.993 0.425 . . . . 10.0 111.043 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -105.24 91.41 3.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.769 -0.651 . . . . 10.0 109.831 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 168.19 -174.39 43.03 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.669 -0.777 . . . . 10.0 111.992 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -95.54 155.69 16.64 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.827 0.346 . . . . 10.0 110.95 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 57.3 t -112.68 108.78 26.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.06 -0.518 . . . . 10.0 110.249 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.83 110.64 32.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.218 -0.446 . . . . 10.0 110.342 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 38.3 p -79.84 159.92 26.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.019 -0.537 . . . . 10.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 247' ' ' ALA . . . . . 0.533 ' H ' ' HA3' ' B' ' 283' ' ' GLY . . . -73.68 42.54 0.13 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.273 0.559 . . . . 10.0 111.838 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -138.19 -13.06 1.4 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.61 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -87.45 67.03 9.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.109 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 55.8 mt -87.12 -4.6 59.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.978 -0.555 . . . . 10.0 111.379 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -94.04 129.24 40.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.305 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 178.77 -158.57 23.01 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.661 -0.78 . . . . 10.0 112.182 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 176.17 -134.66 2.68 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.676 -0.969 . . . . 10.0 110.676 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 13.5 tt -158.42 89.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.498 0.666 . . . . 10.0 111.421 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -140.93 115.31 9.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.367 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 256' ' ' ILE . . . . . 0.4 HG13 ' OE1' ' B' ' 259' ' ' GLN . 8.5 tt -74.83 129.28 36.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.819 -0.628 . . . . 10.0 109.898 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.44 174.16 15.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.125 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.81 145.6 55.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.92 -0.582 . . . . 10.0 112.155 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -147.76 149.07 31.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.761 -0.654 . . . . 10.0 109.703 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 260' ' ' THR . . . . . 0.654 ' HG1' ' N ' ' D' ' 225' ' ' ARG . 12.8 t -71.51 140.29 49.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.005 0.431 . . . . 10.0 110.847 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 261' ' ' THR . . . . . 0.675 ' HG1' ' N ' ' C' ' 225' ' ' ARG . 7.7 m -105.54 134.34 48.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.099 -0.501 . . . . 10.0 110.384 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 262' ' ' ASN . . . . . 0.55 ' HA ' ' O ' ' D' ' 226' ' ' ASN . 18.6 t-20 -122.65 128.36 50.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.875 -0.602 . . . . 10.0 109.5 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 50.0 m -144.63 138.78 27.62 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.737 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.9 p -123.52 145.34 30.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.852 -0.613 . . . . 10.0 110.996 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 265' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' D' ' 229' ' ' LYS . 54.8 mt-10 -82.32 -66.27 0.91 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.491 -0.322 . . . . 10.0 111.735 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.79 129.74 51.04 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.295 0.85 . . . . 10.0 113.295 -178.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 48.3 t -127.19 119.97 54.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.661 -0.7 . . . . 10.0 109.648 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 268' ' ' VAL . . . . . 0.609 ' HB ' ' HD2' ' D' ' 232' ' ' ARG . 58.8 t -117.01 120.08 63.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.794 0.33 . . . . 10.0 110.895 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 269' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -123.77 130.95 7.85 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.976 -0.631 . . . . 10.0 112.121 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -133.04 126.68 32.42 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.913 0.338 . . . . 10.0 111.913 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.17 93.23 0.16 Allowed Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.951 -0.568 . . . . 10.0 113.449 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 64.02 32.47 12.91 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.303 0.573 . . . . 10.0 111.403 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 273' ' ' SER . . . . . 0.459 ' HB3' ' HA3' ' C' ' 269' ' ' GLY . 0.2 OUTLIER -66.46 121.83 16.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.328 -0.851 . . . . 10.0 111.193 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 41.3 mtt180 -124.74 100.89 6.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.147 0.499 . . . . 10.0 109.763 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.484 ' HB ' HG23 ' C' ' 239' ' ' VAL . 22.3 t -101.78 131.86 48.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.041 -0.527 . . . . 10.0 111.411 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' D' ' 240' ' ' GLN . 2.2 tm? -128.01 113.2 15.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.858 -0.61 . . . . 10.0 109.815 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.48 HG12 HD23 ' D' ' 241' ' ' LEU . 56.1 mt -111.0 94.13 2.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.324 0.583 . . . . 10.0 110.756 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 168.19 -165.06 38.5 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.825 -1.31 . . . . 10.0 109.825 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -108.49 148.28 30.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 117.477 0.638 . . . . 10.0 110.946 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -104.94 137.61 42.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.344 -0.389 . . . . 10.0 110.644 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 281' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.2 OUTLIER -131.0 102.16 5.92 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.538 -0.542 . . . . 10.0 109.538 179.411 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 282' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' D' ' 246' ' ' THR . . . -164.98 172.07 40.55 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.689 -0.767 . . . . 10.0 112.434 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -124.34 16.33 7.59 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.782 -0.723 . . . . 10.0 112.522 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -101.68 1.28 37.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.964 0.411 . . . . 10.0 111.179 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 129.86 -116.17 2.04 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.835 -0.906 . . . . 10.0 110.835 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 286' ' ' PHE . . . . . 0.511 ' HB3' ' NE1' ' D' ' 287' ' ' TRP . 0.8 OUTLIER -125.75 -155.78 0.7 Allowed 'General case' 0 C--N 1.323 -0.549 0 O-C-N 123.513 0.184 . . . . 10.0 110.562 179.131 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.417 ' H ' ' HB2' ' C' ' 286' ' ' PHE . 1.7 t90 -63.75 -24.0 67.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.635 0.255 . . . . 10.0 111.284 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 288' ' ' ASP . . . . . 0.405 ' OD2' ' HD2' ' D' ' 238' ' ' ARG . 1.9 p30 -133.47 -171.39 2.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.489 -0.323 . . . . 10.0 110.262 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -143.02 35.44 1.37 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.075 0.464 . . . . 10.0 110.966 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -79.99 0.58 31.01 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.276 0.473 . . . . 10.0 112.276 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 291' ' ' HIS . . . . . 0.661 ' HB2' HH12 ' D' ' 274' ' ' ARG . 0.2 OUTLIER -164.46 155.82 15.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.455 179.125 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 66.34 157.19 0.11 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.399 0.618 . . . . 10.0 112.464 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.26 -93.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.117 0.414 . . . . 10.0 112.117 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -79.69 -81.03 0.12 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.208 0.448 . . . . 10.0 112.208 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 . . . . . 0 C--O 1.249 1.026 0 N-CA-C 109.813 -0.439 . . . . 10.0 109.813 -179.122 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 225' ' ' ARG . . . . . 0.654 ' N ' ' HG1' ' C' ' 260' ' ' THR . 6.4 mtt85 . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.094 -0.336 . . . . 10.0 110.094 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 226' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' C' ' 262' ' ' ASN . 41.5 m-80 -132.36 129.2 39.11 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 121.015 -0.274 . . . . 10.0 110.301 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 227' ' ' SER . . . . . 0.414 ' HB3' ' NBD' ' B' ' 1' ' ' CGO . 42.6 m -151.17 142.83 23.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.89 0.376 . . . . 10.0 111.579 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.85 139.59 53.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.51 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 229' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' C' ' 265' ' ' GLU . 22.5 ttmt -84.54 -66.12 0.93 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.877 0.37 . . . . 10.0 111.601 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -138.51 119.43 14.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.649 0.261 . . . . 10.0 111.113 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 231' ' ' ILE . . . . . 0.422 HG12 HG23 ' D' ' 267' ' ' VAL . 32.7 mt -117.07 130.89 71.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.385 -0.37 . . . . 10.0 110.502 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 232' ' ' ARG . . . . . 0.609 ' HD2' ' HB ' ' C' ' 268' ' ' VAL . 22.2 mmm-85 -118.55 106.38 12.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.176 -0.466 . . . . 10.0 110.66 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 233' ' ' THR . . . . . 0.554 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 1.4 p -112.99 113.3 25.28 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.625 -0.509 . . . . 10.0 109.625 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 234' ' ' GLU . . . . . 0.406 ' HG3' ' HG3' ' D' ' 270' ' ' LYS . 4.2 pt-20 -131.18 147.34 52.59 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.368 0.506 . . . . 10.0 112.368 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 68.38 79.22 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.162 -0.927 . . . . 10.0 113.278 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 55.68 45.64 24.2 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.287 0.565 . . . . 10.0 111.94 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -111.06 157.23 20.21 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.901 -0.591 . . . . 10.0 110.61 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 238' ' ' ARG . . . . . 0.405 ' HD2' ' OD2' ' C' ' 288' ' ' ASP . 0.0 OUTLIER -144.33 151.77 39.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.244 -0.434 . . . . 10.0 110.822 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 239' ' ' VAL . . . . . 0.451 HG23 ' HB ' ' D' ' 275' ' ' VAL . 3.8 p -138.25 133.43 43.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.22 -0.445 . . . . 10.0 110.273 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 240' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' C' ' 276' ' ' LEU . 0.0 OUTLIER -115.21 125.38 53.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.522 179.657 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 241' ' ' LEU . . . . . 0.48 HD23 HG12 ' C' ' 277' ' ' ILE . 3.0 mm? -109.66 92.59 4.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.865 -0.607 . . . . 10.0 110.819 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 175.72 -106.02 0.21 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.716 -0.755 . . . . 10.0 112.466 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -167.91 162.93 13.77 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.637 0.375 . . . . 10.0 110.282 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 244' ' ' VAL . . . . . 0.402 HG21 ' CD1' ' D' ' 287' ' ' TRP . 35.8 t -110.52 111.92 38.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.842 0.353 . . . . 10.0 111.802 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 245' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 17.7 t -113.21 109.98 30.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.383 -0.599 . . . . 10.0 109.383 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 246' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' C' ' 282' ' ' GLY . 82.3 p -89.75 162.77 15.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.945 0.403 . . . . 10.0 111.611 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -72.87 -0.89 14.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.048 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -88.57 -12.08 43.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.407 0.622 . . . . 10.0 109.782 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -97.06 87.76 4.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.387 -0.824 . . . . 10.0 109.983 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 4.5 mp -84.17 -160.16 0.44 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.809 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -79.69 100.52 7.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.088 0.47 . . . . 10.0 111.087 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -174.15 38.73 0.13 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.819 -0.912 . . . . 10.0 110.819 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 101.96 35.11 4.08 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.818 -0.706 . . . . 10.0 111.451 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 10.0 tt -68.0 -38.02 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 121.161 0.505 . . . . 10.0 111.987 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 42.1 mtt-85 -84.04 83.96 7.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.103 0.478 . . . . 10.0 111.551 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 15.5 tt -67.68 -16.97 21.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.215 -0.902 . . . . 10.0 111.739 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 7.7 m 71.1 -83.23 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.369 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -161.14 167.84 25.42 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -160.09 -41.58 0.05 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.137 0.273 . . . . 10.0 111.56 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 13.9 t -144.07 162.05 37.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.867 0.365 . . . . 10.0 111.231 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 261' ' ' THR . . . . . 0.601 HG23 ' HB3' ' D' ' 225' ' ' ARG . 21.8 m -105.44 114.46 28.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.062 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -102.59 104.51 14.9 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.047 -0.524 . . . . 10.0 109.778 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 14.8 m -117.48 126.3 52.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.021 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 9.2 p -123.62 133.37 69.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.151 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 265' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' E' ' 229' ' ' LYS . 67.7 mt-10 -83.71 -82.49 0.16 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.207 -0.451 . . . . 10.0 112.137 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 2.4 p -106.0 119.61 39.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.015 0.436 . . . . 10.0 112.029 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 267' ' ' VAL . . . . . 0.422 HG23 HG12 ' D' ' 231' ' ' ILE . 0.1 OUTLIER -127.67 113.7 32.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.02 179.5 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 268' ' ' VAL . . . . . 0.536 ' HB ' ' HG2' ' E' ' 232' ' ' ARG . 42.0 t -113.0 128.6 69.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.312 -0.404 . . . . 10.0 111.023 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 269' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' E' ' 233' ' ' THR . . . -129.8 115.02 1.8 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.677 -0.969 . . . . 10.0 110.677 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 270' ' ' LYS . . . . . 0.638 ' HB3' ' HG2' ' E' ' 234' ' ' GLU . 5.6 tttp -124.07 125.63 44.85 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.518 0.562 . . . . 10.0 112.518 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.53 89.58 0.4 Allowed Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.592 -0.731 . . . . 10.0 113.876 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 55.58 52.55 10.91 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.161 0.505 . . . . 10.0 111.555 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 6.3 t -103.38 142.39 34.31 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.968 -0.56 . . . . 10.0 110.858 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 274' ' ' ARG . . . . . 0.661 HH12 ' HB2' ' C' ' 291' ' ' HIS . 2.1 mpt_? -122.56 110.6 15.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.218 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 275' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' D' ' 239' ' ' VAL . 26.0 t -99.95 114.96 39.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.991 -0.374 . . . . 10.0 109.991 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 276' ' ' LEU . . . . . 0.456 ' HB3' ' HG3' ' E' ' 240' ' ' GLN . 1.2 tm? -116.43 108.85 16.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.313 0.578 . . . . 10.0 111.27 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 44.3 mm -106.2 99.84 9.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.223 -0.658 . . . . 10.0 109.223 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.1 -171.46 32.72 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.792 -0.718 . . . . 10.0 111.313 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -110.28 161.75 15.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.918 0.389 . . . . 10.0 111.205 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -117.06 134.77 54.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.074 -0.512 . . . . 10.0 111.045 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -125.96 113.61 17.38 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.089 -0.505 . . . . 10.0 110.282 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 282' ' ' GLY . . . . . 0.536 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 161.31 -178.15 37.35 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.271 -0.966 . . . . 10.0 112.64 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -108.37 41.6 2.17 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.839 -0.696 . . . . 10.0 112.965 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt -86.82 -22.23 25.97 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.699 -0.482 . . . . 10.0 109.699 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 98.93 -32.76 6.72 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.049 -0.596 . . . . 10.0 112.149 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 286' ' ' PHE . . . . . 0.79 ' HZ ' ' HG ' ' E' ' 276' ' ' LEU . 2.6 t80 176.71 137.72 0.06 Allowed 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.591 -0.522 . . . . 10.0 109.591 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 287' ' ' TRP . . . . . 0.511 ' NE1' ' HB3' ' C' ' 286' ' ' PHE . 9.6 t90 -55.89 -74.49 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.581 0.55 . . . . 10.0 110.584 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 288' ' ' ASP . . . . . 0.505 ' CG ' ' HE ' ' E' ' 238' ' ' ARG . 48.5 t0 -125.8 117.82 24.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.456 0.646 . . . . 10.0 111.8 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 289' ' ' ASN . . . . . 0.582 ' HA ' ' HD3' ' E' ' 274' ' ' ARG . 10.1 t-20 -156.34 160.86 40.08 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.76 -1.2 . . . . 10.0 107.76 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -80.35 -64.62 1.15 Allowed 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.365 0.506 . . . . 10.0 112.365 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -148.57 -160.65 1.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.647 -0.251 . . . . 10.0 110.955 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -91.29 -161.02 0.77 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.814 -0.439 . . . . 10.0 109.814 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -71.18 133.35 46.1 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.475 -0.195 . . . . 10.0 110.475 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -122.33 147.09 46.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.595 -0.275 . . . . 10.0 110.941 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.355 -0.831 . . . . 10.0 109.6 178.949 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 225' ' ' ARG . . . . . 0.633 ' N ' ' HG1' ' E' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 110.21 -0.293 . . . . 10.0 110.21 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -132.13 114.48 14.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.701 0.286 . . . . 10.0 110.716 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 2.4 m -122.77 141.27 52.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.226 0.536 . . . . 10.0 111.719 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 228' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' E' ' 264' ' ' VAL . . . -135.69 121.09 19.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.813 -0.63 . . . . 10.0 109.41 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 229' ' ' LYS . . . . . 0.545 ' O ' ' HB2' ' D' ' 265' ' ' GLU . 9.7 mttm -79.9 -69.91 0.55 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.066 0.765 . . . . 10.0 113.066 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 230' ' ' ASP . . . . . 0.516 ' HB3' HG23 ' E' ' 266' ' ' THR . 19.9 t70 -124.58 126.0 45.08 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.753 -0.379 . . . . 10.0 111.852 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 54.8 mt -134.35 122.16 39.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.095 0.474 . . . . 10.0 110.78 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 232' ' ' ARG . . . . . 0.536 ' HG2' ' HB ' ' D' ' 268' ' ' VAL . 37.5 mtm180 -122.41 123.34 41.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.087 -0.506 . . . . 10.0 110.336 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 233' ' ' THR . . . . . 0.484 ' O ' ' HA2' ' D' ' 269' ' ' GLY . 0.6 OUTLIER -127.69 114.06 16.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.877 -0.601 . . . . 10.0 111.568 -179.37 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 234' ' ' GLU . . . . . 0.638 ' HG2' ' HB3' ' D' ' 270' ' ' LYS . 48.0 mt-10 -124.83 162.23 24.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.157 -0.474 . . . . 10.0 111.687 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 61.57 74.72 0.43 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.653 0.983 . . . . 10.0 113.653 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 236' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' E' ' 272' ' ' GLU . 18.1 ttp180 50.4 64.04 1.96 Allowed 'General case' 0 C--O 1.234 0.261 0 O-C-N 123.559 0.537 . . . . 10.0 111.69 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -123.15 174.77 7.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.774 -0.648 . . . . 10.0 110.986 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 238' ' ' ARG . . . . . 0.972 ' HD3' ' HG3' ' E' ' 274' ' ' ARG . 0.7 OUTLIER -149.63 149.47 30.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.911 0.386 . . . . 10.0 110.721 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 3.1 p -133.48 118.77 32.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.342 -0.844 . . . . 10.0 109.236 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 240' ' ' GLN . . . . . 0.456 ' HG3' ' HB3' ' D' ' 276' ' ' LEU . 47.5 tt0 -123.82 128.0 48.89 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.921 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 241' ' ' LEU . . . . . 0.568 ' HG ' ' HB ' ' E' ' 277' ' ' ILE . 4.8 mp -123.58 109.72 14.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.387 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 166.82 -173.63 42.15 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.94 -0.648 . . . . 10.0 112.221 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -101.99 137.72 39.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.743 0.306 . . . . 10.0 110.739 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 244' ' ' VAL . . . . . 0.414 ' O ' ' HB3' ' E' ' 281' ' ' TYR . 38.4 t -93.13 123.99 45.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.481 -0.327 . . . . 10.0 110.424 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 24.5 t -121.67 106.61 18.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.979 0.419 . . . . 10.0 110.917 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 246' ' ' THR . . . . . 0.631 ' HB ' ' HA2' ' E' ' 282' ' ' GLY . 8.9 t -68.43 164.73 20.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.845 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.16 -20.54 64.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.092 -0.503 . . . . 10.0 111.967 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -71.52 -19.96 62.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.443 -0.344 . . . . 10.0 110.429 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 59.26 -165.81 0.19 Allowed 'General case' 0 C--O 1.232 0.16 0 O-C-N 123.914 0.759 . . . . 10.0 111.649 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 7.3 tp -95.47 122.45 38.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.421 -0.354 . . . . 10.0 110.082 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -95.61 80.6 3.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.919 0.39 . . . . 10.0 111.354 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 112.57 161.57 15.44 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.687 -0.688 . . . . 10.0 112.094 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 73.43 73.32 0.9 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.912 -0.661 . . . . 10.0 112.015 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 4.3 mt -82.23 51.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.369 0.605 . . . . 10.0 111.045 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -169.04 84.75 0.15 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.158 -0.928 . . . . 10.0 109.022 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 4.2 pt -98.23 153.67 4.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.953 -0.567 . . . . 10.0 112.227 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.64 163.7 39.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.448 -0.796 . . . . 10.0 109.339 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -82.98 86.65 6.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.714 0.769 . . . . 10.0 110.709 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -66.21 -59.31 3.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.252 -0.885 . . . . 10.0 111.332 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 14.8 t -83.02 154.86 24.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.727 -0.67 . . . . 10.0 111.418 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 261' ' ' THR . . . . . 0.633 ' HG1' ' N ' ' E' ' 225' ' ' ARG . 49.3 m -130.81 124.01 30.37 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.335 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -118.16 121.58 40.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.883 -0.599 . . . . 10.0 110.023 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 6.3 m -127.48 104.64 8.01 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.777 -0.453 . . . . 10.0 109.777 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 264' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' E' ' 228' ' ' ALA . 3.8 p -88.77 152.19 3.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 116.013 -0.54 . . . . 10.0 111.086 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 265' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' E' ' 229' ' ' LYS . 76.0 mm-40 -87.55 -82.9 0.21 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.966 -0.561 . . . . 10.0 111.44 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 266' ' ' THR . . . . . 0.516 HG23 ' HB3' ' E' ' 230' ' ' ASP . 18.2 m -132.52 119.96 21.25 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.854 0.359 . . . . 10.0 111.558 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 23.8 t -112.07 111.53 36.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.535 -0.543 . . . . 10.0 109.535 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 18.4 t -113.28 120.51 63.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.307 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -139.46 137.92 8.89 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.67 -0.776 . . . . 10.0 112.158 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 270' ' ' LYS . . . . . 0.518 ' HG3' ' HB2' ' E' ' 234' ' ' GLU . 24.7 ttpp -142.71 112.93 7.15 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.354 -0.239 . . . . 10.0 110.354 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 111.65 84.14 1.4 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.861 -0.685 . . . . 10.0 112.355 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 272' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' E' ' 236' ' ' ARG . 3.5 mm-40 56.31 32.39 20.35 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.361 0.504 . . . . 10.0 112.361 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.3 152.17 38.58 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.002 -0.544 . . . . 10.0 111.449 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 274' ' ' ARG . . . . . 0.972 ' HG3' ' HD3' ' E' ' 238' ' ' ARG . 2.7 ttm180 -135.88 102.06 4.94 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.894 -0.594 . . . . 10.0 109.987 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 26.7 t -107.58 115.43 48.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.685 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 276' ' ' LEU . . . . . 0.79 ' HG ' ' HZ ' ' D' ' 286' ' ' PHE . 0.7 OUTLIER -125.35 113.58 17.76 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.416 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 277' ' ' ILE . . . . . 0.568 ' HB ' ' HG ' ' E' ' 241' ' ' LEU . 46.5 mm -109.48 100.23 10.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.937 0.398 . . . . 10.0 110.653 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 164.28 -148.91 15.33 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.739 -0.664 . . . . 10.0 111.537 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 37.8 p30 -105.38 167.53 9.68 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.747 -0.266 . . . . 10.0 110.693 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 280' ' ' GLU . . . . . 1.032 ' HB2' ' HA ' ' E' ' 288' ' ' ASP . 0.5 OUTLIER -120.48 124.0 44.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.948 0.404 . . . . 10.0 111.397 -179.05 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 281' ' ' TYR . . . . . 0.414 ' HB3' ' O ' ' E' ' 244' ' ' VAL . 9.5 t80 -156.84 94.76 1.47 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.822 -0.626 . . . . 10.0 110.261 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 282' ' ' GLY . . . . . 0.631 ' HA2' ' HB ' ' E' ' 246' ' ' THR . . . -133.99 -81.08 0.16 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.288 -0.958 . . . . 10.0 112.695 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 283' ' ' GLY . . . . . 0.708 ' HA2' ' HB3' ' E' ' 290' ' ' HIS . . . 144.12 30.1 0.1 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.477 -0.868 . . . . 10.0 113.583 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 284' ' ' LYS . . . . . 0.591 ' HG3' ' OD1' ' E' ' 288' ' ' ASP . 6.0 pttp -125.88 -51.66 1.57 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.257 0.465 . . . . 10.0 112.257 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.17 30.03 2.01 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.086 -1.054 . . . . 10.0 113.408 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -147.11 97.98 2.96 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.997 -1.112 . . . . 10.0 107.997 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 73.09 24.66 2.45 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 107.919 -1.141 . . . . 10.0 107.919 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 288' ' ' ASP . . . . . 1.032 ' HA ' ' HB2' ' E' ' 280' ' ' GLU . 2.4 p-10 -170.37 161.42 8.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.035 -1.438 . . . . 10.0 109.375 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -139.31 161.94 36.21 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.914 -0.402 . . . . 10.0 109.914 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 290' ' ' HIS . . . . . 0.708 ' HB3' ' HA2' ' E' ' 283' ' ' GLY . 5.9 p80 -152.82 167.72 28.11 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.155 -0.475 . . . . 10.0 111.133 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -74.51 -74.43 0.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.377 -0.374 . . . . 10.0 110.638 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 26.8 t60 67.68 155.18 0.11 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.674 -0.694 . . . . 10.0 111.96 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -122.48 135.97 54.78 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.294 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -93.88 179.36 5.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.564 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 41.3 t60 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.064 -0.97 . . . . 10.0 109.787 -179.664 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' CGO . . . . . 0.854 ' HBT' ' OAU' ' B' ' 1' ' ' CGO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.621 0.248 . . . . 10.0 110.334 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -106.55 127.9 53.69 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.668 -0.494 . . . . 10.0 109.668 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 263' ' ' SER . 3.3 m -144.98 161.63 38.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.157 0.503 . . . . 10.0 111.572 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.5 158.61 44.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.049 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.553 ' HD3' ' HG3' ' A' ' 265' ' ' GLU . 7.4 tttm -108.81 -59.6 1.86 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.933 0.397 . . . . 10.0 111.34 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -143.23 127.61 17.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.939 0.399 . . . . 10.0 111.345 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 26.7 mt -131.1 131.13 63.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.851 0.357 . . . . 10.0 111.106 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.467 ' HG3' ' HA ' ' A' ' 268' ' ' VAL . 2.0 ptp85 -126.83 114.43 17.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.3 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.94 122.82 44.27 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.881 -0.6 . . . . 10.0 111.214 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -135.71 153.39 51.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.619 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 65.34 80.71 0.22 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.145 -0.934 . . . . 10.0 112.974 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 55.02 34.14 21.81 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.801 -0.636 . . . . 10.0 112.141 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -100.94 164.04 12.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.447 -0.342 . . . . 10.0 110.559 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -147.66 153.09 38.9 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.82 0.343 . . . . 10.0 111.161 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.76 128.6 67.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.219 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.452 ' HB3' HD22 ' A' ' 276' ' ' LEU . 37.0 tt0 -129.26 131.81 47.08 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.065 -0.346 . . . . 10.0 110.065 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.957 ' HG ' ' HB ' ' A' ' 277' ' ' ILE . 0.8 OUTLIER -124.97 142.46 51.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.549 -0.296 . . . . 10.0 110.783 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.38 -109.82 0.73 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.114 -0.565 . . . . 10.0 112.023 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -160.34 147.39 15.95 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.334 -0.617 . . . . 10.0 109.334 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 79.2 t -115.59 116.83 53.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.842 0.353 . . . . 10.0 111.204 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 16.8 t -110.5 112.98 42.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.965 -0.562 . . . . 10.0 109.586 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.416 ' HB ' ' HA2' ' A' ' 282' ' ' GLY . 6.0 m -89.89 151.06 21.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.274 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.01 -15.88 57.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.0 0.428 . . . . 10.0 111.661 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -73.2 -14.36 61.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.906 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -118.99 56.61 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.192 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.488 ' HB3' ' H ' ' A' ' 251' ' ' HIS . 3.3 mm? 64.72 -135.33 0.26 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.317 -0.856 . . . . 10.0 111.951 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.488 ' H ' ' HB3' ' A' ' 250' ' ' LEU . 52.8 p-80 -119.03 -175.45 2.91 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.309 -0.405 . . . . 10.0 110.434 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -75.02 70.92 1.75 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.199 -0.524 . . . . 10.0 112.667 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -65.96 -41.11 95.5 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.114 -0.565 . . . . 10.0 112.815 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 73.6 mt 73.97 141.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 122.946 0.498 . . . . 10.0 111.823 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 61.82 84.18 0.14 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.195 0.522 . . . . 10.0 111.768 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 45.3 mt -124.16 -42.84 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.309 -0.405 . . . . 10.0 110.773 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 6.2 p -125.19 -94.34 0.48 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.203 0.445 . . . . 10.0 112.203 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.1 t0 55.69 67.9 0.94 Allowed 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.653 0.596 . . . . 10.0 110.999 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -120.32 6.62 10.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.732 -0.667 . . . . 10.0 111.005 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.495 ' HG1' ' N ' ' B' ' 225' ' ' ARG . 5.2 t -142.93 142.31 31.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.027 0.441 . . . . 10.0 111.282 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.16 119.75 28.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.757 -0.831 . . . . 10.0 108.757 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.476 ' HB3' HD12 ' B' ' 241' ' ' LEU . 69.6 m-20 -113.73 117.22 30.9 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.606 -0.516 . . . . 10.0 109.606 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 227' ' ' SER . 19.0 m -145.72 137.15 24.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.897 0.379 . . . . 10.0 111.424 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.538 HG23 ' HB3' ' B' ' 228' ' ' ALA . 7.6 p -123.75 144.81 32.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.642 -0.503 . . . . 10.0 109.642 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.553 ' HG3' ' HD3' ' A' ' 229' ' ' LYS . 32.3 tt0 -84.96 -76.33 0.32 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 112.695 0.628 . . . . 10.0 112.695 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.95 125.63 54.6 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.452 0.538 . . . . 10.0 112.452 -177.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 35.9 t -122.37 122.13 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.079 -0.51 . . . . 10.0 110.004 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.467 ' HA ' ' HG3' ' A' ' 232' ' ' ARG . 21.5 t -114.49 118.05 57.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.395 -0.366 . . . . 10.0 110.797 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.14 119.7 4.63 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.019 -0.832 . . . . 10.0 111.019 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -128.9 103.16 6.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.331 0.493 . . . . 10.0 112.331 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 92.37 91.3 1.47 Allowed Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.766 -0.73 . . . . 10.0 114.628 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 58.3 24.85 12.02 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.949 0.722 . . . . 10.0 112.949 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 9.9 m -74.99 135.04 41.34 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.231 0.539 . . . . 10.0 111.666 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 8.2 mtt180 -117.41 106.48 13.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.662 -0.699 . . . . 10.0 109.431 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 41.7 t -92.23 118.32 37.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.382 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' A' ' 240' ' ' GLN . 0.9 OUTLIER -117.57 105.77 12.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.501 -179.688 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.957 ' HB ' ' HG ' ' A' ' 241' ' ' LEU . 22.7 mm -100.71 89.23 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.632 -0.507 . . . . 10.0 109.632 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 161.66 161.49 11.91 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.505 -0.77 . . . . 10.0 111.897 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -76.76 156.65 32.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.677 0.275 . . . . 10.0 110.759 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.08 152.71 35.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.213 -0.449 . . . . 10.0 110.908 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -137.96 93.11 2.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.521 -0.763 . . . . 10.0 109.718 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.416 ' HA2' ' HB ' ' A' ' 246' ' ' THR . . . -137.02 -93.75 0.34 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.447 -0.882 . . . . 10.0 112.842 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.444 ' HA2' ' HB ' ' B' ' 246' ' ' THR . . . 125.32 -66.85 0.53 Allowed Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.223 -0.751 . . . . 10.0 111.223 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -86.49 93.1 9.07 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.253 -0.647 . . . . 10.0 109.253 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.56 86.82 1.74 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.789 -0.924 . . . . 10.0 110.789 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -58.1 98.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.048 0.388 . . . . 10.0 112.048 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 4.0 t90 59.92 -79.37 0.02 OUTLIER 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.192 0.812 . . . . 10.0 113.192 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -141.39 74.78 1.47 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.317 -0.623 . . . . 10.0 109.317 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -151.78 132.69 14.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.952 -0.567 . . . . 10.0 111.493 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -151.62 97.56 2.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.987 -0.551 . . . . 10.0 109.739 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -113.54 128.86 56.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.912 -0.585 . . . . 10.0 111.187 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -115.38 -23.99 8.61 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.977 -0.556 . . . . 10.0 109.973 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -72.77 138.53 46.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.766 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -142.73 136.1 28.61 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.357 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.296 -0.859 . . . . 10.0 110.059 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.495 ' N ' ' HG1' ' A' ' 260' ' ' THR . 5.1 tmm_? . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 110.016 -0.364 . . . . 10.0 110.016 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.511 ' ND2' ' HA2' ' B' ' 278' ' ' GLY . 74.5 m-20 -123.4 116.53 23.41 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 123.413 0.445 . . . . 10.0 110.179 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 227' ' ' SER . . . . . 0.642 ' HB2' ' CBP' ' B' ' 1' ' ' CGO . 0.0 OUTLIER -123.32 141.72 51.69 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.047 -0.524 . . . . 10.0 110.72 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.538 ' HB3' HG23 ' A' ' 264' ' ' VAL . . . -133.58 146.3 50.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.787 0.327 . . . . 10.0 111.823 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.746 ' HB2' ' HA ' ' B' ' 265' ' ' GLU . 6.0 mmtt -90.02 -79.98 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.837 0.68 . . . . 10.0 112.837 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.47 123.06 32.67 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.442 0.639 . . . . 10.0 112.094 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.478 HG23 ' HB ' ' B' ' 267' ' ' VAL . 48.6 mt -121.02 125.72 74.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.507 -0.77 . . . . 10.0 110.656 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 232' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' B' ' 232' ' ' ARG . 19.6 mtt180 -117.82 117.64 29.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.641 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 1.2 p -118.93 120.07 36.2 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.819 -0.628 . . . . 10.0 110.834 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -131.0 153.46 49.21 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.084 0.401 . . . . 10.0 112.084 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 64.31 72.71 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.387 0.884 . . . . 10.0 113.387 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 48.6 mtm-85 60.27 24.29 13.71 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.845 0.683 . . . . 10.0 112.845 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -86.58 147.14 26.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.837 0.351 . . . . 10.0 110.871 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -129.73 153.18 48.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.477 -0.329 . . . . 10.0 110.832 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.461 HG23 ' HB ' ' B' ' 275' ' ' VAL . 2.7 p -136.65 137.25 47.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.658 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -126.29 136.4 52.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.021 0.439 . . . . 10.0 110.741 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.476 HD12 ' HB3' ' A' ' 262' ' ' ASN . 0.2 OUTLIER -115.2 93.82 4.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.741 -0.663 . . . . 10.0 110.183 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 164.87 174.58 34.74 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.434 -0.889 . . . . 10.0 112.596 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -87.02 144.36 26.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.703 0.287 . . . . 10.0 110.973 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 48.3 t -102.96 111.26 32.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.523 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 48.3 t -117.76 109.39 27.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.078 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.444 ' HB ' ' HA2' ' A' ' 283' ' ' GLY . 43.1 p -84.27 171.89 12.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.011 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.23 -11.18 38.25 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.099 -0.5 . . . . 10.0 111.517 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -77.88 -21.48 51.23 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.198 0.523 . . . . 10.0 110.731 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -82.83 -7.83 59.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.786 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 40.1 tp -66.93 133.85 50.82 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.292 -0.633 . . . . 10.0 109.292 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 64.2 m80 66.11 26.56 10.65 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.457 0.473 . . . . 10.0 110.801 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -114.66 169.69 12.97 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.04 -0.6 . . . . 10.0 111.643 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -94.46 79.68 0.93 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.766 -0.73 . . . . 10.0 112.376 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 9.9 mt -79.42 63.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.007 0.432 . . . . 10.0 111.328 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 255' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' B' ' 255' ' ' ARG . 0.3 OUTLIER -168.05 78.22 0.15 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.179 0.514 . . . . 10.0 110.398 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 256' ' ' ILE . . . . . 0.411 HG22 ' HA3' ' C' ' 252' ' ' GLY . 22.6 pt -106.84 38.05 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.547 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 65.78 43.03 3.28 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.634 -0.712 . . . . 10.0 110.362 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -63.74 99.15 0.22 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.152 -0.931 . . . . 10.0 110.616 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -130.49 93.07 3.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.501 -0.772 . . . . 10.0 111.508 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 260' ' ' THR . . . . . 0.637 ' HG1' ' N ' ' C' ' 225' ' ' ARG . 5.4 t -160.24 146.54 15.59 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.886 -0.597 . . . . 10.0 109.932 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.15 121.03 44.01 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.867 -0.606 . . . . 10.0 109.634 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -107.53 122.71 47.21 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.66 -0.496 . . . . 10.0 109.66 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 263' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' B' ' 227' ' ' SER . 65.8 m -146.53 129.99 16.8 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.946 0.403 . . . . 10.0 110.955 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 7.3 p -126.53 142.46 43.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.699 -0.682 . . . . 10.0 109.889 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 265' ' ' GLU . . . . . 0.746 ' HA ' ' HB2' ' B' ' 229' ' ' LYS . 18.3 mt-10 -87.27 -75.04 0.42 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.488 0.551 . . . . 10.0 112.488 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.6 m -108.46 124.65 50.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.41 0.522 . . . . 10.0 112.41 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.478 ' HB ' HG23 ' B' ' 231' ' ' ILE . 3.1 t -122.36 107.51 19.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.763 -0.653 . . . . 10.0 109.94 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.81 118.54 44.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.418 -0.355 . . . . 10.0 111.07 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.48 113.25 2.26 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.312 -0.715 . . . . 10.0 111.312 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -130.39 120.35 24.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.231 0.456 . . . . 10.0 112.231 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 95.5 69.17 1.03 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.618 -0.801 . . . . 10.0 113.412 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 56.86 27.16 12.55 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 112.797 0.665 . . . . 10.0 112.797 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 17.7 m -67.33 156.51 36.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.464 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -128.38 116.06 19.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.686 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.461 ' HB ' HG23 ' B' ' 239' ' ' VAL . 46.0 t -100.64 115.13 41.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.914 -0.584 . . . . 10.0 109.683 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.546 ' HB2' ' CZ2' ' B' ' 287' ' ' TRP . 0.2 OUTLIER -113.17 112.66 24.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.399 -0.364 . . . . 10.0 110.515 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.429 HG22 ' HB3' ' B' ' 226' ' ' ASN . 28.1 mm -105.42 89.05 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.217 0.532 . . . . 10.0 109.659 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 278' ' ' GLY . . . . . 0.511 ' HA2' ' ND2' ' B' ' 226' ' ' ASN . . . 159.93 175.06 30.49 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.594 -0.73 . . . . 10.0 111.603 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 279' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' C' ' 243' ' ' ASN . 16.3 p-10 -93.74 164.87 12.97 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.364 -0.235 . . . . 10.0 110.364 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.1 157.93 36.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.8 0.334 . . . . 10.0 111.317 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.7 71.69 1.36 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.395 -0.82 . . . . 10.0 108.888 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -97.19 -87.99 1.85 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.015 -0.612 . . . . 10.0 112.975 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 113.84 -49.1 0.87 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.765 -0.731 . . . . 10.0 111.861 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -87.71 20.52 2.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.268 0.556 . . . . 10.0 110.45 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 171.57 174.38 39.16 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.493 -1.043 . . . . 10.0 110.493 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -122.57 76.36 1.33 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.028 -0.73 . . . . 10.0 109.028 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.555 ' CH2' ' HB2' ' C' ' 238' ' ' ARG . 15.6 t90 69.82 -59.52 0.5 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.311 -0.859 . . . . 10.0 111.641 -178.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -118.51 -172.48 2.28 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.769 -0.826 . . . . 10.0 108.769 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -101.52 126.69 48.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.224 0.535 . . . . 10.0 112.02 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -155.21 124.95 6.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.894 -0.594 . . . . 10.0 109.923 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 291' ' ' HIS . . . . . 0.609 ' HA ' ' OD1' ' C' ' 289' ' ' ASN . 30.7 t60 -159.74 137.09 9.68 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.519 -0.549 . . . . 10.0 109.519 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -148.42 -167.8 2.91 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 123.148 0.28 . . . . 10.0 110.421 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -104.46 143.15 33.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.784 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -95.19 -173.1 2.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.744 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 4.2 t60 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.905 -1.045 . . . . 10.0 109.178 179.285 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 225' ' ' ARG . . . . . 0.637 ' N ' ' HG1' ' B' ' 260' ' ' THR . 25.4 ttt180 . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 110.253 -0.277 . . . . 10.0 110.253 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 226' ' ' ASN . . . . . 0.407 ' HB3' HG22 ' C' ' 277' ' ' ILE . 29.3 m-80 -127.8 102.9 7.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.015 -0.538 . . . . 10.0 109.812 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.04 133.55 48.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.843 -0.617 . . . . 10.0 111.808 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.438 ' HB1' HD11 ' C' ' 231' ' ' ILE . . . -128.96 129.9 46.03 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.22 -0.659 . . . . 10.0 109.22 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 229' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 5.3 tmtm? -87.55 -81.75 0.23 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.087 0.403 . . . . 10.0 112.087 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -119.06 119.12 33.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.091 0.472 . . . . 10.0 111.872 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.438 HD11 ' HB1' ' C' ' 228' ' ' ALA . 59.3 mt -122.4 133.19 69.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.171 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.522 ' HD3' ' OE1' ' C' ' 234' ' ' GLU . 21.9 ttm-85 -122.97 118.83 28.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.087 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.73 101.54 7.52 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.352 -0.386 . . . . 10.0 110.634 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 234' ' ' GLU . . . . . 0.522 ' OE1' ' HD3' ' C' ' 232' ' ' ARG . 8.0 pt-20 -120.44 156.56 31.19 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.99 0.367 . . . . 10.0 111.99 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 235' ' ' GLU . . . . . 0.473 ' OE2' ' HG3' ' C' ' 270' ' ' LYS . 42.5 mt-10 68.86 68.75 0.28 Allowed 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.966 0.791 . . . . 10.0 111.946 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 57.58 33.18 22.92 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.453 -0.794 . . . . 10.0 112.603 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.29 149.15 22.47 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.864 0.364 . . . . 10.0 110.091 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 238' ' ' ARG . . . . . 0.555 ' HB2' ' CH2' ' B' ' 287' ' ' TRP . 0.3 OUTLIER -133.19 140.75 47.73 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.327 -0.397 . . . . 10.0 110.831 -179.515 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.618 HG23 ' HB ' ' C' ' 275' ' ' VAL . 4.5 p -127.53 138.86 53.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.252 -0.431 . . . . 10.0 111.011 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -123.7 123.94 41.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.974 0.416 . . . . 10.0 110.55 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -103.23 86.72 2.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.353 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.37 -177.78 42.82 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.553 -0.832 . . . . 10.0 112.707 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 243' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' B' ' 279' ' ' ASN . 2.4 p30 -93.63 151.14 19.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.667 0.27 . . . . 10.0 110.577 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 45.9 t -109.0 111.11 34.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.774 0.321 . . . . 10.0 110.617 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 23.7 t -113.94 110.76 33.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.178 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 21.3 p -75.75 161.74 28.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.854 0.359 . . . . 10.0 110.974 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.44 12.78 0.55 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.159 -0.473 . . . . 10.0 112.211 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -109.42 -6.7 15.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.159 0.504 . . . . 10.0 110.135 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -99.72 89.57 4.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.749 -0.659 . . . . 10.0 110.85 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 3.2 mp -118.41 7.08 11.85 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.869 -0.605 . . . . 10.0 111.337 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -93.84 80.66 4.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.217 0.532 . . . . 10.0 109.778 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 252' ' ' GLY . . . . . 0.411 ' HA3' HG22 ' B' ' 256' ' ' ILE . . . -123.65 148.54 16.78 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.438 -0.887 . . . . 10.0 113.188 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -140.77 127.15 3.34 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.118 -1.193 . . . . 10.0 110.118 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 11.9 tt -65.15 109.13 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.395 0.617 . . . . 10.0 112.155 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 -164.5 122.33 1.71 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.482 -0.781 . . . . 10.0 110.574 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 19.1 tt -96.35 137.53 23.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.213 0.53 . . . . 10.0 111.281 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 257' ' ' SER . . . . . 0.551 ' HB2' ' HD3' ' D' ' 255' ' ' ARG . 14.2 m -156.21 -169.6 3.1 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.621 -0.881 . . . . 10.0 108.621 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 258' ' ' ASP . . . . . 0.725 ' HB3' ' HB3' ' D' ' 257' ' ' SER . 0.8 OUTLIER -71.96 163.49 27.77 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.384 -0.228 . . . . 10.0 110.384 179.685 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -153.4 159.45 42.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.744 0.307 . . . . 10.0 111.113 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.17 113.72 15.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.681 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 261' ' ' THR . . . . . 0.602 HG22 ' HB3' ' C' ' 225' ' ' ARG . 0.3 OUTLIER -82.78 143.69 30.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.308 -0.405 . . . . 10.0 110.749 179.726 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -141.84 132.52 25.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.892 0.377 . . . . 10.0 110.683 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 16.7 m -140.97 136.85 32.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.224 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 264' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' D' ' 228' ' ' ALA . 10.3 p -122.81 137.21 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 120.877 0.37 . . . . 10.0 111.145 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 265' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 47.7 mt-10 -79.22 -73.19 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.533 0.568 . . . . 10.0 112.533 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 1.3 m -120.67 123.79 43.63 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.899 0.703 . . . . 10.0 112.899 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.436 ' HB ' HG23 ' C' ' 231' ' ' ILE . 2.8 t -121.06 116.63 50.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.248 -0.649 . . . . 10.0 109.248 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 268' ' ' VAL . . . . . 0.431 ' HB ' ' HG2' ' D' ' 232' ' ' ARG . 59.9 t -114.08 117.15 54.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.898 0.38 . . . . 10.0 111.357 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 269' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -116.09 126.02 6.89 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.762 -0.935 . . . . 10.0 110.762 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 270' ' ' LYS . . . . . 0.473 ' HG3' ' OE2' ' C' ' 235' ' ' GLU . 20.5 ttmm -133.43 125.43 29.02 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.912 0.338 . . . . 10.0 111.912 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 271' ' ' GLY . . . . . 0.46 ' H ' ' HB2' ' C' ' 235' ' ' GLU . . . 80.67 86.87 0.62 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 121.281 -0.485 . . . . 10.0 113.822 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 51.1 37.53 18.33 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.283 0.563 . . . . 10.0 111.699 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 8.0 t -78.29 163.28 25.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.698 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -143.53 121.64 12.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.791 -0.641 . . . . 10.0 110.457 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.618 ' HB ' HG23 ' C' ' 239' ' ' VAL . 33.8 t -111.35 116.56 52.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.152 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' C' ' 276' ' ' LEU . 0.4 OUTLIER -108.03 109.89 21.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.095 0.474 . . . . 10.0 110.472 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.407 HG22 ' HB3' ' C' ' 226' ' ' ASN . 27.1 mm -105.89 91.21 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.409 -0.36 . . . . 10.0 110.448 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 157.66 -174.09 35.05 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.664 -0.779 . . . . 10.0 111.476 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -97.67 149.11 22.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.873 0.336 . . . . 10.0 110.59 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -116.08 142.66 46.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.864 0.364 . . . . 10.0 111.64 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 281' ' ' TYR . . . . . 0.552 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.4 OUTLIER -124.04 96.39 4.92 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.633 -0.876 . . . . 10.0 108.633 178.583 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . -111.18 166.34 12.26 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.848 -0.692 . . . . 10.0 112.935 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -116.51 -51.51 0.38 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.776 -0.726 . . . . 10.0 112.386 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -75.58 -40.82 56.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.434 0.635 . . . . 10.0 109.725 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -165.2 -159.24 11.22 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.715 -0.954 . . . . 10.0 110.715 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -84.11 -173.02 4.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.65 0.225 . . . . 10.0 111.07 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 13.7 t90 -55.0 -33.29 62.44 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.185 0.517 . . . . 10.0 111.386 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -102.28 150.54 23.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.244 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 289' ' ' ASN . . . . . 0.609 ' OD1' ' HA ' ' B' ' 291' ' ' HIS . 4.8 p30 -131.56 54.1 1.95 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.556 0.693 . . . . 10.0 110.38 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -109.37 -18.84 13.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.434 -0.803 . . . . 10.0 111.348 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 291' ' ' HIS . . . . . 0.444 ' HB3' ' OD1' ' D' ' 288' ' ' ASP . 25.3 m80 -138.05 160.17 40.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.588 -0.278 . . . . 10.0 111.113 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 5.0 m170 68.73 175.05 0.28 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.857 0.688 . . . . 10.0 112.857 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -158.74 -85.46 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.168 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -114.8 -71.67 0.73 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.48 -0.327 . . . . 10.0 110.668 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.361 -0.828 . . . . 10.0 110.045 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 225' ' ' ARG . . . . . 0.555 ' HG2' HG23 ' D' ' 261' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 121.589 0.709 . . . . 10.0 109.466 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -101.84 135.6 43.1 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.461 -0.79 . . . . 10.0 109.535 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 227' ' ' SER . . . . . 0.643 ' HB3' ' NAV' ' B' ' 1' ' ' CGO . 29.0 m -137.9 124.5 20.9 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.745 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 228' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' C' ' 264' ' ' VAL . . . -116.83 127.72 54.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.159 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 229' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' D' ' 265' ' ' GLU . 30.7 ttmt -86.25 -73.85 0.44 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.347 0.499 . . . . 10.0 112.347 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -120.36 114.78 22.35 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.643 0.238 . . . . 10.0 111.643 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 54.1 mt -122.94 112.7 34.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.808 -0.441 . . . . 10.0 109.808 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 232' ' ' ARG . . . . . 0.431 ' HG2' ' HB ' ' C' ' 268' ' ' VAL . 36.5 mtm180 -113.44 114.79 27.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.385 -0.371 . . . . 10.0 110.446 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 233' ' ' THR . . . . . 0.432 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 0.9 OUTLIER -123.71 113.07 18.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.272 -0.422 . . . . 10.0 111.781 -179.116 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -128.65 169.97 13.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.985 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 67.72 63.4 0.41 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.065 -0.516 . . . . 10.0 111.658 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 60.2 19.69 9.07 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.451 -0.795 . . . . 10.0 112.659 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 237' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' D' ' 233' ' ' THR . . . -71.3 165.45 23.68 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.006 0.373 . . . . 10.0 112.006 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 238' ' ' ARG . . . . . 0.411 ' HG2' ' HG2' ' D' ' 274' ' ' ARG . 0.1 OUTLIER -147.85 143.56 27.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.148 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 239' ' ' VAL . . . . . 0.684 HG23 ' HB ' ' D' ' 275' ' ' VAL . 4.9 p -137.64 141.72 38.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.47 -0.332 . . . . 10.0 111.459 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 240' ' ' GLN . . . . . 0.531 ' HB3' HD22 ' D' ' 276' ' ' LEU . 0.1 OUTLIER -124.93 134.79 52.51 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.313 -0.403 . . . . 10.0 110.783 179.173 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 241' ' ' LEU . . . . . 0.618 HD13 ' HB ' ' D' ' 277' ' ' ILE . 4.0 mm? -118.11 96.11 5.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.949 -0.569 . . . . 10.0 110.394 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 170.81 -105.63 0.22 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.504 -0.855 . . . . 10.0 112.822 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -166.64 158.17 12.97 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.095 -0.335 . . . . 10.0 110.095 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 26.2 t -110.85 108.12 24.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.928 0.394 . . . . 10.0 111.594 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 245' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 28.6 t -107.47 123.44 62.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.558 -0.904 . . . . 10.0 108.558 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 246' ' ' THR . . . . . 0.533 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 34.7 p -104.58 157.83 16.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.89 0.376 . . . . 10.0 111.802 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.44 9.28 1.4 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.806 -0.634 . . . . 10.0 111.298 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -95.9 -6.13 39.91 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.067 -0.716 . . . . 10.0 109.067 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -105.64 113.51 27.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.509 -0.769 . . . . 10.0 109.923 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 87.8 mt -90.39 -175.16 4.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.137 -0.483 . . . . 10.0 111.026 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -78.06 72.2 4.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.207 0.527 . . . . 10.0 111.192 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -145.04 59.63 0.5 Allowed Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.305 -0.718 . . . . 10.0 111.305 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 88.46 41.67 6.04 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 110.957 -0.857 . . . . 10.0 110.957 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 20.3 tt -84.05 -27.25 7.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.122 0.487 . . . . 10.0 110.707 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 255' ' ' ARG . . . . . 0.551 ' HD3' ' HB2' ' C' ' 257' ' ' SER . 57.8 mtt-85 -78.73 77.71 5.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.767 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 19.7 tt -64.89 -19.63 25.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.485 . . . . 10.0 111.274 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 257' ' ' SER . . . . . 0.725 ' HB3' ' HB3' ' C' ' 258' ' ' ASP . 7.5 m 64.94 -134.54 0.24 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.495 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 258' ' ' ASP . . . . . 0.447 ' OD2' ' HD2' ' D' ' 225' ' ' ARG . 13.1 t70 -118.82 112.28 19.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.143 -0.317 . . . . 10.0 110.143 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -110.85 -79.43 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.862 0.319 . . . . 10.0 111.862 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 15.3 t -90.34 157.35 17.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.143 0.496 . . . . 10.0 111.894 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 261' ' ' THR . . . . . 0.555 HG23 ' HG2' ' D' ' 225' ' ' ARG . 55.9 m -108.64 111.97 24.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.421 -0.809 . . . . 10.0 109.512 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 262' ' ' ASN . . . . . 0.501 ' HB3' HD23 ' E' ' 241' ' ' LEU . 18.3 m120 -103.08 109.38 20.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.854 0.359 . . . . 10.0 110.255 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 16.4 m -119.29 123.27 43.82 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.273 -0.422 . . . . 10.0 110.506 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 264' ' ' VAL . . . . . 0.559 ' C ' ' HAK' ' B' ' 1' ' ' CGO . 8.8 p -125.42 129.93 72.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.605 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 265' ' ' GLU . . . . . 0.573 ' HG2' ' HAF' ' B' ' 1' ' ' CGO . 3.3 mt-10 -87.5 -73.96 0.46 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.371 0.878 . . . . 10.0 113.371 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 7.4 m -102.48 122.1 43.66 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.652 0.612 . . . . 10.0 112.652 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.35 117.72 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.199 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 33.0 t -114.25 128.02 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.024 0.44 . . . . 10.0 111.352 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 269' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' E' ' 233' ' ' THR . . . -132.84 109.5 0.84 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.834 -0.621 . . . . 10.0 111.971 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -125.92 106.73 9.85 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.814 0.301 . . . . 10.0 111.814 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 97.84 88.92 1.9 Allowed Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.834 -0.698 . . . . 10.0 114.353 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 54.24 25.43 5.8 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.338 0.866 . . . . 10.0 113.338 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 273' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' E' ' 237' ' ' ALA . 18.9 m -74.75 142.98 44.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.104 0.478 . . . . 10.0 110.998 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 274' ' ' ARG . . . . . 0.411 ' HG2' ' HG2' ' D' ' 238' ' ' ARG . 26.5 mtm180 -128.32 116.47 19.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.756 -0.656 . . . . 10.0 110.83 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 275' ' ' VAL . . . . . 0.684 ' HB ' HG23 ' D' ' 239' ' ' VAL . 23.9 t -101.81 122.76 54.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.705 -0.679 . . . . 10.0 110.173 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 276' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' D' ' 240' ' ' GLN . 0.3 OUTLIER -120.81 101.83 7.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.145 0.498 . . . . 10.0 110.658 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 277' ' ' ILE . . . . . 0.618 ' HB ' HD13 ' D' ' 241' ' ' LEU . 41.7 mm -100.97 104.24 15.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.239 -0.652 . . . . 10.0 109.239 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 278' ' ' GLY . . . . . 0.554 ' O ' ' HA3' ' E' ' 242' ' ' GLY . . . 154.34 -161.32 30.04 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.892 -0.883 . . . . 10.0 110.892 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -120.86 156.94 30.89 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.232 0.516 . . . . 10.0 111.355 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -114.57 131.58 56.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.661 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -129.18 116.37 19.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.18 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 282' ' ' GLY . . . . . 0.533 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 160.27 177.5 33.42 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.182 -1.008 . . . . 10.0 113.46 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -100.74 44.12 1.63 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.974 -0.632 . . . . 10.0 112.709 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -91.18 -18.81 23.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.128 0.489 . . . . 10.0 110.217 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 285' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' D' ' 286' ' ' PHE . . . 99.91 -32.83 6.81 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.643 -0.708 . . . . 10.0 112.419 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 286' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' D' ' 285' ' ' GLY . 3.9 t80 170.13 147.59 0.03 OUTLIER 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.022 -0.733 . . . . 10.0 109.022 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 35.4 t90 -52.5 -67.28 0.26 Allowed 'General case' 0 C--O 1.233 0.23 0 O-C-N 123.558 0.536 . . . . 10.0 109.821 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 288' ' ' ASP . . . . . 0.473 ' OD2' ' HD3' ' E' ' 238' ' ' ARG . 26.8 t0 -150.35 144.77 25.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.088 0.471 . . . . 10.0 111.785 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -163.56 141.89 7.79 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.139 -1.06 . . . . 10.0 108.139 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 290' ' ' HIS . . . . . 0.5 ' HD2' ' HD2' ' D' ' 291' ' ' HIS . 14.5 t60 -63.64 -33.83 76.49 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.073 0.768 . . . . 10.0 113.073 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 291' ' ' HIS . . . . . 0.5 ' HD2' ' HD2' ' D' ' 290' ' ' HIS . 24.9 p80 -166.82 -172.22 2.04 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.984 0.364 . . . . 10.0 111.984 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -99.43 -154.13 0.46 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.654 -0.869 . . . . 10.0 108.654 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -71.34 121.88 19.3 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.047 -0.353 . . . . 10.0 110.047 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -98.38 127.52 44.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.405 -0.361 . . . . 10.0 110.28 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.326 -0.845 . . . . 10.0 110.069 179.758 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 225' ' ' ARG . . . . . 0.603 ' N ' ' HG1' ' E' ' 261' ' ' THR . 79.1 mtt180 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.355 0.121 . . . . 10.0 110.93 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -135.35 121.67 20.38 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.99 0.424 . . . . 10.0 110.805 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.69 128.62 52.04 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.777 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.3 118.21 22.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 229' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' E' ' 265' ' ' GLU . 30.2 mmmt -82.09 -68.49 0.69 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.273 0.472 . . . . 10.0 112.273 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 230' ' ' ASP . . . . . 0.463 ' HB3' HG23 ' E' ' 266' ' ' THR . 8.3 t70 -124.87 125.25 43.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.653 0.263 . . . . 10.0 111.33 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 79.2 mt -128.02 118.35 48.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.023 -0.535 . . . . 10.0 110.82 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -115.39 105.36 12.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.423 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 233' ' ' THR . . . . . 0.426 HG22 ' HB1' ' E' ' 237' ' ' ALA . 0.3 OUTLIER -118.06 104.81 11.22 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.78 -0.645 . . . . 10.0 110.111 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 234' ' ' GLU . . . . . 0.584 ' HB2' ' HG2' ' E' ' 270' ' ' LYS . 36.0 mt-10 -123.26 149.02 45.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.246 0.461 . . . . 10.0 112.246 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 64.08 86.94 0.12 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 114.036 1.124 . . . . 10.0 114.036 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 56.45 29.36 15.17 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.603 -0.726 . . . . 10.0 112.712 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 237' ' ' ALA . . . . . 0.454 ' HB1' ' HB3' ' E' ' 273' ' ' SER . . . -91.9 155.94 17.82 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.912 -0.585 . . . . 10.0 111.336 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 238' ' ' ARG . . . . . 0.473 ' HD3' ' OD2' ' D' ' 288' ' ' ASP . 0.4 OUTLIER -136.82 147.19 46.44 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.081 179.798 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 239' ' ' VAL . . . . . 0.403 HG13 ' HA ' ' D' ' 275' ' ' VAL . 1.6 p -133.01 125.48 51.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.409 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 240' ' ' GLN . . . . . 0.433 HE21 HD12 ' D' ' 276' ' ' LEU . 8.4 tm0? -118.66 128.49 54.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.156 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 241' ' ' LEU . . . . . 0.61 ' HG ' ' HB ' ' E' ' 277' ' ' ILE . 0.1 OUTLIER -123.4 92.94 3.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.538 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 242' ' ' GLY . . . . . 0.573 ' O ' ' HA3' ' E' ' 278' ' ' GLY . . . 170.51 -161.9 34.93 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.681 -0.771 . . . . 10.0 112.274 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -107.26 147.96 29.55 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.809 0.338 . . . . 10.0 110.6 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 63.3 t -108.32 118.52 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.04 -0.527 . . . . 10.0 109.768 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 39.9 t -118.41 112.46 38.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.001 0.429 . . . . 10.0 111.701 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 246' ' ' THR . . . . . 0.864 ' HB ' ' HA2' ' E' ' 282' ' ' GLY . 7.9 t -69.69 167.23 17.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.504 -0.771 . . . . 10.0 110.749 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.46 -17.33 62.6 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.336 -0.393 . . . . 10.0 111.554 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -67.66 -24.76 65.47 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.406 -0.361 . . . . 10.0 110.766 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 57.01 -163.04 0.18 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.572 -0.74 . . . . 10.0 112.46 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 29.7 mt -89.94 125.13 35.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.856 -0.611 . . . . 10.0 109.847 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -83.65 32.44 0.47 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 10.0 112.045 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 134.22 161.4 9.57 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.833 -0.699 . . . . 10.0 112.381 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 83.89 95.72 0.63 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.143 -0.551 . . . . 10.0 112.507 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 20.2 pt -81.34 -12.72 12.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.981 0.42 . . . . 10.0 111.537 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.01 90.61 8.41 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.697 -0.483 . . . . 10.0 109.697 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 3.1 pt -113.54 92.92 2.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.943 0.72 . . . . 10.0 112.943 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 69.5 m -118.06 139.05 51.79 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -69.03 136.69 52.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.889 0.376 . . . . 10.0 111.194 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -117.93 -48.48 2.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.132 -0.486 . . . . 10.0 110.526 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 4.8 t -78.03 149.8 33.94 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.011 -0.541 . . . . 10.0 110.256 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 261' ' ' THR . . . . . 0.603 ' HG1' ' N ' ' E' ' 225' ' ' ARG . 55.8 m -127.58 113.18 15.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.306 0.574 . . . . 10.0 111.564 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -94.86 102.09 13.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.615 -0.72 . . . . 10.0 109.683 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 10.9 m -114.51 120.11 39.12 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.777 0.322 . . . . 10.0 110.455 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.1 p -114.74 144.5 22.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.229 -0.442 . . . . 10.0 111.169 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 265' ' ' GLU . . . . . 0.535 ' O ' ' HB2' ' E' ' 229' ' ' LYS . 8.1 mm-40 -86.27 -79.28 0.26 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 10.0 111.892 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 266' ' ' THR . . . . . 0.463 HG23 ' HB3' ' E' ' 230' ' ' ASP . 3.6 m -122.16 119.73 32.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.984 0.421 . . . . 10.0 111.797 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 2.7 t -113.53 105.94 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.042 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.18 125.88 68.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 110.01 -0.367 . . . . 10.0 110.01 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -149.83 136.83 5.89 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.702 -0.761 . . . . 10.0 112.123 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 270' ' ' LYS . . . . . 0.584 ' HG2' ' HB2' ' E' ' 234' ' ' GLU . 6.3 mttt -133.64 151.41 51.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.6 0.238 . . . . 10.0 110.837 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 76.3 76.33 0.82 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.086 -0.578 . . . . 10.0 112.513 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 61.32 42.03 12.34 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.998 0.428 . . . . 10.0 111.707 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 273' ' ' SER . . . . . 0.454 ' HB3' ' HB1' ' E' ' 237' ' ' ALA . 9.6 t -64.95 155.04 35.75 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.604 -0.726 . . . . 10.0 111.715 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -136.65 101.68 4.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.351 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 65.7 t -101.45 119.61 49.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.787 0.327 . . . . 10.0 110.182 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.92 114.92 19.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.351 -0.386 . . . . 10.0 110.762 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 277' ' ' ILE . . . . . 0.61 ' HB ' ' HG ' ' E' ' 241' ' ' LEU . 17.2 mm -117.9 84.38 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.799 -0.445 . . . . 10.0 109.799 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 278' ' ' GLY . . . . . 0.573 ' HA3' ' O ' ' E' ' 242' ' ' GLY . . . 178.9 -147.31 7.71 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.494 -0.86 . . . . 10.0 112.485 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.89 146.34 42.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.766 0.317 . . . . 10.0 110.694 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 280' ' ' GLU . . . . . 0.844 ' HB2' ' HA ' ' E' ' 288' ' ' ASP . 3.0 pt-20 -107.82 115.27 29.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.108 0.48 . . . . 10.0 111.156 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -142.8 91.8 2.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.002 -0.544 . . . . 10.0 110.037 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 282' ' ' GLY . . . . . 0.864 ' HA2' ' HB ' ' E' ' 246' ' ' THR . . . -147.86 -95.83 0.16 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.469 -0.872 . . . . 10.0 112.932 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 283' ' ' GLY . . . . . 0.951 ' HA2' ' HB3' ' E' ' 290' ' ' HIS . . . -168.48 -104.71 0.18 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.877 -0.889 . . . . 10.0 110.877 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? 26.24 -85.28 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.396 1.628 . . . . 10.0 115.396 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.96 32.32 0.36 Allowed Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.549 -1.02 . . . . 10.0 110.549 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -161.33 105.51 1.3 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.822 -0.807 . . . . 10.0 108.822 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 75.15 10.7 3.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.896 0.855 . . . . 10.0 109.257 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 288' ' ' ASP . . . . . 0.844 ' HA ' ' HB2' ' E' ' 280' ' ' GLU . 16.8 p-10 -159.83 154.54 24.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.196 -1.366 . . . . 10.0 109.325 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.85 161.86 28.04 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.065 0.394 . . . . 10.0 112.065 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 290' ' ' HIS . . . . . 0.951 ' HB3' ' HA2' ' E' ' 283' ' ' GLY . 4.6 p80 -164.48 167.76 19.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.607 -0.724 . . . . 10.0 109.895 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -106.26 -54.77 2.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.686 0.279 . . . . 10.0 110.679 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 63.28 -164.31 0.25 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.705 -0.679 . . . . 10.0 111.153 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -128.0 125.26 39.07 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.693 -0.484 . . . . 10.0 109.693 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -90.45 133.18 35.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.785 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.09 -0.957 . . . . 10.0 109.714 -179.948 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' CGO . . . . . 0.918 ' HBT' ' OBE' ' B' ' 1' ' ' CGO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.759 ' HB3' HG22 ' A' ' 261' ' ' THR . 2.9 tmm_? . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.977 0.418 . . . . 10.0 110.367 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -113.7 111.01 21.11 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.605 -0.887 . . . . 10.0 108.605 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 263' ' ' SER . 0.7 OUTLIER -133.06 144.85 50.28 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.052 0.76 . . . . 10.0 113.052 -178.489 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.41 151.73 47.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.106 -0.952 . . . . 10.0 108.683 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.44 ' HE3' ' HB2' ' A' ' 229' ' ' LYS . 24.1 ttmt -102.75 -61.24 1.42 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.031 0.752 . . . . 10.0 113.031 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.592 ' O ' ' HA ' ' A' ' 266' ' ' THR . 19.9 t0 -131.79 117.24 18.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.06 0.457 . . . . 10.0 111.882 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.553 HG23 ' HB ' ' A' ' 267' ' ' VAL . 56.0 mt -124.05 136.96 58.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.561 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.3 ptp85 -126.29 105.21 8.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.099 0.476 . . . . 10.0 111.662 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.21 120.33 39.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.011 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.517 ' HB2' ' HG2' ' A' ' 270' ' ' LYS . 17.6 mt-10 -132.46 140.45 48.4 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.405 0.52 . . . . 10.0 112.405 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.421 ' OE1' ' HA2' ' A' ' 271' ' ' GLY . 37.9 tt0 65.61 86.01 0.13 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.162 -0.926 . . . . 10.0 113.231 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 96.7 mtm-85 50.66 35.17 11.12 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.361 -0.836 . . . . 10.0 112.738 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.59 146.95 25.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.69 -0.232 . . . . 10.0 110.45 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -124.83 159.29 31.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.562 -0.29 . . . . 10.0 110.413 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.4 p -142.73 126.32 14.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.857 0.36 . . . . 10.0 111.218 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -118.96 139.57 51.45 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.817 -0.438 . . . . 10.0 109.817 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.13 119.43 26.48 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.095 -0.335 . . . . 10.0 110.095 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 152.31 -108.05 0.36 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.751 -0.737 . . . . 10.0 111.967 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -153.85 158.98 41.63 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.864 -0.421 . . . . 10.0 109.864 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 280' ' ' GLU . 18.1 t -110.88 113.19 43.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.126 0.489 . . . . 10.0 112.233 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 57.9 t -101.5 114.22 40.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 5.0 m -106.28 141.79 37.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.241 -0.436 . . . . 10.0 109.933 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.54 -18.15 27.2 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.539 0.57 . . . . 10.0 112.539 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -73.26 -23.49 60.34 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.287 -0.415 . . . . 10.0 111.353 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -110.26 46.19 1.06 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.199 0.523 . . . . 10.0 110.597 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 250' ' ' LEU . 2.2 mm? 66.36 -155.33 0.24 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.254 -0.884 . . . . 10.0 112.112 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -89.46 -175.64 4.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.147 -0.478 . . . . 10.0 110.849 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -76.06 77.91 1.29 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.079 -0.582 . . . . 10.0 112.463 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -67.78 -43.63 83.35 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.26 -0.495 . . . . 10.0 112.086 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 1.3 mp 69.4 136.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 112.779 0.659 . . . . 10.0 112.779 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? 65.83 89.57 0.1 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.499 -0.773 . . . . 10.0 111.977 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 3.5 mp -129.91 -55.38 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.127 -0.488 . . . . 10.0 111.462 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 5.6 p -105.87 -87.91 0.45 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.631 0.604 . . . . 10.0 112.631 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.25 42.95 17.62 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.76 -0.655 . . . . 10.0 111.634 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.414 ' H ' ' HG2' ' A' ' 259' ' ' GLN . 6.8 pt20 -84.45 -21.84 30.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.821 -0.627 . . . . 10.0 111.748 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . 0.419 ' HG1' ' N ' ' B' ' 225' ' ' ARG . 6.6 t -131.97 143.29 49.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.903 0.382 . . . . 10.0 111.119 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 225' ' ' ARG . 0.2 OUTLIER -87.06 144.12 27.02 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.757 -0.656 . . . . 10.0 109.85 179.306 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -122.06 122.96 40.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.818 0.342 . . . . 10.0 110.449 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' B' ' 227' ' ' SER . 0.9 OUTLIER -139.92 134.49 31.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.156 -0.474 . . . . 10.0 110.894 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.8 p -131.43 137.78 54.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.072 0.463 . . . . 10.0 111.342 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.583 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 40.6 tp10 -77.85 -79.25 0.12 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.862 -0.608 . . . . 10.0 112.344 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 230' ' ' ASP . 3.4 p -120.82 128.58 52.99 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.978 0.733 . . . . 10.0 112.978 -178.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.553 ' HB ' HG23 ' A' ' 231' ' ' ILE . 4.2 t -119.31 127.18 75.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.852 -0.613 . . . . 10.0 109.817 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.477 ' HB ' ' HA ' ' B' ' 232' ' ' ARG . 24.8 t -114.73 120.04 63.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.459 -0.337 . . . . 10.0 110.415 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.23 107.66 0.83 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.892 -0.671 . . . . 10.0 111.714 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.517 ' HG2' ' HB2' ' A' ' 234' ' ' GLU . 89.0 mttt -126.36 148.23 49.62 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.428 -0.212 . . . . 10.0 110.428 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . 0.421 ' HA2' ' OE1' ' A' ' 235' ' ' GLU . . . 76.84 58.96 3.32 Favored Glycine 0 C--O 1.226 -0.356 0 C-N-CA 120.797 -0.716 . . . . 10.0 113.47 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 62.15 21.29 12.32 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.923 0.712 . . . . 10.0 112.923 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 70.0 m -73.17 139.13 46.12 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.997 0.427 . . . . 10.0 111.202 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 12.5 mtt180 -104.57 123.45 47.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 10.0 111.393 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 46.0 t -102.15 117.32 47.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.087 -0.506 . . . . 10.0 109.912 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.41 114.12 21.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.867 0.365 . . . . 10.0 111.511 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 25.9 mm -107.8 103.02 14.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.842 -0.617 . . . . 10.0 109.693 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.34 142.04 3.91 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.792 -0.718 . . . . 10.0 111.908 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -61.85 149.71 39.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.933 0.397 . . . . 10.0 111.683 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.415 ' HA ' ' HB ' ' A' ' 244' ' ' VAL . 0.0 OUTLIER -109.53 158.17 18.27 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.132 -0.485 . . . . 10.0 111.543 -179.42 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -140.09 101.36 4.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.326 -0.852 . . . . 10.0 109.1 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -150.87 -115.37 0.7 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.517 -0.849 . . . . 10.0 113.055 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 146.6 -60.79 0.47 Allowed Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.225 -0.75 . . . . 10.0 111.225 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.492 ' HB3' ' HE2' ' A' ' 284' ' ' LYS . 20.9 ttpt -79.9 85.37 5.55 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.009 -0.738 . . . . 10.0 109.009 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 289' ' ' ASN . . . 95.45 105.43 2.07 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.67 -0.972 . . . . 10.0 110.67 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -75.71 76.24 2.69 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.402 -0.221 . . . . 10.0 110.402 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 18.2 t90 69.38 -58.4 0.51 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.9 -0.591 . . . . 10.0 112.098 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -135.21 90.53 2.63 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.064 -0.717 . . . . 10.0 109.064 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . 0.428 ' HB3' ' HA2' ' A' ' 285' ' ' GLY . 25.1 t-20 -150.34 119.79 6.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.781 0.324 . . . . 10.0 111.631 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -157.93 55.25 0.47 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.398 0.618 . . . . 10.0 109.972 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -105.5 121.56 44.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.644 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -123.24 2.36 9.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.16 0.505 . . . . 10.0 110.797 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -84.01 116.19 22.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.521 -0.763 . . . . 10.0 109.974 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -89.41 127.26 35.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.133 0.492 . . . . 10.0 111.081 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' HIS . . . . . 0.686 ' HE1' ' H ' ' B' ' 291' ' ' HIS . 1.1 p80 . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.355 -0.831 . . . . 10.0 110.711 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.447 ' HB3' HG22 ' B' ' 261' ' ' THR . 14.7 ttm180 . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.201 -0.296 . . . . 10.0 110.201 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -119.13 114.04 21.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.538 -0.542 . . . . 10.0 109.538 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' B' ' 263' ' ' SER . 3.4 m -129.3 134.1 47.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.011 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.71 143.38 50.7 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.695 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.586 ' HB3' ' O ' ' B' ' 265' ' ' GLU . 12.8 tptm -89.99 -79.57 0.34 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.344 -0.389 . . . . 10.0 111.723 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . 0.44 ' CG ' HH21 ' B' ' 232' ' ' ARG . 18.8 t70 -122.56 126.08 47.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.311 0.577 . . . . 10.0 112.498 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.403 HG23 ' HB ' ' B' ' 267' ' ' VAL . 65.6 mt -122.76 114.66 43.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.563 -0.744 . . . . 10.0 109.053 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . 0.477 ' HA ' ' HB ' ' A' ' 268' ' ' VAL . 1.7 ttm180 -109.87 106.78 16.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.926 0.393 . . . . 10.0 110.66 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.624 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 0.8 OUTLIER -118.08 128.69 55.0 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.13 -0.486 . . . . 10.0 111.106 -179.266 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -141.26 168.23 20.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.535 -0.302 . . . . 10.0 111.373 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . 0.487 ' OE1' ' HG2' ' B' ' 270' ' ' LYS . 34.8 mt-10 65.34 62.65 0.68 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.89 -0.595 . . . . 10.0 111.777 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 81.8 mtm-85 57.05 44.91 21.88 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.924 -0.58 . . . . 10.0 112.227 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.624 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -90.08 163.43 14.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.865 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -134.09 122.31 22.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.097 0.475 . . . . 10.0 110.362 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 p -115.86 125.61 73.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.312 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -119.79 128.24 53.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.849 -0.614 . . . . 10.0 111.089 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.35 97.51 6.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.027 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 156.18 169.15 20.03 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.909 -0.663 . . . . 10.0 112.186 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -87.95 137.86 31.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.831 0.348 . . . . 10.0 110.84 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 94.0 t -91.16 123.28 43.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.969 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 17.7 t -121.96 102.29 11.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.41 0.624 . . . . 10.0 110.493 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 68.4 p -81.57 162.8 23.0 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.661 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.412 ' HA ' ' HG ' ' B' ' 250' ' ' LEU . . . -61.95 -14.15 32.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.104 0.478 . . . . 10.0 111.254 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -75.95 -14.83 60.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.692 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -95.44 -2.16 49.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 10.0 111.111 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.412 ' HG ' ' HA ' ' B' ' 247' ' ' ALA . 87.9 mt -76.17 140.35 41.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.334 -0.394 . . . . 10.0 110.385 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 65.97 28.51 10.51 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 123.597 0.56 . . . . 10.0 110.862 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -131.11 174.22 20.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.055 -0.593 . . . . 10.0 111.714 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -83.08 115.83 4.1 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.131 -0.557 . . . . 10.0 112.478 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 29.5 pt -109.71 17.97 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.026 0.441 . . . . 10.0 111.672 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 255' ' ' ARG . . . . . 0.49 HH11 ' HA ' ' B' ' 255' ' ' ARG . 0.0 OUTLIER -129.03 103.82 7.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.27 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 20.1 pt -132.18 35.73 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 111.866 0.321 . . . . 10.0 111.866 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 62.3 m 64.29 33.53 11.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.326 0.584 . . . . 10.0 111.466 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . 0.428 ' CG ' HH12 ' B' ' 255' ' ' ARG . 0.7 OUTLIER -77.79 71.43 4.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.465 -0.789 . . . . 10.0 111.902 -179.582 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -96.15 113.8 25.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.024 -0.535 . . . . 10.0 109.777 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 14.7 t -158.82 141.76 14.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.551 0.691 . . . . 10.0 111.961 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . 0.521 ' O ' ' HD2' ' C' ' 225' ' ' ARG . 0.0 OUTLIER -110.14 95.96 5.92 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.298 -0.864 . . . . 10.0 108.813 178.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -91.37 132.21 36.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.386 -0.37 . . . . 10.0 110.66 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' B' ' 227' ' ' SER . 1.9 p -145.52 136.05 24.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.656 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.442 HG21 HG22 ' B' ' 267' ' ' VAL . 8.0 p -124.56 131.53 72.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.884 -0.598 . . . . 10.0 110.103 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . 0.586 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 17.3 tp10 -73.14 -62.74 1.36 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.333 0.494 . . . . 10.0 112.333 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' B' ' 230' ' ' ASP . 24.8 m -135.46 124.44 24.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.147 0.499 . . . . 10.0 112.087 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.442 HG22 HG21 ' B' ' 264' ' ' VAL . 20.7 t -111.33 118.95 58.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.736 -0.665 . . . . 10.0 109.356 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . 0.464 ' HB ' ' HA ' ' C' ' 232' ' ' ARG . 39.9 t -103.88 116.73 48.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.904 0.383 . . . . 10.0 110.829 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.75 113.34 2.35 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.395 -0.682 . . . . 10.0 111.395 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.487 ' HG2' ' OE1' ' B' ' 235' ' ' GLU . 2.4 ttpp -128.76 131.05 47.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.665 0.269 . . . . 10.0 111.456 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . 0.464 ' H ' ' HB2' ' B' ' 235' ' ' GLU . . . 78.47 71.94 1.2 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.571 -0.823 . . . . 10.0 113.479 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 53.05 43.8 31.22 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.386 0.884 . . . . 10.0 113.386 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.61 149.73 34.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.236 0.541 . . . . 10.0 111.552 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 38.3 mtt180 -120.0 118.7 31.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.652 -0.704 . . . . 10.0 110.024 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 47.4 t -110.11 127.17 67.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.138 -0.483 . . . . 10.0 111.062 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.51 ' HB2' ' CZ2' ' B' ' 287' ' ' TRP . 0.7 OUTLIER -123.83 109.61 13.84 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.857 -0.423 . . . . 10.0 109.857 179.269 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 36.4 mm -102.25 100.37 10.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.993 -0.373 . . . . 10.0 109.993 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.41 176.54 19.45 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.685 -0.566 . . . . 10.0 111.685 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -97.99 156.63 16.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.9 0.35 . . . . 10.0 110.576 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . 0.417 ' OE2' ' HB2' ' B' ' 287' ' ' TRP . 8.1 pt-20 -128.83 161.47 29.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.912 0.386 . . . . 10.0 111.422 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . 0.431 ' HE1' ' HA ' ' C' ' 247' ' ' ALA . 2.7 t80 -134.33 127.04 30.92 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.546 -0.752 . . . . 10.0 109.852 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' C' ' 246' ' ' THR . . . 167.74 152.34 7.47 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.774 -0.727 . . . . 10.0 112.04 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -123.97 8.38 8.64 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.509 -0.853 . . . . 10.0 111.982 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -97.67 15.17 24.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.055 0.455 . . . . 10.0 110.863 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 156.93 -176.44 34.19 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.218 -0.753 . . . . 10.0 111.218 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -127.29 64.09 1.33 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.389 -0.597 . . . . 10.0 109.389 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.638 ' CZ3' ' HB2' ' C' ' 238' ' ' ARG . 17.3 t90 70.46 -54.21 0.64 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.948 0.78 . . . . 10.0 111.42 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 288' ' ' ASP . . . . . 0.447 ' CG ' HH11 ' C' ' 238' ' ' ARG . 3.0 t70 -109.13 -168.52 1.35 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.688 -0.687 . . . . 10.0 109.617 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -111.42 132.71 54.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.058 0.456 . . . . 10.0 111.689 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.41 125.08 6.44 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 291' ' ' HIS . . . . . 0.686 ' H ' ' HE1' ' A' ' 295' ' ' HIS . 0.5 OUTLIER -160.91 143.4 12.62 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.121 -0.326 . . . . 10.0 110.121 -179.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -173.69 -161.99 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.398 -0.364 . . . . 10.0 110.462 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -122.41 149.0 44.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.613 -0.267 . . . . 10.0 111.105 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -83.85 -179.16 7.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.709 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 . . . . . 0 C--O 1.252 1.186 0 CA-C-O 117.909 -1.044 . . . . 10.0 108.852 -179.699 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . 0.706 ' N ' ' HG1' ' C' ' 261' ' ' THR . 1.7 ptt-85 . . . . . 0 N--CA 1.483 1.175 0 N-CA-C 110.21 -0.293 . . . . 10.0 110.21 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . 0.539 ' HB3' HG22 ' C' ' 277' ' ' ILE . 4.2 m120 -131.26 129.06 41.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.349 . . . . 10.0 110.661 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' C' ' 263' ' ' SER . 0.3 OUTLIER -133.07 135.46 45.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.166 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.12 138.33 45.16 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.964 -0.384 . . . . 10.0 109.964 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 18.6 tttm -94.2 -78.65 0.43 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.07 0.396 . . . . 10.0 112.07 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -109.81 116.25 31.32 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.301 0.482 . . . . 10.0 112.301 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 63.4 mt -123.93 117.45 51.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.087 -0.506 . . . . 10.0 110.101 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.533 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 9.3 ttm180 -109.26 120.69 43.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.888 0.375 . . . . 10.0 111.074 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.96 112.85 16.41 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.907 -0.775 . . . . 10.0 108.907 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . 0.533 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 11.5 pt-20 -138.08 161.07 37.72 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.347 0.499 . . . . 10.0 112.347 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 64.73 69.89 0.49 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.883 -1.053 . . . . 10.0 110.943 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 55.58 63.14 2.16 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.845 -1.071 . . . . 10.0 110.449 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -118.47 167.67 11.38 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.766 -0.652 . . . . 10.0 110.442 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . 0.638 ' HB2' ' CZ3' ' B' ' 287' ' ' TRP . 0.0 OUTLIER -153.24 141.6 20.64 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.602 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.666 HG23 ' HB ' ' C' ' 275' ' ' VAL . 5.7 p -125.13 132.81 70.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.499 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.434 ' HB3' HD22 ' C' ' 276' ' ' LEU . 4.0 tm0? -106.72 122.62 46.72 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.592 -0.731 . . . . 10.0 109.122 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.62 69.72 0.7 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.519 -0.309 . . . . 10.0 111.442 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 175.51 -169.5 42.29 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.409 -0.901 . . . . 10.0 112.228 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -95.66 144.93 25.67 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.265 -0.272 . . . . 10.0 110.265 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.96 105.99 19.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.295 -0.411 . . . . 10.0 110.363 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.66 118.71 53.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.254 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' B' ' 282' ' ' GLY . 32.2 p -76.98 163.86 26.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.069 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . 0.431 ' HA ' ' HE1' ' B' ' 281' ' ' TYR . . . -72.89 16.05 0.17 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.685 0.624 . . . . 10.0 112.685 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -121.39 0.67 10.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.067 0.461 . . . . 10.0 109.921 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -109.71 67.14 0.64 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.143 0.497 . . . . 10.0 110.576 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.31 25.84 9.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.059 -0.519 . . . . 10.0 111.295 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -113.99 67.76 0.68 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.36 0.6 . . . . 10.0 111.559 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -140.08 143.04 13.15 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.942 -0.863 . . . . 10.0 110.942 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -95.57 -145.8 19.6 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.113 -1.041 . . . . 10.0 111.833 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 6.9 tp -132.52 110.55 16.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.255 0.55 . . . . 10.0 110.475 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 42.6 ttt85 -158.26 140.5 14.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.782 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 9.6 tt -102.93 134.95 42.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 121.448 0.642 . . . . 10.0 111.587 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 57.9 m -159.73 -170.74 3.01 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.526 -0.761 . . . . 10.0 109.16 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.1 155.42 36.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.789 0.328 . . . . 10.0 111.419 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.02 132.84 12.32 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.247 -0.649 . . . . 10.0 109.247 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . 0.5 ' HA ' ' OD1' ' D' ' 258' ' ' ASP . 3.7 t -68.39 154.14 42.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.328 0.585 . . . . 10.0 112.043 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . 0.706 ' HG1' ' N ' ' C' ' 225' ' ' ARG . 52.8 m -123.44 120.61 33.46 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.451 -0.795 . . . . 10.0 110.23 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' D' ' 226' ' ' ASN . 29.5 t-20 -107.64 125.98 52.01 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.113 -0.699 . . . . 10.0 109.113 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' C' ' 227' ' ' SER . 13.4 m -136.37 131.72 34.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.016 0.436 . . . . 10.0 110.87 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 6.9 p -118.77 139.19 46.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.335 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' D' ' 229' ' ' LYS . 43.2 mt-10 -74.75 -58.59 3.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.199 -0.455 . . . . 10.0 112.046 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 2.7 m -136.51 133.98 37.08 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.386 0.513 . . . . 10.0 112.386 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 24.9 t -123.73 116.72 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.469 -0.937 . . . . 10.0 108.469 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 6.5 t -113.9 108.74 26.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 120.94 0.4 . . . . 10.0 110.906 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -119.55 125.02 6.17 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.907 -0.877 . . . . 10.0 110.907 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . 0.505 ' HG3' ' HG3' ' C' ' 234' ' ' GLU . 45.4 tttm -133.22 117.77 17.8 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.933 0.345 . . . . 10.0 111.933 -178.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 90.33 91.39 1.27 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.885 -0.674 . . . . 10.0 113.122 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 59.25 36.24 23.63 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.94 0.4 . . . . 10.0 111.688 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.85 145.67 42.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.837 -0.62 . . . . 10.0 112.447 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -139.14 109.58 6.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.714 -0.675 . . . . 10.0 110.483 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.666 ' HB ' HG23 ' C' ' 239' ' ' VAL . 22.0 t -102.68 132.74 48.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.052 -0.522 . . . . 10.0 110.651 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.434 HD22 ' HB3' ' C' ' 240' ' ' GLN . 0.2 OUTLIER -121.75 106.31 11.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.685 0.278 . . . . 10.0 110.812 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.539 HG22 ' HB3' ' C' ' 226' ' ' ASN . 23.2 mm -101.69 85.98 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.312 0.577 . . . . 10.0 110.063 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 160.83 -170.33 36.69 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.541 -0.754 . . . . 10.0 111.219 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -102.67 154.94 18.66 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.202 -0.587 . . . . 10.0 110.967 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -108.4 142.67 38.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.321 -0.399 . . . . 10.0 110.407 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . 0.559 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.3 OUTLIER -136.34 97.09 3.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.157 -0.474 . . . . 10.0 109.728 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . -145.96 158.87 27.82 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.861 -0.685 . . . . 10.0 112.781 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -106.5 -15.07 18.25 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.706 -0.759 . . . . 10.0 112.51 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -74.17 -38.59 63.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.275 0.56 . . . . 10.0 110.285 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 170.65 -112.39 0.45 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.147 -1.181 . . . . 10.0 110.147 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -126.08 -169.9 2.09 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.72 -0.474 . . . . 10.0 109.72 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -57.97 -24.3 57.48 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.272 0.558 . . . . 10.0 111.545 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -110.72 157.08 20.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.943 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 289' ' ' ASN . . . . . 0.413 ' OD1' ' HA ' ' B' ' 291' ' ' HIS . 7.5 p30 -133.85 19.84 3.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.151 0.5 . . . . 10.0 111.307 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 290' ' ' HIS . . . . . 0.666 ' HB3' ' NH2' ' D' ' 274' ' ' ARG . 5.2 t-80 -81.15 -10.13 59.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.706 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.52 168.37 22.1 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.305 0.483 . . . . 10.0 112.305 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 66.51 174.04 0.24 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.5 -0.773 . . . . 10.0 112.646 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 N-CA-C 112.351 0.5 . . . . 10.0 112.351 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . 0.493 ' O ' ' HA ' ' C' ' 262' ' ' ASN . 7.5 m120 . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 120.634 0.254 . . . . 10.0 110.995 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 1.8 m -146.42 153.46 40.5 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.277 -0.42 . . . . 10.0 110.764 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.29 148.74 46.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.624 0.249 . . . . 10.0 110.922 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . 0.653 ' HB2' ' HA ' ' D' ' 265' ' ' GLU . 17.5 mttt -89.67 -77.78 0.38 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.393 -0.367 . . . . 10.0 111.045 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -125.13 120.18 30.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.923 0.392 . . . . 10.0 110.913 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 62.1 mt -118.69 124.28 72.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.908 -0.587 . . . . 10.0 110.541 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' D' ' 232' ' ' ARG . 6.1 mtm105 -108.5 127.87 54.3 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.882 -0.599 . . . . 10.0 109.786 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . 0.502 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 0.7 OUTLIER -131.77 111.56 11.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.356 -0.384 . . . . 10.0 110.079 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -124.57 154.56 40.46 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.68 0.622 . . . . 10.0 112.68 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 58.15 78.42 0.25 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 114.996 -1.002 . . . . 10.0 113.365 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 52.82 50.62 17.65 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.237 -0.892 . . . . 10.0 111.783 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' D' ' 233' ' ' THR . . . -104.97 154.86 19.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.187 -0.461 . . . . 10.0 110.423 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.05 144.68 43.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.885 0.374 . . . . 10.0 110.912 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . 0.664 HG23 ' HB ' ' D' ' 275' ' ' VAL . 7.6 p -126.96 131.26 71.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.556 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -113.28 121.7 45.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.353 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . 0.416 HD23 HD13 ' C' ' 277' ' ' ILE . 2.6 mm? -116.06 93.49 4.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.941 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 174.64 -120.2 0.77 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.229 -0.986 . . . . 10.0 112.791 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -152.56 152.95 32.47 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.734 -0.469 . . . . 10.0 109.734 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . 0.517 HG11 ' HD1' ' D' ' 287' ' ' TRP . 22.6 t -97.12 106.37 18.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.163 -0.471 . . . . 10.0 111.873 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 21.2 t -110.16 93.48 2.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.278 -0.638 . . . . 10.0 109.278 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . 0.428 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 41.6 p -74.16 153.54 39.47 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.821 -0.351 . . . . 10.0 110.387 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . 0.442 ' HA ' ' HE1' ' C' ' 281' ' ' TYR . . . -73.29 11.63 0.72 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.826 0.346 . . . . 10.0 111.731 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -95.7 -3.99 45.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.25 0.548 . . . . 10.0 109.653 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -99.61 137.13 38.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.692 -0.686 . . . . 10.0 110.168 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 250' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' D' ' 250' ' ' LEU . 6.9 tp -118.24 -157.38 0.68 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.626 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -91.15 63.88 5.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.038 0.447 . . . . 10.0 111.338 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -132.28 36.67 2.15 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 111.063 -0.815 . . . . 10.0 111.063 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 107.52 52.35 0.72 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.418 -0.673 . . . . 10.0 111.418 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 20.1 tt -87.48 -20.89 7.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.953 0.406 . . . . 10.0 110.87 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -83.97 70.18 10.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.02 0.438 . . . . 10.0 110.794 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 18.1 tt -64.25 -30.2 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.751 -0.659 . . . . 10.0 111.851 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 7.3 m 66.18 -172.8 0.19 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.924 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 258' ' ' ASP . . . . . 0.5 ' OD1' ' HA ' ' C' ' 260' ' ' THR . 4.0 m-20 -80.92 93.94 6.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.911 0.386 . . . . 10.0 110.557 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 259' ' ' GLN . . . . . 0.434 HE21 ' HB2' ' D' ' 259' ' ' GLN . 4.7 tt0 -94.59 -44.05 8.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.12 -0.491 . . . . 10.0 111.431 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 10.3 t -123.25 150.36 43.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.921 0.391 . . . . 10.0 111.003 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 5.5 m -104.46 103.69 13.43 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.415 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' D' ' 226' ' ' ASN . 2.6 m120 -102.64 110.23 22.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.206 -0.452 . . . . 10.0 109.869 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 25.8 m -124.81 131.9 53.4 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.942 0.401 . . . . 10.0 111.047 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' E' ' 228' ' ' ALA . 11.3 p -126.95 138.13 55.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.141 -0.481 . . . . 10.0 110.375 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 265' ' ' GLU . . . . . 0.653 ' HA ' ' HB2' ' D' ' 229' ' ' LYS . 19.8 mt-10 -86.55 -73.02 0.48 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.784 0.661 . . . . 10.0 112.784 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.55 125.8 52.23 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.716 0.635 . . . . 10.0 112.716 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 4.2 t -127.82 113.88 32.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.247 -0.649 . . . . 10.0 109.247 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . 0.68 ' HB ' ' HG2' ' E' ' 232' ' ' ARG . 42.0 t -116.2 113.1 42.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 120.685 0.279 . . . . 10.0 110.976 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.55 137.09 9.44 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.001 -0.619 . . . . 10.0 112.11 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.23 135.8 19.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.638 -0.331 . . . . 10.0 111.122 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.63 89.75 0.23 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.15 -0.547 . . . . 10.0 112.861 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 59.48 38.31 22.61 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.033 0.444 . . . . 10.0 111.444 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 1.5 t -87.56 143.99 26.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.086 -0.506 . . . . 10.0 111.358 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . 0.666 ' NH2' ' HB3' ' C' ' 290' ' ' HIS . 72.0 mtt85 -131.5 110.53 11.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.408 -0.815 . . . . 10.0 109.712 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . 0.664 ' HB ' HG23 ' D' ' 239' ' ' VAL . 36.2 t -101.33 105.35 17.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.994 -0.373 . . . . 10.0 109.994 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . 0.548 HD12 ' HG2' ' E' ' 240' ' ' GLN . 2.1 tm? -107.42 103.59 12.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.929 0.395 . . . . 10.0 110.628 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 42.9 mm -105.03 96.81 4.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.216 -0.447 . . . . 10.0 109.819 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 158.28 178.84 32.69 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.508 -0.637 . . . . 10.0 111.508 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -96.0 156.95 16.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.61 0.243 . . . . 10.0 110.395 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . 0.516 ' HA ' ' HB ' ' D' ' 244' ' ' VAL . 6.0 pt-20 -118.44 131.23 56.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.843 0.354 . . . . 10.0 110.926 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -122.01 123.23 41.14 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.045 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . 0.428 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 155.53 178.68 30.0 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.378 -0.915 . . . . 10.0 112.796 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -108.59 32.77 6.68 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.945 -0.645 . . . . 10.0 112.156 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.19 -9.15 59.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.897 0.379 . . . . 10.0 110.748 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.25 -51.51 1.41 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.076 -0.583 . . . . 10.0 111.709 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -171.42 145.95 2.19 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.831 -0.803 . . . . 10.0 108.831 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . 0.517 ' HD1' HG11 ' D' ' 244' ' ' VAL . 11.5 t90 -56.07 -64.06 0.98 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.041 0.448 . . . . 10.0 110.383 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 288' ' ' ASP . . . . . 0.418 ' CG ' ' HE ' ' E' ' 238' ' ' ARG . 29.6 t0 -136.29 132.33 35.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.3 0.572 . . . . 10.0 110.473 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -171.85 146.64 2.08 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -69.57 -58.96 3.3 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.849 0.685 . . . . 10.0 112.849 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -161.08 -163.04 0.97 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.826 0.306 . . . . 10.0 111.826 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -86.06 -170.49 3.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.891 -0.595 . . . . 10.0 109.819 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -72.76 117.78 14.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.012 0.434 . . . . 10.0 110.987 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -99.07 148.11 24.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.86 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 117.764 -1.112 . . . . 10.0 108.392 178.888 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . 0.517 ' N ' ' HG1' ' E' ' 261' ' ' THR . 57.9 mtt180 . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 110.283 -0.265 . . . . 10.0 110.283 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -128.5 121.33 28.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.369 . . . . 10.0 110.998 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' E' ' 263' ' ' SER . 0.6 OUTLIER -123.0 144.46 49.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.718 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' D' ' 264' ' ' VAL . . . -139.62 125.83 20.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.29 -0.413 . . . . 10.0 109.938 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' D' ' 265' ' ' GLU . 33.5 mttm -84.0 -62.59 1.53 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.05 0.759 . . . . 10.0 113.05 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . 0.733 ' HB3' HG23 ' E' ' 266' ' ' THR . 8.9 t0 -130.85 125.4 33.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.779 0.323 . . . . 10.0 111.142 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 86.5 mt -133.59 123.97 47.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.042 -0.526 . . . . 10.0 110.306 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . 0.68 ' HG2' ' HB ' ' D' ' 268' ' ' VAL . 7.5 mtt180 -122.23 120.35 33.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.143 -0.481 . . . . 10.0 110.538 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 1.2 p -130.45 93.78 3.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.518 -0.764 . . . . 10.0 110.295 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . 0.631 ' HB2' ' HE3' ' E' ' 270' ' ' LYS . 36.1 mt-10 -119.29 152.11 37.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.334 -0.393 . . . . 10.0 111.0 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 70.72 77.22 0.19 Allowed 'General case' 0 C--O 1.236 0.362 0 O-C-N 123.912 0.757 . . . . 10.0 112.335 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 33.1 mtp180 60.67 24.43 14.23 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.078 -0.965 . . . . 10.0 112.246 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -103.47 150.93 23.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.197 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . 0.419 ' HB3' ' HB2' ' D' ' 274' ' ' ARG . 0.0 OUTLIER -144.55 164.57 30.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.201 -0.454 . . . . 10.0 111.777 -179.203 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . 0.743 HG23 ' HB ' ' E' ' 275' ' ' VAL . 7.7 p -134.63 142.58 40.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.767 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . 0.548 ' HG2' HD12 ' D' ' 276' ' ' LEU . 25.5 tm0? -129.89 131.44 46.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.796 -0.638 . . . . 10.0 109.313 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . 0.469 ' HG ' ' HB ' ' E' ' 277' ' ' ILE . 0.4 OUTLIER -128.98 95.35 4.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.075 0.464 . . . . 10.0 111.786 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 166.32 170.76 31.64 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.435 -0.666 . . . . 10.0 111.435 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -88.14 147.59 24.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.827 0.346 . . . . 10.0 110.924 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.15 125.15 49.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.561 -0.533 . . . . 10.0 109.561 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.9 98.51 7.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.002 0.43 . . . . 10.0 109.86 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . 0.449 ' HB ' ' HA2' ' E' ' 282' ' ' GLY . 14.7 t -60.93 161.92 7.62 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.729 -0.669 . . . . 10.0 111.578 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.09 -19.38 64.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.29 -0.414 . . . . 10.0 111.805 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -74.49 -23.47 58.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.536 -0.302 . . . . 10.0 110.242 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 58.07 -170.28 0.11 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.384 -0.826 . . . . 10.0 112.199 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 6.8 mp -83.99 115.66 22.44 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.234 -0.654 . . . . 10.0 109.234 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 . . . . . 0 C--N 1.325 -0.459 0 N-CA-C 112.019 0.378 . . . . 10.0 112.019 -179.354 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 15.3 pt . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.802 0.334 . . . . 10.0 111.42 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.24 159.24 8.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.919 -0.582 . . . . 10.0 109.833 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.83 140.75 32.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.835 0.35 . . . . 10.0 110.225 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -114.11 -65.91 1.14 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.056 0.455 . . . . 10.0 111.113 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 15.3 t -71.46 146.31 48.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.278 0.561 . . . . 10.0 111.868 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . 0.517 ' HG1' ' N ' ' E' ' 225' ' ' ARG . 91.8 m -123.8 110.05 14.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.566 -0.743 . . . . 10.0 109.624 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -111.08 130.76 55.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.84 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' E' ' 227' ' ' SER . 25.1 m -132.66 120.97 22.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.169 -0.469 . . . . 10.0 109.871 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 7.9 p -98.39 143.59 12.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.418 -0.355 . . . . 10.0 110.393 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -76.79 -75.89 0.18 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.358 -0.383 . . . . 10.0 111.895 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . 0.733 HG23 ' HB3' ' E' ' 230' ' ' ASP . 7.7 m -139.81 120.22 14.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.968 0.414 . . . . 10.0 111.14 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 15.1 t -106.4 115.6 48.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.587 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 42.2 t -116.41 97.73 5.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.514 -0.55 . . . . 10.0 109.514 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.89 119.6 4.2 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.864 -0.684 . . . . 10.0 112.08 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . 0.631 ' HE3' ' HB2' ' E' ' 234' ' ' GLU . 15.5 mtpt -132.04 133.32 44.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.525 0.202 . . . . 10.0 110.644 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.75 73.91 1.17 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.747 -0.739 . . . . 10.0 112.696 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 62.92 25.05 14.88 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.023 0.749 . . . . 10.0 113.023 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 4.6 m -79.06 157.77 27.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.206 0.527 . . . . 10.0 111.352 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -142.18 126.15 17.24 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.556 -0.747 . . . . 10.0 109.752 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . 0.743 ' HB ' HG23 ' E' ' 239' ' ' VAL . 18.8 t -102.63 117.64 48.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.448 -0.342 . . . . 10.0 110.142 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . 0.445 HD22 ' HB3' ' E' ' 240' ' ' GLN . 0.2 OUTLIER -109.9 103.27 12.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.267 -0.424 . . . . 10.0 110.315 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . 0.469 ' HB ' ' HG ' ' E' ' 241' ' ' LEU . 37.7 mm -116.52 91.82 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.102 0.477 . . . . 10.0 110.538 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 173.91 -164.59 36.04 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.932 -0.867 . . . . 10.0 110.932 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -95.45 126.76 40.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.722 0.261 . . . . 10.0 110.49 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' E' ' 280' ' ' GLU . 3.4 pm0 -88.41 127.77 35.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.258 0.552 . . . . 10.0 111.77 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -161.99 77.12 0.5 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.847 -0.615 . . . . 10.0 109.961 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . 0.449 ' HA2' ' HB ' ' E' ' 246' ' ' THR . . . -112.92 -82.11 1.14 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.862 -0.685 . . . . 10.0 112.499 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 283' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' E' ' 290' ' ' HIS . . . 135.15 39.85 0.17 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.638 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.21 -63.98 1.21 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.949 0.351 . . . . 10.0 111.949 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 135.84 28.28 0.4 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.318 -0.944 . . . . 10.0 113.293 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -150.68 105.43 3.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.188 -0.671 . . . . 10.0 109.188 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER 68.26 18.03 9.25 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.892 0.853 . . . . 10.0 108.92 -177.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.2 170.48 21.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.938 -1.483 . . . . 10.0 108.098 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -155.37 165.44 36.61 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 121.237 -0.185 . . . . 10.0 110.654 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 290' ' ' HIS . . . . . 0.592 ' HB3' ' HA2' ' E' ' 283' ' ' GLY . 31.5 p-80 -160.24 164.35 32.8 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -81.5 -68.27 0.71 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.304 -0.158 . . . . 10.0 110.699 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 292' ' ' HIS . . . . . 0.571 ' HB2' ' CD2' ' E' ' 290' ' ' HIS . 3.8 t60 69.71 171.5 0.3 Allowed 'General case' 0 CA--C 1.533 0.29 0 O-C-N 123.737 0.648 . . . . 10.0 111.862 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -101.32 116.88 33.8 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.971 -0.558 . . . . 10.0 110.138 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -103.02 127.16 50.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.934 -0.575 . . . . 10.0 110.219 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.834 0 CA-C-O 118.34 -0.838 . . . . 10.0 109.334 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 225' ' ' ARG . 35.5 ttt180 . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.569 0.223 . . . . 10.0 110.585 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -121.82 120.15 33.74 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.352 -0.61 . . . . 10.0 109.352 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 60.6 m -137.29 135.89 37.53 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.589 0.588 . . . . 10.0 112.589 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.48 129.55 43.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.517 -0.765 . . . . 10.0 109.101 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -89.86 -72.47 0.56 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.526 0.565 . . . . 10.0 112.526 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 266' ' ' THR . 41.3 t0 -113.32 120.48 41.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.08 0.467 . . . . 10.0 111.369 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.425 HD12 HG11 ' A' ' 239' ' ' VAL . 8.2 pt -129.18 127.68 65.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.753 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.423 ' HG3' ' HA ' ' A' ' 268' ' ' VAL . 3.6 ptp85 -129.54 125.56 36.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.918 0.389 . . . . 10.0 111.341 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.35 108.49 10.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.231 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.4 ' HB2' ' HD3' ' A' ' 270' ' ' LYS . 5.2 mt-10 -114.57 141.62 47.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 10.0 112.164 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 64.82 93.74 0.06 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 114.189 1.181 . . . . 10.0 114.189 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 50.33 35.12 10.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.564 -0.743 . . . . 10.0 112.94 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -108.8 159.39 16.82 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.201 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -150.4 156.12 40.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.143 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.425 HG11 HD12 ' A' ' 231' ' ' ILE . 4.1 p -136.53 133.45 49.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.164 -0.471 . . . . 10.0 111.107 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -121.29 148.21 44.62 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.772 -0.455 . . . . 10.0 109.772 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 tt -124.99 129.34 50.13 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.068 -0.345 . . . . 10.0 110.068 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.675 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 135.85 -146.68 18.67 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.938 -0.648 . . . . 10.0 112.207 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -121.98 151.46 40.76 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 48.2 t -120.57 101.11 10.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.22 0.533 . . . . 10.0 111.331 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 65.3 t -92.89 115.83 32.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.176 -0.676 . . . . 10.0 109.176 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 43.9 p -82.63 171.05 14.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.741 0.305 . . . . 10.0 111.0 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -71.38 -6.65 41.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.123 0.487 . . . . 10.0 110.958 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -95.51 7.48 46.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.192 0.52 . . . . 10.0 110.14 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -115.2 32.18 6.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.416 -0.811 . . . . 10.0 109.977 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.434 ' HA ' HD13 ' A' ' 250' ' ' LEU . 2.9 mm? 69.62 -85.13 0.03 OUTLIER 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.161 -0.927 . . . . 10.0 112.893 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -148.46 166.58 27.73 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.843 0.354 . . . . 10.0 111.495 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -78.69 69.77 2.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.115 -0.564 . . . . 10.0 112.056 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -76.28 -43.79 19.52 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 121.155 -0.545 . . . . 10.0 112.043 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 64.3 mt 71.41 146.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 123.005 0.522 . . . . 10.0 111.331 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? 70.48 80.33 0.17 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.501 0.667 . . . . 10.0 111.746 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 3.9 mp -114.09 -46.61 4.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.508 -0.769 . . . . 10.0 110.005 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.44 -65.06 0.78 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.901 -0.59 . . . . 10.0 110.234 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 55.95 31.93 18.85 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.992 -0.549 . . . . 10.0 112.157 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -91.07 12.51 19.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.641 -0.709 . . . . 10.0 112.328 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 15.1 t -117.4 143.38 46.05 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.564 0.697 . . . . 10.0 112.674 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.564 ' HB ' ' HG3' ' B' ' 225' ' ' ARG . 0.6 OUTLIER -114.0 101.23 9.05 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.226 -1.027 . . . . 10.0 108.226 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.446 ' ND2' ' HA2' ' B' ' 242' ' ' GLY . 52.2 m-20 -98.52 127.19 44.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.053 -0.521 . . . . 10.0 110.428 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' B' ' 227' ' ' SER . 0.3 OUTLIER -138.02 123.08 19.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.848 -0.615 . . . . 10.0 110.983 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.451 HG21 HG22 ' A' ' 267' ' ' VAL . 14.8 p -123.65 133.82 68.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.287 0.565 . . . . 10.0 111.57 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.583 ' HB3' ' HA ' ' B' ' 229' ' ' LYS . 37.3 tp10 -79.6 -70.88 0.48 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.569 -0.742 . . . . 10.0 112.175 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 230' ' ' ASP . 3.2 m -129.81 126.92 39.21 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.101 0.477 . . . . 10.0 112.105 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.451 HG22 HG21 ' A' ' 264' ' ' VAL . 3.6 t -117.09 126.64 74.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.979 -0.555 . . . . 10.0 109.64 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.451 ' HB ' ' HA ' ' B' ' 232' ' ' ARG . 41.9 t -117.73 122.59 70.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.85 0.357 . . . . 10.0 111.474 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.52 119.62 3.89 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.218 -1.153 . . . . 10.0 110.218 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.4 ' HD3' ' HB2' ' A' ' 234' ' ' GLU . 2.0 tppt? -126.43 110.58 13.47 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.439 0.533 . . . . 10.0 112.439 -178.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.53 91.7 0.77 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.945 -0.645 . . . . 10.0 114.198 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' B' ' 236' ' ' ARG . 38.6 mt-10 51.92 44.06 29.74 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.721 0.637 . . . . 10.0 112.721 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.9 m -96.45 132.58 41.85 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.121 0.486 . . . . 10.0 110.689 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -107.2 114.25 28.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.065 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 30.0 t -105.36 123.12 59.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.508 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.94 108.51 15.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.15 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.496 ' HA ' ' HB2' ' B' ' 241' ' ' LEU . 25.1 mm -93.13 90.4 2.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.768 -0.456 . . . . 10.0 109.768 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.675 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 152.34 -172.52 31.54 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.972 -0.558 . . . . 10.0 112.041 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -101.47 161.24 13.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.077 0.465 . . . . 10.0 111.089 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.99 175.09 7.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.985 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -139.31 67.14 1.39 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.495 -0.775 . . . . 10.0 109.272 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -81.98 115.19 3.97 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.67 -0.695 . . . . 10.0 113.611 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -101.97 -28.78 6.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.824 -0.703 . . . . 10.0 111.854 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -89.8 -45.67 9.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.327 0.584 . . . . 10.0 109.764 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -163.33 156.53 28.35 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.472 -1.051 . . . . 10.0 110.472 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -67.5 112.38 4.64 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 109.549 -0.538 . . . . 10.0 109.549 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 2.3 t90 65.92 -80.38 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 O-C-N 123.797 0.686 . . . . 10.0 110.693 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -162.61 28.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.743 0.782 . . . . 10.0 109.353 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -74.84 117.34 16.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.572 -0.74 . . . . 10.0 111.458 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 -129.06 105.08 7.95 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.919 0.39 . . . . 10.0 110.4 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -115.12 141.68 47.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.673 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -121.4 -53.75 2.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.045 0.45 . . . . 10.0 110.998 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -71.74 142.34 49.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.749 -0.659 . . . . 10.0 110.511 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -143.69 147.35 34.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.347 -0.388 . . . . 10.0 110.427 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 2.7 p80 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.089 -0.958 . . . . 10.0 110.465 179.717 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.564 ' HG3' ' HB ' ' A' ' 261' ' ' THR . 22.9 ttm180 . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 109.845 -0.428 . . . . 10.0 109.845 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -117.59 116.25 26.72 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.522 -0.548 . . . . 10.0 109.522 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' B' ' 263' ' ' SER . 18.5 m -130.15 136.91 49.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.894 0.378 . . . . 10.0 111.018 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.76 148.34 52.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.599 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.583 ' HA ' ' HB3' ' A' ' 265' ' ' GLU . 56.8 tttp -102.84 -80.52 0.51 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 112.855 0.687 . . . . 10.0 112.855 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -112.66 115.0 27.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.778 0.323 . . . . 10.0 111.665 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.42 HG21 HG21 ' B' ' 239' ' ' VAL . 62.2 mt -120.14 111.07 30.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.349 -0.612 . . . . 10.0 109.349 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . 0.451 ' HA ' ' HB ' ' A' ' 268' ' ' VAL . 12.0 mtt180 -109.93 107.68 17.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.064 0.459 . . . . 10.0 111.387 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 0.6 OUTLIER -115.51 122.31 45.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.629 -0.714 . . . . 10.0 110.727 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -130.83 155.52 46.57 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 112.403 0.52 . . . . 10.0 112.403 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 65.31 77.04 0.32 Allowed 'General case' 0 C--O 1.232 0.136 0 N-CA-C 113.914 1.079 . . . . 10.0 113.914 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . 0.611 ' HB2' ' HG2' ' B' ' 272' ' ' GLU . 44.2 mtm-85 56.13 26.72 10.53 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.55 -0.75 . . . . 10.0 112.824 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.466 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -79.49 151.88 30.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.991 0.424 . . . . 10.0 110.806 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.81 133.02 49.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.968 -0.56 . . . . 10.0 110.789 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.603 HG23 ' HB ' ' B' ' 275' ' ' VAL . 4.2 p -130.71 137.43 56.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.09 -0.504 . . . . 10.0 110.976 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -125.22 130.06 51.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.978 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 277' ' ' ILE . 4.0 mm? -103.24 73.01 1.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.731 -0.668 . . . . 10.0 110.42 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . 0.446 ' HA2' ' ND2' ' A' ' 262' ' ' ASN . . . -179.41 -178.59 48.45 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.315 -0.945 . . . . 10.0 112.824 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . 0.486 HD21 HG22 ' B' ' 245' ' ' VAL . 0.2 OUTLIER -95.58 157.58 15.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.662 0.268 . . . . 10.0 110.355 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 56.6 t -104.36 123.95 58.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.084 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . 0.486 HG22 HD21 ' B' ' 243' ' ' ASN . 16.9 t -122.02 100.25 8.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.297 -0.631 . . . . 10.0 109.297 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 29.8 p -80.59 170.09 16.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.399 -0.364 . . . . 10.0 110.885 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.29 -10.05 52.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.066 -0.516 . . . . 10.0 111.599 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -79.24 -17.36 54.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.83 0.347 . . . . 10.0 110.681 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -88.48 -0.61 57.39 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.776 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 44.6 tp -72.65 117.0 13.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.707 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 50.2 m80 67.98 76.69 0.26 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.298 -0.864 . . . . 10.0 111.24 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -171.24 -166.08 29.52 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.663 -0.699 . . . . 10.0 111.705 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -87.6 109.55 3.49 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.817 -0.706 . . . . 10.0 111.87 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 26.2 pt -101.98 13.72 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.992 0.425 . . . . 10.0 111.207 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 12.0 tpt85 -141.37 104.68 4.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.036 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 256' ' ' ILE . . . . . 0.862 ' HA ' ' HA3' ' C' ' 252' ' ' GLY . 10.4 pt -107.0 29.04 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.711 0.291 . . . . 10.0 111.172 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.7 t 64.39 28.54 13.64 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.7 0.762 . . . . 10.0 110.198 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -74.88 139.8 43.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.928 -1.033 . . . . 10.0 111.054 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 19.9 tm0? -152.2 106.52 3.17 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.742 -0.663 . . . . 10.0 109.917 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 6.3 t -162.07 163.02 28.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.373 -0.376 . . . . 10.0 111.017 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.24 122.45 37.79 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.836 -0.62 . . . . 10.0 109.456 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -103.85 111.31 23.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.975 0.417 . . . . 10.0 109.918 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' B' ' 227' ' ' SER . 9.8 m -131.51 119.17 21.17 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.163 0.506 . . . . 10.0 111.118 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 12.3 p -115.15 135.25 55.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.865 -0.607 . . . . 10.0 109.978 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 44.8 tt0 -82.65 -73.15 0.41 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.575 0.583 . . . . 10.0 112.575 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.6 125.83 53.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.889 0.376 . . . . 10.0 111.948 -178.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 2.3 t -124.18 121.68 62.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.864 -0.607 . . . . 10.0 109.584 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 47.6 t -112.63 118.61 58.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.765 0.317 . . . . 10.0 111.079 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.79 113.82 2.28 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 111.288 -0.725 . . . . 10.0 111.288 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -127.92 132.1 49.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.646 0.26 . . . . 10.0 111.074 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.81 66.9 1.44 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.922 -0.656 . . . . 10.0 112.358 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . 0.611 ' HG2' ' HB2' ' B' ' 236' ' ' ARG . 28.9 mt-10 53.43 46.89 25.31 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.819 0.674 . . . . 10.0 112.819 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 6.4 t -77.53 167.16 22.08 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.247 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -135.49 117.46 15.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.099 -0.5 . . . . 10.0 110.017 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.603 ' HB ' HG23 ' B' ' 239' ' ' VAL . 34.5 t -112.11 119.51 60.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.087 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.95 113.59 22.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.961 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 23.1 mm -104.25 86.93 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.101 0.476 . . . . 10.0 109.847 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 158.46 168.62 20.92 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.871 -0.891 . . . . 10.0 110.871 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -88.33 167.39 13.57 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.31 0.555 . . . . 10.0 111.235 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.49 167.2 19.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.151 0.5 . . . . 10.0 111.672 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -147.7 78.77 1.47 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.42 -0.809 . . . . 10.0 108.954 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -94.43 -111.4 2.33 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.832 -0.699 . . . . 10.0 112.865 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 132.27 -36.3 2.21 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.713 -0.756 . . . . 10.0 111.379 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -101.82 23.8 10.83 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 165.06 -175.97 40.86 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.516 -1.434 . . . . 10.0 109.516 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -131.11 65.79 1.55 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 117.068 0.434 . . . . 10.0 109.859 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 26.6 t90 71.26 -47.28 0.66 Allowed 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.836 0.71 . . . . 10.0 111.872 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -116.0 -169.92 1.69 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.791 -0.641 . . . . 10.0 109.31 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -118.3 126.06 51.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.333 0.587 . . . . 10.0 111.849 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -156.47 123.6 5.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.461 -0.791 . . . . 10.0 109.359 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -155.55 138.05 15.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.509 -0.314 . . . . 10.0 110.691 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -168.58 -176.61 2.84 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.512 -0.551 . . . . 10.0 109.512 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -105.76 159.38 16.04 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.678 0.275 . . . . 10.0 110.608 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -91.49 -164.45 1.18 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.013 0.435 . . . . 10.0 111.317 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.067 -0.968 . . . . 10.0 109.63 179.91 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.681 0.277 . . . . 10.0 110.962 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' C' ' 262' ' ' ASN . 2.2 m120 -132.19 113.99 13.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 16.5 m -124.67 141.58 52.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.102 0.477 . . . . 10.0 111.905 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.9 139.54 52.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.636 -0.711 . . . . 10.0 110.512 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' B' ' 265' ' ' GLU . 2.4 tmtm? -84.96 -69.11 0.67 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.121 -0.491 . . . . 10.0 111.912 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -129.4 117.0 19.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.915 0.388 . . . . 10.0 111.658 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.404 HG21 HG21 ' C' ' 239' ' ' VAL . 70.2 mt -120.14 120.6 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.138 -0.483 . . . . 10.0 109.749 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.584 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 15.1 ttm-85 -116.21 115.54 26.17 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.215 -0.448 . . . . 10.0 111.269 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.53 99.0 6.09 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.248 0.546 . . . . 10.0 110.88 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . 0.584 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 8.8 pt-20 -121.22 170.99 9.04 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.004 -0.543 . . . . 10.0 110.557 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . 0.451 ' HB3' ' H ' ' C' ' 271' ' ' GLY . 0.8 OUTLIER 67.87 59.18 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.841 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 10.4 mtp180 63.29 16.79 9.74 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.026 0.75 . . . . 10.0 113.026 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -77.38 176.69 8.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.869 0.366 . . . . 10.0 111.171 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.09 152.05 20.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.203 -0.453 . . . . 10.0 110.747 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.738 HG23 ' HB ' ' C' ' 275' ' ' VAL . 8.2 p -131.92 140.35 48.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.052 0.453 . . . . 10.0 111.428 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -117.14 121.81 42.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.855 -0.611 . . . . 10.0 110.175 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.533 HD13 ' HB ' ' C' ' 277' ' ' ILE . 3.7 mm? -106.44 86.23 2.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.62 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.28 -173.09 43.65 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.341 -0.933 . . . . 10.0 112.816 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -97.99 145.82 26.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.72 0.295 . . . . 10.0 110.656 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 36.8 t -106.87 103.64 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.087 0.47 . . . . 10.0 110.868 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 19.9 t -111.58 112.37 40.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.014 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 34.2 p -82.34 160.94 22.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.426 -0.352 . . . . 10.0 111.145 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.0 5.39 1.17 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.249 0.463 . . . . 10.0 112.249 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -96.48 3.4 52.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.196 -0.457 . . . . 10.0 109.826 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -116.03 84.66 2.15 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.906 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 84.8 mt -95.85 -9.73 30.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.596 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -84.0 110.78 18.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.701 -0.681 . . . . 10.0 109.69 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 252' ' ' GLY . . . . . 0.862 ' HA3' ' HA ' ' B' ' 256' ' ' ILE . . . -144.2 -90.14 0.11 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.51 -0.852 . . . . 10.0 112.786 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 100.66 -156.23 19.35 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.686 -0.769 . . . . 10.0 111.608 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 8.0 tt -147.99 104.23 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.281 0.562 . . . . 10.0 111.304 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -157.43 137.49 12.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.965 -0.561 . . . . 10.0 109.931 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 15.3 tt -103.57 133.87 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.034 0.445 . . . . 10.0 110.813 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 41.1 m -155.96 179.66 9.0 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.404 -0.591 . . . . 10.0 109.404 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 258' ' ' ASP . . . . . 0.553 ' HB3' ' HB3' ' D' ' 257' ' ' SER . 25.8 t0 -72.84 167.13 21.57 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.714 -0.221 . . . . 10.0 110.868 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -158.93 152.98 23.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.606 -0.27 . . . . 10.0 110.521 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . 0.443 ' HA ' ' OD2' ' D' ' 258' ' ' ASP . 6.8 t -64.98 132.27 48.81 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.238 0.542 . . . . 10.0 111.152 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 32.5 m -92.36 126.29 37.38 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.001 -0.545 . . . . 10.0 109.759 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' D' ' 226' ' ' ASN . 1.8 m-80 -118.9 123.76 45.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.688 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' D' ' 227' ' ' SER . 14.2 m -141.75 142.3 33.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.079 -0.509 . . . . 10.0 110.244 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . 0.522 HG23 ' HB3' ' D' ' 228' ' ' ALA . 8.8 p -133.51 144.13 36.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.066 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' D' ' 229' ' ' LYS . 43.1 mt-10 -83.19 -75.92 0.3 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.291 0.478 . . . . 10.0 112.291 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 24.3 m -113.52 127.61 56.15 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.125 0.787 . . . . 10.0 113.125 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.92 109.31 20.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.357 -0.838 . . . . 10.0 108.958 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . 0.561 ' HB ' ' HG2' ' D' ' 232' ' ' ARG . 37.1 t -107.41 125.99 63.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.025 0.44 . . . . 10.0 110.864 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -134.04 120.93 2.6 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.885 -0.598 . . . . 10.0 112.022 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -138.53 124.65 20.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.141 0.496 . . . . 10.0 111.2 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . 0.451 ' H ' ' HB3' ' C' ' 235' ' ' GLU . . . 97.25 74.96 1.21 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.83 -0.7 . . . . 10.0 113.101 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 59.06 22.36 10.41 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.665 0.617 . . . . 10.0 112.665 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 16.0 m -69.55 149.61 48.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.085 0.469 . . . . 10.0 111.916 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . 0.46 ' HB3' ' CZ3' ' C' ' 287' ' ' TRP . 2.3 mtm180 -132.37 122.29 24.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.171 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.738 ' HB ' HG23 ' C' ' 239' ' ' VAL . 41.3 t -108.91 129.61 63.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.742 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.409 HD12 HE21 ' D' ' 240' ' ' GLN . 1.8 tm? -121.31 110.51 16.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.289 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.533 ' HB ' HD13 ' C' ' 241' ' ' LEU . 30.5 mm -107.93 94.14 2.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.135 0.493 . . . . 10.0 110.316 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 160.28 -160.08 31.38 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.565 -0.614 . . . . 10.0 111.565 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -115.53 150.49 36.49 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.315 -0.254 . . . . 10.0 110.315 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -119.29 145.23 46.3 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.075 0.464 . . . . 10.0 112.166 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . 0.523 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.3 OUTLIER -127.63 98.59 5.26 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.373 -0.831 . . . . 10.0 108.943 179.363 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' D' ' 246' ' ' THR . . . -145.55 159.93 28.0 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.546 -0.835 . . . . 10.0 112.757 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -106.95 -30.86 4.07 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.748 -0.739 . . . . 10.0 112.894 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -59.72 -45.09 93.22 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.922 0.391 . . . . 10.0 111.036 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 173.47 -128.2 1.46 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.642 -0.983 . . . . 10.0 110.642 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -110.12 -166.18 1.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.209 -0.293 . . . . 10.0 110.209 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.46 ' CZ3' ' HB3' ' C' ' 274' ' ' ARG . 0.8 OUTLIER -54.4 -30.11 51.16 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.156 0.798 . . . . 10.0 113.156 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.83 157.28 31.44 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 122.336 -0.227 . . . . 10.0 110.718 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -123.83 30.4 6.18 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.36 0.504 . . . . 10.0 112.36 -178.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 290' ' ' HIS . . . . . 0.719 ' HB3' ' NH2' ' D' ' 274' ' ' ARG . 1.5 t-80 -85.7 -17.67 35.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.454 -0.339 . . . . 10.0 110.942 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.67 153.68 51.5 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.995 -0.441 . . . . 10.0 111.619 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.86 179.23 0.16 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 123.654 0.596 . . . . 10.0 110.875 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.333 -0.124 0 N-CA-C 113.992 1.108 . . . . 10.0 113.992 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . 0.632 ' HB3' HG22 ' D' ' 277' ' ' ILE . 20.0 m120 . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 109.859 -0.423 . . . . 10.0 109.859 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' C' ' 263' ' ' SER . 0.0 OUTLIER -129.02 140.72 51.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.985 0.422 . . . . 10.0 111.668 -178.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . 0.522 ' HB3' HG23 ' C' ' 264' ' ' VAL . . . -130.01 147.48 51.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.135 -0.484 . . . . 10.0 110.509 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' C' ' 265' ' ' GLU . 39.2 ttmt -92.79 -72.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.259 -0.428 . . . . 10.0 111.743 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -126.26 117.19 22.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.668 0.271 . . . . 10.0 111.321 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 63.5 mt -121.93 123.62 69.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.096 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . 0.561 ' HG2' ' HB ' ' C' ' 268' ' ' VAL . 26.0 mtm180 -120.22 113.94 21.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.15 0.5 . . . . 10.0 110.662 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . 0.42 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 1.7 p -117.31 111.75 19.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.749 -0.659 . . . . 10.0 110.278 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -124.89 151.54 45.22 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.143 0.423 . . . . 10.0 112.143 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . 0.406 ' OE2' ' HE3' ' D' ' 270' ' ' LYS . 46.2 mt-10 65.01 79.19 0.26 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.975 1.102 . . . . 10.0 113.975 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 58.57 19.44 6.65 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.259 -0.882 . . . . 10.0 113.344 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -81.74 162.23 23.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.857 0.361 . . . . 10.0 111.24 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' D' ' 238' ' ' ARG . 0.1 OUTLIER -141.39 147.76 38.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.061 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . 0.464 HG13 HG13 ' C' ' 275' ' ' VAL . 1.9 p -128.81 127.44 66.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.138 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . 0.409 HE21 HD12 ' C' ' 276' ' ' LEU . 8.6 tm0? -113.47 126.79 55.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.623 -0.717 . . . . 10.0 109.211 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.97 97.98 5.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.406 -0.361 . . . . 10.0 110.593 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 164.15 -108.48 0.33 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.517 -0.849 . . . . 10.0 112.778 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -163.8 153.14 14.32 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.678 0.275 . . . . 10.0 110.388 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 t -112.24 106.26 20.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.801 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 52.6 t -104.55 112.89 39.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . 0.508 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 81.6 p -80.33 150.77 29.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.09 0.471 . . . . 10.0 111.694 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . 0.426 ' HA ' ' HE1' ' C' ' 281' ' ' TYR . . . -74.58 8.06 2.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.928 -0.578 . . . . 10.0 111.39 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -101.33 -8.48 22.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.934 -0.575 . . . . 10.0 109.796 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -91.3 110.11 21.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.058 -0.519 . . . . 10.0 109.731 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.79 163.06 24.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.387 0.613 . . . . 10.0 111.707 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -84.25 63.24 7.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.725 -0.671 . . . . 10.0 112.192 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -131.66 59.08 0.69 Allowed Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 110.405 -1.078 . . . . 10.0 110.405 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 109.71 20.54 7.63 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.27 -1.132 . . . . 10.0 110.27 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 254' ' ' ILE . . . . . 0.43 HD11 HG11 ' D' ' 245' ' ' VAL . 16.6 tt -67.1 -30.8 50.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.851 -0.674 . . . . 10.0 111.425 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -80.05 71.37 6.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.059 0.456 . . . . 10.0 110.874 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 256' ' ' ILE . . . . . 0.411 ' HB ' ' HE2' ' D' ' 281' ' ' TYR . 20.0 tt -65.04 -19.26 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.669 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 257' ' ' SER . . . . . 0.553 ' HB3' ' HB3' ' C' ' 258' ' ' ASP . 4.4 m 66.35 -96.02 0.04 OUTLIER 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.664 -0.698 . . . . 10.0 111.783 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 258' ' ' ASP . . . . . 0.443 ' OD2' ' HA ' ' C' ' 260' ' ' THR . 2.5 t0 -149.19 172.27 15.1 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.411 -0.589 . . . . 10.0 109.411 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -169.27 -74.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.91 0.386 . . . . 10.0 110.581 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 13.5 t -96.17 162.46 13.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.352 0.596 . . . . 10.0 110.838 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 12.8 m -116.9 111.98 20.4 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.055 -0.52 . . . . 10.0 109.872 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -97.25 105.49 17.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.024 -0.535 . . . . 10.0 109.961 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 24.1 m -115.59 118.54 33.42 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.591 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . 0.519 HG23 ' HB3' ' E' ' 228' ' ' ALA . 11.4 p -121.83 137.27 55.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.947 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 265' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' E' ' 229' ' ' LYS . 22.5 mt-10 -84.68 -83.61 0.16 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.919 0.711 . . . . 10.0 112.919 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.69 122.75 46.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.298 0.851 . . . . 10.0 113.298 -177.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 43.7 t -121.16 114.5 43.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.233 -0.654 . . . . 10.0 109.233 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 16.9 t -111.54 119.87 60.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.816 0.341 . . . . 10.0 111.403 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' E' ' 233' ' ' THR . . . -123.8 125.93 6.02 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.336 -0.705 . . . . 10.0 111.336 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . 0.406 ' HE3' ' OE2' ' D' ' 235' ' ' GLU . 19.3 tptt -134.4 108.71 8.32 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.825 0.306 . . . . 10.0 111.825 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.92 102.38 0.64 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 114.698 0.639 . . . . 10.0 114.698 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 51.69 36.17 16.87 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.561 0.578 . . . . 10.0 112.561 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' E' ' 237' ' ' ALA . 4.0 m -85.25 139.2 31.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.162 0.506 . . . . 10.0 111.853 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . 0.719 ' NH2' ' HB3' ' C' ' 290' ' ' HIS . 81.2 mtt85 -118.94 113.24 20.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.558 -0.746 . . . . 10.0 110.273 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 46.0 t -102.49 113.45 39.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.357 -0.608 . . . . 10.0 109.357 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . 0.61 HD12 HE21 ' E' ' 240' ' ' GLN . 1.7 tm? -117.39 97.57 5.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.171 0.51 . . . . 10.0 110.867 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . 0.632 HG22 ' HB3' ' D' ' 226' ' ' ASN . 44.1 mm -102.0 91.91 2.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.645 -0.872 . . . . 10.0 108.645 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . 0.426 ' O ' ' HA3' ' E' ' 242' ' ' GLY . . . 166.17 -163.01 36.53 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.639 -0.709 . . . . 10.0 111.564 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -120.41 156.02 32.26 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.73 -0.277 . . . . 10.0 110.922 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -114.62 136.02 53.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.218 -0.447 . . . . 10.0 110.621 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . 0.411 ' HE2' ' HB ' ' D' ' 256' ' ' ILE . 0.5 OUTLIER -124.59 113.35 17.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.347 -179.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . 0.508 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 156.21 171.58 22.69 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.232 -0.985 . . . . 10.0 112.819 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -110.05 53.86 0.57 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.613 -0.803 . . . . 10.0 112.825 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -89.29 -18.11 27.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.204 0.526 . . . . 10.0 109.983 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 118.95 -47.9 0.99 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.775 -0.93 . . . . 10.0 110.775 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . 0.453 ' CE1' HG21 ' E' ' 244' ' ' VAL . 4.7 t80 176.15 145.62 0.08 Allowed 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.871 -1.159 . . . . 10.0 107.871 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 17.1 t90 -50.38 -74.47 0.03 OUTLIER 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.435 0.46 . . . . 10.0 111.761 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -134.81 133.24 39.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.185 0.517 . . . . 10.0 111.301 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -172.51 147.55 1.88 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -73.68 -57.52 3.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.816 0.341 . . . . 10.0 110.984 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -154.74 175.02 14.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.072 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 292' ' ' HIS . . . . . 0.751 ' HD2' ' HB3' ' E' ' 286' ' ' PHE . 5.9 m80 -97.25 -154.72 0.46 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.599 -0.273 . . . . 10.0 111.455 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -58.91 125.78 24.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.124 0.488 . . . . 10.0 111.486 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -123.51 147.6 47.07 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.691 -0.686 . . . . 10.0 109.939 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.186 -0.911 . . . . 10.0 109.623 179.688 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . 0.551 ' N ' ' HG1' ' E' ' 261' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 110.662 -0.125 . . . . 10.0 110.662 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' E' ' 262' ' ' ASN . 21.4 m120 -137.55 111.82 8.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.65 0.262 . . . . 10.0 110.466 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' E' ' 263' ' ' SER . 21.3 m -122.4 138.35 54.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.157 0.503 . . . . 10.0 111.084 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . 0.519 ' HB3' HG23 ' D' ' 264' ' ' VAL . . . -130.4 129.27 42.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.851 -0.613 . . . . 10.0 109.547 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' D' ' 265' ' ' GLU . 8.0 mttm -84.77 -64.63 1.12 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.57 0.581 . . . . 10.0 112.57 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . 0.805 ' HB3' HG23 ' E' ' 266' ' ' THR . 4.6 t70 -130.79 127.39 38.59 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.779 -0.368 . . . . 10.0 111.278 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 90.9 mt -128.03 123.27 60.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.761 -0.459 . . . . 10.0 109.761 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . 0.404 ' HE ' ' HB2' ' E' ' 232' ' ' ARG . 1.2 ttm180 -116.75 118.29 32.11 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.385 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . 0.426 ' O ' ' HA2' ' D' ' 269' ' ' GLY . 0.8 OUTLIER -128.66 111.19 12.92 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.013 -0.539 . . . . 10.0 110.862 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -129.87 145.56 51.6 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.154 0.427 . . . . 10.0 112.154 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 66.39 81.9 0.19 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.2 0.815 . . . . 10.0 113.2 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 58.35 26.09 13.61 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.902 -0.59 . . . . 10.0 112.246 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' D' ' 273' ' ' SER . . . -94.2 153.32 18.13 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.9 160.52 41.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.829 0.347 . . . . 10.0 111.544 -178.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.34 134.28 49.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.889 -0.596 . . . . 10.0 110.779 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . 0.61 HE21 HD12 ' D' ' 276' ' ' LEU . 21.0 tm0? -127.84 127.52 43.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.932 -0.576 . . . . 10.0 109.845 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . 0.77 ' HG ' ' HB ' ' E' ' 277' ' ' ILE . 0.7 OUTLIER -126.16 105.48 8.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.442 -0.345 . . . . 10.0 110.587 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . 0.493 ' O ' ' HA3' ' E' ' 278' ' ' GLY . . . 164.36 -158.02 30.54 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.757 -0.735 . . . . 10.0 112.445 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -117.34 144.32 45.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.917 0.389 . . . . 10.0 110.649 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . 0.453 HG21 ' CE1' ' D' ' 286' ' ' PHE . 61.6 t -101.24 120.33 50.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.111 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 3.6 t -116.92 101.37 12.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.98 0.419 . . . . 10.0 110.867 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . 0.557 HG23 ' H ' ' E' ' 248' ' ' ALA . 15.0 t -67.53 173.7 3.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.169 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.76 -19.66 64.19 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.794 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . 0.557 ' H ' HG23 ' E' ' 246' ' ' THR . . . -75.52 -22.34 57.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.277 -0.42 . . . . 10.0 110.727 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 55.84 -161.68 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.871 -0.604 . . . . 10.0 111.861 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 5.1 mp -103.27 89.13 3.3 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.034 0.445 . . . . 10.0 110.362 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 . . . . . 0 C--N 1.327 -0.399 0 CA-C-O 121.418 0.628 . . . . 10.0 110.159 179.375 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 6.5 pt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.134 0.492 . . . . 10.0 110.928 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 1.4 m -145.04 151.12 38.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.1 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -85.86 84.3 7.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.769 0.795 . . . . 10.0 111.105 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -70.25 -25.73 63.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.227 -0.897 . . . . 10.0 112.251 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 14.6 t -107.24 148.51 28.85 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.09 0.472 . . . . 10.0 111.334 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . 0.551 ' HG1' ' N ' ' E' ' 225' ' ' ARG . 79.7 m -129.21 114.3 16.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.583 -0.735 . . . . 10.0 111.206 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . 0.407 ' HB2' ' ND2' ' E' ' 226' ' ' ASN . 14.1 m120 -107.85 100.1 9.5 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.311 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' E' ' 227' ' ' SER . 12.9 m -109.04 117.64 34.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.157 -0.474 . . . . 10.0 109.767 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 4.8 p -107.26 152.27 8.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.842 0.353 . . . . 10.0 111.074 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -86.47 -88.11 0.13 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.152 -0.477 . . . . 10.0 111.457 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . 0.805 HG23 ' HB3' ' E' ' 230' ' ' ASP . 9.0 m -125.12 120.95 32.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.966 0.413 . . . . 10.0 111.605 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.16 116.28 51.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.46 110.61 32.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.856 0.36 . . . . 10.0 111.24 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.6 136.14 10.21 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.642 -0.583 . . . . 10.0 111.642 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -140.03 126.6 20.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.017 0.437 . . . . 10.0 111.024 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.89 82.07 1.17 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.748 -0.739 . . . . 10.0 113.647 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 61.43 22.58 12.97 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.295 0.85 . . . . 10.0 113.295 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 45.2 m -73.1 152.32 41.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.886 0.374 . . . . 10.0 111.291 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -131.45 120.48 23.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.815 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 40.3 t -102.44 118.99 50.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.921 -0.581 . . . . 10.0 109.464 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . 0.562 HD22 ' HB3' ' E' ' 240' ' ' GLN . 0.2 OUTLIER -120.57 110.28 16.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.744 -179.345 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . 0.77 ' HB ' ' HG ' ' E' ' 241' ' ' LEU . 46.4 mm -117.74 95.96 4.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.144 0.497 . . . . 10.0 110.178 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' E' ' 242' ' ' GLY . . . 170.89 -126.57 1.34 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.515 -0.634 . . . . 10.0 111.515 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -141.01 151.85 44.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 10.0 111.156 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . 0.695 ' HB2' ' HA ' ' E' ' 288' ' ' ASP . 2.6 pt-20 -105.29 138.61 41.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.095 -0.502 . . . . 10.0 111.913 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -162.55 71.28 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.956 -0.566 . . . . 10.0 110.193 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . 0.505 ' HA2' ' HB ' ' E' ' 246' ' ' THR . . . -112.9 -105.83 2.75 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.853 -0.689 . . . . 10.0 112.626 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 283' ' ' GLY . . . . . 0.601 ' HA2' ' HB3' ' E' ' 290' ' ' HIS . . . 179.37 25.2 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.564 -0.827 . . . . 10.0 113.364 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.1 -119.79 0.3 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.987 0.394 . . . . 10.0 111.819 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -168.69 46.64 0.22 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.478 -0.868 . . . . 10.0 113.258 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 286' ' ' PHE . . . . . 0.751 ' HB3' ' HD2' ' D' ' 292' ' ' HIS . 46.2 t80 -174.38 103.43 0.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.543 -0.54 . . . . 10.0 109.543 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 72.55 5.47 5.25 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.762 0.664 . . . . 10.0 109.616 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 288' ' ' ASP . . . . . 0.695 ' HA ' ' HB2' ' E' ' 280' ' ' GLU . 0.4 OUTLIER -168.49 131.94 1.5 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.133 -1.394 . . . . 10.0 107.388 179.29 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -136.2 172.76 12.53 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.649 -0.251 . . . . 10.0 111.147 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 290' ' ' HIS . . . . . 0.601 ' HB3' ' HA2' ' E' ' 283' ' ' GLY . 2.9 p-80 -157.82 -163.36 1.32 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.333 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -110.67 -73.06 0.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.513 -0.18 . . . . 10.0 110.513 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 292' ' ' HIS . . . . . 0.43 ' HB2' ' CD2' ' E' ' 290' ' ' HIS . 37.8 t60 70.89 150.31 0.09 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.722 0.639 . . . . 10.0 112.38 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -88.58 112.92 23.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.417 -0.586 . . . . 10.0 109.417 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -96.23 143.28 27.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.268 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.376 -0.821 . . . . 10.0 110.368 -179.713 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 110.62 -0.141 . . . . 10.0 110.62 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' A' ' 262' ' ' ASN . 14.7 m-80 -116.24 134.72 54.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.769 0.318 . . . . 10.0 110.201 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 263' ' ' SER . 57.0 m -147.89 157.79 43.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.181 0.515 . . . . 10.0 111.771 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.17 154.66 45.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.533 -0.758 . . . . 10.0 109.168 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.561 ' HB2' ' HA ' ' A' ' 265' ' ' GLU . 44.7 mttt -107.34 -70.97 0.77 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.571 0.582 . . . . 10.0 112.571 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.561 ' O ' ' HA ' ' A' ' 266' ' ' THR . 43.0 t0 -124.02 110.35 14.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.366 -177.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 66.8 mt -119.4 126.37 75.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.385 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.9 ptp85 -124.31 116.26 22.34 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.102 0.477 . . . . 10.0 110.658 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 0.7 OUTLIER -123.52 127.6 48.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.827 -0.624 . . . . 10.0 110.768 -179.305 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -141.91 169.41 17.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.602 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.2 60.11 1.0 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.843 -0.617 . . . . 10.0 111.674 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 62.72 29.49 16.78 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.723 -0.671 . . . . 10.0 112.479 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.409 ' HB3' ' HB ' ' A' ' 233' ' ' THR . . . -86.63 157.29 19.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.43 -0.35 . . . . 10.0 110.612 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -135.22 151.2 50.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.247 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.24 139.52 36.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.832 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -137.78 130.12 29.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.266 -0.425 . . . . 10.0 110.205 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.534 ' HG ' ' HB ' ' A' ' 277' ' ' ILE . 5.8 mp -116.82 118.55 32.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.491 -0.322 . . . . 10.0 110.526 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.48 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 152.74 -169.55 31.8 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.824 -0.703 . . . . 10.0 112.694 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.63 126.58 41.0 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.057 -0.349 . . . . 10.0 110.057 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 90.9 t -98.29 116.39 40.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.207 0.527 . . . . 10.0 112.075 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.806 HG11 ' HA2' ' A' ' 252' ' ' GLY . 77.8 t -111.49 116.9 53.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.783 -0.644 . . . . 10.0 109.756 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.77 158.97 15.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.714 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.57 -19.99 65.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.019 0.437 . . . . 10.0 110.766 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -85.98 11.46 11.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.772 -0.649 . . . . 10.0 110.632 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 250' ' ' LEU . . . -121.36 36.03 4.72 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.5 -0.556 . . . . 10.0 109.5 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 3.6 mm? 75.99 -82.22 0.03 OUTLIER 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.44 -0.8 . . . . 10.0 112.645 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 26.0 p-80 -158.22 171.89 19.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.445 -0.343 . . . . 10.0 110.514 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.806 ' HA2' HG11 ' A' ' 245' ' ' VAL . . . -80.62 64.39 4.07 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.002 -0.618 . . . . 10.0 112.749 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -69.63 -46.41 54.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.311 -0.471 . . . . 10.0 112.187 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 84.1 mt 74.15 141.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 122.981 0.513 . . . . 10.0 111.67 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 255' ' ' ARG . 30.1 ttt-85 68.54 82.98 0.16 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.341 0.591 . . . . 10.0 111.245 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 55.6 mt -112.17 -45.92 5.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.765 -0.652 . . . . 10.0 111.532 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 7.0 p -135.28 -82.98 0.41 Allowed 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.293 0.479 . . . . 10.0 112.293 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 11.3 t70 59.4 76.57 0.35 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.478 -0.783 . . . . 10.0 110.981 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -118.05 24.41 11.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.726 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . 0.683 ' HG1' ' N ' ' B' ' 225' ' ' ARG . 5.2 t -155.32 143.04 19.79 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.208 0.528 . . . . 10.0 111.43 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 4.1 m -91.31 120.53 32.27 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.507 -0.923 . . . . 10.0 108.507 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.441 ' O ' ' HA ' ' A' ' 226' ' ' ASN . 67.2 m-20 -111.08 111.71 23.0 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.954 -0.387 . . . . 10.0 109.954 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 227' ' ' SER . 49.7 m -141.07 132.96 27.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.043 0.449 . . . . 10.0 111.708 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.6 HG23 ' HB3' ' B' ' 228' ' ' ALA . 9.9 p -121.6 139.22 49.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.795 -0.639 . . . . 10.0 110.004 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.561 ' HA ' ' HB2' ' A' ' 229' ' ' LYS . 6.0 tt0 -79.35 -77.29 0.18 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.29 0.478 . . . . 10.0 112.29 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 230' ' ' ASP . 1.7 m -115.28 133.36 56.11 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.735 0.643 . . . . 10.0 112.735 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 17.4 t -128.47 124.72 62.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.459 -0.791 . . . . 10.0 109.035 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.459 ' HB ' ' HD3' ' B' ' 232' ' ' ARG . 39.7 t -116.65 121.88 68.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.85 0.357 . . . . 10.0 111.116 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -126.63 118.59 3.1 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.979 -0.629 . . . . 10.0 112.056 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -132.81 110.56 10.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.724 0.297 . . . . 10.0 110.966 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 107.45 67.71 0.65 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.636 -0.792 . . . . 10.0 112.563 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 56.48 32.0 19.93 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 13.2 m -69.19 141.67 54.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.253 0.549 . . . . 10.0 110.611 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . 0.401 ' HB2' ' HB3' ' B' ' 238' ' ' ARG . 19.6 mtt180 -114.87 107.08 14.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.386 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 40.8 t -98.97 113.88 35.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.06 -0.518 . . . . 10.0 111.226 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.71 114.79 26.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.246 -0.434 . . . . 10.0 109.863 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.534 ' HB ' ' HG ' ' A' ' 241' ' ' LEU . 29.2 mm -108.91 114.22 46.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.776 -0.453 . . . . 10.0 109.776 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 132.48 163.61 10.7 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.631 -0.795 . . . . 10.0 112.281 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -76.9 147.07 37.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.127 0.489 . . . . 10.0 111.503 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -126.39 152.65 46.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.12 -0.491 . . . . 10.0 111.069 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -129.63 116.63 19.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.726 -0.67 . . . . 10.0 110.581 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' B' ' 246' ' ' THR . . . -166.8 153.3 22.9 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.137 -0.554 . . . . 10.0 111.751 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -128.3 -7.7 4.33 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.431 -0.89 . . . . 10.0 113.327 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -80.07 -43.43 21.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.124 0.487 . . . . 10.0 110.805 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -155.48 157.18 27.53 Favored Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 110.3 -1.12 . . . . 10.0 110.3 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -80.97 74.53 7.96 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.917 0.358 . . . . 10.0 110.894 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 25.0 t90 67.36 -63.93 0.28 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.219 0.949 . . . . 10.0 112.874 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -144.08 96.64 2.92 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.118 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -160.34 144.34 14.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.936 -0.575 . . . . 10.0 110.354 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -157.06 60.7 0.51 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.116 -0.698 . . . . 10.0 109.116 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -83.86 103.73 13.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.852 -0.613 . . . . 10.0 111.769 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -101.56 -31.8 10.68 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.647 -0.706 . . . . 10.0 110.084 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -84.61 124.6 31.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.577 -0.738 . . . . 10.0 109.905 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.42 139.72 47.75 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.785 0.326 . . . . 10.0 110.72 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.509 -0.758 . . . . 10.0 110.378 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.683 ' N ' ' HG1' ' A' ' 260' ' ' THR . 4.7 ttm-85 . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 110.286 -0.265 . . . . 10.0 110.286 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.442 ' HB3' HG22 ' B' ' 277' ' ' ILE . 69.9 m-20 -126.54 124.23 39.54 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.326 -0.62 . . . . 10.0 109.326 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 263' ' ' SER . 5.1 m -139.32 152.95 47.61 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.624 0.25 . . . . 10.0 111.184 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.6 ' HB3' HG23 ' A' ' 264' ' ' VAL . . . -144.24 148.5 35.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.154 -0.476 . . . . 10.0 111.448 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.49 ' HB2' ' HA ' ' B' ' 265' ' ' GLU . 1.1 tmtm? -90.56 -62.35 1.48 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.217 -0.447 . . . . 10.0 111.957 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 266' ' ' THR . 7.3 t0 -145.6 132.25 19.92 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.006 0.431 . . . . 10.0 111.412 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 64.9 mt -125.24 122.92 64.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.086 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . 0.459 ' HD3' ' HB ' ' A' ' 268' ' ' VAL . 3.8 mmt180 -102.74 112.52 25.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.165 -0.471 . . . . 10.0 109.95 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.407 ' O ' ' HA2' ' A' ' 269' ' ' GLY . 1.0 OUTLIER -121.23 115.0 22.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.882 0.372 . . . . 10.0 111.327 -179.226 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.34 164.32 28.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.339 -0.391 . . . . 10.0 111.477 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . 0.43 ' HB2' ' H ' ' B' ' 271' ' ' GLY . 25.8 mt-10 65.64 62.59 0.64 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.595 -0.729 . . . . 10.0 111.872 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . 0.461 ' HB2' ' HG2' ' B' ' 272' ' ' GLU . 63.6 mtm-85 57.83 32.29 21.71 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.894 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.12 159.59 22.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.887 0.375 . . . . 10.0 111.065 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.401 ' HB3' ' HB2' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -137.62 141.82 41.23 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.951 0.405 . . . . 10.0 111.238 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 4.3 p -127.1 135.81 62.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.723 -0.671 . . . . 10.0 110.989 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -118.74 123.23 44.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.61 -0.723 . . . . 10.0 109.227 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.78 84.78 1.98 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.877 0.37 . . . . 10.0 110.504 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 165.41 179.06 38.98 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.482 -0.866 . . . . 10.0 112.233 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -92.26 131.64 37.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.798 0.332 . . . . 10.0 110.664 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 46.7 t -95.77 109.13 22.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.014 0.435 . . . . 10.0 110.707 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 20.3 t -109.24 114.11 46.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 282' ' ' GLY . 32.8 p -81.91 169.01 17.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.087 -0.506 . . . . 10.0 111.324 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -72.12 -4.92 31.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.691 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -78.43 -18.17 55.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.601 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -91.01 3.1 55.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.647 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 20.6 tp -64.58 131.19 46.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.426 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 1.9 t60 60.07 47.89 9.13 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.261 0.553 . . . . 10.0 110.89 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -137.48 -156.52 7.27 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.884 -0.674 . . . . 10.0 111.866 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.51 120.4 4.29 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.987 -0.625 . . . . 10.0 111.736 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 52.5 mt -103.5 -33.48 3.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.22 0.533 . . . . 10.0 110.733 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 255' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' B' ' 255' ' ' ARG . 4.0 tpt180 -79.82 81.06 6.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.975 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 21.4 pt -102.34 37.51 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.798 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.7 t 65.87 36.22 6.18 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.925 -0.58 . . . . 10.0 110.616 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -65.94 122.43 17.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.397 -0.82 . . . . 10.0 110.154 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . 0.4 ' OE1' HG13 ' C' ' 256' ' ' ILE . 12.8 tt0 -139.28 109.25 6.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.333 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 8.5 t -175.38 177.1 1.89 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.998 0.428 . . . . 10.0 110.56 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 71.2 m -150.48 117.47 5.92 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.901 -0.777 . . . . 10.0 108.901 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -99.69 116.06 30.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.991 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 50.8 m -135.78 113.9 11.37 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.881 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' C' ' 228' ' ' ALA . 13.2 p -113.14 146.2 18.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.556 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . 0.49 ' HA ' ' HB2' ' B' ' 229' ' ' LYS . 28.4 mt-10 -85.01 -75.5 0.35 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.173 0.435 . . . . 10.0 112.173 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' B' ' 230' ' ' ASP . 4.3 m -123.24 130.14 52.34 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.748 0.647 . . . . 10.0 112.748 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 37.3 t -119.77 122.87 69.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.376 -0.829 . . . . 10.0 109.041 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . 0.418 ' HB ' ' HA ' ' C' ' 232' ' ' ARG . 35.3 t -104.3 114.02 42.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.815 0.34 . . . . 10.0 110.348 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.41 97.6 0.72 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.556 -0.618 . . . . 10.0 111.556 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -119.89 118.98 32.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.728 0.299 . . . . 10.0 111.189 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . 0.43 ' H ' ' HB2' ' B' ' 235' ' ' GLU . . . 100.65 62.57 0.79 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.325 -0.941 . . . . 10.0 112.595 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . 0.461 ' HG2' ' HB2' ' B' ' 236' ' ' ARG . 12.1 mt-10 54.58 37.68 28.45 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.124 0.786 . . . . 10.0 113.124 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' C' ' 237' ' ' ALA . 7.3 m -77.81 151.16 34.1 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.899 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 13.2 mtt85 -116.25 121.08 40.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.344 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 40.8 t -108.84 119.42 58.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.486 -0.561 . . . . 10.0 109.486 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.597 ' HB3' ' HG3' ' C' ' 240' ' ' GLN . 0.1 OUTLIER -117.97 113.37 21.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.666 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.442 HG22 ' HB3' ' B' ' 226' ' ' ASN . 43.3 mm -103.54 88.33 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.896 0.379 . . . . 10.0 110.074 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 158.66 175.07 29.18 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.899 -0.667 . . . . 10.0 111.974 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -93.05 159.35 15.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.152 -0.314 . . . . 10.0 110.152 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.46 160.83 27.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.192 0.52 . . . . 10.0 111.684 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.02 71.27 1.33 Allowed 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -97.3 -65.03 0.9 Allowed Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.213 -0.903 . . . . 10.0 111.885 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . 0.533 ' HA3' ' H ' ' C' ' 247' ' ' ALA . . . 82.35 -46.99 3.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.247 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' B' ' 284' ' ' LYS . 27.9 mtpp -67.35 -26.69 66.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.411 0.624 . . . . 10.0 110.126 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -152.73 164.22 30.66 Favored Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 110.216 -1.154 . . . . 10.0 110.216 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -97.87 64.18 1.71 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.93 -0.396 . . . . 10.0 109.93 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.447 ' CH2' ' HB2' ' C' ' 238' ' ' ARG . 16.1 t90 71.19 -43.11 0.55 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.387 -0.824 . . . . 10.0 112.341 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -139.02 -170.54 2.89 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.863 -0.421 . . . . 10.0 109.863 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.38 142.19 58.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.419 -0.355 . . . . 10.0 110.777 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -166.48 89.73 0.39 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 110.397 -0.223 . . . . 10.0 110.397 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -155.52 119.35 4.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.82 0.343 . . . . 10.0 111.796 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.97 -176.49 5.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.125 -0.488 . . . . 10.0 110.457 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.6 154.17 17.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.817 0.341 . . . . 10.0 111.477 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 294' ' ' HIS . . . . . 0.565 ' HB2' ' HA ' ' C' ' 291' ' ' HIS . 29.1 p80 -116.16 -174.07 2.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.41 -0.814 . . . . 10.0 109.211 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.218 -0.896 . . . . 10.0 109.73 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . 0.675 ' N ' ' HG1' ' C' ' 261' ' ' THR . 31.2 ptt180 . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.485 0.183 . . . . 10.0 110.549 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . 0.442 ' HB3' HG22 ' C' ' 277' ' ' ILE . 21.5 m120 -127.72 111.51 13.77 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.28 152.59 47.94 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.051 0.453 . . . . 10.0 111.572 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.413 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -149.06 143.82 26.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.774 -0.648 . . . . 10.0 109.995 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . 0.456 ' HG2' ' OE2' ' B' ' 265' ' ' GLU . 38.3 mttm -91.91 -72.27 0.6 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.633 0.605 . . . . 10.0 112.633 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -122.06 126.29 48.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.865 0.365 . . . . 10.0 111.558 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 49.7 mt -129.52 115.05 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.382 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.428 ' HD2' HG13 ' C' ' 268' ' ' VAL . 14.7 ttm-85 -101.45 115.12 29.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.396 -0.365 . . . . 10.0 110.561 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -125.29 100.7 6.64 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.447 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -125.32 161.58 26.66 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.014 0.376 . . . . 10.0 112.014 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 66.45 75.15 0.33 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.358 -0.837 . . . . 10.0 112.108 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 53.33 55.17 9.1 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.297 -0.865 . . . . 10.0 111.133 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' B' ' 273' ' ' SER . . . -107.97 165.89 11.12 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.712 -0.676 . . . . 10.0 111.164 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . 0.447 ' HB2' ' CH2' ' B' ' 287' ' ' TRP . 1.5 ptp180 -153.1 138.01 17.14 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.854 -0.612 . . . . 10.0 110.16 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.484 HG23 ' HB ' ' C' ' 275' ' ' VAL . 4.4 p -135.06 136.46 51.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.191 -0.459 . . . . 10.0 110.614 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.597 ' HG3' ' HB3' ' B' ' 276' ' ' LEU . 27.6 tt0 -126.07 128.61 47.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.993 0.425 . . . . 10.0 111.043 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -105.24 91.41 3.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.769 -0.651 . . . . 10.0 109.831 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 168.19 -174.39 43.03 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.669 -0.777 . . . . 10.0 111.992 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -95.54 155.69 16.64 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.827 0.346 . . . . 10.0 110.95 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 57.3 t -112.68 108.78 26.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.06 -0.518 . . . . 10.0 110.249 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.83 110.64 32.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.218 -0.446 . . . . 10.0 110.342 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 38.3 p -79.84 159.92 26.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.019 -0.537 . . . . 10.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . 0.533 ' H ' ' HA3' ' B' ' 283' ' ' GLY . . . -73.68 42.54 0.13 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.273 0.559 . . . . 10.0 111.838 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -138.19 -13.06 1.4 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.61 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -87.45 67.03 9.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.109 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 55.8 mt -87.12 -4.6 59.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.978 -0.555 . . . . 10.0 111.379 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -94.04 129.24 40.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.305 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 178.77 -158.57 23.01 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.661 -0.78 . . . . 10.0 112.182 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 176.17 -134.66 2.68 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.676 -0.969 . . . . 10.0 110.676 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 13.5 tt -158.42 89.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.498 0.666 . . . . 10.0 111.421 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -140.93 115.31 9.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.367 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 256' ' ' ILE . . . . . 0.4 HG13 ' OE1' ' B' ' 259' ' ' GLN . 8.5 tt -74.83 129.28 36.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.819 -0.628 . . . . 10.0 109.898 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.44 174.16 15.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.125 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.81 145.6 55.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.92 -0.582 . . . . 10.0 112.155 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -147.76 149.07 31.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.761 -0.654 . . . . 10.0 109.703 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 12.8 t -71.51 140.29 49.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.005 0.431 . . . . 10.0 110.847 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . 0.675 ' HG1' ' N ' ' C' ' 225' ' ' ARG . 7.7 m -105.54 134.34 48.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.099 -0.501 . . . . 10.0 110.384 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . 0.55 ' HA ' ' O ' ' D' ' 226' ' ' ASN . 18.6 t-20 -122.65 128.36 50.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.875 -0.602 . . . . 10.0 109.5 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 50.0 m -144.63 138.78 27.62 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.737 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.9 p -123.52 145.34 30.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.852 -0.613 . . . . 10.0 110.996 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' D' ' 229' ' ' LYS . 54.8 mt-10 -82.32 -66.27 0.91 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.491 -0.322 . . . . 10.0 111.735 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.79 129.74 51.04 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.295 0.85 . . . . 10.0 113.295 -178.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 48.3 t -127.19 119.97 54.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.661 -0.7 . . . . 10.0 109.648 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . 0.609 ' HB ' ' HD2' ' D' ' 232' ' ' ARG . 58.8 t -117.01 120.08 63.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.794 0.33 . . . . 10.0 110.895 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -123.77 130.95 7.85 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.976 -0.631 . . . . 10.0 112.121 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -133.04 126.68 32.42 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.913 0.338 . . . . 10.0 111.913 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.17 93.23 0.16 Allowed Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.951 -0.568 . . . . 10.0 113.449 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 64.02 32.47 12.91 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.303 0.573 . . . . 10.0 111.403 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . 0.459 ' HB3' ' HA3' ' C' ' 269' ' ' GLY . 0.2 OUTLIER -66.46 121.83 16.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.328 -0.851 . . . . 10.0 111.193 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 41.3 mtt180 -124.74 100.89 6.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.147 0.499 . . . . 10.0 109.763 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.484 ' HB ' HG23 ' C' ' 239' ' ' VAL . 22.3 t -101.78 131.86 48.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.041 -0.527 . . . . 10.0 111.411 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' D' ' 240' ' ' GLN . 2.2 tm? -128.01 113.2 15.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.858 -0.61 . . . . 10.0 109.815 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.48 HG12 HD23 ' D' ' 241' ' ' LEU . 56.1 mt -111.0 94.13 2.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.324 0.583 . . . . 10.0 110.756 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 168.19 -165.06 38.5 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.825 -1.31 . . . . 10.0 109.825 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -108.49 148.28 30.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 117.477 0.638 . . . . 10.0 110.946 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -104.94 137.61 42.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.344 -0.389 . . . . 10.0 110.644 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.2 OUTLIER -131.0 102.16 5.92 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.538 -0.542 . . . . 10.0 109.538 179.411 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' D' ' 246' ' ' THR . . . -164.98 172.07 40.55 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.689 -0.767 . . . . 10.0 112.434 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -124.34 16.33 7.59 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.782 -0.723 . . . . 10.0 112.522 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -101.68 1.28 37.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.964 0.411 . . . . 10.0 111.179 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 129.86 -116.17 2.04 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.835 -0.906 . . . . 10.0 110.835 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . 0.511 ' HB3' ' NE1' ' D' ' 287' ' ' TRP . 0.8 OUTLIER -125.75 -155.78 0.7 Allowed 'General case' 0 C--N 1.323 -0.549 0 O-C-N 123.513 0.184 . . . . 10.0 110.562 179.131 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.417 ' H ' ' HB2' ' C' ' 286' ' ' PHE . 1.7 t90 -63.75 -24.0 67.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.635 0.255 . . . . 10.0 111.284 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 288' ' ' ASP . . . . . 0.405 ' OD2' ' HD2' ' D' ' 238' ' ' ARG . 1.9 p30 -133.47 -171.39 2.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.489 -0.323 . . . . 10.0 110.262 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -143.02 35.44 1.37 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.075 0.464 . . . . 10.0 110.966 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -79.99 0.58 31.01 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.276 0.473 . . . . 10.0 112.276 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 291' ' ' HIS . . . . . 0.661 ' HB2' HH12 ' D' ' 274' ' ' ARG . 0.2 OUTLIER -164.46 155.82 15.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.455 179.125 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 66.34 157.19 0.11 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.399 0.618 . . . . 10.0 112.464 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 N-CA-C 112.117 0.414 . . . . 10.0 112.117 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' C' ' 262' ' ' ASN . 19.1 m120 . . . . . 0 CA--C 1.52 -0.178 0 N-CA-C 110.301 -0.259 . . . . 10.0 110.301 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 42.6 m -151.17 142.83 23.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.89 0.376 . . . . 10.0 111.579 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.85 139.59 53.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.51 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' C' ' 265' ' ' GLU . 22.5 ttmt -84.54 -66.12 0.93 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.877 0.37 . . . . 10.0 111.601 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -138.51 119.43 14.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.649 0.261 . . . . 10.0 111.113 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . 0.422 HG12 HG23 ' D' ' 267' ' ' VAL . 32.7 mt -117.07 130.89 71.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.385 -0.37 . . . . 10.0 110.502 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . 0.609 ' HD2' ' HB ' ' C' ' 268' ' ' VAL . 22.2 mmm-85 -118.55 106.38 12.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.176 -0.466 . . . . 10.0 110.66 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . 0.554 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 1.4 p -112.99 113.3 25.28 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.625 -0.509 . . . . 10.0 109.625 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . 0.406 ' HG3' ' HG3' ' D' ' 270' ' ' LYS . 4.2 pt-20 -131.18 147.34 52.59 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.368 0.506 . . . . 10.0 112.368 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 68.38 79.22 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.162 -0.927 . . . . 10.0 113.278 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 55.68 45.64 24.2 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.287 0.565 . . . . 10.0 111.94 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -111.06 157.23 20.21 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.901 -0.591 . . . . 10.0 110.61 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . 0.405 ' HD2' ' OD2' ' C' ' 288' ' ' ASP . 0.0 OUTLIER -144.33 151.77 39.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.244 -0.434 . . . . 10.0 110.822 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . 0.451 HG23 ' HB ' ' D' ' 275' ' ' VAL . 3.8 p -138.25 133.43 43.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.22 -0.445 . . . . 10.0 110.273 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' C' ' 276' ' ' LEU . 0.0 OUTLIER -115.21 125.38 53.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.522 179.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . 0.48 HD23 HG12 ' C' ' 277' ' ' ILE . 3.0 mm? -109.66 92.59 4.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.865 -0.607 . . . . 10.0 110.819 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 175.72 -106.02 0.21 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.716 -0.755 . . . . 10.0 112.466 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -167.91 162.93 13.77 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.637 0.375 . . . . 10.0 110.282 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . 0.402 HG21 ' CD1' ' D' ' 287' ' ' TRP . 35.8 t -110.52 111.92 38.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.842 0.353 . . . . 10.0 111.802 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 17.7 t -113.21 109.98 30.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.383 -0.599 . . . . 10.0 109.383 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' C' ' 282' ' ' GLY . 82.3 p -89.75 162.77 15.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.945 0.403 . . . . 10.0 111.611 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -72.87 -0.89 14.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.048 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -88.57 -12.08 43.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.407 0.622 . . . . 10.0 109.782 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -97.06 87.76 4.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.387 -0.824 . . . . 10.0 109.983 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 4.5 mp -84.17 -160.16 0.44 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.809 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -79.69 100.52 7.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.088 0.47 . . . . 10.0 111.087 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -174.15 38.73 0.13 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.819 -0.912 . . . . 10.0 110.819 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 101.96 35.11 4.08 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.818 -0.706 . . . . 10.0 111.451 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 10.0 tt -68.0 -38.02 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 121.161 0.505 . . . . 10.0 111.987 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 42.1 mtt-85 -84.04 83.96 7.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.103 0.478 . . . . 10.0 111.551 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 15.5 tt -67.68 -16.97 21.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.215 -0.902 . . . . 10.0 111.739 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 7.7 m 71.1 -83.23 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.369 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -161.14 167.84 25.42 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -160.09 -41.58 0.05 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.137 0.273 . . . . 10.0 111.56 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 13.9 t -144.07 162.05 37.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.867 0.365 . . . . 10.0 111.231 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 21.8 m -105.44 114.46 28.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.062 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -102.59 104.51 14.9 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.047 -0.524 . . . . 10.0 109.778 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 14.8 m -117.48 126.3 52.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.021 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 9.2 p -123.62 133.37 69.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.151 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 265' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' E' ' 229' ' ' LYS . 67.7 mt-10 -83.71 -82.49 0.16 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.207 -0.451 . . . . 10.0 112.137 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 2.4 p -106.0 119.61 39.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.015 0.436 . . . . 10.0 112.029 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . 0.422 HG23 HG12 ' D' ' 231' ' ' ILE . 0.1 OUTLIER -127.67 113.7 32.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.02 179.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . 0.536 ' HB ' ' HG2' ' E' ' 232' ' ' ARG . 42.0 t -113.0 128.6 69.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.312 -0.404 . . . . 10.0 111.023 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' E' ' 233' ' ' THR . . . -129.8 115.02 1.8 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.677 -0.969 . . . . 10.0 110.677 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . 0.638 ' HB3' ' HG2' ' E' ' 234' ' ' GLU . 5.6 tttp -124.07 125.63 44.85 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.518 0.562 . . . . 10.0 112.518 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.53 89.58 0.4 Allowed Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.592 -0.731 . . . . 10.0 113.876 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 55.58 52.55 10.91 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.161 0.505 . . . . 10.0 111.555 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 6.3 t -103.38 142.39 34.31 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.968 -0.56 . . . . 10.0 110.858 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . 0.661 HH12 ' HB2' ' C' ' 291' ' ' HIS . 2.1 mpt_? -122.56 110.6 15.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.218 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' D' ' 239' ' ' VAL . 26.0 t -99.95 114.96 39.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.991 -0.374 . . . . 10.0 109.991 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . 0.456 ' HB3' ' HG3' ' E' ' 240' ' ' GLN . 1.2 tm? -116.43 108.85 16.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.313 0.578 . . . . 10.0 111.27 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 44.3 mm -106.2 99.84 9.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.223 -0.658 . . . . 10.0 109.223 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.1 -171.46 32.72 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.792 -0.718 . . . . 10.0 111.313 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -110.28 161.75 15.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.918 0.389 . . . . 10.0 111.205 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -117.06 134.77 54.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.074 -0.512 . . . . 10.0 111.045 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -125.96 113.61 17.38 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.089 -0.505 . . . . 10.0 110.282 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . 0.536 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 161.31 -178.15 37.35 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.271 -0.966 . . . . 10.0 112.64 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -108.37 41.6 2.17 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.839 -0.696 . . . . 10.0 112.965 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt -86.82 -22.23 25.97 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.699 -0.482 . . . . 10.0 109.699 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 98.93 -32.76 6.72 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.049 -0.596 . . . . 10.0 112.149 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . 0.79 ' HZ ' ' HG ' ' E' ' 276' ' ' LEU . 2.6 t80 176.71 137.72 0.06 Allowed 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.591 -0.522 . . . . 10.0 109.591 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . 0.511 ' NE1' ' HB3' ' C' ' 286' ' ' PHE . 9.6 t90 -55.89 -74.49 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.581 0.55 . . . . 10.0 110.584 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 288' ' ' ASP . . . . . 0.505 ' CG ' ' HE ' ' E' ' 238' ' ' ARG . 48.5 t0 -125.8 117.82 24.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.456 0.646 . . . . 10.0 111.8 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 289' ' ' ASN . . . . . 0.582 ' HA ' ' HD3' ' E' ' 274' ' ' ARG . 10.1 t-20 -156.34 160.86 40.08 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.76 -1.2 . . . . 10.0 107.76 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -80.35 -64.62 1.15 Allowed 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.365 0.506 . . . . 10.0 112.365 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -148.57 -160.65 1.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.647 -0.251 . . . . 10.0 110.955 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -91.29 -161.02 0.77 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.814 -0.439 . . . . 10.0 109.814 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -71.18 133.35 46.1 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.475 -0.195 . . . . 10.0 110.475 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -122.33 147.09 46.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.595 -0.275 . . . . 10.0 110.941 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.355 -0.831 . . . . 10.0 109.6 178.949 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . 0.633 ' N ' ' HG1' ' E' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 110.21 -0.293 . . . . 10.0 110.21 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -132.13 114.48 14.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.701 0.286 . . . . 10.0 110.716 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 2.4 m -122.77 141.27 52.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.226 0.536 . . . . 10.0 111.719 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' E' ' 264' ' ' VAL . . . -135.69 121.09 19.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.813 -0.63 . . . . 10.0 109.41 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . 0.545 ' O ' ' HB2' ' D' ' 265' ' ' GLU . 9.7 mttm -79.9 -69.91 0.55 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.066 0.765 . . . . 10.0 113.066 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . 0.516 ' HB3' HG23 ' E' ' 266' ' ' THR . 19.9 t70 -124.58 126.0 45.08 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.753 -0.379 . . . . 10.0 111.852 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 54.8 mt -134.35 122.16 39.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.095 0.474 . . . . 10.0 110.78 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . 0.536 ' HG2' ' HB ' ' D' ' 268' ' ' VAL . 37.5 mtm180 -122.41 123.34 41.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.087 -0.506 . . . . 10.0 110.336 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . 0.484 ' O ' ' HA2' ' D' ' 269' ' ' GLY . 0.6 OUTLIER -127.69 114.06 16.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.877 -0.601 . . . . 10.0 111.568 -179.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . 0.638 ' HG2' ' HB3' ' D' ' 270' ' ' LYS . 48.0 mt-10 -124.83 162.23 24.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.157 -0.474 . . . . 10.0 111.687 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 61.57 74.72 0.43 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.653 0.983 . . . . 10.0 113.653 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' E' ' 272' ' ' GLU . 18.1 ttp180 50.4 64.04 1.96 Allowed 'General case' 0 C--O 1.234 0.261 0 O-C-N 123.559 0.537 . . . . 10.0 111.69 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -123.15 174.77 7.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.774 -0.648 . . . . 10.0 110.986 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . 0.972 ' HD3' ' HG3' ' E' ' 274' ' ' ARG . 0.7 OUTLIER -149.63 149.47 30.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.911 0.386 . . . . 10.0 110.721 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 3.1 p -133.48 118.77 32.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.342 -0.844 . . . . 10.0 109.236 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . 0.456 ' HG3' ' HB3' ' D' ' 276' ' ' LEU . 47.5 tt0 -123.82 128.0 48.89 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.921 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . 0.568 ' HG ' ' HB ' ' E' ' 277' ' ' ILE . 4.8 mp -123.58 109.72 14.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.387 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 166.82 -173.63 42.15 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.94 -0.648 . . . . 10.0 112.221 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -101.99 137.72 39.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.743 0.306 . . . . 10.0 110.739 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . 0.414 ' O ' ' HB3' ' E' ' 281' ' ' TYR . 38.4 t -93.13 123.99 45.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.481 -0.327 . . . . 10.0 110.424 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 24.5 t -121.67 106.61 18.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.979 0.419 . . . . 10.0 110.917 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . 0.631 ' HB ' ' HA2' ' E' ' 282' ' ' GLY . 8.9 t -68.43 164.73 20.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.845 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.16 -20.54 64.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.092 -0.503 . . . . 10.0 111.967 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -71.52 -19.96 62.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.443 -0.344 . . . . 10.0 110.429 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 59.26 -165.81 0.19 Allowed 'General case' 0 C--O 1.232 0.16 0 O-C-N 123.914 0.759 . . . . 10.0 111.649 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 7.3 tp -95.47 122.45 38.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.421 -0.354 . . . . 10.0 110.082 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 120.919 0.39 . . . . 10.0 111.354 -179.527 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 4.2 pt . . . . . 0 CA--C 1.519 -0.226 0 CA-C-O 121.081 0.467 . . . . 10.0 112.227 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.64 163.7 39.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.448 -0.796 . . . . 10.0 109.339 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -82.98 86.65 6.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.714 0.769 . . . . 10.0 110.709 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -66.21 -59.31 3.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.252 -0.885 . . . . 10.0 111.332 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 14.8 t -83.02 154.86 24.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.727 -0.67 . . . . 10.0 111.418 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . 0.633 ' HG1' ' N ' ' E' ' 225' ' ' ARG . 49.3 m -130.81 124.01 30.37 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.335 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -118.16 121.58 40.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.883 -0.599 . . . . 10.0 110.023 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 6.3 m -127.48 104.64 8.01 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.777 -0.453 . . . . 10.0 109.777 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' E' ' 228' ' ' ALA . 3.8 p -88.77 152.19 3.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 116.013 -0.54 . . . . 10.0 111.086 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 265' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' E' ' 229' ' ' LYS . 76.0 mm-40 -87.55 -82.9 0.21 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.966 -0.561 . . . . 10.0 111.44 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . 0.516 HG23 ' HB3' ' E' ' 230' ' ' ASP . 18.2 m -132.52 119.96 21.25 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.854 0.359 . . . . 10.0 111.558 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 23.8 t -112.07 111.53 36.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.535 -0.543 . . . . 10.0 109.535 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 18.4 t -113.28 120.51 63.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.307 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -139.46 137.92 8.89 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.67 -0.776 . . . . 10.0 112.158 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . 0.518 ' HG3' ' HB2' ' E' ' 234' ' ' GLU . 24.7 ttpp -142.71 112.93 7.15 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.354 -0.239 . . . . 10.0 110.354 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 111.65 84.14 1.4 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.861 -0.685 . . . . 10.0 112.355 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' E' ' 236' ' ' ARG . 3.5 mm-40 56.31 32.39 20.35 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.361 0.504 . . . . 10.0 112.361 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.3 152.17 38.58 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.002 -0.544 . . . . 10.0 111.449 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . 0.972 ' HG3' ' HD3' ' E' ' 238' ' ' ARG . 2.7 ttm180 -135.88 102.06 4.94 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.894 -0.594 . . . . 10.0 109.987 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 26.7 t -107.58 115.43 48.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.685 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . 0.79 ' HG ' ' HZ ' ' D' ' 286' ' ' PHE . 0.7 OUTLIER -125.35 113.58 17.76 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.416 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . 0.568 ' HB ' ' HG ' ' E' ' 241' ' ' LEU . 46.5 mm -109.48 100.23 10.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.937 0.398 . . . . 10.0 110.653 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 164.28 -148.91 15.33 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.739 -0.664 . . . . 10.0 111.537 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 37.8 p30 -105.38 167.53 9.68 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.747 -0.266 . . . . 10.0 110.693 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . 1.032 ' HB2' ' HA ' ' E' ' 288' ' ' ASP . 0.5 OUTLIER -120.48 124.0 44.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.948 0.404 . . . . 10.0 111.397 -179.05 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . 0.414 ' HB3' ' O ' ' E' ' 244' ' ' VAL . 9.5 t80 -156.84 94.76 1.47 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.822 -0.626 . . . . 10.0 110.261 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . 0.631 ' HA2' ' HB ' ' E' ' 246' ' ' THR . . . -133.99 -81.08 0.16 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.288 -0.958 . . . . 10.0 112.695 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 283' ' ' GLY . . . . . 0.708 ' HA2' ' HB3' ' E' ' 290' ' ' HIS . . . 144.12 30.1 0.1 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.477 -0.868 . . . . 10.0 113.583 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 284' ' ' LYS . . . . . 0.591 ' HG3' ' OD1' ' E' ' 288' ' ' ASP . 6.0 pttp -125.88 -51.66 1.57 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.257 0.465 . . . . 10.0 112.257 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.17 30.03 2.01 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.086 -1.054 . . . . 10.0 113.408 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -147.11 97.98 2.96 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.997 -1.112 . . . . 10.0 107.997 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 73.09 24.66 2.45 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 107.919 -1.141 . . . . 10.0 107.919 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 288' ' ' ASP . . . . . 1.032 ' HA ' ' HB2' ' E' ' 280' ' ' GLU . 2.4 p-10 -170.37 161.42 8.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.035 -1.438 . . . . 10.0 109.375 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -139.31 161.94 36.21 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.914 -0.402 . . . . 10.0 109.914 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 290' ' ' HIS . . . . . 0.708 ' HB3' ' HA2' ' E' ' 283' ' ' GLY . 26.3 p-80 -152.82 167.72 28.11 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.155 -0.475 . . . . 10.0 111.133 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -74.51 -74.43 0.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.377 -0.374 . . . . 10.0 110.638 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 292' ' ' HIS . . . . . 0.564 ' HB2' ' CD2' ' E' ' 290' ' ' HIS . 26.8 t60 67.68 155.18 0.11 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.674 -0.694 . . . . 10.0 111.96 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -122.48 135.97 54.78 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.294 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -93.88 179.36 5.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.564 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 41.3 t60 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.064 -0.97 . . . . 10.0 109.787 -179.664 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.621 0.248 . . . . 10.0 110.334 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -106.55 127.9 53.69 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.668 -0.494 . . . . 10.0 109.668 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 263' ' ' SER . 3.3 m -144.98 161.63 38.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.157 0.503 . . . . 10.0 111.572 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.5 158.61 44.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.049 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.553 ' HD3' ' HG3' ' A' ' 265' ' ' GLU . 7.4 tttm -108.81 -59.6 1.86 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.933 0.397 . . . . 10.0 111.34 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -143.23 127.61 17.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.939 0.399 . . . . 10.0 111.345 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 26.7 mt -131.1 131.13 63.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.851 0.357 . . . . 10.0 111.106 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.467 ' HG3' ' HA ' ' A' ' 268' ' ' VAL . 2.0 ptp85 -126.83 114.43 17.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.3 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.94 122.82 44.27 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.881 -0.6 . . . . 10.0 111.214 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -135.71 153.39 51.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.619 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 65.34 80.71 0.22 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.145 -0.934 . . . . 10.0 112.974 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 55.02 34.14 21.81 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.801 -0.636 . . . . 10.0 112.141 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -100.94 164.04 12.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.447 -0.342 . . . . 10.0 110.559 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -147.66 153.09 38.9 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.82 0.343 . . . . 10.0 111.161 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.76 128.6 67.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.219 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.452 ' HB3' HD22 ' A' ' 276' ' ' LEU . 37.0 tt0 -129.26 131.81 47.08 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.065 -0.346 . . . . 10.0 110.065 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.957 ' HG ' ' HB ' ' A' ' 277' ' ' ILE . 0.8 OUTLIER -124.97 142.46 51.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.549 -0.296 . . . . 10.0 110.783 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.38 -109.82 0.73 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.114 -0.565 . . . . 10.0 112.023 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -160.34 147.39 15.95 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.334 -0.617 . . . . 10.0 109.334 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 79.2 t -115.59 116.83 53.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.842 0.353 . . . . 10.0 111.204 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 16.8 t -110.5 112.98 42.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.965 -0.562 . . . . 10.0 109.586 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.416 ' HB ' ' HA2' ' A' ' 282' ' ' GLY . 6.0 m -89.89 151.06 21.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.274 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.01 -15.88 57.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.0 0.428 . . . . 10.0 111.661 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -73.2 -14.36 61.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.906 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -118.99 56.61 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.192 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.488 ' HB3' ' H ' ' A' ' 251' ' ' HIS . 3.3 mm? 64.72 -135.33 0.26 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.317 -0.856 . . . . 10.0 111.951 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.488 ' H ' ' HB3' ' A' ' 250' ' ' LEU . 52.8 p-80 -119.03 -175.45 2.91 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.309 -0.405 . . . . 10.0 110.434 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -75.02 70.92 1.75 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.199 -0.524 . . . . 10.0 112.667 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -65.96 -41.11 95.5 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.114 -0.565 . . . . 10.0 112.815 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 73.6 mt 73.97 141.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 122.946 0.498 . . . . 10.0 111.823 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 61.82 84.18 0.14 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.195 0.522 . . . . 10.0 111.768 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 45.3 mt -124.16 -42.84 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.309 -0.405 . . . . 10.0 110.773 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 6.2 p -125.19 -94.34 0.48 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.203 0.445 . . . . 10.0 112.203 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.1 t0 55.69 67.9 0.94 Allowed 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.653 0.596 . . . . 10.0 110.999 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -120.32 6.62 10.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.732 -0.667 . . . . 10.0 111.005 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . 0.495 ' HG1' ' N ' ' B' ' 225' ' ' ARG . 5.2 t -142.93 142.31 31.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.027 0.441 . . . . 10.0 111.282 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.16 119.75 28.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.757 -0.831 . . . . 10.0 108.757 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.476 ' HB3' HD12 ' B' ' 241' ' ' LEU . 69.6 m-20 -113.73 117.22 30.9 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.606 -0.516 . . . . 10.0 109.606 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 227' ' ' SER . 19.0 m -145.72 137.15 24.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.897 0.379 . . . . 10.0 111.424 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.538 HG23 ' HB3' ' B' ' 228' ' ' ALA . 7.6 p -123.75 144.81 32.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.642 -0.503 . . . . 10.0 109.642 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.553 ' HG3' ' HD3' ' A' ' 229' ' ' LYS . 32.3 tt0 -84.96 -76.33 0.32 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 112.695 0.628 . . . . 10.0 112.695 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.95 125.63 54.6 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.452 0.538 . . . . 10.0 112.452 -177.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 35.9 t -122.37 122.13 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.079 -0.51 . . . . 10.0 110.004 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.467 ' HA ' ' HG3' ' A' ' 232' ' ' ARG . 21.5 t -114.49 118.05 57.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.395 -0.366 . . . . 10.0 110.797 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.14 119.7 4.63 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.019 -0.832 . . . . 10.0 111.019 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -128.9 103.16 6.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.331 0.493 . . . . 10.0 112.331 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 92.37 91.3 1.47 Allowed Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.766 -0.73 . . . . 10.0 114.628 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 58.3 24.85 12.02 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.949 0.722 . . . . 10.0 112.949 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 9.9 m -74.99 135.04 41.34 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.231 0.539 . . . . 10.0 111.666 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 8.2 mtt180 -117.41 106.48 13.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.662 -0.699 . . . . 10.0 109.431 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 41.7 t -92.23 118.32 37.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.382 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' A' ' 240' ' ' GLN . 0.9 OUTLIER -117.57 105.77 12.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.501 -179.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.957 ' HB ' ' HG ' ' A' ' 241' ' ' LEU . 22.7 mm -100.71 89.23 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.632 -0.507 . . . . 10.0 109.632 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 161.66 161.49 11.91 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.505 -0.77 . . . . 10.0 111.897 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -76.76 156.65 32.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.677 0.275 . . . . 10.0 110.759 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.08 152.71 35.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.213 -0.449 . . . . 10.0 110.908 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -137.96 93.11 2.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.521 -0.763 . . . . 10.0 109.718 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.416 ' HA2' ' HB ' ' A' ' 246' ' ' THR . . . -137.02 -93.75 0.34 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.447 -0.882 . . . . 10.0 112.842 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.444 ' HA2' ' HB ' ' B' ' 246' ' ' THR . . . 125.32 -66.85 0.53 Allowed Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.223 -0.751 . . . . 10.0 111.223 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -86.49 93.1 9.07 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.253 -0.647 . . . . 10.0 109.253 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.56 86.82 1.74 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.789 -0.924 . . . . 10.0 110.789 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -58.1 98.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.048 0.388 . . . . 10.0 112.048 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 4.0 t90 59.92 -79.37 0.02 OUTLIER 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.192 0.812 . . . . 10.0 113.192 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -141.39 74.78 1.47 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.317 -0.623 . . . . 10.0 109.317 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -151.78 132.69 14.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.952 -0.567 . . . . 10.0 111.493 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -151.62 97.56 2.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.987 -0.551 . . . . 10.0 109.739 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -113.54 128.86 56.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.912 -0.585 . . . . 10.0 111.187 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -115.38 -23.99 8.61 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.977 -0.556 . . . . 10.0 109.973 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -72.77 138.53 46.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.766 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -142.73 136.1 28.61 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.357 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.296 -0.859 . . . . 10.0 110.059 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.495 ' N ' ' HG1' ' A' ' 260' ' ' THR . 5.1 tmm_? . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 110.016 -0.364 . . . . 10.0 110.016 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.511 ' ND2' ' HA2' ' B' ' 278' ' ' GLY . 74.5 m-20 -123.4 116.53 23.41 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 123.413 0.445 . . . . 10.0 110.179 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' B' ' 263' ' ' SER . 0.0 OUTLIER -123.32 141.72 51.69 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.047 -0.524 . . . . 10.0 110.72 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.538 ' HB3' HG23 ' A' ' 264' ' ' VAL . . . -133.58 146.3 50.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.787 0.327 . . . . 10.0 111.823 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.746 ' HB2' ' HA ' ' B' ' 265' ' ' GLU . 6.0 mmtt -90.02 -79.98 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.837 0.68 . . . . 10.0 112.837 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.47 123.06 32.67 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.442 0.639 . . . . 10.0 112.094 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.478 HG23 ' HB ' ' B' ' 267' ' ' VAL . 48.6 mt -121.02 125.72 74.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.507 -0.77 . . . . 10.0 110.656 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' B' ' 232' ' ' ARG . 19.6 mtt180 -117.82 117.64 29.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.641 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 1.2 p -118.93 120.07 36.2 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.819 -0.628 . . . . 10.0 110.834 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -131.0 153.46 49.21 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.084 0.401 . . . . 10.0 112.084 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 64.31 72.71 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.387 0.884 . . . . 10.0 113.387 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 48.6 mtm-85 60.27 24.29 13.71 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.845 0.683 . . . . 10.0 112.845 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -86.58 147.14 26.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.837 0.351 . . . . 10.0 110.871 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -129.73 153.18 48.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.477 -0.329 . . . . 10.0 110.832 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.461 HG23 ' HB ' ' B' ' 275' ' ' VAL . 2.7 p -136.65 137.25 47.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.658 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -126.29 136.4 52.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.021 0.439 . . . . 10.0 110.741 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.476 HD12 ' HB3' ' A' ' 262' ' ' ASN . 0.2 OUTLIER -115.2 93.82 4.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.741 -0.663 . . . . 10.0 110.183 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 164.87 174.58 34.74 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.434 -0.889 . . . . 10.0 112.596 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -87.02 144.36 26.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.703 0.287 . . . . 10.0 110.973 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 48.3 t -102.96 111.26 32.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.523 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 48.3 t -117.76 109.39 27.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.078 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . 0.444 ' HB ' ' HA2' ' A' ' 283' ' ' GLY . 43.1 p -84.27 171.89 12.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.011 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.23 -11.18 38.25 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.099 -0.5 . . . . 10.0 111.517 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -77.88 -21.48 51.23 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.198 0.523 . . . . 10.0 110.731 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -82.83 -7.83 59.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.786 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 40.1 tp -66.93 133.85 50.82 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.292 -0.633 . . . . 10.0 109.292 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 64.2 m80 66.11 26.56 10.65 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.457 0.473 . . . . 10.0 110.801 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -114.66 169.69 12.97 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.04 -0.6 . . . . 10.0 111.643 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -94.46 79.68 0.93 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.766 -0.73 . . . . 10.0 112.376 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 9.9 mt -79.42 63.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.007 0.432 . . . . 10.0 111.328 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 255' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' B' ' 255' ' ' ARG . 0.3 OUTLIER -168.05 78.22 0.15 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.179 0.514 . . . . 10.0 110.398 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 256' ' ' ILE . . . . . 0.411 HG22 ' HA3' ' C' ' 252' ' ' GLY . 22.6 pt -106.84 38.05 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.547 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 65.78 43.03 3.28 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.634 -0.712 . . . . 10.0 110.362 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -63.74 99.15 0.22 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.152 -0.931 . . . . 10.0 110.616 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -130.49 93.07 3.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.501 -0.772 . . . . 10.0 111.508 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . 0.637 ' HG1' ' N ' ' C' ' 225' ' ' ARG . 5.4 t -160.24 146.54 15.59 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.886 -0.597 . . . . 10.0 109.932 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.15 121.03 44.01 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.867 -0.606 . . . . 10.0 109.634 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -107.53 122.71 47.21 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.66 -0.496 . . . . 10.0 109.66 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' B' ' 227' ' ' SER . 65.8 m -146.53 129.99 16.8 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.946 0.403 . . . . 10.0 110.955 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 7.3 p -126.53 142.46 43.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.699 -0.682 . . . . 10.0 109.889 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . 0.746 ' HA ' ' HB2' ' B' ' 229' ' ' LYS . 18.3 mt-10 -87.27 -75.04 0.42 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.488 0.551 . . . . 10.0 112.488 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.6 m -108.46 124.65 50.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.41 0.522 . . . . 10.0 112.41 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.478 ' HB ' HG23 ' B' ' 231' ' ' ILE . 3.1 t -122.36 107.51 19.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.763 -0.653 . . . . 10.0 109.94 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.81 118.54 44.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.418 -0.355 . . . . 10.0 111.07 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.48 113.25 2.26 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.312 -0.715 . . . . 10.0 111.312 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -130.39 120.35 24.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.231 0.456 . . . . 10.0 112.231 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 95.5 69.17 1.03 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.618 -0.801 . . . . 10.0 113.412 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 56.86 27.16 12.55 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 112.797 0.665 . . . . 10.0 112.797 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 17.7 m -67.33 156.51 36.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.464 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -128.38 116.06 19.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.686 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.461 ' HB ' HG23 ' B' ' 239' ' ' VAL . 46.0 t -100.64 115.13 41.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.914 -0.584 . . . . 10.0 109.683 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.546 ' HB2' ' CZ2' ' B' ' 287' ' ' TRP . 0.2 OUTLIER -113.17 112.66 24.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.399 -0.364 . . . . 10.0 110.515 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.429 HG22 ' HB3' ' B' ' 226' ' ' ASN . 28.1 mm -105.42 89.05 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.217 0.532 . . . . 10.0 109.659 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . 0.511 ' HA2' ' ND2' ' B' ' 226' ' ' ASN . . . 159.93 175.06 30.49 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.594 -0.73 . . . . 10.0 111.603 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' C' ' 243' ' ' ASN . 16.3 p-10 -93.74 164.87 12.97 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.364 -0.235 . . . . 10.0 110.364 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.1 157.93 36.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.8 0.334 . . . . 10.0 111.317 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.7 71.69 1.36 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.395 -0.82 . . . . 10.0 108.888 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -97.19 -87.99 1.85 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.015 -0.612 . . . . 10.0 112.975 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 113.84 -49.1 0.87 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.765 -0.731 . . . . 10.0 111.861 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -87.71 20.52 2.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.268 0.556 . . . . 10.0 110.45 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 171.57 174.38 39.16 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.493 -1.043 . . . . 10.0 110.493 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -122.57 76.36 1.33 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.028 -0.73 . . . . 10.0 109.028 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.555 ' CH2' ' HB2' ' C' ' 238' ' ' ARG . 15.6 t90 69.82 -59.52 0.5 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.311 -0.859 . . . . 10.0 111.641 -178.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -118.51 -172.48 2.28 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.769 -0.826 . . . . 10.0 108.769 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -101.52 126.69 48.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.224 0.535 . . . . 10.0 112.02 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -155.21 124.95 6.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.894 -0.594 . . . . 10.0 109.923 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 291' ' ' HIS . . . . . 0.609 ' HA ' ' OD1' ' C' ' 289' ' ' ASN . 30.7 t60 -159.74 137.09 9.68 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.519 -0.549 . . . . 10.0 109.519 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -148.42 -167.8 2.91 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 123.148 0.28 . . . . 10.0 110.421 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -104.46 143.15 33.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.784 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -95.19 -173.1 2.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.744 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 4.2 t60 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.905 -1.045 . . . . 10.0 109.178 179.285 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . 0.637 ' N ' ' HG1' ' B' ' 260' ' ' THR . 25.4 ttt180 . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 110.253 -0.277 . . . . 10.0 110.253 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . 0.407 ' HB3' HG22 ' C' ' 277' ' ' ILE . 16.1 m120 -127.8 102.9 7.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.015 -0.538 . . . . 10.0 109.812 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.04 133.55 48.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.843 -0.617 . . . . 10.0 111.808 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.438 ' HB1' HD11 ' C' ' 231' ' ' ILE . . . -128.96 129.9 46.03 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.22 -0.659 . . . . 10.0 109.22 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 5.3 tmtm? -87.55 -81.75 0.23 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.087 0.403 . . . . 10.0 112.087 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -119.06 119.12 33.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.091 0.472 . . . . 10.0 111.872 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.438 HD11 ' HB1' ' C' ' 228' ' ' ALA . 59.3 mt -122.4 133.19 69.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.171 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.522 ' HD3' ' OE1' ' C' ' 234' ' ' GLU . 21.9 ttm-85 -122.97 118.83 28.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.087 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.73 101.54 7.52 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.352 -0.386 . . . . 10.0 110.634 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . 0.522 ' OE1' ' HD3' ' C' ' 232' ' ' ARG . 8.0 pt-20 -120.44 156.56 31.19 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.99 0.367 . . . . 10.0 111.99 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . 0.473 ' OE2' ' HG3' ' C' ' 270' ' ' LYS . 42.5 mt-10 68.86 68.75 0.28 Allowed 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.966 0.791 . . . . 10.0 111.946 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 57.58 33.18 22.92 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.453 -0.794 . . . . 10.0 112.603 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.29 149.15 22.47 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.864 0.364 . . . . 10.0 110.091 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . 0.555 ' HB2' ' CH2' ' B' ' 287' ' ' TRP . 0.3 OUTLIER -133.19 140.75 47.73 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.327 -0.397 . . . . 10.0 110.831 -179.515 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.618 HG23 ' HB ' ' C' ' 275' ' ' VAL . 4.5 p -127.53 138.86 53.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.252 -0.431 . . . . 10.0 111.011 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -123.7 123.94 41.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.974 0.416 . . . . 10.0 110.55 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -103.23 86.72 2.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.353 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.37 -177.78 42.82 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.553 -0.832 . . . . 10.0 112.707 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' B' ' 279' ' ' ASN . 2.4 p30 -93.63 151.14 19.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.667 0.27 . . . . 10.0 110.577 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 45.9 t -109.0 111.11 34.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.774 0.321 . . . . 10.0 110.617 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 23.7 t -113.94 110.76 33.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.178 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 21.3 p -75.75 161.74 28.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.854 0.359 . . . . 10.0 110.974 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.44 12.78 0.55 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.159 -0.473 . . . . 10.0 112.211 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -109.42 -6.7 15.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.159 0.504 . . . . 10.0 110.135 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -99.72 89.57 4.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.749 -0.659 . . . . 10.0 110.85 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 3.2 mp -118.41 7.08 11.85 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.869 -0.605 . . . . 10.0 111.337 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -93.84 80.66 4.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.217 0.532 . . . . 10.0 109.778 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 252' ' ' GLY . . . . . 0.411 ' HA3' HG22 ' B' ' 256' ' ' ILE . . . -123.65 148.54 16.78 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.438 -0.887 . . . . 10.0 113.188 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -140.77 127.15 3.34 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.118 -1.193 . . . . 10.0 110.118 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 11.9 tt -65.15 109.13 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.395 0.617 . . . . 10.0 112.155 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 -164.5 122.33 1.71 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.482 -0.781 . . . . 10.0 110.574 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 19.1 tt -96.35 137.53 23.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.213 0.53 . . . . 10.0 111.281 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 257' ' ' SER . . . . . 0.551 ' HB2' ' HD3' ' D' ' 255' ' ' ARG . 14.2 m -156.21 -169.6 3.1 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.621 -0.881 . . . . 10.0 108.621 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 258' ' ' ASP . . . . . 0.725 ' HB3' ' HB3' ' D' ' 257' ' ' SER . 0.8 OUTLIER -71.96 163.49 27.77 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.384 -0.228 . . . . 10.0 110.384 179.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -153.4 159.45 42.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.744 0.307 . . . . 10.0 111.113 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.17 113.72 15.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.681 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . 0.602 HG22 ' HB3' ' C' ' 225' ' ' ARG . 0.3 OUTLIER -82.78 143.69 30.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.308 -0.405 . . . . 10.0 110.749 179.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -141.84 132.52 25.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.892 0.377 . . . . 10.0 110.683 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 16.7 m -140.97 136.85 32.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.224 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' D' ' 228' ' ' ALA . 10.3 p -122.81 137.21 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 120.877 0.37 . . . . 10.0 111.145 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 47.7 mt-10 -79.22 -73.19 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.533 0.568 . . . . 10.0 112.533 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 1.3 m -120.67 123.79 43.63 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.899 0.703 . . . . 10.0 112.899 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.436 ' HB ' HG23 ' C' ' 231' ' ' ILE . 2.8 t -121.06 116.63 50.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.248 -0.649 . . . . 10.0 109.248 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . 0.431 ' HB ' ' HG2' ' D' ' 232' ' ' ARG . 59.9 t -114.08 117.15 54.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.898 0.38 . . . . 10.0 111.357 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -116.09 126.02 6.89 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.762 -0.935 . . . . 10.0 110.762 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . 0.473 ' HG3' ' OE2' ' C' ' 235' ' ' GLU . 20.5 ttmm -133.43 125.43 29.02 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.912 0.338 . . . . 10.0 111.912 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . 0.46 ' H ' ' HB2' ' C' ' 235' ' ' GLU . . . 80.67 86.87 0.62 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 121.281 -0.485 . . . . 10.0 113.822 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 51.1 37.53 18.33 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.283 0.563 . . . . 10.0 111.699 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 8.0 t -78.29 163.28 25.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.698 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -143.53 121.64 12.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.791 -0.641 . . . . 10.0 110.457 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.618 ' HB ' HG23 ' C' ' 239' ' ' VAL . 33.8 t -111.35 116.56 52.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.152 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' C' ' 276' ' ' LEU . 0.4 OUTLIER -108.03 109.89 21.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.095 0.474 . . . . 10.0 110.472 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.407 HG22 ' HB3' ' C' ' 226' ' ' ASN . 27.1 mm -105.89 91.21 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.409 -0.36 . . . . 10.0 110.448 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 157.66 -174.09 35.05 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.664 -0.779 . . . . 10.0 111.476 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -97.67 149.11 22.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.873 0.336 . . . . 10.0 110.59 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -116.08 142.66 46.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.864 0.364 . . . . 10.0 111.64 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . 0.552 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.4 OUTLIER -124.04 96.39 4.92 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.633 -0.876 . . . . 10.0 108.633 178.583 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . -111.18 166.34 12.26 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.848 -0.692 . . . . 10.0 112.935 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -116.51 -51.51 0.38 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.776 -0.726 . . . . 10.0 112.386 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -75.58 -40.82 56.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.434 0.635 . . . . 10.0 109.725 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -165.2 -159.24 11.22 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.715 -0.954 . . . . 10.0 110.715 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -84.11 -173.02 4.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.65 0.225 . . . . 10.0 111.07 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 13.7 t90 -55.0 -33.29 62.44 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.185 0.517 . . . . 10.0 111.386 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -102.28 150.54 23.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.244 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 289' ' ' ASN . . . . . 0.609 ' OD1' ' HA ' ' B' ' 291' ' ' HIS . 4.8 p30 -131.56 54.1 1.95 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.556 0.693 . . . . 10.0 110.38 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -109.37 -18.84 13.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.434 -0.803 . . . . 10.0 111.348 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 291' ' ' HIS . . . . . 0.444 ' HB3' ' OD1' ' D' ' 288' ' ' ASP . 25.3 m80 -138.05 160.17 40.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.588 -0.278 . . . . 10.0 111.113 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 5.0 m170 68.73 175.05 0.28 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.857 0.688 . . . . 10.0 112.857 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 4.3 t60 . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.168 179.452 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 7.7 m120 . . . . . 0 N--CA 1.445 -0.714 0 N-CA-C 109.535 -0.542 . . . . 10.0 109.535 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 29.0 m -137.9 124.5 20.9 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.745 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' C' ' 264' ' ' VAL . . . -116.83 127.72 54.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.159 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' D' ' 265' ' ' GLU . 30.7 ttmt -86.25 -73.85 0.44 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.347 0.499 . . . . 10.0 112.347 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -120.36 114.78 22.35 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.643 0.238 . . . . 10.0 111.643 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 54.1 mt -122.94 112.7 34.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.808 -0.441 . . . . 10.0 109.808 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . 0.431 ' HG2' ' HB ' ' C' ' 268' ' ' VAL . 36.5 mtm180 -113.44 114.79 27.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.385 -0.371 . . . . 10.0 110.446 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . 0.432 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 0.9 OUTLIER -123.71 113.07 18.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.272 -0.422 . . . . 10.0 111.781 -179.116 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -128.65 169.97 13.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.985 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 67.72 63.4 0.41 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.065 -0.516 . . . . 10.0 111.658 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 60.2 19.69 9.07 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.451 -0.795 . . . . 10.0 112.659 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' D' ' 233' ' ' THR . . . -71.3 165.45 23.68 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.006 0.373 . . . . 10.0 112.006 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . 0.411 ' HG2' ' HG2' ' D' ' 274' ' ' ARG . 0.1 OUTLIER -147.85 143.56 27.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.148 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . 0.684 HG23 ' HB ' ' D' ' 275' ' ' VAL . 4.9 p -137.64 141.72 38.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.47 -0.332 . . . . 10.0 111.459 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . 0.531 ' HB3' HD22 ' D' ' 276' ' ' LEU . 0.1 OUTLIER -124.93 134.79 52.51 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.313 -0.403 . . . . 10.0 110.783 179.173 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . 0.618 HD13 ' HB ' ' D' ' 277' ' ' ILE . 4.0 mm? -118.11 96.11 5.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.949 -0.569 . . . . 10.0 110.394 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 170.81 -105.63 0.22 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.504 -0.855 . . . . 10.0 112.822 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -166.64 158.17 12.97 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.095 -0.335 . . . . 10.0 110.095 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 26.2 t -110.85 108.12 24.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.928 0.394 . . . . 10.0 111.594 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 28.6 t -107.47 123.44 62.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.558 -0.904 . . . . 10.0 108.558 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . 0.533 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 34.7 p -104.58 157.83 16.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.89 0.376 . . . . 10.0 111.802 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.44 9.28 1.4 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.806 -0.634 . . . . 10.0 111.298 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -95.9 -6.13 39.91 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.067 -0.716 . . . . 10.0 109.067 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -105.64 113.51 27.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.509 -0.769 . . . . 10.0 109.923 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 87.8 mt -90.39 -175.16 4.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.137 -0.483 . . . . 10.0 111.026 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -78.06 72.2 4.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.207 0.527 . . . . 10.0 111.192 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -145.04 59.63 0.5 Allowed Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.305 -0.718 . . . . 10.0 111.305 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 88.46 41.67 6.04 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 110.957 -0.857 . . . . 10.0 110.957 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 20.3 tt -84.05 -27.25 7.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.122 0.487 . . . . 10.0 110.707 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 255' ' ' ARG . . . . . 0.551 ' HD3' ' HB2' ' C' ' 257' ' ' SER . 57.8 mtt-85 -78.73 77.71 5.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.767 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 19.7 tt -64.89 -19.63 25.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.485 . . . . 10.0 111.274 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 257' ' ' SER . . . . . 0.725 ' HB3' ' HB3' ' C' ' 258' ' ' ASP . 7.5 m 64.94 -134.54 0.24 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.495 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -118.82 112.28 19.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.143 -0.317 . . . . 10.0 110.143 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -110.85 -79.43 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.862 0.319 . . . . 10.0 111.862 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 15.3 t -90.34 157.35 17.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.143 0.496 . . . . 10.0 111.894 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 55.9 m -108.64 111.97 24.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.421 -0.809 . . . . 10.0 109.512 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . 0.501 ' HB3' HD23 ' E' ' 241' ' ' LEU . 18.3 m120 -103.08 109.38 20.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.854 0.359 . . . . 10.0 110.255 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 16.4 m -119.29 123.27 43.82 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.273 -0.422 . . . . 10.0 110.506 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 8.8 p -125.42 129.93 72.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.605 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 265' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' D' ' 229' ' ' LYS . 3.3 mt-10 -87.5 -73.96 0.46 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.371 0.878 . . . . 10.0 113.371 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 7.4 m -102.48 122.1 43.66 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.652 0.612 . . . . 10.0 112.652 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.35 117.72 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.199 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 33.0 t -114.25 128.02 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.024 0.44 . . . . 10.0 111.352 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' E' ' 233' ' ' THR . . . -132.84 109.5 0.84 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.834 -0.621 . . . . 10.0 111.971 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -125.92 106.73 9.85 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.814 0.301 . . . . 10.0 111.814 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 97.84 88.92 1.9 Allowed Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.834 -0.698 . . . . 10.0 114.353 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 54.24 25.43 5.8 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.338 0.866 . . . . 10.0 113.338 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' E' ' 237' ' ' ALA . 18.9 m -74.75 142.98 44.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.104 0.478 . . . . 10.0 110.998 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . 0.411 ' HG2' ' HG2' ' D' ' 238' ' ' ARG . 26.5 mtm180 -128.32 116.47 19.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.756 -0.656 . . . . 10.0 110.83 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . 0.684 ' HB ' HG23 ' D' ' 239' ' ' VAL . 23.9 t -101.81 122.76 54.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.705 -0.679 . . . . 10.0 110.173 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' D' ' 240' ' ' GLN . 0.3 OUTLIER -120.81 101.83 7.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.145 0.498 . . . . 10.0 110.658 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . 0.618 ' HB ' HD13 ' D' ' 241' ' ' LEU . 41.7 mm -100.97 104.24 15.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.239 -0.652 . . . . 10.0 109.239 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . 0.554 ' O ' ' HA3' ' E' ' 242' ' ' GLY . . . 154.34 -161.32 30.04 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.892 -0.883 . . . . 10.0 110.892 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -120.86 156.94 30.89 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.232 0.516 . . . . 10.0 111.355 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -114.57 131.58 56.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.661 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -129.18 116.37 19.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.18 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . 0.533 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 160.27 177.5 33.42 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.182 -1.008 . . . . 10.0 113.46 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -100.74 44.12 1.63 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.974 -0.632 . . . . 10.0 112.709 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -91.18 -18.81 23.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.128 0.489 . . . . 10.0 110.217 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' D' ' 286' ' ' PHE . . . 99.91 -32.83 6.81 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.643 -0.708 . . . . 10.0 112.419 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' D' ' 285' ' ' GLY . 3.9 t80 170.13 147.59 0.03 OUTLIER 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.022 -0.733 . . . . 10.0 109.022 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 35.4 t90 -52.5 -67.28 0.26 Allowed 'General case' 0 C--O 1.233 0.23 0 O-C-N 123.558 0.536 . . . . 10.0 109.821 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 288' ' ' ASP . . . . . 0.473 ' OD2' ' HD3' ' E' ' 238' ' ' ARG . 26.8 t0 -150.35 144.77 25.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.088 0.471 . . . . 10.0 111.785 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -163.56 141.89 7.79 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.139 -1.06 . . . . 10.0 108.139 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 290' ' ' HIS . . . . . 0.5 ' HD2' ' HD2' ' D' ' 291' ' ' HIS . 14.5 t60 -63.64 -33.83 76.49 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.073 0.768 . . . . 10.0 113.073 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 291' ' ' HIS . . . . . 0.5 ' HD2' ' HD2' ' D' ' 290' ' ' HIS . 24.9 p80 -166.82 -172.22 2.04 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.984 0.364 . . . . 10.0 111.984 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -99.43 -154.13 0.46 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.654 -0.869 . . . . 10.0 108.654 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -71.34 121.88 19.3 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.047 -0.353 . . . . 10.0 110.047 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -98.38 127.52 44.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.405 -0.361 . . . . 10.0 110.28 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.326 -0.845 . . . . 10.0 110.069 179.758 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . 0.603 ' N ' ' HG1' ' E' ' 261' ' ' THR . 79.1 mtt180 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.355 0.121 . . . . 10.0 110.93 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . 0.568 HD22 ' HB2' ' E' ' 262' ' ' ASN . 23.7 m120 -135.35 121.67 20.38 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.99 0.424 . . . . 10.0 110.805 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.69 128.62 52.04 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.777 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.3 118.21 22.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' E' ' 265' ' ' GLU . 30.2 mmmt -82.09 -68.49 0.69 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.273 0.472 . . . . 10.0 112.273 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . 0.463 ' HB3' HG23 ' E' ' 266' ' ' THR . 8.3 t70 -124.87 125.25 43.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.653 0.263 . . . . 10.0 111.33 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 79.2 mt -128.02 118.35 48.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.023 -0.535 . . . . 10.0 110.82 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -115.39 105.36 12.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.423 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . 0.426 HG22 ' HB1' ' E' ' 237' ' ' ALA . 0.3 OUTLIER -118.06 104.81 11.22 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.78 -0.645 . . . . 10.0 110.111 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . 0.584 ' HB2' ' HG2' ' E' ' 270' ' ' LYS . 36.0 mt-10 -123.26 149.02 45.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.246 0.461 . . . . 10.0 112.246 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 64.08 86.94 0.12 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 114.036 1.124 . . . . 10.0 114.036 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 56.45 29.36 15.17 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.603 -0.726 . . . . 10.0 112.712 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . 0.454 ' HB1' ' HB3' ' E' ' 273' ' ' SER . . . -91.9 155.94 17.82 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.912 -0.585 . . . . 10.0 111.336 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . 0.473 ' HD3' ' OD2' ' D' ' 288' ' ' ASP . 0.4 OUTLIER -136.82 147.19 46.44 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.081 179.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . 0.403 HG13 ' HA ' ' D' ' 275' ' ' VAL . 1.6 p -133.01 125.48 51.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.409 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . 0.433 HE21 HD12 ' D' ' 276' ' ' LEU . 8.4 tm0? -118.66 128.49 54.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.156 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . 0.61 ' HG ' ' HB ' ' E' ' 277' ' ' ILE . 0.1 OUTLIER -123.4 92.94 3.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.538 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . 0.573 ' O ' ' HA3' ' E' ' 278' ' ' GLY . . . 170.51 -161.9 34.93 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.681 -0.771 . . . . 10.0 112.274 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . 0.489 HD22 HG23 ' E' ' 245' ' ' VAL . 2.7 p-10 -107.26 147.96 29.55 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.809 0.338 . . . . 10.0 110.6 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 63.3 t -108.32 118.52 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.04 -0.527 . . . . 10.0 109.768 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . 0.489 HG23 HD22 ' E' ' 243' ' ' ASN . 39.9 t -118.41 112.46 38.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.001 0.429 . . . . 10.0 111.701 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . 0.864 ' HB ' ' HA2' ' E' ' 282' ' ' GLY . 7.9 t -69.69 167.23 17.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.504 -0.771 . . . . 10.0 110.749 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.46 -17.33 62.6 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.336 -0.393 . . . . 10.0 111.554 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -67.66 -24.76 65.47 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.406 -0.361 . . . . 10.0 110.766 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 57.01 -163.04 0.18 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.572 -0.74 . . . . 10.0 112.46 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 29.7 mt -89.94 125.13 35.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.856 -0.611 . . . . 10.0 109.847 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 10.0 112.045 -179.13 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 3.1 pt . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 112.943 0.72 . . . . 10.0 112.943 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 69.5 m -118.06 139.05 51.79 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -69.03 136.69 52.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.889 0.376 . . . . 10.0 111.194 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -117.93 -48.48 2.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.132 -0.486 . . . . 10.0 110.526 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 4.8 t -78.03 149.8 33.94 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.011 -0.541 . . . . 10.0 110.256 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . 0.603 ' HG1' ' N ' ' E' ' 225' ' ' ARG . 55.8 m -127.58 113.18 15.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.306 0.574 . . . . 10.0 111.564 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . 0.568 ' HB2' HD22 ' E' ' 226' ' ' ASN . 7.6 m120 -94.86 102.09 13.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.615 -0.72 . . . . 10.0 109.683 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 10.9 m -114.51 120.11 39.12 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.777 0.322 . . . . 10.0 110.455 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.1 p -114.74 144.5 22.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.229 -0.442 . . . . 10.0 111.169 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 265' ' ' GLU . . . . . 0.535 ' O ' ' HB2' ' E' ' 229' ' ' LYS . 8.1 mm-40 -86.27 -79.28 0.26 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 10.0 111.892 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . 0.463 HG23 ' HB3' ' E' ' 230' ' ' ASP . 3.6 m -122.16 119.73 32.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.984 0.421 . . . . 10.0 111.797 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 2.7 t -113.53 105.94 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.042 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.18 125.88 68.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 110.01 -0.367 . . . . 10.0 110.01 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -149.83 136.83 5.89 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.702 -0.761 . . . . 10.0 112.123 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . 0.584 ' HG2' ' HB2' ' E' ' 234' ' ' GLU . 6.3 mttt -133.64 151.41 51.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.6 0.238 . . . . 10.0 110.837 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 76.3 76.33 0.82 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.086 -0.578 . . . . 10.0 112.513 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 61.32 42.03 12.34 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.998 0.428 . . . . 10.0 111.707 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . 0.454 ' HB3' ' HB1' ' E' ' 237' ' ' ALA . 9.6 t -64.95 155.04 35.75 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.604 -0.726 . . . . 10.0 111.715 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -136.65 101.68 4.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.351 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 65.7 t -101.45 119.61 49.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.787 0.327 . . . . 10.0 110.182 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.92 114.92 19.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.351 -0.386 . . . . 10.0 110.762 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . 0.61 ' HB ' ' HG ' ' E' ' 241' ' ' LEU . 17.2 mm -117.9 84.38 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.799 -0.445 . . . . 10.0 109.799 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . 0.573 ' HA3' ' O ' ' E' ' 242' ' ' GLY . . . 178.9 -147.31 7.71 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.494 -0.86 . . . . 10.0 112.485 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.89 146.34 42.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.766 0.317 . . . . 10.0 110.694 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . 0.844 ' HB2' ' HA ' ' E' ' 288' ' ' ASP . 3.0 pt-20 -107.82 115.27 29.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.108 0.48 . . . . 10.0 111.156 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -142.8 91.8 2.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.002 -0.544 . . . . 10.0 110.037 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . 0.864 ' HA2' ' HB ' ' E' ' 246' ' ' THR . . . -147.86 -95.83 0.16 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.469 -0.872 . . . . 10.0 112.932 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 283' ' ' GLY . . . . . 0.951 ' HA2' ' HB3' ' E' ' 290' ' ' HIS . . . -168.48 -104.71 0.18 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.877 -0.889 . . . . 10.0 110.877 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? 26.24 -85.28 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.396 1.628 . . . . 10.0 115.396 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.96 32.32 0.36 Allowed Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.549 -1.02 . . . . 10.0 110.549 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -161.33 105.51 1.3 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.822 -0.807 . . . . 10.0 108.822 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 75.15 10.7 3.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.896 0.855 . . . . 10.0 109.257 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 288' ' ' ASP . . . . . 0.844 ' HA ' ' HB2' ' E' ' 280' ' ' GLU . 16.8 p-10 -159.83 154.54 24.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.196 -1.366 . . . . 10.0 109.325 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.85 161.86 28.04 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.065 0.394 . . . . 10.0 112.065 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 290' ' ' HIS . . . . . 0.951 ' HB3' ' HA2' ' E' ' 283' ' ' GLY . 20.3 p-80 -164.48 167.76 19.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.607 -0.724 . . . . 10.0 109.895 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -106.26 -54.77 2.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.686 0.279 . . . . 10.0 110.679 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 292' ' ' HIS . . . . . 0.521 ' HB2' ' CD2' ' E' ' 290' ' ' HIS . 4.9 t-80 63.28 -164.31 0.25 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.705 -0.679 . . . . 10.0 111.153 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -128.0 125.26 39.07 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.693 -0.484 . . . . 10.0 109.693 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -90.45 133.18 35.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.785 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.09 -0.957 . . . . 10.0 109.714 -179.948 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.759 ' HB3' HG22 ' A' ' 261' ' ' THR . 2.9 tmm_? . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.977 0.418 . . . . 10.0 110.367 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -113.7 111.01 21.11 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.605 -0.887 . . . . 10.0 108.605 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 263' ' ' SER . 0.7 OUTLIER -133.06 144.85 50.28 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.052 0.76 . . . . 10.0 113.052 -178.489 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.41 151.73 47.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.106 -0.952 . . . . 10.0 108.683 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.44 ' HE3' ' HB2' ' A' ' 229' ' ' LYS . 24.1 ttmt -102.75 -61.24 1.42 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.031 0.752 . . . . 10.0 113.031 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.592 ' O ' ' HA ' ' A' ' 266' ' ' THR . 19.9 t0 -131.79 117.24 18.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.06 0.457 . . . . 10.0 111.882 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.553 HG23 ' HB ' ' A' ' 267' ' ' VAL . 56.0 mt -124.05 136.96 58.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.561 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.3 ptp85 -126.29 105.21 8.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.099 0.476 . . . . 10.0 111.662 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.21 120.33 39.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.011 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.517 ' HB2' ' HG2' ' A' ' 270' ' ' LYS . 17.6 mt-10 -132.46 140.45 48.4 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.405 0.52 . . . . 10.0 112.405 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.421 ' OE1' ' HA2' ' A' ' 271' ' ' GLY . 37.9 tt0 65.61 86.01 0.13 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.162 -0.926 . . . . 10.0 113.231 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 96.7 mtm-85 50.66 35.17 11.12 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.361 -0.836 . . . . 10.0 112.738 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.59 146.95 25.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.69 -0.232 . . . . 10.0 110.45 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -124.83 159.29 31.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.562 -0.29 . . . . 10.0 110.413 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.4 p -142.73 126.32 14.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.857 0.36 . . . . 10.0 111.218 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -118.96 139.57 51.45 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.817 -0.438 . . . . 10.0 109.817 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.13 119.43 26.48 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.095 -0.335 . . . . 10.0 110.095 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 152.31 -108.05 0.36 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.751 -0.737 . . . . 10.0 111.967 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -153.85 158.98 41.63 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.864 -0.421 . . . . 10.0 109.864 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 280' ' ' GLU . 18.1 t -110.88 113.19 43.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.126 0.489 . . . . 10.0 112.233 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 57.9 t -101.5 114.22 40.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 5.0 m -106.28 141.79 37.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.241 -0.436 . . . . 10.0 109.933 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.54 -18.15 27.2 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.539 0.57 . . . . 10.0 112.539 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -73.26 -23.49 60.34 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.287 -0.415 . . . . 10.0 111.353 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -110.26 46.19 1.06 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.199 0.523 . . . . 10.0 110.597 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 250' ' ' LEU . 2.2 mm? 66.36 -155.33 0.24 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.254 -0.884 . . . . 10.0 112.112 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -89.46 -175.64 4.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.147 -0.478 . . . . 10.0 110.849 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -76.06 77.91 1.29 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.079 -0.582 . . . . 10.0 112.463 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -67.78 -43.63 83.35 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.26 -0.495 . . . . 10.0 112.086 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 1.3 mp 69.4 136.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 112.779 0.659 . . . . 10.0 112.779 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? 65.83 89.57 0.1 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.499 -0.773 . . . . 10.0 111.977 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 3.5 mp -129.91 -55.38 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.127 -0.488 . . . . 10.0 111.462 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 5.6 p -105.87 -87.91 0.45 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.631 0.604 . . . . 10.0 112.631 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.25 42.95 17.62 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.76 -0.655 . . . . 10.0 111.634 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.414 ' H ' ' HG2' ' A' ' 259' ' ' GLN . 6.8 pt20 -84.45 -21.84 30.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.821 -0.627 . . . . 10.0 111.748 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.419 ' HG1' ' N ' ' B' ' 225' ' ' ARG . 6.6 t -131.97 143.29 49.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.903 0.382 . . . . 10.0 111.119 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.759 HG22 ' HB3' ' A' ' 225' ' ' ARG . 0.2 OUTLIER -87.06 144.12 27.02 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.757 -0.656 . . . . 10.0 109.85 179.306 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -122.06 122.96 40.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.818 0.342 . . . . 10.0 110.449 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' B' ' 227' ' ' SER . 0.9 OUTLIER -139.92 134.49 31.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.156 -0.474 . . . . 10.0 110.894 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.8 p -131.43 137.78 54.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.072 0.463 . . . . 10.0 111.342 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.583 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 40.6 tp10 -77.85 -79.25 0.12 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.862 -0.608 . . . . 10.0 112.344 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 230' ' ' ASP . 3.4 p -120.82 128.58 52.99 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.978 0.733 . . . . 10.0 112.978 -178.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.553 ' HB ' HG23 ' A' ' 231' ' ' ILE . 4.2 t -119.31 127.18 75.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.852 -0.613 . . . . 10.0 109.817 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.477 ' HB ' ' HA ' ' B' ' 232' ' ' ARG . 24.8 t -114.73 120.04 63.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.459 -0.337 . . . . 10.0 110.415 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.23 107.66 0.83 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.892 -0.671 . . . . 10.0 111.714 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.517 ' HG2' ' HB2' ' A' ' 234' ' ' GLU . 89.0 mttt -126.36 148.23 49.62 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.428 -0.212 . . . . 10.0 110.428 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . 0.421 ' HA2' ' OE1' ' A' ' 235' ' ' GLU . . . 76.84 58.96 3.32 Favored Glycine 0 C--O 1.226 -0.356 0 C-N-CA 120.797 -0.716 . . . . 10.0 113.47 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 62.15 21.29 12.32 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.923 0.712 . . . . 10.0 112.923 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 70.0 m -73.17 139.13 46.12 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.997 0.427 . . . . 10.0 111.202 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 12.5 mtt180 -104.57 123.45 47.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 10.0 111.393 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 46.0 t -102.15 117.32 47.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.087 -0.506 . . . . 10.0 109.912 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.41 114.12 21.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.867 0.365 . . . . 10.0 111.511 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 25.9 mm -107.8 103.02 14.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.842 -0.617 . . . . 10.0 109.693 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.34 142.04 3.91 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.792 -0.718 . . . . 10.0 111.908 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -61.85 149.71 39.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.933 0.397 . . . . 10.0 111.683 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.415 ' HA ' ' HB ' ' A' ' 244' ' ' VAL . 0.0 OUTLIER -109.53 158.17 18.27 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.132 -0.485 . . . . 10.0 111.543 -179.42 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -140.09 101.36 4.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.326 -0.852 . . . . 10.0 109.1 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -150.87 -115.37 0.7 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.517 -0.849 . . . . 10.0 113.055 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 146.6 -60.79 0.47 Allowed Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.225 -0.75 . . . . 10.0 111.225 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.492 ' HB3' ' HE2' ' A' ' 284' ' ' LYS . 20.9 ttpt -79.9 85.37 5.55 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.009 -0.738 . . . . 10.0 109.009 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 289' ' ' ASN . . . 95.45 105.43 2.07 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.67 -0.972 . . . . 10.0 110.67 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -75.71 76.24 2.69 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.402 -0.221 . . . . 10.0 110.402 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 18.2 t90 69.38 -58.4 0.51 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.9 -0.591 . . . . 10.0 112.098 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -135.21 90.53 2.63 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.064 -0.717 . . . . 10.0 109.064 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . 0.428 ' HB3' ' HA2' ' A' ' 285' ' ' GLY . 25.1 t-20 -150.34 119.79 6.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.781 0.324 . . . . 10.0 111.631 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -157.93 55.25 0.47 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.398 0.618 . . . . 10.0 109.972 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -105.5 121.56 44.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.644 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -123.24 2.36 9.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.16 0.505 . . . . 10.0 110.797 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -84.01 116.19 22.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.521 -0.763 . . . . 10.0 109.974 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -89.41 127.26 35.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.133 0.492 . . . . 10.0 111.081 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . 0.686 ' HE1' ' H ' ' B' ' 291' ' ' HIS . 1.1 p80 . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.355 -0.831 . . . . 10.0 110.711 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.447 ' HB3' HG22 ' B' ' 261' ' ' THR . 14.7 ttm180 . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.201 -0.296 . . . . 10.0 110.201 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -119.13 114.04 21.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.538 -0.542 . . . . 10.0 109.538 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' B' ' 263' ' ' SER . 3.4 m -129.3 134.1 47.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.011 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.459 ' CA ' ' HAK' ' B' ' 1' ' ' CGO . . . -130.71 143.38 50.7 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.695 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.586 ' HB3' ' O ' ' B' ' 265' ' ' GLU . 12.8 tptm -89.99 -79.57 0.34 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.344 -0.389 . . . . 10.0 111.723 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . 0.44 ' CG ' HH21 ' B' ' 232' ' ' ARG . 18.8 t70 -122.56 126.08 47.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.311 0.577 . . . . 10.0 112.498 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.403 HG23 ' HB ' ' B' ' 267' ' ' VAL . 65.6 mt -122.76 114.66 43.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.563 -0.744 . . . . 10.0 109.053 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . 0.477 ' HA ' ' HB ' ' A' ' 268' ' ' VAL . 1.7 ttm180 -109.87 106.78 16.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.926 0.393 . . . . 10.0 110.66 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.624 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 0.8 OUTLIER -118.08 128.69 55.0 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.13 -0.486 . . . . 10.0 111.106 -179.266 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -141.26 168.23 20.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.535 -0.302 . . . . 10.0 111.373 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.487 ' OE1' ' HG2' ' B' ' 270' ' ' LYS . 34.8 mt-10 65.34 62.65 0.68 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.89 -0.595 . . . . 10.0 111.777 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 81.8 mtm-85 57.05 44.91 21.88 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.924 -0.58 . . . . 10.0 112.227 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.624 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -90.08 163.43 14.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.865 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -134.09 122.31 22.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.097 0.475 . . . . 10.0 110.362 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 p -115.86 125.61 73.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.312 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -119.79 128.24 53.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.849 -0.614 . . . . 10.0 111.089 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.35 97.51 6.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.027 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 156.18 169.15 20.03 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.909 -0.663 . . . . 10.0 112.186 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -87.95 137.86 31.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.831 0.348 . . . . 10.0 110.84 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 94.0 t -91.16 123.28 43.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.969 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 17.7 t -121.96 102.29 11.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.41 0.624 . . . . 10.0 110.493 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 68.4 p -81.57 162.8 23.0 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.661 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.412 ' HA ' ' HG ' ' B' ' 250' ' ' LEU . . . -61.95 -14.15 32.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.104 0.478 . . . . 10.0 111.254 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -75.95 -14.83 60.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.692 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -95.44 -2.16 49.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 10.0 111.111 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.412 ' HG ' ' HA ' ' B' ' 247' ' ' ALA . 87.9 mt -76.17 140.35 41.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.334 -0.394 . . . . 10.0 110.385 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 65.97 28.51 10.51 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 123.597 0.56 . . . . 10.0 110.862 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -131.11 174.22 20.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.055 -0.593 . . . . 10.0 111.714 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -83.08 115.83 4.1 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.131 -0.557 . . . . 10.0 112.478 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 29.5 pt -109.71 17.97 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.026 0.441 . . . . 10.0 111.672 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . 0.49 HH11 ' HA ' ' B' ' 255' ' ' ARG . 0.0 OUTLIER -129.03 103.82 7.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.27 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 20.1 pt -132.18 35.73 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 111.866 0.321 . . . . 10.0 111.866 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 62.3 m 64.29 33.53 11.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.326 0.584 . . . . 10.0 111.466 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.428 ' CG ' HH12 ' B' ' 255' ' ' ARG . 0.7 OUTLIER -77.79 71.43 4.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.465 -0.789 . . . . 10.0 111.902 -179.582 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -96.15 113.8 25.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.024 -0.535 . . . . 10.0 109.777 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 14.7 t -158.82 141.76 14.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.551 0.691 . . . . 10.0 111.961 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . 0.521 ' O ' ' HD2' ' C' ' 225' ' ' ARG . 0.0 OUTLIER -110.14 95.96 5.92 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.298 -0.864 . . . . 10.0 108.813 178.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -91.37 132.21 36.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.386 -0.37 . . . . 10.0 110.66 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . 0.621 ' HB2' ' CAL' ' B' ' 1' ' ' CGO . 1.9 p -145.52 136.05 24.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.279 -0.419 . . . . 10.0 111.656 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.52 ' N ' ' HAL' ' B' ' 1' ' ' CGO . 8.0 p -124.56 131.53 72.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.884 -0.598 . . . . 10.0 110.103 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . 0.586 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 17.3 tp10 -73.14 -62.74 1.36 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.333 0.494 . . . . 10.0 112.333 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' B' ' 230' ' ' ASP . 24.8 m -135.46 124.44 24.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.147 0.499 . . . . 10.0 112.087 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.442 HG22 HG21 ' B' ' 264' ' ' VAL . 20.7 t -111.33 118.95 58.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.736 -0.665 . . . . 10.0 109.356 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . 0.464 ' HB ' ' HA ' ' C' ' 232' ' ' ARG . 39.9 t -103.88 116.73 48.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.904 0.383 . . . . 10.0 110.829 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.75 113.34 2.35 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.395 -0.682 . . . . 10.0 111.395 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.487 ' HG2' ' OE1' ' B' ' 235' ' ' GLU . 2.4 ttpp -128.76 131.05 47.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.665 0.269 . . . . 10.0 111.456 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . 0.464 ' H ' ' HB2' ' B' ' 235' ' ' GLU . . . 78.47 71.94 1.2 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.571 -0.823 . . . . 10.0 113.479 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 53.05 43.8 31.22 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.386 0.884 . . . . 10.0 113.386 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.61 149.73 34.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.236 0.541 . . . . 10.0 111.552 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 38.3 mtt180 -120.0 118.7 31.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.652 -0.704 . . . . 10.0 110.024 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 47.4 t -110.11 127.17 67.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.138 -0.483 . . . . 10.0 111.062 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.51 ' HB2' ' CZ2' ' B' ' 287' ' ' TRP . 0.7 OUTLIER -123.83 109.61 13.84 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.857 -0.423 . . . . 10.0 109.857 179.269 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 36.4 mm -102.25 100.37 10.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.993 -0.373 . . . . 10.0 109.993 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.41 176.54 19.45 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.685 -0.566 . . . . 10.0 111.685 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -97.99 156.63 16.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.9 0.35 . . . . 10.0 110.576 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . 0.417 ' OE2' ' HB2' ' B' ' 287' ' ' TRP . 8.1 pt-20 -128.83 161.47 29.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.912 0.386 . . . . 10.0 111.422 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.431 ' HE1' ' HA ' ' C' ' 247' ' ' ALA . 2.7 t80 -134.33 127.04 30.92 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.546 -0.752 . . . . 10.0 109.852 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' C' ' 246' ' ' THR . . . 167.74 152.34 7.47 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.774 -0.727 . . . . 10.0 112.04 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -123.97 8.38 8.64 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.509 -0.853 . . . . 10.0 111.982 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -97.67 15.17 24.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.055 0.455 . . . . 10.0 110.863 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 156.93 -176.44 34.19 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.218 -0.753 . . . . 10.0 111.218 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -127.29 64.09 1.33 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.389 -0.597 . . . . 10.0 109.389 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.638 ' CZ3' ' HB2' ' C' ' 238' ' ' ARG . 17.3 t90 70.46 -54.21 0.64 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.948 0.78 . . . . 10.0 111.42 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . 0.447 ' CG ' HH11 ' C' ' 238' ' ' ARG . 3.0 t70 -109.13 -168.52 1.35 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.688 -0.687 . . . . 10.0 109.617 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -111.42 132.71 54.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.058 0.456 . . . . 10.0 111.689 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.41 125.08 6.44 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . 0.686 ' H ' ' HE1' ' A' ' 295' ' ' HIS . 0.5 OUTLIER -160.91 143.4 12.62 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.121 -0.326 . . . . 10.0 110.121 -179.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -173.69 -161.99 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.398 -0.364 . . . . 10.0 110.462 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -122.41 149.0 44.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.613 -0.267 . . . . 10.0 111.105 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -83.85 -179.16 7.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.709 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 . . . . . 0 C--O 1.252 1.186 0 CA-C-O 117.909 -1.044 . . . . 10.0 108.852 -179.699 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . 0.706 ' N ' ' HG1' ' C' ' 261' ' ' THR . 1.7 ptt-85 . . . . . 0 N--CA 1.483 1.175 0 N-CA-C 110.21 -0.293 . . . . 10.0 110.21 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . 0.539 ' HB3' HG22 ' C' ' 277' ' ' ILE . 4.2 m120 -131.26 129.06 41.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.349 . . . . 10.0 110.661 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' C' ' 263' ' ' SER . 0.3 OUTLIER -133.07 135.46 45.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.166 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.12 138.33 45.16 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.964 -0.384 . . . . 10.0 109.964 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 18.6 tttm -94.2 -78.65 0.43 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.07 0.396 . . . . 10.0 112.07 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -109.81 116.25 31.32 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.301 0.482 . . . . 10.0 112.301 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 63.4 mt -123.93 117.45 51.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.087 -0.506 . . . . 10.0 110.101 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.533 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 9.3 ttm180 -109.26 120.69 43.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.888 0.375 . . . . 10.0 111.074 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.96 112.85 16.41 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.907 -0.775 . . . . 10.0 108.907 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . 0.533 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 11.5 pt-20 -138.08 161.07 37.72 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.347 0.499 . . . . 10.0 112.347 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 64.73 69.89 0.49 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.883 -1.053 . . . . 10.0 110.943 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 55.58 63.14 2.16 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.845 -1.071 . . . . 10.0 110.449 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -118.47 167.67 11.38 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.766 -0.652 . . . . 10.0 110.442 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . 0.638 ' HB2' ' CZ3' ' B' ' 287' ' ' TRP . 0.0 OUTLIER -153.24 141.6 20.64 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.602 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.666 HG23 ' HB ' ' C' ' 275' ' ' VAL . 5.7 p -125.13 132.81 70.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.499 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.434 ' HB3' HD22 ' C' ' 276' ' ' LEU . 4.0 tm0? -106.72 122.62 46.72 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.592 -0.731 . . . . 10.0 109.122 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.62 69.72 0.7 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.519 -0.309 . . . . 10.0 111.442 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 175.51 -169.5 42.29 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.409 -0.901 . . . . 10.0 112.228 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -95.66 144.93 25.67 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.265 -0.272 . . . . 10.0 110.265 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.96 105.99 19.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.295 -0.411 . . . . 10.0 110.363 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.66 118.71 53.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.254 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' B' ' 282' ' ' GLY . 32.2 p -76.98 163.86 26.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.069 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . 0.431 ' HA ' ' HE1' ' B' ' 281' ' ' TYR . . . -72.89 16.05 0.17 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.685 0.624 . . . . 10.0 112.685 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -121.39 0.67 10.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.067 0.461 . . . . 10.0 109.921 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -109.71 67.14 0.64 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.143 0.497 . . . . 10.0 110.576 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.31 25.84 9.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.059 -0.519 . . . . 10.0 111.295 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -113.99 67.76 0.68 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.36 0.6 . . . . 10.0 111.559 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -140.08 143.04 13.15 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.942 -0.863 . . . . 10.0 110.942 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -95.57 -145.8 19.6 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.113 -1.041 . . . . 10.0 111.833 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 6.9 tp -132.52 110.55 16.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.255 0.55 . . . . 10.0 110.475 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 42.6 ttt85 -158.26 140.5 14.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.782 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 9.6 tt -102.93 134.95 42.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 121.448 0.642 . . . . 10.0 111.587 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 57.9 m -159.73 -170.74 3.01 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.526 -0.761 . . . . 10.0 109.16 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.1 155.42 36.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.789 0.328 . . . . 10.0 111.419 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.02 132.84 12.32 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.247 -0.649 . . . . 10.0 109.247 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . 0.5 ' HA ' ' OD1' ' D' ' 258' ' ' ASP . 3.7 t -68.39 154.14 42.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.328 0.585 . . . . 10.0 112.043 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . 0.706 ' HG1' ' N ' ' C' ' 225' ' ' ARG . 52.8 m -123.44 120.61 33.46 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.451 -0.795 . . . . 10.0 110.23 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' D' ' 226' ' ' ASN . 29.5 t-20 -107.64 125.98 52.01 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.113 -0.699 . . . . 10.0 109.113 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' C' ' 227' ' ' SER . 13.4 m -136.37 131.72 34.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.016 0.436 . . . . 10.0 110.87 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 6.9 p -118.77 139.19 46.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.335 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' D' ' 229' ' ' LYS . 43.2 mt-10 -74.75 -58.59 3.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.199 -0.455 . . . . 10.0 112.046 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 2.7 m -136.51 133.98 37.08 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.386 0.513 . . . . 10.0 112.386 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 24.9 t -123.73 116.72 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.469 -0.937 . . . . 10.0 108.469 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 6.5 t -113.9 108.74 26.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 120.94 0.4 . . . . 10.0 110.906 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -119.55 125.02 6.17 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.907 -0.877 . . . . 10.0 110.907 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . 0.505 ' HG3' ' HG3' ' C' ' 234' ' ' GLU . 45.4 tttm -133.22 117.77 17.8 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.933 0.345 . . . . 10.0 111.933 -178.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 90.33 91.39 1.27 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.885 -0.674 . . . . 10.0 113.122 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 59.25 36.24 23.63 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.94 0.4 . . . . 10.0 111.688 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.85 145.67 42.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.837 -0.62 . . . . 10.0 112.447 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -139.14 109.58 6.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.714 -0.675 . . . . 10.0 110.483 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.666 ' HB ' HG23 ' C' ' 239' ' ' VAL . 22.0 t -102.68 132.74 48.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.052 -0.522 . . . . 10.0 110.651 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.434 HD22 ' HB3' ' C' ' 240' ' ' GLN . 0.2 OUTLIER -121.75 106.31 11.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.685 0.278 . . . . 10.0 110.812 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.539 HG22 ' HB3' ' C' ' 226' ' ' ASN . 23.2 mm -101.69 85.98 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.312 0.577 . . . . 10.0 110.063 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 160.83 -170.33 36.69 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.541 -0.754 . . . . 10.0 111.219 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -102.67 154.94 18.66 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.202 -0.587 . . . . 10.0 110.967 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -108.4 142.67 38.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.321 -0.399 . . . . 10.0 110.407 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . 0.559 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.3 OUTLIER -136.34 97.09 3.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.157 -0.474 . . . . 10.0 109.728 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . -145.96 158.87 27.82 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.861 -0.685 . . . . 10.0 112.781 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -106.5 -15.07 18.25 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.706 -0.759 . . . . 10.0 112.51 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -74.17 -38.59 63.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.275 0.56 . . . . 10.0 110.285 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 170.65 -112.39 0.45 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.147 -1.181 . . . . 10.0 110.147 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -126.08 -169.9 2.09 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.72 -0.474 . . . . 10.0 109.72 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -57.97 -24.3 57.48 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.272 0.558 . . . . 10.0 111.545 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -110.72 157.08 20.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.943 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . 0.413 ' OD1' ' HA ' ' B' ' 291' ' ' HIS . 7.5 p30 -133.85 19.84 3.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.151 0.5 . . . . 10.0 111.307 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . 0.666 ' HB3' ' NH2' ' D' ' 274' ' ' ARG . 5.2 t-80 -81.15 -10.13 59.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.706 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -147.52 168.37 22.1 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.305 0.483 . . . . 10.0 112.305 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 66.51 174.04 0.24 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.5 -0.773 . . . . 10.0 112.646 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . 0.454 ' HB3' ' H ' ' C' ' 294' ' ' HIS . 0.1 OUTLIER -155.85 -145.46 0.16 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.351 0.5 . . . . 10.0 112.351 -179.47 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . 0.454 ' H ' ' HB3' ' C' ' 293' ' ' HIS . 20.1 t-80 -68.6 -83.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.923 0.712 . . . . 10.0 112.923 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.08 0 N-CA-C 109.106 -0.702 . . . . 10.0 109.106 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . 0.487 ' HG3' HG23 ' D' ' 261' ' ' THR . 3.1 mpt_? . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.84 0.352 . . . . 10.0 111.367 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . 0.493 ' O ' ' HA ' ' C' ' 262' ' ' ASN . 7.5 m120 -63.77 123.01 17.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.995 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 1.8 m -146.42 153.46 40.5 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.277 -0.42 . . . . 10.0 110.764 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.29 148.74 46.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.624 0.249 . . . . 10.0 110.922 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . 0.653 ' HB2' ' HA ' ' D' ' 265' ' ' GLU . 17.5 mttt -89.67 -77.78 0.38 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.393 -0.367 . . . . 10.0 111.045 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -125.13 120.18 30.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.923 0.392 . . . . 10.0 110.913 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 62.1 mt -118.69 124.28 72.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.908 -0.587 . . . . 10.0 110.541 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' D' ' 232' ' ' ARG . 6.1 mtm105 -108.5 127.87 54.3 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.882 -0.599 . . . . 10.0 109.786 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . 0.502 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 0.7 OUTLIER -131.77 111.56 11.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.356 -0.384 . . . . 10.0 110.079 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -124.57 154.56 40.46 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.68 0.622 . . . . 10.0 112.68 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 58.15 78.42 0.25 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 114.996 -1.002 . . . . 10.0 113.365 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 52.82 50.62 17.65 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.237 -0.892 . . . . 10.0 111.783 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' D' ' 233' ' ' THR . . . -104.97 154.86 19.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.187 -0.461 . . . . 10.0 110.423 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.05 144.68 43.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.885 0.374 . . . . 10.0 110.912 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . 0.664 HG23 ' HB ' ' D' ' 275' ' ' VAL . 7.6 p -126.96 131.26 71.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.556 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -113.28 121.7 45.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.353 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . 0.416 HD23 HD13 ' C' ' 277' ' ' ILE . 2.6 mm? -116.06 93.49 4.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.941 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 174.64 -120.2 0.77 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.229 -0.986 . . . . 10.0 112.791 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -152.56 152.95 32.47 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.734 -0.469 . . . . 10.0 109.734 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . 0.517 HG11 ' HD1' ' D' ' 287' ' ' TRP . 22.6 t -97.12 106.37 18.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.163 -0.471 . . . . 10.0 111.873 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 21.2 t -110.16 93.48 2.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.278 -0.638 . . . . 10.0 109.278 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . 0.428 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 41.6 p -74.16 153.54 39.47 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.821 -0.351 . . . . 10.0 110.387 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . 0.442 ' HA ' ' HE1' ' C' ' 281' ' ' TYR . . . -73.29 11.63 0.72 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.826 0.346 . . . . 10.0 111.731 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -95.7 -3.99 45.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.25 0.548 . . . . 10.0 109.653 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -99.61 137.13 38.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.692 -0.686 . . . . 10.0 110.168 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' D' ' 250' ' ' LEU . 6.9 tp -118.24 -157.38 0.68 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.626 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -91.15 63.88 5.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.038 0.447 . . . . 10.0 111.338 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -132.28 36.67 2.15 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 111.063 -0.815 . . . . 10.0 111.063 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 107.52 52.35 0.72 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.418 -0.673 . . . . 10.0 111.418 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 20.1 tt -87.48 -20.89 7.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.953 0.406 . . . . 10.0 110.87 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -83.97 70.18 10.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.02 0.438 . . . . 10.0 110.794 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 18.1 tt -64.25 -30.2 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.751 -0.659 . . . . 10.0 111.851 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 7.3 m 66.18 -172.8 0.19 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.924 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . 0.5 ' OD1' ' HA ' ' C' ' 260' ' ' THR . 4.0 m-20 -80.92 93.94 6.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.911 0.386 . . . . 10.0 110.557 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . 0.434 HE21 ' HB2' ' D' ' 259' ' ' GLN . 4.7 tt0 -94.59 -44.05 8.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.12 -0.491 . . . . 10.0 111.431 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 10.3 t -123.25 150.36 43.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.921 0.391 . . . . 10.0 111.003 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . 0.487 HG23 ' HG3' ' D' ' 225' ' ' ARG . 5.5 m -104.46 103.69 13.43 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.415 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' D' ' 226' ' ' ASN . 2.6 m120 -102.64 110.23 22.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.206 -0.452 . . . . 10.0 109.869 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 25.8 m -124.81 131.9 53.4 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.942 0.401 . . . . 10.0 111.047 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' E' ' 228' ' ' ALA . 11.3 p -126.95 138.13 55.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.141 -0.481 . . . . 10.0 110.375 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 265' ' ' GLU . . . . . 0.653 ' HA ' ' HB2' ' D' ' 229' ' ' LYS . 19.8 mt-10 -86.55 -73.02 0.48 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.784 0.661 . . . . 10.0 112.784 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.55 125.8 52.23 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.716 0.635 . . . . 10.0 112.716 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 4.2 t -127.82 113.88 32.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.247 -0.649 . . . . 10.0 109.247 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . 0.68 ' HB ' ' HG2' ' E' ' 232' ' ' ARG . 42.0 t -116.2 113.1 42.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 120.685 0.279 . . . . 10.0 110.976 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.55 137.09 9.44 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.001 -0.619 . . . . 10.0 112.11 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.23 135.8 19.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.638 -0.331 . . . . 10.0 111.122 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.63 89.75 0.23 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.15 -0.547 . . . . 10.0 112.861 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 59.48 38.31 22.61 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.033 0.444 . . . . 10.0 111.444 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 1.5 t -87.56 143.99 26.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.086 -0.506 . . . . 10.0 111.358 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . 0.666 ' NH2' ' HB3' ' C' ' 290' ' ' HIS . 72.0 mtt85 -131.5 110.53 11.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.408 -0.815 . . . . 10.0 109.712 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . 0.664 ' HB ' HG23 ' D' ' 239' ' ' VAL . 36.2 t -101.33 105.35 17.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.994 -0.373 . . . . 10.0 109.994 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . 0.548 HD12 ' HG2' ' E' ' 240' ' ' GLN . 2.1 tm? -107.42 103.59 12.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.929 0.395 . . . . 10.0 110.628 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 42.9 mm -105.03 96.81 4.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.216 -0.447 . . . . 10.0 109.819 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 158.28 178.84 32.69 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.508 -0.637 . . . . 10.0 111.508 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -96.0 156.95 16.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.61 0.243 . . . . 10.0 110.395 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . 0.516 ' HA ' ' HB ' ' D' ' 244' ' ' VAL . 6.0 pt-20 -118.44 131.23 56.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.843 0.354 . . . . 10.0 110.926 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -122.01 123.23 41.14 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.045 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . 0.428 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 155.53 178.68 30.0 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.378 -0.915 . . . . 10.0 112.796 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -108.59 32.77 6.68 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.945 -0.645 . . . . 10.0 112.156 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.19 -9.15 59.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.897 0.379 . . . . 10.0 110.748 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.25 -51.51 1.41 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.076 -0.583 . . . . 10.0 111.709 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -171.42 145.95 2.19 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.831 -0.803 . . . . 10.0 108.831 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . 0.517 ' HD1' HG11 ' D' ' 244' ' ' VAL . 11.5 t90 -56.07 -64.06 0.98 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.041 0.448 . . . . 10.0 110.383 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . 0.418 ' CG ' ' HE ' ' E' ' 238' ' ' ARG . 29.6 t0 -136.29 132.33 35.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.3 0.572 . . . . 10.0 110.473 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -171.85 146.64 2.08 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -69.57 -58.96 3.3 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.849 0.685 . . . . 10.0 112.849 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -161.08 -163.04 0.97 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.826 0.306 . . . . 10.0 111.826 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -86.06 -170.49 3.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.891 -0.595 . . . . 10.0 109.819 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -72.76 117.78 14.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.012 0.434 . . . . 10.0 110.987 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -99.07 148.11 24.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.86 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 117.764 -1.112 . . . . 10.0 108.392 178.888 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . 0.517 ' N ' ' HG1' ' E' ' 261' ' ' THR . 57.9 mtt180 . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 110.283 -0.265 . . . . 10.0 110.283 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -128.5 121.33 28.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.369 . . . . 10.0 110.998 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' E' ' 263' ' ' SER . 0.6 OUTLIER -123.0 144.46 49.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.718 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' D' ' 264' ' ' VAL . . . -139.62 125.83 20.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.29 -0.413 . . . . 10.0 109.938 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' D' ' 265' ' ' GLU . 33.5 mttm -84.0 -62.59 1.53 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.05 0.759 . . . . 10.0 113.05 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . 0.733 ' HB3' HG23 ' E' ' 266' ' ' THR . 8.9 t0 -130.85 125.4 33.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.779 0.323 . . . . 10.0 111.142 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 86.5 mt -133.59 123.97 47.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.042 -0.526 . . . . 10.0 110.306 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . 0.68 ' HG2' ' HB ' ' D' ' 268' ' ' VAL . 7.5 mtt180 -122.23 120.35 33.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.143 -0.481 . . . . 10.0 110.538 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 1.2 p -130.45 93.78 3.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.518 -0.764 . . . . 10.0 110.295 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . 0.631 ' HB2' ' HE3' ' E' ' 270' ' ' LYS . 36.1 mt-10 -119.29 152.11 37.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.334 -0.393 . . . . 10.0 111.0 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 70.72 77.22 0.19 Allowed 'General case' 0 C--O 1.236 0.362 0 O-C-N 123.912 0.757 . . . . 10.0 112.335 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 33.1 mtp180 60.67 24.43 14.23 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.078 -0.965 . . . . 10.0 112.246 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -103.47 150.93 23.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.197 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . 0.419 ' HB3' ' HB2' ' D' ' 274' ' ' ARG . 0.0 OUTLIER -144.55 164.57 30.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.201 -0.454 . . . . 10.0 111.777 -179.203 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . 0.743 HG23 ' HB ' ' E' ' 275' ' ' VAL . 7.7 p -134.63 142.58 40.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.767 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . 0.548 ' HG2' HD12 ' D' ' 276' ' ' LEU . 25.5 tm0? -129.89 131.44 46.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.796 -0.638 . . . . 10.0 109.313 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . 0.469 ' HG ' ' HB ' ' E' ' 277' ' ' ILE . 0.4 OUTLIER -128.98 95.35 4.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.075 0.464 . . . . 10.0 111.786 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 166.32 170.76 31.64 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.435 -0.666 . . . . 10.0 111.435 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -88.14 147.59 24.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.827 0.346 . . . . 10.0 110.924 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.15 125.15 49.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.561 -0.533 . . . . 10.0 109.561 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.9 98.51 7.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.002 0.43 . . . . 10.0 109.86 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . 0.449 ' HB ' ' HA2' ' E' ' 282' ' ' GLY . 14.7 t -60.93 161.92 7.62 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.729 -0.669 . . . . 10.0 111.578 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.09 -19.38 64.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.29 -0.414 . . . . 10.0 111.805 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -74.49 -23.47 58.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.536 -0.302 . . . . 10.0 110.242 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 58.07 -170.28 0.11 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.384 -0.826 . . . . 10.0 112.199 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 6.8 mp -83.99 115.66 22.44 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.234 -0.654 . . . . 10.0 109.234 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -80.42 1.32 29.63 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.019 0.378 . . . . 10.0 112.019 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -177.75 152.95 12.36 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.697 -0.561 . . . . 10.0 111.697 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 111.93 107.81 2.95 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.652 -0.785 . . . . 10.0 112.673 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 36.3 mt -96.3 -22.15 5.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.252 0.549 . . . . 10.0 109.951 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -82.56 58.89 4.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.813 -0.63 . . . . 10.0 110.71 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 15.3 pt -67.8 119.05 12.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.056 -0.52 . . . . 10.0 111.42 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.24 159.24 8.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.919 -0.582 . . . . 10.0 109.833 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.83 140.75 32.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.835 0.35 . . . . 10.0 110.225 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -114.11 -65.91 1.14 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.056 0.455 . . . . 10.0 111.113 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 15.3 t -71.46 146.31 48.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.278 0.561 . . . . 10.0 111.868 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . 0.517 ' HG1' ' N ' ' E' ' 225' ' ' ARG . 91.8 m -123.8 110.05 14.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.566 -0.743 . . . . 10.0 109.624 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -111.08 130.76 55.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.84 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' E' ' 227' ' ' SER . 25.1 m -132.66 120.97 22.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.169 -0.469 . . . . 10.0 109.871 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 7.9 p -98.39 143.59 12.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.418 -0.355 . . . . 10.0 110.393 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -76.79 -75.89 0.18 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.358 -0.383 . . . . 10.0 111.895 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . 0.733 HG23 ' HB3' ' E' ' 230' ' ' ASP . 7.7 m -139.81 120.22 14.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.968 0.414 . . . . 10.0 111.14 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 15.1 t -106.4 115.6 48.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.587 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 42.2 t -116.41 97.73 5.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.514 -0.55 . . . . 10.0 109.514 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.89 119.6 4.2 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.864 -0.684 . . . . 10.0 112.08 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . 0.631 ' HE3' ' HB2' ' E' ' 234' ' ' GLU . 15.5 mtpt -132.04 133.32 44.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.525 0.202 . . . . 10.0 110.644 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.75 73.91 1.17 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.747 -0.739 . . . . 10.0 112.696 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 62.92 25.05 14.88 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.023 0.749 . . . . 10.0 113.023 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 4.6 m -79.06 157.77 27.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.206 0.527 . . . . 10.0 111.352 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -142.18 126.15 17.24 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.556 -0.747 . . . . 10.0 109.752 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . 0.743 ' HB ' HG23 ' E' ' 239' ' ' VAL . 18.8 t -102.63 117.64 48.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.448 -0.342 . . . . 10.0 110.142 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . 0.445 HD22 ' HB3' ' E' ' 240' ' ' GLN . 0.2 OUTLIER -109.9 103.27 12.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.267 -0.424 . . . . 10.0 110.315 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . 0.469 ' HB ' ' HG ' ' E' ' 241' ' ' LEU . 37.7 mm -116.52 91.82 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.102 0.477 . . . . 10.0 110.538 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 173.91 -164.59 36.04 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.932 -0.867 . . . . 10.0 110.932 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -95.45 126.76 40.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.722 0.261 . . . . 10.0 110.49 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' E' ' 280' ' ' GLU . 3.4 pm0 -88.41 127.77 35.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.258 0.552 . . . . 10.0 111.77 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -161.99 77.12 0.5 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.847 -0.615 . . . . 10.0 109.961 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . 0.449 ' HA2' ' HB ' ' E' ' 246' ' ' THR . . . -112.92 -82.11 1.14 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.862 -0.685 . . . . 10.0 112.499 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' E' ' 290' ' ' HIS . . . 135.15 39.85 0.17 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.638 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.21 -63.98 1.21 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.949 0.351 . . . . 10.0 111.949 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 135.84 28.28 0.4 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.318 -0.944 . . . . 10.0 113.293 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -150.68 105.43 3.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.188 -0.671 . . . . 10.0 109.188 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER 68.26 18.03 9.25 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.892 0.853 . . . . 10.0 108.92 -177.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.2 170.48 21.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.938 -1.483 . . . . 10.0 108.098 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -155.37 165.44 36.61 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 121.237 -0.185 . . . . 10.0 110.654 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . 0.592 ' HB3' ' HA2' ' E' ' 283' ' ' GLY . 31.5 p-80 -160.24 164.35 32.8 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -81.5 -68.27 0.71 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.304 -0.158 . . . . 10.0 110.699 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . 0.571 ' HB2' ' CD2' ' E' ' 290' ' ' HIS . 3.8 t60 69.71 171.5 0.3 Allowed 'General case' 0 CA--C 1.533 0.29 0 O-C-N 123.737 0.648 . . . . 10.0 111.862 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -101.32 116.88 33.8 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.971 -0.558 . . . . 10.0 110.138 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -103.02 127.16 50.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.934 -0.575 . . . . 10.0 110.219 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.834 0 CA-C-O 118.34 -0.838 . . . . 10.0 109.334 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' CGO . . . . . 0.741 ' OAU' ' HBT' ' B' ' 1' ' ' CGO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 225' ' ' ARG . 35.5 ttt180 . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.569 0.223 . . . . 10.0 110.585 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -121.82 120.15 33.74 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.352 -0.61 . . . . 10.0 109.352 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 60.6 m -137.29 135.89 37.53 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.589 0.588 . . . . 10.0 112.589 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.48 129.55 43.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.517 -0.765 . . . . 10.0 109.101 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -89.86 -72.47 0.56 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.526 0.565 . . . . 10.0 112.526 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 266' ' ' THR . 41.3 t0 -113.32 120.48 41.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.08 0.467 . . . . 10.0 111.369 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.425 HD12 HG11 ' A' ' 239' ' ' VAL . 8.2 pt -129.18 127.68 65.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.753 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.423 ' HG3' ' HA ' ' A' ' 268' ' ' VAL . 3.6 ptp85 -129.54 125.56 36.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.918 0.389 . . . . 10.0 111.341 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.35 108.49 10.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.231 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.4 ' HB2' ' HD3' ' A' ' 270' ' ' LYS . 5.2 mt-10 -114.57 141.62 47.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 10.0 112.164 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 64.82 93.74 0.06 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 114.189 1.181 . . . . 10.0 114.189 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 50.33 35.12 10.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.564 -0.743 . . . . 10.0 112.94 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -108.8 159.39 16.82 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.201 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -150.4 156.12 40.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.143 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.425 HG11 HD12 ' A' ' 231' ' ' ILE . 4.1 p -136.53 133.45 49.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.164 -0.471 . . . . 10.0 111.107 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -121.29 148.21 44.62 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.772 -0.455 . . . . 10.0 109.772 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 tt -124.99 129.34 50.13 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.068 -0.345 . . . . 10.0 110.068 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.675 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 135.85 -146.68 18.67 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.938 -0.648 . . . . 10.0 112.207 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -121.98 151.46 40.76 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 48.2 t -120.57 101.11 10.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.22 0.533 . . . . 10.0 111.331 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 65.3 t -92.89 115.83 32.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.176 -0.676 . . . . 10.0 109.176 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 43.9 p -82.63 171.05 14.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.741 0.305 . . . . 10.0 111.0 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -71.38 -6.65 41.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.123 0.487 . . . . 10.0 110.958 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -95.51 7.48 46.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.192 0.52 . . . . 10.0 110.14 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -115.2 32.18 6.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.416 -0.811 . . . . 10.0 109.977 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.434 ' HA ' HD13 ' A' ' 250' ' ' LEU . 2.9 mm? 69.62 -85.13 0.03 OUTLIER 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.161 -0.927 . . . . 10.0 112.893 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -148.46 166.58 27.73 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.843 0.354 . . . . 10.0 111.495 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -78.69 69.77 2.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.115 -0.564 . . . . 10.0 112.056 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -76.28 -43.79 19.52 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 121.155 -0.545 . . . . 10.0 112.043 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 64.3 mt 71.41 146.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 123.005 0.522 . . . . 10.0 111.331 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? 70.48 80.33 0.17 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.501 0.667 . . . . 10.0 111.746 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 3.9 mp -114.09 -46.61 4.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.508 -0.769 . . . . 10.0 110.005 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.44 -65.06 0.78 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.901 -0.59 . . . . 10.0 110.234 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 55.95 31.93 18.85 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.992 -0.549 . . . . 10.0 112.157 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -91.07 12.51 19.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.641 -0.709 . . . . 10.0 112.328 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 15.1 t -117.4 143.38 46.05 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.564 0.697 . . . . 10.0 112.674 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.564 ' HB ' ' HG3' ' B' ' 225' ' ' ARG . 0.6 OUTLIER -114.0 101.23 9.05 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.226 -1.027 . . . . 10.0 108.226 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.446 ' ND2' ' HA2' ' B' ' 242' ' ' GLY . 52.2 m-20 -98.52 127.19 44.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.053 -0.521 . . . . 10.0 110.428 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' B' ' 227' ' ' SER . 0.3 OUTLIER -138.02 123.08 19.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.848 -0.615 . . . . 10.0 110.983 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.451 HG21 HG22 ' A' ' 267' ' ' VAL . 14.8 p -123.65 133.82 68.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.287 0.565 . . . . 10.0 111.57 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.583 ' HB3' ' HA ' ' B' ' 229' ' ' LYS . 37.3 tp10 -79.6 -70.88 0.48 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.569 -0.742 . . . . 10.0 112.175 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 230' ' ' ASP . 3.2 m -129.81 126.92 39.21 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.101 0.477 . . . . 10.0 112.105 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.451 HG22 HG21 ' A' ' 264' ' ' VAL . 3.6 t -117.09 126.64 74.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.979 -0.555 . . . . 10.0 109.64 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.451 ' HB ' ' HA ' ' B' ' 232' ' ' ARG . 41.9 t -117.73 122.59 70.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.85 0.357 . . . . 10.0 111.474 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.52 119.62 3.89 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.218 -1.153 . . . . 10.0 110.218 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.4 ' HD3' ' HB2' ' A' ' 234' ' ' GLU . 2.0 tppt? -126.43 110.58 13.47 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.439 0.533 . . . . 10.0 112.439 -178.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.53 91.7 0.77 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.945 -0.645 . . . . 10.0 114.198 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' B' ' 236' ' ' ARG . 38.6 mt-10 51.92 44.06 29.74 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.721 0.637 . . . . 10.0 112.721 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.9 m -96.45 132.58 41.85 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.121 0.486 . . . . 10.0 110.689 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -107.2 114.25 28.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.065 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 30.0 t -105.36 123.12 59.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.508 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.94 108.51 15.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.15 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.496 ' HA ' ' HB2' ' B' ' 241' ' ' LEU . 25.1 mm -93.13 90.4 2.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.768 -0.456 . . . . 10.0 109.768 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.675 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 152.34 -172.52 31.54 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.972 -0.558 . . . . 10.0 112.041 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -101.47 161.24 13.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.077 0.465 . . . . 10.0 111.089 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.99 175.09 7.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.985 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -139.31 67.14 1.39 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.495 -0.775 . . . . 10.0 109.272 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -81.98 115.19 3.97 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.67 -0.695 . . . . 10.0 113.611 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -101.97 -28.78 6.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.824 -0.703 . . . . 10.0 111.854 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -89.8 -45.67 9.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.327 0.584 . . . . 10.0 109.764 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -163.33 156.53 28.35 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.472 -1.051 . . . . 10.0 110.472 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -67.5 112.38 4.64 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 109.549 -0.538 . . . . 10.0 109.549 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 2.3 t90 65.92 -80.38 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 O-C-N 123.797 0.686 . . . . 10.0 110.693 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -162.61 28.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.743 0.782 . . . . 10.0 109.353 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -74.84 117.34 16.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.572 -0.74 . . . . 10.0 111.458 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 -129.06 105.08 7.95 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.919 0.39 . . . . 10.0 110.4 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -115.12 141.68 47.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.673 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -121.4 -53.75 2.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.045 0.45 . . . . 10.0 110.998 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -71.74 142.34 49.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.749 -0.659 . . . . 10.0 110.511 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -143.69 147.35 34.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.347 -0.388 . . . . 10.0 110.427 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 2.7 p80 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.089 -0.958 . . . . 10.0 110.465 179.717 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.564 ' HG3' ' HB ' ' A' ' 261' ' ' THR . 22.9 ttm180 . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 109.845 -0.428 . . . . 10.0 109.845 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -117.59 116.25 26.72 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.522 -0.548 . . . . 10.0 109.522 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . 0.561 ' C ' ' HAK' ' B' ' 1' ' ' CGO . 18.5 m -130.15 136.91 49.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.894 0.378 . . . . 10.0 111.018 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.76 148.34 52.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.599 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.583 ' HA ' ' HB3' ' A' ' 265' ' ' GLU . 56.8 tttp -102.84 -80.52 0.51 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 112.855 0.687 . . . . 10.0 112.855 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -112.66 115.0 27.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.778 0.323 . . . . 10.0 111.665 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.42 HG21 HG21 ' B' ' 239' ' ' VAL . 62.2 mt -120.14 111.07 30.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.349 -0.612 . . . . 10.0 109.349 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . 0.451 ' HA ' ' HB ' ' A' ' 268' ' ' VAL . 12.0 mtt180 -109.93 107.68 17.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.064 0.459 . . . . 10.0 111.387 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 0.6 OUTLIER -115.51 122.31 45.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.629 -0.714 . . . . 10.0 110.727 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -130.83 155.52 46.57 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 112.403 0.52 . . . . 10.0 112.403 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 65.31 77.04 0.32 Allowed 'General case' 0 C--O 1.232 0.136 0 N-CA-C 113.914 1.079 . . . . 10.0 113.914 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . 0.611 ' HB2' ' HG2' ' B' ' 272' ' ' GLU . 44.2 mtm-85 56.13 26.72 10.53 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.55 -0.75 . . . . 10.0 112.824 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.466 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -79.49 151.88 30.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.991 0.424 . . . . 10.0 110.806 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.81 133.02 49.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.968 -0.56 . . . . 10.0 110.789 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.603 HG23 ' HB ' ' B' ' 275' ' ' VAL . 4.2 p -130.71 137.43 56.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.09 -0.504 . . . . 10.0 110.976 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -125.22 130.06 51.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.978 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 277' ' ' ILE . 4.0 mm? -103.24 73.01 1.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.731 -0.668 . . . . 10.0 110.42 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . 0.446 ' HA2' ' ND2' ' A' ' 262' ' ' ASN . . . -179.41 -178.59 48.45 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.315 -0.945 . . . . 10.0 112.824 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . 0.486 HD21 HG22 ' B' ' 245' ' ' VAL . 0.2 OUTLIER -95.58 157.58 15.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.662 0.268 . . . . 10.0 110.355 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 56.6 t -104.36 123.95 58.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.084 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . 0.486 HG22 HD21 ' B' ' 243' ' ' ASN . 16.9 t -122.02 100.25 8.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.297 -0.631 . . . . 10.0 109.297 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 29.8 p -80.59 170.09 16.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.399 -0.364 . . . . 10.0 110.885 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.29 -10.05 52.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.066 -0.516 . . . . 10.0 111.599 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -79.24 -17.36 54.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.83 0.347 . . . . 10.0 110.681 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -88.48 -0.61 57.39 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.776 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 44.6 tp -72.65 117.0 13.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.707 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 50.2 m80 67.98 76.69 0.26 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.298 -0.864 . . . . 10.0 111.24 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -171.24 -166.08 29.52 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.663 -0.699 . . . . 10.0 111.705 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -87.6 109.55 3.49 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.817 -0.706 . . . . 10.0 111.87 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 26.2 pt -101.98 13.72 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.992 0.425 . . . . 10.0 111.207 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 12.0 tpt85 -141.37 104.68 4.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.036 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . 0.862 ' HA ' ' HA3' ' C' ' 252' ' ' GLY . 10.4 pt -107.0 29.04 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.711 0.291 . . . . 10.0 111.172 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.7 t 64.39 28.54 13.64 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.7 0.762 . . . . 10.0 110.198 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -74.88 139.8 43.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.928 -1.033 . . . . 10.0 111.054 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 19.9 tm0? -152.2 106.52 3.17 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.742 -0.663 . . . . 10.0 109.917 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 6.3 t -162.07 163.02 28.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.373 -0.376 . . . . 10.0 111.017 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.24 122.45 37.79 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.836 -0.62 . . . . 10.0 109.456 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -103.85 111.31 23.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.975 0.417 . . . . 10.0 109.918 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' B' ' 227' ' ' SER . 9.8 m -131.51 119.17 21.17 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.163 0.506 . . . . 10.0 111.118 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 12.3 p -115.15 135.25 55.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.865 -0.607 . . . . 10.0 109.978 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 44.8 tt0 -82.65 -73.15 0.41 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.575 0.583 . . . . 10.0 112.575 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.6 125.83 53.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.889 0.376 . . . . 10.0 111.948 -178.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 2.3 t -124.18 121.68 62.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.864 -0.607 . . . . 10.0 109.584 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 47.6 t -112.63 118.61 58.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.765 0.317 . . . . 10.0 111.079 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.79 113.82 2.28 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 111.288 -0.725 . . . . 10.0 111.288 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -127.92 132.1 49.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.646 0.26 . . . . 10.0 111.074 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.81 66.9 1.44 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.922 -0.656 . . . . 10.0 112.358 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . 0.611 ' HG2' ' HB2' ' B' ' 236' ' ' ARG . 28.9 mt-10 53.43 46.89 25.31 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.819 0.674 . . . . 10.0 112.819 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 6.4 t -77.53 167.16 22.08 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.247 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -135.49 117.46 15.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.099 -0.5 . . . . 10.0 110.017 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.603 ' HB ' HG23 ' B' ' 239' ' ' VAL . 34.5 t -112.11 119.51 60.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.087 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.95 113.59 22.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.961 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 23.1 mm -104.25 86.93 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.101 0.476 . . . . 10.0 109.847 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 158.46 168.62 20.92 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.871 -0.891 . . . . 10.0 110.871 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -88.33 167.39 13.57 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.31 0.555 . . . . 10.0 111.235 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.49 167.2 19.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.151 0.5 . . . . 10.0 111.672 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -147.7 78.77 1.47 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.42 -0.809 . . . . 10.0 108.954 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -94.43 -111.4 2.33 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.832 -0.699 . . . . 10.0 112.865 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 132.27 -36.3 2.21 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.713 -0.756 . . . . 10.0 111.379 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -101.82 23.8 10.83 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 165.06 -175.97 40.86 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.516 -1.434 . . . . 10.0 109.516 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -131.11 65.79 1.55 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 117.068 0.434 . . . . 10.0 109.859 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 26.6 t90 71.26 -47.28 0.66 Allowed 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.836 0.71 . . . . 10.0 111.872 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -116.0 -169.92 1.69 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.791 -0.641 . . . . 10.0 109.31 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -118.3 126.06 51.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.333 0.587 . . . . 10.0 111.849 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -156.47 123.6 5.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.461 -0.791 . . . . 10.0 109.359 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -155.55 138.05 15.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.509 -0.314 . . . . 10.0 110.691 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -168.58 -176.61 2.84 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.512 -0.551 . . . . 10.0 109.512 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -105.76 159.38 16.04 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.678 0.275 . . . . 10.0 110.608 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -91.49 -164.45 1.18 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.013 0.435 . . . . 10.0 111.317 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.067 -0.968 . . . . 10.0 109.63 179.91 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.681 0.277 . . . . 10.0 110.962 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' C' ' 262' ' ' ASN . 2.2 m120 -132.19 113.99 13.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 16.5 m -124.67 141.58 52.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.102 0.477 . . . . 10.0 111.905 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.9 139.54 52.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.636 -0.711 . . . . 10.0 110.512 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' B' ' 265' ' ' GLU . 2.4 tmtm? -84.96 -69.11 0.67 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.121 -0.491 . . . . 10.0 111.912 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -129.4 117.0 19.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.915 0.388 . . . . 10.0 111.658 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.404 HG21 HG21 ' C' ' 239' ' ' VAL . 70.2 mt -120.14 120.6 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.138 -0.483 . . . . 10.0 109.749 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.584 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 15.1 ttm-85 -116.21 115.54 26.17 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.215 -0.448 . . . . 10.0 111.269 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.53 99.0 6.09 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.248 0.546 . . . . 10.0 110.88 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . 0.584 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 8.8 pt-20 -121.22 170.99 9.04 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.004 -0.543 . . . . 10.0 110.557 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . 0.451 ' HB3' ' H ' ' C' ' 271' ' ' GLY . 0.8 OUTLIER 67.87 59.18 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.841 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 10.4 mtp180 63.29 16.79 9.74 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.026 0.75 . . . . 10.0 113.026 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -77.38 176.69 8.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.869 0.366 . . . . 10.0 111.171 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.09 152.05 20.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.203 -0.453 . . . . 10.0 110.747 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.738 HG23 ' HB ' ' C' ' 275' ' ' VAL . 8.2 p -131.92 140.35 48.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.052 0.453 . . . . 10.0 111.428 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -117.14 121.81 42.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.855 -0.611 . . . . 10.0 110.175 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.533 HD13 ' HB ' ' C' ' 277' ' ' ILE . 3.7 mm? -106.44 86.23 2.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.62 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.28 -173.09 43.65 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.341 -0.933 . . . . 10.0 112.816 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -97.99 145.82 26.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.72 0.295 . . . . 10.0 110.656 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 36.8 t -106.87 103.64 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.087 0.47 . . . . 10.0 110.868 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 19.9 t -111.58 112.37 40.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.014 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 34.2 p -82.34 160.94 22.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.426 -0.352 . . . . 10.0 111.145 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -69.0 5.39 1.17 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.249 0.463 . . . . 10.0 112.249 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -96.48 3.4 52.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.196 -0.457 . . . . 10.0 109.826 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -116.03 84.66 2.15 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.906 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 84.8 mt -95.85 -9.73 30.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.596 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -84.0 110.78 18.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.701 -0.681 . . . . 10.0 109.69 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . 0.862 ' HA3' ' HA ' ' B' ' 256' ' ' ILE . . . -144.2 -90.14 0.11 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.51 -0.852 . . . . 10.0 112.786 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 100.66 -156.23 19.35 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.686 -0.769 . . . . 10.0 111.608 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 8.0 tt -147.99 104.23 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.281 0.562 . . . . 10.0 111.304 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -157.43 137.49 12.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.965 -0.561 . . . . 10.0 109.931 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 15.3 tt -103.57 133.87 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.034 0.445 . . . . 10.0 110.813 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 41.1 m -155.96 179.66 9.0 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.404 -0.591 . . . . 10.0 109.404 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . 0.553 ' HB3' ' HB3' ' D' ' 257' ' ' SER . 25.8 t0 -72.84 167.13 21.57 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.714 -0.221 . . . . 10.0 110.868 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -158.93 152.98 23.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.606 -0.27 . . . . 10.0 110.521 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . 0.703 ' HG1' ' N ' ' D' ' 225' ' ' ARG . 6.8 t -64.98 132.27 48.81 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.238 0.542 . . . . 10.0 111.152 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 32.5 m -92.36 126.29 37.38 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.001 -0.545 . . . . 10.0 109.759 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' D' ' 226' ' ' ASN . 1.8 m-80 -118.9 123.76 45.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.688 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' D' ' 227' ' ' SER . 14.2 m -141.75 142.3 33.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.079 -0.509 . . . . 10.0 110.244 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . 0.522 HG23 ' HB3' ' D' ' 228' ' ' ALA . 8.8 p -133.51 144.13 36.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.351 -0.386 . . . . 10.0 111.066 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' D' ' 229' ' ' LYS . 43.1 mt-10 -83.19 -75.92 0.3 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.291 0.478 . . . . 10.0 112.291 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 24.3 m -113.52 127.61 56.15 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.125 0.787 . . . . 10.0 113.125 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.92 109.31 20.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.357 -0.838 . . . . 10.0 108.958 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . 0.561 ' HB ' ' HG2' ' D' ' 232' ' ' ARG . 37.1 t -107.41 125.99 63.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.025 0.44 . . . . 10.0 110.864 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -134.04 120.93 2.6 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.885 -0.598 . . . . 10.0 112.022 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -138.53 124.65 20.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.141 0.496 . . . . 10.0 111.2 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . 0.451 ' H ' ' HB3' ' C' ' 235' ' ' GLU . . . 97.25 74.96 1.21 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.83 -0.7 . . . . 10.0 113.101 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 59.06 22.36 10.41 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.665 0.617 . . . . 10.0 112.665 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 16.0 m -69.55 149.61 48.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.085 0.469 . . . . 10.0 111.916 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . 0.46 ' HB3' ' CZ3' ' C' ' 287' ' ' TRP . 2.3 mtm180 -132.37 122.29 24.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.171 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.738 ' HB ' HG23 ' C' ' 239' ' ' VAL . 41.3 t -108.91 129.61 63.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.742 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.409 HD12 HE21 ' D' ' 240' ' ' GLN . 1.8 tm? -121.31 110.51 16.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.289 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.533 ' HB ' HD13 ' C' ' 241' ' ' LEU . 30.5 mm -107.93 94.14 2.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.135 0.493 . . . . 10.0 110.316 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 160.28 -160.08 31.38 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.565 -0.614 . . . . 10.0 111.565 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -115.53 150.49 36.49 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.315 -0.254 . . . . 10.0 110.315 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -119.29 145.23 46.3 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.075 0.464 . . . . 10.0 112.166 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . 0.523 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.3 OUTLIER -127.63 98.59 5.26 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.373 -0.831 . . . . 10.0 108.943 179.363 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' D' ' 246' ' ' THR . . . -145.55 159.93 28.0 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.546 -0.835 . . . . 10.0 112.757 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -106.95 -30.86 4.07 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.748 -0.739 . . . . 10.0 112.894 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -59.72 -45.09 93.22 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.922 0.391 . . . . 10.0 111.036 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 173.47 -128.2 1.46 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.642 -0.983 . . . . 10.0 110.642 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -110.12 -166.18 1.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.209 -0.293 . . . . 10.0 110.209 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.46 ' CZ3' ' HB3' ' C' ' 274' ' ' ARG . 0.8 OUTLIER -54.4 -30.11 51.16 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.156 0.798 . . . . 10.0 113.156 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.83 157.28 31.44 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 122.336 -0.227 . . . . 10.0 110.718 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -123.83 30.4 6.18 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.36 0.504 . . . . 10.0 112.36 -178.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . 0.719 ' HB3' ' NH2' ' D' ' 274' ' ' ARG . 1.5 t-80 -85.7 -17.67 35.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.454 -0.339 . . . . 10.0 110.942 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.67 153.68 51.5 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.995 -0.441 . . . . 10.0 111.619 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.86 179.23 0.16 Allowed 'General case' 0 C--O 1.233 0.235 0 O-C-N 123.654 0.596 . . . . 10.0 110.875 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . 0.43 ' HB3' ' H ' ' C' ' 294' ' ' HIS . 0.2 OUTLIER -165.27 -99.72 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 113.992 1.108 . . . . 10.0 113.992 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . 0.43 ' H ' ' HB3' ' C' ' 293' ' ' HIS . 8.0 t-160 -100.73 -88.64 0.36 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.612 0.597 . . . . 10.0 112.612 -177.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 3.7 t60 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.428 -0.796 . . . . 10.0 111.269 -177.969 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . 0.703 ' N ' ' HG1' ' C' ' 260' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 110.15 -0.315 . . . . 10.0 110.15 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . 0.632 ' HB3' HG22 ' D' ' 277' ' ' ILE . 20.0 m120 -127.84 111.44 13.62 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.859 -0.423 . . . . 10.0 109.859 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . 0.621 ' HB2' ' NBD' ' B' ' 1' ' ' CGO . 0.0 OUTLIER -129.02 140.72 51.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.985 0.422 . . . . 10.0 111.668 -178.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . 0.522 ' HB3' HG23 ' C' ' 264' ' ' VAL . . . -130.01 147.48 51.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.135 -0.484 . . . . 10.0 110.509 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' C' ' 265' ' ' GLU . 39.2 ttmt -92.79 -72.35 0.6 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.259 -0.428 . . . . 10.0 111.743 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -126.26 117.19 22.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.668 0.271 . . . . 10.0 111.321 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 63.5 mt -121.93 123.62 69.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.096 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . 0.561 ' HG2' ' HB ' ' C' ' 268' ' ' VAL . 26.0 mtm180 -120.22 113.94 21.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.15 0.5 . . . . 10.0 110.662 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . 0.42 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 1.7 p -117.31 111.75 19.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.749 -0.659 . . . . 10.0 110.278 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -124.89 151.54 45.22 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.143 0.423 . . . . 10.0 112.143 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . 0.406 ' OE2' ' HE3' ' D' ' 270' ' ' LYS . 46.2 mt-10 65.01 79.19 0.26 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.975 1.102 . . . . 10.0 113.975 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 58.57 19.44 6.65 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.259 -0.882 . . . . 10.0 113.344 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -81.74 162.23 23.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.857 0.361 . . . . 10.0 111.24 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' D' ' 238' ' ' ARG . 0.1 OUTLIER -141.39 147.76 38.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.061 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . 0.464 HG13 HG13 ' C' ' 275' ' ' VAL . 1.9 p -128.81 127.44 66.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.138 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . 0.409 HE21 HD12 ' C' ' 276' ' ' LEU . 8.6 tm0? -113.47 126.79 55.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.623 -0.717 . . . . 10.0 109.211 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.97 97.98 5.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.406 -0.361 . . . . 10.0 110.593 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 164.15 -108.48 0.33 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.517 -0.849 . . . . 10.0 112.778 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -163.8 153.14 14.32 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.678 0.275 . . . . 10.0 110.388 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 t -112.24 106.26 20.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.801 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 52.6 t -104.55 112.89 39.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . 0.508 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 81.6 p -80.33 150.77 29.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.09 0.471 . . . . 10.0 111.694 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . 0.426 ' HA ' ' HE1' ' C' ' 281' ' ' TYR . . . -74.58 8.06 2.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.928 -0.578 . . . . 10.0 111.39 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -101.33 -8.48 22.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.934 -0.575 . . . . 10.0 109.796 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -91.3 110.11 21.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.058 -0.519 . . . . 10.0 109.731 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.79 163.06 24.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.387 0.613 . . . . 10.0 111.707 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -84.25 63.24 7.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.725 -0.671 . . . . 10.0 112.192 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -131.66 59.08 0.69 Allowed Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 110.405 -1.078 . . . . 10.0 110.405 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 109.71 20.54 7.63 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.27 -1.132 . . . . 10.0 110.27 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . 0.43 HD11 HG11 ' D' ' 245' ' ' VAL . 16.6 tt -67.1 -30.8 50.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.851 -0.674 . . . . 10.0 111.425 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -80.05 71.37 6.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.059 0.456 . . . . 10.0 110.874 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . 0.411 ' HB ' ' HE2' ' D' ' 281' ' ' TYR . 20.0 tt -65.04 -19.26 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.669 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . 0.553 ' HB3' ' HB3' ' C' ' 258' ' ' ASP . 4.4 m 66.35 -96.02 0.04 OUTLIER 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.664 -0.698 . . . . 10.0 111.783 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . 0.454 ' OD2' ' HD3' ' D' ' 225' ' ' ARG . 2.5 t0 -149.19 172.27 15.1 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.411 -0.589 . . . . 10.0 109.411 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -169.27 -74.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.91 0.386 . . . . 10.0 110.581 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 13.5 t -96.17 162.46 13.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.352 0.596 . . . . 10.0 110.838 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . 0.513 HG23 ' HB3' ' D' ' 225' ' ' ARG . 12.8 m -116.9 111.98 20.4 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.055 -0.52 . . . . 10.0 109.872 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -97.25 105.49 17.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.024 -0.535 . . . . 10.0 109.961 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 24.1 m -115.59 118.54 33.42 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.591 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . 0.519 HG23 ' HB3' ' E' ' 228' ' ' ALA . 11.4 p -121.83 137.27 55.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.947 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 265' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' E' ' 229' ' ' LYS . 22.5 mt-10 -84.68 -83.61 0.16 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.919 0.711 . . . . 10.0 112.919 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.69 122.75 46.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.298 0.851 . . . . 10.0 113.298 -177.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 43.7 t -121.16 114.5 43.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.233 -0.654 . . . . 10.0 109.233 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 16.9 t -111.54 119.87 60.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.816 0.341 . . . . 10.0 111.403 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' E' ' 233' ' ' THR . . . -123.8 125.93 6.02 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.336 -0.705 . . . . 10.0 111.336 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . 0.406 ' HE3' ' OE2' ' D' ' 235' ' ' GLU . 19.3 tptt -134.4 108.71 8.32 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.825 0.306 . . . . 10.0 111.825 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.92 102.38 0.64 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 114.698 0.639 . . . . 10.0 114.698 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 51.69 36.17 16.87 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.561 0.578 . . . . 10.0 112.561 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' E' ' 237' ' ' ALA . 4.0 m -85.25 139.2 31.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.162 0.506 . . . . 10.0 111.853 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . 0.719 ' NH2' ' HB3' ' C' ' 290' ' ' HIS . 81.2 mtt85 -118.94 113.24 20.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.558 -0.746 . . . . 10.0 110.273 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 46.0 t -102.49 113.45 39.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.357 -0.608 . . . . 10.0 109.357 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . 0.61 HD12 HE21 ' E' ' 240' ' ' GLN . 1.7 tm? -117.39 97.57 5.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.171 0.51 . . . . 10.0 110.867 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . 0.632 HG22 ' HB3' ' D' ' 226' ' ' ASN . 44.1 mm -102.0 91.91 2.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.645 -0.872 . . . . 10.0 108.645 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . 0.426 ' O ' ' HA3' ' E' ' 242' ' ' GLY . . . 166.17 -163.01 36.53 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.639 -0.709 . . . . 10.0 111.564 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -120.41 156.02 32.26 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.73 -0.277 . . . . 10.0 110.922 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -114.62 136.02 53.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.218 -0.447 . . . . 10.0 110.621 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . 0.411 ' HE2' ' HB ' ' D' ' 256' ' ' ILE . 0.5 OUTLIER -124.59 113.35 17.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.347 -179.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . 0.508 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 156.21 171.58 22.69 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.232 -0.985 . . . . 10.0 112.819 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -110.05 53.86 0.57 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.613 -0.803 . . . . 10.0 112.825 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -89.29 -18.11 27.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.204 0.526 . . . . 10.0 109.983 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 118.95 -47.9 0.99 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.775 -0.93 . . . . 10.0 110.775 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . 0.453 ' CE1' HG21 ' E' ' 244' ' ' VAL . 4.7 t80 176.15 145.62 0.08 Allowed 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.871 -1.159 . . . . 10.0 107.871 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 17.1 t90 -50.38 -74.47 0.03 OUTLIER 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.435 0.46 . . . . 10.0 111.761 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -134.81 133.24 39.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.185 0.517 . . . . 10.0 111.301 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -172.51 147.55 1.88 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -73.68 -57.52 3.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.816 0.341 . . . . 10.0 110.984 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -154.74 175.02 14.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.072 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . 0.751 ' HD2' ' HB3' ' E' ' 286' ' ' PHE . 5.9 m80 -97.25 -154.72 0.46 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.599 -0.273 . . . . 10.0 111.455 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -58.91 125.78 24.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.124 0.488 . . . . 10.0 111.486 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -123.51 147.6 47.07 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.691 -0.686 . . . . 10.0 109.939 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.186 -0.911 . . . . 10.0 109.623 179.688 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . 0.551 ' N ' ' HG1' ' E' ' 261' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 110.662 -0.125 . . . . 10.0 110.662 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' E' ' 262' ' ' ASN . 21.4 m120 -137.55 111.82 8.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.65 0.262 . . . . 10.0 110.466 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' E' ' 263' ' ' SER . 21.3 m -122.4 138.35 54.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.157 0.503 . . . . 10.0 111.084 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . 0.519 ' HB3' HG23 ' D' ' 264' ' ' VAL . . . -130.4 129.27 42.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.851 -0.613 . . . . 10.0 109.547 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' D' ' 265' ' ' GLU . 8.0 mttm -84.77 -64.63 1.12 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.57 0.581 . . . . 10.0 112.57 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . 0.805 ' HB3' HG23 ' E' ' 266' ' ' THR . 4.6 t70 -130.79 127.39 38.59 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.779 -0.368 . . . . 10.0 111.278 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 90.9 mt -128.03 123.27 60.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.761 -0.459 . . . . 10.0 109.761 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . 0.404 ' HE ' ' HB2' ' E' ' 232' ' ' ARG . 1.2 ttm180 -116.75 118.29 32.11 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.385 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . 0.426 ' O ' ' HA2' ' D' ' 269' ' ' GLY . 0.8 OUTLIER -128.66 111.19 12.92 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.013 -0.539 . . . . 10.0 110.862 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -129.87 145.56 51.6 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.154 0.427 . . . . 10.0 112.154 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 66.39 81.9 0.19 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.2 0.815 . . . . 10.0 113.2 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 58.35 26.09 13.61 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.902 -0.59 . . . . 10.0 112.246 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' D' ' 273' ' ' SER . . . -94.2 153.32 18.13 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.9 160.52 41.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.829 0.347 . . . . 10.0 111.544 -178.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.34 134.28 49.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.889 -0.596 . . . . 10.0 110.779 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . 0.61 HE21 HD12 ' D' ' 276' ' ' LEU . 21.0 tm0? -127.84 127.52 43.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.932 -0.576 . . . . 10.0 109.845 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . 0.77 ' HG ' ' HB ' ' E' ' 277' ' ' ILE . 0.7 OUTLIER -126.16 105.48 8.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.442 -0.345 . . . . 10.0 110.587 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . 0.493 ' O ' ' HA3' ' E' ' 278' ' ' GLY . . . 164.36 -158.02 30.54 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.757 -0.735 . . . . 10.0 112.445 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -117.34 144.32 45.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.917 0.389 . . . . 10.0 110.649 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . 0.453 HG21 ' CE1' ' D' ' 286' ' ' PHE . 61.6 t -101.24 120.33 50.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.111 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 3.6 t -116.92 101.37 12.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.98 0.419 . . . . 10.0 110.867 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . 0.557 HG23 ' H ' ' E' ' 248' ' ' ALA . 15.0 t -67.53 173.7 3.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.169 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.76 -19.66 64.19 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.331 -0.395 . . . . 10.0 111.794 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . 0.557 ' H ' HG23 ' E' ' 246' ' ' THR . . . -75.52 -22.34 57.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.277 -0.42 . . . . 10.0 110.727 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 55.84 -161.68 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.871 -0.604 . . . . 10.0 111.861 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 5.1 mp -103.27 89.13 3.3 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.034 0.445 . . . . 10.0 110.362 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -79.92 90.24 5.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.418 0.628 . . . . 10.0 110.159 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 112.2 68.88 0.54 Allowed Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.651 -0.98 . . . . 10.0 110.651 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -165.49 75.03 0.16 Allowed Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.263 -0.735 . . . . 10.0 111.263 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 28.9 mt -70.28 -35.56 63.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.031 0.443 . . . . 10.0 110.351 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -103.19 101.94 11.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.469 -0.332 . . . . 10.0 110.587 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 6.5 pt -99.87 113.0 33.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.134 0.492 . . . . 10.0 110.928 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 1.4 m -145.04 151.12 38.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.1 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -85.86 84.3 7.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.769 0.795 . . . . 10.0 111.105 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -70.25 -25.73 63.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.227 -0.897 . . . . 10.0 112.251 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 14.6 t -107.24 148.51 28.85 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.09 0.472 . . . . 10.0 111.334 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . 0.551 ' HG1' ' N ' ' E' ' 225' ' ' ARG . 79.7 m -129.21 114.3 16.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.583 -0.735 . . . . 10.0 111.206 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . 0.407 ' HB2' ' ND2' ' E' ' 226' ' ' ASN . 14.1 m120 -107.85 100.1 9.5 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.311 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' E' ' 227' ' ' SER . 12.9 m -109.04 117.64 34.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.157 -0.474 . . . . 10.0 109.767 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 4.8 p -107.26 152.27 8.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.842 0.353 . . . . 10.0 111.074 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -86.47 -88.11 0.13 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.152 -0.477 . . . . 10.0 111.457 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . 0.805 HG23 ' HB3' ' E' ' 230' ' ' ASP . 9.0 m -125.12 120.95 32.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.966 0.413 . . . . 10.0 111.605 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.16 116.28 51.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.46 110.61 32.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.856 0.36 . . . . 10.0 111.24 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.6 136.14 10.21 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.642 -0.583 . . . . 10.0 111.642 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -140.03 126.6 20.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.017 0.437 . . . . 10.0 111.024 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.89 82.07 1.17 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.748 -0.739 . . . . 10.0 113.647 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 61.43 22.58 12.97 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.295 0.85 . . . . 10.0 113.295 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 45.2 m -73.1 152.32 41.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.886 0.374 . . . . 10.0 111.291 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -131.45 120.48 23.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.815 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 40.3 t -102.44 118.99 50.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.921 -0.581 . . . . 10.0 109.464 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . 0.562 HD22 ' HB3' ' E' ' 240' ' ' GLN . 0.2 OUTLIER -120.57 110.28 16.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.744 -179.345 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . 0.77 ' HB ' ' HG ' ' E' ' 241' ' ' LEU . 46.4 mm -117.74 95.96 4.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.144 0.497 . . . . 10.0 110.178 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' E' ' 242' ' ' GLY . . . 170.89 -126.57 1.34 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.515 -0.634 . . . . 10.0 111.515 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -141.01 151.85 44.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 10.0 111.156 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . 0.695 ' HB2' ' HA ' ' E' ' 288' ' ' ASP . 2.6 pt-20 -105.29 138.61 41.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.095 -0.502 . . . . 10.0 111.913 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -162.55 71.28 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.956 -0.566 . . . . 10.0 110.193 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . 0.505 ' HA2' ' HB ' ' E' ' 246' ' ' THR . . . -112.9 -105.83 2.75 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.853 -0.689 . . . . 10.0 112.626 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . 0.601 ' HA2' ' HB3' ' E' ' 290' ' ' HIS . . . 179.37 25.2 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.564 -0.827 . . . . 10.0 113.364 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.1 -119.79 0.3 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.987 0.394 . . . . 10.0 111.819 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -168.69 46.64 0.22 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.478 -0.868 . . . . 10.0 113.258 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . 0.751 ' HB3' ' HD2' ' D' ' 292' ' ' HIS . 46.2 t80 -174.38 103.43 0.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.543 -0.54 . . . . 10.0 109.543 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 72.55 5.47 5.25 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.762 0.664 . . . . 10.0 109.616 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . 0.695 ' HA ' ' HB2' ' E' ' 280' ' ' GLU . 0.4 OUTLIER -168.49 131.94 1.5 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.133 -1.394 . . . . 10.0 107.388 179.29 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -136.2 172.76 12.53 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.649 -0.251 . . . . 10.0 111.147 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . 0.601 ' HB3' ' HA2' ' E' ' 283' ' ' GLY . 2.9 p-80 -157.82 -163.36 1.32 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.333 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -110.67 -73.06 0.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.513 -0.18 . . . . 10.0 110.513 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . 0.43 ' HB2' ' CD2' ' E' ' 290' ' ' HIS . 37.8 t60 70.89 150.31 0.09 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.722 0.639 . . . . 10.0 112.38 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -88.58 112.92 23.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.417 -0.586 . . . . 10.0 109.417 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -96.23 143.28 27.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.268 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.376 -0.821 . . . . 10.0 110.368 -179.713 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' CGO . . . . . 0.897 ' OBE' ' HBT' ' B' ' 1' ' ' CGO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 110.62 -0.141 . . . . 10.0 110.62 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' A' ' 262' ' ' ASN . 14.7 m-80 -116.24 134.72 54.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.769 0.318 . . . . 10.0 110.201 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 263' ' ' SER . 57.0 m -147.89 157.79 43.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.181 0.515 . . . . 10.0 111.771 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.17 154.66 45.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.533 -0.758 . . . . 10.0 109.168 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.561 ' HB2' ' HA ' ' A' ' 265' ' ' GLU . 44.7 mttt -107.34 -70.97 0.77 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.571 0.582 . . . . 10.0 112.571 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.561 ' O ' ' HA ' ' A' ' 266' ' ' THR . 43.0 t0 -124.02 110.35 14.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.366 -177.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 66.8 mt -119.4 126.37 75.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.385 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.9 ptp85 -124.31 116.26 22.34 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.102 0.477 . . . . 10.0 110.658 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 0.7 OUTLIER -123.52 127.6 48.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.827 -0.624 . . . . 10.0 110.768 -179.305 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -141.91 169.41 17.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.602 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 64.2 60.11 1.0 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.843 -0.617 . . . . 10.0 111.674 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 62.72 29.49 16.78 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.723 -0.671 . . . . 10.0 112.479 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.409 ' HB3' ' HB ' ' A' ' 233' ' ' THR . . . -86.63 157.29 19.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.43 -0.35 . . . . 10.0 110.612 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -135.22 151.2 50.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.247 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.24 139.52 36.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.832 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -137.78 130.12 29.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.266 -0.425 . . . . 10.0 110.205 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.534 ' HG ' ' HB ' ' A' ' 277' ' ' ILE . 5.8 mp -116.82 118.55 32.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.491 -0.322 . . . . 10.0 110.526 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.48 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 152.74 -169.55 31.8 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.824 -0.703 . . . . 10.0 112.694 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.63 126.58 41.0 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.057 -0.349 . . . . 10.0 110.057 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 90.9 t -98.29 116.39 40.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.207 0.527 . . . . 10.0 112.075 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.806 HG11 ' HA2' ' A' ' 252' ' ' GLY . 77.8 t -111.49 116.9 53.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.783 -0.644 . . . . 10.0 109.756 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.77 158.97 15.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.714 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.57 -19.99 65.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.019 0.437 . . . . 10.0 110.766 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -85.98 11.46 11.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.772 -0.649 . . . . 10.0 110.632 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 250' ' ' LEU . . . -121.36 36.03 4.72 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.5 -0.556 . . . . 10.0 109.5 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 3.6 mm? 75.99 -82.22 0.03 OUTLIER 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.44 -0.8 . . . . 10.0 112.645 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 26.0 p-80 -158.22 171.89 19.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.445 -0.343 . . . . 10.0 110.514 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.806 ' HA2' HG11 ' A' ' 245' ' ' VAL . . . -80.62 64.39 4.07 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.002 -0.618 . . . . 10.0 112.749 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -69.63 -46.41 54.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.311 -0.471 . . . . 10.0 112.187 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 84.1 mt 74.15 141.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 122.981 0.513 . . . . 10.0 111.67 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 255' ' ' ARG . 30.1 ttt-85 68.54 82.98 0.16 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.341 0.591 . . . . 10.0 111.245 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 55.6 mt -112.17 -45.92 5.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.765 -0.652 . . . . 10.0 111.532 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 7.0 p -135.28 -82.98 0.41 Allowed 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.293 0.479 . . . . 10.0 112.293 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 11.3 t70 59.4 76.57 0.35 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.478 -0.783 . . . . 10.0 110.981 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -118.05 24.41 11.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.726 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.683 ' HG1' ' N ' ' B' ' 225' ' ' ARG . 5.2 t -155.32 143.04 19.79 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.208 0.528 . . . . 10.0 111.43 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 4.1 m -91.31 120.53 32.27 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.507 -0.923 . . . . 10.0 108.507 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.441 ' O ' ' HA ' ' A' ' 226' ' ' ASN . 67.2 m-20 -111.08 111.71 23.0 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.954 -0.387 . . . . 10.0 109.954 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 227' ' ' SER . 49.7 m -141.07 132.96 27.55 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.043 0.449 . . . . 10.0 111.708 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.6 HG23 ' HB3' ' B' ' 228' ' ' ALA . 9.9 p -121.6 139.22 49.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.795 -0.639 . . . . 10.0 110.004 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.561 ' HA ' ' HB2' ' A' ' 229' ' ' LYS . 6.0 tt0 -79.35 -77.29 0.18 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.29 0.478 . . . . 10.0 112.29 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 230' ' ' ASP . 1.7 m -115.28 133.36 56.11 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.735 0.643 . . . . 10.0 112.735 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 17.4 t -128.47 124.72 62.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.459 -0.791 . . . . 10.0 109.035 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.459 ' HB ' ' HD3' ' B' ' 232' ' ' ARG . 39.7 t -116.65 121.88 68.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.85 0.357 . . . . 10.0 111.116 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -126.63 118.59 3.1 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.979 -0.629 . . . . 10.0 112.056 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -132.81 110.56 10.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.724 0.297 . . . . 10.0 110.966 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 107.45 67.71 0.65 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.636 -0.792 . . . . 10.0 112.563 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 56.48 32.0 19.93 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 13.2 m -69.19 141.67 54.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.253 0.549 . . . . 10.0 110.611 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . 0.401 ' HB2' ' HB3' ' B' ' 238' ' ' ARG . 19.6 mtt180 -114.87 107.08 14.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.386 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 40.8 t -98.97 113.88 35.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.06 -0.518 . . . . 10.0 111.226 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.71 114.79 26.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.246 -0.434 . . . . 10.0 109.863 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.534 ' HB ' ' HG ' ' A' ' 241' ' ' LEU . 29.2 mm -108.91 114.22 46.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.776 -0.453 . . . . 10.0 109.776 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 132.48 163.61 10.7 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.631 -0.795 . . . . 10.0 112.281 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -76.9 147.07 37.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.127 0.489 . . . . 10.0 111.503 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -126.39 152.65 46.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.12 -0.491 . . . . 10.0 111.069 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -129.63 116.63 19.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.726 -0.67 . . . . 10.0 110.581 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' B' ' 246' ' ' THR . . . -166.8 153.3 22.9 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.137 -0.554 . . . . 10.0 111.751 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -128.3 -7.7 4.33 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.431 -0.89 . . . . 10.0 113.327 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -80.07 -43.43 21.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.124 0.487 . . . . 10.0 110.805 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -155.48 157.18 27.53 Favored Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 110.3 -1.12 . . . . 10.0 110.3 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -80.97 74.53 7.96 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.917 0.358 . . . . 10.0 110.894 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 25.0 t90 67.36 -63.93 0.28 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.219 0.949 . . . . 10.0 112.874 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -144.08 96.64 2.92 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.118 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -160.34 144.34 14.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.936 -0.575 . . . . 10.0 110.354 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -157.06 60.7 0.51 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.116 -0.698 . . . . 10.0 109.116 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -83.86 103.73 13.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.852 -0.613 . . . . 10.0 111.769 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -101.56 -31.8 10.68 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.647 -0.706 . . . . 10.0 110.084 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -84.61 124.6 31.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.577 -0.738 . . . . 10.0 109.905 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.42 139.72 47.75 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.785 0.326 . . . . 10.0 110.72 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.509 -0.758 . . . . 10.0 110.378 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.683 ' N ' ' HG1' ' A' ' 260' ' ' THR . 4.7 ttm-85 . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 110.286 -0.265 . . . . 10.0 110.286 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.442 ' HB3' HG22 ' B' ' 277' ' ' ILE . 69.9 m-20 -126.54 124.23 39.54 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.326 -0.62 . . . . 10.0 109.326 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 263' ' ' SER . 5.1 m -139.32 152.95 47.61 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.624 0.25 . . . . 10.0 111.184 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.6 ' HB3' HG23 ' A' ' 264' ' ' VAL . . . -144.24 148.5 35.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.154 -0.476 . . . . 10.0 111.448 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.49 ' HB2' ' HA ' ' B' ' 265' ' ' GLU . 1.1 tmtm? -90.56 -62.35 1.48 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.217 -0.447 . . . . 10.0 111.957 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 266' ' ' THR . 7.3 t0 -145.6 132.25 19.92 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.006 0.431 . . . . 10.0 111.412 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 64.9 mt -125.24 122.92 64.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.086 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . 0.459 ' HD3' ' HB ' ' A' ' 268' ' ' VAL . 3.8 mmt180 -102.74 112.52 25.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.165 -0.471 . . . . 10.0 109.95 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.407 ' O ' ' HA2' ' A' ' 269' ' ' GLY . 1.0 OUTLIER -121.23 115.0 22.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.882 0.372 . . . . 10.0 111.327 -179.226 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.34 164.32 28.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.339 -0.391 . . . . 10.0 111.477 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.43 ' HB2' ' H ' ' B' ' 271' ' ' GLY . 25.8 mt-10 65.64 62.59 0.64 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.595 -0.729 . . . . 10.0 111.872 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . 0.461 ' HB2' ' HG2' ' B' ' 272' ' ' GLU . 63.6 mtm-85 57.83 32.29 21.71 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.894 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.12 159.59 22.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.887 0.375 . . . . 10.0 111.065 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.401 ' HB3' ' HB2' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -137.62 141.82 41.23 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.951 0.405 . . . . 10.0 111.238 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 4.3 p -127.1 135.81 62.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.723 -0.671 . . . . 10.0 110.989 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -118.74 123.23 44.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.61 -0.723 . . . . 10.0 109.227 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.78 84.78 1.98 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.877 0.37 . . . . 10.0 110.504 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 165.41 179.06 38.98 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.482 -0.866 . . . . 10.0 112.233 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -92.26 131.64 37.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.798 0.332 . . . . 10.0 110.664 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 46.7 t -95.77 109.13 22.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.014 0.435 . . . . 10.0 110.707 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 20.3 t -109.24 114.11 46.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 282' ' ' GLY . 32.8 p -81.91 169.01 17.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.087 -0.506 . . . . 10.0 111.324 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -72.12 -4.92 31.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.691 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -78.43 -18.17 55.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.601 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -91.01 3.1 55.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.647 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 20.6 tp -64.58 131.19 46.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.426 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 1.9 t60 60.07 47.89 9.13 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.261 0.553 . . . . 10.0 110.89 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -137.48 -156.52 7.27 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.884 -0.674 . . . . 10.0 111.866 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.51 120.4 4.29 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.987 -0.625 . . . . 10.0 111.736 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 52.5 mt -103.5 -33.48 3.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.22 0.533 . . . . 10.0 110.733 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' B' ' 255' ' ' ARG . 4.0 tpt180 -79.82 81.06 6.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.975 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 21.4 pt -102.34 37.51 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.798 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.7 t 65.87 36.22 6.18 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.925 -0.58 . . . . 10.0 110.616 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -65.94 122.43 17.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.397 -0.82 . . . . 10.0 110.154 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . 0.4 ' OE1' HG13 ' C' ' 256' ' ' ILE . 12.8 tt0 -139.28 109.25 6.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.333 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 8.5 t -175.38 177.1 1.89 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.998 0.428 . . . . 10.0 110.56 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 71.2 m -150.48 117.47 5.92 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.901 -0.777 . . . . 10.0 108.901 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -99.69 116.06 30.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.991 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 50.8 m -135.78 113.9 11.37 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.881 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' C' ' 228' ' ' ALA . 13.2 p -113.14 146.2 18.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.556 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . 0.49 ' HA ' ' HB2' ' B' ' 229' ' ' LYS . 28.4 mt-10 -85.01 -75.5 0.35 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.173 0.435 . . . . 10.0 112.173 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' B' ' 230' ' ' ASP . 4.3 m -123.24 130.14 52.34 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.748 0.647 . . . . 10.0 112.748 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 37.3 t -119.77 122.87 69.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.376 -0.829 . . . . 10.0 109.041 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . 0.418 ' HB ' ' HA ' ' C' ' 232' ' ' ARG . 35.3 t -104.3 114.02 42.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.815 0.34 . . . . 10.0 110.348 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.41 97.6 0.72 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.556 -0.618 . . . . 10.0 111.556 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -119.89 118.98 32.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.728 0.299 . . . . 10.0 111.189 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . 0.43 ' H ' ' HB2' ' B' ' 235' ' ' GLU . . . 100.65 62.57 0.79 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.325 -0.941 . . . . 10.0 112.595 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . 0.461 ' HG2' ' HB2' ' B' ' 236' ' ' ARG . 12.1 mt-10 54.58 37.68 28.45 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.124 0.786 . . . . 10.0 113.124 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' C' ' 237' ' ' ALA . 7.3 m -77.81 151.16 34.1 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.899 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 13.2 mtt85 -116.25 121.08 40.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.344 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 40.8 t -108.84 119.42 58.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.486 -0.561 . . . . 10.0 109.486 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.597 ' HB3' ' HG3' ' C' ' 240' ' ' GLN . 0.1 OUTLIER -117.97 113.37 21.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.666 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.442 HG22 ' HB3' ' B' ' 226' ' ' ASN . 43.3 mm -103.54 88.33 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.896 0.379 . . . . 10.0 110.074 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 158.66 175.07 29.18 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.899 -0.667 . . . . 10.0 111.974 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -93.05 159.35 15.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.152 -0.314 . . . . 10.0 110.152 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.46 160.83 27.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.192 0.52 . . . . 10.0 111.684 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.02 71.27 1.33 Allowed 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -97.3 -65.03 0.9 Allowed Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.213 -0.903 . . . . 10.0 111.885 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . 0.533 ' HA3' ' H ' ' C' ' 247' ' ' ALA . . . 82.35 -46.99 3.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.247 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' B' ' 284' ' ' LYS . 27.9 mtpp -67.35 -26.69 66.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.411 0.624 . . . . 10.0 110.126 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -152.73 164.22 30.66 Favored Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 110.216 -1.154 . . . . 10.0 110.216 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -97.87 64.18 1.71 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.93 -0.396 . . . . 10.0 109.93 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.447 ' CH2' ' HB2' ' C' ' 238' ' ' ARG . 16.1 t90 71.19 -43.11 0.55 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.387 -0.824 . . . . 10.0 112.341 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -139.02 -170.54 2.89 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.863 -0.421 . . . . 10.0 109.863 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.38 142.19 58.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.419 -0.355 . . . . 10.0 110.777 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -166.48 89.73 0.39 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 110.397 -0.223 . . . . 10.0 110.397 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -155.52 119.35 4.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.82 0.343 . . . . 10.0 111.796 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.97 -176.49 5.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.125 -0.488 . . . . 10.0 110.457 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.6 154.17 17.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.817 0.341 . . . . 10.0 111.477 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . 0.565 ' HB2' ' HA ' ' C' ' 291' ' ' HIS . 29.1 p80 -116.16 -174.07 2.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.41 -0.814 . . . . 10.0 109.211 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.218 -0.896 . . . . 10.0 109.73 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . 0.675 ' N ' ' HG1' ' C' ' 261' ' ' THR . 31.2 ptt180 . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.485 0.183 . . . . 10.0 110.549 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . 0.442 ' HB3' HG22 ' C' ' 277' ' ' ILE . 21.5 m120 -127.72 111.51 13.77 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . 0.446 ' HB2' ' CAW' ' B' ' 1' ' ' CGO . 0.0 OUTLIER -128.28 152.59 47.94 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.051 0.453 . . . . 10.0 111.572 -178.607 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.413 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -149.06 143.82 26.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.774 -0.648 . . . . 10.0 109.995 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . 0.456 ' HG2' ' OE2' ' B' ' 265' ' ' GLU . 38.3 mttm -91.91 -72.27 0.6 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.633 0.605 . . . . 10.0 112.633 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -122.06 126.29 48.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.865 0.365 . . . . 10.0 111.558 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 49.7 mt -129.52 115.05 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.382 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.428 ' HD2' HG13 ' C' ' 268' ' ' VAL . 14.7 ttm-85 -101.45 115.12 29.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.396 -0.365 . . . . 10.0 110.561 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -125.29 100.7 6.64 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.447 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -125.32 161.58 26.66 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.014 0.376 . . . . 10.0 112.014 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 66.45 75.15 0.33 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.358 -0.837 . . . . 10.0 112.108 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 53.33 55.17 9.1 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.297 -0.865 . . . . 10.0 111.133 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' B' ' 273' ' ' SER . . . -107.97 165.89 11.12 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.712 -0.676 . . . . 10.0 111.164 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . 0.447 ' HB2' ' CH2' ' B' ' 287' ' ' TRP . 1.5 ptp180 -153.1 138.01 17.14 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.854 -0.612 . . . . 10.0 110.16 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.484 HG23 ' HB ' ' C' ' 275' ' ' VAL . 4.4 p -135.06 136.46 51.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.191 -0.459 . . . . 10.0 110.614 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.597 ' HG3' ' HB3' ' B' ' 276' ' ' LEU . 27.6 tt0 -126.07 128.61 47.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.993 0.425 . . . . 10.0 111.043 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -105.24 91.41 3.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.769 -0.651 . . . . 10.0 109.831 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 168.19 -174.39 43.03 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.669 -0.777 . . . . 10.0 111.992 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -95.54 155.69 16.64 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.827 0.346 . . . . 10.0 110.95 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 57.3 t -112.68 108.78 26.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.06 -0.518 . . . . 10.0 110.249 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.83 110.64 32.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.218 -0.446 . . . . 10.0 110.342 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 38.3 p -79.84 159.92 26.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.019 -0.537 . . . . 10.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . 0.533 ' H ' ' HA3' ' B' ' 283' ' ' GLY . . . -73.68 42.54 0.13 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.273 0.559 . . . . 10.0 111.838 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -138.19 -13.06 1.4 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.61 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -87.45 67.03 9.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.109 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 55.8 mt -87.12 -4.6 59.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.978 -0.555 . . . . 10.0 111.379 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -94.04 129.24 40.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.305 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 178.77 -158.57 23.01 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.661 -0.78 . . . . 10.0 112.182 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 176.17 -134.66 2.68 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.676 -0.969 . . . . 10.0 110.676 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 13.5 tt -158.42 89.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.498 0.666 . . . . 10.0 111.421 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -140.93 115.31 9.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.367 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . 0.4 HG13 ' OE1' ' B' ' 259' ' ' GLN . 8.5 tt -74.83 129.28 36.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.819 -0.628 . . . . 10.0 109.898 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.44 174.16 15.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.125 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.81 145.6 55.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.92 -0.582 . . . . 10.0 112.155 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -147.76 149.07 31.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.761 -0.654 . . . . 10.0 109.703 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . 0.654 ' HG1' ' N ' ' D' ' 225' ' ' ARG . 12.8 t -71.51 140.29 49.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.005 0.431 . . . . 10.0 110.847 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . 0.675 ' HG1' ' N ' ' C' ' 225' ' ' ARG . 7.7 m -105.54 134.34 48.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.099 -0.501 . . . . 10.0 110.384 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . 0.55 ' HA ' ' O ' ' D' ' 226' ' ' ASN . 18.6 t-20 -122.65 128.36 50.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.875 -0.602 . . . . 10.0 109.5 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 50.0 m -144.63 138.78 27.62 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.737 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.9 p -123.52 145.34 30.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.852 -0.613 . . . . 10.0 110.996 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' D' ' 229' ' ' LYS . 54.8 mt-10 -82.32 -66.27 0.91 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.491 -0.322 . . . . 10.0 111.735 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.79 129.74 51.04 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.295 0.85 . . . . 10.0 113.295 -178.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 48.3 t -127.19 119.97 54.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.661 -0.7 . . . . 10.0 109.648 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . 0.609 ' HB ' ' HD2' ' D' ' 232' ' ' ARG . 58.8 t -117.01 120.08 63.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.794 0.33 . . . . 10.0 110.895 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -123.77 130.95 7.85 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.976 -0.631 . . . . 10.0 112.121 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -133.04 126.68 32.42 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.913 0.338 . . . . 10.0 111.913 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.17 93.23 0.16 Allowed Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.951 -0.568 . . . . 10.0 113.449 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 64.02 32.47 12.91 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.303 0.573 . . . . 10.0 111.403 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . 0.459 ' HB3' ' HA3' ' C' ' 269' ' ' GLY . 0.2 OUTLIER -66.46 121.83 16.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.328 -0.851 . . . . 10.0 111.193 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 41.3 mtt180 -124.74 100.89 6.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.147 0.499 . . . . 10.0 109.763 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.484 ' HB ' HG23 ' C' ' 239' ' ' VAL . 22.3 t -101.78 131.86 48.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.041 -0.527 . . . . 10.0 111.411 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' D' ' 240' ' ' GLN . 2.2 tm? -128.01 113.2 15.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.858 -0.61 . . . . 10.0 109.815 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.48 HG12 HD23 ' D' ' 241' ' ' LEU . 56.1 mt -111.0 94.13 2.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.324 0.583 . . . . 10.0 110.756 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 168.19 -165.06 38.5 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.825 -1.31 . . . . 10.0 109.825 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -108.49 148.28 30.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 117.477 0.638 . . . . 10.0 110.946 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -104.94 137.61 42.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.344 -0.389 . . . . 10.0 110.644 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.2 OUTLIER -131.0 102.16 5.92 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.538 -0.542 . . . . 10.0 109.538 179.411 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' D' ' 246' ' ' THR . . . -164.98 172.07 40.55 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.689 -0.767 . . . . 10.0 112.434 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -124.34 16.33 7.59 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.782 -0.723 . . . . 10.0 112.522 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -101.68 1.28 37.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.964 0.411 . . . . 10.0 111.179 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 129.86 -116.17 2.04 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.835 -0.906 . . . . 10.0 110.835 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . 0.511 ' HB3' ' NE1' ' D' ' 287' ' ' TRP . 0.8 OUTLIER -125.75 -155.78 0.7 Allowed 'General case' 0 C--N 1.323 -0.549 0 O-C-N 123.513 0.184 . . . . 10.0 110.562 179.131 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.417 ' H ' ' HB2' ' C' ' 286' ' ' PHE . 1.7 t90 -63.75 -24.0 67.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.635 0.255 . . . . 10.0 111.284 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . 0.405 ' OD2' ' HD2' ' D' ' 238' ' ' ARG . 1.9 p30 -133.47 -171.39 2.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.489 -0.323 . . . . 10.0 110.262 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -143.02 35.44 1.37 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.075 0.464 . . . . 10.0 110.966 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -79.99 0.58 31.01 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.276 0.473 . . . . 10.0 112.276 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . 0.661 ' HB2' HH12 ' D' ' 274' ' ' ARG . 0.2 OUTLIER -164.46 155.82 15.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.455 179.125 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 66.34 157.19 0.11 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.399 0.618 . . . . 10.0 112.464 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.26 -93.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.117 0.414 . . . . 10.0 112.117 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -79.69 -81.03 0.12 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.208 0.448 . . . . 10.0 112.208 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 . . . . . 0 C--O 1.249 1.026 0 N-CA-C 109.813 -0.439 . . . . 10.0 109.813 -179.122 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . 0.654 ' N ' ' HG1' ' C' ' 260' ' ' THR . 6.4 mtt85 . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.094 -0.336 . . . . 10.0 110.094 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' C' ' 262' ' ' ASN . 19.1 m120 -132.36 129.2 39.11 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 121.015 -0.274 . . . . 10.0 110.301 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . 0.414 ' HB3' ' NBD' ' B' ' 1' ' ' CGO . 42.6 m -151.17 142.83 23.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.89 0.376 . . . . 10.0 111.579 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.85 139.59 53.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.51 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' C' ' 265' ' ' GLU . 22.5 ttmt -84.54 -66.12 0.93 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.877 0.37 . . . . 10.0 111.601 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -138.51 119.43 14.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.649 0.261 . . . . 10.0 111.113 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . 0.422 HG12 HG23 ' D' ' 267' ' ' VAL . 32.7 mt -117.07 130.89 71.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.385 -0.37 . . . . 10.0 110.502 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . 0.609 ' HD2' ' HB ' ' C' ' 268' ' ' VAL . 22.2 mmm-85 -118.55 106.38 12.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.176 -0.466 . . . . 10.0 110.66 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . 0.554 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 1.4 p -112.99 113.3 25.28 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.625 -0.509 . . . . 10.0 109.625 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . 0.406 ' HG3' ' HG3' ' D' ' 270' ' ' LYS . 4.2 pt-20 -131.18 147.34 52.59 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.368 0.506 . . . . 10.0 112.368 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 68.38 79.22 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.162 -0.927 . . . . 10.0 113.278 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 55.68 45.64 24.2 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.287 0.565 . . . . 10.0 111.94 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -111.06 157.23 20.21 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.901 -0.591 . . . . 10.0 110.61 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . 0.405 ' HD2' ' OD2' ' C' ' 288' ' ' ASP . 0.0 OUTLIER -144.33 151.77 39.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.244 -0.434 . . . . 10.0 110.822 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . 0.451 HG23 ' HB ' ' D' ' 275' ' ' VAL . 3.8 p -138.25 133.43 43.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.22 -0.445 . . . . 10.0 110.273 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' C' ' 276' ' ' LEU . 0.0 OUTLIER -115.21 125.38 53.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.522 179.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . 0.48 HD23 HG12 ' C' ' 277' ' ' ILE . 3.0 mm? -109.66 92.59 4.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.865 -0.607 . . . . 10.0 110.819 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 175.72 -106.02 0.21 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.716 -0.755 . . . . 10.0 112.466 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -167.91 162.93 13.77 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.637 0.375 . . . . 10.0 110.282 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . 0.402 HG21 ' CD1' ' D' ' 287' ' ' TRP . 35.8 t -110.52 111.92 38.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.842 0.353 . . . . 10.0 111.802 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 17.7 t -113.21 109.98 30.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.383 -0.599 . . . . 10.0 109.383 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' C' ' 282' ' ' GLY . 82.3 p -89.75 162.77 15.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.945 0.403 . . . . 10.0 111.611 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -72.87 -0.89 14.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.048 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -88.57 -12.08 43.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.407 0.622 . . . . 10.0 109.782 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -97.06 87.76 4.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.387 -0.824 . . . . 10.0 109.983 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 4.5 mp -84.17 -160.16 0.44 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.809 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -79.69 100.52 7.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.088 0.47 . . . . 10.0 111.087 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -174.15 38.73 0.13 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.819 -0.912 . . . . 10.0 110.819 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 101.96 35.11 4.08 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.818 -0.706 . . . . 10.0 111.451 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 10.0 tt -68.0 -38.02 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 121.161 0.505 . . . . 10.0 111.987 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 42.1 mtt-85 -84.04 83.96 7.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.103 0.478 . . . . 10.0 111.551 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 15.5 tt -67.68 -16.97 21.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.215 -0.902 . . . . 10.0 111.739 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 7.7 m 71.1 -83.23 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.369 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -161.14 167.84 25.42 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -160.09 -41.58 0.05 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.137 0.273 . . . . 10.0 111.56 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 13.9 t -144.07 162.05 37.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.867 0.365 . . . . 10.0 111.231 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . 0.601 HG23 ' HB3' ' D' ' 225' ' ' ARG . 21.8 m -105.44 114.46 28.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.062 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -102.59 104.51 14.9 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.047 -0.524 . . . . 10.0 109.778 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 14.8 m -117.48 126.3 52.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.021 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 9.2 p -123.62 133.37 69.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.151 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 265' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' E' ' 229' ' ' LYS . 67.7 mt-10 -83.71 -82.49 0.16 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.207 -0.451 . . . . 10.0 112.137 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 2.4 p -106.0 119.61 39.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.015 0.436 . . . . 10.0 112.029 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . 0.422 HG23 HG12 ' D' ' 231' ' ' ILE . 0.1 OUTLIER -127.67 113.7 32.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.152 -0.476 . . . . 10.0 110.02 179.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . 0.536 ' HB ' ' HG2' ' E' ' 232' ' ' ARG . 42.0 t -113.0 128.6 69.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.312 -0.404 . . . . 10.0 111.023 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' E' ' 233' ' ' THR . . . -129.8 115.02 1.8 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.677 -0.969 . . . . 10.0 110.677 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . 0.638 ' HB3' ' HG2' ' E' ' 234' ' ' GLU . 5.6 tttp -124.07 125.63 44.85 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.518 0.562 . . . . 10.0 112.518 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.53 89.58 0.4 Allowed Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.592 -0.731 . . . . 10.0 113.876 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 55.58 52.55 10.91 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.161 0.505 . . . . 10.0 111.555 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 6.3 t -103.38 142.39 34.31 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.968 -0.56 . . . . 10.0 110.858 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . 0.661 HH12 ' HB2' ' C' ' 291' ' ' HIS . 2.1 mpt_? -122.56 110.6 15.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.218 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' D' ' 239' ' ' VAL . 26.0 t -99.95 114.96 39.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.991 -0.374 . . . . 10.0 109.991 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . 0.456 ' HB3' ' HG3' ' E' ' 240' ' ' GLN . 1.2 tm? -116.43 108.85 16.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.313 0.578 . . . . 10.0 111.27 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 44.3 mm -106.2 99.84 9.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.223 -0.658 . . . . 10.0 109.223 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.1 -171.46 32.72 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.792 -0.718 . . . . 10.0 111.313 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -110.28 161.75 15.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.918 0.389 . . . . 10.0 111.205 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -117.06 134.77 54.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.074 -0.512 . . . . 10.0 111.045 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -125.96 113.61 17.38 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.089 -0.505 . . . . 10.0 110.282 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . 0.536 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 161.31 -178.15 37.35 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.271 -0.966 . . . . 10.0 112.64 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -108.37 41.6 2.17 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.839 -0.696 . . . . 10.0 112.965 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt -86.82 -22.23 25.97 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.699 -0.482 . . . . 10.0 109.699 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 98.93 -32.76 6.72 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.049 -0.596 . . . . 10.0 112.149 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . 0.79 ' HZ ' ' HG ' ' E' ' 276' ' ' LEU . 2.6 t80 176.71 137.72 0.06 Allowed 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.591 -0.522 . . . . 10.0 109.591 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . 0.511 ' NE1' ' HB3' ' C' ' 286' ' ' PHE . 9.6 t90 -55.89 -74.49 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.581 0.55 . . . . 10.0 110.584 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . 0.505 ' CG ' ' HE ' ' E' ' 238' ' ' ARG . 48.5 t0 -125.8 117.82 24.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.456 0.646 . . . . 10.0 111.8 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . 0.582 ' HA ' ' HD3' ' E' ' 274' ' ' ARG . 10.1 t-20 -156.34 160.86 40.08 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.76 -1.2 . . . . 10.0 107.76 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -80.35 -64.62 1.15 Allowed 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.365 0.506 . . . . 10.0 112.365 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -148.57 -160.65 1.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.647 -0.251 . . . . 10.0 110.955 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -91.29 -161.02 0.77 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.814 -0.439 . . . . 10.0 109.814 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -71.18 133.35 46.1 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.475 -0.195 . . . . 10.0 110.475 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -122.33 147.09 46.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.595 -0.275 . . . . 10.0 110.941 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.355 -0.831 . . . . 10.0 109.6 178.949 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . 0.633 ' N ' ' HG1' ' E' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 110.21 -0.293 . . . . 10.0 110.21 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -132.13 114.48 14.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.701 0.286 . . . . 10.0 110.716 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 2.4 m -122.77 141.27 52.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.226 0.536 . . . . 10.0 111.719 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' E' ' 264' ' ' VAL . . . -135.69 121.09 19.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.813 -0.63 . . . . 10.0 109.41 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . 0.545 ' O ' ' HB2' ' D' ' 265' ' ' GLU . 9.7 mttm -79.9 -69.91 0.55 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.066 0.765 . . . . 10.0 113.066 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . 0.516 ' HB3' HG23 ' E' ' 266' ' ' THR . 19.9 t70 -124.58 126.0 45.08 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.753 -0.379 . . . . 10.0 111.852 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 54.8 mt -134.35 122.16 39.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.095 0.474 . . . . 10.0 110.78 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . 0.536 ' HG2' ' HB ' ' D' ' 268' ' ' VAL . 37.5 mtm180 -122.41 123.34 41.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.087 -0.506 . . . . 10.0 110.336 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . 0.484 ' O ' ' HA2' ' D' ' 269' ' ' GLY . 0.6 OUTLIER -127.69 114.06 16.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.877 -0.601 . . . . 10.0 111.568 -179.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . 0.638 ' HG2' ' HB3' ' D' ' 270' ' ' LYS . 48.0 mt-10 -124.83 162.23 24.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.157 -0.474 . . . . 10.0 111.687 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 61.57 74.72 0.43 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.653 0.983 . . . . 10.0 113.653 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' E' ' 272' ' ' GLU . 18.1 ttp180 50.4 64.04 1.96 Allowed 'General case' 0 C--O 1.234 0.261 0 O-C-N 123.559 0.537 . . . . 10.0 111.69 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -123.15 174.77 7.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.774 -0.648 . . . . 10.0 110.986 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . 0.972 ' HD3' ' HG3' ' E' ' 274' ' ' ARG . 0.7 OUTLIER -149.63 149.47 30.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.911 0.386 . . . . 10.0 110.721 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 3.1 p -133.48 118.77 32.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.342 -0.844 . . . . 10.0 109.236 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . 0.456 ' HG3' ' HB3' ' D' ' 276' ' ' LEU . 47.5 tt0 -123.82 128.0 48.89 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.921 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . 0.568 ' HG ' ' HB ' ' E' ' 277' ' ' ILE . 4.8 mp -123.58 109.72 14.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.387 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 166.82 -173.63 42.15 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.94 -0.648 . . . . 10.0 112.221 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -101.99 137.72 39.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.743 0.306 . . . . 10.0 110.739 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . 0.414 ' O ' ' HB3' ' E' ' 281' ' ' TYR . 38.4 t -93.13 123.99 45.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.481 -0.327 . . . . 10.0 110.424 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 24.5 t -121.67 106.61 18.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.979 0.419 . . . . 10.0 110.917 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . 0.631 ' HB ' ' HA2' ' E' ' 282' ' ' GLY . 8.9 t -68.43 164.73 20.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.845 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.16 -20.54 64.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.092 -0.503 . . . . 10.0 111.967 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -71.52 -19.96 62.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.443 -0.344 . . . . 10.0 110.429 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 59.26 -165.81 0.19 Allowed 'General case' 0 C--O 1.232 0.16 0 O-C-N 123.914 0.759 . . . . 10.0 111.649 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 7.3 tp -95.47 122.45 38.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.421 -0.354 . . . . 10.0 110.082 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -95.61 80.6 3.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.919 0.39 . . . . 10.0 111.354 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 112.57 161.57 15.44 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.687 -0.688 . . . . 10.0 112.094 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 73.43 73.32 0.9 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.912 -0.661 . . . . 10.0 112.015 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 4.3 mt -82.23 51.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.369 0.605 . . . . 10.0 111.045 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -169.04 84.75 0.15 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.158 -0.928 . . . . 10.0 109.022 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 4.2 pt -98.23 153.67 4.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.953 -0.567 . . . . 10.0 112.227 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.64 163.7 39.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.448 -0.796 . . . . 10.0 109.339 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -82.98 86.65 6.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.714 0.769 . . . . 10.0 110.709 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -66.21 -59.31 3.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.252 -0.885 . . . . 10.0 111.332 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 14.8 t -83.02 154.86 24.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.727 -0.67 . . . . 10.0 111.418 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . 0.633 ' HG1' ' N ' ' E' ' 225' ' ' ARG . 49.3 m -130.81 124.01 30.37 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.335 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -118.16 121.58 40.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.883 -0.599 . . . . 10.0 110.023 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 6.3 m -127.48 104.64 8.01 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.777 -0.453 . . . . 10.0 109.777 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' E' ' 228' ' ' ALA . 3.8 p -88.77 152.19 3.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 116.013 -0.54 . . . . 10.0 111.086 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 265' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' E' ' 229' ' ' LYS . 76.0 mm-40 -87.55 -82.9 0.21 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.966 -0.561 . . . . 10.0 111.44 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . 0.516 HG23 ' HB3' ' E' ' 230' ' ' ASP . 18.2 m -132.52 119.96 21.25 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.854 0.359 . . . . 10.0 111.558 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 23.8 t -112.07 111.53 36.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.535 -0.543 . . . . 10.0 109.535 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 18.4 t -113.28 120.51 63.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.307 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -139.46 137.92 8.89 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.67 -0.776 . . . . 10.0 112.158 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . 0.518 ' HG3' ' HB2' ' E' ' 234' ' ' GLU . 24.7 ttpp -142.71 112.93 7.15 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.354 -0.239 . . . . 10.0 110.354 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 111.65 84.14 1.4 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.861 -0.685 . . . . 10.0 112.355 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' E' ' 236' ' ' ARG . 3.5 mm-40 56.31 32.39 20.35 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.361 0.504 . . . . 10.0 112.361 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.3 152.17 38.58 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.002 -0.544 . . . . 10.0 111.449 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . 0.972 ' HG3' ' HD3' ' E' ' 238' ' ' ARG . 2.7 ttm180 -135.88 102.06 4.94 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.894 -0.594 . . . . 10.0 109.987 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 26.7 t -107.58 115.43 48.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.685 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . 0.79 ' HG ' ' HZ ' ' D' ' 286' ' ' PHE . 0.7 OUTLIER -125.35 113.58 17.76 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.416 -179.673 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . 0.568 ' HB ' ' HG ' ' E' ' 241' ' ' LEU . 46.5 mm -109.48 100.23 10.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.937 0.398 . . . . 10.0 110.653 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 164.28 -148.91 15.33 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.739 -0.664 . . . . 10.0 111.537 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 37.8 p30 -105.38 167.53 9.68 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.747 -0.266 . . . . 10.0 110.693 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . 1.032 ' HB2' ' HA ' ' E' ' 288' ' ' ASP . 0.5 OUTLIER -120.48 124.0 44.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.948 0.404 . . . . 10.0 111.397 -179.05 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . 0.414 ' HB3' ' O ' ' E' ' 244' ' ' VAL . 9.5 t80 -156.84 94.76 1.47 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.822 -0.626 . . . . 10.0 110.261 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . 0.631 ' HA2' ' HB ' ' E' ' 246' ' ' THR . . . -133.99 -81.08 0.16 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.288 -0.958 . . . . 10.0 112.695 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . 0.708 ' HA2' ' HB3' ' E' ' 290' ' ' HIS . . . 144.12 30.1 0.1 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.477 -0.868 . . . . 10.0 113.583 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . 0.591 ' HG3' ' OD1' ' E' ' 288' ' ' ASP . 6.0 pttp -125.88 -51.66 1.57 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.257 0.465 . . . . 10.0 112.257 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.17 30.03 2.01 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.086 -1.054 . . . . 10.0 113.408 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -147.11 97.98 2.96 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.997 -1.112 . . . . 10.0 107.997 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 73.09 24.66 2.45 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 107.919 -1.141 . . . . 10.0 107.919 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . 1.032 ' HA ' ' HB2' ' E' ' 280' ' ' GLU . 2.4 p-10 -170.37 161.42 8.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.035 -1.438 . . . . 10.0 109.375 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -139.31 161.94 36.21 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.914 -0.402 . . . . 10.0 109.914 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . 0.708 ' HB3' ' HA2' ' E' ' 283' ' ' GLY . 26.3 p-80 -152.82 167.72 28.11 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.155 -0.475 . . . . 10.0 111.133 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -74.51 -74.43 0.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.377 -0.374 . . . . 10.0 110.638 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . 0.564 ' HB2' ' CD2' ' E' ' 290' ' ' HIS . 26.8 t60 67.68 155.18 0.11 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.674 -0.694 . . . . 10.0 111.96 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -122.48 135.97 54.78 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.294 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -93.88 179.36 5.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.564 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 41.3 t60 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.064 -0.97 . . . . 10.0 109.787 -179.664 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' CGO . . . . . 0.854 ' OAU' ' HBT' ' B' ' 1' ' ' CGO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.621 0.248 . . . . 10.0 110.334 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -106.55 127.9 53.69 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.668 -0.494 . . . . 10.0 109.668 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 263' ' ' SER . 3.3 m -144.98 161.63 38.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.157 0.503 . . . . 10.0 111.572 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.5 158.61 44.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.049 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.553 ' HD3' ' HG3' ' A' ' 265' ' ' GLU . 7.4 tttm -108.81 -59.6 1.86 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.933 0.397 . . . . 10.0 111.34 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -143.23 127.61 17.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.939 0.399 . . . . 10.0 111.345 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 26.7 mt -131.1 131.13 63.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.851 0.357 . . . . 10.0 111.106 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.467 ' HG3' ' HA ' ' A' ' 268' ' ' VAL . 2.0 ptp85 -126.83 114.43 17.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.3 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.94 122.82 44.27 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.881 -0.6 . . . . 10.0 111.214 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -135.71 153.39 51.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.619 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 65.34 80.71 0.22 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.145 -0.934 . . . . 10.0 112.974 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 55.02 34.14 21.81 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.801 -0.636 . . . . 10.0 112.141 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -100.94 164.04 12.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.447 -0.342 . . . . 10.0 110.559 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -147.66 153.09 38.9 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.82 0.343 . . . . 10.0 111.161 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.76 128.6 67.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.219 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.452 ' HB3' HD22 ' A' ' 276' ' ' LEU . 37.0 tt0 -129.26 131.81 47.08 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.065 -0.346 . . . . 10.0 110.065 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.957 ' HG ' ' HB ' ' A' ' 277' ' ' ILE . 0.8 OUTLIER -124.97 142.46 51.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.549 -0.296 . . . . 10.0 110.783 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.38 -109.82 0.73 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.114 -0.565 . . . . 10.0 112.023 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -160.34 147.39 15.95 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.334 -0.617 . . . . 10.0 109.334 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 79.2 t -115.59 116.83 53.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.842 0.353 . . . . 10.0 111.204 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 16.8 t -110.5 112.98 42.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.965 -0.562 . . . . 10.0 109.586 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.416 ' HB ' ' HA2' ' A' ' 282' ' ' GLY . 6.0 m -89.89 151.06 21.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.274 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.01 -15.88 57.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.0 0.428 . . . . 10.0 111.661 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -73.2 -14.36 61.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.906 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -118.99 56.61 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.192 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.488 ' HB3' ' H ' ' A' ' 251' ' ' HIS . 3.3 mm? 64.72 -135.33 0.26 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.317 -0.856 . . . . 10.0 111.951 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.488 ' H ' ' HB3' ' A' ' 250' ' ' LEU . 52.8 p-80 -119.03 -175.45 2.91 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.309 -0.405 . . . . 10.0 110.434 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -75.02 70.92 1.75 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.199 -0.524 . . . . 10.0 112.667 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -65.96 -41.11 95.5 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.114 -0.565 . . . . 10.0 112.815 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 73.6 mt 73.97 141.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 122.946 0.498 . . . . 10.0 111.823 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 61.82 84.18 0.14 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.195 0.522 . . . . 10.0 111.768 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 45.3 mt -124.16 -42.84 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.309 -0.405 . . . . 10.0 110.773 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 6.2 p -125.19 -94.34 0.48 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.203 0.445 . . . . 10.0 112.203 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.1 t0 55.69 67.9 0.94 Allowed 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.653 0.596 . . . . 10.0 110.999 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -120.32 6.62 10.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.732 -0.667 . . . . 10.0 111.005 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.495 ' HG1' ' N ' ' B' ' 225' ' ' ARG . 5.2 t -142.93 142.31 31.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.027 0.441 . . . . 10.0 111.282 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.16 119.75 28.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.757 -0.831 . . . . 10.0 108.757 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.476 ' HB3' HD12 ' B' ' 241' ' ' LEU . 69.6 m-20 -113.73 117.22 30.9 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.606 -0.516 . . . . 10.0 109.606 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 227' ' ' SER . 19.0 m -145.72 137.15 24.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.897 0.379 . . . . 10.0 111.424 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.538 HG23 ' HB3' ' B' ' 228' ' ' ALA . 7.6 p -123.75 144.81 32.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.642 -0.503 . . . . 10.0 109.642 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.553 ' HG3' ' HD3' ' A' ' 229' ' ' LYS . 32.3 tt0 -84.96 -76.33 0.32 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 112.695 0.628 . . . . 10.0 112.695 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.95 125.63 54.6 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.452 0.538 . . . . 10.0 112.452 -177.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 35.9 t -122.37 122.13 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.079 -0.51 . . . . 10.0 110.004 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.467 ' HA ' ' HG3' ' A' ' 232' ' ' ARG . 21.5 t -114.49 118.05 57.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.395 -0.366 . . . . 10.0 110.797 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.14 119.7 4.63 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.019 -0.832 . . . . 10.0 111.019 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -128.9 103.16 6.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.331 0.493 . . . . 10.0 112.331 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 92.37 91.3 1.47 Allowed Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.766 -0.73 . . . . 10.0 114.628 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 58.3 24.85 12.02 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.949 0.722 . . . . 10.0 112.949 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 9.9 m -74.99 135.04 41.34 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.231 0.539 . . . . 10.0 111.666 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 8.2 mtt180 -117.41 106.48 13.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.662 -0.699 . . . . 10.0 109.431 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 41.7 t -92.23 118.32 37.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.382 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' A' ' 240' ' ' GLN . 0.9 OUTLIER -117.57 105.77 12.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.501 -179.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.957 ' HB ' ' HG ' ' A' ' 241' ' ' LEU . 22.7 mm -100.71 89.23 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.632 -0.507 . . . . 10.0 109.632 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 161.66 161.49 11.91 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.505 -0.77 . . . . 10.0 111.897 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -76.76 156.65 32.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.677 0.275 . . . . 10.0 110.759 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.08 152.71 35.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.213 -0.449 . . . . 10.0 110.908 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -137.96 93.11 2.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.521 -0.763 . . . . 10.0 109.718 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.416 ' HA2' ' HB ' ' A' ' 246' ' ' THR . . . -137.02 -93.75 0.34 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.447 -0.882 . . . . 10.0 112.842 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.444 ' HA2' ' HB ' ' B' ' 246' ' ' THR . . . 125.32 -66.85 0.53 Allowed Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.223 -0.751 . . . . 10.0 111.223 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -86.49 93.1 9.07 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.253 -0.647 . . . . 10.0 109.253 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.56 86.82 1.74 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.789 -0.924 . . . . 10.0 110.789 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -58.1 98.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.048 0.388 . . . . 10.0 112.048 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 4.0 t90 59.92 -79.37 0.02 OUTLIER 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.192 0.812 . . . . 10.0 113.192 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -141.39 74.78 1.47 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.317 -0.623 . . . . 10.0 109.317 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -151.78 132.69 14.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.952 -0.567 . . . . 10.0 111.493 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -151.62 97.56 2.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.987 -0.551 . . . . 10.0 109.739 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -113.54 128.86 56.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.912 -0.585 . . . . 10.0 111.187 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -115.38 -23.99 8.61 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.977 -0.556 . . . . 10.0 109.973 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -72.77 138.53 46.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.766 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -142.73 136.1 28.61 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.357 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.296 -0.859 . . . . 10.0 110.059 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.495 ' N ' ' HG1' ' A' ' 260' ' ' THR . 5.1 tmm_? . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 110.016 -0.364 . . . . 10.0 110.016 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.511 ' ND2' ' HA2' ' B' ' 278' ' ' GLY . 74.5 m-20 -123.4 116.53 23.41 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 123.413 0.445 . . . . 10.0 110.179 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . 0.642 ' HB2' ' CBP' ' B' ' 1' ' ' CGO . 0.0 OUTLIER -123.32 141.72 51.69 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.047 -0.524 . . . . 10.0 110.72 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.538 ' HB3' HG23 ' A' ' 264' ' ' VAL . . . -133.58 146.3 50.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.787 0.327 . . . . 10.0 111.823 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.746 ' HB2' ' HA ' ' B' ' 265' ' ' GLU . 6.0 mmtt -90.02 -79.98 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.837 0.68 . . . . 10.0 112.837 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.47 123.06 32.67 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.442 0.639 . . . . 10.0 112.094 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.478 HG23 ' HB ' ' B' ' 267' ' ' VAL . 48.6 mt -121.02 125.72 74.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.507 -0.77 . . . . 10.0 110.656 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' B' ' 232' ' ' ARG . 19.6 mtt180 -117.82 117.64 29.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.641 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 1.2 p -118.93 120.07 36.2 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.819 -0.628 . . . . 10.0 110.834 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -131.0 153.46 49.21 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.084 0.401 . . . . 10.0 112.084 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 64.31 72.71 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.387 0.884 . . . . 10.0 113.387 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 48.6 mtm-85 60.27 24.29 13.71 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.845 0.683 . . . . 10.0 112.845 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -86.58 147.14 26.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.837 0.351 . . . . 10.0 110.871 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -129.73 153.18 48.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.477 -0.329 . . . . 10.0 110.832 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.461 HG23 ' HB ' ' B' ' 275' ' ' VAL . 2.7 p -136.65 137.25 47.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.658 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -126.29 136.4 52.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.021 0.439 . . . . 10.0 110.741 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.476 HD12 ' HB3' ' A' ' 262' ' ' ASN . 0.2 OUTLIER -115.2 93.82 4.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.741 -0.663 . . . . 10.0 110.183 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 164.87 174.58 34.74 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.434 -0.889 . . . . 10.0 112.596 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -87.02 144.36 26.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.703 0.287 . . . . 10.0 110.973 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 48.3 t -102.96 111.26 32.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.523 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 48.3 t -117.76 109.39 27.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.078 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.444 ' HB ' ' HA2' ' A' ' 283' ' ' GLY . 43.1 p -84.27 171.89 12.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.011 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.23 -11.18 38.25 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.099 -0.5 . . . . 10.0 111.517 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -77.88 -21.48 51.23 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.198 0.523 . . . . 10.0 110.731 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -82.83 -7.83 59.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.786 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 40.1 tp -66.93 133.85 50.82 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.292 -0.633 . . . . 10.0 109.292 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 64.2 m80 66.11 26.56 10.65 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.457 0.473 . . . . 10.0 110.801 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -114.66 169.69 12.97 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.04 -0.6 . . . . 10.0 111.643 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -94.46 79.68 0.93 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.766 -0.73 . . . . 10.0 112.376 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 9.9 mt -79.42 63.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.007 0.432 . . . . 10.0 111.328 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' B' ' 255' ' ' ARG . 0.3 OUTLIER -168.05 78.22 0.15 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.179 0.514 . . . . 10.0 110.398 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . 0.411 HG22 ' HA3' ' C' ' 252' ' ' GLY . 22.6 pt -106.84 38.05 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.547 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 65.78 43.03 3.28 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.634 -0.712 . . . . 10.0 110.362 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -63.74 99.15 0.22 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.152 -0.931 . . . . 10.0 110.616 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -130.49 93.07 3.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.501 -0.772 . . . . 10.0 111.508 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . 0.637 ' HG1' ' N ' ' C' ' 225' ' ' ARG . 5.4 t -160.24 146.54 15.59 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.886 -0.597 . . . . 10.0 109.932 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.15 121.03 44.01 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.867 -0.606 . . . . 10.0 109.634 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -107.53 122.71 47.21 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.66 -0.496 . . . . 10.0 109.66 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' B' ' 227' ' ' SER . 65.8 m -146.53 129.99 16.8 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.946 0.403 . . . . 10.0 110.955 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 7.3 p -126.53 142.46 43.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.699 -0.682 . . . . 10.0 109.889 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . 0.746 ' HA ' ' HB2' ' B' ' 229' ' ' LYS . 18.3 mt-10 -87.27 -75.04 0.42 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.488 0.551 . . . . 10.0 112.488 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.6 m -108.46 124.65 50.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.41 0.522 . . . . 10.0 112.41 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.478 ' HB ' HG23 ' B' ' 231' ' ' ILE . 3.1 t -122.36 107.51 19.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.763 -0.653 . . . . 10.0 109.94 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.81 118.54 44.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.418 -0.355 . . . . 10.0 111.07 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.48 113.25 2.26 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.312 -0.715 . . . . 10.0 111.312 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -130.39 120.35 24.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.231 0.456 . . . . 10.0 112.231 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 95.5 69.17 1.03 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.618 -0.801 . . . . 10.0 113.412 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 56.86 27.16 12.55 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 112.797 0.665 . . . . 10.0 112.797 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 17.7 m -67.33 156.51 36.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.464 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -128.38 116.06 19.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.686 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.461 ' HB ' HG23 ' B' ' 239' ' ' VAL . 46.0 t -100.64 115.13 41.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.914 -0.584 . . . . 10.0 109.683 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.546 ' HB2' ' CZ2' ' B' ' 287' ' ' TRP . 0.2 OUTLIER -113.17 112.66 24.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.399 -0.364 . . . . 10.0 110.515 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.429 HG22 ' HB3' ' B' ' 226' ' ' ASN . 28.1 mm -105.42 89.05 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.217 0.532 . . . . 10.0 109.659 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . 0.511 ' HA2' ' ND2' ' B' ' 226' ' ' ASN . . . 159.93 175.06 30.49 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.594 -0.73 . . . . 10.0 111.603 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' C' ' 243' ' ' ASN . 16.3 p-10 -93.74 164.87 12.97 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.364 -0.235 . . . . 10.0 110.364 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.1 157.93 36.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.8 0.334 . . . . 10.0 111.317 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.7 71.69 1.36 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.395 -0.82 . . . . 10.0 108.888 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -97.19 -87.99 1.85 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.015 -0.612 . . . . 10.0 112.975 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 113.84 -49.1 0.87 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.765 -0.731 . . . . 10.0 111.861 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -87.71 20.52 2.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.268 0.556 . . . . 10.0 110.45 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 171.57 174.38 39.16 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.493 -1.043 . . . . 10.0 110.493 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -122.57 76.36 1.33 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.028 -0.73 . . . . 10.0 109.028 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.555 ' CH2' ' HB2' ' C' ' 238' ' ' ARG . 15.6 t90 69.82 -59.52 0.5 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.311 -0.859 . . . . 10.0 111.641 -178.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -118.51 -172.48 2.28 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.769 -0.826 . . . . 10.0 108.769 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -101.52 126.69 48.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.224 0.535 . . . . 10.0 112.02 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -155.21 124.95 6.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.894 -0.594 . . . . 10.0 109.923 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . 0.609 ' HA ' ' OD1' ' C' ' 289' ' ' ASN . 30.7 t60 -159.74 137.09 9.68 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.519 -0.549 . . . . 10.0 109.519 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -148.42 -167.8 2.91 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 123.148 0.28 . . . . 10.0 110.421 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -104.46 143.15 33.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.784 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -95.19 -173.1 2.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.744 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 4.2 t60 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.905 -1.045 . . . . 10.0 109.178 179.285 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . 0.637 ' N ' ' HG1' ' B' ' 260' ' ' THR . 25.4 ttt180 . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 110.253 -0.277 . . . . 10.0 110.253 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . 0.407 ' HB3' HG22 ' C' ' 277' ' ' ILE . 16.1 m120 -127.8 102.9 7.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.015 -0.538 . . . . 10.0 109.812 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.04 133.55 48.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.843 -0.617 . . . . 10.0 111.808 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.438 ' HB1' HD11 ' C' ' 231' ' ' ILE . . . -128.96 129.9 46.03 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.22 -0.659 . . . . 10.0 109.22 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 5.3 tmtm? -87.55 -81.75 0.23 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.087 0.403 . . . . 10.0 112.087 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -119.06 119.12 33.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.091 0.472 . . . . 10.0 111.872 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.438 HD11 ' HB1' ' C' ' 228' ' ' ALA . 59.3 mt -122.4 133.19 69.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.171 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.522 ' HD3' ' OE1' ' C' ' 234' ' ' GLU . 21.9 ttm-85 -122.97 118.83 28.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.087 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.73 101.54 7.52 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.352 -0.386 . . . . 10.0 110.634 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . 0.522 ' OE1' ' HD3' ' C' ' 232' ' ' ARG . 8.0 pt-20 -120.44 156.56 31.19 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.99 0.367 . . . . 10.0 111.99 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . 0.473 ' OE2' ' HG3' ' C' ' 270' ' ' LYS . 42.5 mt-10 68.86 68.75 0.28 Allowed 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.966 0.791 . . . . 10.0 111.946 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 57.58 33.18 22.92 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.453 -0.794 . . . . 10.0 112.603 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.29 149.15 22.47 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.864 0.364 . . . . 10.0 110.091 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . 0.555 ' HB2' ' CH2' ' B' ' 287' ' ' TRP . 0.3 OUTLIER -133.19 140.75 47.73 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.327 -0.397 . . . . 10.0 110.831 -179.515 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.618 HG23 ' HB ' ' C' ' 275' ' ' VAL . 4.5 p -127.53 138.86 53.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.252 -0.431 . . . . 10.0 111.011 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -123.7 123.94 41.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.974 0.416 . . . . 10.0 110.55 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -103.23 86.72 2.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.353 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.37 -177.78 42.82 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.553 -0.832 . . . . 10.0 112.707 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' B' ' 279' ' ' ASN . 2.4 p30 -93.63 151.14 19.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.667 0.27 . . . . 10.0 110.577 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 45.9 t -109.0 111.11 34.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.774 0.321 . . . . 10.0 110.617 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 23.7 t -113.94 110.76 33.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.178 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 21.3 p -75.75 161.74 28.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.854 0.359 . . . . 10.0 110.974 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.44 12.78 0.55 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.159 -0.473 . . . . 10.0 112.211 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -109.42 -6.7 15.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.159 0.504 . . . . 10.0 110.135 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -99.72 89.57 4.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.749 -0.659 . . . . 10.0 110.85 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 3.2 mp -118.41 7.08 11.85 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.869 -0.605 . . . . 10.0 111.337 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -93.84 80.66 4.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.217 0.532 . . . . 10.0 109.778 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . 0.411 ' HA3' HG22 ' B' ' 256' ' ' ILE . . . -123.65 148.54 16.78 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.438 -0.887 . . . . 10.0 113.188 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -140.77 127.15 3.34 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.118 -1.193 . . . . 10.0 110.118 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 11.9 tt -65.15 109.13 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.395 0.617 . . . . 10.0 112.155 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 -164.5 122.33 1.71 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.482 -0.781 . . . . 10.0 110.574 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 19.1 tt -96.35 137.53 23.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.213 0.53 . . . . 10.0 111.281 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . 0.551 ' HB2' ' HD3' ' D' ' 255' ' ' ARG . 14.2 m -156.21 -169.6 3.1 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.621 -0.881 . . . . 10.0 108.621 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . 0.725 ' HB3' ' HB3' ' D' ' 257' ' ' SER . 0.8 OUTLIER -71.96 163.49 27.77 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.384 -0.228 . . . . 10.0 110.384 179.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -153.4 159.45 42.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.744 0.307 . . . . 10.0 111.113 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.17 113.72 15.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.681 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . 0.602 HG22 ' HB3' ' C' ' 225' ' ' ARG . 0.3 OUTLIER -82.78 143.69 30.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.308 -0.405 . . . . 10.0 110.749 179.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -141.84 132.52 25.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.892 0.377 . . . . 10.0 110.683 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 16.7 m -140.97 136.85 32.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.224 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' D' ' 228' ' ' ALA . 10.3 p -122.81 137.21 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 120.877 0.37 . . . . 10.0 111.145 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 47.7 mt-10 -79.22 -73.19 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.533 0.568 . . . . 10.0 112.533 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 1.3 m -120.67 123.79 43.63 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.899 0.703 . . . . 10.0 112.899 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.436 ' HB ' HG23 ' C' ' 231' ' ' ILE . 2.8 t -121.06 116.63 50.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.248 -0.649 . . . . 10.0 109.248 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . 0.431 ' HB ' ' HG2' ' D' ' 232' ' ' ARG . 59.9 t -114.08 117.15 54.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.898 0.38 . . . . 10.0 111.357 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' D' ' 233' ' ' THR . . . -116.09 126.02 6.89 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.762 -0.935 . . . . 10.0 110.762 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . 0.473 ' HG3' ' OE2' ' C' ' 235' ' ' GLU . 20.5 ttmm -133.43 125.43 29.02 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.912 0.338 . . . . 10.0 111.912 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . 0.46 ' H ' ' HB2' ' C' ' 235' ' ' GLU . . . 80.67 86.87 0.62 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 121.281 -0.485 . . . . 10.0 113.822 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 51.1 37.53 18.33 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.283 0.563 . . . . 10.0 111.699 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 8.0 t -78.29 163.28 25.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.698 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -143.53 121.64 12.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.791 -0.641 . . . . 10.0 110.457 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.618 ' HB ' HG23 ' C' ' 239' ' ' VAL . 33.8 t -111.35 116.56 52.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.152 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' C' ' 276' ' ' LEU . 0.4 OUTLIER -108.03 109.89 21.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.095 0.474 . . . . 10.0 110.472 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.407 HG22 ' HB3' ' C' ' 226' ' ' ASN . 27.1 mm -105.89 91.21 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.409 -0.36 . . . . 10.0 110.448 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 157.66 -174.09 35.05 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.664 -0.779 . . . . 10.0 111.476 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -97.67 149.11 22.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.873 0.336 . . . . 10.0 110.59 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -116.08 142.66 46.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.864 0.364 . . . . 10.0 111.64 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . 0.552 ' HA ' ' O ' ' D' ' 245' ' ' VAL . 0.4 OUTLIER -124.04 96.39 4.92 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.633 -0.876 . . . . 10.0 108.633 178.583 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . -111.18 166.34 12.26 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.848 -0.692 . . . . 10.0 112.935 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -116.51 -51.51 0.38 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.776 -0.726 . . . . 10.0 112.386 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -75.58 -40.82 56.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.434 0.635 . . . . 10.0 109.725 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -165.2 -159.24 11.22 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.715 -0.954 . . . . 10.0 110.715 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -84.11 -173.02 4.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.65 0.225 . . . . 10.0 111.07 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 13.7 t90 -55.0 -33.29 62.44 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.185 0.517 . . . . 10.0 111.386 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -102.28 150.54 23.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.244 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . 0.609 ' OD1' ' HA ' ' B' ' 291' ' ' HIS . 4.8 p30 -131.56 54.1 1.95 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.556 0.693 . . . . 10.0 110.38 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -109.37 -18.84 13.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.434 -0.803 . . . . 10.0 111.348 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . 0.444 ' HB3' ' OD1' ' D' ' 288' ' ' ASP . 25.3 m80 -138.05 160.17 40.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.588 -0.278 . . . . 10.0 111.113 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 5.0 m170 68.73 175.05 0.28 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.857 0.688 . . . . 10.0 112.857 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -158.74 -85.46 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.168 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -114.8 -71.67 0.73 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.48 -0.327 . . . . 10.0 110.668 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.361 -0.828 . . . . 10.0 110.045 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . 0.555 ' HG2' HG23 ' D' ' 261' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 121.589 0.709 . . . . 10.0 109.466 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -101.84 135.6 43.1 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.461 -0.79 . . . . 10.0 109.535 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . 0.643 ' HB3' ' NAV' ' B' ' 1' ' ' CGO . 29.0 m -137.9 124.5 20.9 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.745 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' C' ' 264' ' ' VAL . . . -116.83 127.72 54.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.159 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' D' ' 265' ' ' GLU . 30.7 ttmt -86.25 -73.85 0.44 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.347 0.499 . . . . 10.0 112.347 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -120.36 114.78 22.35 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.643 0.238 . . . . 10.0 111.643 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 54.1 mt -122.94 112.7 34.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.808 -0.441 . . . . 10.0 109.808 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . 0.431 ' HG2' ' HB ' ' C' ' 268' ' ' VAL . 36.5 mtm180 -113.44 114.79 27.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.385 -0.371 . . . . 10.0 110.446 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . 0.432 ' O ' ' HA2' ' C' ' 269' ' ' GLY . 0.9 OUTLIER -123.71 113.07 18.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.272 -0.422 . . . . 10.0 111.781 -179.116 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -128.65 169.97 13.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.985 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 67.72 63.4 0.41 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.065 -0.516 . . . . 10.0 111.658 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 60.2 19.69 9.07 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.451 -0.795 . . . . 10.0 112.659 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' D' ' 233' ' ' THR . . . -71.3 165.45 23.68 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.006 0.373 . . . . 10.0 112.006 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . 0.411 ' HG2' ' HG2' ' D' ' 274' ' ' ARG . 0.1 OUTLIER -147.85 143.56 27.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.148 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . 0.684 HG23 ' HB ' ' D' ' 275' ' ' VAL . 4.9 p -137.64 141.72 38.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.47 -0.332 . . . . 10.0 111.459 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . 0.531 ' HB3' HD22 ' D' ' 276' ' ' LEU . 0.1 OUTLIER -124.93 134.79 52.51 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.313 -0.403 . . . . 10.0 110.783 179.173 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . 0.618 HD13 ' HB ' ' D' ' 277' ' ' ILE . 4.0 mm? -118.11 96.11 5.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.949 -0.569 . . . . 10.0 110.394 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 170.81 -105.63 0.22 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.504 -0.855 . . . . 10.0 112.822 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -166.64 158.17 12.97 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.095 -0.335 . . . . 10.0 110.095 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 26.2 t -110.85 108.12 24.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.928 0.394 . . . . 10.0 111.594 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' C' ' 281' ' ' TYR . 28.6 t -107.47 123.44 62.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.558 -0.904 . . . . 10.0 108.558 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . 0.533 ' OG1' ' HA3' ' D' ' 282' ' ' GLY . 34.7 p -104.58 157.83 16.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.89 0.376 . . . . 10.0 111.802 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -73.44 9.28 1.4 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.806 -0.634 . . . . 10.0 111.298 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -95.9 -6.13 39.91 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.067 -0.716 . . . . 10.0 109.067 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -105.64 113.51 27.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.509 -0.769 . . . . 10.0 109.923 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 87.8 mt -90.39 -175.16 4.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.137 -0.483 . . . . 10.0 111.026 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -78.06 72.2 4.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.207 0.527 . . . . 10.0 111.192 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -145.04 59.63 0.5 Allowed Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.305 -0.718 . . . . 10.0 111.305 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 88.46 41.67 6.04 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 110.957 -0.857 . . . . 10.0 110.957 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 20.3 tt -84.05 -27.25 7.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.122 0.487 . . . . 10.0 110.707 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . 0.551 ' HD3' ' HB2' ' C' ' 257' ' ' SER . 57.8 mtt-85 -78.73 77.71 5.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.767 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 19.7 tt -64.89 -19.63 25.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.485 . . . . 10.0 111.274 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . 0.725 ' HB3' ' HB3' ' C' ' 258' ' ' ASP . 7.5 m 64.94 -134.54 0.24 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.495 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . 0.447 ' OD2' ' HD2' ' D' ' 225' ' ' ARG . 13.1 t70 -118.82 112.28 19.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.143 -0.317 . . . . 10.0 110.143 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -110.85 -79.43 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.862 0.319 . . . . 10.0 111.862 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 15.3 t -90.34 157.35 17.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.143 0.496 . . . . 10.0 111.894 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . 0.555 HG23 ' HG2' ' D' ' 225' ' ' ARG . 55.9 m -108.64 111.97 24.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.421 -0.809 . . . . 10.0 109.512 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . 0.501 ' HB3' HD23 ' E' ' 241' ' ' LEU . 18.3 m120 -103.08 109.38 20.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.854 0.359 . . . . 10.0 110.255 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 16.4 m -119.29 123.27 43.82 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.273 -0.422 . . . . 10.0 110.506 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . 0.559 ' C ' ' HAK' ' B' ' 1' ' ' CGO . 8.8 p -125.42 129.93 72.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.605 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 265' ' ' GLU . . . . . 0.573 ' HG2' ' HAF' ' B' ' 1' ' ' CGO . 3.3 mt-10 -87.5 -73.96 0.46 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.371 0.878 . . . . 10.0 113.371 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 7.4 m -102.48 122.1 43.66 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.652 0.612 . . . . 10.0 112.652 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.35 117.72 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.199 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 33.0 t -114.25 128.02 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.024 0.44 . . . . 10.0 111.352 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' E' ' 233' ' ' THR . . . -132.84 109.5 0.84 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.834 -0.621 . . . . 10.0 111.971 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -125.92 106.73 9.85 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.814 0.301 . . . . 10.0 111.814 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 97.84 88.92 1.9 Allowed Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.834 -0.698 . . . . 10.0 114.353 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 54.24 25.43 5.8 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.338 0.866 . . . . 10.0 113.338 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' E' ' 237' ' ' ALA . 18.9 m -74.75 142.98 44.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.104 0.478 . . . . 10.0 110.998 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . 0.411 ' HG2' ' HG2' ' D' ' 238' ' ' ARG . 26.5 mtm180 -128.32 116.47 19.86 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.756 -0.656 . . . . 10.0 110.83 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . 0.684 ' HB ' HG23 ' D' ' 239' ' ' VAL . 23.9 t -101.81 122.76 54.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.705 -0.679 . . . . 10.0 110.173 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' D' ' 240' ' ' GLN . 0.3 OUTLIER -120.81 101.83 7.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.145 0.498 . . . . 10.0 110.658 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . 0.618 ' HB ' HD13 ' D' ' 241' ' ' LEU . 41.7 mm -100.97 104.24 15.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.239 -0.652 . . . . 10.0 109.239 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . 0.554 ' O ' ' HA3' ' E' ' 242' ' ' GLY . . . 154.34 -161.32 30.04 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.892 -0.883 . . . . 10.0 110.892 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -120.86 156.94 30.89 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.232 0.516 . . . . 10.0 111.355 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -114.57 131.58 56.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.661 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -129.18 116.37 19.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.18 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . 0.533 ' HA3' ' OG1' ' D' ' 246' ' ' THR . . . 160.27 177.5 33.42 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.182 -1.008 . . . . 10.0 113.46 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -100.74 44.12 1.63 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.974 -0.632 . . . . 10.0 112.709 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -91.18 -18.81 23.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.128 0.489 . . . . 10.0 110.217 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' D' ' 286' ' ' PHE . . . 99.91 -32.83 6.81 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.643 -0.708 . . . . 10.0 112.419 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' D' ' 285' ' ' GLY . 3.9 t80 170.13 147.59 0.03 OUTLIER 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.022 -0.733 . . . . 10.0 109.022 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 35.4 t90 -52.5 -67.28 0.26 Allowed 'General case' 0 C--O 1.233 0.23 0 O-C-N 123.558 0.536 . . . . 10.0 109.821 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . 0.473 ' OD2' ' HD3' ' E' ' 238' ' ' ARG . 26.8 t0 -150.35 144.77 25.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.088 0.471 . . . . 10.0 111.785 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -163.56 141.89 7.79 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.139 -1.06 . . . . 10.0 108.139 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . 0.5 ' HD2' ' HD2' ' D' ' 291' ' ' HIS . 14.5 t60 -63.64 -33.83 76.49 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.073 0.768 . . . . 10.0 113.073 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . 0.5 ' HD2' ' HD2' ' D' ' 290' ' ' HIS . 24.9 p80 -166.82 -172.22 2.04 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.984 0.364 . . . . 10.0 111.984 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -99.43 -154.13 0.46 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.654 -0.869 . . . . 10.0 108.654 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -71.34 121.88 19.3 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.047 -0.353 . . . . 10.0 110.047 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -98.38 127.52 44.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.405 -0.361 . . . . 10.0 110.28 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.326 -0.845 . . . . 10.0 110.069 179.758 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . 0.603 ' N ' ' HG1' ' E' ' 261' ' ' THR . 79.1 mtt180 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.355 0.121 . . . . 10.0 110.93 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . 0.568 HD22 ' HB2' ' E' ' 262' ' ' ASN . 23.7 m120 -135.35 121.67 20.38 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.99 0.424 . . . . 10.0 110.805 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.69 128.62 52.04 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.777 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.3 118.21 22.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' E' ' 265' ' ' GLU . 30.2 mmmt -82.09 -68.49 0.69 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.273 0.472 . . . . 10.0 112.273 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . 0.463 ' HB3' HG23 ' E' ' 266' ' ' THR . 8.3 t70 -124.87 125.25 43.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.653 0.263 . . . . 10.0 111.33 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 79.2 mt -128.02 118.35 48.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.023 -0.535 . . . . 10.0 110.82 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -115.39 105.36 12.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.423 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . 0.426 HG22 ' HB1' ' E' ' 237' ' ' ALA . 0.3 OUTLIER -118.06 104.81 11.22 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.78 -0.645 . . . . 10.0 110.111 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . 0.584 ' HB2' ' HG2' ' E' ' 270' ' ' LYS . 36.0 mt-10 -123.26 149.02 45.28 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.246 0.461 . . . . 10.0 112.246 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 64.08 86.94 0.12 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 114.036 1.124 . . . . 10.0 114.036 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 56.45 29.36 15.17 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.603 -0.726 . . . . 10.0 112.712 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . 0.454 ' HB1' ' HB3' ' E' ' 273' ' ' SER . . . -91.9 155.94 17.82 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.912 -0.585 . . . . 10.0 111.336 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . 0.473 ' HD3' ' OD2' ' D' ' 288' ' ' ASP . 0.4 OUTLIER -136.82 147.19 46.44 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.081 179.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . 0.403 HG13 ' HA ' ' D' ' 275' ' ' VAL . 1.6 p -133.01 125.48 51.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.409 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . 0.433 HE21 HD12 ' D' ' 276' ' ' LEU . 8.4 tm0? -118.66 128.49 54.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.156 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . 0.61 ' HG ' ' HB ' ' E' ' 277' ' ' ILE . 0.1 OUTLIER -123.4 92.94 3.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.538 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . 0.573 ' O ' ' HA3' ' E' ' 278' ' ' GLY . . . 170.51 -161.9 34.93 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.681 -0.771 . . . . 10.0 112.274 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . 0.489 HD22 HG23 ' E' ' 245' ' ' VAL . 2.7 p-10 -107.26 147.96 29.55 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.809 0.338 . . . . 10.0 110.6 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 63.3 t -108.32 118.52 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.04 -0.527 . . . . 10.0 109.768 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . 0.489 HG23 HD22 ' E' ' 243' ' ' ASN . 39.9 t -118.41 112.46 38.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.001 0.429 . . . . 10.0 111.701 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . 0.864 ' HB ' ' HA2' ' E' ' 282' ' ' GLY . 7.9 t -69.69 167.23 17.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.504 -0.771 . . . . 10.0 110.749 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.46 -17.33 62.6 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.336 -0.393 . . . . 10.0 111.554 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -67.66 -24.76 65.47 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.406 -0.361 . . . . 10.0 110.766 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 57.01 -163.04 0.18 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.572 -0.74 . . . . 10.0 112.46 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 29.7 mt -89.94 125.13 35.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.856 -0.611 . . . . 10.0 109.847 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -83.65 32.44 0.47 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 10.0 112.045 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 134.22 161.4 9.57 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.833 -0.699 . . . . 10.0 112.381 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 83.89 95.72 0.63 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.143 -0.551 . . . . 10.0 112.507 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 20.2 pt -81.34 -12.72 12.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.981 0.42 . . . . 10.0 111.537 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.01 90.61 8.41 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.697 -0.483 . . . . 10.0 109.697 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 3.1 pt -113.54 92.92 2.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.943 0.72 . . . . 10.0 112.943 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 69.5 m -118.06 139.05 51.79 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -69.03 136.69 52.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.889 0.376 . . . . 10.0 111.194 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -117.93 -48.48 2.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.132 -0.486 . . . . 10.0 110.526 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 4.8 t -78.03 149.8 33.94 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.011 -0.541 . . . . 10.0 110.256 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . 0.603 ' HG1' ' N ' ' E' ' 225' ' ' ARG . 55.8 m -127.58 113.18 15.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.306 0.574 . . . . 10.0 111.564 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . 0.568 ' HB2' HD22 ' E' ' 226' ' ' ASN . 7.6 m120 -94.86 102.09 13.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.615 -0.72 . . . . 10.0 109.683 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 10.9 m -114.51 120.11 39.12 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.777 0.322 . . . . 10.0 110.455 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.1 p -114.74 144.5 22.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.229 -0.442 . . . . 10.0 111.169 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 265' ' ' GLU . . . . . 0.535 ' O ' ' HB2' ' E' ' 229' ' ' LYS . 8.1 mm-40 -86.27 -79.28 0.26 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 10.0 111.892 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . 0.463 HG23 ' HB3' ' E' ' 230' ' ' ASP . 3.6 m -122.16 119.73 32.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.984 0.421 . . . . 10.0 111.797 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 2.7 t -113.53 105.94 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.042 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.18 125.88 68.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 110.01 -0.367 . . . . 10.0 110.01 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -149.83 136.83 5.89 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.702 -0.761 . . . . 10.0 112.123 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . 0.584 ' HG2' ' HB2' ' E' ' 234' ' ' GLU . 6.3 mttt -133.64 151.41 51.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.6 0.238 . . . . 10.0 110.837 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 76.3 76.33 0.82 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.086 -0.578 . . . . 10.0 112.513 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 61.32 42.03 12.34 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.998 0.428 . . . . 10.0 111.707 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . 0.454 ' HB3' ' HB1' ' E' ' 237' ' ' ALA . 9.6 t -64.95 155.04 35.75 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.604 -0.726 . . . . 10.0 111.715 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -136.65 101.68 4.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.351 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 65.7 t -101.45 119.61 49.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.787 0.327 . . . . 10.0 110.182 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.92 114.92 19.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.351 -0.386 . . . . 10.0 110.762 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . 0.61 ' HB ' ' HG ' ' E' ' 241' ' ' LEU . 17.2 mm -117.9 84.38 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.799 -0.445 . . . . 10.0 109.799 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . 0.573 ' HA3' ' O ' ' E' ' 242' ' ' GLY . . . 178.9 -147.31 7.71 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.494 -0.86 . . . . 10.0 112.485 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.89 146.34 42.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.766 0.317 . . . . 10.0 110.694 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . 0.844 ' HB2' ' HA ' ' E' ' 288' ' ' ASP . 3.0 pt-20 -107.82 115.27 29.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.108 0.48 . . . . 10.0 111.156 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -142.8 91.8 2.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.002 -0.544 . . . . 10.0 110.037 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . 0.864 ' HA2' ' HB ' ' E' ' 246' ' ' THR . . . -147.86 -95.83 0.16 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.469 -0.872 . . . . 10.0 112.932 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . 0.951 ' HA2' ' HB3' ' E' ' 290' ' ' HIS . . . -168.48 -104.71 0.18 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.877 -0.889 . . . . 10.0 110.877 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? 26.24 -85.28 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.396 1.628 . . . . 10.0 115.396 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.96 32.32 0.36 Allowed Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.549 -1.02 . . . . 10.0 110.549 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -161.33 105.51 1.3 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.822 -0.807 . . . . 10.0 108.822 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 75.15 10.7 3.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.896 0.855 . . . . 10.0 109.257 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . 0.844 ' HA ' ' HB2' ' E' ' 280' ' ' GLU . 16.8 p-10 -159.83 154.54 24.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.196 -1.366 . . . . 10.0 109.325 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.85 161.86 28.04 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.065 0.394 . . . . 10.0 112.065 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . 0.951 ' HB3' ' HA2' ' E' ' 283' ' ' GLY . 20.3 p-80 -164.48 167.76 19.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.607 -0.724 . . . . 10.0 109.895 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -106.26 -54.77 2.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.686 0.279 . . . . 10.0 110.679 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . 0.521 ' HB2' ' CD2' ' E' ' 290' ' ' HIS . 4.9 t-80 63.28 -164.31 0.25 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.705 -0.679 . . . . 10.0 111.153 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -128.0 125.26 39.07 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.693 -0.484 . . . . 10.0 109.693 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -90.45 133.18 35.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.785 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.09 -0.957 . . . . 10.0 109.714 -179.948 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' CGO . . . . . 0.918 ' OBE' ' HBT' ' B' ' 1' ' ' CGO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_